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This dissertation aimed to understand formal and informal ayurvedic knowledge and practice through 
the framework of commodification, in the context of the recent emergence of global ayurvedic tourism 
in Kerala, India. The objective was to understand how commodification, both old and new, have 
affected knowledges and livelihoods of  actors constituting the ayurvedic commodity chain, with a 
focus on ‘social lives’ of ayurvedic pharmaceuticals and select herb-ingredients. I argue that the 
trajectory of commodification in Kerala provides a stark contrast to the national mainstream with its 
focus on classical vis-à-vis proprietary medicines. This therapy-centric business model maintained the 
integrity of traditional ayurvedic practice by keeping the ayurvedic doctor within the loop. I suggest 
that the new wave of multi-faceted tourism-inspired commodification draws on this strength. This in 
turn has created a paradigmatic shift in the way ayurveda is commodified locally and globally, by 
switching focus from ‘pharmaceuticals’ to ‘services’, and ‘illness’ to ‘wellness’. 
 
I suggest that conceptualizing classical medicines as ‘open-source commodities’, brings attention to the 
significance of background knowledge processes. While distinct stakeholder characteristics and historic 
State patronage are significant factors, at the root of the commercial viability of open-source-
ayurveda, I argue, is the continuity of a cultural practice, the robustness of it I attribute to its 
historical evolution in Kerala as a mass commodity in contrast to its elitist status elsewhere. However, 
industrialization threatens the traditional role of knowledge-intensive actors: doctors, consumers, raw 
drug shops and medicinal plant collectors. I argue that the industry’s role is contributory rather than 
causal; more significant in endangering ayurvedic metis are effects of modern institutionalization 
shaped by goals of homogenization and scientization. Discussing the nature of deskilling each node has 
undergone, I demonstrate the significance of ‘cultural stakes’ in the conservation of common property 
resources that are more often that not at loggerheads with ‘economic stakes’.  
 
The arguments in this dissertation are built over and contribute to three bodies of anthropological 
research: economic anthropology engaged in the study of commodities and commodification processes, 
ecological anthropology concerned with conservation of common property resources, and medical 
anthropology concerned with study of medical systems and pharmaceuticals.  
 1 
 
CH 1 INTRODUCTION 
 
The weather was unbearably sultry and rains were continuing to play truant for the second 
month of the monsoon season. I was trying to locate a bench to wait for my turn to be called in, after 
handing over my visiting card to the attendant at the door of a government officer in Trivandrum, 
Kerala. Before I could find a seat,  I was summoned inside. I was pleasantly surprised; I had heard some 
voices inside the office, and  had assumed that it might take a while. Typically, waiting in government 
offices in India whether you come with an appointment or otherwise can take hours. “Yes! What do you 
want?” without asking me to sit, the official asked, looking at the visiting card rather than at me in a 
typical Indian government office style. The office was more like a large sprawling hall than a room, the 
space and the large table obviously designed to signify the rank of the officer and to intimidate less 
privileged visitors like me. Two other visitors seated in front of him stared at me curiously. Hiding my 
discomfort at the incivility, I hesitantly proceeded with my introduction. Hardly had I uttered the word 
medicinal plants, he rudely interrupted me,  “You people from America come here and take our 
knowledge away and then patent it!” I had not seen that coming. Not someone known for my presence 
of mind, I was at a loss of words. Thankfully, to my relief he continued, “Anyway, let me see what I 
can do. Please come after half an hour, I have some work to attend at the moment”. I walked out 
dazed, wondering whether I should take the trouble of going back at all. Besides the fact he was rude 
it did not feel good to be downright implicated as being part of the international biopiracy racket. I 
wondered if he would react that way if I did not ‘look’ native and consequently less powerful.  A small 
inner voice cultivated as a journalism student pulled me back, reminding me that the ‘scoop’ always 
lay in uncomfortable, if not dangerous corners. I should not take it personally, I told myself. On second 
thoughts, he was probably justified in being apprehensive, given the history of cases like turmeric 
where scientists of Indian origin were responsible for filing American patents on what is household 
knowledge in India. After all, wasn’t this something I was already expecting before entering the field? 
 This was the second month of my pilot field work in India. I was doing exploratory leg work to 
identify specific issues within the larger framework of indigenous knowledge of medicine and medicinal 
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plants. I was visiting some of the government departments connected to the Indian medicine systems, 
pharmacognosy, forestry and related offices in Trivandrum, the capital city of Kerala.  A few months 
before heading to the field for my pilot study I had come across a news piece on a bizarre anecdote: a 
European student studying tribal medicine in Kerala had been apprehended as a foreign intelligence 
agent. It began with an incident of local people accusing her of stealing tribal knowledge. When 
officials came to investigate her belongings, they saw the CIA fact sheet on India, and lo and behold, 
the case was nailed! Kerala, the Marxist capital of India, obviously had to be a place hypersensitive 
about issues of biopiracy and especially suspicious of America, the country spearheading global 
capitalism. Over the last two decades, Kerala had also grown to become the global capital of Ayurveda, 
which had made the State hyper-aware of the revenue potential and consequently, of the vulnerability 
of indigenous knowledges. In fact, Kerala was the first State in India to pass an Intellectual Property 
Rights Bill in 2008, courting controversy for legislating on a Central subject outside its jurisdiction.  
When I went back after half an hour the official was surprisingly composed; there was no trace 
of the previous outburst. I wondered if it was the audience that had inspired his performance. Probably 
the large room and table were not symbolic enough to represent his power. Its dusty, commonplace 
appearance might have lost its former esteem amongst the swanky interiors of today’s ultra-modern 
offices. Hence the power had to be demonstrated in other ways. What better way than having the 
gumption to tell off someone coming from a superpower nation? This time, he listened patiently as I 
explained my intentions. What seemed to put him to total ease was the information that I was a social 
scientist. Poor social scientist, ignorant of the complexity of botanical and chemical knowledge that 
the little plants concealed in them. He had in fact plenty to say, much of it reveling in the pride of 
India, and especially Kerala being the sole place in the world sought out for its medicinal knowledge. 
“You know, people from all over the world are coming here. Why do you think? This is the only country 
in the world with such rich plant diversity”. He was telling this to me, a representative of all outsiders 
purportedly in awe of Kerala’s botanical wealth. In the next three years, I was to hear such statements 
repeated often at various meeting and public forums. Global attention had turned a self-contained 
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culture into a self-conscious culture. Two decades ago, Ayurveda in Kerala targeted only Keralites.1 
Everywhere the Keralites went, Kerala ayurvedic products followed them, be it Bombay or Dubai, 
Singapore or UK. In fact, one of the top priorities of Malayalee2 associations outside the State was to 
run a Kerala Ayurvedic medicine outlet, invariably equipped with a Malayalee doctor. As a result, 
Ayurvedic products from Kerala already had a national and global presence, though the patrons until 
recently was mostly limited to the Kerala diaspora. In India, Keralites have been historically famous 
and infamous for their mobility. The story of a Keralite running a tea-shop on the moon when Neil 
Armstrong landed there is a household joke in India. So big is the Diaspora that expatriate remittances 
constitute a quarter of the state’s GDP. Kerala has been historically famous for its model of 
development, for achieving development indicators equivalent to developed nations (Frank and Chasin 
1990). But poor industrialization combined with a highly educated workforce has created an 
environment conducive for labor migration3. Kerala’s high population density more than double the 
national average (819/sq.km Vs 325/sq.km), consequently high pressure on land resources, has also 
been an important factor in driving labor migration. Bulk of the State’s manpower exports constitutes 
of low-skill labor to gulf countries, and nursing practitioners to Gulf and European countries4.  
Over the past two decades, Kerala has grown to become the cynosure of global Ayurveda. For 
Ayurveda practitioners in Kerala and across 
the country, people from the powerful 
West with their lucrative Dollars and Euros 
not only promised a much needed wealth 
but also a prestige that was sorely lacking 
at home. For a medical system enervated 
by competition with state-sponsored 
biomedicine, the Kerala phenomenon was a 
                                                 
1 Term used to denote residents of Kerala.  
2 An alternative term used to denote residents of Kerala, based on the local language Malayalam. 
3 Unemployment rate in Kerala 11.6% (rural), 12.2% (urban) as against India:  2.3% (rural), 5.7% (urban). Around 4 million 
unemployed persons registered in employment exchange, 50% of which are graduates or technically qualified.  
4 An estimated 2.5 million in Gulf countries as at 2008. (Govind 2008). 
 
Aimed at the outsider: Ayurvedic tourism services, Varkala 
 4 
 
welcome opportunity for reinvention and rejuvenation of its identity.  It was after all the West that 
had delegitimized the system, and it was perhaps natural that people look up to the same authority to 
restore the lost legitimacy.  
By the end of four months of pilot study in the summer of 2006, I was beginning to recognize 
that the concept of “Ayurveda” or “tradition” in Kerala was inconsistent with the findings of research 
studies in other parts of India. It was also very different from my lived experience in the States of 
Karnataka and Maharashtra. But I was yet to realize then, the potential significance of this perceived 
difference, in informing my future analysis. At the time, I was enthralled by the myriad forms of 
commodities and the new modes of selling emerging in the ayurvedic market. In industry-starved 
Kerala, Ayurveda seemed to be one of the most happening sectors next to real estate, gold and liquor. 
Stories on Ayurveda had become a daily feature in the newspapers. Newly booming market of health 
magazines were brimming with advertisements of ayurvedic products and services, creating an illusion 
of Ayurveda overtaking allopathic medicine, common Indian term for biomedicine. I am saying illusion 
because in terms of numbers, Ayurveda nowhere matches up with the hype. A recent survey conducted 
by Kerala Sasthra Sahithya Parishath (KSSP) revealed that only 6.6% of the population of Kerala opted 
Ayurveda, while 87% preferred allopathic treatment ( Kumar, 2012). The ayurvedic  industry in Kerala 
is a mere quarter of the allopathic market in size, but for a State known for its exemplary biomedical 
primary care infrastructure (Kannan 2005), this is quite significant. But I am saying illusion, because 
ayurvedic medicine still constitutes.  
However, the post-tourist ayurvedic hype had led to many fast paced developments —  the 
State government was in an intervention mode with policies on regulation of tourist Ayurveda, plans to 
augment forest collection to boost revenue, and aggressive promotion of subsidy schemes for medicinal 
plant farming.  M.S. Swaminathan, the architect of the Indian green revolution, had called for the 
development of a ‘bio-valley’ in Kerala (Hindu 2009). Despite paucity of land, tropical Kerala was being 
seen as an ideal place to promote medicinal plant cultivation.  The most picturesque of all was the 
tourist segment. Beaches and hill resorts were dotted with Panchakarma (cleansing therapy) centers, 
ayurvedic resorts and massage parlors. High-profile actors were entering the ayurvedic market, ranging 
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from some of the largest business groups in the country to high-end hospitality chains, from biomedical 
pharmaceutical companies to multinational consumer goods companies. It was so distracting that I 
didn’t know where to look; the action was rapid and high-pitched. A single question kept coming back 
to my mind; how is all this commercialization transforming Ayurveda? What are the implications of 
these changes for practitioners and consumers, and to the medical system itself? Ayurvedic medicine, 
especially as practiced in Kerala,  leans heavily on a pharmacopeia of herbs that move through varied 
commodity chains which too must be undergoing change.  Of the several vantage points that could be 
used to investigate the subject, the theoretical framework of ‘commodification’ seemed most 
appropriate.  
During the period of my pilot study, I traveled across ten of the fourteen districts in Kerala and 
met with several people including ayurvedic doctors, manufacturers, raw drug traders and medicinal 
plant collectors. I visited diverse sites where Ayurveda was being consumed, including raw drug shops, 
government and private clinics and hospitals and tourist spas.  If one were to choose the subject of 
research based on visibility, it had to be the ayurvedic tourism segment, novel, dynamic and colorful. 
But to me, as an insider, it was the backdrop of Ayurveda in Kerala that was attractive. While the 
tourist Ayurveda was the most eye-catching, it was the sustained home consumption of ayurvedic 
commodities and services in Kerala that had enabled the system to survive and compete with the 
biomedical machinery powered by capital and the State. I was an insider in the sense that I was a 
native of India and a consumer of Ayurveda myself, but at the same time I was an outsider to Kerala; a 
native of Dakshina Kannada, a district in southern Karnataka that borders Kerala. In some ways, this 
region is more similar to Kerala than the rest of Karnataka, but the differences far outweighed the 
similarities in many cultural spheres.   
 The difference aroused my curiosity. Raw drug shops, a feature that could be seen only in city 
markets in other parts of the country, dotted Kerala’s rural and urban landscape. Uncertified vaidyans5 
                                                 
5 Vaidyan is the Malayalam equivalent for Sanskrit vaidya, meaning doctor. Though this is an umbrella term for a practitioner of 
any system of medicine including biomedicine, it is typically used to refer to practitioners of indigenous systems of medicine. I 
use it here and in most of the dissertation to refer to ayurvedic doctors who are informally trained (licensed or unlicensed) in 
contrast with those who are institutionally trained.  
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of indigenous medicine and practitioners of Kalari martial arts6 and Marma7, continued to practice and 
struggle against the professionalized mainstream. At the same time, the burgeoning tourist industry 
had spawned a modern training industry that churned out three to six month diploma holding masseurs 
and ayurvedic nurses by the dozen. Rapid commodification seemed to hold the potential to alter the 
culture, and in the process perhaps jeopardize the role of certain actors, enhance the role of certain 
others. Between all of them, there was one thing common, ayurvedic pharmaceuticals. The consumer, 
the producer, the collector, all of them were linked directly or indirectly by the role they played in 
producing these commodities. Studying ayurvedic commodities seemed to be an appropriate technique 
to capture the dynamics of ayurvedic culture in Kerala.  The theoretical inspiration for this 
methodological approach comes from Appadurai’s (1986) “social lives of things”. Appadurai 
recommends a re-orientation in the focal point of discussion on commodification towards the study of 
“things”, that include both concrete commodities and services. He emphasizes the commodity context 
of things, wherein commodity is just a transient state in the life of things; a thing becomes a 
commodity in certain social and culturally defined situations. Approaching medicines as things with 
social lives would eventually lead to the understanding of the contexts that convert them into 
commodities, and the role of various actors in influencing this process. Though medicine commodities 
have not been widely studied by anthropologists, anthropology offers a rich background of research on 
a variety of commodities to fall back on for theoretical inspiration. Commodity studies are replete with 
examples of loss of identity and integrity of cultural practices when exposed to the forces of 
commodification. Reinventions and diversions are noted in the studies of Soukouss music in Congo 
(White 2000), commodification of hunger foods into luxury commodities in Laos (Van Esterik 2006) and 
oriental carpets in Turkey (Spooner 1986). Western ideas of authenticity are imposed on non-western 
commodities (Steiner 1994, Spooner 1986). Trade-mediators are found to play an important role in 
shaping consumption which in turn to influences production. For example, the shaping aesthetic 
experience and value by an elite group of standard-setters in the art market in New York (Plattner 
                                                 
6Kalaripayattu is the martial art tradition of Kerala, whose practitioners are called Kalari practitioners,  referred to respectfully 
as gurukkal or Kalari ashans.   
7 Marma practitioners are those who base their practice on the theory of pressure points. It is also a branch in Ayurveda, and is of 
central importance in Siddha medical system. Kalari Marma practitioners combine the knowledge of both the systems.  
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2000), construction of authenticity of oriental carpets, an exotic commodity shaped by commercial 
interests of dealers (Spooner 1986). The paucity of genuine information and the subjectivity of ‘taste’ 
provide traders immense opportunity for manipulation.  
Attention to commodities and commodification has been peripheral in studies on indigenous  
medicine systems across the world (for example, see Ernst 2002); the focus has been mostly of their 
marginalization by bio-medicine. In fact, what is commonly portrayed is the juxtaposition between a 
culturally-embedded indigenous medicine enclosed in a sacred realm and a commodity-centric 
biomedicine.  It is important to recognize at the outset that classical medical systems have been 
different in their response to commodification compared to non-codified traditions, because they were 
already exposed to pre-industrial forms of commodification, standardization and institutionalization. 
American Anthropologist Charles Leslie is credited for opening up a fresh approach to studying 
the complex classical medical systems of India and China. His major contribution has been his account 
of the evolution of ‘modern Ayurveda’ in India, that he portrays as being based in shaped by the 
religious revivalist ideologies closely associated with the growth of nationalist movements (Leslie 1976, 
1992). At the end of his long engagement with the study of Ayurveda in India, he had begun to notice 
the significance of the manufacturing industry in shaping the destiny of modern Ayurveda. Drawing on 
observation of three companies representing different corners of the country, Leslie (1989) argued that 
ayurvedic and unani drug 
companies enjoyed a burgeoning 
market based in the urban middle 
classes. He pointed out that it was 
important to pay attention to “the 
irrational aspects of 
commercialization and the central 
role of drug companies in 
sustaining the revival movement” 
that “implement radical breaks 
 
Catering to the insiders: Ayurvedic Pharmaceuticals 
National Ayurvedic Industrial Exposition, Coimbatore, 2008 
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with many aspects of humoral thinking and practice”. He felt it important “to understand their effect 
on popular health cultures, and the degree to which they irrationally distort the economy of health 
care” (Leslie 1989: 31).  
However, pharmaceuticals and the manufacturing industry are among the least studied aspects 
of Ayurveda in social science literature. This is not surprising given that anthropological attention to 
pharmaceuticalization has been very recent (Bell and Figert 2012). Medical anthropologists had not 
extended the inquiry of symbolic, cultural logic to pharmaceuticals until the eighties (Whyte et al 
2002, Van der Geest et al. 1996, Geest 2006). The few studies done until then were mostly on issues 
like the use of antibiotics, and almost none dealt with indigenous pharmaceuticals. By 1988, the term 
pharmaceutical anthropology came into vogue, and there were 16 papers on transactions and meanings 
of medicines in developing countries (Van der Geest and Whyte 1989) covering thirteen different 
countries in Asia, Africa and Latin America. Nichter and Vuckovic (1994), who studied parts of Asia and 
America, found medicines to be ‘vehicles of ideology’ capable of not only changing perceptions of 
health, but also influencing social values and relations.  
Even those who study pharmaceuticals rarely include the study of manufacturers or the process 
of manufacturing. Whyte et al (2002) suggest reasons for this lacunae: 
The near non-existence of anthropological fieldwork in the pharmaceutical industry should not 
come as a surprise. First, there is the reluctance of anthropologists to enter the complex and 
highly technical world of industrial manufacturing. Most still prefer the relatively simple and 
conveniently arranged local community to conduct their fieldwork….More important, however, is 
the refusal by manufacturers to allow social scientists in their midst, most likely because our 
studies do not serve the interests of the industry. In addition, anthropologists anticipate that 
refusal and do not even try. Industries are defensive about their commercial aims. …If the raison 
d’être of the drug industry, profit-making, is so much in conflict with the ideal image of its 
products, it is indeed to wise to close its doors to inquisitive social scientists who will certainly 
focus their attention on what the industry is not showing to the outside world (Whyte et al 
2002:138-139). 
But the phenomenon of commodification has been so central to Ayurveda’s development that 
anthropologists and sociologists who have studied Ayurveda from various vantage points have provided 
some glimpses into its workings. The issues Leslie raised have influenced subsequent researchers on 
Ayurveda (Langford 1995, Zysk 1995, Nichter 1989, Reddy 2002, Nisula 2006, Khan 2006).  
Studies have ranged from case studies of physicians (Trawick 1987, Langford 1999) to 
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ethnographies of pharmaceutical companies (Bright 1998, Banerjee 2002, Bode 2006). The ayurvedic 
market is seen as predominantly dominated by medicine substances, a process that is termed as 
‘pharmaceuticalization’ (Nichter 1989). In the industrial era, the manufacturers emerge as the most 
powerful stakeholders with the power to influence the larger culture of ayurvedic practice.  
Researchers who have specifically focused on the study of ayurvedic pharmaceuticals, have found the 
production and marketing of ayurvedic medicines to be predominantly driven by commercial logic 
(Banerjee 2002, Bode 2006).   
Meanwhile modern institutionalization and professionalization of Ayurveda was also leading to 
the homogenization of an otherwise diverse and regionally varied culture of indigenous medical 
practice. On the one hand, this process brought about a struggle between institutionally qualified 
practitioners and the traditionally trained practitioners. On the other hand, institutionalization and 
commodification appeared to be leading to various kinds of homogenization which was taking its toll on 
local practical knowledge or metis as Scott (1998) terms it.  Nevertheless, modern production  and 
consumption of medicine continues to link and utilize the traditional knowledge and skills of various 
actors through a complex commodity chain, despite an increasing reliance on codified ayurvedic texts 
and certified professionals. Reviewing literature in the field, I found that the usual focus of 
anthropological studies on Ayurveda were limited to visible foreground processes. I aimed to add to this 
knowledge by addressing on all the nodes of the ayurvedic commodity chain to get a more nuanced 
understanding of the effects of commodification on the various actors in terms of knowledge, 
livelihood and health care.  
1.1 Evolution of the research framework 
Four months of exploratory pilot study (June-September, 2006) supported by summer research 
grant from Washington University, provided data and insights that led to the development of research 
questions and design for the dissertation field work. It also provided preliminary contacts and potential 
informants for the proposed field work. A research proposal was formulated to further this objective, 
entitled, “Journey From Plant To Medicine: A Study Of Ayurvedic Commodity Chains In Kerala.” The 
proposal was awarded research grants by the Wenner Gren Foundation for Anthropological Research 
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(2008-2009) and National Science Foundation Dissertation Improvement Grant (2008-2010). Following 
research questions were formulated to direct the investigation:  
 What are the roles played by the different actors in the ayurvedic commodity chain in connection to 
ayurvedic pharmaceuticals? Has there been a substantial transition in knowledge and skill demands and 
livelihood outcomes over the past decade?  
 What is the consequence of commodification of herbs and herbal products on local practical knowledge of 
actors historically involved in the production and consumption of ayurvedic medicines? Does it lead to 
concentration of intellectual property in a few hands?  
 How do various stakeholders influence the making and consumption of medicines?  
 How do new developments in commodification influence the form and delivery of formal (institutionalized) 
and informal medicine?  
These were the questions I began the study with. But as is common with anthropological research, the 
fieldwork took me to many unexpected places, requiring me to ask new questions, some of which 
turned out to be central in shaping the final framework of analysis. Before I go further into the 
description of the research process, a brief introductory note on Ayurveda is in order.  
1.2 Ayurveda: an introductory note 
1.2.1 Brief  history and current status of Ayurveda in India 
Ayurveda is one among the four8 officially recognized as Indian Systems of Medicine (ISM). 
Though it had official recognition, it was only in 1995 that a separate Department (Indian Systems of 
Medicine and Homeopathy (ISMH)  was constituted to represent their interests, under the Ministry of 
Health and Family Welfare. In 2003, it was renamed Department of Ayurveda, Yoga & Naturopathy, 
Unani, Siddha and Homeopathy, now most commonly known by its acronym, AYUSH.  
Literally translated the science of ‘life’ or ‘longevity’, Ayurveda is a classical system of 
medicine whose origins go back to the period of classics in ancient India. The magico-religious medicine 
of the Vedic ages (C.1500 BCE) underwent a transformation during early Upanishadic era9 (C. 800-600 
BCE) leading to a series of medical treatises and monographs, of which little evidence is left today. 
Today the ayurvedic system of medicine locates its origins in the ‘Big Three’ Samhitas (compendiums), 
the Charaka Samhita (C. 1st BCE), the Sushruta Samhita (C. 500 A.D) and the Ashtanga Hridaya Samhita 
(C.7th century CE). The first specializes in internal medicine and the second in surgery, and the third is 
                                                 
8 The other three are Unani, Siddha and Sowa-Rigpa. Sowa-Rigpa or Amchi,  practiced in the States in the Himalayan belt, 
recently gained official recognition and is hence not part of the acronym of AYUSH. 
9 Era of Upanishads, a kind of literature that followed Vedas (800 BCE-600 BCE) that laid the basis for Indian philosophy, 
considered the renaissance period for ancient Indian literature, philosophy, science and religion.  
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a redaction and synthesis of the first two. Ayurveda appears to have attained the status of a 
professional medicine by the time it was taught at Takshashila University (600 BCE). Buddhist 
universities played an important role in systematizing Ayurvedic education in the medieval ages, the 
most important of which was the University of Nalanda (6th to 12th century CE). Ayurveda also had 
specialized branches of practice applied to animals and plants, namely, Gaja/Hastyayurveda (for 
elephants), Asvayurveda (for horses), and Vrksayurveda (for trees).  
Muslim invasions, beginning sporadically in the 10th century and culminating in Persian rule in 
the 14th century, were the first important source of transformation in ayurvedic practice. The 
intermingling of Greco-Arabic medicine and Ayurveda resulted in Unani, today recognized as an 
independent system of Indian medicine. The medieval era also saw the codification of another Indian 
medical system called Siddha, based in Tamil Nadu. Despite foreign invasions, the production of texts 
in both Sanskrit and regional languages continued unabated, the latest of which was produced in the 
18th  century. Europeans colonizers since the 15th century were involved in compiling and borrowing 
from Indian indigenous medicinal knowledge to their pharmacopeia (Kumar 2001). But by 19th century, 
indigenous medicine had fallen out of favor and gradually lost official status and state patronage. The 
revival movement associated with nationalism in late 18th and early 19th century succeeded in creating 
an alternative space for Ayurveda, though biomedicine continued to be the official system of medicine 
post independence. Ayurveda came under centralized State regulation for the first time in 1970, with 
the installation of the Central Council of Indian Medicine, as an apex body to regulate the education 
and certification of ayurvedic practitioners in the country. A uniform curriculum was designed for the 
entire country and the degree of Ayurvedacharya/Bachelor of Ayurvedic Medicine and Surgery (BAMS) 
came to be considered the sole qualification for ayurvedic practice. Deadlines were set up for 
practitioners with traditional training to register, the States were given the flexibility to fix their own 
timeframe and specifications. Today practitioners with pre-formal institutionalized training are locally 
referred to as paramparya vaidyans (traditional practitioners). Today in India there are 4.5 mn 
registered practitioners of Ayurveda, and another 1.5 mn unregistered practitioners (Planning 
Commission of India 2000). A total of 2402  ayurvedic hospitals and 13913 dispensaries are run by the 
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State. Ayurvedic educational system comprising of 242 medical colleges produces 11225 
undergraduates and 991 postgraduates annually.  
1.2.2 Ayurveda in Kerala 
Kerala, a tropical state in the southern tip of India, saw the world's highest growth rate in 
tourism over the past decade. Rising global tourist interest has led the state to position Ayurveda as a 
cornerstone of its tourism campaign. Though foreign tourists are fewer in number than domestic 
tourists, their spending capacity is high. Moreover, Western tourist demand has conferred a new 
prestige on Ayurveda. Another globalizing force is the wealthy Keralite diaspora that contributes a 
quarter of the State Domestic Product (Kannan and Hari 2002); it provides a new clientele and an 
important medium for the spread of Ayurveda. Consequently “Kerala” has emerged as a brand name 
for Ayurveda both within and outside the country, developing its own niche in the larger context of 
India's emergence as a global biomedical tourism hub. 
The Kerala State government has a primary health network exclusive to Ayurveda (also for 
homeopathy) parallel to allopathy. The presence of Unani and Siddha in Kerala is minor10. The state’s 
network of 126 ayurvedic hospitals and 898 dispensaries treat around 2 million patients a year. But the 
government system accounts for only a tenth of the total practitioners, another tenth are employed in 
the manufacturing sector, the rest are engaged in private practice. There are 16639 registered 
practitioners of Ayurveda, and an equal number of unregistered traditional practitioners (AYUSH 2011). 
There are an estimated 4000 private ayurvedic clinics and hospitals (Kerala State Planning Board 2006). 
There are around 1177 ayurvedic drug manufacturing units with a total turnover of approximately six 
billion rupees ($ 120 mn)11. The state has been conservative till recently in granting permission to 
educational institutions in the private sector and therefore has a limited number, that is, 16 colleges 
with an annual intake capacity of 680 graduate students and 4 postgraduate colleges with an admission 
capacity of 88 students.  
                                                 
10 Unani in Kerala has 64 registered practitioners, one dispensary and one manufacturing unit. Siddha has 1326 registered 
practitioners, 3 drug manufacturing units, 2 state run hospitals and 6 state run dispensaries. 
11
Rupee to dollar conversions are based on the value $1= 50 Rs., a crude average of the prevalent exchange rate. 
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1.2.3 A brief overview of Ayurvedic theory12  
Ayurveda is a system of health maintenance rather than disease treatment, giving equal 
importance to preventive and health maintaining practices. Ayurvedic medicine was conceptualized 
and practiced as eight major clinical subspecialties in addition to numerous adjunctive specialties. 
These include: 1. Internal Medicine (Kayachikitsa) 2. General Surgery (Shalya Tantra) 3. 
Otorhinolaryngology or ENT (Shalakya) 4. Pediatrics and Obstetrics/Gynecology (Kaumarabhrtya) 5. 
Psychiatry (Bhutavidya) 6. Toxicology (Agada Tantra) 7. Nutrition, Detoxification and Rejuvenation 
(Rasayana Tantra) 8. Fertility and Virility (Vajikarana). 
Ayurvedic cosmology evolved during the Upanishadic age of intellectual ferment (C. 800-600 
BCE), a time during which the six schools of Indian philosophy (Darshanas) took shape.  It draws its 
physical and metaphysical views from the school of Nyaya-Vaisheshika (a synthesis of the schools of 
logic and atomism13) and dialectics from the school of Sankhya (enumeration). Ayurvedic epistemology, 
is derived from Sankhya, is based on three pramanas (means of valid knowledge): direct sense 
perception (pratyaksha), inference (anumana14) and advice of the text or wise people (aptopadesha). 
The distinguishing feature of the Nyaya school of philosophy is the ‘belief in the utility of analysis’, and 
‘reliability of reason’. The Nyaya-Vaisheshika is considered ‘realistic’ because it believes in the 
independent existent of the external world, in other words, inferred through senses and mind but not 
dependent on them. At the same time it is also ‘pluralistic’ as it holds the ultimate reality as many.  
Samkhya postulates a notion of dualistic reality, wherein the cosmic world is derived from two 
primary principles, Purusha (the absolute spirit) and Prakriti (the primordial matter). Before creation 
only the Purusha or the Absolute exists. When desire first disrupted  the Absolute, the equilibrium in 
Prakriti is disturbed and the whole universe of unlimited permutations and combinations comes into 
existence. When Prakriti became aware of its existence, it evolved into the state of cosmic 
intelligence/consciousness called mahat. This intelligence then develops an atomized form (tanmatra 
form) aware of its individuality and differentiates itself into individual bundles of ego (aham). Ego has 
                                                 
12 Based on Kutumbiah (1962), Svoboda (1992), Wujastyk (1998). 
13 School of thought that postulates that all objects in the physical universe are reducible to a finite number of atoms.  
14 Three kinds of inferences are described: from cause to effect, effect to cause and inference from similarities.  
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three qualities: inertia (tamas), activity (rajas),  and equilibrium (satva)15. From the quality of inertia 
evolve five subtle elements (tanmatras), i.e., the five objects of the senses (sound, touch, color, taste 
and smell). From this are derived gross elements Panchabhutas, i.e., “five great elements” (earth, air, 
fire, wind, ether) which are the basis constituents of the universe. From the quality of activity, evolve 
the mind (manas) and ten senses16. The phenomenal world is a manifestation of the various 
combination of these cosmic principles.  
It follows from this that the body, or any other object in nature, could be seen as a microcosm 
constituted of the five primordial elements and different proportions of the three primordial qualities. 
Though there was a substantial anatomical knowledge, ayurvedic pathology is predominantly based on 
a functional view of the human body. The body including the mind, is constituted of the five elements, 
that manifest as a combination of three doshas (forces or humors), along with the seven dhatus 
(tissues) and three malas (waste products)17. The body is constituted by the action of three 
forces/humors, Vata, Pitta, and Kapha. These are best characterized as dynamic rather than 
typological categories, that are in charge of  circulatory, transformative and maintenance functions, 
respectively. Ayurvedic pathology recognizes disease as an underlying disturbance of one or more of 
these forces, manifested by the vitiating effect on the seven body tissues. Ayurvedic etiology is 
predominantly naturalistic. Charaka Samhita recognizes three causes of disease: 1. excessive, deficient 
or wrongful use of sense objects; 2. climatic characteristics of heat and cold; and 3. the misuse of 
intelligence. Sushruta Samhita classifieds diseases by etiology as: 1. physical (hereditary, congenital, 
dosha-vitiation), 2. externally caused (weapons, wild animals) and 3. caused by acts of god or nature 
(seasonal, providential and natural).  
The Ayurvedic diagnostic protocol is of two types: Examination of the patient (Rogi parikhsa) 
and examination of the disease (Roga pariksha). The ten-fold diagnostic protocol (Dasha-vidha 
pariksha) recommends understanding of patient characteristics with regard to:  age (Vaya), body 
constitution (Prakriti), pathological state (Vikriti), tissue vitality (Sara), body conformation 
                                                 
15 Modern scholars have equated tamas  to potential energy and rajas to kinetic energy. 
16 Five senses of perception: hearing, touch, sight, taste and smell; Five senses of action: organs of speech for communication, 
hands for all creative action, feet for locomotion, genitals for reproduction and anus for elimination. 
17An alternative view of the human body based on subtle physiology including Marma (pressure points), Chakras (energy centers) 
and Nadis (channels) is more popular in the West owing to its popularity in Yoga and the Tantric school of thought. In Kerala, 
practitioners of Marma give preeminence to this view.    
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(Samhanana), body measurement (Pramana), capacity for exercise (Vyayama shakti), adaptability 
(Satmya), psychic constitution (Satva), and digestive capacity (Ahara Shakti). The doctor is expected to 
elicit these parameters through interrogation (Prasna) and using the five senses (Panchendriya 
Pariksha). Additionally an eight-fold examination (Ashtavidha Pariksha) is recommended that includes 
investigation of pulse, tongue, voice, skin, eye, general appearance, urine and stool.   
Medicine is one of the four modes of treatment, the other three being cleansing, diet and 
lifestyle correction. The classificatory system of ayurvedic pharmacology is based on a synthesis of the 
schools of atomism and the school of logic, according to which the world is made of “six objects of 
experience” (See Appendix D.1). Of these the most important in pharmacology are the “qualities” of 
matter that are perceived by the  senses in the form of “tastes”. As matter and body can be reduced to 
the same five elements, the physician’s skill is in using the three means of valid knowledge in assessing 
the pathology in terms of these fundamental elements, and using the faculty of taste (Rasa) to assess 
the quality of the materia medica that can help correct the imbalance.  
1.2.4 Ayurvedic pharmaceutical commodities 
Manufacturing of indigenous medicines is governed by the Drugs and Cosmetics Act (DCA) of 
1940 and Drug and Magic Remedies Act (DMR) of 1958. There are two broad categories of ayurvedic 
medicine commodities, classical and proprietary. Classical medicines18 are based on officially approved 
56 classical texts. Such products do not require registration. They carry the name of the reference text 
on their labels; a single product composition can vary from text to text. Documented recipes for 
medicinal formulations number over 100,000 (Balachandran and Govindarajan 2007). Proprietary 
medicines are new formulations that require approval and registration in the relevant regional Drug 
Controlling Authority. Practitioners and manufactures are allowed the freedom of creating formulations 
that are typically improvisations or modifications of classical formulations, restricted to the use of the 
pharmacopeia mentioned in approved texts. Around 1500 classical formulations and 30,000 proprietary 
ayurvedic formulations are found in the Indian market (Sharma 2008). As at 2011 total of 7699 
ayurvedic manufacturing units manufacture ayurvedic medicines worth around `100 billion (US $ 2 
                                                 
18 These products have been referred to as ‘traditional’ products by some researchers (for example, Bode 2006).  
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billion) annually.  
Another class of medicine commodities that are part of ayurvedic health care are raw drugs, 
though they do not have a distinctive identity, as they can be used by any system of medicine. Across 
India, these are predominantly secondary commodities, that is, raw material  that manufacturers and 
practitioners use in making medicines. Hence, shops selling such merchandise are located in 
specialized market centers and in large cities and towns. In Kerala, given the high prevalence of 
household involvement in medicine making, the raw drug retail node has been a key node of pre-
industrial ayurvedic consumption. Raw drug shop is therefore a ubiquitous feature in both the urban 
and rural landscape of Kerala.  
1.3 A shift in the analytical framework 
During the pilot study and much of the fieldwork period I was preoccupied with the various 
ramifications of industrial commodification, which was based in the framework of a commodity chain – 
a  chain of relations that itself was a product of one century of industrial commodification of Ayurveda. 
As I gathered more intimate knowledge of the various nodes beginning from medicine collectors to raw 
drug sellers, manufacturers to practitioners, I began comparing my findings to that of other 
researchers. It was during this process that analysis took a different turn; the originally intended 
parameters of analysis began to pale in comparison as issues of greater theoretical salience and 
practical importance began to emerge. I realized that if I restricted myself to the analytical structure 
that I began with, I would miss the central story, a story that has either remained unstudied or 
unnoticed or  perhaps ignored as an exception because it does not fall into the expected pattern. What 
appeared most interesting was not that the expected process of centralization had come about, but 
that, much of what had occurred elsewhere in India during the process of industrialization had not 
occurred in Kerala. I argue that ‘what had not occurred’ has shaped the current and perhaps the future 
pattern of commodification of Ayurveda in the State. If this story were to be told two decades ago, it 
would have appeared as nothing more than an interesting, but isolated case with limited 
generalizability. But today this story has a special significance because it is this Kerala model of 
Ayurveda that eventually turned out to be the motive force behind the new spate of commodification 
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of Ayurveda both at national and global levels. In order to address this story, during the last phase of 
the field work, I added new questions, which to a certain extent modified and reoriented the focus of 
the research study:  
 What are the features of Kerala pattern of industrial commodification of Ayurveda? How is it 
related to the other facets of ayurvedic practice in Kerala? 
 
 How is it similar and how is it different from Ayurveda in rest of the country, and what are 
the reasons and implications of this difference?  
 
 How can the understanding of this difference contribute to commodification theory and 
inform the study of comparable commodities?  
1.4 Research methodology and sample 
The research design involved two components: the first and the central part was ethnographic 
study of actors at different nodes of the ayurvedic commodity chain. This was aimed at collecting 
information on the role played by each set of actors, demands on knowledge and skills, relationships of 
stakeholders with each other, and with the commodities with respect to both historical and ongoing 
changes in the patterns of production, practice and consumption. The second part of the research 
design centered around the study of "social lives” (Appadurai 1986) of plants that go into the 
production of ayurvedic medicine. This aimed at the construction of “commodity careers” of selected 
plants, i.e., accounts of the changes in states and uses at each stage of their commodity chains. Since 
both components were complementary and overlapping, data collection was more often than not 
combined. Biographies of plants provided insight into roles played by and knowledge demand made on 
actors at each node and changes that have taken place in their roles in the context of industrialized 
commodification. Understanding of the social lives of plants was especially useful in providing insights 
into the upstream supply chain and to a certain extent on the nature of household herbal/medicinal 
knowledge and consumption. However, social lives of individuals plants did not to lead to other facets 
of ayurvedic practice, production and consumption. Ayurvedic medicines are predominantly polyherbal 
formulations; individual identities of plants are subsumed under the class of raw drugs and are invisible 
after they enter the factory.  Therefore, the study of commodity careers of plants was helpful, but less 
central than what was proposed prior to fieldwork.  
Seven nodes of the ayurvedic commodity chain were identified during the four month pilot 
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study conducted in the summer of 2006 including: 1. Medicinal plant collectors/farmers  2. Raw 
drug retail shops 3. Raw drug wholesalers 4. Ayurvedic manufacturers 5. Ayurvedic retail medicine 
stores  6. Practitioners/clinics/tourist spas/hospitals and 7. Consumers. Detailed attention was paid to 
actors at all nodes except for raw drug wholesalers and hospitals. Among the rest, greatest importance 
was given to three set of actors: raw drug shops, practitioners and manufacturers.  At each node, semi-
structured in-depth interviews and participant observation methods were used to collect data. Field 
study was conducted for a period of 33 months between March 2008 and Nov 2010. A brief three week 
field visit was made in February-March 2012.  
Index plants and location-specificity of three of the nodes (manufacturing, forest collection 
and tourism) set the geographical limit within which sample for the other nodes were selected. Raw-
drug shops and pharmaceutical agencies were selected from three towns and three villages that were 
in proximity to the manufacturing and forest collection nodes. Within the region, universal sampling 
method was used; all practitioners and all retail shops available in these regions were selected for 
primary visit. Those who were willing to be interviewed were pursued for more in-depth interviews. 
Raw drug shop keepers in these regions were asked to name the vaidyans in the region, because unlike 
formally qualified doctors who were visible and accessible in their clinics and hospitals in the town, 
they practiced from their homes located in interior villages.  
Around one-third of the sample of small manufacturers and practitioners were based on 
contacts made in conference and workshops. Around half the consumer informants were approached 
through  personal contacts and the other half were selected based on references provided by 
informants at various nodes, mainly raw drug shops and practitioners.  
Knowledge demands vary from plant to plant, depending on the part harvested, seasonality, 
perishability, and nature of processing required. Five index herbs were selected to represent the local 
commodity chain were: Brahmi (Bacopa monnieri), Kurunthoti (Sida rhombifolia spp. retusa), 
Koovalam (Aegle marmelos), Kattupadavalam (Trichosanthes cucumerina/doica/lobata) and Njavara 
(Oriza sativa spp.). These were chosen to represent mainly two criteria,  
1. Diversity of habitat – forest/commons/cultivation and consequently, diversity of sources 
i.e., forest collectors/forest cultivation/commons collectors/farmers/raw drug market.  
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2. Botanical diversity (herb/shrub/tree/creeper/grass) and diversity of plant part used in 
medicine production (whole herb/shrub root/tree root/fruit).  
Of the herbs sourced locally, three were selected as index plants, from among the most 
commonly used raw drugs in ayurvedic medicine production in the Kerala industry.  
 Koovalam represents the tree root class of drugs that are among the most endangered and also 
provides illustration to the practice of acceptable and unacceptable substitution in ayurvedic 
medicine production.  
 Kurunthoti, an abundantly available and hardy plant to throws light on issues related to large 
scale extraction from the commons.  
 Brahmi  represented issues of concern to a highly perishable class of fresh herbs.  
Three plants were chosen to represent two distinct and recent phenomena.  
 Kattupadavalam represents a forest plant that has entered into cultivation recently. 
 Njavara is a medicinal variety of rice that leads us outside the pharmaceutical commodity 
chain to the ayurvedic therapy segment. It has entered into a new commodity chain post-
tourist commodification, by virtue of its being one of the few star medicinal herbs commonly 
used in therapeutic massages. Unlike the other four, it is not commonly used as a 
pharmaceutical ingredient.  
 Besides being a common ayurvedic herb, Brahmi is distinct from the others by virtue of its 
individual identity built over its traditional reputation as memory enhancer. Its distinct 
commodity career helps in providing insights into various newly emerging commodity forms. 
 
Of the 36 co-operative societies under the Kerala Scheduled Caste/Scheduled Tribe19 
Federation (Hereinafter SCST Federation) that hold the monopoly for minor forest produce collection, 
nine were selected to represent the four branches of the Federation. Further, five of them were 
selected to represent two of the index plants that were being sourced from the forest commodity chain 
(kurunthoti and kattupadavalam). Idukki district was selected as one of the principal field sites to 
follow up the commodity chain of kattupadavalam; the sample in the district included 4 collection 
societies and 5 collection agents. The total sample in the forest supply chain consisted of 6 community 
elders and 8 medical practitioners representing 6 of the 35 Scheduled Tribe (ST) communities of 
Kerala, viz., Muthuvan, Kani, Mannan, Kuruchiyar, Kadar, and Urali. 
                                                 
19 Scheduled Caste and Tribes are designated communities as per the Constitution of India Article 366 (25), who are protected 
with policies of positive discrimination as they are considered historically marginalized. While there is some overlap, typically 
scheduled caste members are untouchable communities within the Hindu fold, whereas Scheduled Tribe members are those who 
were historically secluded from the mainstream, and mainly lived in endogamous groups in hilly regions and forests.  
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Two other field sites were selected in 
Ernakulam and Thrissur (Trichur) districts 
keeping in mind the manufacturing and trading 
node. Thrissur district in Central Kerala, 
considered the cultural capital of the State, 
has the largest raw drug market and is the hub 
of ayurvedic manufacturing in Kerala. The 
adjacent district Ernakulam was selected 
because it borders Thrissur on one side and 
Idukki on the other. But also because being the 
financial capital of Kerala, it is also a vibrant 
site of ayurvedic manufacturing and wholesale 
raw drug trade.  
The initial plan to do an in-depth study 
of a small sample of manufacturers, was 
abandoned in favor of an extensive sample. In terms of turnover size, the sample included six large, 
seven medium large, six medium, eight small, two mini and six micro level manufacturers, that is a 
total of 35 manufacturers.20 Not all manufacturers were given equal attention21. All five of the largest 
manufacturers of Kerala were part of the sample. Since two of them were located in Thrissur and one 
in Idukki, the rest of the industry sample was selected from these two districts and also from 
Ernakulam district bordering Thrissur (total of 13 from Thrissur, 8 from Ernakulam and 6 from Idukki). 
Six medium and medium large companies were selected from other districts mainly through contacts 
made during industrial expositions. Five each of medium large and medium sized companies were 
selected from the above three districts purposively, to include the most reputed. The intention was to 
understand the predominant characteristics of successful manufacturers, organizational history, market 
                                                 
20 Large: 300 million ($6 million) and above; Medium large: 100-300 million ($20-60 million); Medium: 50-100 million ($10-20 
million); Small: 10-50 million ($2-10 million); Mini: 1-10 million (0.2 to 2 million); Micro: Below one million.  
21Interviews were conducted with MDs and other staff of 22 companies, tier one management and other staff of 7 companies, tier 
two managerial staff of 4 companies and secretarial staff of 2 medium sized companies. Some were single-session interviews, 
while some other interviews went over multiple sessions and involved factory tours. Four of the interviews did not involve site 
visits, as they were conducted with one or two of the managerial staff at the site of industrial expositions.   
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outlook and product strategy. It was expected that the largest and most reputed in the State would 
provide a representative big picture of the Kerala manufacturing industry. Attempt was also made to 
represent variety in focus and organizational history (See Appendix A.1). Small, mini and micro 
companies were selected through references given by sampled raw drug shops and others through 
contacts made during visits to the three national ayurvedic industrial expositions held during the period 
of my field work.22 The Director of the ayurvedic industrial cluster of Kerala, State Ayurvedic Drugs 
Controller and Drugs Inspectors, General Secretaries of the State and national manufacturers’ 
associations, were other informants who provided insights relevant to the manufacturing node. The 
industry sample also included a herbal  extract industry from Kerala and three non-Kerala ayurvedic 
manufactures, a small manufacturer from Karnataka, a medium sized company owner from Delhi, and 
the CEO-owner of one of the top ten companies, based in Maharashtra.  
I visited two large and two small raw drug markets, and three fresh herb markets in Kerala.23 
But as this was not a node of focus, the final sample was restricted to one large and one small raw drug 
wholesaler in Thrissur, one large and one small fresh herb trader in Malappuram district, and a fresh 
herb trader from Kozhinjampara. Smaller traders included one fresh herb agent in Idukki, a farmers’ 
co-operative society and a voluntary organization who are into fresh herb supply. Ten medicinal plant 
collectors who supplied to these markets or/and to manufacturers were interviewed.  
Data for the tourist node was collected through brief single-session interviews with owners or 
managers of 19 tourist ayurvedic Centers and six therapists. Though no systematic effort was made 
during sample selection to account for diversity of institutions, analysis showed they represented a 
variety of stakeholders and were chosen from four of the most important tourist locations of Kerala24. 
(See Appendix A.5 for stakeholder and regional break up). Data was also collected from eight therapist 
training institutes of which three were briefly interviewed.   
The rest of the sample including raw drug shops, retail ayurvedic agencies, farmers, consumers 
and practitioners were selected mainly from the districts of Thrissur, Idukki and Ernakulam in locations 
                                                 
22 in Coimbatore (Aug. 2008), Jaipur (Dec. 2008) and Thrissur, Kerala (2009). Each attracted 50-80 manufactures from across the 
country; the Thrissur exposition was dominated by manufacturers from Kerala. 
23 large markets in Thrissur and Kochi and minor markets in Moovattupuzah and Kottayam, the fresh herb market in Wadakara in 
North Kerala and Kozhinjampara bordering Tamil Nadu, and the Kani tribal market in Trivandrum. 
24 Varkala and Kovalam beaches in Trivandrum, Thekkady and Munnar hill resorts, backwaters in Kumarakom, and the historical 
city of Fort Kochi in Ernakulam 
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adjacent to sampled manufactures to optimize travel time. A few informants from other districts were 
drawn from contacts made during visits to forest collection sites in Wayanad, raw drug market and 
tourist centers in Kottayam, government offices in Trivandrum and manufacturers in Palakkad district. 
The sample of retail shops included 18 raw drug shops and 15 exclusive pharmaceutical company 
agencies (See Appendix A.2 for district-wise breakup). Three retail outlets from the neighboring state 
of Karnataka were included, out of which two were agencies of Kerala manufacturers. Informants also 
included two wholesale distributors of ayurvedic medicines (one from Thrissur and one from Idukki) and 
four medical representatives. Practitioner sample included 17 traditional practitioners, 16 degree 
holding practitioners, 12 practitioners from outside Kerala and nine tribal medical practitioners. As for 
traditional practitioners, effort was made to include practitioners from various specializations. (See 
Appendix A. 3 for detailed breakup). Besides clinics, dispensaries and hospitals that overlap with the 
practitioners’ sample, three other hospitals were also part of the sample. Except for one hospital were 
participant observation was conducted, all other interactions were interview-based.  
The sample of farmers included four subsidy farmers, two fresh herb trader-farmers, two home 
gardeners, two farmers’ collectives, two monocroppers, four farmers from Scheduled Tribe (ST) 
communities, and several practitioners and manufacturers with medicinal farms. The sample was 
mainly selected from the list of suppliers provided by the State manufacturer Oushadhi and the subsidy 
farmers list provided by the State Medicinal Plant Board.  
A total of fifty consumers were either interviewed or observed during the process of 
consultation25. Other miscellaneous informants included seven street vendors, two medicinal plant 
nursery owners, five college teachers and thirteen students (see Appendix A.4). Several government, 
quasi-government officials and office holders of various professional associations were also part of the 
sample (see Appendix A.6).  Data was also collected from participant observation and interactions at 
six national/international conferences and various other workshops and meetings (see Appendix A.7). 
Note: In some cases, locations and identities of respondents have been protected, either by 
restricting to initials or by using pseudonyms. Pseudonyms have been coined to maintain the 
gender and community affiliations of the original name, and they are italicized to distinguish 
from real names.  
                                                 
25 Selection of consumers was mainly based on encounters in other nodes, i.e., practitioners, retail raw drug and Ayurvedic 
medicine shops, clinics, hospitals, tourist centers or from chance encounters in other public spaces. 
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1.5 Central Arguments and the organization of the dissertation 
Commodification of Ayurveda in Kerala remained distinct from the rest of India by focusing on 
‘classical medicines’, that I refer to as ‘open-source commodities’ because they are based on published 
classical texts. Open-source production provides for transparency and distributed innovation. Though 
the way open-source works may be different from domain to domain, there are certain general 
features that are common to open-source knowledge based production. “Open source production is 
characterized by transparency, exploitation of peer review and feedback loops, low cost and ease of 
engagement, and a mixture of formal and informal governance mechanisms built around a shared set of 
technical goals” (Hope : 2008 15-16). 
Unlike ayurvedic industry in the rest of India that focused on proprietary medicines and 
sidelined the ayurvedic doctor, this model of commodification kept the integrity of ayurvedic practice 
by maintaining the doctor’s role as the mediator. This culture of integrated practice went on to 
provide the foundation for the new era of commodification, primarily triggered by western tourist 
interest. “Panchakarma” (a set of cleansing therapies), a classical tradition of Ayurveda preserved in 
Kerala has become the selling point of this new era of commodification26. This eventually led to a 
radical change in the commodification of Ayurveda not only in Kerala, but in rest of India. This shift 
can be called paradigmatic because the focus of commodification shifted not only from 
pharmaceuticals to services, but also from illness to wellness. At the same time, as envisaged during 
the pilot study industrialization in Kerala did lead to the loss of knowledge at various nodes of the 
commodity chain resulting in deskilling and alienation among various actors. Though this is similar to 
what happened elsewhere in the country, the nature of change and its consequences in Kerala are 
different because of the intensity of household involvement in medicine making.  
The dissertation elaborates each of these arguments in three parts. I will present here a brief 
description of the main arguments in each part. The theoretical and conceptual background of the 
argument will be presented in the prologue that precedes each part.  
                                                 
26 However, in practice, what gets sold are preparatory procedures of Panchakarma (i.e., Poorvakarma) of sweating and oleation 
including massages. In Kerala, these procedures have an independent standing as therapeutical procedures.  
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1.5.1 Part 1: Uniqueness of Commodification of Ayurveda in Kerala  
Despite the similarities shared with rest of India in the modernization process, the trajectory of 
ayurvedic commodification in Kerala has remained distinct. I demonstrate this based on a comparison 
of ethnographic data on the manufacturing sector in Kerala with secondary data and research findings 
from other parts of India. Unlike the proprietary-product centric business model of ayurvedic industry 
in rest of India, the Kerala model is based on open-source knowledge, in other words, classical 
medicines based on ayurvedic texts. To apply the framework of commodification theory (Marx 1876), 
industrialization of ayurvedic medicine production in rest of India led to accumulation of capital which 
in turn sought to remove the conventional barriers to commodification. The ‘classical medicine 
category’ was a barrier to commodification, because it required the ayurvedic physician to mediate 
consumption and therefore limited the circulation potential of the medicine commodities. 
Manufacturers outside Kerala used two strategies to create diversion in the path of these 
commodities to remove them out of the commodity context (Appadurai 1986) of therapeutic Ayurveda. 
By selling OTC products to consumers and prescription products through allopathic physicians they 
bypassed the ayurvedic physician and created a radical break with the humoral tradition. The Kerala 
model of commodification on the other hand was loyal to the classical ayurvedic therapeutic context 
and kept the ayurvedic practitioner within the commodity chain. Because of the continued involvement 
of the practitioner, the system of medicine remained integrated; diet-related advices and therapies 
like Panchakarma, remained part of mainstream ayurvedic practice. Consequently, Kerala did not 
undergo the kind of pharmaceuticalization  that characterized Ayurveda in the rest of India. The 
contrast between Kerala and rest of India in the commodification of pharmaceuticals is brought out in 
Chapter two.  
Closer analysis of the Kerala distinction reveals the role of stakeholder-characteristics in 
differentially affecting trajectories of commodification. Though historical socio-cultural processes are 
primarily responsible for producing different stakeholder configurations, in this paper I limit the 
discussion to a proximal and visible variable, ‘manufacturer characteristic’. Unlike the business-
professional led mainstream ayurvedic industry, Kerala industry is dominated by practitioner-
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manufacturers, who combine within them the roles of both commodifiers and gatekeepers. Unlike the 
pharmaceutical-focused mainstream, Kerala manufacturers have been heavily invested in therapeutic 
services both at personal and institutional levels.   
I argue that the agency model of distribution used by Kerala manufacturers played a significant 
role in making this mode commercially viable. By providing an exclusive channel for the flow of 
ayurvedic classical commodities combined with consultation services, it helped in maintaining them 
within the therapeutic context. I further argue that such a model emerged and continued to be viable 
because of the availability of a wide pool of practitioners who shared a common pharmacopeia. Over 
generations of practice, they had established a mass consumer base familiar with the classical mode of 
medicine consumption. The popularity of classical Ayurveda among the masses and the presence of a 
wide pool of practitioners, I argue, is rooted in the unique sociology of ayurvedic practice in Kerala 
that has made the classical tradition diffuse across all castes and religions. I identify and briefly discuss 
two factors as being formative: the social reform movements of the 18th-19th century and the role of 
pre-colonial and postcolonial state in popularizing and providing patronage to indigenous education. 
Discussion of the sociology of practice and the contributing historical factors is presented in Chapter 3. 
1.5.2 Part 2: Industrial production of medicines: Deskilling and alienation 
Though Kerala managed to maintain the overall integrity of ayurvedic practice, industrial 
commodification did have the expected effect in terms of deskilling actors at various nodes. Those 
directly affected are practitioners and consumers who were alienated from medicine making.  Of the 
indirectly affected, the most notable are retail raw drug shop sellers, traders and collectors. I use 
Scott’s conceptual framework of metis (local practical knowledge), and his discussion of the struggle 
between science and metis, to elaborate on the impact of homogenization on innovation and 
transmission of ayurvedic knowledge. The concepts of alienation (Marx 1876) and deskilling (Stone 
2007) provide a framework for analysis of knowledge and skill loss at both foreground and background 
nodes of the ayurvedic commodity chain. 
Prima facie, industrialization appears to take away only a part of doctor’s role, that too the 
lower order skill of medicine-making. However, I argue that, this seemingly lower order knowledge is 
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vital to the cognitive processes involved in diagnosis and treatment, and is critical in maintaining the 
link between clinical practice and innovation. The nature of knowledge and consequences of deskilling 
of the practitioner is the subject of discussion of Chapter four. While alienating the practitioner from 
medicine-making was an obvious and common impact, what was unique to Kerala was the involvement 
of people in medicine making. Chapter five presents ethnographic evidence for this involvement and 
discusses the consequences of deskilling. I argue that given the centrality of the polyherbal decoction 
in Kerala pharmacopeia, commodification of the decoction is the most important milestone in the 
industrialization of ayurvedic medicine production in Kerala. Consumers’ involvement in medicine 
making has two important consequences. Firstly, consumers alienated from medicine making can force 
doctors to switch their prescription habits in favor of industrially produced standardized formulations. 
Secondly, alienation from medicine-making distances people from the knowledge of medicinal plant 
resources which has an adverse effect on active and passive conservation of resources in homegardens 
and commons. 
The retail raw drug shop, the key node of ayurvedic consumption in the pre-industrial era is the 
most affected by industrialized production. Chapter six provides a glimpse into the nature of 
knowledge involved in transactions at this node and presents a discussion on the consequences of 
deskilling. The subject of Chapter seven is the upstream supply chain. Increasing distance between 
manufacturers and raw material makes room for several problems — raw material quality, exploitation 
of medicinal plant collectors and unsustainable harvesting of resources. The nature and consequences 
of alienation and deskilling are different for the forest and non-forest supply chains, each of which is 
described in detail. This chapter also includes a brief discussion on the nascent area of medicinal plant 
farming. On the whole, though industrial commodification appears to lead to deskilling, vice versa is 
also true. Deskilling is caused by various macro socio-economic changes unrelated to industrialized 
production. Such deskilling provides a conducive environment for commodification, making actors at 
each node vulnerable to further deskilling. I contend that weakening of the skilling process has made 
the practitioner vulnerable to the deskilling effects of industrialization. The modern revivalist-led 
homogenization of Ayurveda as a monolithic ‘science’ led to the institutionalization of education in a 
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form inimical to the transmission of metis. This led to the gradual replacement of the traditional 
medical practitioner with institutionally trained practitioners that contributed to switching in 
prescription habits towards standardized formulations. This in turn affected both the consumers and 
the raw drug shops. But this is not a one-way cause-effect relationship. Deskilling at the consumer 
level is also caused by other macro-economic changes. Processes of urbanization and modernization 
and resultant changes in occupational profiles and cropping pattern also contributed deskilling. At the 
same time, it should be noted that there is significant resistance to deskilling; attempts are made by 
actors at all nodes to adapt or to counter the effects of alienation. A few examples for such resistance 
are discussed in chapters 5 and 6.  
1.5.3 Part 3: Dissolving Boundaries: New Wave of Commodification  
Post-tourist commodification of Ayurveda focused on the commodification of services, 
especially those focused on wellness. In Kerala, this led to the expansion of a seasonal wellness therapy 
(Karkidaka Sukha Chikitsa)  from an elite practice into a mass commodity. But in the rest of India, that 
had no history of such practice, Panchakarma centers spread like wild fire, creating new categories of 
wellness clinics and wellness consumers. In the process, Kerala evolved as a new inspirational core for 
Ayurveda in India, leading to the emergence of a “Kerala brand” in Ayurveda. The new market built 
around Kerala Ayurveda attracted new non-ayurvedic stakeholders who have created new spaces, new 
modes and new commodities, unfettered by traditional barriers, stretching the meaning of  the term 
“Ayurvedic” in innovative and often controversial ways.  This on one hand had a positive impact by 
bringing back into focus non-medicinal aspects of Ayurveda that had escaped commodification in the 
first place. On the other hand, it gave rise to allegations of misinterpretation, overuse and misuse of 
various Ayurvedic services. The new market created a “diversion” from its regular “path”, and created 
a new “commodity context” for the selling of therapies outside its traditional context, the doctor’s 
clinic. Menu and package model of therapy vending have been among the most visible of diversions.  
Characteristics considered the inherent strength and foundation of Ayurveda like for instance, 
the principle of individualization, ironically, were the most amenable for commodification. Preventive 
and wellness treatments also provide infinite potential for commodification because the hospital is no 
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more limited by the relatively narrow context of disease and illness. The “holism” of Ayurveda that 
includes diet, lifestyle modification and cleansing opens up several opportunities for commodification. 
Chapter 8 is devoted to the discussion of the commodification of services. The chapter includes a brief 
account of ramifications of tourist selling in Kerala and its effect on the domestic market in other parts 
of India. New developments in the commodification of ayurvedic medicine commodities are discussed 
in chapter 9. The discussion covers a gamut of new commodities ranging from form-changes of classical 
medicines to commodities that co-evolved with the commodification of services.  
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PART ONE  
FOCUSING ON THE DIFFERENCE 
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PROLOGUE 
 
By the end of his long engagement as an anthropologist researching Ayurveda in India, Charles 
Leslie had begun to realize the significance of paying attention to the commercial production of 
indigenous pharmaceuticals and the role of the industry in shaping medical practice.   
If I were planning today another conference on the comparative study of humoral traditions in 
Asia, I would include researchers who have studied the commercial production of traditional 
Chinese and Kanpo health care products, which are manufactured for regional and international 
markets. We should compare the history and role of this traditional medicine industry in Asia with 
allopathic companies. They implement radical breaks with many aspects of humoral thinking and 
practice in these societies. We need to understand their effect on popular health cultures, and the 
degree to which they irrationally distort the economy of health care (Leslie 1989: 30).  
Though insights into some aspects of commodification was provided by researchers studying 
various other facets of Ayurveda, only three studies have paid close attention to ayurvedic 
manufacturers and pharmaceuticals. These are: Banerjee’s (2002) study of market strategies of Dabur, 
the largest ayurvedic company in India, Bode’s (2008) study of five large indigenous pharmaceutical 
firms, and Harilal’s (2010) study of ayurvedic manufacturing industry in Kerala.  
Banerjee (2002) elaborates on the phenomenon of pharmaceuticalization of Ayurveda based on 
the analysis of marketing strategies of Dabur from their beginnings in early 1900 until today. She 
identifies three stages and four strategies in the industrial production of ayurvedic medicines. 
The first step was to produce quality medicine in original forms, but with better packaging, a 
strategy adopted by most late 19th century firms. They basically wanted to make ayurvedic 
medicines as ‘readily available’ as allopathic medicines, a moment of confrontation with 
allopathy. This failed mainly because the pharmacopeia was too large, too expensive to make, and 
not a profitable venture. This was also a time when there was stiff competition from allopathic 
antiseptics and antidotes.  
As a consequence, there was a moment of withdrawal in the 1940s-50s, characterized by the 
admission of the superiority of allopathy and acceptance of the terms of discourse set up by 
allopathy, which altered the course of modern Ayurveda irrevocably. The second step was to cast 
old formulations in modern forms, tablets, capsules, accompanied by focus on cosmetics like hair 
oil, dental products. This phase also saw the entry of new firms like Himalaya, which focused on 
this strategy.   
And then followed was a moment of diversion in the 60s-70s, which occurred in the ideological 
background of alternative movement towards holism and return to nature. Ayurvedic industry 
reworked its profile to target this niche market. The third step was to make new formulations on 
the basis of old knowledge of medicinal properties confirmed by modern research, including 
cosmetics.  
The fourth strategy, yet to take shape, is to create a new category of products, neutraceuticals. 
(Banerjee 2002: 441) 
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The third strategy shifts the focus from mass market to niche consumers, though it is not clear 
how this strategy shaped the nature of products.  She argues that ayurvedic industry aimed at the 
moneyed class, departing from its traditional reputation of accessibility to the lower income and rural 
segment. Consumers did not benefit from economies of scale. Instead, ayurvedic medicines went on to 
become higher priced than allopathic, due to transition towards mechanization of production. As 
primary patrons, the higher income group played a key role in transforming medicines by imposing their 
expectations carried over from their experience with allopathic medicine. A consensus had developed 
regarding the place of Ayurveda vis-à-vis allopathy. Allopathy was considered the first resort for minor 
infections, serious diseases like TB and cholera, and for emergency interventions and surgery. Ayurveda 
was considered good for minor problems such as cough and cold, to maintain health like digestives, and 
to address chronic problems like asthma and arthritis. With this differentiation achieving the status of 
common sense logic, ayurvedic medicine got downgraded in the hierarchy. She concludes that 
Ayurveda was successful in commercializing its marketable aspects at the cost of losing its integrity; it 
moved away from medicine to FMCG, from drugs to candy. She conjectures that because of the high 
investment requirement, only commercially successful products like vitality medicines and cosmetics 
might remain and the rest could fade away.  
Though the business has been profitable to Dabur, it is questionable whether this is a success story 
for Ayurveda…off the shelf ayurvedic medicine has taken place at the expense of the ayurvedic 
drugs being prepared and dispensed by the vaidyan. As the price of success, Ayurveda had cast 
itself in the mould of modern medicine. Attempts to commercialize mass-produced ayurvedic 
medicines affected the internal order of the ayurvedic knowledge system (Banerjee 2002: 464). 
Bode’s study (2008) is particularly relevant because he approaches the subject from the 
perspective of the theoretical framework of commodification. He analyses marketing strategies of five 
of the largest manufacturers, four ayurvedic and one Unani. He finds that the product profile has been 
reworked to suit a commercial logic, and like Banerjee (2002), he finds the market skewed towards 
branded products. Branded medicines constitute an average of 90% of the revenue, of which 75% are 
OTCs and 15% ethical (prescription products). He finds that not only is the market skewed towards 
branded products as a category, it is skewed towards a handful of  superstar products, promoted by 
extensive ad campaigns. Like Banerjee, Bode notes that the branded products cater to and are 
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advertised to modern educated urban-middle-class consumers. Profusion of these brands at the 
expense of cheaper indigenous medicine deprives poorer sections from affordable ayurvedic products.  
Against the portrayal of ayurvedic production being dominated by a commercial logic, the 
distinctiveness of the Kerala industry does get noted but gets only perfunctory mention. Leslie (1989) 
makes a brief note on Arya Vaidya Sala (AVS), the largest of the Kerala ayurvedic manufacturers, but 
he uses it as an example to illustrate pharmaceutical firms becoming centers of power, accumulating 
social capital by running educational institutions. Bode (2008) whose five larger manufacturer sample 
includes AVS, notes it as being an exception to the commercial logic. He notes that it has no branded 
products, and consequently the revenue is meager; its profits are diffused across 500 odd products, 
with three top selling products accounting for 20% of the sales. Harilal (2010) does a fairly 
comprehensive analysis of the ayurvedic industry in Kerala based on a sample of 9 large and medium 
large manufacturers. His analysis is primarily quantitative, he assesses the rate of growth and the 
potential and production efficiency based on various  indicators like sales turnover, assets and profit 
margins, and so on.  Noting the preponderance of what he calls ‘pure’ ayurvedic medicines of AVS he 
states, “Though ayurveda in Kerala is modernized, it is not commercialized (Harilal 2010: 128)”.  
Neither Bode nor Harilal take their analysis beyond observing the preponderance of classical 
medicines. Bode’s analysis focused on deriving a common and overarching national trend; examining 
AVS closely to understand the nature and cause of the exception was evidently outside the scope of his 
study. Naturally he did not realize it was not just an exception by itself, but a representative of the 
manufacturing culture in Kerala. If he did, he would have been puzzled to find a model inconsistent 
with the ‘commercial logic’ that he had found dominating the indigenous medicine manufacturing 
industry in the national scene. Harilal on the other hand, perceives Kerala as merely being a little 
slower on the path of commercialization. “Thus though in many parts of India, commercialization is in 
full swing, Kerala is still in the final stages of the process of commercializing its sector. Increasing 
expenditure in packing and advertisement is a sign of increasing commercialization of the Kerala 
ayurvedic industry (Harilal 2010:128)”.  Citing the example of Pankajakasthuri Herbals, a proprietary-
focused company as reflective of the growing trend, he concludes:  
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A major concern is the change in product pattern and importance given by most of the firms 
towards neutraceuticals and cosmetics, and the failure of regulation systems, which may hamper 
the spread of ayurvedic therapeutic tradition and its clinical value in future. Conscious efforts are, 
therefore, required to promote the therapeutic aspects of ayurveda as a system (Harilal 2009:51). 
I argue that, while it is true that industrial commodification in Kerala does share many 
similarities with that of rest of India, to focus on them would be to miss the more important story, i.e., 
the difference. The focus of analysis in Part 1 is this difference, the concrete manifestation of which as 
reflected in the pharmacopeia will be the focus of analysis in Chapter Two.  This difference has its 
roots in the larger climate of ayurvedic practice in Kerala.    
A distinct culture of practice  
December, 27, 2008. International conference of Ayurveda has been in session for the second 
day in the  campus of the National Institute of Ayurveda, in the city of Jaipur. The evening plenary 
session has gathered in the main conference hall to discuss the status of ayurvedic education in the 
country and to propose curricular reforms. Some of the notable people in the field of ayurvedic 
education, representing the government and the premier national research institutes are on the stage. 
The audience include conference participants from all over the country and a large collection of 
students, most of them from the host institution. The key note speaker, decides to wrap up his speech 
with a piece of advice to the medical students in the audience.  
I know that all of you, once you finish your education, will be practicing mostly allopathy. Many of 
you will end up working in allopathic establishments. But I request you, contribute something to 
your profession. Practice at least some Ayurveda!  
While the larger audience received this message in silence, from one corner of the hall a lone hand 
pops up in defiance. A middle-aged man gets up and declares,  
I am a professor from a government college in Kerala. I would like to tell you that not a single of 
my student nor any other student from any other institution in Kerala would practice even an iota 
of allopathy, I can vouch for that.  
The speaker accepting the correction, apologized for the generalization, but justified his remark.  
I have visited Kerala and I do have a fair idea of your culture of practice, although I admit I did not 
know it was so genuine all over the State. I am very pleased to hear that. But anyway I was not 
even thinking of Kerala when I was talking because it is after all a minority exception
27
. I was 
basically addressing the students gathered here, most of whom belong to this institution.   
                                                 
27 Kerala has only 16 of the 215 Ayurvedic medical colleges and 15,068 practitioners, a small number compared to large North 
Indian States (For example, 132,981 in Bihar, 61,240 in Uttar Pradesh, 63,030 in Maharashtra and 47,602 in Madhya Pradesh).  
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The clarification drew a huge murmur from the audience. Overhearing bits and pieces from the 
hushed discussion, I gathered that most of the audience, predominantly North Indian, were unaware of 
the Kerala exception to the rule, and were finding it difficult to digest the piece of information. During 
the rest of the conference I met a number of North Indian doctors most of whom were unaware of the 
Kerala ayurvedic practice culture. The typical reaction was of disbelief.  How is it possible to practice 
pure Ayurveda? It was clearly beyond imagination. A practitioner who had gone for advanced training in 
Kerala enjoyed becoming the center of attention, regaling other practitioners with exotic stories of 
this remote location that sounded like a pipe dream of an ayurvedic practitioner. It also slowly dawned 
on me that what I thought was behind the door practice had in fact become so run of the mill that it 
was perfectly acceptable to bring it up in full limelight on the podium of a national forum, in the 
campus of a premier national institute of Ayurveda.  
The term Ayurallopathy or Ayuropathy, commonly used by practitioners in Kerala (for example, 
Muarleedharan 2006a) best describes contemporary practice of Ayurveda in most of India. A series of 
anthropological surveys of indigenous medicine practice in the mid-60s and early 70s were the first to 
note this trend. An extensive survey of indigenous practitioners represents trends in both North and 
South India. It showed that over 80% indigenous practitioners in Mysore, and 82%  in Punjab prescribed 
allopathic medicines. Powerful antibiotics labeled in English were often misinterpreted by the 
indigenous practitioners. In Mysore, 50% of the patients were getting injections of penicillin (Taylor 
1976). Burghart (1988) has written in detail on the use of injections by ayurvedic practitioners, and the 
manner in which penicillin injection was integrated by vaidyans into the ayurvedic framework claiming 
indigenous origins. A survey of a Tamilnadu town in 1968-69 found that two-thirds of the practitioners 
mixed various traditions (Montgomery 1976).  
The seeds of discontent were sown in the formative years of institutionalization of Ayurveda 
that began in West Bengal in early 19th century.  The Sanskrit College started under British patronage in 
1824 in Calcutta was the first to incorporate parallel instruction in allopathy and ayurveda. Macaulay’s 
infamous educational policy of 1835 proved to be the watershed moment for indigenous education, 
including medicine. The teaching of Ayurveda was abolished from the Sanskrit college. Subsequently 
 35 
 
well-funded allopathic medical schools began to attract talented students including heirs of ayurvedic 
practitioner families. Formal schools across the country had begun to provide ayurvedic students 
exposure to modern medicine and biology. Students of Ayurveda were attracted towards the more 
prestigious allopathy and were giving less attention to classical Ayurveda (Gupta 1976). Given this 
scenario, the expectation was that the indigenous medical systems in India would be eventually phased 
out (For example, Dunn 1976, Taylor 1976).  Though nothing of that sort occurred, colleges of 
indigenous medicine ended up being “backdoors” to allopathic practice of allopathy, for those who 
could not get entry into the allopathic system (Leslie 1976, Bode 2008).  
But the situation in Kerala does not conform to this pattern. In two other conferences I 
attended in 2009 and 2010, I heard the same sentiments repeated over and over again. I met many 
North Indian doctors who were envious about their counterparts in Kerala. It sounded as if they were 
responding to societal expectations than had willingly perpetuated such a culture of practice.  
Practitioners in Kerala talk about a period where the boundaries between allopathy and 
ayurveda were permeable. Just as Europeans were borrowing from the Indian pharmacopeias, 
indigenous practitioners were experimenting with European drugs and extracts. In fact, the early 
ayurvedic degree was conceived as an integrated degree, a generation of practitioners emerged with 
integrated training. At some point of time, there emerged a gradual consensus among ayurvedic 
practitioners  in Kerala to keep away from allopathic medicines and procedures. It is not clear when 
and how this took place. There are  conflicting discourses as to when and who is responsible for such a 
strict compartmentalization to evolve. Investigating them and getting at the bottom of this phenomena 
would be an interesting research project to follow up. Among the others, an important factor to 
investigate would be the significance of allopathic professionalization practices in influencing 
ayurvedic practice. The allopathic practitioners’ body in Kerala is known to be particularly vocal in its 
opposition to cross-over practices. This could be due to the widespread of Ayurveda in Kerala creating 
a competitive atmosphere between the two professions. Additionally, Kerala does not have a 
substantial health care access problem, a factor that promotes the advocacy for indigenous 
practitioners’ rights to practice emergency medicine elsewhere in India.  
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The consumer culture prevalent in rest of India is characterized by a lack of familiarity with 
classical Ayurveda leading people to approach Ayurveda with biomedical lenses. It has led to and is 
further shaped by OTC culture of Ayurveda, where the ayurvedic doctor has very little role to play. 
Nisula’s (2006) study in the city of Mysore in Karnataka State shows how patients impose their 
expectations on ayurvedic doctors drawn from their experience with allopathic medicine and diagnosis. 
She found that, but for a section of people historically exposed to Ayurveda, typically from the elite 
castes, people in general were unfamiliar with Ayurveda. People’s knowledge of Ayurvedic medicines 
was limited to one or two products of leading companies, which she finds contradictory with Trawick’s 
(1992) finding of the widespread popular knowledge of basic Ayurvedic concepts (in South India). 
Many of the non-Keralite doctors I spoke to expressed unhappiness about being relegated to the 
margins. One said he would have to shut shop if they were to practice pure Ayurveda. But they also 
mentioned of a minority of “pure Ayurveda” practitioners who catered to a discriminating audience 
from among the elite. Less educated masses who had little historical knowledge of Ayurveda were said 
to be attracted towards the prestigious allopathy. A particularly candid practitioner in Southern 
Karnataka, Dr. Shastri, told me that people preferred to come to him even for allopathic medicines 
because they found allopathic doctors to be intimidating and dismissive of their preferences. Unlike 
allopathic doctors he was open to patients negotiating diagnosis and prescriptions. Though initially he 
was against many popular “superstitions” (for example, tying a talisman), he soon found it was 
beneficial for his practice to let them stick to their beliefs. He spoke of the existence of a small set of 
‘pure’ practitioners in the region, listing a couple of names of such doctors in neighboring towns.  Such 
practice, he said “is only possible if you are treating upper class and educated, who are usually 
discerning, and are by tradition familiar with Ayurveda”.   
The consumer culture in Kerala is different. Though allopathy is the official and the dominant 
system of medicine, Ayurveda and homeopathy have their own niches. By and large, patients tend to 
choose each system of medicine for specific reasons, based on their historic experience of efficacy. 
Cross-over practice is considered quackery simply because of people’s familiarity with each system that 
leads them to have system-specific expectations. Besides this, unlike in rest of India, Ayurvedic 
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practice and consumption in Kerala cut across all socio-economic barriers. None of the interviewed 
Ayurvedic practitioners in Kerala found distinctness in patient profiles in terms of education, class, 
caste, religion, or region. What was special about Kerala? After all, it was the regions skirting the 
Himalayan belt and the Gangetic plain in the North that were the ancient centers of codification of the 
formal ayurvedic system of medicine. How did the southernmost state of Kerala become a stronghold 
of this medical tradition? In chapter 3 I present ethnographic evidence on practitioner landscape of 
Kerala along with a brief historical analysis that throws some light on the distinctness of the ayurvedic 
culture in Kerala.  
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2. CH 2 OPEN-SOURCE COMMODITIES 
Things resist the process of commodification either owing to inherent physical limitations or 
due to a variety of formal and informal socio-cultural barriers. Unlike art and fashion commodities that 
are a common focus of ethnographic research, medicine is characterized by specific need-driven 
consumption, arising out of circumstances of an illness condition. This limits its consumption to a 
narrow and limited context. The process of ‘commodification’ is nothing but extension of the 
commodity form to new spheres. Kloppenburg (2004) points out that capitalism constantly pushes 
against the barriers posed by the commodity in order to expand it to new commodity spheres, a 
process termed by Marx (1876) as ‘primitive accumulation’. In the context of capitalist extension into 
farming, Kloppenburg shows how the seed was turned into a commodity by breaking existing barriers, a 
process facilitated by advances in science and technology. The biological barrier of its inherent 
replicability was broken with hybrid technology; the institutional barriers of public sector breeding was 
broken through political strategies that included policy making.  
Medicine, being more in the expert realm than farming, is even more susceptible to primitive 
accumulation through advances in science and technology. Biomedical pharmaceutical manufacturers 
use various strategies to lower both technical and social barriers to expand the commodity context. 
One way is attempt at extension of medical jurisdiction or expansion of medical boundaries, commonly 
referred to as ‘medicalization’ (Conrad and Leiter 2004). This is often done in by redefining categories 
of health and disease either by narrowing the definition of health so that normal experiences get 
labeled as pathologic or by expanding the definition of disease (Woloshin and Schwartz 2006). 
Pharmaceutical industry is considered the prime stakeholder that attempts to influence this process, 
what Moynihan and Henry (2006) term ‘disease mongering’.  
But classical medical systems are inherently less vulnerable to commodification because the 
knowledge that goes into the making of medicines is not entirely produced and owned by centralized 
institutions. There is a large component of knowledge that can be considered ‘open-source’, that is 
knowledge based in documents that are open to all for use and experimentation. Though biomedicine 
also derives much from open-source knowledge, the nature of the commodity and the political 
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economy of the system is such that the products tend to be inherently conducive to intellectual 
property ownership. Certain inherent features of ayurvedic classical medicines make them less 
amenable to ‘primitive accumulation’ (Section 2.1). Firstly, being open-source there is no scope for 
intellectual property exclusivity. Secondly, the humoral context limits their circulation to doctor 
mediated ayurvedic contexts.  
In most commodities, traders, markets and middlemen play an important role in the fashioning 
of taste and creating demand (Applbaum 2005). But the peculiarity of the medicine commodity is that 
its consumption is mediated by an expert, the doctor, whose mediation is mandatory for prescription 
products. Unlike standard setters of luxury commodities, doctor mediators are in charge of 
commodities meant for solving a practical problem that is often life-critical. The biggest barriers for 
commodification of pharmaceutical commodities or service in any system of medicine is  therefore the 
doctor. As long as the doctors are rooted strongly in practitioner ethos, they can be a serious barrier 
for pharmaceutical producers. Paradoxically, they also hold the potential to become the most 
conducive vehicles for medicine commodities. If capital has to get more hold on medicine, it has to 
either circumvent or co-opt this barrier. Ayurvedic industry in rest of India broke the barriers of the 
classical commodity to expand its market and make it more profitable using two strategies. First was to 
target the consumer by focusing on OTC products both by selling of traditional OTCs and diversion of 
classical products to OTC segments. This is also a common strategy employed in the biomedical 
pharmaceutical market (Cohen et al 2004). Second was to target proprietary therapeutic products, 
referred to as ‘ethical products’ using the allopathic doctor as the mediator. Strategies used by large 
scale ayurvedic manufacturers are analyzed in detail with the help of secondary data in Section 2.3. To 
use Appadurai’s (1986) conceptual framework, the former strategy can be called a ‘diversion’ from the 
established path, whereas the latter strategy is an attempt to “enclave” open-source products as 
proprietary. Both these strategies sidelined the ayurvedic doctor as the expert mediator and diverted 
ayurvedic products out of their humoral context.  
In direct contrast with the proprietary-medicine focus of ayurvedic industry in rest of India, 
manufacturing industry in Kerala has maintained a distinct culture of commodification surrounding 
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“open-source” commodities, i.e., classical medicines. Section 2.4.1 brings evidence from field work to 
substantiate. Section 2.4.2 shows how proprietary focused manufacturers who diverted from this trend 
were also heavily invested in the classical market. In Section 2.4.3, I briefly point out changing trends 
in the Kerala Ayurveda market, proliferation of blockbuster OTC products and changing consumer 
preferences to palatable and convenient products.  
In section 2.5 I question the representativeness of turnover as an index for classical medicine 
consumption. In Section 2.6 I suggest that Kerala ayurvedic manufacturers foray in new segments like 
cosmetics can be considered more as a ‘diversification’ than ‘diversion’. I argue that neither OTCs nor 
cosmetics have the potential to displace classical medicines and that the greatest threat is posed by 
the ethical/prescription product segment. In Section 2.7 I suggest that though the status of classical 
medicine may appear pale amidst the clamor of new commodities, a potential of revival cannot be 
ruled out. Proliferation of “brand Kerala” across the country and expansion in the therapy segment in 
the post-tourist era could be contributing factors. 
In contrast with rest of India, in Kerala ayurvedic classical products are sold through a network 
of exclusive pharmaceutical agencies most of which are equipped with doctors. Section 2.9 provides a 
brief ethnographic description of the ayurvedic retail segment in three locations in Kerala. Section 
2.9.1 provides a break up of OTC consumption in the ayurvedic agencies. In Section 2.9.2, I argue that 
the agency distribution model is indispensable for making classical product marketing a viable 
proposition. In section 2.10, I argue that ayurvedic manufacturing in Kerala remains distinct because it 
is rooted in practitioner ethos. The continued involvement of proprietor-managers of ayurvedic 
companies in clinical practice at both personal and institutional levels makes them natural stakeholders 
in therapeutic Ayurveda in contrast to manufacturers outside Kerala whose identity is limited to being 
sellers of ayurvedic pharmaceutical commodities.  
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2.1 Classical ayurvedic medicine: a barrier to commodification 
2.1.1 The open-source barrier 
Classical medicines can be best characterized as ‘open-source commodities’ that are based on the 
collective knowledge of the community expressed in various classical texts. In many respects they are 
similar to biomedical generics28. Technically, they are based on formulations provided in the 56 texts 
approved by the 1940 Drugs and Cosmetics Act, the legislation that governs manufacturing and 
distribution of medicines. But practically, in Kerala, they also include formulations based in popular 
oral traditional knowledge or regional texts that do not figure in the official list.29 Manufacturers have 
no choice but to register such medicines as proprietary.  
Classical medicines have inherent features that make them recalcitrant to commodification 
beyond simple scaling up of production. Both medical formulations and categories of diseases are 
derived from an already existing historical textual framework, neither of them shaped by market 
forces. As will be discussed in detail in Part 2, ayurvedic knowledge production is historically 
decentralized. Unlike biomedicine, products and information do not flow from laboratories to 
practitioners. Also because they are open-source, manufacturers have no product exclusivity, and this 
works advantageous to customers. Accessibility is high; consumers are free to pick a brand of their 
choice, and competition between manufacturers keeps prices in check.  
2.1.2 The humoral barrier 
Classical products pose significant barrier to unlimited commodification because they are embedded in 
a humoral context. The primary target consumers are ayurvedic physicians who acts as  expert 
mediators in their end consumption. These medicines are not only unintelligible to common people, in 
their original form they remain outside the purview of practitioners of other medical systems. The 
formulations are invariably polyherbal, containing an average of 10-30 herbs, some of them going 
above 100. The combinations are based on a complex ayurvedic pharmacological logic (See Section 
5.5). Compared to biomedicine that defines and measures diseases by concrete parameters and treats 
                                                 
28 The term generic is often used to refer to classical products, but Bode (2008) points out it is incorrect because the term 
suggests uniformity, while Ayurvedic compositions vary.  I prefer to avoid the term because generics in biomedicine are products 
that move out of the patent regime, which is not so in Ayurveda.  
29 Some popular texts that are not part of the official list include Chikitsamanjari, Yogamritham, Vaidyamritham and Jyotsnika. 
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with one or two molecules, Ayurveda looks at disease as a complex of symptoms that have systemic 
and individually variable causes. Hence, the treatment protocol is complex and unpredictable. For 
instance, classical Ayurveda recognizes 20 types of diabetes, each of which demands a different 
protocol (Agnivesh 2008). Though most practitioners might depend on the blood sugar count for 
diagnosis, treatment prescribed varies  depending on their diagnosis of humoral factors involved. Due 
to this complexity, the average patient has no clue as to the action of a particular medicine and 
doctors do not go out of their way to explain unless they find the patient curious or knowledgeable, not 
different from biomedical practice. However, over long term use, patients do associate certain 
medicines with certain conditions, a knowledge that they use to self-medicate.  
The names of ayurvedic classical poly-herbal formulations are not designed for lay people. 
They typically begin with the name of the medicinal herb which is considered the primary ingredient 
(E.g., in Patoladi decoction, where the herb patola is primary and the adi suffix means “and so on”) or 
by the names of groups of drugs (Dashamoolarishtam, vine of ten-roots, a class of drugs), or after the 
scholar-sage who is the formulator 
(Agastyarasayanam after sage Agastya). Very 
rarely do medicine names refer directly to a 
disease. For example, though many regular 
users may be aware that the ayurvedic 
decoction Nishakathakadi, is used for diabetic 
treatment, there is nothing in its name to 
indicate that. On the other hand, almost every 
proprietary product begins with the name of 
the disease condition, either the English name Dia, (E.g. Diarid, Diabecon) or with the Sanskrit word 
Madhumeha or Prameha (for example, Pramehoushadhi). Like biomedicine, these medicines are 
disease-centric than patient-centric and are therefore amenable to self-prescription. 
The ingredient list on the classical product is aimed at physicians rather than the end user. 
Each herb is aimed at a specific pharmacological function, the significance of which only a physician 
 
Vaidyan-owner of an ayurvedic classical  
medicine agency 
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would be able to comprehend. Consumers are unlikely to buy a product because it contains a particular 
herb or set of herbs. Many proprietary drugs on the other hand aim at ‘star herbs’ as a selling point, 
cashing on people’s familiarity with herbs. For example, one of the best selling proprietary medicines 
in Kerala is a cough syrup based on the sacred herb tulasi,  which is also a commonly known home 
remedy used to treat coughs and colds. Another good example is the commodification of the index herb 
brahmi’s popular image, of being a memory enhancer (See Section 9.5).  
2.1.3 Commodifiable features of classical medicine 
Though classical medicines are resistant to some facets of commodification, they are 
susceptible to two of the tactics regularly applied to push medicine consumption: over-emphasis on 
medicines in comparison to non-medicine methods of treatment and over-prescription (prescribing 
excessive number of medicines). Both of these are probable, when a practitioner profits from the sale 
of medicines. Though most ayurvedic doctors working in agencies are paid on a retainership basis, it is 
common for the agency owners to give additional commission on medicine sales.  Though not a 
common practice, one  manufacturer known for their aggressive marketing practices was reportedly 
providing incentives to doctors in the form of providing “one medicine free for one sold”. It is difficult 
to investigate the extent of such practices without a detailed study of prescription patterns. Based on 
observations of clinical encounters and conversations with consumers in Kerala, I conjecture that three 
factors act as a check to such practices.  
1. Peoples’ traditional familiarity with treatment process provides a check against over prescription. 
In Kerala, it is common to hear complaints regarding commercial mentality of doctors over-prescription 
of laboratory tests, allopathic medicines and surgical procedures. This concern extends to practitioners 
of other systems. By habitual consumption people tend to have an estimate how much a treatment 
episode should cost. For example, Sajikumar, a Malayalee resident of Mumbai went to the agency of a 
reputed Kerala manufacturer to consult a doctor for his persisting cold. He was prescribed a course of 
medicine that cost him ` 500 ($10), way beyond his estimated cost. Though the money was not a drain 
on his upper middle class pocket, he felt so upset on being taken for a ride that he swore he would 
never visit that agency again. A doctor who makes it a practice of overprescribing is in danger of losing 
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customers in the long run. An average customer may not be able to discern this, but a few informed 
customers are sufficient to spread the word. Raw drug shop dealers and experienced retail ayurvedic 
shop keepers can recognize anomalies in practice and pass on their observations to  regular customers. 
Here is an example from the field to illustrate.   
A rural middle class patient went to buy medicines from a raw drug shop with the local 
government ayurvedic doctor’s prescription which listed three classical decoctions and one 
proprietary medicine. The raw drug shop keeper who knew her well, made an oblique comment on 
the increasing fashion of prescribing expensive proprietary medicines, stating that he did not 
prefer to stock such medicines. “Customers who come to me typically cannot afford such pricey 
medicines” he said. The patient got the message. She decided to stick to the classical protocol 
and ignore the proprietary medicine30.  
2. Ayurvedic doctors who have a traditionalist service ethic opposed to commercialization provide a 
standard of comparison for the consumers. As patients in Kerala are prone to cross-consultation they 
are highly likely to compare doctors on different parameters including expenses.  
Sarala, a Malayalee working woman who lives in Mumbai had consulted several doctors in Kerala 
for a complicated health problem. She had plenty to say about each experience, both ayurvedic 
and biomedical. On one extreme was a traditional vaidyan family owned hospital in her native 
place in Thrissur that made her undergo ‘‘unnecessary’’ therapies. On the other extreme was an 
average ayurvedic doctor  in her town who strictly told her he could treat her only if she could 
come in every 4th day to give feedback so he could tweak the medicines. Since this was not 
practically feasible for her, she consulted another reputed traditional family elsewhere in Kerala, 
which despite its ‘staunchness’’ and ‘non-commercial’ approach was open to remote treatment.  
Sarala had developed her own critique of the medical system, both allopathic and ayurvedic, especially 
about who was money-minded and who was not. Over a life time, patients accumulate this wisdom not 
only from personal experiences but also from socially acquired knowledge.  
3. Doctors who have commercial inclinations are likely to focus on more lucrative options, propriety 
medicine prescription or/and over-prescription of services (see Section 8.10).  
2.2 Commodification of Ayurveda in rest of India: Breaking barriers 
As manufacturers evolved from traditional vaidyan families to large business houses, controlled 
more by business interests than professional ethos, they began to be disinterested in low-margin 
classical medicines. Some of the major ayurvedic manufacturers were associated with the manufacture 
of allopathic medicines from their early days. They brought their experiences with allopathic 
                                                 
30 She did not tell this to the doctor, as it is a common practice for patients to ignore one or two medicines that did not confirm 
to their expectations. 
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proprietary products and expectation of high profit margins to the ayurvedic market. Two different 
strategies emerged that enabled them to break the biggest barrier that classical medicines posed to 
commodification – the ayurvedic doctor. To use Appadurai’s (1986) concept, diversions were created 
from established paths of medicine commodities to expand their market.  
1. To focus on OTC products targeting segments of popular demand. These products could be sold to 
consumers without the barrier of the physician.  
 
2. Targeting prescription products to the allopathic physician circumventing the ayurvedic physician.  
The account here is based on secondary sources like brochures, published company financial accounts, 
company websites, business reports in the media, and press releases.  
2.2.1 OTC product focus 
In Ayurveda, there is no official demarcation between OTC and prescription products; 
categorization is left to the discretion of the individual manufacturer. It was Dabur which took the 
initiative in developing the ayurvedic OTC segment. The founder’s son, a business graduate of Harvard, 
is credited with the new business strategy that shifted its original classical focus to OTC products. The 
OTC segment that includes nine products with annual turnover of a billion rupee ($20 mn) each, 
brought in 80% of Dabur’s ` 20 billion ($40 mn) revenue in 2007.  The marketing of Dabur is now done 
through a gigantic network of 50 C & F agents, 5000 distributors and 2.8 mn retail outlets spread across 
India (Dabur 2010). Distribution of OTCs ‘diverted’ from its original ‘path’ (Appadurai 1986). The retail 
outlets that sell these medicines range from large biomedical stores to tiny general stores, from 
supermarkets to paan-beeda (mouth-freshener cum digestive) stalls. Zandu Pharmaceuticals followed 
suit. The company is now most known to Indians by its flagship product, Zandu Balm31, a pain balm. 
From just 70 odd distributors in 1976, Zandu has grown to 1500 distributors supplying through over one 
million retail outlets across India. The turnover of the company touched ` 1.5 billion ($30 mn) in 2008, 
with OTC products accounting to 90% of the turnover; 4-5 OTC products contribute to 60% of its total 
sales in the year 2003 (Financial Express 2003). Baidyanath, a company from Eastern India also followed 
this model marketing its OTC products through 10,000 distributors and over 100,000 retail outlets in 
                                                 
31 With 25% of market share in the pain balm segment, the product is so popular that it has become synonymous to pain balm. In 
Sep. 2010 the name of the product was used in a figurative sense in a Bollywood chartbuster, leading to legal action from the 
company for infringement of trademark, that was rescinded later after the company realized its publicity value.  
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addition to 3500 odd exclusive showrooms (Baidyanath 2012).  
The OTC class of products can be classified into five types.  
1. Traditional OTC segment: Most ayurvedic OTC products are those they naturally belong in that class; 
there is no product diversion or breaking of traditional barriers. Common categories are digestives, 
carminatives, pain balms, topical applications for skin problems, and expectorants.  
2. FMC(H)G (Fast moving consumer/health goods) segment: A new trend emerged in late 90s when all 
OTC focusing companies expanded their range to include FMCG, comprising mainly of ayurvedic 
cosmetics like soaps, toothpastes, hair conditioners, skin creams and a few common medicine products 
like digestives, cough and cold relievers, oral health and baby care products. This segment grew large 
enough to be newly designated as FMHG (fast moving health goods). The trend setter in the segment is 
again Dabur, the 4th largest FMCG manufacturer in India. Himalaya entered the OTC-FMHG market only 
in 1999, with a launch of its ‘Personal Care’ range. On the occasion of the release the CEO pointed out 
that while for medical problems consumers prefer quick-relief to Ayurveda which is “perceived to be 
long drawn out cure’, “in the FMHG and Personal Care segment..is a much greater acceptance of 
ayurvedic products” (Business India 2004). Baidyanath made its foray into the FMCG industry in 2002 
with its new subsidiary (Ayurvedanta Pvt. Ltd.), (Chatterjee 2002). Ethical product-focused Charak 
Pharma too entered the OTC segment in 2000, after forging a joint venture with Nicholas Piramal, a 
biomedical pharmaceutical company (Jagdale 2007). 
3. Diverted classical products: Some classical products are marketed as OTC, an example of a 
‘diversion’. For example, though classical, Chyawanaprash, the largest selling classical ayurvedic 
medicine, is heavily advertized to consumers as a health supplement tonic. Dabur which popularized 
the product accounts for over 65% of the product’s market share (Dabur 2010). Most large 
manufacturers except those in Kerala have followed in the footsteps of Dabur. From the perspective of 
classical tradition, selling a classical prescription medicine as OTC, even if it is traditionally considered 
a tonic, is unacceptable. Manufacturers outside Kerala conveniently overlook this distinction in the 
desire for expanding the market. Over time, such diversions from classical to OTC appear to have 
achieved a status of common sense logic. Take for example, the statement made by the proprietor-MD 
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of Baidyanath in a recent television interview. When asked if it was appropriate to self-medicate, the 
MD said nonchalantly “In Ayurveda you can completely self medicate. Just don’t overdo it, but you can 
completely self-medicate”. He lauded the popular use of Chyawanaprash, and went on to add, “certain 
fermented preparations like Arjunarishta are excellent heart tonics”. He said it was safe to self-
medicate “because ayurvedic medicines have no side effects.” (NDTV 2010). The “no-side effect 
status” of ayurvedic medicines has  achieved a level of convenient common sense among 
manufacturers and sellers of ayurvedic medicine.  
4. New segments of consumption created: As discussed earlier, classical medicines do not yield for easy 
commodification because the categories are based in a therapeutic context uninfluenced by  
commodity pressures. Branded commodities provide the flexibility to create new categories. The 
discussion in Chapter 9 will show how non-traditional stakeholders use this flexibility to create new 
segments, that include memory enhancers, aphrodisiacs, anti-obesity and anti-stress medications. 
5. Commodifying single herb identities: Himalaya initiated another trend, of selling single herb 
capsules, which perhaps evolved out of their focus on global market. Beginning with 12 herbs in 2002, 
the company now makes 27 single herb capsules of herbs like Tulasi and Neem. Of late, many 
manufacturers have begun to imitate the trend. Only one of the big five manufacturers of Kerala, 
(Nagarjuna Herbal Concentrates Ltd.) sports single herb products that find mention only in its export 
portfolio. Such products usually ride on the prevalent popular knowledge of herbs and their medicinal 
properties – brahmi  for enhancing memory, ginger as a digestive, garlic as hypolipidemic, Tulsi as an 
antioxidant, Asvagandha to promote vitality, and so on. The others are lesser known but potent 
medicines that target high-prevalence disease categories, for example, Arjuna as cardiac support.  
2.2.2 Ethical/Prescription product focus 
Humoral diagnostic thinking of the ayurvedic physician was a barrier to selling products by 
biomedical disease categories. Himalaya Drug Company pioneered in breaking this barrier in another 
innovative way, by focusing on prescription products at the biomedical market, a strategy that Bode 
(2008) terms “biomedical enclaving”. It was a German consultant who turned the focus of the company 
towards allopathic physicians, in the mid-60s. It made market sense to target a large and lucrative 
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market that drew crowds rather than depend on a effeminate 
ayurvedic system. One of Himalaya’s early 
prescription products launched in 1955, a hepato-
protective syrup known as Liv 52 went on to become 
a blockbuster drug, featuring among the top 15 
Pharma products (including biomedical). The 
turnover of Liv-52 as reported in July 2010 was ` 1.2 
billion ($24 mn), higher than the total turnover of 
the largest manufacturer of Kerala. Today Himalaya 
has a pharmaceutical range of 40 products mainly 
aimed at biomedical physicians (Himalaya 2012). 
OTC-focused companies like Dabur and Zandu are not highly invested in the prescription 
product segment32. Large companies with a strong prescription product focus are Charak Pharma (estb. 
1947, turnover: $22 million in 2006) and SDL (Estb. 1853, turnover: $20 million in 2005). Charak’s 99% 
sales is from the prescription segment (1% from OTC)33. In a media interview, the MD of Charak said,  
Sixty years ago, information related to ayurveda was available in a generic form.… Initially we had 
to work hard to change the identity of ayurvedic medicines, which were tagged as a crude form of 
medicines. However, we managed to turn them into an acceptable form having a scientific base 
(Jagdale 2007). 
Despite being strongly rooted in the ethos of a vaidyan family, SDL’s product strategy of the company is 
not different from the other large manufacturers. Though the company launched its ethical segment in 
1975, it is only after forging their joint venture with Nicholas Piramal that there was a serious shift in 
focus. Because “the needs of the consumer changed from the traditional products to branded 
products… Ethical marketing became the forte of the company.” Later in 1998 it spun off its ethical 
division as a separate company.34  
                                                 
32 Dabur’s attention to this market is recent, with the establishment of Dabur Ayurvedic Specialties in 1995.  The division has only 
9 medicines that brings in 15% of the turnover. The ethical division of Zandu started in 1978 nets in 10% of the sales. The highest 
selling ethical drug categories are arthritis, gynecological problems and nervous disorders. 
33 This includes 42 products sold to allopathic doctors through 500 medical representatives, 1500 stockists and 100,000 chemists. 
Besides general physicians, their main catchment comes from gynecologists and GE specialists (IIFL 2004).   
34 Shree Dhootapapeshwar India Limited, e-brochure. www.sdlindia.com 
 
Himalaya’s eye-catching stall at an ayurvedic 
industrial exposition 
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2.2.3 Classical segment 
Baidyanath, a ` 350 mn ($7 mn) turnover company based in Calcutta, founded in 1917 by an 
ayurvedic vaidyan, is perhaps the single large manufacturer outside Kerala who has close links to 
classical Ayurveda. Though their turnover comes mainly from OTC products, they have a large range of 
700 products most of which are classical (NDTV 2010). But for Himalaya and Maharishi, other 
manufacturers maintained their core range of classical products35, though the share in turnover is 
insignificant, that is less than 10%. In 2008, Dabur’s ayurvedic division with 350 classical products 
brought only 7% of the total revenue, so negligible that it is almost equal to their revenue from a single 
blockbuster OTC product. The only two classical products of Himalaya are Chyawanaprash and Triphala 
that are as good as OTC outside the Kerala market. Some of their prescription products are based on 
classical (for example, Geriforte, a geriatric rejuvenative based on Chyawanaprash), but its classical 
identity plays no role in the marketing of the product.  
2.2.4 Global focus 
Though Himalaya has a considerable global focus and orientation, the pioneer in the field is 
MAPI (Maharishi Ayurveda Products International), for whom the primary market is the western market. 
Export market accounts for 50-60% of their 2 billion rupee turnover. MAPI is the pharmaceutical wing of 
the organization founded by Maharishi Mahesh Yogi, founder of the Transcendental Meditation 
movement in 1985. He created an almost parallel version of Ayurveda that came to be known as 
Maharishi Ayur-Ved, and was instrumental in popularizing Ayurveda in the West. Jeannotat (2008) calls 
it the first attempt at globalization of Ayurveda.  Naturally, the product portfolio had to be modified. 
Firstly, medicines had to be packaged as herbal supplements (for example, BP support, cardio-
balance). Secondly, they had to fit into categories that western consumers were more tuned to, like 
herbal teas and cosmetics. Some of their best selling products are, Deep Rest, Blissful sleep, Stress 
free mind.  Another significant departure is that the formulations sold in the West include local non-
Indian herbs.  
                                                 
35 Zandu makes around 300 classical products, SDL makes around 130, Charak has a narrow range of 80 products. 
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2.2.5 Ayurvedic cosmetics 
A few large cosmetic companies like Emami and Aimil are known for their historic focus on 
herbal commodities. Their ayurvedic connection is too tenuous to designate them as ayurvedic 
manufacturers. Until the recently acquired international prestige of brand ‘Ayurveda’, very few 
cosmetic manufacturers targeted the ayurvedic market. Products in the ayurvedic segment were 
limited to a few famous products like a skin cream (Vicco turmeric ayurvedic cream) and a toothpaste 
(Dabur Lal Dant Manjan). Several small companies were locally marketing traditional tooth care 
powders and hair oils, though they were rarely marketed as ‘Ayurvedic’. Kerala was the only State that 
had an Ayurvedic soap segment initiated and dominated by Chandrika since 1940. In the past decade, 
the rising prestige of Ayurveda has caused many cosmetic manufacturers to label their products 
Ayurvedic (for example, Shahnaz Herbals). Historically, registration as Ayurvedic proprietary medicine 
was a strategy used for getting into a lower tax bracket (4% instead of the regular 11% on cosmetics). 
Of late, however the cosmetics trend has caught on with most of the large ayurvedic manufacturers36.  
2.3 Commodifying without breaking barriers: Manufacturers from Kerala 
In complete contrast to the proprietary-medicine focused ayurvedic industry in other parts of 
India, manufacturers in Kerala have been heavily dependent on the classical market for their bread and 
butter. The 1.3 billion rupee ($20 mn) annual turnover (2007-8) of Arya Vaidya Sala (AVS) from Kerala 
(one of the top ten, the largest in South India), is spread over 550 classical products. For more than a 
century, the company had no proprietary product. The next four companies from Kerala (annual 
turnover of ` 300-500 mn/$6-10 mn) are also classical-focused.  
 Vaidyaratnam Oushadhashala has a narrow range of around 20 proprietary products. Around 400 classical 
products constitute 80-85% of the market share. 
 Arya Vaidya Pharmacy (AVP) in Coimbatore derives around 80% of their revenue from 450 classical medicines, 
despite a repertoire of 50 proprietary medicines. 
 Oushadhi,  the state-owned pharmacy that mainly supplies to the government system makes around 400 
classical medicines that contribute to 90% of its turnover. 
 Nagarjuna Herbal Concentrates Ltd. (here onwards Nagarjuna) established in 1999, stands apart from the 
others. Started by entrepreneurs from a non-ayurvedic background, it has a corporate identity and a local 
reputation for relative aggressiveness to marketing. Despite this, 75% of their turnover comes from around 350 
classical medicines, 15% from 35 ethical/prescription products and 10% from 18 OTC products.  
                                                 
36 Himalaya launched Ayurvedic Concepts, a range of personal care products in 1999 that grew to account for 40% of sales within 
3 years (Himalaya 2012). In 2002, Baidyanath acquired Puma, an export company, to enter the skin and hair care segment 
(Chatterjee 2002). SDL entered the health care product market with its product range Aashwamedh, to market single herb 
tablets, herbal oils, teas and cosmetics. In mid-2008, Zandu was acquired by Emami Ltd., a Kolkata-based six  billion rupee ($ 
120 million) herbal cosmetics company, severing it from its traditional vaidya family roots (Financial Express 2008). 
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All of the small and micro manufacturers interviewed except one, reported that they were 
heavily dependent on classical medicines for their survival. Of the three medium large companies, 
classical products constitute 80-90% of the turnover of the SNA Oushadhashala (SNA) and Sitaram 
Ayurveda Pharmacy, both based in Thrissur. The third, KAL (Kerala Ayurveda Limited) based in 
Ernakulam has shifted more towards branded medicine following its recent acquisition by a non-
traditional stakeholder. It still derives most of its bread and butter from classical, but is relatively 
proprietary-focused, with 50 products accounting for 40% of its annual turnover of around ` 180 mn 
($30.6 mn) in 2009. 
There is an uncanny parallel between the ayurvedic and the movie industries of North Versus 
Kerala. The nine OTC products of Dabur grossing a billion rupee turnover each are akin to Bollywood 
blockbusters, both making money by selling fantasies. The average Bollywood blockbuster showcases 
protagonists from upper middle class who live in sprawling urban apartments driving imported cars and 
dining in five star hotels. In contrast, box office hits in Kerala are low budget Malayalam movies 
grounded in daily life dealing with subjects of concern to the middle class and the working class. In a 
somewhat similar vein, Ayurvedic manufacturers of Kerala sell plain classical products to meet 
everyday therapeutic needs.  It is the demand that drives the ayurvedic industry in Kerala. Dabur and 
the other North Indian companies on the other hand, are heavily depend on blockbusters that are 
meant to cater to the moneyed class. They splurge millions on product advertising (i.e., 15% of the 
turnover (Dabur 2010)) and are also heavily dependent on celebrity endorsements. The advertizing 
techniques and images used by them have been subject to detailed analysis (for example Nichter 1989, 
Bode 2008). AVS does not advertize products, neither do most of the large manufacturers. It spends  
little over 2% of its revenue on advertising. The most non-traditional of the large manufacturers, 
Nagarjuna spends 10% of its sales value, KAL 5% (Harilal 2010). Bode reports AVS’s justification against 
advertising ayurvedic formulas to the public, quoting the  Marketing Manager, 
 When you advertise products to consumers you have to give general indications for us which 
they can understand. This is contradictory to ayurveda where medicines have many uses 
depending upon the humoral characteristics of patients, ailments and environments. (Bode 
2008: 126) 
Most classical focused manufacturers focus on promoting the brand rather than products. The usual 
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advertisement is a reminder of the legacy of the establishment, its traditional reputation in therapy 
and quality of medicine production. An innovative AVS advertisement in a recent Malayalam health 
magazine Mathrubhumi Arogyam, simply attempts to remind the fast modernizing Malayalee the  
significance of a popular cultural therapeutic practice of Ennnathechukuli  (Malayalam term for 
applying medicated oil before bath), touting it as “the ayurvedic secret” for promoting “youthfulness”. 
 
Kerala Ayurveda Samajam’s full page ad 
with institutional profile and history 
 
 There was an ascendance of proprietary focused companies in Kerala in late 80s-early 90s. 
Some like Nupal were classical  product companies that evolved a proprietary focus. Companies like 
Kandamkulathy Vaidyasala and Pankajakasthuri began with proprietary and built their empires over the 
success of one or two products, but eventually expanded to include the full range of classical products.  
Kandamkulathy Vaidyasala  is a classic case of an entrepreneur son 
capitalizing on the family vaidyan tradition. The founder K. P. Pathrose 
belonged to a Catholic family of Kandamkulathy in interior Ernakulam. The 
vaidyan in his life time had expanded practice to three locations in the 
neighborhood towns and had acquired a local reputation. In the early 80s, 
after his passing away, his son took reins of his small vaidyashala (pharmacy). 
In 1988, he took up Eladi Lehyam, an expectorant which was part of their 
family medical kit, and launched it in the market as an OTC product. He 
conceptualized it to be sold in sizes and prices that suited people’s pockets. 
This strategy went on to be a great success. Now it is their flagship product 
bringing in 50% of the company’s annual revenue. Though the product has 
many competitors now, Eladi still enjoys much of the market share. Two large Kerala based 
companies and even Dabur which has a reputed product in the segment in the North failed in their 
efforts to market a competing product. All proprietary products put together account for around 
60% of their total turnover of the company that approached ` 70 mn ($1.4 mn) in 2008-9.  Despite 
the aggressive OTC model, 40% of the revenue comes from classical products sold through 68 
 
Brand advertisement of Vaidyaratnam Oushadhashala 
 
 
Eladi lehyam  
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exclusive agencies concentrated in Central Kerala. In 2002, they launched the brand of 
Ayursoukhyam, short listing some of the agencies to provide treatment facilities. The company is 
also an active participant in the tourist market37.  
Pankajakasthuri Herbals India, a multi-million dollar company started with a single product in 1988.  
The founder Dr. Harindran Nair is a modern ayurvedic practitioner-entrepreneur. 
He began as an ordinary ayurvedic doctor who designed a medicine for respiratory 
illness. Confident of its efficacy, he attempted to sell it personally to doctors 
going around on a motorbike. Finding the going slow, he decided to switch to 
aggressive ad-based selling. Today the flagship product, Pankajakasthuri Breathe 
Eazy contributes 70% of the total turnover of ` 220 mn ($4.4 mn) (2008-9). In 
contrast to classical-based companies, it spends 25% of its turnover in 
advertisement. However, despite the initial focus on a single product, the 
company has evolved into a full-fledged ayurvedic manufacturing company. Its 
ethical division has 13 products and classical division has around 440 products. 
Medicines are sold through franchisees branded Pankajakasthuri Jeevanam. (from 
various Press Releases, Pankajakasturi, n.d.) 
 
Despite the fact that their revenue is earned by a single product, both take the trouble of 
manufacturing a large classical pharmacopeia, opening exclusive agencies to distribute and provide 
consultation. In the Kerala market, growing from rags to riches with a few branded products does not 
earn respect. To be considered at part with the established  manufacturers, it is imperative to get into 
the full range of activities connected to what is considered ‘serious Ayurveda’38. Manufacturers based 
in the classical tradition that dominate the Kerala Ayurveda scene sneer at those who make quick 
money with a few products. Companies that make money by selling cosmetics like soaps get even 
scantier respect. Commitment to serious medicine making on the other hand commands high esteem, 
irrespective of its profit potential. However, it should be noted that though identity does matter in 
influencing market strategy, the driving factor as of today is the market. The two cases discussed 
above show that classical market continues to make business sense in Kerala; identity as of now is more 
a by product than a causal factor. However, there is some change in the Kerala manufacturing scenario 
in the past half a decade. A distinct breed of ayurvedic companies has come up. These have opened up 
new market segments, the most popular being cosmetics, anti-obesity drugs, and aphrodisiacs. Many 
traditional stakeholders who shied of cosmetics are now making ayurvedic soaps, opening up new 
divisions to handle marketing or forging strategic alliances with non-ayurvedic companies. They are 
                                                 
37 Source: Mr. Babu Joseph, General Manager, Kandamkulathy Vaidyasala.   
38 This is not a consciously expressed sentiment, but a deduction I have made based on various statements made by interviewed 
manufacturers, retail medicine sellers and practitioners. 
 54 
 
also reluctantly shifting towards more convenient forms of medicine like decoction tablets to suit the 
convenience of new customers (For detailed discussion, see Chapter 9).   
A change in practitioner and consumer culture forced AVS to give up its century old resistance 
to the proprietary. It rolled out its first batch of 20 proprietary products in early 2010, produced from a 
separate factory in Nanjangud, Karnataka. For the first time in  a century, suit and tie-wielding 
executives have begun to step out of this classical 
traditional establishment, a development that is 
bound to be a trifle too unsettling to the 
conservative practitioners, manufacturers and 
consumers of Kerala. Here again, the growth 
trajectory is strikingly comparable with the 
transition in the Malayalam movie industry, that 
over the past decade, has been seeing a noticeable 
shift towards high budget movies. In terms of 
themes, extravagancy of sets and costumes, new 
box office hits have begun to resemble Hindi and 
Tamil movies. The earlier generation character actors have turned superheroes, moving from realism to 
high drama. The traditional slow and melodious songs based on classical ragas are replaced with fast 
paced music and dance sequences, often mixed with western music and English lyrics. Older generation 
producers, directors, actors and movie connoisseurs of yester years complain about this corrupting 
trend, lamenting the loss of realism, art and character acting. New producers justify the shift as an 
inevitable strategy adapted to meet competition from Tamil movies. Movie directors bend backwards 
to accommodate tastes of youngsters who are now distanced from rural realities and have got 
accustomed to the flashy Hindi and Tamil movies surrounding campus love stories. 
But it is too early to say whether the move towards branded medicine is just a temporary phase 
or a trend that is here to stay. In 2005, on the occasion of  introducing a new classical drug, 
Vaidyaratnam Oushadhashala announced its desire to continue with its tradition of manufacturing 
 
Banner at AVS stall announcing the recently 
launched proprietary range, Ayurvedic Industrial 
Exposition, Trivandrum, 2012 
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classical drugs instead of shifting focus to OTC products (Hindu 2005). In the 2010 celebration of their 
90th year of founding, SNA released “Unni Mooss Series” introducing 12 classical products into the 
market (see image below). AVS, despite its entry into the new line of proprietary products continue its 
loyalty to the classical market. Though the viability of around 70% of their products is low they have 
not had to cut down on their products. Post the tourist popularization of Kerala Ayurveda, they see a 
potential to expand their classical product catchment to other parts of the country. Many  
manufacturers including AVS are conducting training 
programs that are in demand from ayurvedic doctors across 
the country interested in gaining exposure to Kerala 
Ayurveda. This provides them opportunity to expand their 
market by educating doctors outside Kerala about Kerala 
Ayurvedic products. For example, a group of Ayurvedic 
doctors from Maharashtra attending a pre-conference 
pharmaceutical workshop organized by one of the largest 
manufacturers of Kerala, were found to be keen on 
experimenting with decoction and oil based products. They were already familiar with the products 
from their ayurvedic textual knowledge, but for some reason, certain classes of products like 
decoctions and oils were hardly in use, possibly due to the dominance of herbo-mineral preparations in 
their pharmacopeia.  
2.4 Is big Pharma turnover an adequate representative of classical medicine consumption?  
Focused on the study of large pharmaceutical manufacturers, researchers have confirmed 
Leslie’s (1989:30) suspicion of their role in “irrationally distorting the economy of health care” They 
have noted that the ayurvedic companies target middle class consumers based on analysis of marketing 
strategies of large manufacturers (For example, Bode 2008, Banerjee 2002). Pharmaceutical turnover is 
a fairly good indicator of medicine consumption trends, but how representative is it of overall 
consumption patterns? Would it be appropriate to gauge ayurvedic consumption merely in terms of the 
turnovers of these large manufacturers? Bode (2008) provides a more incisive analysis, he estimates the 
 
Unni Mooss Series: Classical series 
introduced by SNA Oushadhashala in 2010 
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classical market as constituting a turnover of $ 62.5 mn, which is 10% of the market39. But classical 
medicines, historically, were never made by manufacturers. They were mostly made by practitioners. 
Practitioners outside Kerala often make their own medicines because of lack of availability of classical 
medicines in the market, a point also noted by Bode (2008). There are also innumerable practitioners 
who are unregistered micro manufacturers; an ayurvedic doctor is not required to obtain 
manufacturing license unless he plans to distribute it in the retail market. There are around 1.5 mn 
unregistered practitioners of indigenous medicine in the country (Planning Commission of India 2000).  
It appears that it is this unexploited niche in rest of India that has been targeted by Yoga guru 
Baba Ramdev’s Divya pharmacy that has seen an unprecedented expansion in the past couple of years. 
Since 2008-2009, riding on the popularity of his yoga fame, Baba Ramdev has expanded franchisees 
across the country, growing to a total of 1049 and an additional 794 treatment centers within 3-4 
years. Most of his products are classical and traditional, priced at highly competitive rates.  The 
products also include semi-processed medicines like decoction mixes. An informant knowledgeable 
about the North Indian market reported that sales of small manufacturers across North India has 
dropped by 50% in the past two years due to Ramdev’s expansion.   
In addition to this, a bulk of ayurvedic consumption is home based. A recent survey showed 
that rural  households consumed 86,000 MT of botanical raw drugs, accounting to 27% of the total 
estimated consumption of herbal raw drugs in the country (Ved and Goraya 2007). The estimation of 
ayurvedic market shifting towards branded products or moving away from the rural poor class cannot 
be supported by merely looking at shares of turnover of manufacturers. It is also important to take into 
account the classical medicine consumption of the unorganized market comprising of practitioner made 
and home processed medicines. The difficulty of investigating the unorganized sector is noted by a 
researcher who has extensively studied ayurvedic industry in Kerala.  
Unregistered units are believed to be large number in Kerala and the estimation of its contribution 
relative to the factory sectors is impossible. This is mainly because the household vaidyans still 
forms a major part of the ayurvedic sector, and generally they are not officially registered. Our 
analysis is confined to the organized licensed manufacturing units of Kerala….. since the efforts to 
collect the data regarding the first category turned futile (Harilal 2010: 44). 
                                                 
39 As at 2010, the market is around $1.2 billion. If the growth is proportionate, classical would be around $100 million.  
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2.5 Diversion or diversification? which is the more appropriate term? 
The commercial logic that governs production of ayurvedic pharmaceuticals has been feared to 
affect the integrity of the medical system (Bode 2008). The commercializing trend that Banerjee 
(2002) sees as affecting the internal order of the ayurvedic knowledge system in large scale ayurvedic 
manufacturing in India, has been perceived to be affecting the manufacturing industry in Kerala 
(Harilal 2009, 2010).  
A major concern is the change in product pattern and importance given by most of the firms 
towards neutraceuticals and cosmetics, and the failure of regulation systems, which may hamper 
the spread of ayurvedic therapeutic tradition and its clinical value in future (Harilal 2009: 51). 
But there is little hard evidence to conclude that such trends would displace classical consumption. In 
fact, prima facie they appear to be far less threatening than ethical proprietary products; cosmetics 
and soaps expand the catchment of manufacturers to new segments of consumption, whereas the 
latter directly compete with classical products. The only inference one can logically draw on the basis 
of marketing strategies and turnovers of large manufacturers, is about the shift in focus of the large 
manufacturer. But a manufacturer can theoretically focus on one segment without affecting another, 
because these are not competing segments. Turnover comparison that show OTC as surpassing the 
classical, is often taken to gauge the market as being overly commercialized and inimical to classical 
medicines. But none of the OTC products are serious competitors to a classical ayurvedic product. By 
definition, these are meant for minor ailments that traditionally people were most unlikely to have 
been going to a doctor for redress. If factory-made OTCs are displacing a traditional practice, they are 
most likely substituting the use of home remedies. These customers are most likely to be those already 
distanced from such uses and are most likely to be those who are looking around for quick fixes for 
daily annoyances like cough, cold and indigestion. In the absence of easily available ayurvedic 
products, such customers could be easily lured by biomedical products. For example, an urban middle 
class professional might substitute the use of Dabur digestive for a antacid, an ayurvedic cough syrup 
for a biomedical cough syrup, an ayurvedic eczema ointment to a biomedical one. A study shows that 
indigenous medicines constitute 27.3% of the OTC segment in India, compared to a 16.7% in Europe and 
5.3% in the US (Paninchukunnath 2007). 
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Even if large manufacturers shy away from the classical market, this need not necessarily be a 
drawback; it would allow room for other minor stakeholders in the segment. In fact, the lesser 
manufacturer focus and market availability of classical products, higher is the chance that doctors 
make their own medicines40. Paradoxically, the Kerala industry, by standardizing classical distribution 
through agency format, pose a greater threat to doctors’ practice of making medicines.  
On the other hand, branded ethical/prescription products could pose a serious threat because 
they directly substitute classical products for many important therapeutic categories. For example, let 
us take arthritis. Here are two samples of medicine protocols for arthritis I encountered in Kerala 
contrasted with a patient’s prescription from Bangalore. 
Patient 1, Idukki, Kerala: Four classical medicines: Pinda Tailam for topical application, Bala 
Hathadi Tailam for application on head, Gandharva Hastadi Kashayam and Punarnava Asavam for 
internal consumption, Orthocure (proprietary medicine) for internal consumption, a herb infusion 
for bath made of four herbs ( avanakku, puli, karinochi, erikku) and a herb infusion of the leaves 
of thazhuthama and dried njerinjil  to be boiled and substituted for drinking water.  
Patient 2, Thrissur Kerala: Rasnerandadi Kashayam, Triphala Churnam, Vaishvanara Churnam, 
Dashamoola Haritaki Lehyam, and a Kuzhambu for topical application.  
Arthritic patient, Bangalore: Rumalaya tablets for internal consumption and Rumalaya gel for 
topical application, both proprietary products of Himalaya Pharma.  
Though ethical products are expected to be mediated by doctors, Bode (2008) notes that 2/3rd of 
ethical product purchase is over the counter. It is not understood as to what extent these replace 
classical consumption, because the champions of this strategy, Himalaya and Charak have been mainly 
targeting allopathic doctors.41  
2.6 Classical products: a new lease of life? 
A decade ago, it would have appeared as if the march of the branded medicine to the 
detriment of classical medicine was inevitable. Though it does not match the branded product in terms 
of growth rates, classical medicine continues to hold forte and may be even undergoing a gradual 
revival. In Chapter one I argued that the new wave of post-tourist commodification of services led to 
                                                 
40 Most of his products are classical and traditional, priced at highly competitive rates. The products also include semi-processed 
medicines like decoction mixes. An informant who was knowledgeable about the North Indian market reported that sales of small 
manufacturers across North India has dropped by 50% in the past two years due to Ramdev’s expansion.   
41 If their threat to classical products have to be estimated, historic prescription patterns will have to be taken into account. This 
will require historic product wise sales data, but it will have to be controlled for periodic rise and fall in disease prevalence. 
Another confounding factor is the trajectory of competition from biomedical products.  
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the emergence of Brand Kerala in Ayurveda. This went on to influence the practice of Ayurveda in the 
rest of the country. While on one hand it might have led to diversions considered unacceptable by the 
traditional stakeholders of Ayurveda, it also appears to have expanded a market for therapeutic 
Ayurveda. This trend also seems to be leading to a renewed interest in classical medicines, most likely 
influenced by the Kerala model. Many manufacturers of Kerala have begun to expand their reach to 
other parts of India. While marketing attention to classical medicines is rare, a recent study (Singh 
2011) that does a SWOT analysis of classical and branded products has some interesting observations to 
make. In fact, the choice of the subject itself indicates a upsurge in interest in classical.  Singh notes 
that low price, low expenditure on R&D and marketing are strengths of classical; weaknesses include 
consumer’s problem in remembering names and hesitance in prescribing and using because of the 
complexity involved. He observes a gradual switch over in prescribing habits of ayurvedic physicians as 
well as purchasing habits of patients, and notes that generic ayurvedic medicines are rapidly emerging 
as alternative to branded medicines.  
Addressing shareholders, a large North Indian company based in a vaidyan family portends a 
change in the mindset of ayurvedic physicians.  
OTC and FMCG have been some of the marketing paths adopted in most ayurvedic companies. Rx 
products for the discerning but fast accepting modern science physicians, has also been a key 
focus area. But imagine Ayurveda accepted in toto by the ayurvedic physicians, in its true 
sense…what this opportunity means. It is like Hindi accepted by Indians as their main language of 
communication. Can you hear the roar of 100 crore (one billion) Indians being serviced by over 
600,000 ayurvedic Physicians. The day is not far and frankly - we do not need 100% subscription to 
show exponential surge in volumes. Your company has seen the emergence of this wave at its 
inception (SDL 2004). 
In a personal interview, Mr. Ranjit Puranik, owner-CEO of Dhootapapeshwar, General Secretary 
of Ayurvedic Drug Manufacturers Association (2002-2010), admitted  that his optimistic expectations 
were not met and that the classical market was pretty much stagnant.  
2.7 Classical medicines Vs doctor-made proprietary medicines 
Not just in manufacturing, even in clinical practice there appears to be difference between 
practitioners in Kerala and outside in terms of their approach to medicine making. It is common to 
come across practitioners in cities like Pune and Bangalore making their own medicines in a small 
scale, usually in a large kitchen attached to the clinic. According to one version, this is because of the 
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problem of unavailability of classical medicines in market. One doctor in Pune whom I was personally 
consulting, saved on labor cost by taking advantage of training requirements of interns. Another doctor 
in Bangalore had a range of branded proprietary medicines that she sold in a pharmacy counter 
attached to her clinic, though they were not registered. Higher profit margins is another motive 
attributed. I asked the owner-CEO of a large manufacturing company in Central India who had several 
years of experience in selling medicines to doctors in the region, if such an allegation was really true.  
He rolled his eyes surprised I was asking for evidence for a more than obvious phenomena and 
exclaimed, “of course, 1000%!” referring to the profit margins involved. (One more instance of the 
anthropologist sheepishly looking for third party verbal evidence for a palpable phenomenon, with an 
inherent danger of being considered as ‘lacking in commonsense’).  
Such doctor-made medicines tend to be proprietary in nature42. They are either labeled with 
proprietary names or are handed out without names. In either case, patients are left in the dark; 
unlike registered proprietary medicines they do not list ingredients. Such practice has two main 
drawbacks. Firstly, it makes the treatment process non-transparent. Secondly, it does not build a 
relationship between  patients and medicines. It is as if the doctor wants to prevent such a 
relationship, thereby retaining greater authority on the patient. Because the patients do not know 
names of classical medicines these practices do not create a market for repeat prescription or help in 
contributing to cultural knowledge of classical medical names.   
An important attribute of an open-system is ‘transparency’. Classical medicine based 
prescriptions on the other hand provide for transparency of the treatment process. This provides 
patients the flexibility to switch doctors, which is especially useful for people who are mobile or those 
who travel to distant places to consult expert doctors. Ayurvedic doctors in Kerala seldom maintain 
patient records. Besides symptoms, an important source of information about the past diagnostic 
process, is the prescription record. Even with their own patients, doctors frequently ask the 
prescription history, especially when they return after long intervals. This helps them remind of their 
own diagnostic framework and treatment strategy. If the patient is new to them, the prescription helps 
                                                 
42 Based on personal experience of consultations, reports from eight patient-customers and interviews of two doctors from Pune 
and suburban Bombay. Though this appears to be the dominant pattern, two patients also had experience with doctors who 
prescribed a combination of classical and proprietary medicines. 
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them gauge the treatment logic used by the other doctor. Added to this, information on the  patient’s 
response to these medicines provides with valuable data.   
Despite widespread availability of classical medicines, it is common for doctors in Kerala to 
make medicines, most often driven by their personal perceptions of authenticity that may or may not 
be combined with desire for additional profit. But in Kerala doctor-made medicines at the micro-level 
tend to be classical rather than proprietary. Occasionally, one does come across a shrewd doctor who 
has figured out ways of tweaking classical practice to make it more profitable. Some manufacturers 
add the term ‘special’ to the classical name, to distinguish medicines tweaked according to the 
doctor’s logic and experience. For example, SNA Oushadhashala makes around 50 special proprietary 
formulations that are modifications in classical formulations made by the Ashtavaidyans (an elite group 
of Brahmin practitioner families) over their generations of family practice. However, this tactic is also 
sometimes used as a commercial strategy for stopping patients from buying from competitors. A doctor 
from central Kerala boasted about his clever business trick. He made minor modification in the names 
of classical medicines, making it difficult for the consumers to find them elsewhere in the market. In 
fact, the names sound so similar to classical that unsuspecting patients try to procure it from local 
agencies often leading to confusion among retail sellers. Two of his long distance patients complained 
that they were forced to travel all the way to his clinic for medicines, even the prescription was just a 
continuation of the earlier one.  
This is not to say that doctor-made medicines are not legitimate practice or less-effective. 
After all, practitioners were expected to make their own medicines in the pre-industrial era. In fact, 
many patients consider doctor-made medicines to be authentic in contrast to mass produced factory 
medicines of unknown quality, a perception also shared by doctors who are unwilling to trust market 
medicines. However, the point I am making here is that classical and proprietary medicines have 
different long-term implications for the ayurvedic market. Doctor-made medicines unlabeled medicines 
create an exclusive and closed commodity market, whereas classical medicines help creating an open 
market and a transparent consultation process.  This brings us to a classic difference between open-
source and proprietary products in general. The latter is limiting in terms of profitability as seen from a 
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conventional business perspective, but the former gives more control and bargaining power to the 
consumer.  
2.8 Ayurvedic shops and their wares: three profiles  
For those unfamiliar with Kerala, the manner in which ayurvedic medicines is sold might itself 
appear strange.  Outside Kerala, ayurvedic medicines are mostly sold in multi-branded medical stores 
that tend to be concentrated in towns and cities. In Kerala, multi-brand shops are rare to find, the 
default mode of selling is through manufacturers’ 
agencies. An average town in Kerala, has anywhere from 
3 to 10 such agencies, often exceeding the number of 
grocery shops; village junctions have 1 to 3 depending on 
the size of the village43. I have been often taken aback 
by surprise on seeing ayurvedic agencies in some of the 
remotest villages. Three descriptive profiles will 
illustrate the nature and spread of the ayurvedic retail 
segment in Kerala.  
2.8.1 RS, a large town in Ernakulam district 
RS is a bustling town in Central Kerala, with a density of population nearing around 1300 per 
sq. km. Like most towns in Kerala, this has emerged from an unplanned organic agglomeration of shops 
and market areas. In historic Kerala, towns were concentrated near sea ports and inland waterways. 
Today they are mostly located at hubs of roads or railways. RS is located at one such important 
junction in central Kerala, at the intersection of a national highway and one of the busiest state 
highways. Two important neighboring towns of historic significance add to the importance of the town. 
The main town area stretches from the center to around a kilometer into each of the three main roads 
that branch off from the town junction, and also into three to four minor roads, a couple of parallel 
roads and connecting lanes. The shops and commercial establishments in the town cater to not only the 
inhabitants of the town but also to the surrounding villages.  
                                                 
43 Based on observation during my field work in four districts. 
 
Multi-brand Ayurvedic Shop, Dakshina 
Kannada, Karnataka 
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In the RS town, the most visible commercial establishment is a towering 800-bedded multi-
storey building of a multi-specialty Hospital that caters to around 1500 outpatients daily.  There is also 
a district government hospital and two small 10-20 bedded private hospitals within 4 sq. kms. of the 
town. Like the typical Kerala scenario, there are no independent doctors’ clinics in the town44. Half a 
dozen hospital employees, who live in the town region engage in private practice in clinics attached to 
their homes. While the hospital has its own pharmacy to distribute medicines, there are around 15-20 
medical stores in the town that sell allopathic medicines. They do stock a small number of ayurvedic 
medicines that include mostly OTC medicines45, ethical products and fortified food products. These 
include products of a few reputed Kerala companies46 and a few from small unheard of companies in 
Kerala that specialize in a narrow range of proprietary products47.  
Classical ayurvedic products are sold in 
exclusive retail shops. There are ten such shops in 
this town, all but one of which are equipped with 
qualified ayurvedic doctors for consultation. Seven of 
these shops are agencies of ayurvedic 
pharmaceutical companies. Of these, four belong to 
the largest of the Kerala manufacturers and three to 
medium scale manufactures. Five of the 
pharmaceutical agencies are run by small businessmen where ayurvedic doctors work as part-time 
consultants, one agency is owned by a doctor, and one agency is part of a raw drug shop. Three 
ayurvedic retail shops belong to doctor-manufacturers with a history of practice. While these doctors 
make medicines mainly for their patients, they take advantage of their road-front shops to tap into the 
retail market. There are six raw drug shops. As is common in most of the towns, all are located in the 
                                                 
44 In other regions in India where I have lived, i.e., in the States of Karnataka and Maharashtra, patients most commonly consult 
doctors practicing in independent clinics, hospitals being the last resort.  
45 OTC products mainly include proprietary products of a small segment of local medium sized manufacturers. Some of the often 
seen products are hair oils, sexual health and general health enhancement tonics, liver supplements, memory enhancement 
tonics aimed at school children, and digestives. 
46 The most common being Nagarjuna, KAL, Pankajakasthuri, Nupal and Bipha Labs. The ethical product segment is dominated by 
North Indian companies like Himalaya, medium level companies like Charak, and a few products of lesser known medium sized 
companies based in western India like Ban Labs and Ayurchem. 
47 For example, Ulset for acidity and stomach ulcers by Shankar Pharmacy.  
 
Ayurvedic Agency ensconced in a commercial 
complex ( Extreme left, first floor), Thrissur Dt. 
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core market region where daily items from dry fish to vegetables, agricultural implements to grocery 
items, are sold in small shops huddled in narrow crowded alleys. Two of them do not sell much finished 
medicine, three others stock medicines of multiple brands, while one combines a franchise of a 
medium level manufacturer along with his raw drug business. Brief profiles of three agencies 
representative of three common categories from the town is provided in Appendix B.  
2.8.2 PS, a small village in Ernakulam district 
PS is an interior village located at a distance of 6 kms. from RS town. Historically an important 
and busy junction, the PS village junction has been sidelined by urban growth shifting towards the AN 
junction in the South-East where a highway had come up eight years ago.  The buildings in the village 
junction are old, most of them still sporting hand-painted boards, unlike the highway part of the 
village that sports modern colorful flex boards, now a commonplace sight in Kerala. It makes sense to 
look at both the junctions as they are just a mile apart from each other and serve almost the same 
population. PS village stretches between these town junctions, densely packed with standalone 
homesteads with 10-20 cents of land, and small farm houses with an acre or two of farmland, a habitat 
structure characteristic of much of Kerala. Though the population density and consequent accessibility 
to services makes it appear urban,  people in the region are rooted in rural ethos, a close knit-
community based in a traditional, predominantly agrarian culture. However, much of the farmland has 
vanished, the land prices have skyrocketed, with a single cent of land48 averaging ` 250,000 ($5000). In 
fact,  the source of wealth that is exuded by many of the ultra-luxury houses can be traced to income 
from sales of inherited land. The price of land combined with high daily wages49 has made farming an 
unviable proposition. A few die-hard farmers driven by traditionally cultivated passion continue to do  
                                                 
48 Cent = 1/100th of an acre.  
49 Ranging from ` 150 ($3) a day for unskilled worker to ` 300-500 ($6-10) for skilled workers. 
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group farming (koottu krishi) of paddy. The only serious farming effort goes into rubber plantations and 
occasional coconut groves. A large section of the population are service workers, office workers, 
teachers, nurses and factory workers who work in nearby cities. Because of the proximity of RS, there 
are no allopathic  clinics or hospitals in the old town. The South Eastern junction has a small allopathic 
hospital, a diagnostic lab, two allopathic who offer an hour or two of clinical practice in their homes, 
and three homeopathic practitioners.  But there is no dearth of ayurvedic establishments. In the AN 
junction, there are three agencies of one large, and two medium sized manufacturers (See Appendix 
B.1 for profiles of two pharmacies).  
In the interior town junction, there is a government ayurvedic dispensary, a raw drug shop, and 
three ayurvedic retail shops. One of these is an agency of a large non-local manufacturer, one of a 
local micro-manufacturer, and the third is a shady outlet that sells ayurvedic wines as a disguise to sell 
illicit liquor. The people in this village also have access 
to two more agencies in the neighboring village junction, 
just a mile away. These include an agency of a large 
manufacturer, and an outlet of a local doctor-
manufacturer. There is only one raw drug shop in the 
inner layer of the older town, the rest prefer to go to 
RS.  There are around 5-6 doctors within 20 sq. km. But 
for the local doctor with his pharmacy, the rest are part-
time consultants in the pharmacies. There is an 
ayurvedic clinic run by a doctor from a local vaidyan family located three kilometers away on the 
highway between their village and the next large town. The clinic has recently expanded to a ten 
bedded hospital. Eight kilometers to the South, there is another large town, that has many ayurvedic 
establishments including two large private ayurvedic hospitals. Residents from this village travel there 
for work and other requirements. The connectivity between all these regions is very good, there is a 
bus every 5 minutes on the highway that connects the two large towns through the village junction. 
The maximum distance people living in the interior village have to walk to the bus stop, is a kilometer.  
 
Doctor-owned Ayurvedic Medicine Agency, 
Cochin City 
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2.8.3 KN, a small town in Thrissur district 
KN is a small town located on a busy intersection of two major roads that link a large city and a 
coastal town touching the national highway. It is one-tenth the size of the large town described 
above. An old center of commerce, it appears to have far outgrown its capacity; roads are narrow and 
cramped, shops are almost on the road and there is hardly any space for a pedestrian walk. The town 
has a theater, three small restaurants, four tea shops, two juice shops, two banks, an ATM, two offset 
presses, two cyber cafes, four textile shops, a couple of hardware shops, a dozen grocery shops and 
four vegetable and fruit sellers. But for shopkeepers, and employees of banks and local government 
offices, the town has little reason to attract people. Those who come here are either non-local passers-
by making use of the bus junction or people from neighboring villages who come to shop for 
commodities and services. There is one homeopathic  clinic, and seven allopathic shops and seven 
ayurvedic agencies in the town including a co-operative fair price(neethi) medical store.  The town has 
ayurvedic agencies of all the five largest manufacturers of Kerala, one of a medium manufacturer 
(Santigiri) and a small local pharmacy.  Two agencies provide part time ayurvedic doctors for 
consultation. The local pharmacy, specializing in pediatrics, is run by a formally trained heir of a 
traditional pediatrician. Besides these, there is also an independent practitioner, a  retired ayurvedic 
college professor who in the words of another agency owners, is the  “catchment50” for the agency of 
AVP, a large manufacturer.  Around 1.5 Km. from this town there is a government ayurvedic dispensary 
and three ayurvedic agencies. All together there are around 10 doctors located within 3 km. radius of 
KN town. There is no raw drug shop in the town, but two are located 3 km. down the road in the next 
junction which by its location located in an ancient boat landing was a historic center of commerce.  
2.9 Over the counter buying of classical medicines 
Agencies report that 30-50% of medicines are sold51 without prescription. Over the counter 
medicines contribute to some part of the non-prescription sales. Most of the OTCs tend to be low-
                                                 
50 The English word catchment is widely used in Malayalam, deriving from the usage in the context of dams.  
51 From reports of agencies, see Appendix 3.12 
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priced small items for common ailments, a few of them are high priced items52. Most of these items are 
heavily advertized in print and electronic media. Five common types of non-prescription purchase of 
classical products can be identified53.     
A large proportion of repeat prescriptions:  These are patients who on the reoccurrence of the 
condition resort to an earlier prescribed medicine. The repetition can be immediate. For example, an 
arthritic patient on pain medication for a month, continues it for another month without consulting the 
doctor. Repeat use can also be episodic. For example, a patient prescribed Abhayarishtam for 
indigestion and has found it efficacious might take it again in the next episode (or for another family 
member) without consulting the doctor again. Some of such repetitions may last for life, or might also 
spread to other family members and friends. Such practices work typically only when a single medicine 
for a single identifiable condition is involved.  
Classical products that are part of collective knowledge because of widespread traditional use have 
acquired an automatic OTC status.  Some common examples are, digestive and general tonics like 
Dashamoolarishtam and Chyavanaprasha, Triphala for digestive complaints and Dhanwantaram 
decoction for cough and. Bode (2008) points out that the first three constitute 20% of AVS sales and are 
frequently brought without physician consultation. In central Kerala that has a strong tradition of 
classical practice, people have acquired familiarity with many classical medicines over generations of 
use, similar to long term users of allopathic medicines.  Achyutan, an agency owner in a rural town in 
Thrissur who does not hire a doctor sells more than 50% of medicines without prescription.  Do you 
really have to ‘prescribe’ medicines to people of Thrissur?( Thrissurkarkku Marunnu kurichittu karyam 
undo?).  
Medicines meant for post-delivery care are very rarely sold on prescription. Though some of the post-
delivery tonics are also classical ayurvedic medicines,  for most consumers these are part of a routine 
protocol that they are traditionally familiar with.  
Buying medicines based on others’ experience or advice is a fairly common practice both in allopathic 
                                                 
52 Examples for low-priced items that are sold heavily are expectorants like Eladi Lehyam ((`10/$0.2 for 25 gm.), Tulsi cough 
syrup (`19/$0.38 for a 100 gm. bottle), pain balms (` 10/$0.2 in  10-25 gm.). Some high priced items are Breathe Eazy for 
respiratory problems (60 tablets for ` 200/$4), Santosh brahmi granules for memory enhancement (450 gm. for ` 160/$3.2). 
53 I have not done a quantitative study, this is based on observations and interviews. 
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and ayurvedic medicine. For example, Ameena, a school teacher in her mid-40s, on hearing that 
fomentation with a combination of two medicinal oils (Rasnerandadi and Dhanwantaram) was 
alleviating her sister’s arthritic joint inflammation, promptly bought the oils for herself. Vinayak, a 30 
year old bank employee who wanted to increase his weight, learnt from a colleague that Narasimha 
Rasayana was an ideal supplement. But this typically works only for simple medicine protocols; most of 
the classical prescriptions are individually tailored complex protocols that are not easily transferable 
from one patient to the other. Though there is no particular advantage in circumventing a physician 
because consultation is more often than not free of charge, there are other reasons. It could be a 
simple reason of saving traveling time;, the patient does not have to personally go for buying 
medicines. Or it could be a more complex reason like reluctance to submit to the doctor’s authority, of 
having to subject oneself to diet and life style recommendations. Diet prescription is considered the 
single largest deterrent that makes people shy away from ayurveda. 
Prescriptions can be invisible. This happens when patients do not carry the prescription note to the 
pharmacy because they are already familiar with the names of medicine.  
Doctors differ in their attitude towards OTC consumption of classical medicines. The concern is 
not about episodic consumption, but about long-term self-prescription.  This concern stems from the 
ayurvedic approach to pathology;  whereby the nature, stage and intensity of disease are expected to 
vary from time to time, and may require variation in treatment.  An ex-ayurvedic Drugs Controller 
showed strict disapproval, saying “there is no OTC category in Ayurveda, even the hair oil is medicinal 
and should not be consumed  without prescription”. On the other hand, a vice-chairman of an 
ayurvedic college, declared that “People of Kerala don’t have to be always told by a doctor. Every 
expecting woman knows that she has to take Dhanwantaram decoction”.  
2.10  The agency model of distribution: features and significance 
An overview of the ayurvedic retail market in Kerala shows that but for a small proportion of 
proprietary medicines sold in allopathic shops, ayurvedic retail selling is mainly done though exclusive 
manufacturers’ agencies. These agencies stock 50-70% of the pharmacopeia of the manufacturers; 
other medicines are supplied on request. This provides the essential range of ready pharmacopeia for 
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doctors working within a classical therapeutic framework, a facility doctors in other parts of India 
outside large cities lack54.  The agencies get a commission of 20-30% on medicine sales. All agencies, 
except those of the largest manufacturer AVS, have the liberty to stock non-competitive products of 
other manufacturers. Obtaining agencies of large manufacturers, especially in high density areas is not 
easy. Large manufacturers like AVS and Vaidyaratnam Oushadhashala have a large number of applicants 
on the waiting list. But small manufacturers often go searching for people to open agencies, 
established raw drug shops being an ideal target.  
I prefer to use the term agencies instead of franchisees as these are not run in the ‘modern 
professional’ franchisee format. Manufacturers have not formalized rules regarding product stocking, 
arrangement, designing of space, etc. The shops are however required to display a uniformly designed 
board that makes it possible to easily identify the manufacturer. Elegantly designed shop boards, 
usually a combination of bands of one or bright colors55, matched by labels in bottles sitting in neat 
rows on shelves, make ayurvedic agencies a colorful and attractive sight, in stark contrast to the messy 
appearance of raw drug shops.    
 
Over the counter buying is the most common 
mode of ayurvedic consumption outside Kerala. Besides 
legitimate OTC products that form the bulk of 
consumption, these also include buying prescription 
medicines by consulting the pharmacist. This practice 
is common across urban and rural India in the context 
of biomedicine (Nichter 1989, Kamat and Nichter 
1998). This practice does not work well in most of the 
agencies in Kerala, because agencies are either owned 
by doctors or hire doctors to provide part-time 
consultation. Consultations are free, so patients have very less reason to avoid doctors and to purchase 
                                                 
54Based on interviews with Ayurvedic doctors from Maharashtra and Rajasthan. Also, Bode (2008) notes practitioners’ complaints 
of unavailability of classical medicines in the market.  
55 For example, blue & white for AVS, green & white for Vaidyaratnam, red & yellow for Kandamkulathy. 
 
Agency of Deseeya Ayurvedic Pharmacy, 
Wayanad  
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directly from the pharmacist. Since medicine and consultation are so conveniently packaged together 
in one place, patients do not even have to make an effort to go to two different places. Though 
pharmacy owners do not hesitate to give medicines for customers who ask for them without 
prescription, anyone asking for medicine advice is directed to the doctor. Salespersons are usually 
uncomfortable in using their judgment in giving medicines when they have a doctor present. I got a 
first hand experience of this when I attempted to buy medicines directly without consulting doctors for 
Chikungunya 56. The tendency of Kerala consumers to consult doctors rather than self-medicate is not 
limited to Ayurveda. A recent study found that only 18% of antibiotics consumed in Kerala was obtained 
without prescription (Saradamma et al. 2000).  
On the other hand, pharmacies without doctors tend to be more liberal in proffering advice, 
especially if they are have substantial experience to fall back on. Joseph, who has been running the 
shop in rural interior Thrissur for several years, often recommends medicines to patients based on his 
knowledge.  If he does not have a particular medicine requested by a customer, he sometimes tries to 
push equivalent medicines. He has to be aggressive in doing this because he has no doctor to provide 
consultation; if he pushes the consumer to the doctor, the patient is least likely to get back to him to 
for buying medicines57. He complains that not having a doctor is definitely disadvantageous for sales. 
This is the reason why some of the manufacturers take active interest in helping agencies locate 
doctors. In some of the regions they send their branch doctors to spend a couple of hours once in a 
week in agencies that cannot afford to hire doctors.   
The distribution of shops in all the three locations is also to be seen from the point of view of 
the settlement pattern. Kerala has a distributed settlement pattern wherein each house is located 
within a homestead unlike most of India where people live in hamlets, i.e., agglomeration of houses 
surrounded by farms. This makes a big difference in terms of service distribution. Hamlet pattern has 
been the most conducive for services of all nature because it provides for viability of scale and 
                                                 
56 The previous year Kerala was rocked by the dreaded epidemic that was so devastating that it almost crippled the economy of 
the state. Despite Ayurveda’s reputation in addressing the problem, there was no proprietary product in the market. I inquired in 
eight pharmacies. Six refused to name any medicine. Their typical response was, “we can’t say, why don’t you consult the 
doctor, the doctor will be here at such and such a time”. The response of the other two who named the most commonly 
medicines but insisted that, “it depends on the case, you will have to consult the doctor”.  Later on I learnt that practitioners in 
Kerala had made a systematic effort to develop a protocol (See Appendix B), which provides a glimpse into the complexity of 
Ayurvedic approach to treatment that resists simple commodification.   
57 It is rare to find independent doctors who are not attached to agencies. 
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proximity of access even in low-population conditions. In a distributed settlement pattern, service 
accessibility is unviable without a higher density. Since population density in Kerala is extraordinarily 
high58, it provides for a higher viability of scale even in the remotest of the villages. Population is 
spread out rather than being not concentrated in large cities. Consequently, even interior villages have 
accessibility to services and facilities equivalent to urban regions elsewhere, a reason why Kerala has 
been called an urban-rural continuum (Sreekumar 1993). 
In attributing the density of ayurvedic shops to popularity of Ayurveda in Kerala, the 
confounding factor is population density. Comparison with MT village in South Kanara district in 
Karnataka State will help because this district in Karnataka bordering Kerala, has the same settlement 
pattern, but a population density half that of Kerala (averaging 399/sq.km.). Though MT is a village, it 
has lately grown into a busy town, owing to the growth of private educational institutions. There is one 
undergraduate and two professional colleges in the village. Recently a small supermarket has opened in 
the town. There are five allopathic shops all of which sell proprietary ayurvedic medicines.  There are 
three retail ayurvedic shops, two of them less than a decade old. Only one of them is exclusive, which 
is the agency of a large manufacturer from Kerala, run by a person of Kerala origin. There is only one 
ayurvedic doctor with a 5-bedded clinic 2 kms. from the town.  A town of this size in Kerala would have 
at least 5-6 agencies, 2-3 raw drug shops and 3-4 ayurvedic doctors. But there is one more confounding 
factor. Shops in South Kanara and rest of India are multi-brand like allopathic shops. In Kerala, they are 
agencies of individual manufacturers. In the past decade, there has been an unprecedented expansion 
in the number of agencies. Manufacturers see it in their interest to expand to more and more towns. 
The quantum of ayurvedic shops versus allopathic shops do not necessarily signify greater business for 
the former. In fact, it is usually the other way round. Increasing number of agencies, and dropping 
levels of profit are a common grouse among retail agency owners.  
Ten years back when Achyutan opened the agency of Oushadhi, the State-owned ayurvedic 
manufacturer, there were only two other agencies, and an outlet of a traditional micro-
pharmacy.  Today six more have opened within 20 sq. km. area. Though a part of the growth can 
be attributed to a natural increase in demand in proportion to growth in population, ten is too 
much of a crowd for this small business, Achyutan complains. Of course they continue to do just 
                                                 
58 The average density of Kerala State is 819/sq. km., but this figure is skewed because of low density in the hill districts. In the 
coastal districts the density ranges around 1000. Densities in the districts that I did field work in are as follows: Ernakulam: 1050, 
Thrissur: 981, Idukki: 252, Kottayam: 722 and Trivandrum: 1476.  
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enough business to keep them afloat, but it does considerably eat into their profit margins.  
Two features of ayurvedic retail selling makes them attractive to small entrepreneurs looking 
for a stable and safe business to invest their little capital. Firstly, the agency model makes no demand 
on knowledge and skill, either of inventory management or of technical know-how. Secondly, there is 
no requirement as yet for any qualification or special license to run an ayurvedic shop compared to 
allopathic or homeopathic shops. While private doctors and retired government doctors are an 
important clientele, agencies are run by a variety of people, ranging from gulf-repatriates looking for a 
leisurely business to retired service people investing their gratuity funds.  Hence, from the distribution 
pattern itself, no definite statement can be made about the quantum of demand. Macro level numbers 
are a better measure. Today there are an estimated number of 20-25,000 ayurvedic agencies in Kerala 
spread over 1100 manufactures59. Of these 80% are small having one to five agencies. The largest, AVS 
has 1306 agencies, the other four large manufacturers, Nagarjuna has 950, AVP and Vaidyaratnam 800 
each, Oushadhi owns 600, making it a total of 4456 between the five largest manufacturers. Of the rest 
on whom I have information, medium large manufacturers like Sitaram Ayurveda Pharmacy has 600, SD 
Pharmacy has 550, SNA and Desheeya Pharmacy have 300 each. Medium sized manufactures like 
Kandamkulathy Vaidyasala and Dhanwanthari Vaidyasala have 68 and 100, respectively.   
Though researchers have neglected to note its significance, manufacturers in Kerala themselves 
seem to have recognized the uniqueness of their distribution model. In the centenary celebration 
souvenir, AVS presented an address to the dealers calling them ‘extended arms of AVS’,  
Our institution has a unique distribution culture.  As you know today many Ayurveda institutions 
survive not by distribution of medicines, but their main income comes from selling soap, paste and 
such other cosmetics. All those get sold by public distribution. Producing around 500 medicines, 
and reaching them to people only through agencies is what we have done. It is true that because 
of this, we do not get as much business as we would if we did through the public market, but this 
mechanism has helped us to ensure the originality (tanima) and quality of the medicines we make. 
This situation increases your responsibility… the modern institutions have mechanisms to monitor 
the working of the agencies.. But as you know, we never had to institute such monitoring 
mechanism. Commitment and trust have been the cornerstones of our relationship…What we have 
are not ‘consumers’, but ‘customers’. As far as consumers are concerned, there are no personal 
relationships and no consideration of likes and dislikes. A consumer might never return again to 
the same shop. But customer is not like that. We keep seeing them, and we will be seeing them 
tomorrow… If we have to be customer-friendly, if we have to satisfy their requirements we have 
to understand their interest and preferences….In brief, our agencies ought to be not a mere sale 
agents, but information centers (AVS 2003: 225-226). 
                                                 
59 Source: Director, AMMOI. Ayurvedic medicine manufacturers organization of India. 
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The manufacturer notes that the distribution culture is unique, that though they lose on profit 
by not exploiting non-exclusive retail chains, it has helped them in ensuring quality. There is a 
reminder to the agency owners of the importance of commitment and trust, especially because these 
are not run in rigid framework like modern franchisees and are not subject to strict monitoring. There 
is an attempt to differentiate between a tentative commodity relationship (consumer) and a long term 
relationship (customer); the importance of earning trust and understanding customer preferences is 
emphasized. Finally, agencies are imagined to be information centers, not just sellers of commodities. 
The last statement in the address is poignant, where a mythological analogy is brought out to represent 
the relationship between the manufacturer and the agency owner. “Friends, you know the story of 
Kartaveeryarjuna in the Puranas. His strength came from the thousand hands he had. You are the 
thousand hands of Arya Vaidya Sala. Your strength is our strength” (AVS 2003:226). Much emphasis is 
given to relationship here, between the manufacturer and the agency owner, between the agency 
owner and the customer. When Dabur and other manufacturers sell their commodities through a million 
retail shops, they cannot afford to focus on relationships. To use Appadurai’s concepts, ayurvedic 
medicine commodities in Kerala circulate in exclusive channels, whereas those in rest of India have 
been subverted from this path and taken out of its “commodity context” to break the barriers of its 
original therapeutic context. Of course, except AVS, other Kerala manufactures do sell their OTC 
products through retail shops, some sell prescription products through regular ‘English medicine shops’ 
(Engleesh marunnu kada).60 But this is just a marginal practice, the central channel for ayurvedic 
commodities is the exclusive ayurvedic agency. 
I argue that the agency distribution model is central to the maintenance of the classical 
ayurvedic tradition in Kerala, which allowed the bulk of ayurvedic consumption to remain within the 
humoral paradigm and inside the therapeutic context. It provided a viable channel for ayurvedic 
manufacturers in Kerala to market their classical products. The agency model evolved in Kerala as an 
outgrowth of the expansion of Arya Vaidya Sala (AVS) in the 50s. However, it would be wrong to 
attribute the marketing strategy to a consciously cultivated and carefully crafted plan designed by 
                                                 
60 In rest of India, there are medical shops and Ayurvedic medical shops, medicine being a default term for biomedical. In Kerala, 
allopathic shops are specifically called English medicine shops, denying them the default status of medicine.   
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innovative manufacturers. AVS admits that the agency model of distribution was an organic evolution 
rather than a designed strategy, a spontaneous response to the market demand61.  
Around the same time as he founded the manufacturing unit in the early decades of the 20th 
century, P. S. Varier played a significant role in the organization of Keraleeya Ayurveda Samajam, the 
first Kerala wide association of ayurvedic doctors. “The symbiotic relationship between the Samajam 
and the Vaidya Sala must have been instrumental in encouraging a steady demand of medicines from 
the vaidyans (Varier 2002:32)”. Increasing demand for the consultation and treatment facilities of AVS, 
initially led to the establishment of local branches, agencies manned by doctors being only a logical 
extension. As demand got regularized, it made sense for practitioners to maintain a stock of commonly 
used medicines, rather than the more time consuming mail ordering. The fact that not only AVS, but all 
manufacturers, large, medium and small, found it viable to expand the agency model, implies there 
was no dearth of demand for classical medicines. However, what was critical for such an expansion was 
the availability of a wide pool of practitioners acquainted with the classical pharmacopeia. From 
today’s standpoint it is easy to take this fact for granted, to overlook its significance. It is important to 
remember that this was a period in which formal education had not yet taken root.  
2.11  Kerala Vs Rest of India: Why the difference in manufacturing culture? 
A quick perusal of the industry today shows that Ayurvedic doctors are conspicuous by their 
absence in the top management brass of the large trend-setting industries outside Kerala. As Ayurvedic 
manufacturers evolved from traditional vaidyan families to large business houses, business interests 
took precedence. In fact, some already had historical experience in marketing biomedical patent 
products (Leslie 1989). Dabur, the OTC trend-setter, was founded in 1884 in Bengal, the inspirational 
core of the modern ayurvedic revivalist movement that also shaped the entrepreneurial climate. 
Follow the biomedical model of pricing, and entrepreneur had also begun to export ayurvedic 
medicines to Europe, growing to be one of the richest men in Calcutta by the end of 19th century. As 
early as the first decade of the 20th century, another entrepreneur had begun to produce ayurvedic 
medicines in modern forms (Gupta 1976). The founder of Dabur was a biomedical doctor who began his 
                                                 
61Based on response from the Research Department, AVS, that was whetted by the MD, P. K. Warrier 
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career with the production with biomedicines. Not a single ayurvedic doctor is visible in the five 
generations of the founding family (Dabur n. d.), which is not surprising given that ayurveda has always 
been only a part of its identity. As the fourth largest FMCG company today it positions itself “as one of 
the leading consumer goods company of India with interests in health care, personal care and foods”.  
Another large company that took off from this region in 1921, Baidyanath, was a partnership between a 
vaidya and a business family (Bode 2008).  Despite its classical brand image, its product  portfolio 
showcases products containing popular early European medicine compounds like salicylic acid and 
quinine, carries forward the historical influence (Baidyanath 2012). Zandu Pharmaceuticals,  
established in Bombay in 1910, was founded by the grandson of a reputed ayurvedic physician from 
Gujarat in partnership with a business family. The company was involved in the manufacture of 
biomedicines since 1936. In mid-2008, the company was fully severed from its Vaidya roots, after it was 
fully acquired by a herbal cosmetics company (Zandu, n. d.).   
Unlike the rest, Himalaya Drug Company and Maharishi Ayurveda Products International (MAPI), 
had no traditional ayurvedic background, making it easy for them to carve their own niches. The 
former, founded by a herb trader rose to prominence in 1934, with the launching of a natural 
antihypertensive, which was later marketed entered the biomedical pharmacopeia as the BP drug 
Reserpine. Naturally the company evolved a marketing strategy targeting biomedical physicians (See 
Section 2.2.2). MAPI is the pharmaceutical wing of “Maharishi Ayur-Ved”, a brand established by the 
founder of the Transcendent Movement, considered the first attempt at globalization of Ayurveda 
(Jeannotat 2008). It  derives half of its $40 million turnover selling ayurvedic commodities tailored to 
the Western market.  
Ayurvedic industry in Kerala provides a contrasting picture, continuing to be predominantly 
owned and managed by doctor-manufacturers. These are a unique group of stakeholders. On one hand, 
they are dictated by commercial pressures and on the other, as traditional mediators of ayurvedic 
medicine consumption, they are bound by professional ethos that resist market forces.  
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 Witnessing the grandeur of AVS in a 
conference, Bode points out that, “the size of 
the Arya Vaidya Sala does not justify the fact 
that its centenary was celebrated as a national 
event” (2008: 174). But it is important to note 
that while medicine selling may be its 
mainstay, the charisma of AVS comes from its 
multi-faceted reputation spanning treatment 
and education segments. It is also a charity 
trust that ploughs three-quarters of its profits 
into various charitable activities: free medicines and treatment in its biomedical hospital, management 
of college, professional publications, research and so on (Bode 2008). It runs one of the most reputed 
ayurvedic hospitals in the country with a track record of treating several national and international 
celebrities. The occupancy rate of AVS’s 160-bedded hospital is so high that it takes 4-6 months of 
advanced reservation to get an admission. This fact is not unique to AVS. Of the several 50-100 bedded 
hospitals in Kerala, some of the most reputed ones are run by established manufacturers. Companies 
like Vaidyaratnam and SNA derive their primary identity from their historical reputation in family 
practice, that help them grow as medicine-sellers.  Even owner-managers of large companies that 
derived their primary income from medicine selling divide their time equally between the factory and 
the clinic. Doctor-MDs of many companies including AVS regularly contribute write-ups on clinical 
experiences to local ayurvedic journals and popular health magazines.  
Of the 15 small, mini and micro companies with turnovers less than $10 million, one was State 
owned. Of the rest only one was not owned by a doctor, but this was run by a traditional vaidyan 
family which had no inheritor in this generation. Of the 14 doctor-run companies, all except two were 
inheritors  of a traditional family or guru-lineage. Of the 20 companies larger than $10 million, one is 
State owned. All the doctor-run companies are involved in treatment as part of their routine practice, 
three own small hospitals, one is a large hospital which has less focus on medicine sales. Of the rest 19,  
 
AVS Stall in Ayurvedic Industrial Exposition, 
Trivandrum,  2012  
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the breakup is as follows: four are run by businessmen, of which two are new generation companies 
focused on the classical market (Nagarjuna and Everest), and one proprietary focused company 
(Kandamkulathy) but has a strong classical presence because it was inherited from traditional vaidyan 
father. The only plain business company with business focus is the aphrodisiac seller, Kunnath Pharma.  
Of these, two are involved in treatment, Kandamkulathy and Nagarjuna. For the former, it is a 
continuation of the Vaidyan tradition.  For the latter, it is an important segment, and though 
established in 1999, it has already established a reputation in practice. Of the rest of the 15 
companies, two are new generation doctor-entrepreneurs, one of whom acquired a traditional 
company and is classical focused (Sitaram Pharmacy), whereas one is proprietary-focused but is 
founded by a doctor who began his career with treatment-centric manufacturing and continues to be 
involved in treatment. The other 13 companies all have some kind of traditional background: three  
have guru lineages (AVS, AVP, AVN), five 
are family lineages (Vaidyaratnam, 
Vaidyamadham, SNA,  Nupal, 
Dhanwantary). All except AVS which is 
run by a charitable trust, are family run.  
KAS is primarily an association of doctors. 
Two are owned by religious trusts, one 
Christian missionary and one Ezhava 
Hindu religious group. One is a traditional 
family acquired by a businessman 
managed by the family heir (KAL), one is 
a new entrepreneur who acquired an old 
tradition (Sitaram), one is a traditional 
company that has been run on contract by a business group (Vaidyaraj). All of them run medium to 
large sized hospitals.  
 Though the average ayurvedic company in Kerala, big or small has roots in practitioner 
 
An ayurvedic doctor mans a large manufacturer’s stall in an 
Ayurvedic Industrial Expo  
Poster in the background announces their expertise in 
treatments 
 78 
 
families, the trend-setter AVS was not from a practitioner family. Its founder Dr. P. S. Varier who had 
both ayurvedic and biomedical training, and who set up the company mainly as a medicine-making 
company. However, the important fact to be noted is that the target consumer was the ayurvedic 
vaidyan, a target that till date continues to be the focus of the classical-focused ayurvedic companies 
in Kerala. Excerpts from the AVS foundation day announcement of Dr. P. S. Varier in 1902 show that 
the production was clearly aimed at ayurvedic vaidyans62.   
Vaidyans should organize themselves in a group and  form a company that will examine all raw 
material thoroughly… processed with the utmost zeal and attention, making no deviations whatsoever 
in what the ancient ayurvedic scientists have prescribed in their texts or in the experience that has 
been garnered to date. It is my belief that if other vaidyans begin to buy medicines processed in this 
way, use them properly and conduct treatment in a befitting manner, both groups will enjoy a profit 
that will equal in their effort, that patients will be benefited and people will have faith and 
satisfaction in native medicine (Krishnankutty 2001:50).  
Varrier’s expectation was soon fulfilled. Several companies came in Kerala as vaidyan co-
operatives. Two of them have grown very large, one in Calicut in Northern Kerala and one in Kollam in 
Southern Kerala. Various other formats and partnerships also emerged. For instance, one of the small 
ayurvedic companies in the study sample, Sree Sakthi Ayurvedics in Palakkad, caters exclusively to a 
group of doctors. The company was started by Dr. K. V. Krishnan, 20 years ago with a mere ` 250,000 
($5000) investment as a small scale enterprise,  has grown to an annual turnover of around ` 20 million 
($400,000). The vaidyan makes 250 classical products and five proprietary products for a group of 40 
doctors who are his loyal customers. It is a mutually beneficial strategy. Doctors have access to 
authentic products tailored to their satisfaction, but they also get  a higher profit margin. The 
production can be scaled up or down; medicines can be tailored to meet doctors’ requirements. The 
doctor-manufacturer has a guaranteed clientele and is free of marketing hassles. Selling OTCs or 
prescription products requires an  entrepreneurial mindset and a different skill set, besides the 
willingness to compromise on ayurvedic principles. Selling therapy products to doctors is the most 
practical tried and tested business model that cashes in on the doctors’ expertise. For an 
entrepreneurial minded doctor, it is a default business model that simply caters to existing demand, 
requiring no skills or investment on marketing. Observing AVS success, Bode (2008: 76) says that “it 
illustrates that the sale of classical formulas in conjunction with humoral diagnosis and treatment is 
                                                 
62Though customers also included patients who consulted AVS by mail.  
 79 
 
another way to be successful in the highly competitive market of ayurvedic and unani medicine.”   
More importantly, medicine-selling was only part of the identity for the majority of the 
sampled companies. Of the 15 small, mini and micro companies with turnovers less than $10 million, 
one was State owned. Of the rest only one was not owned by a doctor, but this was run by a traditional 
vaidyan family which had no inheritor in this generation. Of the 14 doctor-run companies, all except 
two were inheritors  of a traditional family or guru-lineage. Of the 20 companies larger than $10 
million, one is State owned. All the doctor-run companies are involved in treatment as part of their 
routine practice, three own small hospitals, one is a large hospital which has less focus on medicine 
sales. Of the rest 19,  the breakup is as follows: four are run by businessmen, of which two are new 
generation companies focused on the classical market (Nagarjuna and Everest), and one proprietary 
focused company (Kandamkulathy) but has a strong classical presence because it was inherited from 
traditional vaidyan father. The only plain business company with business focus is the aphrodisiac 
seller, Kunnath Pharma.  Of these, two are involved in treatment, Kandamkulathy and Nagarjuna. For 
the former, it is a continuation of the Vaidyan tradition.  For the latter, it is an important segment, 
and though established in 1999, it has already established a reputation in practice.  
Of the rest of the 15 companies, two are new generation doctor-entrepreneurs, one of whom 
acquired a traditional company and is classical focused (Sitaram Pharmacy), whereas one is 
proprietary-focused but is founded by a doctor who began his career with treatment-centric 
manufacturing and continues to be involved in treatment. The other 13 companies all have some kind 
of traditional background: three have guru lineages (AVS, AVP, AVN), five are family lineages 
(Vaidyaratnam, Vaidyamadham, SNA,  Nupal, Dhanwantary). All except AVS which is run by a charitable 
trust, are family run.  KAS is primarily an association of doctors. Two are owned by religious trusts, one 
Christian missionary and one Ezhava Hindu religious group. One is a traditional family acquired by a 
businessman managed by the family heir (KAL), one is a new entrepreneur who acquired an old 
tradition (Sitaram), one is a traditional company that has been run on contract by a business group 
(Vaidyaraj). All 15 manufacturers run medium to large hospital establishments.  
According to Dr. Joy Varghese, Director of the ayurvedic industrial cluster in Kerala, around 
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90% of manufactures in Kerala are doctors, which he claims provides an “inbuilt mechanism for quality 
control”. A more conservative estimate puts the numbers to 70%. It is safe to infer that doctor-
practitioners have historically dominated both the small and big manufacturing sector in Kerala. 
Manufacturers rooted in clinical practice tend to look at medicines from the view point of a doctor. 
One respondent, a new generation doctor-manufacturer in rural Ernakulam, started a company in the 
80s. After establishing reputation as a doctor, he teamed up with a bunch of friends as business 
partners to start a medicine unit. Soon he realized that his business-minded partners’ expectations 
required him to make compromises not palatable to his doctor ethos. He refused to yield; the team 
broke up and the business did not grow. He contents himself making 250 classical products selling them 
through two outlets. But this attitude is not unique to doctors. Everest Pharma is a half a million dollar 
company run by a business family.  The owner-MD of the company, Mr. Joyachan Erinjery, said they got 
into the medicine business moved by the personal experience of the owner who was nursed back from 
the deathbed by a traditional vaidyan. The company began with decoction powders on the advice of 
the vaidyan that they continue to specialize in. In his attitude towards modern marketing strategies, he 
exudes a conservativeness that is indistinguishable from a doctor.  It requires more ethnographic work 
to delve into the nuances, but prima facie it appears that what is at work is the collective ethos of 
ayurvedic practice that sets standards for ayurvedic practice and medicine production. 
CEO of SDL (Sree Dhootapapeshwar Limited), Mr. Ranjit Puranik hails from the founding vaidya 
family. The company represents the minority of large manufacturers outside Kerala that continue to be 
strongly rooted in vaidya ethos. A regular in ayurvedic industry meets and conferences, Puranik is often 
heard heaping praise on Kerala for preserving the classical tradition lost elsewhere. In a personal 
interview, he said that while shift in market had forced them to seek greener pastures, he attributed 
part of the shift to the lack of “commitment factor” among the trend-setting industries. He identified 
four pockets63 in India that upheld the classical ayurvedic tradition, none of them matched Kerala in 
magnitude.  What Puranik considers “commitment”, is what the large industry outside Kerala sees as a 
hurdle in its path of progress. In a personal interview, Secretary of the Manufacturers’ Association of 
                                                 
63 Dakshina Kannada district in Karnataka (adjacent to Kerala), Surat-Baroda belt in Gujarat, Pune-Nashik belt in Maharashtra, 
and Varanasi, in Uttar Pradesh. Though not a match to Kerala in scale, small manufacturers in such locations are likely to 
resemble classical manufacturers of Kerala in their production and marketing strategies. 
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Karnataka State criticized Kerala’s adherence to classical medicines as hidebound, saying that it was 
time to move towards “scientifically validated modern products and neutraceuticals”. The Director of 
Dabur Research Foundation writes,  
The lack of a killer instinct in the ayurvedic industry…domestic as well as in the international 
market has resulted in loss of opportunities, which should rather have been grabbed not only 
for the benefit of the industry but also for the benefit of the nation as a whole (Kohli 2006: 
71).  
This ‘modernist’ attitude outside Kerala came to the fore during a conversation with Dr. J. D. 
S. Pani, President of Karnataka Indian Medicine Manufacturers Association (KIMMA) and 
Chairman at Ayurpark Health Care Limited AYUSH cluster. His perception of the market and his vision 
for marketing of Ayurveda reflected an approach that is typical outside Kerala. Stating that classical 
medicines were outdated and had no established ‘scientific’ credentials, he contended that it was 
inevitable that the ayurvedic industry move towards modern and scientific products. “No meaning in 
giving the same classical medicines – what is the evidence that a medicine like Ashokarishtam works? 
Special R & D has to be done. We need modern products, should do research and develop products”. He 
was critical of the Kerala industry which he felt was old fashioned and out of touch with the market. 
“Kerala industry is stuck in tradition, they need to move along with the times. Doctors keep following 
the same method, same medicines, they don’t give a thought to whether it is meaningful or not”. He 
saw no future in the therapy market. He was trying his best to get new entrepreneurs to invest in new 
segments like neutraceuticals and cosmoceuticals, which he felt was the right direction for the industry 
to take. Talking about practitioner family based companies, he said there were around 60 companies in 
the two districts in Karnataka that bordered Kerala64, “I won’t consider them as Karnataka, take them 
away and add them to Kerala. Anyway, I will give 20 years, by then the tradition will go”, he joyfully 
submitted, clearly relieved that the tradition was on its way out, giving a better chance for modernity.  
2.12 Conclusion 
Classical products resist commodification in two major ways. Firstly, they are limited to the 
humoral therapeutic context and therefore need the ayurvedic doctor to mediate consumption. 
Secondly, being open-source they do not offer exclusivity to the manufacturer. Ayurvedic industry 
                                                 
64 Erstwhile DK district, one of the four regions pointed out by Mr. Ranjit Puranik as surviving traditional pockets of Ayurveda. 
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outside India broke these barriers by diverting commodities out of their conventional context. The first 
strategy was to reach the consumer directly through OTC commodities, the second was to sell 
ethical/prescription products through biomedical physicians. Both strategies circumvented the 
ayurvedic physician. Breakup of turnovers of large manufacturers shows that OTC products account for 
70-90%, ethical products to 10-15%, and classical medicines to 10% or below. In complete contrast to 
this, manufacturers in Kerala, both big and small have remained faithful to classical products. The 
largest five derive 75-100% of their turnover from classical medicines. Even those companies with 
aggressive proprietary focus are invested in the classical market not only because it makes business 
sense, but also because it is essential to earn respectability in the therapy-focused Kerala market.  In a 
nutshell, unlike the predominant trend in ayurvedic industry in rest of India to divert products to new 
channels to suit commercial logic, manufacturers in Kerala adapted a model of commodification 
without diverting commodities from their established paths.  
Closer analysis of the Kerala distinction reveals the role of stakeholder-characteristics in 
differentially affecting trajectories of commodification. Unlike the business-professional led 
mainstream ayurvedic industry, Kerala industry is dominated by practitioner-manufacturers, who 
combine within them the roles of both commodifiers and gatekeepers. Unlike the pharmaceutical-
focused mainstream, they have been heavily invested in providing therapeutic services, which I suggest 
has led to the preponderance of ‘practitioner logic’ over ‘commercial logic’. Most of the manufacturers 
in Kerala had established their brand value in the medicine market over a long history of clinical 
practice. Unlike the sellers of blockbuster products, their clientele are ayurvedic doctors to whom they 
were committed to sell a whole pharmacopeia irrespective of the low market viability of individual 
products. Rather than being barriers classical product manufacturers saw ayurvedic doctors as essential 
to create a demand for therapy products by attracting patients. On the other hand, the large 
manufacturers of North India were significantly influenced by the biomedical market, both in terms of 
marketing strategies and profit margin expectations. Their strategies of diversion were likely to have 
been further precipitated by an already deteriorated status of clinical practice caused by ayurvedic 
doctors shifting their allegiance to allopathy.  
 83 
 
I further argue that the agency model of distribution used by Kerala manufacturers played a 
significant role in making this mode commercially viable. It provided an exclusive channel for the flow 
of ayurvedic classical commodities; the therapeutic context was maintained because the mediator and 
the product were packaged together. It was not only convenient for the patients, but also for ayurvedic 
doctors who had a large classical pharmacopeia available at their finger tips.  
However, amidst this overarching classical climate, a discordant note is visible in the past 
decade, that has accompanied the emergence of a new generation of consumers who prioritize 
convenience and palatability. A new breed of narrow product range companies have come up in the 
past decade focusing on the aggressive selling of OTCs diverting therapeutic products from their 
established paths. The cacophony of advertisements in the media and the turnover figures of a few of 
these products make it appear as if the days of the classical medicines are numbered. But whether this 
is a parallel or a subversive trend cannot be ascertained without further investigation. Firstly, 
turnovers of large manufacturers may not be an adequate representation of classical medicine 
consumption. It is important to note that there is a large unorganized sector comprising of unregistered 
practitioner-manufacturers on which there is no data available. Secondly, comparison of classical 
turnovers with OTCs and cosmetics can be misleading as these are independent segments in the market 
that do not eat into each other’s revenue. Classical medicine manufacturers’ move to expand into 
these segments might suggest a trend in ‘diversification’ rather than ‘diversion’. Thirdly, it is not clear 
to what extent the reported change in consumer culture in Kerala is the result of expansion in the 
catchment of consumers rather than change in attitude of conventional Ayurveda consumers.  
Further discussion on new trends in the ayurvedic commodity and service market will be taken 
up in Part three. As of now, though the growth of classical market may be slow it continues to 
dominate the ayurvedic industry in Kerala. Not only do the traditional stakeholders profess continued 
allegiance to classical products, even the new generation proprietary manufacturers as they grow in 
size, aspire to participate in the classical market. There is also a likelihood that increasing popularity 
of Brand Kerala Ayurveda across India might regenerate a hitherto absent market for ayurvedic 
treatment services which in turn may inspire a revival of the classical market in other parts of India.  
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3. CH 3 ROOTS OF THE DIFFERENCE 
Availability of a large pool of ayurvedic practitioners linked to the practice of a common 
classical pharmacopeia was a pre-requisite for the growth of an industry based on classical ayurvedic 
commodities. Without the advantage of scale, open-source classical products with their narrow profit 
margins are known to be financially unviable for mass production and distribution. Within a few years 
after its establishment in 1902, Arya Vaidya Sala began to be flooded with inquires from vaidyans from 
the nooks and corners of Kerala. The diffused practice of Ayurveda across various castes and 
communities in Kerala is likely to have played a role in producing this human resource.  Unlike the 
Sanskrit-heavy tradition that was restricted to elite Hindus, in Kerala, classical ayurvedic practice was 
not restricted to the traditional elite. Section 3.1 provides an overview of this culture of practice, 
supported by ethnographic evidence in Section 3.3.  
Though mainstream discourse in Kerala toes the lines of Hindu revivalist reconstruction of 
Ayurveda (Section 3.1.1), both the elite rung of Brahmin practitioner families and non-elite Ezhava 
community trace their tradition to ancient Buddhist legacy (Section 3.1.2). Ashtanga Hridayam (AH), 
the last of the classical triad of compendiums written by Buddhist sage Vagbhata (C. 7th Century CE) 
played a significant role in popularizing Ayurveda in Kerala. Besides this, proliferation of vernacular 
language texts also contributed to the popularization of classical ayurvedic knowledge. Consequently, 
vaidyans of various hues and backgrounds shared in common the knowledge of a classical 
pharmacopeia, thus creating a ready market for classical products.  
In Section 3.2 I suggest that there is nothing unique about the medieval history of ayurveda in 
Kerala, in terms of proliferation of vernacular texts or in the significance of Buddhism in contributing 
to the popularity of medicine outside the Sanskrit tradition. Evidence from other parts of India shows 
the involvement of various reformist sects in the dissemination of medicine in the medieval period. I 
argue that developments in the recent past that were unique to Kerala helped in empowering an 
existing vibrant community of vaidyans to upgrade their knowledge to meet the demands of modern 
professionalized practice and enabling them to participate in the new entrepreneurial environment. 
The most important of these are: social reform movements of the 18th-19th century and continued state 
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patronage to ayurvedic education and practice during and after the colonial period. 
3.1 Transcending class, caste and religion: Ayurveda in Kerala 
 “What is special about Kerala is that vaidyans from various castes and communities have been 
practicing and continue to practice Ayurveda”, the Secretary of Keraleeya Ayurveda Samajam (KAS), 
Mr. M. Muraleedharan, asserted with pride. The institution welcomes its visitors from a mile’s distance 
with a supersized hoarding overlooking the Bharatapuzha river declaring itself “the world’s first 
Ayurveda Center.” It was founded in 1902 by some of the most illustrious and elite physicians under the 
patronage of the erstwhile kings of Cochin and Malabar. This is also a staunch ‘purist’ institution in 
Kerala known for its opposition to modernization. Talking about Ayurveda, another trustee of the 
institution expressed pride in its popularity among common people across Kerala. There was no 
attempt to present a glorified history of the institution, its royal heritage or its elite base; the pride 
was instead about the mass appeal of Ayurveda. Though he emphasized the uniqueness of their 
organization in maintaining the sanctity of tradition, it was not aimed at a select elite, but to the hoi 
polloi who had the ability to recognize authenticity by sheer strength of habit.  
 That the statement on the pan-communal nature of Ayurveda was not mere discourse was 
more than evident by the fact that the institution’s ayurvedic medical college managed under the 
auspices of monastery of Shankaracharya (the 
architect of Hindu revivalism) was headed by a 
Catholic nun. A soft-spoken lady with a life 
time of medical experience, the principal of 
PNNM college, Dr. (Sr.) Donata is among the 
most respected of the senior scholars and 
practitioners in Kerala, who was previously the 
chief physician of the Amala Ayurveda Hospital, 
the ayurvedic  wing of the Christian missionary run biomedical hospital historically reputed as a cancer 
treatment and research center. She is the first catholic nun from Kerala to get into ayurvedic practice, 
though today it is common to see nuns from various Christian orders in ayurvedic practice  Sister 
Malayalee Christian Nuns visiting the Global 
Ayurveda  Festival in Trivandrum, 2012 
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Donata’s entry into Ayurveda was fortuitous; she was requested by a priest to change her choice from 
allopathy to Ayurveda as he felt they had too many allopathic doctors in the church establishment, but 
none specializing in Ayurveda. Sister Donata found nothing discordant between her religious role and 
Ayurveda. For her, faith and spirituality were important in the practice of ayurvedic medicine, but this 
was unaffected by religious persuasion. Secularism, for her, meant not indifference to religion, but an 
ideology tolerant and inclusive of multiple faiths.65  
This is an oft-expressed sentiment. Dr. Verghese 
Pattarumadom, a third generation doctor from a Syrian 
catholic Christian vaidyan family. His grandfather 
acquired the knowledge of medicine from a brahmin 
guru. Dr. Verghese had the advantage of rigorous formal 
training, in addition to learning at home. Before 
entering the Diploma program, he attended a Sanskrit 
school that his father was intent on sending him to, 
despite it being a 13-14 kms walk through wilderness.  A 
framed picture of Mary, and a sculpted idol of 
Dhanwantari, the Hindu God of medicine, adorn his 
display shelf along with the framed degree certificates. 
narrates the story about an elderly Hindu couple who had come to him for treatment eight years ago. 
Seeing him lighting the lamp and praying every day before commencing the treatment, they were 
impressed. The identity of the God in question was irrelevant; faith conveyed discipline and 
commitment. Since then, he said proudly, “For the past seven years, they  have been coming to me 
every year for a month’s wellness treatment”. To be pious was what was important, whatever be the 
sect and whoever be the god. This is a message often expressed by practitioners who see faith as an 
important marker of a disciplined life free of vices, and also a cushion that protects from the stresses 
and strains of everyday life.  
                                                 
65 I probed into this question reluctantly, with the sole purpose of getting verbal evidence for an otherwise palpable lived 
experience.  
 
Dr. Verghese Pattarumadom at his office: on 
the display shelf are credentials, awards, an 
idol of the Hindu God of Medicine 
Dhanwantari, and a painting of Jesus 
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For Vaidyan James Mathew, a Syrian 
Christian practitioner in his early 60s, ayurveda 
is not only not antithetical to his faith, it 
becomes an instrument in furthering his 
religious goals. An unlicensed practitioner he 
runs a small clinic-shop in eastern Kerala. This 
is possible only because of his interior location 
in a migratory region;  there are no established 
stakeholders here to alert authorities. His shop 
attracts attention with its picturesque walls, adorned with hand-painted images of Jesus all over, both 
on the inner and outer walls. He is proud of the art work that he himself has created. He had begun his 
training with his vaidyan father, but unable to tolerate his dictatorial methods, he ran away from as a 
teenager. apprenticed under gurus of various hues. At the end of the interview, he presented me with 
a self-published priced booklet that combined catholic evangelization with medical advice.   
Another example of fluidity in ayurvedic practitioners’ concept of faith and religiosity comes 
from Dr. Raghavan, a pious Hindu Ezhava practitioner. A BAMS degree holding doctor in his mid 40s, he 
is among the minority of ayurvedic doctors who use astrological knowledge to guide diagnosis. 
Watching his consultation processes, I found him to be a stickler to the holistic view of disease 
etiology, of investigating into social and psychological causes of illness. Every time, before writing the 
prescription, he would close his eyes and meditate, claiming he did it based on divine guidance. 
Though he was seeking guidance within a Hindu religious framework, that did not limit the purview of 
his spiritual guidance. Among his success stories is an interesting case of a middle aged Muslim lady. By 
divine guidance he diagnosed her illness as caused by defaulting on a religious obligation; she admitted 
to it only after much probing. He advised her to attend to it without delay, and he claims that as son as 
she performed it, she was cured of the ailment that she was long suffering from.  
“Religious identity has no place or relevance in Kalari” says Mohammad Gurukkal, a Muslim 
marital art practitioner-vaidyan in Thrissur.  In the pre-British educational system, Kalari ‘ashans’ 
 
Hand painted images of Jesus displayed with vaidyan 
credentials in an ayurvedic medicine shop 
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(masters) often doubled up as pre-school teachers. With Kalari’s growing popularity, Hindu mothers 
have been bringing their children to him to conduct the ceremony of Vidyarambam (Hindu ritual 
initiation to education). Gurukkal religiously lights the lamp and does pooja (worship) to the idol of 
Kalari Paradevata, the goddess of Kalari, a form of Hindu goddess Bhagawati.  
A poignant illustration to the cultural difference between Kerala and other parts of India comes 
from the  account of an AVS agency owner in Bangalore. A Christian entrepreneur from central Kerala, 
Michael opened an ayurvedic agency in the outskirts of Bangalore after he failed in his earlier business, 
choosing the location because of a significant Malayalee presence. Though he also gets local customers, 
his experience with them is not as positive.   
The Kannada people are difficult customers to handle. They are unfamiliar with ayurvedic 
medicines and are unwilling to consume bitter decoctions. They often request the doctors for 
more palatable medicines. There were some who even came back with the medicines, though the 
doctor, especially the one who hailed from Kerala, insisted that they consume the medicines.  
Though he has two part-time doctors on his rolls, customers are prone to asking him for medicine 
advice prompting him to stock proprietary medicines, especially hot-selling categories like anti-obesity. 
In stocking these medicines, he knew he was transgressing the manufacturer’s policy, but he says 
outside Kerala, it is difficult to survive only on classical medicine sales. The most interesting part of his 
narrative was his experience with local people associating Ayurveda as a Hindu brahmanical practice.  
People around here seem to think that Ayurveda is a Hindu, that too a Brahmin business! Many of 
them assume from my looks that I am an elite Brahmin. I don’t try to dispel their notions; it is 
good for my business. As you very well know this is not how we think in Kerala! Some customers 
get confused when they see this picture (pointing to the large framed photo of Jesus hanging on 
the wall). One customer even asked me, “when did the Christians buy up the Arya Vaidya Sala?” 
There is no point in explaining to these people, they won’t understand.  
A Keralite, functioning in an outside milieu, Michael’s experience holds a mirror to the contrast 
between cultures inside and outside of Kerala.  
3.2  Discourse Vs Practice 
It was common for informants to mention that Ayurveda in Kerala is not restricted to elite 
Hindus, leading me to suspect it was part of a common discourse. At the same time, it appeared 
unconnected to any particular agenda, not targeted at any particular clientele. Though tourism has led 
to the marketing of ‘tradition’, a review of tourist ads shows that the focus is on the pan-Indian Vedic 
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tradition to confirm to the existing imagery in tourists’ minds, both domestic and foreign. Why then do 
people emphasize on the secular nature of Kerala Ayurveda? Self-consciousness of the differentness of 
Kerala might have arisen in encountering a Hinduized version of Ayurveda outside Kerala. It might also 
be a part of the image of Kerala as an abode of communal harmony, again a self-consciousness arising 
from being juxtaposed with communal politics elsewhere in India. It is interesting to note that such 
sentiments and identities persist despite Kerala Ayurveda community’s internalization of the Hindu 
revivalist ideology (Panikkar 1992) that shaped the development of modern Ayurveda (Leslie 1976).  
 
Glenn Stone at an Ayurvedic hotel-spa: Image right to the elephant painting 
include  an Islamic symbol, Krishna, Ezhava Guru, Jesus.  
On the counter is a Ganesha idol and a therapy poster adorns the side wall  
In most of India, prolonged Muslim rule between the 14th and 18th centuries had created a synthesis 
between Persian and Indian medicines to produce what Leslie (1976) terms ‘syncretic medicine’. 
Revivalism in Ayurveda was closely linked to the re-invention of religion partly associated with the 
nationalist movement. European orientalists’ quest for finding common roots in an ancient Aryan/Indo-
European past heavily relying on Brahmanical interpretations of Indian society, led to a selective re-
interpretation. Categories like “Hinduism” led to the forced categorization of all that lay in the grey 
area to the brahmanical ideal (Samuel 2008, Metcalf and Metcalf 2002). The protestant concept of 
‘religion’ was imposed on an  inherently pluralist spiritual geography of India, forcing groups with 
mixed identity into water tight religious compartments like ‘Muslim’ and ‘Hindu’ (Samuel 2008). The 
colonial administrative apparatus furthered the compartmentalization process for different ends 
ranging from revenue collection to strategizing military cohesion, further solidifying these categories 
through its census surveys and anthropological survey projects (Dirks 2001). Just as in religion,  it led to 
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a re-interpretation of the present to match an imagined past tradition of medicinal practice, 
compartmentalizing Muslim Unani and Hindu Ayurveda, sidelining or co-opting discordant traditions 
(Sivaramkrishnan 2006, Banerjee 2009). Kerala escaped this part of the reconstruction because it 
neither had a syncretic tradition nor the divisive communal politics that characterized rest of India.66 
Being isolated from Muslim rule, Ayurveda in Kerala was uninfluenced by the alchemy dominant Persian 
medicine, staying closer to the classical herbal tradition (Svoboda 1992). 
Though mainstream ayurvedic discourse in Kerala may toe the lines of the larger revivalist 
theory, it has not made much dent in the everyday culture of practice. To get a glimpse of this culture 
one does not have to dig deep. A good place to begin would be the Arya Vaidya Sala (AVS), the largest 
ayurvedic manufacturer of South India. An outside visitor to the town of Kottakkal in Northern Kerala 
might be taken aback to see the bastion of Kerala Ayurveda wedged in a town that looks and feels like 
mini-Arabia. It is not easy to locate a vegetarian outlet in the town that reeks with the spicy aroma of 
Malabar biriyani, and abounds in grills that churn out mutton kabobs and shawarmas by the dozen. 
Malappuram, the district in which Kottakkal is located has 32% of Kerala’s Muslims, who account for 
around 66% of the district’s population. People of AVS who are predominantly from the founding Varier 
caste67, who belong to the minority Malayalee vegetarian population (an estimated  2%), do not forget 
to provide specific directions to the few invisible vegetarian food outlets for their non-local visitors.  
The founder of AVS was especially known for his close relationship with the Muslim community 
hailing back to the period when he shielded them during the famous Mapilla Rebellion68. During the 
period of my field work, one of their annual founder’s day celebration was presided over by the State 
President of the Indian Union Muslim League, a minority political party. The forty families who supply 
fresh herbs to AVS are Muslims, who grew with the institution from small time herb collectors to 
become powerful stakeholders in the fresh herb market. Despite the imposing presence of AVS with its 
two hospitals and medicinal gardens occupying most of the real estate in and around Kottakkal city, 
right under its nose there are numerous other small pharmacies that hail from local traditional 
                                                 
66 The festival culture of Kerala is also unique. The secular harvest festival Onam celebrated by all religions is the State festival. 
There is a conspicuous absence of popular Hindu festivals like Diwali and Dusharra. 
67 One of the Ambalavasins (temple-dwelling) group of castes, who assist Brahmin-priests in daily maintenance of the temple.  
68 Armed uprising of Mapilla Muslims of the Malabar against the British in 1921. 
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practitioner families, mostly Muslims. Though some establishments combine Unani with Ayurveda, the 
presence of Unani is weak. The data speaks for itself, in all of Kerala there is a single drug 
manufacturing unit and a single government dispensary for Unani; and it accounts for a paltry 0.4% of 
the ISM practitioners.  
The revivalist ideology buttressed Ayurveda’s image of golden past accusing Muslim rule and 
Buddhism for its decline (Leslie 1976). Paradoxically, Buddhism along with a variety of ascetic 
traditions other than Buddhists were involved in the practice and dissemination of medicine both in the 
pre-compendium and post compendium period. Between 6th and 12th centuries CE, Buddhist Universities 
played an important role in the systematization and dissemination of ayurvedic education (Zysk 1998). 
Overemphasis on Sanskrit classics that were considered to be representative of the pan-Indian 
ayurvedic tradition, has led to lack of attention to regional traditions and histories (Chattopadhyaya 
1977). A handful of scholars of ayurvedic history have made up for this lacunae69. Varier’s (2005) semi-
academic account of the history of Ayurveda with focus on Kerala, Ayurveda in 14th-17th century Andhra 
(Hymavathi 1993) and history of medicine in early 19th century Punjab by Sivaramakrishnan (2006)70.  
These accounts provide a glimpse into a medieval past that was a potpourri of religious and medical 
traditions parallel to the Sanskrit-Vedic tradition. Proliferation of regional ayurvedic texts were 
important in facilitating liberalization of access. The Bhakti (devotion) movement, an anti-caste 
humanist social reformist movement that swept across India around 12th century led to the 
strengthening of vernacular literature (Pande and Zide 1965) providing non-elites access to knowledge. 
Continuing with the Buddhist missionary use of medicine as an arm of religious expansion (Zysk 1998), 
in the medieval era various sects vied with each other in providing medical education (Hymavathi 
1993). In 19th century Punjab there was a co-existence of two distinct streams of practitioners, elite 
brahmin practitioners and a medley of Hindu, Jain and Sikh ascetic orders. The latter strived to diffuse 
ayurvedic education to new centers where there was no traditional concentration of Sanskrit 
patashalas (schools).  Practice of medicine provided them with both a means to livelihood and support 
from local community for their monastic settlements (Sivaramakrishnan 2006).  
                                                 
69This statement is limited to historians of Ayurveda; scholars who have studied the history of Tantra, Buddhism, Jainism and 
historians of ancient India have paid attention to ascetic traditions.  
70 This statement is restricted to literature accessible in the English language.  
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Ayurveda also had several other influences, apart from Vedic and Buddhist sources, Tantric71 
schools of thought were an equally significant influence (Kurup 1996). Kerala is considered a hotbed for 
astrological and magico-religious traditions that might have got relegated to background both owing to 
the Vedic-centric ideology of revivalism and modern rationalist movement. The branches of 
Agadatantra (toxicology) and Bhutavidya (psychiatry) are said to have drawn much from Tantric 
traditions (Nambisan 1996). Ayurveda in Kerala is also influenced by Siddha, especially in the regional 
practice traditions of Southern Kerala (mainly Trivandrum) bordering Tamil Nadu. In fact, until the 
modern compartmentalization, vaidyans drew their knowledge from eclectic sources irrespective of 
their lineages. It would have been difficult to differentiate between an Ayurvedic and Siddha 
practitioner in certain regions or between Ayurvedic and Unani in certain others. As mentioned earlier, 
the revivalist discourse ignores the various influences and the regional diversions that diverge from the 
static ‘Vedic’ view of ayurveda. Varier (1996: 41) points out that to call Kerala as the cradle of 
Ayurveda goes against facts, but “ the claim is generously allowed by lovers of Ayurveda elsewhere also 
due to some features which are pleasing to them”. By doing this, both parties take advantage of each 
other. Ayurveda in Kerala becomes the representative of what is considered classical and pristine and a 
straw to hold on for the drowning prestige of Ayurveda  in rest of India. And in the Sanskritized  
identity of modern mainstream Ayurveda, Kerala gets to claim a direct historical legacy. 
What I mean by ‘classical Ayurveda’ in this dissertation, is not restricted to the view of a  
classical tradition frozen in texts, but to a fluid and shared tradition of Ayurveda. It includes regional 
variations and unwritten practitioner metis, but is linked to a collective culture that draws on one or 
another of the recognized classical compendiums of ayurveda as a base for theoretical framework. 
Such a collective culture had led to a certain extent of  commonalty in the pharmacopeia used, that 
drew from Sahasrayogam and Ashtanga Hridayam and from other local texts. When mass production 
took off in early 1900s there was a large pool of doctor-consumers who shared the knowledge of a 
common pharmacopeia in order to provide a viable consumer base. It is also likely that the classical 
pharmacopeia we see today was partly produced in the interaction of manufacturers and practitioners 
                                                 
71 Tantric = of Tantra. “Tantra is a system of internal sacrificial rites that uses the inner environment to influence the outer 
environment” (Svoboda 1992:58). 
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through a mass distribution system, leading to some extent of homogenization. When the State 
manufacturer, Oushadhi, was formalizing production in the era of Cochin kingdom (estb. 1941), a 
committee was formed with five reputed vaidyans who after 14 sittings prepared a manual called 
Ayurveda Nirmana Kramam (Method of Manufacturing Ayurveda). The founder of AVS also wrote a 
similar book in the early 1900s, besides producing a book on medicine indications and dosages. 
However, in the early years AVS promised the doctors that they would also make medicines based on 
advance orders.72 Vaidyans’ orders would have helped manufactures to gauge the nature of demand, 
eventually contributing to the evolution of a common pharmacopeia.  
3.3 The Buddhist connection to Ayurveda in Kerala 
Unlike many regions in the Himalayan belt, Kerala does not have a direct claim to ancient 
Vedic heritage. Kerala’s connection to Ayurveda comes through Buddhism, a legacy claimed by two 
major but distinct groups of practitioners in Kerala, Ashtavaidyans (elite brahmin practitioner families) 
and dalit (subaltern) Ezhavas. This is counter-intuitive because there is no trace of Buddhism left in 
contemporary religion or culture. But there was reportedly strong Buddhist and Jain foothold in the 
early centuries of the common era, a history that lies buried under Hindu temples.73 This is not 
surprising given that Kerala was the seat of the pan-Indian Hindu revivalist movement in 10th century 
led by guru Shankaracharya who hailed from Kaladi in Central Kerala. Incidentally he was also known as 
‘Prachanna Buddha’ (Buddha in disguise)74. Several linguistic examples are cited for the Buddhist 
connection. The Buddhist term Margam (path) is used in Malayalam equivalent to ‘religion’ 
(Thirumulpad 1977).  It is claimed that schools attached to Buddha Viharas made literacy and other 
branches of learning widespread. The Malayalam term for school, Pallikoodam (Palli = Buddhist 
monastery) is cited as a supporting evidence (Murali 2004). In evaluating the factors that had led to 
high literacy rate of Trivandrum in early 19th century, Tharakan (1984) draws evidence from historians 
that show a rich history of indigenous school education. Based on these studies, he argues that 
                                                 
72 For example, an advertisement in their medical magazine Dhanwantari in early 1905, tells doctors of their intention to be 
producing Ksheerabala 101 asking those interested to place order ( medicine takes 4-6 months to produce). Two issues down the 
line, an apologetic posting in the magazine informed doctors that the medicine was already sold out in advance (AVS 1905).  
73 I visited one such temple, Kallil Kshetram in Ernakulam, originally Jain, now brahmin-run.  
74 After training himself in  Buddhist logic he defeated Buddhists in scholarly debates across the country. He then  went on to 
establish four powerful Hindu monasteries, again influenced by the Buddhist religious organization. 
 94 
 
pallikudams or kudipallikudams had popularized basic education among non-brahmin communities. He 
further cites research studies that trace the origins of such schools to early Buddhist and Jain 
influences.  
The elite Ashtavaidyan tradition is shared by 18 Namboothiri brahmin families who claim to be 
the first to learn Ayurveda from the Buddhist physician-scholar Vagbhata (C. 600 CE)75. Today it is 
perhaps the only tradition classical medical tradition in India that can boast of an unbroken continuity 
with the classical past, also providing Kerala Ayurveda with its historical identity. Only eight of these 
families are extant.76 The decision to practice medicine proved costly to Ashtavaidyans who were 
promptly downgraded to Moosad, a lesser caste of Brahmins, and were denied rights to conduct Vedic 
rites77. Not surprising, given that even the Gods had to bear the brunt for learning the evil science.78 
Though Ashtavaidyans today emphasize on the Vedic heritage of Ayurveda in line with the larger 
revivalist ideology, they are not shy of talking about their Buddhist origins. They venerate the day of 
Vagbhata’s death by refraining from reading the Ashtanga Hridayam; the house of Pulamanthol Moos 
where he is supposed to have lived and died is considered sacred. Some scholars suspect the veracity of 
Vagbhata’s Buddhist origins. Some others trace textual connections. For example, Vagbhata’s focus on 
“sorrow, its cause, its cure and the right path”, and on “eight right paths” are connected to Buddhist 
thought (Thirumulpad 1977). 
Ezhavas, a community in Kerala, who belonged to the lowest run of Hindu caste hierarchy also 
claim Buddhist legacy, but with a different history, as erstwhile Buddhists migrants from Sri Lanka. 
Though there is no evidence to prove the link, the story is strongly rooted in the oral traditions of the 
community, sufficient to inspire the late 19th century Ezhava social reformer Narayana Guru to 
contemplating a wholesale conversion of the community to Buddhism.  
                                                 
75Vagbhata’s Buddhist origins have been contested. But I give more weight to the version of Ashtavaidyans who have more 
reasons to hide than fabricate a story of Buddhist origins.  
76There are two interpretations for the meaning of Ashta (eight) in their names. The popular interpretation is that it signifies 
expertise in all the eight branches of Ayurveda. Another argument is that the name is derived from their being followers of the 
Ashtanga tradition of Vagbhata (Pande and Zide 1965).  
77As told by an Ashtavaidya and also by a temple trustee of a temple near Thrissur known for its four centuries of unbroken 
annual chanting of Yajur-Veda. This is not surprising because ancient Hindu moral codes considered medicine practice as impure. 
Physicians are among the list of impure persons not allowed to attend divine sacrifices. The Hindu moral code Manu Smriti (C. 1st 
century CE) states that the food given to or received from the doctor is as vile as pus and blood (Chattopadhyaya 1977).  
78 According to legends, Indra, the God of heaven denied rights to ritual sacrifice to Ashwins (the twin horsemen gods) because 
they were physicians. The Ashwins retrieved their rights after promising Chyavana, an old sage with a medicinal formula to 
regain his youth. Named Chyavanaprash, today it is the top selling Ayurvedic classical medicine in India.    
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There are two links in the popular lore in Kerala that connect to the wandering ascetic-
vaidyans in the past. The lesser known of these is the cultural institution of Aryan Kavus, ‘sacred 
groves’ meant for wandering Buddhist monks who refused to stay at people’s homes; it was an elite 
privilege to be able to maintain such reserves.79 Another link alive in public memory is that of Lada 
Gurus, itinerant medicine men who were spotted occasionally up to the late 90s. Lada Gurus came 
once a year on routine rounds, camped outdoors in the night on the farms of friendly hosts, accepted 
food and offered treatment in return80. Occasionally they would part with secrets if they found 
someone deserving. Lakshmi, a 60 year old, illiterate single-root practitioner in rural Idukki specializes 
in treating hemorrhoids. A passing by Lada guru noticed her young son afflicted with acute 
hemorrhoids. Taking pity on his predicament, he told her the herbal formula to treat the problem, 
warning her not to part with the secret. The boy was cured; Lakshmi added the medicine to her 
repertoire. Over the years, her reputation for treatment for hemorrhoids has spread, bringing patients 
from distant villages.  
However, mainstream ayurvedic discourse in Kerala is indistinguishable from that of rest of 
India; the highlight is on the Vedic heritage, with the Buddhist link getting only a passing mention. This 
is not surprising given that the architects of modern Ayurveda in Kerala primarily drew inspiration from 
Bengal81. Arnold cites the example of  the indigenous revival in Kerala led by Arya Vaidya Sala, which 
he terms “a war on two fronts” that attempted to establish Ayurveda as an alternative to allopathy, 
while at the same time sought to “supplant what were seen as ignorant and superstitious folk 
practices” (Arnold 2000:179). Attempts to  professionalize and standardize “adversely affected popular 
medical practices of non-literate groups uninformed by textual knowledge and unsystematized by 
formal training” (Panikkar 1992:308). Institutionalized indigenous medical system sought to 
“differentiate itself from local health care practices that did not identify with the larger tradition” 
(Cleetus 2007: 156). Despite their claim to Buddhist tradition, Ezhavas sought to integrate their 
                                                 
79 ‘Kavu’ means sacred grove and though Arya has a Brahmanical connotation, it was a common reference to Buddhist monks. 
Today the village Punaloor Kavu in southern Kerala, is the only popularly known connection to this history.  
80 According to popular accounts, they hail from Andhra, were bearded and had the Sanyasi (ascetic) appearance. Some 
remember them as people with exceptional and mystic medicinal capabilities, others call them ‘quacks’. They appeared to be 
linked to the originally Buddhist Jangamas, who were traditional mendicants, about whom I learnt from an Ayurvedic doctor from 
Andhra Pradesh who belonged to this community.  
81 Based on articles in Dhanwantari the first Ayurvedic magazine of Kerala started in the 1930s.  
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medical practices with the elites just as the reformist leaders moved away from initial plans to convert 
to Buddhism, instead choosing to locate themselves within the Hindu framework. In the desire for 
social mobility, the reformers tried to correct cultural practices considered ‘socially backward’ by the 
standards of more ‘refined’ upper caste practices. In Ayurveda, community-specific oral traditional 
knowledge was negated in the attempt to acquire access to the prestigious Sanskrit textual tradition. 
The architect of Ezhava reform Narayana Guru, a vaidyan himself, was “driving the point that faith had 
to be interpreted in the light of rationality, in the same way medicine also had to be based on logic 
and rationality. Thus claim to tradition was possible only through the integration of the traditional 
knowledge systems analyzed in the light of rationality” (Cleetus 2007: 163).  
3.4 The role of regional texts in diffusion of ayurvedic knowledge 
Given the modern Ayurveda focus on Sanskrit-centric literature there is little acknowledgement 
of the role played by regional language texts and associated traditions. The Bhakti (devotion) 
movement of the 12th century lead to the strengthening of vernacular literature (Pande and Zide 1965) 
that provided access to knowledge to the masses. Proliferation of regional medical texts (for example, 
in Telugu, Hymavathi 1993) was important in facilitating liberalization of access. In Punjab, schools run 
by the ascetic orders taught in Punjabi or Gurumukhi countering the Brahmanistic orientation of 
Sanskrit (Sivaramakrishnan 2006). In Kerala, regional texts played a prominent role in making medical 
knowledge accessible to across communities.  
Most significant is the fact that the classical tradition of Ayurveda in Kerala was based on a 
compendium that was not accepted elsewhere in India.  The last of the classical triad of compendiums, 
the Buddhist sage Vagbhata’s 7th Century CE text Ashtanga Hridayam (AH) was a redaction and 
integration of the first two compendiums, but is considered a masterpiece by the ayurvedic community 
in Kerala. Here Kerala shares a similar history with Tibet82. It is said that Vagbhata, a Buddhist convert, 
son of a reputed brahmin vaidyan in Sindh traveled across the country before landing in Kerala where 
                                                 
82 Tibet also received Ashtangahridayam along with Buddhism in the same period, that is around 7th century CE (Zysk 1998). It is 
now one of the two core texts of Tibetan medicine (Pathak et al 1997) and is known to be the source for the principal medical 
treatise in Srilanka (Liyanaratne 2001). 
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he found his first followers, Namboothiri Brahmin families83. At the end of his laborious work, caught 
up with anxiety regarding the potential reaction to his work, he wonders if his work will ever be 
accepted given that he was not a sage. He goes on to remark that he cannot help if people did not 
want to read his text and instead preferred to break their head and struggle over the tough classics 
(Thirumulpad 1977). In the following centuries, he was to be proven right. The orthodox medical 
tradition in North India stuck to the two oldest compendiums and resisted the third, perhaps because 
the author was a Buddhist or because they felt that accepting the simplified version would undermine 
their scholarship. “In the absence of patronage, orthodoxy arises where the tendency is to hold on to 
the old, pristine texts” (Thirumulpad 1977: 44-45). Perhaps Kerala was either not yet exposed to 
orthodox traditions of Ayurveda or even if it was, it would not have been as entrenched in tradition as 
elsewhere in India.  
Because of its relative simplicity, AH must have been an important milestone in the evolution 
of Ayurveda in Kerala by popularizing a classical tradition otherwise restricted to erudite scholars84. 
Traditional education in Ayurveda in North India was arduous; the student had to master four classical 
texts85 to become a vaidyan. But in 
Kerala, by consensus of scholars, AH was 
accepted as both a necessary and 
sufficient requirement. An average 
Sanskrit student in Kerala began his 
learning with literature, progressing to 
grammar, logic, astrology, and the 
medical text Ashtanga Hridayam, in that 
order (Varier 2005).  AH became part 
and parcel of Sanskrit education 
                                                 
83 For this to be possible, there must have been an established network of Buddhist institutions though the only evidence for the 
occurrence of this event comes from oral history.  
84 Over the centuries several commentaries were written on the text, in fact no other compendium had as many commentaries 
written (Pathak et al 1997) indicating its popularity.  
85 Classical works of Charaka, Sushruta, Madhava and Chakradatta 
 
Ashtanga Hridayam recital at the Annual Ashtanga Satram, 
Kanyakumari, 2009 
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whether one intended to be a vaidyan or not. This ensured a far wider spread of theoretical knowledge 
of Ayurveda in the population86. In fact, the text is so central to Kerala ayurvedic tradition that the 
word Ashtangahridayam was used as synonymous to Ayurveda. An administrator’s account in early 20th 
century says, “There are three schools of medicines prevalent in Travancore, viz. Ashtangahridayam, 
Chintamani and Yunani”  (Nagam Aiya 1906: 551). With centralization of education and the dominance 
of North Indian practitioners in shaping policies, Ashtanga Hridayam found no place in the national 
Ayurvedic curriculum. It was only recently that practitioners from Kerala were successful in their 
efforts to get it incorporated into the curriculum, an achievement that the Secretary of the largest 
Ayurvedic manufacturing association in Kerala, proudly cites as a personal accomplishment during his 
tenure as a member of CCIM (Central Council for Indian Medicine).  
It is not known to what extent scholarship in Sanskrit in Kerala was historically exclusive to 
Brahmins. Claims are made by some practitioners and scholars from Kerala that even when Sanskrit 
education was restricted, the language diffused across various Sudra communities. According to some, 
formal entry to Sanskrit scholarship was limited to Brahmins, but it diffused to Ezhavas and other non-
Brahmin castes in two significant ways. Firstly, people from lower caste communities, especially 
Ezhavas worked as assistants to brahmin vaidyans in collecting medicinal herbs and making medicines, 
and thereby picked up both medical and Sanskrit textual knowledge. Secondly, it is attributed to the 
caste mixing that happened owing to the unique local sociological practice of Sambandhams (literally 
‘relationships’), formal alliances between Brahmin men, and women from non-Brahmin castes like 
Ambalavasins and Nairs (Unithiri 1996). Another view is that Ezhavas historically had access to Sanskrit 
education by way of their historical connection with medicine; though they had no access to 
brahmanical institutions they had learned vaidyan teachers to provide Sanskrit education to community 
members. Though there is no evidence to substantiate this view, such an eventuality cannot be ruled 
out — the medicine specialist Baid caste in Bengal were found to have historical access to Sanskrit 
scholarship despite being Sudras because of their access to medical texts (Dutt 1965).  
A common mistake is to equate textual scholarship with Sanskrit education or with the 
knowledge of classical compendiums. Vaidyans in Kerala had access to vernacular texts that included 
                                                 
86 This could explain the presence of non-practitioner scholars in Tamil Nadu (Sujatha 2007) and in Kerala until recently.  
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translations of classics, commentaries and diagnostic manuals written by local practitioners and 
scholars (Varier 2005). The most important of these, that can be called the bible of Kerala Ayurveda, is 
a practitioner’s hand book in Malayalam called Sahasrayogam (literally ‘thousand recipes’), of unknown 
authorship and antiquity. This simple book has made ayurvedic knowledge far more accessible to those 
without the advantage of scholarly training. Besides recipes that are arranged according to disease 
categories, it also has a section on diagnostics and therapeutic procedures written in simple and lucid 
language. There is no practitioner or raw drug seller who does not own a copy of this book, its popular 
reputation  an index of the spread and popularity of Ayurveda in Kerala. Other examples of Kerala 
origin texts are Chikitsamanjari, Yogamritham, Vaidyamanjari, Arogyakalpadrumam and toxicology 
specific texts like Prayogasamuchaya and Jyotsnika.  
 
  
 
A traditionally trained vaidyan, leafing through 
Malayalam Ashtangahridayam to support his argument 
 
A lady traditional vishahari vaidyan (poison-
healer) in a remote rural region referring to a 
Malayalam toxicology classic 
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Reputed practitioner-scholars of Kerala have pointed to the significance of these texts (for example, 
Rajagopalan (1996), Varier 2005, Thirumulpad 2008). Rajagopalan 
writes about a book that used to be simply called ‘Chikitsa’ (i.e., 
Treatment) written in colloquial Malayalam that had made several 
modifications in some of the well-known formulations. Even those who 
are considered less theoretically sophisticated, like the ottamooli 
(single-root) practitioners87 trace their tradition to Chintarmani (a 
Malayalam corruption of Siddha) and a popular text among them is 
Agastyaproktam, which has 160 single herb formulations. Ashtanga 
Hridayam with a section on single root medicines, is also considered 
to have been a significant source for their medicines.   
3.5 Roots of the difference 
What contributed to the diffusion of textual knowledge across practitioners in Kerala binding 
them closely into a collective tradition of practice? Though there is plenty of evidence about 
involvement of various other castes in medicine (Leslie 1976), Sanskritic or scholarly education was 
limited to the elite castes (Sivaramakrishnan 2006). Buddhism was a missionary religion for which 
medicine was an important arm of expansion, and it had played an important role in the 
institutionalization and dissemination of ayurveda through medieval universities such as Nalanda (Zysk 
1998). A somewhat similar, but more tenuous link to textual tradition has been documented in coastal 
Tamil Nadu, where 40% of the folk practitioners used local texts and palm leaves (Sujatha 2007). Here 
again, Sanskritic Ayurveda was paralleled with an equally vibrant Tamil scholarship of the Siddhars, 
whose legacy Varier (2005) traces to Buddhism in Andhra in 2nd century CE and to the Buddhist 
University of Nalanda in Bihar (6th to 12th century CE). But at the same time, there is also some 
evidence from other parts of the country of vaidyans from non-elite castes having access to ayurvedic 
education through vernacular languages mainly through non-brahmanical spiritual sects. For example, 
                                                 
87 Practitioners who specialize in giving medicine to a narrow range of ailments (mainly urinary problems, hemorrhoids, 
migraine). Unlike others they are not considered to be learned in theoretical knowledge and are secretive about their medicines. 
 
 
A single-root practitioner’s 
personal copy of 
Agastyaproktam: the second 
line below the title says 
‘inclusive of single-root 
recipes’ 
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Sikhism and Jainism in Punjab (Sivaramakrishnan 2006). Medieval history of India shows a proliferation 
of various sects that carried forward the reformative and missionary spirit that was set in motion by 
Buddhism and Jainism (Hymavathi 1993). Another point to note is that vaidyans’ access to textual 
scholarship was a point of divergence from the regular social order. Among lower castes across all 
communities, medicine was one of the few vocations that rendered the opportunity for intellectual 
scholarship; the other two being temple-masons and astrologers (Wood 1985). A concrete evidence for 
the significance of medicos access to Sanskrit scholarship, comes from Bengal. It is this access that 
made it possible for the medicine-specialist Baidyas, a Shudra  caste to claim an upgrade to 
Brahminism (Dutt 1965). 
Buddhism provides only a partial explanation for Kerala’s unique sociology of ayurvedic 
practice. Some recent developments appear to have democratized access to classical Ayurveda, the 
most important being: 1. The unique character of social reform movement in 18th and 19th century 
Kerala and 2. State patronage to Ayurveda in both colonial and postcolonial periods.  
3.5.1 Social Reform movements of the 18th and 19th century 
Vaidyans from non-elite communities in Kerala gained access to Sanskrit education as early as 
late 18th century, a development that did not occur in other parts of the country until the 
formalization of ayurvedic education in the mid-20th century. The key figure in the late 19th century 
Ezhava social reform movement of Kerala, Narayana Guru, not only hailed from a family of physicians, 
but also got extensive Sanskrit education including the study of Vedic texts from another reputed 
Ezhava scholar (Wood 1985). The counterparts of the Ezhavas, Bhillavas in the border across 
Karnataka88 and the Nadars in Tamil Nadu89 provide a contrast. Both had similar historical background 
in medicine, but were not similarly empowered to participate in the modern evolution of Ayurveda’s 
Sanskrit-centric scholarship. The difference has partly to do with the nature of social reform in Kerala. 
Heimsath (1978) makes a case for Kerala’s uniqueness in the nature of social reform in comparison to 
                                                 
88 Billavas in South Kanara(the district in Karnataka State bordering Kerala) are also toddy tappers,  and have a similar history of 
social discrimination. The typical village medical practitioner, commonly referred to among Tulu people as Pandit (literally, 
scholar) belongs to this community88. The twin heroes of the Tulu epic are Billavas and their mother was a medicine woman. 
When they died in combat, gymnasiums (Garadi) were set up all over Tulu Nadu in their memory.  
89 Nadars in Tamil Nadu have a similar profile: toddy-tappers, martial artists, closely associated with Siddha medicine.  
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rest of India. In contrast to the elite-led social reform in the British Indian provinces, social reform 
movement in Kerala began in 19th century among low castes. Also, unlike the elite social reformist 
leaders of British India, Malayalee elites did not see Kerala as a ‘land of depravity’. Heismath 
attributes two reasons: the  internal stability of Kerala, and women’s status in the society. Neither was 
the society plagued by famine and war nor by the social evils of sati, purdah, widows, early marriage, 
that created the helplessness, guilt and self-approbation among social reformers in other parts of India. 
Nambuthiris, the Kerala Brahmins, unlike their counterpart in other parts of the country, remained 
aloof from English education and stuck to their orthodox lifestyles. Unlike most parts of India where 
social reform was led by a western educated rationalist intelligentsia who strove towards a western 
modernity, in Kerala, popularizing indigenous knowledge was seen as a respectable and socially 
uplifting activity. In the mid-1800s members from the Travancore ruling families had begun to teach 
ayurvedic medicine based on AH to the people of the state irrespective of caste-class hierarchies 
(Wood 1985). As a result, there emerged several Ezhava ayurvedic physicians who earned reputation in 
scholarship. Some went on to found academic institutions, hospitals and ayurvedic journals (Cleetus 
2007).  
Mere cultural capital, that is family tradition or access to elite education cannot explain the 
proliferation of vaidyashalas (pharmacies) across the barrier of class and caste. An important aspect of 
social reform was the proactive land reform policy of the State that began with Travancore kingdom as 
early as 1865 (Menon 1967). The ascendance of Marxist political power was instrumental in the 
legislation and implementation of progressive land reform policies the most important of which was 
Kerala Land Reforms Act of 1969, considered among the most radical in South Asia (Frank and Chasin 
1994). Statistics on the status of land holdings in Kerala today showcase the successful implementation 
of policies.  Per capita landholding averages are 0.13 ha of total land and 0.1 ha. of cultivable land, 
with 90% of holdings being below one hectare. Access to land must have enabled practitioners from all 
castes to build on their cultural capital equipping them with the basic infrastructure to be able to 
participate effectively in the commodified economy. 
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3.5.2 State patronage in colonial and post-colonial Kerala 
In the pre-colonial period, royal patronage played a significant role in supporting advanced 
scholarship in various branches of knowledge. Sivaramakrishnan’s (2006) study of medicine in 19th 
century Punjab demonstrates the role of the Lahore court in providing patronage for ayurvedic learning 
and practice. The Udasi Sikh order, a major beneficiary of land grants was able to disseminate 
ayurvedic learning and provide gratuitous ayurvedic treatment in their establishments (akharas). 
Besides ayurvedic medical schools, they also ran bungas (rest houses), which provided theological and 
philosophical instruction including medicine. One such Bunga had as many as 100-150 students and had 
reputed scholars as teachers. Colonial policies after 1849 led to withdrawal of grants to traditional 
intellectuals leading to the demise of the Udasis. Lambert (1997) points out that loss of royal 
patronage in Rajasthan led to the decline of Pahalvans (literally ‘wrestlers’), specialists in bone setting 
and massage. Unlike regions under British influence, princely states that had relative freedom from 
colonial interference provided a better climate for indigenous medicine. Alexander and Shivaswamy 
(1971) found a high density of indigenous practitioners in Mysore which they attribute it to being a 
princely state. They point out that the difference in official patronage between princely states and 
Indian provinces under British rule was an important factor in producing inter-state variations in 
the status of indigenous medical practice. Princely States had greater autonomy and unlike the latter, 
their administration was geared to serve the natives. 
Travancore kingdom’s relative freedom from colonial interference  
The Northern part of Kerala, ‘the Malabar’, was under direct British rule as part of Madras 
Presidency. The southern part was under the Travancore-Cochin kingdom, a princely state that came 
under indirect British rule in the early 19th century. In Malabar, the meager western medical care that 
was provided was targeted at the British minority and at the same time indigenous system of medicine 
lost patronage, which was not the case in Travancore (Devi 2010). Scholars who have studied Ayurveda 
in Kerala have acknowledged the role of Travancore kingdom in encouraging indigenous education (for 
example, Panikkar 1992, Cleetus 2007, Harilal 2010). Prominent ayurvedic practitioner scholars of 
Kerala also identify royal patronage of Travancore as the most critical factor that helped strengthen 
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Ayurveda in Kerala (AVS 2005, Jalaja 2009).  
Though interest in western medicine led to a slackening of royal patronage to Ayurveda during  
the first quarter of the 19th century90 and the last quarter of the 20th century, Maharaja Mulam Tirunal 
took favorable steps towards indigenous medicine. He carried on despite resistance by the British 
physician who was acting as a Darbar (court) physician. The government’s involvement in indigenous 
medicine began with its supporting a private ayurvedic Patashala (school) established and run by a 
palace physician in 1886, the first of its kind in India. The King established a Kashayapura (decoction-
house) for supplying medicines to the hospital attached to school. Soon, he took over the school and by 
1917, ayurvedic education for doctors was further organized91. In 1918 the first large scale government 
Ayurveda hospital was established92, followed by more government hospitals and grants to private 
hospitals in various parts of Travancore93. The government pharmacy also provided low cost medicines 
to the public. An important step was taken in 1895-96, with the introduction of grant-in-aid system to 
vaidyans and a subsequent establishment of an Ayurveda Department for grants administration. By 
1938, there were 150 Grant-in-aid vaidyashalas (pharmacies) in the nook and corner of the kingdom 
that supplemented ayurvedic hospitals in urban areas. The dispensaries also included traditional 
specialties of toxicology, ophthalmology, Marma, Siddha and Unani. The government took measures to 
supply medicinal plants for vaidyashalas for preparing medicines. In 1935, government sanctioned 
cultivation of medicinal plants inside the Veli Pulayanarkotta Reserve in 150 acres of land (Devi 2010). 
State patronage post-independence 
Medicine in India is a subject on the Concurrent List of the Indian Constitution, that is, an area 
where the Central and State governments both play a role in legislation and administration and 
                                                 
90 A European royal physician was appointed with a  hierarchy of medical officers below him; vaccination and sanitary 
departments were established. The first hospital for public opened in 1817 and a medical school in 1860. During this period 
officials, intellectuals and missionaries were critical of indigenous medicine. 
91 The period of education was extended from 4 to 5 years, a superintendent was appointed to supervise examinations.  
Successful candidates of 3rd and 5th year exams were awarded the titles Vaidya Sastri and Vaidya Kalanidhi respectively. 
Students could specialize in any branch of Ayurveda after they completed the 5th year, for a term of two years, and on 
submission of a dissertation they would earn the title of Ayurveda Acharya. Those seeking proficiency in toxicology,  would be 
given an alternative title of Visha Vaidya Visharada. One Siddha, and four Ayurveda high schools were founded to serve as 
feeders to the medical college. Ayurvedic manuscripts were collected, examined and published. 
92 It had five OP sections, taking care of traditional specializations like Marma, eye, toxicology, surgery and pediatrics.  
93Though funding to Ayurvedic hospitals and vaidyashala gradually increased, it was nowhere comparable to the funding for 
allopathy. The latter had a larger network. Statistics in 1930-31 showed that government institutions treated nearly five times as 
those treated by the indigenous medicine. However, this does not give a composite picture of health care because meanwhile 
several prominent vaidyans had launched private medical enterprises.  
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allocation of funds. The modern Indian State both at the central and regional levels continued with the 
colonial policy of privileging biomedicine. Up to 2002, all Indian medical systems together were 
supported by not more than 2% of the total central health budget, equivalent to the budget of a single 
premier biomedical institute (Sreekumar 2010). In the absence of State patronage various Indian 
systems of medicine survived mainly on the strength of consumer patronage. As a result, the 
manufacturing industry emerged as the biggest stakeholder surpassing the State. Consequently, despite 
its role as a regulator and certifier, the State remains a weaker force.  This explains the industry’s poor 
compliance of industry with State established pharmacopeia standards and lack of respect for CCIM 
that were observed by Bode (2008).  
Unlike the Central government and most other regional governments, Kerala government 
continued with its sympathetic attitude to indigenous medical systems despite the officially privileged 
status of biomedicine. While at the national level, lack of patronage to indigenous systems allowed 
private sector to emerge as a major force, the Kerala government, with its manufacturing and 
treatment networks, provides a counterforce to the private sector and played an important role in 
maintaining affordability of medicine to masses94. Beginning from mid 60s, a parallel primary health 
network of Ayurveda and homeopathy was created that has grown to 126 hospitals and 898 dispensaries 
that treat two to three million outpatients a year.95   
As far as the manufacturing sector is concerned, the State government’s role as a regulator 
(licensing and inspecting authority) is little more than of a rubber stamp (see Section 9.4). Its most 
important role is in running the ayurvedic manufacturing company Oushadhi96 which despite its service 
focus97 is profit-making, and is one of the five largest ayurvedic companies in Kerala. In fact, it supplies 
medicines to several other State governments and is the largest of the public sector ayurvedic 
companies in the country. Though it caters mainly to the government system, it has around 600 
exclusive sales outlets.  
In the education sector, the Kerala government played a protectionist role by providing heavily 
                                                 
94 In government hospitals and dispensaries, part of the medicine supply is free for the economically disadvantaged, the rest is 
left to the local administration.  
95 2.2 million outpatients in year 2006-7. Source: Directorate of Ayurveda, Trivandrum.  
96 The pharmacy set up in 1941 to supply medicines to the Maharaja  of Kochi and government ayurvedic hospitals in Thrissur was 
converted into a co-operative in 1959 and later incorporated as a Public Sector Corporation in 1976. 
97 60% of its medicines are supplied to the government medical system at 40% reduced cost.  
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subsidized education. Since the introduction of the BAMS degree in late 70s, the government had kept 
the private sector under bay by strictly regulating licensing of education limiting it to established 
traditional stakeholders (i.e., five colleges, three state-owned and two grant-in-aid) keeping in check 
the number (190 per year) and quality of ayurvedic graduates. This policy was pursued despite losing 
revenue to neighboring states like Karnataka who had liberal educational policies that capitalized on 
demand from Malayalees. The historic role of the State as an anti-commodity force changed in the 90s 
when the State emerged as a major stakeholder promoting Ayurveda as a tourist commodity. Besides 
funding publicity drives, the government also participated as a direct stakeholder with its own tourist 
resort (Tanneermukham). The government’s attitude to education also changed in favor of the private 
sector. Since liberalization of educational policy in 2000, 11 self-financing institutions have come up in 
Kerala adding 600 more seats per year.  
3.6 Practitioner landscape of Kerala 
Ethnography of ayurvedic practitioners in Kerala showed a diversity that is in some ways 
comparable to findings of researchers elsewhere in India, but also different in other significant ways. 
Elsewhere in India, though there participation in medical practice is not caste-exclusive, there is a gulf 
separating elite practitioners connected to the textual tradition and others. These others have been 
historically referred to as ‘folk practitioners’, a term considered politically incorrect today in 
anthropology, but similar terms are used in various regional languages (for instance, Nati Vaidya in 
Kannada). A  brief review of literature on practitioner sociology in other parts of India would be in 
order here.  Though classics of Charaka and Sushruta restrict practice of medicine to the three upper 
Varnas, in ancient India, medicine was far from being an elite profession; there was much ambivalence 
regarding the status of the vaidyan (Basham 1976).  
It is clear from the medical texts that the vaidyas of early India were not a caste, but rather a fraternity 
of men drawn from various classes and castes … united by a common training and discipline for the high 
purpose of promoting human health and welfare (Basham 1976:36). 
As per ancient Hindu moral codes, medical practice was considered impure (See footnote 77) 
and was meant to be practiced by Ambashtas, a caste made up of mixed caste offspring 
(Chattopadhyaya 1977) though the only place where such a specialized vaidya caste emerged was in 
 107 
 
Bengal (Dutt 1965).  However, in recent history, there is no evidence of medical practice being 
restricted to the upper castes. Several communities of Sudras have been involved in the practice of 
indigenous medicine across India (Leslie 1976).  This is substantiated by studies in different parts of 
India other, for example, Tamil Nadu (Sujatha 2007), Mysore (Alexander and Shivaswamy 1971) and 
Madras (Ramesh and Hyma 1981). On  the other hand, advanced Sanskrit text-based scholarship in 
Ayurveda was found to be dominated by elite castes in the recent past. A survey of indigenous 
education in Punjab in the late 19th century found that ayurvedic learning was controlled by Brahmin 
pundits (Leitner 1882). This Brahmin-controlled Sanskritic mode of ayurvedic education of Punjab, 
“corresponded to the overall image of Ayurveda in India, which was in line with the practice and 
teaching of Ayurveda elsewhere in North India in early 19th century” (Sivaramakrishnan 2006: 15). 
Vaidyans in 19th and 20th century Bengal, referred to as Kavirajas,98 were orthodox Hindus who 
followed strict religious rules; it was the commonalty in religious background that endeared orthodox 
patients to them in preference to an allopathic doctor (Gupta 1976).  
The elite hold on Ayurveda appears to have continued with modernization. The modern revival 
of indigenous medicine was spearheaded by middle-class urban entrepreneurs of Brahmin and other 
higher castes (Leslie 1976). In Tamil Nadu, despite the modern ayurvedic colleges opening up the 
transmission of tradition, “the Sanskrit component remains central, and the modernization of 
Ayurveda, like its traditional transmission remains largely in Brahman hands” (Trawick 1992:130). Given 
this historic gulf between elite and non-elite practitioners, a distinction naturally emerged. On one 
hand were ‘professional’ elites trained in Sanskrit and on the other hand, were ‘folk’ vaidyans who 
lacked textual learning and theoretical sophistication. A possibility of the latter having exposure to 
vernacular texts was ignored, because in the revivalist frame of thinking, Sanskrit was the only 
legitimate medium of knowledge. No significant attempt has been made to investigate into sociological 
differences  within the so-called ‘folk’ and ‘professional’ spheres of practice. While some scholars 
differentiate between the formal and folk traditions, others argue against the compartmentalization 
suggesting that it be seen as a continuum. The former apply the term Ayurveda to the classical 
tradition, the latter believe that all kinds of practices together constitute Ayurveda. The former 
                                                 
98 Literally prince of verses, a title given to physicians in Bengal 
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assumes Sanskritic learning and scholarship as classical and all the rest as ‘folk’, ignoring the possibility 
of a permeable boundary between them. The latter approach pools everything together underplaying 
the differences. Neither pays attention to the nuances. Differences in social structure from state to 
state and consequent differences in the relationship between classical and oral traditions make it 
difficult to draw any kind of generalization from the existing scraps of data99.  
Kerala practitioner landscape has similarities with the rest of India. Prima facie there appears 
to be a historical elite dominance in Ayurvedic practice in the State. A group of Brahmin families 
constitute the elite rung of physicians (Ashtavaidyans), there is some evidence of Sanskrit education 
being restricted to the elite castes in 19th century in Northern parts of Kerala (Wood 1985) in contrast 
to Southern Kerala; the revitalization movement was led by landed aristocracy (Panikkar 1992). Despite 
this, it is possible to identify some distinctive features about the sociology of medical practice in 
Kerala. Firstly, though Ashtavaidyans, the elite rung of physicians were Brahmins, they trace their 
legacy to Buddhist tradition. Secondly, Ezhavas, a historically disadvantaged caste that is the largest 
contributor to the practitioner pool in Kerala, also claim Buddhist origins. Thirdly, men from the 
untouchable community of Velan were the default village pediatricians and women, default midwives. 
This is a fact worth special mention in a State known to have had one of the worst track records in 
caste discrimination in the country. Finally, Ayurveda in Kerala is not bound by religion, unlike most of 
India. There is no dearth of vaidyan families among Christians and Muslims.100  
While the connection of Brahmins and other upper caste Hindus to classical Ayurveda does not 
require much illustration, I present here some vignettes from field work to showcase the involvement 
of lower castes and non-Hindu communities in classical Ayurveda. The account is by no means 
representative of the actual proportion of practitioners in the population as the sample was not 
selected to represent sociological variables. The practitioner landscape of Kerala provided here is 
constructed from three sources: practitioners’ personal histories, organizational histories from 
brochures of ayurvedic institutions and narratives of people other than practitioners including 
                                                 
99 In the absence of data, generalization like North India/South India can be misleading. For example, Trawick’s (1992) 
generalization of Tamil Nadu as South India is questionable given its distinctness from the other three South Indian States.    
100 In Kerala both religions were rooted in a peaceful historic antiquity, unlike rest of India where they were byproducts of 
political/territorial expansion. Christianity came in 1st century CE and Islam in 8th century CE. unlike rest of India where the 
former came with colonialism in 16th century and the latter with Mughal invasion in 13th century.  
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consumers, modern ayurvedic practitioners and people working in the industry.  
3.6.1 Christians and Ayurveda 
Christians constitute 19% of Kerala’s population which is significantly large compared to 2.3% in 
rest of India. Interactions with practitioners and clients showed that Ayurveda was deeply entrenched 
in the culture of these communities. It does not take an in-depth sociological study to gauge proximity 
of Ayurveda to the Christian community in Kerala. A small Catholic church in Kottakkal calls itself the 
Ayurmatha Church101. A roadside hoarding of the Mother Mary Ayurveda Hospital in interior Ernakulam 
displays several images of therapeutic procedures, including poses of yogic meditation (see image). 
Practitioners from Christian communities were found across the continuum, ranging from Ottamooli  
  
Ayurvedic Hospital, Kottayam Dt. Ayurmatha Church, Kottakkal 
 (single-root) practitioners to Sanskrit-educated scholars from Kalari martial art practitioners to 
toxicologists. In fact,  in the 17-18th century, Jesuit priests were known to have cultivated the 
knowledge of toxicology as an aid to community service102. Christian communities dominate raw drug 
trade in Thrissur market103, many of whom have historical links to medicinal practice. Doctors from the 
                                                 
101 An adaptation of “Health of Mary” Church, inspired by the presence of Arya Vaidya Sala in the town. 
102 From popular narratives.  
103 In 18th century, the king of Cochin had brought in and settled several Syrian Christian families in Thrissur with the intention of 
developing the city as a center of trade and commerce (Menon 1967). 
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community were also found in high level positions in the State104.  
 Practitioners from Christian communities constituted 42% of the sample, closer to the 
population distribution105which included six degree-holders  and six informally trained vaidyans. Of the 
latter, three were specialists, viz., a poison-healer, a veterinarian, and a bone-setter, fields in which 
there was less expectation of formal certification. Three were unlicensed general practitioners, of 
which only one was into active practice. Two had learnt from gurus, the rest from a family member. 
The poison-healer and veterinarian, both women, had inherited the tradition from their parents-in-law. 
Of the degree-holders, two were from practitioner families.  
 Of the 35 manufacturers in the sample, four were Christian owned, two of which have family 
history of practice. Kandamkulathy Vaidyasala in central Kerala has grown to achieve an annual 
turnover of ` 70 million ($1.4 million), building its success over its vaidyan family reputation in the 
Thrissur-Ernakulam region. The second, Kalan Pharmaceuticals is an heir of the Kalan Vaidyan, a 
pioneer in selling branded medicine heavily advertized in dailies. Advertisement for their flagship 
products Kalan hair oil and a tonic was so popular that people in their late 50s-60s still recollect the 
advertisement verbatim. Fight for the family name ‘Kalan’ has led family members into protracted 
legal battles. Today the interior street in Nellayi village in Thrissur district is dotted with small 
companies, all carrying the name Kalan with different prefixes, none of them seeing eye to eye. The 
                                                 
104 The current Director of the State ISMH Department is a Christian woman from Kerala. Other illustrious members included  
Chairman of the State manufacturer Oushadhi, Secretary of AMAI, the practitioner association of Kerala, the President of the 
largest body of traditional Kerala practitioners, the Kerala Ayurveda Mandal and the Director of the ayurvedic industrial cluster. 
105 The four districts from which the practitioner sample was drawn from (Thrissur, Ernakulam, Kottayam and Idukki) accounts for 
53% of the Christian population of the State. 
 
Hoardings in front of the ancestral house  of Kalan Vaidyan claiming 
legacy to the family brand 
 
Kalan Pharma MD talks 
about a intra-family 
trademark conflict case 
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family who inherited the ancestral house and company has put up a large hoarding on the street 
claiming itself as the only legitimate heir of the Kalan brand.  
The entry of the other two companies into Ayurveda is recent. Everest Pharma  is run by a 
business family from Thrissur whose entry into Ayurveda was fortuitous, inspired by a personal 
experience of miraculous recovery (for details see 5.9). Sahyadri is the brand name for the ayurvedic 
activities of an NGO founded by the Bishop of the Catholic diocese of Kanjirapally. Sahyadri announces 
its connection to ‘the ancient Vedic heritage’, their logo features the typical image of Hindu sage-guru 
with his disciple. They state in their brochure that all ayurvedic treatments begin with a prayer from 
Rig Veda106. From a small company in early 80s, it has grown into a large establishment with a 
manufacturing unit, a full-fledged hospital and an ayurvedic resort. They are also pioneers in ayurvedic 
nursing training and in forging tie-ups with luxury hotel chains to provide ayurvedic services.  
The community is also well represented in the treatment segment. One of the most reputed in 
Central Kerala is a 100-bedded hospital in Ernakulam run by Parathuvaylil family established in the 50s, 
reputed for the treatment of musculo-skeletal disorders. An example of a medium range hospital is 
Kayalvarath in South Kerala, the founder’s biography illustrates prevalence of Sanskrit-education was 
not restricted to Hindus.107  
Varghese vaidyan was immensely inspired by the dedication of his father (a traditional vaidyan)… 
showed a keen interest to master Sanskrit language. At the age of 17 he was absorbed into the 
Ayurvedic College, Trivandrum…earned the title of 'Vaidyakalanidhi' with a first rank and gold 
medal...he spent a few years in the companionship of ayurvedic maestros putting into practice 
what he learned and later in 1929 set up his own 'Vaidyasala' in Perinad108 
Another illustrious Christian family-run hospital is Sukhodaya in Kottayam, one of the pioneers 
in the wellness market predating ayurvedic tourism (See Section 8.9). Now they have two hospitals, an 
ayurvedic resort; they offer a B.Sc degree in Panchakarma affiliated to a University in Rajasthan. The 
origins of this institution goes 3 decades back to a small clinic set up by the late Varghese vaidyan, an 
eye specialist from Kanjirapally, a  village in Kottayam, dominated by well-to-do Christian rubber-
estate owners. The website of the village Kanjirapally lists 22 odd existing and late vaidyans of repute 
                                                 
106 Sahyadri, e-brochure, www.ayurvedaexcellence.com/html/treatments.htm. 
107 Parathuvayalil and Kayalvarath are institutions of which I have only indirect information from patients’ reports.   
108 Kayalvarath Ayurveda Hospital, e-brochure, n.d. Accessed at http://www.kayalvarath.com/history.php  
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(with pre-BAMS degrees), 9 of which are Christians109.  
Matha Netrakanthi Siddha Vaidya Ashramam, an eye care clinic located in an interior village in 
the border of Idukki near Ernakulam, is run by Sister Theyamma, a Roman Catholic nun who hailed from 
a traditional family of eye-specialists. She rebelled and quit convent  when she was not permitted to 
practice by her Church management. On hearing this, the Syrian orthodox church took her in and also 
provided logistical support for her to practice. She now runs this flourishing eye-clinic, assisted by the 
nuns from her convent. The demand for her services is so high that she has fixed consultations all days 
of the week in seven different locations, mostly under church auspices, in four surrounding districts110. 
The problem in her case was personal rather than religious; Roman Catholic church is not known to 
have conflict with ayurvedic practice, in fact, a Catholic  Bishop in Kottayam district has reportedly 
provided space adjacent to his official residence for a traditional ayurvedic allergy specialist.   
3.6.2 Muslims and Ayurveda 
A Hindu practitioner-manufacturer in rural Ernakulam, talking about patients claimed that 
“Muslims are more passionate about Ayurveda than Hindus.” A graduate of AVS in the late 70s, he said 
that every batch of medical students had 3-4 Muslim students including women. This opinion was 
confirmed by Hafiza who had just finished her BAMS degree from AVS. She had qualified for the 
competitive Guru-Shishya (student-disciple) scheme of the central government that allows selected 
students to apprentice under prominent ayurvedic gurus. Religion she said was not an impediment for 
her education. In fact, there was a higher demand for women practitioners among Muslims, because of 
reservations about cross-gender consultation. But representation of Muslim community in the study 
sample is low because the community is concentrated in northern Kerala; the sampled districts 
accounted for only 14% of the population. The only Muslim manufacturer whom I indirectly met was a 
manufacturer-cum hospital owner KMK, in the role of a tourist service provider in a luxury hotel in Fort 
Kochi. KMK provides the following account of its founder in its publicity brochure,  
Dr. K. Mohideen Kunju Lebba started his school education in a reputed Sanskrit school in Kerala. 
His interest in Sanskrit language made him to read many books written in Sanskrit. He graduated 
with first rank from government Ayurveda medical college, Trivandrum in the year 1949. He 
                                                 
109 www. kanjirapalli.com  
110 I met her clinic assistants, but this story is from other indirect sources: a practitioner and a fresh herb agent.   
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started practicing under Chavara Govinda Pillai, a famous ayurvedic physician belonging a family 
of traditional ayurvedic doctors. In 1951, he started his own ayurvedic clinic in a small way, in his 
house….At that time his close friend Dr. Faizee Ibrahim presented him with a bunch of ‘Thaliolas’ 
(palm leaf manuscripts) containing details of traditional ayurvedic medicines and treatments. This 
prompted him to go more deep into Ayurveda and Panchakarma111.  
The only Muslims in my sample of practitioners were two unlicensed vaidyans, a pediatrician and a 
bone-setter from Kalari (martial art) tradition.  
Abdulla Kutti, an ayurvedic pediatrician, has inherited his tradition from his father. He practices 
from his home in rural interior Thrissur, careful not to display a board to avoid controversy. He 
does not need one anyway; he has been living in the same house where his father had practiced, 
and has inherited a legacy of reputation in the local community. He is frank to admit that his 
scholarship is patchy, knowledge of Sanskrit limited, and his learning being limited to hands-on 
training. He has studied relevant parts of the Ashtanga Hridayam, but mainly uses the text 
Sahasrayogam for his prescriptions. His father was a reputed vaidyan who studied Sanskrit and 
medicine from a reputed local Brahmin vaidyan family. His uncle graduated from the renowned 
Ashtavaidyan Alathiyur Nambi’s gurukula112. The family tradition continues with one of his sons 
who is a qualified ayurvedic doctor working in the Middle East.  
Mohammad Gurukkal113, a 65 year old Kalari martial art practitioner based in rural Thrissur in 
Central Kerala, started his Kalari martial art school in 1969. He proudly states that two of his 
students were selected for the Kalari demonstration team for the upcoming Commonwealth Games 
in New Delhi. Now that Gurukkal is old, his son is the main instructor. Between the age of  10 and 
the founding of his own school, Gurukkal had studied under 12 different gurus. Even after that, he 
continued with learning, “There is so much knowledge, that there is no end to learning. Even at 
this age I am still ready to learn.”  As a child, he had no interest in school studies. After passing 
fifth standard with great difficulty, when he expressed his wish to study Kalari, it was met with 
stiff disapproval. His father had an impression that martial art education would lead to 
involvement in violence. But his grandfather, a Vata specialist vaidyan who knew the value of 
Kalari education, encouraged him and provided him with money to pay the fee, which used to be 
50 paisa per week then. “The situation is different now. Earlier even fathers were not interested in 
their sons learning, now mothers are bringing their sons and daughters114 to learn Kalari”.  
 
3.6.3 The Ezhava connection to Ayurveda 
The Ezhava (alias Thiyya) community can be aptly termed chief custodians of traditional 
medicinal knowledge in Kerala. There are a large number of vaidyan families in this community who 
are known to have been practicing medicine for generations (Varier 2005). Consequently, some of the 
Ezhava families carry vaidyan as their family name. For a community that was historically kept outside 
the temple, with a specialization in the marginal occupation of toddy-tapping, the depth and expanse 
                                                 
111 KMK Hospital, promotional brochure, n.d. Also available from http://www.kmkayurveda.com/profile.htm 
112 Gurukula is a term used to refer to residential master-disciple mode of education taking place in the Guru’s house or in a 
space attached to Guru’s house. 
113 Malayalam respectful plural form of Guru, is a default term of reference to Kalari masters.  
114 Kalari education for girls is not a new development, even in his young days there used to be girls learning Kalari. But he said 
that in Northern Kerala, it was far more common for girls to learn Kalari than in South.  
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of scholarship in Ayurveda has been noteworthy. An important, oft-quoted piece of historical evidence 
for the Ezhava medical expertise is Hortus Malabaricus, a renowned botanical classic, by Van Rheede, 
the 16th century Dutch governor of Malabar. The most important contributor to this tome was Itti 
Achuthan from an Ezhava vaidyan family. Ezhavas’ reported Buddhist origins could explain their 
proximity to medicine, though it is not backed by historical evidence. However, there is historic 
evidence to show that some of the most prominent Kalari martial art practitioners in the war torn 
period between 14th and 16th centuries were from this community (Sadasivan 2000: 341), an additional 
explanation for their exceptional affinity to medical practice.  
Though not as successful as the elite castes, the community has produced several illustrious 
entrepreneurs. An Ezhava practitioner proudly listed four large Ezhava owned companies115. Many 
practitioners from the community are active stakeholders in the post-tourist service commodification 
market. Keraleeya Panchakarma, an institution run by vaidyans of this community was recently 
acquired by the Birlas, one of the largest business houses in India. Dr. N. K. Padmanabhan Vaidyar, the 
owner Chairman of Nupal Remedies Pvt. Ltd. (turnover around $20 million), is proud of the community 
tradition which he traces to his family’s vaidya lineage 1500 years back to Sri Lankan Buddhist 
tradition. He claims that the 50 proprietary medicines he has so far designed were based on 
accumulated knowledge of generations.  
The Ezhava vaidyans that I interviewed include four traditional practitioners of which two are 
Vishaharis (poison-healers), an eye specialist and a burn-cure specialist. Here are brief profiles.  
Poison-healer, formally certified: Krishnan Vaidyan, based in rural Thrissur is highly qualified; he 
had cleared the Vishahari examination instituted by erstwhile Travancore kingdom earning a title 
and  grant-in-aid  offered by the State. His family has now geared up to new market opportunities 
by upgrading the family farm into a tourist resort. It now attracts a small number of clients from 
Germany where one of his sons, though not formally qualified, runs a Panchakarma center.  
Poison-healer, uncertified: Kuttappan Vaidyan, based in rural Kottayam is in his late 70s, plagued 
by ill health but unable to retire because of constant demand from the local people. He started 
his studies with a Brahmin Vishahari when he was around 12; his father had requested that he be 
taken as a student after finding him uninterested in school. Instruction was mainly based on a 
subject text written by an erstwhile Kochi prince, besides relevant parts of Ashtanga Hridayam.  
Ashokan Vaidyan, an eye specialist in his late 70s, is mainly occupied running his raw drug shop in 
a small interior town in central Kerala. He has an interesting family history. His father’s younger 
brother had completed Vaidya Shiromani (a pre-BAMS degree) from Madras, but he died just when 
                                                 
115 Nupal, Kerala Ayurveda Limited (KAL), S.D. Pharmacy, and the Ayurvedic soap company Chandrika 
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he was about to start practice. His father was determined to get his children to follow his path. 
He sent his eldest son to study Ayurveda in the AVS college and he wanted another son to undergo 
a specialist training. That is how Ashokan went to study under a reputed traditional eye specialist. 
He managed to get entry only with a strong recommendation of a vaidyan, a family friend. In the 
five years of education, he did not have to pay fees. Besides serving as an apprentice, he supplied 
the gurukula with home grown agriculture produce. The guru has given him some chembolas 
(engraved copper foils) with verses on medicine, but he has no idea what language it is written in. 
All he knows is that it is a sacred tradition. He also studied some amount of Ashtanga Hridayam, 
but not thoroughly, and would refer to it for only for medicine recipes. He started practice at the 
age of 18, immediately after he finished his studies. Later, he worked along with his brother who 
set up a clinic after graduation, helping him with medicine making. This he said, was his most 
valued learning, something his college educated brother had little knowledge in.  
Kumaran Vaidyan, a 65 year old Pollal-vaidyan (burn-doctor) who practices in a remote village in 
Kottayam district, is reputed far and wide for his expertise. People who know of his expertise, 
prefer his treatment to mainstream medicine because it is more effective and leaves no scars. His 
medical repertoire consists of a single medicinal ointment that he learnt from his mother’s 
brother, a reputed Sanskirt scholar and vaidyan. He says he found classical ayurvedic medicine too 
complicated to study. He makes his living basically as a farmer. The practice of burn cure was just 
a hobby, a service he was providing free of charge until recently. He now charges a fee because 
prices of oil and raw drugs have escalated. Besides that, preparing the medicine also requires 
much time and labor that in his young years.  
3.6.4 Velans,  the default pediatricians 
Popular narratives from central Kerala reveal that five to six decades ago vaidyans from the 
Scheduled Caste Velan community were the de-facto village pediatricians (Bala Vaidyans). Velan 
women specialized as midwives and were also in charge of postpartum care. The community’s 
association with medical practice has been mentioned in the Tamil classic Tolkappiyam of the Sangam 
era (C. 300 BCE - 300 CE); medicine does not figure in its list of six duties of the brahmin (Varier 2003). 
Despite being untouchable, both popular and practitioner narratives reveal that vaidyans of this 
community commanded respect from all strata of society. P.S. Varier, the founder of Arya Vaidya Sala, 
was known to have frequented the Velan vaidyan in his neighborhood, to consult him when in doubt, a 
practice perhaps unthinkable elsewhere in India. Two vaidyan informants, one Muslim and another 
Ezhava, said their forefathers had learnt their trade from a Velan vaidyan. For example, when Ashokan 
Vaidyan (the eye specialist mentioned above) began his practice, there was a 90 year old reputed 
Velan vaidyan in the neighborhood.  Kannan spent much time hanging out with him, and in the process 
he picked up many valuable tricks that he incorporated into his practice. There is a general feeling 
among practitioners that it is hard for others to match the expertise of vaidyans from this community. 
An unconfirmed popular theory claims that the Velan community got its tradition from the author of 
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Bhela116 Samhita (Murali 2004). Pointing out that some of the lost verses from the Samhita are found in 
Kerala’s master treatise on pediatrics, Arogyakalpadrumam, Varier (2003) conjectures that the author 
collected the knowledge from Velan practitioners from oral or/and ancient manuscripts.  
Before Ayurveda got formalized, every region was known to have had such a pediatric 
specialist, who serviced around 7-10 villages located around a radius of 10 km. But unlike vaidyans 
from other communities, the vaidyan families of Velans are not traceable anymore, at least in the 
areas that I studied117.  The only source of information is the collective memory of elderly residents of 
these villages. Rajashekaran, an elderly degree-holding practitioner in interior Ernakulam shared his 
recollections of a late Velan vaidyan who was his contemporary. The vaidyan had come to his 
neighboring town from a remote village, but had established quite a reputation in a short period of 
time. Though he was not well versed in textual knowledge, he was known for his kai punyam (best 
translated as ‘prowess of the hand’). His son, a BAMS degree holder now runs his clinic-pharmacy in the 
town with a single sales outlet announcing specialized care and medicines for children’s ailments. 
Rajashekaran took care to caution me that it would be considered offensive to identify him by caste.  
A traditional elite farmer from Thrissur now in his mid 60s, recounts his experiences with a 
Velan vaidyan in his youth. The vaidyan humbly referred to himself as Dasan (‘servant’) and slept in the 
elevated verandah whenever he stayed overnight like most non-family guests did,  but he was treated 
royally. It was considered a privilege to have him come and stay; it was important that he was fed and 
paid well for his services so that he would not hesitate to come in terms of need. While all vaidyans 
commanded respect, being the children’s doctor, Velan had a special place; he was a standard fixture 
in all social occasions be it wedding or funeral. Elderly residents of TA, an interior village in Kottayam 
district fondly remember KV for his services rendered for three generations, spanning over five 
decades. Here is a profile of KV built from the collective memories of the village residents. 
Being the youngest of the uncles, informant Balan now in his early 60s was often sent on the run 
to get the vaidyan from his residence 7 km. away whenever a child took seriously ill. Once in a 
month, the vaidyan would go on rounds  visiting households with children, inquiring if there was 
any requirement for medicines. A small fee would be given to him to cover the cost of medicine, 
                                                 
116 Agnivesha’s Guru Atreya was known to have had six students, each of whom produced a thesis. Bhela was one of them. 
Agnivesha’s work was redacted by Charaka, that is now considered the earliest foundation classic of Ayurveda.  
117 Efforts to trace two such vaidyan families yielded no fruit, as the families had moved away from the region. Aonedditionally, 
stigma attached to the caste makes it difficult to approach the subject. 
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and to compensate his trouble of coming over. However during festivals and harvest he would be 
liberally rewarded besides being given his share of harvest as per the patron-client system. KV had 
a small wooden medicine chest the size of a school instrument box, divided into several tiny 
compartments that held varieties of tiny hand-made pills, and a tweezers to handle them. The 
pills were to be ground with various substances, water, buttermilk, juices of fresh medicinal 
herbs. The weirdest prescription was fresh drops of blood from the chicken, the torturous process 
of acquiring it by making a tiny gash on the chicken, is indelible in Balan’s memory.  In case of 
complex illnesses he would prescribe decoctions or oils. The youngsters were put in charge of 
gathering  and buying raw material. Mariamma remembers the countless times she had to run to 
the raw drug shop to buy raw drugs, hunt around in the farm and neighborhood for fresh herbs. In 
their large joint family, there would be one aunt or the other who would be in charge of making 
the decoctions. It was not much of work, the herbs had to boil constantly on a low flame, someone 
had to occasionally go and monitor the fire and keep the time. With the introduction of allopathic 
hospital in the region in the 60s KV’s prominence came down, but he continued to be in demand 
till the end of 70s.  He stopped visiting patients by mid 70s, but there was a steady flow of 
patients to his home which kept him busy. By mid-eighties, allopathic medical care had become 
highly established, and the schooled generation had begun to lose interest in traditional remedies. 
KV was known to have based his practice on a set of texts he had. He meticulously maintained a 
thick notebook that was choc-a-bloc with medicinal recipes. Abraham, a farmer whose family had 
utilized his services frequently, said that when he was a father with two young kids, KV had left 
his text with him and told him to copy recipes for some of the medicines he often required to 
treat common ailments (shows a channel of flow of textual knowledge to the popular realm). 
Abraham had made extensive use of the medicines for all his four children, but when the joint 
family broke up and he moved to the divided farm, he lost track of the recipes. KV’s book was left 
behind in his ancestral house until taken away by his son two years ago. 
3.7 Conclusion 
Ethnographical evidence from Kerala points to a diffused culture of ayurvedic practice and 
consumption that transcends caste, class and religion, in contrast with Ayurveda’s elitist Hindu image 
in rest of India. Though discourse in Kerala has been significantly influenced by the Hindu revivalist 
ideology, in practice there are stark inconsistencies. For instance, claiming of Buddhist legacy by both 
the elite Ashtavaidyans and subaltern Ezhava practitioners or the active participation of Christians and 
Muslims in the practice and consumption of Ayurveda. It is possible to conjecture the Buddhist heritage 
of Ayurveda could account for some of this distinction. However, besides lacking in evidence, this 
argument is weakened by a few, but substantial fragments of evidence of the involvement of various 
reformist sects in the dissemination of medicine across India in the medieval period. The historical 
continuity of colonial patronage in Kerala in contrast to the rest of India, is perhaps a better 
explanation. Colonial rule, by disrupting royal patronage to religious and medical institutions and by 
delegitimizing indigenous medicines in favor of allopathy had significantly affected the status of 
indigenous medicine in many parts of the country. Southern Kerala under the Travancore kingdom 
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escaped colonial  interference to some extent and was able to continue with its support to indigenous 
medicine, despite switching allegiance to allopathy as the official system. This patronage continued in 
post-independent Kerala, with the State playing a significant role not only in running a robust parallel 
medical services in Ayurveda, but also in emerging as a successful competitor in the pharmaceutical 
market. The State’s company Oushadhi is among the top five ayurvedic manufacturers in Kerala, which 
primarily focuses on providing subsidized medicine to the government medical system, a phenomenon 
which has no parallel elsewhere in  India.  
Royal patronage however may not fully explain the diffusion of classical practice across 
communities, which is better explained by the social reform movement in 18th and 19th century Kerala 
which had two unique characteristics that favored Ayurveda. Firstly, it was led by the lower caste 
unlike rest of India. Secondly, in contrast to the modernity-oriented  elite elsewhere, for the Kerala 
elite, social reform meant democratization of access to advanced learning in indigenous traditions. The 
textual history of Kerala which is also connected to the Buddhist legacy adds some more explanation 
for the Kerala distinction in practice. In contrast to Ayurveda in rest of India that is based on the two 
oldest of the classic compendium triad, Kerala ayurvedic practice is founded on the third compendium 
written by the Buddhist sage Vagbhata. This text, a synthesis and a simplified version of the other two 
was so popular in Kerala that its name Ashtanga Hridayam was historically used as a default reference 
to the system of medicine, synonymous to Ayurveda. Whether the shift in usage towards Ayurveda or in 
fact ‘Arya Vaidya’ as popularized by Varrier, was influenced by the modern revivalist influence from 
rest of India, is a question worth investigating into. A parallel textual tradition in the vernacular 
(Manipravalam and Malayalam) ranging from commentaries on classic compendiums to drug recipe 
books also contributed to popularizing ayurvedic knowledge. This is also a factor that present in some 
other regions like Andhra Pradesh. Whether  the vernacular textual culture was particularly strong in 
Kerala or whether a similar textual tradition existing elsewhere disintegrated owing to other factors 
like pre-colonial shift in power towards elitist traditions or disruption of patronage due to colonial rule, 
is a question that would require investigation. The most noteworthy of the vernacular texts was 
Sahasrayogam, a popular medical recipe book that was shared among medical practitioners of all hues 
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and levels of expertise, including raw drug shop keepers.  
I conjecture that when AVS began to produce medicines in early 1900s, the Kerala wide 
demand for classical products would not have been possible if there was not an  already wide pool of 
practitioners in Kerala who were familiar with the classical pharmacopeia. Because the demand was 
not restricted to a small group of elite practitioners which might have been the case in other parts of 
India, the Kerala practitioner market would have been sufficiently large to attract several companies 
that have over time established mainly as sellers of classical medicines. This includes not only the 
largest manufacturers of Kerala, but several medium and small companies and unregistered 
practitioner-manufacturers.   
Historically diffused practice had created a consumer culture unique to Kerala. It had 
familiarized and habituated the masses to a classical mode of medicine consumption. A classical mode 
of medicine consumption would mean people’s habituation to consulting ayurvedic practitioners when 
confronted by illness (in contrast to self-prescription or pharmacist-prescription), familiarity and faith 
in humoral diagnosis, familiarity with classical ayurvedic medicines (in contrast to branded medicines) 
and their tongue-twisting Sanskrit names, familiarity with the processes of simple medicine and 
readiness to expend time and labor on the making of medicines, familiarity and association with the 
tastes and smells of raw drugs and medicines and consequent ability to make judgments on quality, 
readiness to consume unpalatable medicines like decoctions, familiarity with local herbs and market 
raw material that regularly goes into the making of medicines, familiarity and readiness to follow 
pathya (dietary regimen), familiarity and willingness to undertake therapeutic procedures (that used to 
be traditionally managed at home with the help of knowledgeable assistants), faith and willingness to 
bear with complex protocols for lengthy periods of time. The significance of these would be evident 
from the ethnographic vignettes presented in Part two. 
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PART TWO  
 
INDUSTRIAL COMMODIFICATION OF AYURVEDIC MEDICINES  
DESKILLING, ALIENATION AND RESISTANCE 
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PROLOGUE 
While commodification of ayurvedic pharmaceuticals in Kerala retained the integrity of 
Ayurveda as a system of diagnosis and therapy, it is difficult to ignore the impact of industrial 
concentration and mass production on knowledge and skill base of actors who are linked to ayurvedic 
commodities at various phases of its consumption and production, i.e., consumers, practitioners, raw 
drug sellers, medicinal plant collectors and herb traders. The focus of analysis in Part II is on the 
process of industrialization induced homogenization with emphasis on local practical knowledge at 
various nodes of the ayurvedic commodity chain. Scott’s (1998) concept of metis provides the 
analytical framework to comprehend ayurvedic knowledge in juxtaposition with pressures of 
homogenization. Metis represents a “wide array of practical skills and acquired intelligence in 
responding to a constantly changing natural and human environment” (Scott 1998:313) in contrast to 
techne, which is comparable to science, signifying something that could be precisely and 
comprehensively expressed in the form of concrete rules, principles and propositions. Concepts of 
‘alienation’ (Marx 1876) and ‘deskilling’ (Stone 2007) help in unpacking the nuances of the process of 
knowledge and skill loss that results from industrial commodification.  
Industrial commodification can lead to deskilling in two ways, either by displacing the 
traditional skill-holder by providing a cheaper or better alternative or by taking away part of the 
process. Most traditional skills that went into oblivion post industrial era fall into the former category, 
for example, weaving, pottery.  While it takes away part of the process, it does not displace the skill-
holder but ends up mediating and altering the traditional process. In farming for instance, the industry 
provides inputs to farmers, but leaves the farming to them. Stone (2007) points out that deskilling 
process in the context of farming is different from the typical factory floor situation. 
Since agricultural practice is dynamic, constantly changing in response to environmental variables, 
the farmer does not mechanically applied knowledge. Agricultural deskilling is not the 
displacement of a static set of skills but rather the disruption of an ongoing process of 
skilling….Whether they have the skill or not, farmers still have to make decisions about the use of 
technologies. There is a crucial difference between an industrial situation in which skill has no 
place and an agricultural situation in which skill is needed but cannot be acquired. Agricultural 
deskilling is not simply the automation of farm tasks; it is the degradation of the farmer’s ability 
to perform, the ability and freedom to innovate. (Stone 2007: 73). 
To understand what how industrialization affects Ayurveda, it is first important to understand 
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the structure of ayurvedic knowledge. It is comparable to other forms of traditional knowledge like 
ecological or agricultural knowledge in that it is produced in situ, is more embodied than theoretical 
and is metis-heavy.  But it is different from the others by virtue of its being more in the expert realm 
than popular. It is significantly codified and institutionalized and hence more specialized and less 
widely distributed in the society. The doctor is the official mediator of both production and 
consumption of medicine. Unlike agricultural or ecological knowledge where the skilling process is 
hands on, the latter tends to have a theoretical component that demands formal instruction. However, 
given that knowledge has freely flowed outside institutions for centuries, there are several levels of 
informal knowledge that co-exists and sometimes competes with the official version of expertise. 
Commodification has brought into relief the struggle between institutionalized experts and various 
other levels of practitioners. Besides practitioners, ayurvedic knowledge of various kinds and degrees 
are also distributed across various nodes of the commodity chain, for example, with raw drug shop 
keepers, fresh herb collector-aggregators and so on.  
Ayurvedic knowledge can be classified into three broad components, each of which consists of 
both theoretical and practical dimensions.   
 Diagnosis: Theoretical knowledge of ayurvedic physiology, pathology, etiology  and practical knowledge 
of evaluating physical parameters of the patient and arriving at a diagnosis.   
 Treatment: Theoretical knowledge of various protocols of treatment including diet, medicine, and 
therapies, knowledge of daily regimen, pharmacology, pharmacological properties of the materia medica; 
practical knowledge of administration of therapies and familiarity with materia medica. 
 Making of medicines: Theoretical knowledge of medicine making and practical knowledge of 
identification of plants, organoleptic knowledge of materia medica and processing skills. 
The domains of theoretical and practical knowledge cannot be separated; one feeds into 
another. Much of the knowledge that goes into diagnosis and treatment can be characterized as ‘tacit 
knowledge’ (Polanyi 1958). The knowledge component of concern to this study, ‘medicine-making’ is 
based on a theoretical foundation but is equally or more heavily based on practical experience.  Skills 
involved in medicine making are similar to that required in specialized cooking. For example, 
recognizing the right stage of pakam (syrup-thickness) in the making of lehyams (medicinal jams). As 
lehyams are expected to be shelf-steady for 2 years, it is important that the moisture content 
evaporates. But if the mixture gets overdone, it becomes hard and difficult to consume. Other 
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examples include: 
 Recognizing the limit of boiling for ayurvedic oils, based on frothing 
 Recognizing the limit of boiling for ayurvedic ghees, subsiding of frothing 
 Recognizing the various stages of pakam  syrup-consistency for ayurvedic oils depending on use, whether 
internal, external or for nasal drip application. 
 Recognizing the smell and color of oils, taste of decoctions 
 Recognizing the fineness of particle-size of (Rekhapurnathwavam)118, mineral-ashes. 
Ayurveda presents a high complexity of material in the context of medicine designing and 
making. It is this complexity and variability that makes metis important at every node of the ayurvedic 
commodity chain. Application of rules of thumb is most valuable in situations that present a challenge 
because of their variability (Scott 1998).  Classical medical texts often provide cryptic or incomplete 
information; doctors make their own connections and interpretations that often demands original, 
creative and more importantly, situational thinking. “Knowing how and when to apply the rules of thumb 
in a concrete situation is the essence of metis” (Scott 1998:316). Farquhar (1994) makes a distinction 
between ‘knowing’ and ‘knowledge’ in the context of Chinese medicine, a distinction that Hsu (1999:5) 
interprets as “the particular way in which Chinese medical knowledge is applied to Chinese medical 
practice.” She also points out that there are “styles of knowing” that differ “according to one’s 
perception of and attitudes to knowledge”(Hsu 1999:1).  
All the three components mentioned above are closely interlinked in the practice of ayurvedic 
medicine. But for the medicine making component which is the focus of this study, the rest are 
comparable to biomedical knowledge. In biomedicine, medicine making is not the doctor’s domain; 
drugs, and knowledge related to prescription of drugs, flow from centralized institutions (academic 
institutions and private pharmaceutical companies) to practitioners. Unlike biomedicine that relies 
heavily on proprietary intellectual property119, Ayurveda depends on a large body of open-source 
knowledge, the foundation of which is laid in classical texts. This includes besides the theoretical 
framework of pharmacology, information on properties of materia medica and also recipes of 
standardized formulations. Over the centuries, several variations and new combinations got added, 
some of which are documented in regional drug manuals and recipe books. Some of it remained oral 
and passed down within families or guru-shishya (student-disciple)  lineages. The innovations that are 
                                                 
118Literally means “ability to fill the lines”, the powder should settle inside the creases of the forefinger.  
119Though with time, a lot of this becomes open-source in the form of generic drugs, but doctors or consumers have no knowledge 
or control in making the medicines. The practitioner is just a user, not a participant in drug innovation.  
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built over the classical knowledge by individual practitioners either fed back into the system or are 
enclaved as proprietary knowledge. Historically these remained as personal or family secrets and today 
when they get registered as proprietary drugs, they are protected as trade secrets.  
Unlike a biomedical pharmaceutical company that produces the product and the knowledge, 
the ayurvedic manufacturer takes up only the ‘processing’ component. Manufacturers are well aware of 
this and do not pretend to be more than that. A respondent at AVS said that investing in R & D did not 
mean much to them because they were at the core just manufacturers and distributors of traditional 
products, other activities being incidental120. So we see that like the seed industry does in the case of 
the cotton farmer (Stone 2007), ayurvedic industry takes up only part of the  process; it supplies 
medicine to the doctor but leaves the diagnostic  and treatment decisions to them. Therefore, like in 
farming, the industry has the potential to endanger only part of the skill. However, depending on the 
nature of input, it also has the potential to alter the rest of the behavior of the skill holders. The 
consequences are different for classical and proprietary medicines. In the case of a commodification 
model centered around proprietary — the knowledge flows from the industry to the doctor, comparable 
to biomedical pharmaceuticals. Though the doctor applies the knowledge, industry informs the doctor 
how and when to use the medicine. On the other hand, in the context of classical ayurvedic medicine, 
the industry replaces only the processing function. Since industry in Kerala has been predominantly 
oriented towards the classical market, it is this context that is relevant for the discussion here. 
Therefore the question to be asked is: If the ayurvedic industry is taking up only the processing skill, is 
the consequential deskilling worth being concerned about? After all, the separation of medicine-making 
from the practitioner was common among pre-industrial medical systems, for example apothecaries of 
medieval England (Kapil 1988).  
There are two kinds of actors that ayurvedic industry has direct impact on — the doctor and the 
consumer. In Kerala, both were involved in medicine making. Doctors made complex medicines; simple 
medicine making was left to the consumer. There were also other actors in the commodity chain who 
got affected by industrialization: the retail raw drug seller and various actors in the upstream supply 
chain including plant collectors and traders. The raw drug seller has the highest potential to be 
                                                 
120He was explaining why their venture into patenting led by some well meaning scientists did not yield useful results. 
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deskilled of all the actors because the raw drug commodity is directly displaced by the industrial 
commodity. As for the consumer and actors in the upstream supply chain, the primary problem is of 
alienation rather than deskilling. Because traditional knowledge is expert knowledge, concerns 
regarding consequences of industrial commodification would be paramount with regard to practitioner 
knowledge. The significance of knowledge of medicinal plants and of the knowledge of making of 
medicines in the training of the ayurvedic practitioner in the pre-industrial era has been noted by 
Banerjee (2009). In Chapter 4, I argue that the making of medicines is connected to cognitive processes 
that are part of the process of innovation in Ayurveda and the issue of deskilling has to be understood 
in this context. Further I argue that while the industry does contribute to deskilling of the doctor, the 
root of deskilling lies in the weakening of the skilling process that makes practitioners vulnerable to 
further deskilling. This weakening I argue is the result of the shift from the guru-disciple system 
towards modern classroom-lecture oriented institutions that were not adapted to suit the transmission 
of the metis component of Ayurveda. 
Household involvement in medicine making in Kerala can be classified into two broad types — 
knowledge and use of home remedies and processing of simple classical medicines. To a certain extent 
industrial commodification can replace the former with OTC products, but in the context of classical 
Ayurveda we are mainly concerned with the latter. It is the simple processing of classical medicine like 
the decoction that is most threatened by industrial commodification. The relevance of this skill to the 
survival of classical Ayurveda is subtle and indirect. Medicine making connects people to the knowledge 
of raw drugs and local plant identities; this association plays a significant role in the active and passive 
conservation of these resources. It is the consumer culture that primarily kept the classical practices 
alive in Kerala till today, the significance of which is more than evident in its decline. Consumers’ 
reluctance to make medicine indirectly threatens practitioner metis, by forcing them to shift their 
prescription habits in favor of industrially produced standardized formulations. People’s habit and skill 
of making medicine is a barrier to the industry that tries to convince the consumer that their products 
are as authentic as home-made products, may be even more so because they use ‘scientific’ processes. 
In Chapter five, I point out the significance of commodification of decoction in distancing the consumer 
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from medicine making. However, in Kerala, the shift from home to factory is nowhere near complete. 
Classical ayurvedic product is comparable to the readymade masala market in that the users already 
have the knowhow to make the products. In this market, for commodities to be marketable, not only 
people have to be hard-pressed for time, prices have to be low enough to make them an attractive 
alternative. For open-source commodities, this is not easy, because of competition arising from lack of 
exclusivity121. Hence, despite the inroads made by finished medicine, there is sufficient evidence in 
Kerala of the continuation of a vibrant popular cultural involvement in medicine making.  
The raw drug retail shop which is a key node of pre-industrial medicine consumption is most 
directly affected by industrialization of medicine production. The sellers are not displaced, but 
deskilling is inevitable. Being a raw drug seller demands a high degree of metis including identification 
of raw drug and some working knowledge of medicine and materia medica. Retail selling of factory 
processed ayurvedic medicine on the other hand, is an activity that demands no skill or knowledge. A 
description of metis involved in raw drug retail selling along with a discussion on the nature and status 
of deskilling is presented in chapter 6. 
Large scale production increases the distance of raw material from the site of production and 
thereby reduces collector-manufacturer relationship. The alienation thus caused has effects at three 
levels: on production,  on livelihoods of collectors and on the resource itself. For a vaidyan, a 
medicinal plant carries much meaning; it is not just a means to livelihood but the centerfold of the 
science – both the tool and raw material for experiments with medicine. This sense of meaning and 
ethos is communicated to collectors when they are bound in a close relationship with the vaidyan. 
Information asymmetry thus caused in the absence of such a relationship makes the situation conducive 
for overexploitation of collectors, resources and also threatens quality of raw drugs. Some extent of 
alienation had already occurred in the pre-industrial era in the context of large scale artisanal 
production, when vaidyan-producers began to rely on casual laborers for collection gradually losing 
their own skills of identification. Early manufacturers attempted to correct this by systematizing 
knowledge and training and maintaining loyal relationships, some of which still continue. Even if these 
                                                 
121 As explained in the first chapter, it was this low viability of classical products that had led first Dabur and other North Indian 
companies to move their focus towards branded products.  
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erstwhile collectors have now become aggregators, they are still bound in trust-based relationships 
with the manufacturers. But with expansion of the industry and increase in scale, source of raw 
material gradually moved further away leading to far flung networks of collection. Meanwhile, decline 
in professional collectors due to  macro social and economic changes has led to a situation of 
dependence on casual laborers, a situation inimical to both quality of raw material and conservation. 
Chapter 7 is devoted to the discussion of alienation and deskilling in the local fresh herb supply chain, 
that includes a detailed account of both forest and non-forest streams of collection  and a brief 
account of the nascent field of medicinal plant farming.  
Prima facie it might appear as if industrial commodification has a major role in deskilling 
people. However, it is simplistic to draw a one way causal arrow. Though industrialization might have 
hastened the process of deskilling, it is important to recognize the context in which it was occurring. 
The main impetus for industrial commodification of Ayurveda came from the environment created by 
the influx of allopathic patent medicines (Leslie 1976). On one hand, the modern Indian state by 
privileging biomedicine as the official system made it easily accessible and affordable. On the other 
hand, consumers grew habituated to ‘convenience’ offered by ready-to-consume pills that could be 
bought off the shelf. In parallel, rapid urbanization was under way, as a part of the overall 
transformation of the society, polity and economy. Shift from a predominantly agrarian to a service 
economy was distancing people from rural habitats122. Modern education, professions and life style also 
served to alienate people from knowledge of herbs and ecology. Decline of metis due to such variables 
can itself be a causal factor rather than the result of industrial deskilling. It is therefore important to 
understand the two-way relationship between deskilling and industrialization, that have resulted in a 
vicious cycle in which one augments the other.   
In the following four chapters, I attempt to draw an ethnographic account of the nature of 
ayurvedic production and consumption in Kerala and the nature of deskilling that has occurred at each 
significant node. The account will show how various actors respond to industrial commodification 
showcasing examples of acceptance, resistance and accommodation.  
                                                 
122 Sector wise contribution of GDP from 1960 to 2010 of  primary sector : from 56% to 16% (Kerala State Planning Board 2010) 
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4. CH 4 DESKILLING THE VAIDYAN  
Classical ayurvedic framework had left much to the discretion of the vaidyan. Although several 
standardized formulations were recommended, vaidyans were expected to use their Yukti  (reason) to 
vary, add, reduce, and substitute ingredients of their choice. I use the term thinking medicine to refer 
to the cognitive process of combining various medicinal ingredients to design a formulation, which 
involves applying the knowledge of ayurvedic pharmacological principles in combination with 
information derived from humoral diagnosis (See section 1.2.3). The process of thinking medicine and 
its significance are discussed in section 4.1. I argue that though the skill of medicine making per se is 
not extraordinary, it is the involvement in medicine-making that connects the vaidyan to the sensory 
knowledge of materia medica and thereby to an embodied knowledge of pharmacology.  
These cognitive processes, besides contributing to solving practical medical problems, also lead 
to innovations that may enrich collective knowledge. The role of vaidyan as medicine designer has 
been hitherto instrumental in creating a large body of open-source collective metis, partly textual and 
partly held in practitioners’ collective memories. Industrialized commodification distances 
practitioners from making medicines and thereby from associated cognitive processes.  The result has 
parallels with agricultural deskilling which “is not the displacement of a static set of skills but rather 
the disruption of an ongoing process of skilling” (Stone 2007:73) Section 4.2.1 provides a picture of the 
beginnings of industrialization of Ayurveda in early 20th Century, the role it played in  initiating the 
process of homogenization, and its effect on the practitioner. Section 4.2.2 discusses the relevance of 
metis in medicine production in the industry today. The culture of thinking medicine, does survive 
within the precincts of the ayurvedic factory in Kerala, but is concentrated and limited to a small 
number of people. Innovation at the vaidyan level on the other hand has the advantage of 
decentralized or distributed innovation, a factor that has been attributed to the robustness of open-
source software in comparison to proprietary (Kogut  and Metiu 2001).  Historically, in the evolution of 
traditional medicinal knowledge, distributed innovation also mattered because of the multifariousness 
 129 
 
and the connectedness of herb knowledge to local ecology (Barsh 1997). Until the freezing of 
pharmacopeia by the 1940 Cosmetics and Drug Act, local adaptation was important because among one 
of the most important of vaidyan’s skills was to identify local plant substitutes.  
In Section 4.2.3, I argue that commodification in Kerala that was hitherto centered around 
classical products played a limited role in deskilling. But increasing importance of branded prescription 
products in the market has the potential to intensify the deskilling process. Factors favorable to the 
proliferation of an prescription product market can be broadly classified as practitioner-driven, 
consumer-driven and manufacturer-driven.  
Institutionalization of ayurvedic education was non-conducive to accommodate the flexibility, 
variability and dynamism that was characteristic of ayurvedic metis. Section 4.3.1 describes how 
‘scientization’ of Ayurveda, a process that began with the modern institutionalization and 
professionalization was instrumental in the homogenization of a medical system that was inherently 
pluralistic. Further, in section 4.3.2, formalization of education broke the traditional chain of 
transmission that endangered the transfer of collective metis from vaidyans to disciples.  
4.1 Thinking medicine: Role of vaidyan’s Yukti in medicine making 
Classical ayurvedic epistemology accepts three sources of knowledge as valid: pratyaksha 
pramana (direct perception), anumana pramana (inferential evidence) and aptopadesha (advice of 
trusted source, i.e., texts or other experienced vaidyans). The vaidyan is expected to use Yukti 
(reason) in combining knowledge obtained from the text, personal clinical experience and information 
that he or she gets from fellow vaidyans. In fact, the classics say that those doctors who follow the 
texts verbatim are manda buddhis (mentally challenged) and that such doctors should be avoided 
(Tirumulpad 1977). Yukti that is often construed as intuition123 is comparable to some extent to that 
used by biomedical doctors124. Ayurvedic clinical practice demands a greater extent of metis because 
treatment has to be individualized. Its contrast with biomedicine in this respect is reflected in an often 
                                                 
123Though commonly considered a non-rational process, intuition in the case of a doctor means a creative process that weaves 
together different types of information (cognitive, emotional and intuitive) to arrive at a new insight (Stewart 2005).   
124Scott (1998: 329) gives three examples of biomedical metis: 1. after encountering several patients during a diphtheria 
epidemic a doctor became so adept in diagnosing that he could ‘smell’ out the disease 2. A doctor who could tell if an infant was 
ill just by looking. 3. a physician with a high success rate diagnosing syphilis by unconsciously registering patients’ eye tremor.  
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quoted maxim: “ayurvedic diagnosis treats the patient rather than the disease”. The classical eight-
fold or ten-fold diagnostic protocol of Ayurveda lays emphasis on the understanding of patient 
characteristics that are subjective (for example, healthiness of the tissues, temperament) and 
therefore better elicited by an experienced eye. Additionally, information in the classical texts is often 
cryptic and incomplete requiring the doctor to be a skilled interpreter. This is not surprising given that 
despite reliance on objective parameters of diagnosis, the biomedical doctor’s skill as an interpreter is 
considered to be important (Leder 1990).  
Based on the diagnosis of the nature and stage of disease125, the vaidyan is expected to design 
a treatment protocol that may include a combination of diet, behavior modification, medicine, and 
therapies. The medicine could be a standardized classical formulation, a modified form of a classical 
formulation or a new combination created by the vaidyan. Modification or new combinations are 
possible either when the doctor makes the medicine or prescribes raw drugs for the consumer to make 
at home. Besides diagnostic criteria, cost considerations could also influence the choice of ingredients. 
Even in prescribing standardized formulations, the vaidyan is expected to be knowledgeable of the 
ingredients. Sometimes the difference between one medicine and another could be a single ingredient, 
the choice between them guided by the individual ingredient’s pharmacological properties.126 Dosage 
of medicine is also left to the vaidyan’s discretion.127 Ayurvedic physicians consider dosage a critical 
determinant in treatment. In the words of a practitioner-scholar from Kerala, “Three drops of 
Maharajaprasarini twice in Dhanwantaram Kashayam saves a particular paralytic patient near to death 
with flaccid viscera. It is specific for the specific patient – ten instead of three drops would have killed 
him (Muraleedharan 2006b:22).” 
In the process of diagnosis and treatment, the vaidyan is not just applying learnt knowledge 
but is being innovative, a process of innovation best described as “a recombination (bricolage) of 
                                                 
125 Six stages of disease progression according to Ayurvedic pathology, caya (accumulation), prakopa (aggravation), prasara 
(dissemination), sthana samasraya (localization), vyakti (manifestation), and bheda (chronicity). 
126 For example, between Chitraka Kashayam and Shaddarana Kashayam, the difference is of a single ingredient. The former has 
Kaduka (myrobalan), the latter has bark of maramanjal (Coccinia fenestratum). 
127 The master classic on pharmacology says, “Determination of weights and measures of drugs is not rigid. The physicians should 
decide it taking into consideration the season, digestive-capacity, age, strength, constitution, humors, and habitat (SDS Ch.1: 37-
39). The author then goes on to suggest a particular dosage system, “best suited for the people of the contemporary Kaliyuga”. 
He mentions two systems weights and measures, Kalinga and Magadha, he recommends the latter. However, Kerala traditionally 
followed a distinct system of weights and measures in Ayurvedic medicine making (See footnote 249). 
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existing elements” (Scott 1998:324). Obeyesekere (1992: 172) uses the term,  ‘Samyogic 
experimentation’ which he defines as “a process based on clinical falsification, which makes it possible 
to generate new prescriptions, a feature that establishes Ayurveda as a science of medicine”. By 
providing ready pharmacopeia, and asking doctors and consumers to stop medicine-making, the 
industry has the potential to reduce the variability of prescription and narrowing the range of 
pharmacopeia in use. The metis that the gurukula-trained older generation practitioners are most 
concerned with is related to practitioner metis of ‘medicine making’. Concern is not just about the 
processing skills, but about the relationship of this process to the larger cognitive processes related to 
the practice of medicine itself. The process of “thinking medicine” is possible only if the 
pharmacological knowledge of plants is embedded within the mind and comes into play when required. 
Similar to the experienced cook128 who can imagine and combine the spices mentally to produce a 
desired taste, the vaidyan combines the knowledge of medicinal properties in visualizing a medicine 
combination. The term vruddha vaidyan, in vogue in Kerala, is based on the traditional understanding 
of the significance of metis. Vruddha means old, but in this context, is a term that is specifically used 
to designate expertise and experience in medicine. Whenever there is an ambiguity, “vruddha vaidya 
matham” (opinion of the elderly physician) is considered the final recourse. The significance of the 
vruddha vaidyan has been noted by Wood (1985). 
There were prescriptions in verse…. but detailed instructions to interpret them and actually make 
the medicines were lacking, so that one had to learn from someone who already had practical 
knowledge and experience. However these qualities and qualitative effects of medical substance 
were not measures by an experienced physicians’ developed sense of judgment in prescribing for 
the ailment of a particular patient. Only a vruddha vaidyan or an experienced physician would 
have developed the sense to know what combination of medicines should be prescribed for 
particular case, given the nature of the ailment and the particular constitution of the patient. 
That a physician of this kind could be very effective in his prescription seems to be widely 
acknowledged in Kerala. (Wood 1985:116).  
Citing examples from the field of medicine to show how metis has provided ingenuous discoveries 
specially mentioning the practice of variolation129, Scott lists the ingredients of practical knowledge:   
a pressing need (in this case, a matter literally of life and death), a few promising leads that 
                                                 
128 To a certain extent, Indian cooking involves a rudimentary form of this thinking. For instance, cooking lentils, considered gas-
producing, with asafetida as a carminative, combining cumin to counter heat-producing properties, turmeric as an disinfectant. 
129 He lists several examples of traditional medical discoveries and makes special mention of the widespread use of  variolation 
(inhalation of attenuated small pox matter from an infected person or scratching the same into the skin) long before Jenner’s 
development of the vaccination technique in 1798, was practiced in India, the Middle East, Europe and China by 16th century.  
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worked in analogous contexts (inoculation), a vast army of freelance experimenters willing to try 
almost anything, time to "simmer" (as the experimenters and their clients observed the results of 
various stratagems through successive epidemics), and the sharing (through chains of 
communication) of the experimental results. As long as it didn't require an electron microscope, it 
would in fact be surprising if such a combination of passionate interest, close observation, large 
numbers of amateur specialists trying different possibilities, and the time necessary for trial and 
error did not produce many novel solutions to practical problems (Scott 1998: 326).    
Here are two examples that demonstrate how practitioner metis is fed back to collective knowledge of 
diagnosis and medicine, a process that is central to the continuity of ayurvedic innovation.  
Case 1: Ashtavaidyan Cheriya Narayana Namboothiri: Case of a patient with chronic urinary 
incontinence.  
Once when I was in my clinic, a smart (capable) lady from Hyderabad came with her 9 yr old 
daughter. As they did not know Malayalam, I interrogated her with the help of my aides. The girl 
had a chronic urinary incontinence problem; she had undergone 7-8  surgeries without success. 
The lady insisted on admitting her to the hospital for treatment, but the case was complicated 
and I was clueless. So I told them to take medicines for a couple of months and that, I will decide 
how to proceed after seeing the response.….I fixed a protocol of medicines and asked them to try 
it out for 2-3 months. But after a month when there was no much progress, she got impatient and 
kept pestering me to admit her, so I had to relent. And then when I pondered deeply over the 
issue, a verse came to my mind. It contained a recommendation that Ghritam (medicated ghee) 
be administered to patients suffering from urinary problems in two separate dozes…This procedure 
is termed as Avapeethaka Snehapanam.130 I couldn’t easily recollect it earlier because it was not 
in the Chikitsitam (remedy section), but in the Sutra Sthanam (section on fundamentals). 
Calculating an ideal doze for Snehapanam (protocol for consumption of medicated ghee/oil) for a 
nine year old girl wasn't easy. With much calculation and trepidation, I decided to give 120 grams 
of medicated ghee, 40 grams before breakfast, the rest in the afternoon around 3.00 p.m. A Mridu 
Swedam (light sweating procedure) was applied to her on the next day, some Virechaka 
(purgative) medicines were also given. On the third day some of the medicines were vomited, but 
surprisingly the urination came under control (Namboothiri 2008:150-152).  
Case 2: Dr. Verghese Pattarumadom, A DAM (pre-BAMS formal degree) qualified third generation family 
practitioner on encountering a middle-aged patient from Tamil Nadu, with shrunk limbs, referred to 
him by a colleague from Madras.  
The patient had tried all other systems of medicine without any success. It was a complicated 
case. I had no clue how to address it, and I was not much hopeful of finding a solution either. But 
the case was preying on my mind. One day, during an early morning meditation walk, a verse from 
Ashtanga Hridayam popped into my mind. It was about a simple recipe, to make decoction of 
uzhunnu (black gram) with induppu (potassium chloride), and make a medicinal oil out of it. It 
seemed silly, so I ignored it. But it kept coming back to my mind. It sounded too simple for such a 
complicated problem. Anyway, I thought what do I have to lose by trying? So I tried the 
application, and I couldn’t believe it when, on the fourth day, I saw a mild recovery. I then 
pondered over it, and tried all possible combinations with the same oil, including internal 
consumption. In around 14 days, the patient had significantly recovered.  
In both the examples mentioned above, the doctors were faced with a novel problem that they 
were clueless as to etiology and treatment. They were almost reluctant to pay close attention to them, 
                                                 
130 Note that he does not even mention the text, assuming the default text in Kerala to be Ashtanga Hridayam. 
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as they had implicitly classified the disease as incurable.131 They were forced to use all mental 
resources and knowledge at their disposal due to the insistence of patients to be treated. And in both 
cases the inspiration  for the treatment came from a classical textual source, which they modified and 
experimented using yukti. The first case was published in a book written by the vaidyan himself on his 
clinical experiences. The second was narrated to me personally, but it is also an information that he 
had  published in a practitioner journal long ago. It is also an information which doctors like him 
routinely exchange with colleagues and student interns. A few months later after publishing the 
article, he bumped into a vaidyan-owner of a large manufacturing company who told him that after 
reading his article he added the medicine to their classical product list. Francis Vaidyan was happy that 
his acumen was acknowledged. It was a classical medicine that he had rediscovered and applied to a 
particular context, he was proud that he had contributed his bit to the medical system. Innovation in 
ayurveda often constitutes of applying formulations existing in classical text to a particular disease 
condition. The application can be simple, merely recognizing the importance of a particular medicinal 
recipe, or more complex, like modifying it to work better to the specified context or applying it to a 
new disease context in the existing or modified form. 
Many such bits and pieces of clinical experience accumulate as collective metis, those that are 
not recorded or published circulate among networks of practitioners. Despite the fact that I was not an 
ayurvedic doctor and was uninterested in medicine formulae, the vaidyan wanted me to note down a 
secret formula given to him by a trusted guru. Though it may seem that doctors are not willing to share 
their secrets with others, usually such exchanges take place after months and even years of rapport 
building after the guru considers the disciple worthy of transferring the knowledge.  
The traditional context of ayurvedic practice provided an atmosphere conducive for distributed 
innovation to be carried out as part of everyday practice of practitioners, that may get exchanged 
through formal and informal professional networks, and over the generations through guru-disciple or 
family lineages. Kerala Ayurveda Mandalam is an association dominated by old timers, that is, licensed 
                                                 
131 Much importance is given in the classics to the assessment of patient characteristics before beginning diagnosis, to assess 
whether the patient is curable, incurable or palliable. The doctor is strictly advised not to treat patients close to death, lest it 
spoil his reputation. Elaborate guidelines are provided to recognize signs of death. Stories of master practitioners commonly 
refer to their prowess in recognizing imminent signs of death.  
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traditional practitioners and practitioners holding pre-BAMS degrees. In one of their annual meetings I 
saw Dr. N. K. Padmanabhan Vaidyar, the owner Chairman of a leading ayurvedic company Nupal 
Remedies, dropping into the meeting with two plants in hand. When it was his turn to speak, he waved 
a plant in front of the audience, asking if anyone could identify. The plant was passed around among 
the small, but eager audience, most of them senior vaidyans and a few youngsters. It must have been a 
rare plant; only one of the assembled vaidyans recognized it, identifying it as a relative of another 
more well known plant. An animated discussion followed, touching various topics like plant’s 
characteristics,  experience with similar plants, comparative medicinal uses, and so on.  
Despite being a proud owner of a multi-million rupee business empire, Dr. Padmanabhan, in his 
late 70s, comes across as a humble and passionate vaidyan-scientist. He is obsessed with the 
pharmacological promise an ordinary plant holds, seeing before him a world of wonders waiting to be 
discovered by the traditional organoleptic method.  His thinking about plants and potential medicines 
is closely associated with his constant clinical practice, to the problems he encounters, and the 
answers he seeks. This also includes commercial concerns, informed by the prevalence and incidence 
of particular diseases, the nature of public demand, availability and cost of raw material, and so on. 
Information that modernized pharmaceuticals like Dabur collect through market surveys comes to him 
through everyday clinical experience. He spends more time in his clinic than his factory; it is easy to 
get an appointment with him as a patient than as a researcher. His armor of 50 proprietary medicines 
are derived through this process of experimentation, built over generations of accumulated metis that 
he traces back to 1500 years of Buddhist legacy.  
In the next speech, the President of the Mandalam, launched into an elaborate discussion on 
the making of a particular medicine. The description was somewhere in between a chef’s animated 
recipe recital and a chemist’s enthusiastic narrative of a chemical reaction. During his speech, a young 
doctor raised a query on the use of Takradhara (therapy procedure with medicated buttermilk). 
Though his question was directed at a minor technicality, while describing the procedure he 
inadvertently revealed that he bought butter milk from the neighboring Arya Bhavan, a vegetarian 
hotel. This revelation sent the senior audience into a stunned silence. Without much ado, a senior 
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vaidyan reprimanded him: “How can you even dream that it is okay to use butter milk from the hotel 
to use for treatment? Making medicated butter milk is a process in itself, you can’t just add medicine 
to butter milk and expect it to be the same!” For the young doctor, who is used to the culture of 
buying medicines from the shop, the ability to discriminate between them appeared to be non-
existent. In fact, the innocence with which he revealed this to the senior audience shows that he was 
not even remotely aware of his transgression. In a chat after the meeting, Gangadharan lamented, 
“people will not any more practice like in the olden days, those days are numbered!”   
In the process of varying ingredients, and observing results, over a life time of practice, the 
vaidyan might arrive at different formulations, some of which might be more effective for particular 
cases. The chances of an individual vaidyan arriving at a more effective variant of a formulation or 
protocol during the course of treatment is high, given that a vaidyan is considered to be constantly 
experimenting and getting feedback from the patients he examines. Sometimes an experiment with a 
single case might lead to a formulation that might be then repeatedly used for several other similar 
cases. Here is a classic example, again from the Ashtavaidyan family of Vaidyamadham Vaidyasala. 
Chembai Vaidyanatha Bhagavatar, a nationally renowned classical musician, had a strange problem 
during the heydays of his career. He lost his voice suddenly during a concert following a fit of 
cough, and could not finish the concert. He tried a number of treatments from far away cities like 
Bangalore, but without success. My father met him once in Guruvayoor during this period and told 
him he can treat him provided he stays with him during the treatment. He readily agreed and 
came with my father. He told me to look up the texts for any reference related to  'swarasadam' 
(voice improvement).  I looked into Chikitsa Manjari, Sahasrayogam and Ashtanga Hridayam. I 
would read the pertinent verses to my father during his resting time in the evenings, often in the 
night too. In certain passages he would ask me to repeat the verses, which would mean that he 
would meditate more on that. Finally he zeroed down on some medicines from Sahasrayogam 
(older version).  A medicinal ghee and a medicinal powder was chosen, and he asked me to add 
the leaves of gooseberry in the latter, as recommended from the text Chikitsa Manjari.  He 
wanted me to make the medicines at the earliest. The medicines were made in four days and the 
Bhagavatar started taking it. We also started sweating procedures along with certain medicines, as 
well as a couple of nasal cleansing procedures. Within two weeks of this treatment the condition 
improved and there was a marginal recovery.  He could utter a few words with difficulty. At the 
end of the two weeks he asked my father whether he could start practicing his music and my 
father consented. In a short while his voice was around 75 percent normalized, after which it 
gradually improved, getting even better than what it used to be.  The medicines tailored for him 
are now sold in our pharmacy, named after him, as Special Powder (VNB) and Special Ghee (VNB). 
(Namboothiri 2008:31-35). 
Depending on the inclination of the particular vaidyan, an innovation such as this might either 
remain a family/lineage secret or be shared with other vaidyans. In this case, despite the fact that 
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they sell these as proprietary medicine, the vaidyan has openly discussed the source and formulation in 
his published book on clinical experiences. In some instances, it does happen that vaidyans’ (or popular 
knowledge) gets acquired and privatized by companies. For example, SH, a medium size company, 
reported that some of their proprietary medicines were derived from local knowledge that they 
obtained from a traditional vaidyan they consulted. They mentioned three medicinal oils, indicated for 
sinusitis, sleep disorders, numbness, and persistent cold. A new generation company, DuCare, 
aggressively markets a branded medicine for hemorrhoids as a ‘tribal formula’ (in Malayalam ‘adivasi 
formula’). In mid 2010, the company’s attempt to formally acquire a medical formulation from a 
traditional vaidyan from northern Kerala landed them in a legal tussle.  
Vaidyans with small capital are ill equipped to participate in the branded product market. One 
elderly vaidyan in a rural region, mistook me as a business aspirant, despite my repeated efforts to 
dispel the notion. He had a few proprietary products up his sleeve that he would subtly try to market 
to me.  He once allowed a hawker to market his medicines, but soon had to put a stop when he found 
that he was selling adulterated products. One of the professed objectives of the recently set up 
country’s first ayurvedic industrial cluster in Thrissur, Confederation for Ayurvedic Renaissance (CARe-
Keralam, refer Section 7.7) is to enable such small vaidyans to package and market their own 
proprietary formulations.  
Collective knowledge gets enriched by constant feedback from individual doctors’ experiences. 
Since this process is not necessarily centralized, over time it leads to local differences that may evolve 
into regional traditions, some of which gets codified. For example, a Kerala text Vaidyatarakam is 
considered to contain the essence of southern Kerala tradition. Much importance is given to one drug 
amalpori (Rauwolifa serpentina of the Reserpine fame), introduced in several classical formulations as 
an anxiety-alleviator, demonstrating a regional focus on anxiety in disease etiology (Varier 2003). 
Thirumulpad notes that the strength of Kerala Ayurveda is that the physicians did not get stuck with 
classical texts, but went on to codify other texts based on practical experimentation.  
Many believe that Ayurveda must be practiced as it is prescribed in the texts. I differ with them. 
the practitioners dared to think differently and succeeded. This essentially is the success of 
Ayurved and also shows the strength of its basic principles…It is in this context that Ayurveda in 
Kerala became acceptable to its people. The local vaidyans were considered a friend of the people 
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in his locality. His was not an exalted profession one as we see today (2008:15-16).   
For metis to operate and lead to innovation, certain minimum social conditions are required, 
says Scott (1998). These include a community of interest, accumulated information, and ongoing 
experimentation,  which could be provided either by formal institutions or by informal exchanges. 
Ayurvedic metis traditionally circulated through various channels, through formal exchanges in gurukulas 
between guru and disciples, educational institutions attached to royal palaces and temples, in meetings 
of practitioner associations and informal exchanges between practitioners through social networks. This 
was true of not only Ayurveda but all forms of traditional education (Wood 1985).  
Metis is not just what is acquired by individuals in their lifetime, but a product of accumulated 
experience of a community. The doctor is just a member of a community that serves as a “living, oral 
reference library for observations, practices and experiments – a body of knowledge that an individual 
could never amass alone.” (Scott 1998:324). A review of eminent local ayurvedic practitioner-scholars’ 
writings on the Kerala tradition of Ayurveda and Panchakarma (Rajagopalan 2009, Namboothiri132 2004) 
shows that it differs from its textual foundation in the classics only in minor ways133, too insignificant 
to explain the newly acquired fame of the so-called “Kerala tradition”. This elusive tradition is nothing 
but invisible collective “practical” knowledge and ethos that have evolved over a shared history of 
practice134. This knowledge remains tacit, informing the choice of treatment protocols that includes 
the use of pharmacopeia, therapeutic procedures and diet advices. It also included bits of technical 
information in identifying plants, purifying poisonous plants, cooking decoctions, and so on135.  
There is an important aspect of practitioner metis not discussed here, that concerns areas of 
medical expertise that are metis-heavy; such specialist medical practices require more hands-on skill 
and little or no textual knowledge. The most important of these are surgery, poison-healing and bone-
setting. Today surgery in Ayurveda is limited to the treatment of hemorrhoids, but it is the most 
illustrative of the significance of metis.  The master treatise on surgery, Sushruta Samhita describes  
                                                 
132 Kaladi Parameshwaran Namboothiiri is an expert on Panchakarma, recognized with the title Panchakarmakulapati Ratna. 
133 Modification of the immersion oil bath prescribed into classical texts into a oil-drip application procedure (Pizhichil), addition 
of Takradhara (butter-milk pouring application) to the already existing Dhara procedures, inclusion of local ingredients like 
tender coconut in medicinal formulations, and so on. 
134 Though there are similarities across Kerala that make it seem like a unitary tradition,  there are variations within them that 
could be regional, familial or  restricted to teacher-student lineages.  
135 For example, adding right quantity of Dhataki135 (Woodfordia fruticosa) in fermenting Arishtams depending on the nature of 
ingredients in the particular formulation and the ambient temperature.  
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120 surgical instruments, eight categories of human surgery and 
300 surgical procedures including ophthalmic couching, cutting for 
stone, removal of arrows and splinters, suturing and re-stitching of 
ears and nose. But it provided no illustration nor detailed 
description of the procedures used. Wujastyk (1996) points out that 
the famous historical event of the 'Hindu method' of plastic surgery 
recorded by the British in Poona in 1794, could not have been 
transmitted textually.  
 
 
The surgeon who performed the Poona operation was not a traditional physician (he was a 
potter)… probably knew no Sanskrit at all. He had the skill in hands, not in his head. And the skill 
that have been probably have been specific to his caste, or even family. Indeed, may be it was an 
extraordinary survival of a technique from Sushruta's time. But in that case it was transmitted by 
means wholly outside the learned practice of traditional Indian physicians (Wujastyk 1996:27).   
Unlike textual classical Ayurvedic knowledge, metis-dense branches of medicine are more 
vulnerable to deskilling, for evident reasons. The text-centric thinking that dominates modern 
Ayurveda derecognizes the knowledge and skill of traditional practitioners which in such branches can 
lead to irreversible deskilling. A good example is the near to close extinction of surgery which used to 
be one of the two main branches of medicine in classical Ayurveda136. This is also the case with bone-
setters as will be discussed in brief in Section 8.6.1. 
4.2 Role of industrial commodification in deskilling the vaidyan 
4.2.1 First Steps towards homogenization 
Arya Vaidya Sala from Kerala is the largest Ayurvedic manufacturer in South India and one of 
the top ten in the country. Below here are excerpts of an announcement made by Dr. P. S. Varier, the 
founder of Arya Vaidya Sala (AVS),  more than a century ago (Oct.16, 1902), on the occasion of laying 
the foundation stone of the company in the sleepy village of Kottakkal in North Kerala. By then, five 
                                                 
136 Doctors in ancient India were said to be divided in two branches: surgeons (Dhanwantariyans) and physicians 
(Bharadwajeeyans) 
Ayurvedic surgical instrument 
models: Ayurvedic Industrial 
Exposition, Trivandrum, 2012 
 139 
 
other companies had started manufacturing ayurvedic medicines on a large scale137.  
We have reached a stage where it is generally only those who work for daily wages who now 
gather, stock, sell, buy, process and use these raw materials, mainly herbs. Not only do they not 
mix it in the right proportions and at the right time, it has even become a habit with them to 
make mistakes and confuse even those drugs that are easily available and identifiable. Apart from 
this, because of a growing lack of familiarity with them, innumerable medicinal plants and roots 
have now become impossible to identify.……I have said all this only because I feel that all vaidyans 
must be familiar with the various kinds of herbs they prescribe; you must not think that I insist 
that all vaidyans should prepare many kinds of medicines and keep them ready for use. Not that 
this is not a good thing to do; it is just that it is not possible to do it. Although food, clothes, 
household articles and so on are things that everyone needs, we all know it would be contrary to 
the way of the world to try and manufacture each of these things ourselves, besides being 
impossible. 
Therefore…it is imperative that we do not suffer in isolation but that we unite, trust each other, 
distribute the work we have to do among ourselves and be of help to each other. Vaidyans should 
organize themselves in a group and form a company that will examine all raw material thoroughly 
and see that they are processed with the utmost zeal and attention, making no deviations 
whatsoever in what the ancient ayurvedic scientists have prescribed in their texts or in the 
experience that have been garnered to date. It is my belief that if other vaidyans begin to buy 
medicines processed in this way, use them properly and conduct treatment in a befitting manner, 
both groups will enjoy a profit that will equal their effort, that patients will be benefited and 
people will have faith and satisfaction in native medicine.  This is the special advantage that 
practitioners of English medicine enjoy. There are numerous shops in all cities to provide them 
with the medicines and materials that they need for treatment. Why cannot we create the same 
facilities for ourselves? (Krishnankutty 2001:48-52). 
He makes a case for the need for prepared medicines for the ayurvedic vaidyans, on the basis 
of two arguments. First, the vaidyan’s loss of knowledge in identifying herbs because of over-reliance 
on others to pluck. Second, convenience of having a ready pharmacopeia for treatment; an observation 
that followed from the developments in ‘English medicine’. Though Varier as a committed doctor might 
have been genuinely worried about the status of ayurvedic practice, perhaps consciously or 
unconsciously he was also framing a business strategy, trying to carve a niche for his products. It was 
not possible for an ayurvedic manufacturer to make much headway in marketing his products without 
delinking practitioners from medicine making. This is not to suggest that Varier’s observation on the 
defectiveness of practitioner herbal knowledge was concocted or exaggerated. But the proposal of 
centralization of production and distribution as a solution to this problem was most likely inspired by 
the biomedical market, a mindset that was shared by ayurvedic entrepreneurs of that era. Citing the 
example of two North Indian companies, Bode (2008)  points out that the ayurvedic and Unani 
                                                 
137 Two in west Bengal, in 1884 and 1898, one in East Bengal in 1901, Dhootapapeshwar near Bombay in 1872, Dabur in 1884 in 
Calcutta. Two more were to open soon -  Zandu in 1910 in Mumbai, and Baidyanath in 1917 in Calcutta. 
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manufacturers propagated a division of labor; traditional physicians were told to stop making 
medicines and were seduced to buy factory products.  
Dr. P. S. Varier’s observations and entrepreneurial plans were based in his lived experiences in 
the northern part of Kerala, the Malabar region which was under colonial rule. On the other hand, the 
southern part of Kerala under Travancore kingdom favored and funded indigenous medicinal education 
and traditions (see Section 3.5.2)138. Did the deteriorated status of indigenous medicine under colonial 
rule and a consequent decline in metis in Malabar, present a landscape conducive for capitalist 
intervention? If this was true, then it would mean that though the industry might eventually cause 
further deskilling, deskilled status of the practitioner could have made space for industrialization of 
production in the first place. There is some supporting evidence. In his biographical work on Arya 
Vaidya Sala, Varier (2002) points out that Malabar was ahead of Cochin and Travancore in adapting to 
modern trends because of disruptive British policies. The deteriorated situation of indigenous medicine 
in Malabar led to the marginalization of genuine traditional practitioners which was conducive to the 
rise of quackery. This in turn forced ayurvedic physicians to organize giving rise to the growth of an 
influential physicians association, the Arya Vaidya Samajam. Formalization of education in the form of 
Arya Vaidyan Diploma course was a development of Samajam’s activities. The factory was a parallel 
and related outcome of this effort to organize and combat the march of allopathic medicine. At the 
same time, it is important to note that industrial commodification was not necessarily the first step 
separating the medicine making from the doctor. Not all traditional doctors in Kerala were in the 
practice of making medicines. By the time AVS was founded, the separation between prescription and 
processing was already well established, as evidenced by the widespread presence of artisanal production 
units (vaidyashalas). 
Even if you go to inner country, you will see board of vaidyashala (medicine manufacturers). In 
many places you will see multiple vaidyashalas. In any Malayalam newspaper, 85% advertisements 
are of vaidyashala (Varier 1915:80-85).  
                                                 
138 In Travancore, by 1938, there were 150 Grant-in-aid  vaidyashala in the nook and corner of the kingdom. The private gurukula 
started by a palace doctor was taken over by the King, who provided for an organized system of education by 1917, complete 
with a hospital system and medicine making unit. 
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In  late 18th and early 19th century, the high cost of allopathic medicine and treatment139 would 
have inspired the idea of medicine making and selling as a profitable venture, and the availability of 
print media must have made it possible for manufacturers to publicize and expand their clientele. 
According to Harilal (2008), the period between 1830-1880 was the age at which familial production 
had given way to ‘petty production’. He points out modern institutionalization had displaced 
traditional practitioners who went on to becoming manufacturers and salesmen. Artisan manufacturers 
made life simpler for doctors. A physician, for a successful practice, had to have at least some 
medicines ready at hand. At a small scale it was unviable to make a large range of medicines, 
especially complex medicinal formulations like Asavas and Arishtas (fermented preparations) that took 
25-40 days. Even those who had a larger scale of operation and had assistants to help them, were 
limited to making a few commonly used medicines. The founder of AVS puts it very clearly, 
Opening a vaidyashala and running it is an expensive affair. Anyone Vaidya starting a vaidyashala 
with a small capital, they will have to wait for the first batch to be sold. That will take some time 
for others to know, and by the time the medicine might become old. If they sell the old medicine, 
then the reputation is gone. Rich people ought to be supporting good vaidyans, but they don’t, 
because they anyway have vaidyans to assist them….Knowing Vaidya, and being truthful won’t 
alone work. You need to know business and marketing (Varier 1915: 80-85) 
Besides this, there were also a large number of practitioners whose practice was limited to 
consultation and prescription (see Section 5.7). The founder of AVS says, “Paramparya (traditional) 
vaidyans’ business is advising people, they are not used to the responsibility of making medicines and 
providing it (Varier 1915: 80-85)”. It was in this space that the artisan manufacturer had emerged, 
making it convenient for both consumers and doctors. Industrialization of ayurvedic medicine has been 
seen as a major contributor to the deskilling of the vaidyan (for example, Banerjee 2002). Ayurvedic 
practitioners and scholars themselves recognize this. Principal of an ayurvedic college in Kerala writes, 
The physician has finally escaped from the heat, smoke, soot and discomfort  of the furnaces of 
his “marunnupura” (the kitchen were medicines are prepared) and practices with pen and 
prescription pad. Their thought process is confined to the medicines available in the market, their 
therapeutic skills are waning. And when a stage comes when even the standard medicines 
available now also disappear from the market, they would satisfy themselves from the proprietary 
medicines of the pharmaceutical companies. Then there will not be any distinction between 
allopathy and ayurveda; ayurveda will lose its identity; if it has not already done so (Agnivesh 
2011: 84) 
                                                 
139 As learnt from accounts of practitioners presented in Usman committee report on indigenous medicine systems (1923). 
According to one vaidyan’s account, cost of treatment per patient in the allopathic system was 6-7 annas, compared to 10-12 
pies in Ayurveda, that is 6 times higher (one anna = 12 pies).  
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4.2.2 Relevance of metis in medicine production today 
Observing the relentless march of industrialization and its effects on practitioner and consumer 
metis brings some questions to the fore. How relevant is the concern for disappearing metis today,  after a 
century of industrialization of production? “Much of the world of metis that we have lost is the all but 
inevitable result of industrialization and the division of' labor. And much of this loss was experienced as a 
liberation from toil and drudgery” (Scott 1998:335). It is important to examine the significance of 
medicine-making from this perspective, both at household and practitioner nodes. 
In the context of fading away of household metis, it is the ‘grandmother’ whose knowledge 
everyone refers to, not the grandfather140. The shift towards prepared masalas might endanger the metis 
of cooking, but its role in  empowering the working woman needs to be recognized. Some respondents 
were driven by perceptions of authenticity of medicine, similar to the commonly heard romanticization of 
the taste of the stone-ground chutney and home made masalas. But such perceptions and expectations 
tend to burden the already overworked working women141, capital intrusion into local knowledge could 
have the salutary effect of ameliorating gendered drudgery in the kitchen.  
With regard to  practitioner-metis, which aspect of medicine-making would be worth the attention 
in the context of deskilling? Artisanal production involved manual labor in cutting, chopping and grinding. 
Laborious procedures were prescribed for medicine preparation that involved countless hours of grinding. 
When pulverizing machines and mechanized grinding stones can replace manual labor, is it really 
important to grind or crush the medicines by hand? Machines are typically blamed for displacing labor, 
but this would not be relevant to Kerala which reels from an acute labor supply shortage.  But how 
important is the skill of cooking medicine? If we look at the beginning of industrialization in early 
1900s, we see that the manufacturers were highly concerned about metis. Varier chose his helpers with 
care, because the texture of medicines had to be absolutely right when they were taken off the fire 
and had to be carefully tested by an expert. “There were two foremen who worked with the actual 
processing, one to weigh the ingredients, the other to check the consistencies as the medicines boiled 
                                                 
140 Respondents often referred to the demise of grandmother as the turning point in their household medicine making, for example, 
shifting to market commodities instead of cooking post-delivery medicine at home. 
141 Even if Kerala has a greater proportion of working women than many other parts of the country, the kitchen is still a woman’s 
province, it is rare to see men giving a helping hand. 
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over a fire fed with coconut fiber. They remained in the service of the Arya Vaidya Sala for many years. 
P. S. Varier himself supervised every stage of the processing, anxious to make sure that nothing went 
wrong (Krishnankutty 2001:53-54).    
The factories have changed a lot since then. AVS incorporated wet grinders in 1952, steam 
boilers in 1967, wooden vats for fermentation were replaced by stainless steel vessels in the 70s, 
automated filling lines in the late 70s, modern chemistry-based quality assurance system in the 80s, 
automatic tableting system in 1987. With the modernization of arishtasava (ayurvedic fermented 
wines) manufacturing, mainly high speed centrifuge for quick sedimentation, batch sizes scaled up 
from 50-100 liter to 2000-5000 liters. Today medicine 
making in the factory appears transformed. The imposing 
image of bottles moving on conveyor belts being filled by 
medicine dispensers, getting neatly sealed and labeled by 
machines rolling out all ready for packing, can easily give a 
wrong impression. Processes in the ayurvedic factories in 
Kerala are not yet automated as this image would make us 
believe. Bode (2008: 123) calls the AVS manufacturing unit, 
a “kitchen factory”, which he says to him looked like a 
“workshop where artisans perform their craft.” But nothing 
the firm’s reluctance to be photographed, he expresses 
surprise because he says western manufactures tend to 
boast if they are engaged in artisanal production. This is because of the predominance of the modernist 
discourse in ayurveda which can be often misleading. It is deceptively identical to that of rest of India, 
but it is more of a reaction to a stauncher local strain of traditionalist ayurveda. AVS has been the 
harbinger of modernity in Kerala, and it has significantly influenced the local ayurvedic discourse in the 
direction of modernity. In a way, the modernism of Kerala is likely to be considered traditionalist by 
national standards, though this difference is often not discernible unless one closely observes 
manufacturing practices. Bode (2008: 125) has been perspicacious in noting this distinction. “Tradition 
 
 
Modern ayurvedic factory: from AVS files 
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is a relative affair”, he observes, noting that AVS which is traditional by standards of rest of India, had 
to face much opposition on its home turf for modernizing medicine production. He also notes the 
prevalent critique in Kerala of mass production and of the perceived effectiveness of freshly made 
medicines, devoid of preservatives.`  
In comparison to artisanal production, three major technical changes can be identified in the 
modern Kerala industry: 1. Shift from manual labor to mechanical power, saves labor and time 2. Shift 
from direct firewood fire to steam, provides for a controlled temperature and a soot-free  
environment, and 3. Change in the material of vessels used from brass Urulis (cauldrons) to stainless 
steel (SS) jacketed vessels and wooden vats to SS vats for fermentation of Asavas and Arishtams. Even 
these minor changes are sufficient to provoke guilt among Kerala manufacturers. A medium sized 
manufacturer assures its customers, “We maintain traditional methodology for ayurvedic medicine 
preparation…For thermal processing of decoctions, firewood ensures controlled and continuous 
heat…We have adopted modern technology only in pre-processing stage like disintegration, 
pulverization and in preservation of kashayam142”.  Though using steam jackets to process medicine is 
not really considered a big step, it is still guilt provoking and therefore the attempt to direct readers’ 
attention to ‘firewood’ by emphasizing the term. The manufacturer also assures that modern 
technology is used only pre-processing, not in processing. Another small manufacturer assures its 
customers that “The conventional system of factory has been renovated to the GMP Standards. 
However utmost care is taken to maintain quality of the medicines”143(Italics mine). Ironically, GMP, a 
quality standard from a modern perspective is seen as a necessary evil, in fact, a shortcoming from a 
traditionalist worldview. Even Kairali resort, an ayurvedic tourism stakeholder who is a newcomer into 
manufacturing likes to claim that they “do not stray away” from “traditional methods written in the 
ancient manuscripts” except in using “modern methods of manufacturing to meet the ever-growing 
demand”.  Ironically, the tourist market emphasis on tradition makes such stakeholders appear closer 
to the erstwhile ‘purist’ segment of ayurveda144.   
  
                                                 
142Dhanwanthari Vaidyasala, Thodupuzah, promotional leaflet, n.d. 
143 Vaidyamadham, Shoranur, e-brochure, n.d. http://vaidyamadham.com/html/0700fram.htm 
144 Kairali Ayurvedic Health Resort, Palakkad, Promotional leaflet, n.d. 
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 Traditionalists like the Keraleeya Ayurveda Samajam 
continue to maintain old conditions of production, 
cooking medicines on Urulis (brass cauldrons) on 
firewood stoves, using wooden vats for fermentation, 
continuing to stick to specified firewood, and so on. The 
factory work space does not look any different from a 
large kitchen, of the scale typical of a wedding 
celebration. But such a model is difficult or rather 
impossible to adhere to in the context of large scale 
production. Interviews with production managers and 
R&D departments of medium and large scale 
manufacturers in Kerala reveal that though they have 
yielded to the inevitability of change, they struggle to 
minimize the impact in various ways. Firstly, they try to 
get machines to mimic many of the traditional processes. For example, motors are fixed to traditional 
instruments like hand-pounds for crushing material and ammis (flat stone grinders) for wet-grinding 
pastes rather than switching to conventional grinders145. Secondly, they try not to divert from classical 
procedures; no attempt is made to make use of technology  that could potentially alter the consistency 
of the end product, despite the temptation to reduce time and increase production capacity. For 
example, sticking to a 30-40 day cycle to get the pills ground or Arishtas fermented by refusing to use 
technologies to accelerate fermentation of Arishtams and Asavas146, keeping the mechanical flat 
grinder speed in check to match the traditional manual speed, continuing to produce hand-made 
shapeless pills along with the blister-packed modern tablets147 and so on. ‘Progressive’ manufacturers 
from other parts of India would no doubt consider this a hide-bound mindset that impedes the ability to 
move forward with the times.  
                                                 
145Comparable to people’s preference to have grinding stones fitted with mortars for wet grinding than using blenders. 
146 Though they incorporated high-speed centrifugal technology for speeding up the process of sedimentation that substantially 
reduced the turnaround time of Arishtas and Asavas.  
147 Certain other preparations, especially medicinal oils that need potentiation take longer time. For example,  Ksheerabala – 101 
Avarti (potency), that is 101 repetitions of the process takes 3-6 months. 
Kitchen-factory images 
Source: Kerala Ayurveda Samajam 
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But the industry in Kerala like elsewhere can still be blamed for displacing traditional 
production, and a case can be made for the authenticity of hand-made medicine, but  the metis that 
needs attention in the ayurvedic context is a far more complex level of knowledge. In cooking for 
instance, it is the chef’s metis that we are concerned with; it matters less whether the vegetable is 
chopped by hand or in the food processor, whether the material is ground by hand or by the blender. 
The chef in the ayurvedic kitchen is not compromised as long as the ayurvedic doctor continues to be in 
charge of product design and supervision of production. Relationship between clinical experience and 
medicine making is an important component of ayurvedic practice. Unlike biomedicine where research 
is produced by specialists employed by large institutions, in Ayurveda, knowledge is produced by 
practitioners in clinical settings. Their individual experiences draw upon collective experience, and 
then feed back into collective experience thereby adding to the collective repository of knowledge. 
This process is subtle and intangible, not something that yields to quantification or documentation. 
Firstly, though there are botanists and pharmacologists in the factories, ayurvedic doctors continue to 
play an important role both in medicine design and production, and consequently, humoral logic 
continues to play a role in thinking medicine ‘inside the factory’. Secondly, most small and large 
manufacturers in Kerala, as discussed in Section 2.11, are closely involved in treatment. Though the 
production manager himself is not involved in treatment, the process of thinking medicines happens in 
the interaction between the researchers  in R & D departments (includes ayurvedic doctors, botanists 
and pharmacologists) with doctors in the hospital. The day to day clinical experience of doctors feeds 
into the making of medicines which does not factor into the R & D cost. This is often ignored by those 
who use biomedical standards of comparison, and reprimand Ayurvedic manufacturers for low R&D 
investment. A methodology would have to be devised to take into account the collective clinical 
experience of the organization feeds back into medicine production.148  For example, the Director, R&D 
of Oushadhi, Dr. Sheela Karalam, is a government Ayurvedic Senior Medical officer on deputation with 
26 years of clinical experience. Even today she works as doctor-consultant in two ayurvedic 
pharmaceutical agencies besides being engaged in home-based private practice. Oushadhi’s 
antihyperlipidemic drug was based on her clinical experience. Over the years of treating patients, she 
                                                 
148 In the case of open-source systems like Wikipedia or Linux, the R&D cost is measured in terms of man hour input.  
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had found two classical decoction powders to have remarkable lipid lowering efficacy. Given the recent 
demand in the market, she thought it would be ideal if these were converted into a convenient 
combination pill format. She used the knowledge of phytochemistry to identify and narrow down the 
main ingredients and then based on ayurvedic pharmacological attributes, added garlic and curry 
leaves for their ability to unclog arteries. And then they followed the usual procedure of drug 
designing, including clinical trials to eventually to arrive at blister-packed tablet Lipocare.  
In small scale operations, the vaidyan is in control of everything including sourcing, but in large 
scale operations, certain processes get divided – sourcing of material is left to the marketing group. But 
for this aspect of metis (location and habitat of the herb), the ayurvedic doctors as production 
managers in large factories are closely involved in all other aspects of medicine-making. During the 
course of an interview with Dr. K. Satheeshnath, the Deputy Production Manager at Oushadhi, I saw 
him doing a careful visual, tactile, olfactory and taste test of samples that kept pouring in every few 
minutes. He confidently assured me that he could identify and recognize quality differences of all raw 
material used, which is around 600 individual ingredients including around 300-350 plants.  
The use of organoleptic measures both in checking the quality of raw ingredients, and in the 
cooking of end products continues to be critical in production. In the following excerpt from an 
interview, Dr. T. S. Muraleedharan, the quality control scientist of AVS talks about the traditional 
parameters and the pressures brought in by the new regulations,  
The process of standardization is alien to us and culturally we have very different parameters of 
looking at food and medicine. Take this example of what happens in a typical household. If the 
pickle gathers fungus, the typical housewife just scrapes of the upper part and uses the rest 
nonchalantly. This signifies the typical Indian approach… I am not justifying, but an average Indian 
takes things in stride. The philosophy of GMP (Good Manufacturing Practices)149 is a heavily 
influenced by high technology intensive modern medicine, which those systems can easily afford 
because of their high margins…Classical texts have concepts of bhasma, of rekha pooritham: as 
fine as to fit on the lines of fingers, Tantupuritham – the consistency of a thread, all which are 
relatively subjective, personalized parameters which are considered no more valid. The 
government has come out with pharmacopeia standards for ayurvedic formulations that talk about 
certain physicochemical parameters. We have been so far using organoleptic parameters. In 
Ayurveda where we have a product which uses 115 ingredients of herbs that go through various 
processes of cooking (we in fact always call our factory as our adukkala, i.e. kitchen) we really 
don’t know what the final product contains chemically, its efficacy and action profiles150. 
                                                 
149 Good Manufacturing Practices (GMP) as a central policy measure to streamline manufacturing of indigenous medicines was 
first conceived in 2000; it was implemented in phases and eventually made a mandatory requirement for manufacturing license.   
150 Interview with T.S. Muraleedharan, Chief Technician, Arya Vaidya Sala, Kottakkal, 07/10/2006. 
 148 
 
He is referring here to the standards being established for ayurvedic single drugs and formulations. 
Ayurvedic Pharmacopeia of India has established standards for 540 single drugs, 101 formulations, and 
Ayurvedic Formulary of India for 635 formulations. However, dissatisfied that the standards do not 
satisfy regional differences in practice, the manufacturers continue to stick to in-house standards 
established over several years of practice. Following the requirements of Good Manufacturing Policy 
(GMP) imposed by the State since 2000, manufacturers have instituted quality control procedures like 
microscopic examination and chromatographic test of raw material, and chemical testing of the end 
product for moisture and microbial levels151. Standard operating procedures (SOPs) are created and 
displayed on factory floors. But as of now, these procedures supplement the organoleptic processes 
rather than displacing them. Threat to metis in the factory would arise if operations get automated to 
the extent that organoleptic methods in medicine making are no more relevant. Most of the large 
manufacturers outside Kerala have already moved into that kind of a setup152. Now Kerala is also 
witnessing the rise of modern and ultra-modern factories. AVS has set up a new factory at Nanjangud 
to make proprietary products (2009-2010). AVP has progressed to the next step of complying to the 
WHO GMP with an eye on the export market153 (2008-2010). 
In Kanjikode factory we are manufacturing Traditional Kerala Type medicines in the traditional 
way of processing (all classical forms including new forms, decoction tablets and soft-gel 
capsules)…In our second factory at Thennalipuram we are manufacturing only proprietary 
medicines (syrup, hard gelatin capsules, granules, hair oil, cream and ointments and ayurvedic 
transparent soap). Now we have started…a new Factory…as per W.H.O G.M.P specifications154  
4.2.3 Limitations of classical-product centric commodification in deskilling the practitioner 
The significance of medicine making to the process of innovation does not mean that all 
doctors have to make medicine. Historically there were many practitioners who limited their practice 
to prescription. However, their prescription was predominantly in the form of raw drugs, and hence 
they had an active role in designing medicines, though this often meant minor modification in classical 
formulas. These were done taking into account various variables, patient’s constitution, particularity of 
                                                 
151 As of now, heavy metal testing is limited only to export products. Though there is pressure on the industry to do it for 
domestic distribution, they argue that it would make medicines too expensive.  
152 As narrated by two R&D staff from Kerala companies who had visited large manufacturers’ factories in North India. 
153 As learnt from personal interview of Head, R&D Department. 
154 AVP, ebrochure, http://www.avpayurveda.com/ayurveda/avp-manufacturing-unit.html. Accessed on 12-08-2012. 
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disease,  economic considerations and so on. Today, there is a danger that the doctor might 
increasingly lean on standardized formulations available in the market.  
However, it is important to note that the industry producing classical medicine per se need not 
deskill the doctor. Despite a century of industrial commodification, it is common to see practitioners in 
Kerala following the traditional style of practice that involves prescribing standardized formulations in 
combination with raw drugs. Doctors also prescribe raw drugs for decoctions unavailable in the market. 
Here are two examples:  
1. When Savitha consulted the doctor for digestive complaint, she was prescribed two classical 
formulations (one lehyam, one decoction) and a combination of seven raw drugs to be boiled 
and consumed with butter milk. The doctor was part of a traditional establishment in Palakkad, 
that had facilities to mix medicine combinations and also to dispense some of the raw drugs. 
The patient was asked to personally source two ingredients from her surroundings, curry leaves 
and the bark of drumstick tree.  
 
2. When arthritic patient Susheela went to the doctor she was prescribed three classical 
formulations (two  decoctions, one topical application), one proprietary formulation. She was 
also asked to consume a decoction of four fresh medicinal herbs. This government doctor who 
practiced in rural Ernakulam is an average Kerala practitioner who studied in the Arya Vaidya 
Sala. She chose to do Ayurveda because it matched her credentials, not because of any 
particular passion. She does not have a traditional family background nor does she come across 
as a particularly classical-oriented doctor. In fact, she is among the growing breed of modern 
doctors who are not shy of being profit-oriented. Like many government doctors do, she has a 
thriving home based private practice that brings her more than double her government salary. 
In her prescriptions, she mixes and matches classical medicines, proprietary medicines, raw 
drugs and therapy keeping in mind both therapeutic requirement and budgetary constraints.  
These two disparate examples point out that it is not only the first kind of traditionalist 
vaidyan who sticks to the classical tradition of prescription, but it has been the style of practice of an 
average doctor in the regions that I studied. Note that I am focusing only on  medicine and treatment 
practice here, as far as diagnosis is concerned there is substantial difference between first generation 
schooled practitioners and lineage based practitioners. The former are conversant with the biomedical 
understanding of the body and disease and use it either as parallel system of knowledge to draw from 
or just to satisfy a section of patients who are not conversant with Ayurvedic thinking. 
On the other hand, a move away from classical to the ethical/prescription product market can 
directly lead to deskilling of the doctor155. Given that prescription products are typically standardized 
to match biomedical parameters of evidence, such a shift can also adversely affect the humoral 
                                                 
155 As discussed in chapter 2, proprietary commodities sidelined and thereby jeopardized the role of the ayurvedic doctor.   
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framework of ayurvedic clinical practice. This is somewhat comparable to the effect that a proprietary 
seed may have on a farmer’s cognitive and practical skill involved in developing new breeds. But in the 
ayurvedic context, the industry has an additional potential to endanger the original skill holders by 
shifting allegiance to a different set of actors, the biomedical doctors. The discussion in Section 2.2 
showed that such a shift and consequent deskilling of the ayurvedic practitioner had already occurred 
in rest of India.   
An observation regarding the gradual change in the mindset of new generation doctors in 
Kerala towards an increasing preference of prescription medicines, was made by some respondents 
(both practitioners and manufacturers), and also voiced by practitioners in various public forums (for 
example, Agnivesh 2003, 2011). Such changes also correspond to shifts in consumer preference towards 
convenient and palatable medicine. There are several different factors that contribute to increasing 
importance of proprietary product consumption in Kerala.  
1. Practitioner-driven change – Some of the respondents attributed the attitude change among doctors to 
the proliferation of private ayurvedic colleges and self-financed education. Allegations of poor quality 
have been leveled against the new self-financing colleges (Kunnathoor 2012). This allegedly produces 
doctors with poor classical medicine knowledge, besides  making them vulnerable to industry incentives. 
 
2. Consumer-driven change: Two common trends in consumer-driven change  are:  
 
Generational change in attitudes towards medicine, that is younger generations in households that were 
earlier loyal consumers of classical medicines are shifting towards convenient and palatable products, 
eroding the loyal classical consumer base.  
 
Influx of new consumers: Ayurveda is drawing a new category of patients either because of its new-found 
popularity or/and the changing disease profile. These patients tend to be similar to patients outside 
Kerala in that they bring with them with their diagnostic framework of biomedicine (for example, Nisula 
2006, Naraindas 2006) and are unfamiliar with classical medicine. I have come across many instances of 
ayurvedic doctors having problems of patient compliance owing to this reason. For example, doctors 
commonly repute patients reluctance to consume ghee based medicines due to increased association of 
ghee and other fats with ‘cholesterol.’ 
 
3. Manufacturer-driven change: Increased brand value of Kerala Ayurveda has led Kerala-based 
manufacturers to expand their focus outside Kerala. This has led them to tailor marketing strategies to 
meet outsider consumer needs, some of which also get carried on to the home market. Saturation of the 
Kerala classical market (mainly due to manufacturer crowding) also is an impetus for manufacturers to 
move to unconventional segments. To a certain extent, manufacturers also make changes to meet 
expectations of being progressive and technology-savvy (see for example Section 9.1).  
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4.3 Role of modern institutional homogenization in deskilling the vaidyan 
4.3.1 Scientization of Ayurveda: opposition to local variation 
The revivalist ideologues who shaped modern Ayurveda (See Section 3.2) heavily relied on the 
rationalist antiquity in their attempt to defend Ayurveda as a ‘science’.  In defending Ayurveda from its 
detractors who used biomedical standards to dub all other systems of medicine as unscientific, they 
subconsciously accepted the parameters of positivist science. In doing so, besides compartmentalizing 
identities (Ayurveda/Siddha/Unani), they moved away from practiced medicine156 (Leslie 1976).  
Institutionalization of modern Ayurveda led to the development of a ‘professional Ayurveda’, or as 
Langford calls it a ‘parallel science.’ Ironically, just as biomedicine looked down at other systems of 
medicine as unscientific, Ayurveda strived to separate itself from the rest now considered as ‘folk’ 
systems. This process began in mid 19th century with the colonial translation of Indian medical 
knowledge of botanicals,  which accepted the empirical validity of knowledge, but discounted 
ayurvedic theory on grounds of epistemological supremacy of European ‘science’ and incorporated 
Indian knowledge by way of translation into ‘English’, a process that Wolfgram (2009) calls ‘primal 
baptism.’ The colonial approach was carried forward by the elite leadership whose views were 
formative in policy making (Bala 2012). This is not surprising because, “the emergence and existence of 
India is inseparable from the authority of science” (Prakash 1999). The hegemony of biomedical science 
and its role in shaping ayurvedic discourse and practice has got much scholarly attention from 
historians of medicine (for example, Kumar 2000, Bala 1991).  
Two distinct approaches can be identified in the modern reconstruction of Ayurveda as a science.  
1. One which challenges the monolithic biomedical view of science and holds Ayurveda as a 
science in its own right.  
2. One which accepts the universality and superiority of biomedical parameters of science, argues 
that such ‘scientific’ principles are inherent in Ayurveda and holds that attempts should be 
made to make them explicit using the language and methods of experimental science.  
The first is a minority position, held by staunch advocates of Shuddha (pure) Ayurveda. It is the 
latter view held by the mainstream majority that has led to the project of ‘scientizing Ayurveda’, 
which involves translation of ayurvedic concepts in biomedical terms and validating medicines and 
                                                 
156 Leslie (1976) termed the medicine in practice as ‘traditional culture medicine’ distinct from the imagined rationalistic system 
rooted in a classical past. 
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protocols using biomedical standards. Wolfgram (2009) points out that ‘ primal baptism’ shifted to 
‘telescopal baptism’ in early 20th century when the focus shifted from the plant to its constituents with 
the ascendance of chemical pharmacology. Today, the project of ‘scientization’ is well established. It 
revolves around randomized clinical trials and pharmacological evaluation of medicines and plants. The 
‘cultural authority’ of science (Prakash 1999:3) governs the official approach towards ISMs. For 
example, the apex body of ayurvedic research, CCRAS, focuses clearly on ‘scientific’, and 
‘experimental’ aspects of Ayurveda157, stating phyto-medical research as the fundamental requirement 
for the formulation of a new ayurvedic drug.  
The project of scientization has brought in a new set of stakeholders – scholars  from various 
modern scientific disciplines mainly ethnobotanists, ethnopharmacologists, and biotechnologists, some 
of whom overpower their ayurvedic counterparts. Though not all of those involved in this project 
reject the non-translatable parts of Ayurveda, the approach automatically sidelines elements that do 
not confirm to the standards of positivist science.  
 
 
 
 
                                                 
157 Three of the four objectives listed by Central Council for Research in Ayurvedic Sciences are 1. Formulate aims…of research 
on scientific lines in Ayurvedic system of medicine. 2.  Initiate, aid, develop, encourage and coordinate scientific research in 
fundamental and applied aspects of Ayurveda 3.Propagate basic knowledge and experimental measures relating to the cause and 
prevention of diseases and exchange information with other institutions with a similar approach.  
  
Presentation snapshots, Ayurvedic conference Thrissur, 2009 
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In the past decade, the project of translation has taken a new turn, led by a few scientists who  
have questioned the monolithic view of science158. This approach appears closer to the minority view 
that holds Ayurveda as a different kind of science but in terms of its intentions to translate, it is closer 
to the second. Arguing that reductionist science has limitations in interpreting holistic concepts of 
Ayurveda, these scholars borrow concepts from systems theory, genetics and other advanced sciences 
to design new methods of validation and interpretation. The most prominent of these are: system 
analysis of ayurvedic theory of physiology in terms of energy pathways (for example, the work of 
American physicist Alex Hankey 2005), biotechnologist approach correlating ayurvedic constitutional 
typology with genetic parameters (led by the proponents of Ayurgenomics, Patwardhan & Bodeker 
2008) and the use of nano-technology to validate ayurvedic mineral medicines (for example, 
Bhattacharya 2011).  
A good example for this 
synthetic thinking comes from the 
most prominent spokesman of 
Ayurveda today, Dr. M. S. Valiathan, a 
cardiac surgeon, former president of 
the Indian Science Academy, who also 
happens to be a native of Kerala. 
Having trained himself in classical 
Ayurveda post retirement, he has 
produced scholarly work on each of the three compendiums and is uniquely advantaged in speaking in 
both ayurvedic and biomedical languages. He spearheads teams of scientists working on advanced 
genetics and biology to decipher ayurvedic theory and medicine and delivers popular and charismatic 
speeches on the subject159.  He exhorts the ayurvedic community to be open to translation while at the 
same time he is sensitive to the limits of such translation. In 2006, the Indian Academy of Sciences 
(IAS) produced a decadal vision document authored by him, “towards ayurvedic biology.” In the 
                                                 
158 I am making this observation based on talks presented in five conferences of Ayurveda that I attended during my field work, 
Coimbatore 2008, Jaipur 2009, Thrissur-Kerala 2010, Bangalore 2011, Trivandrum-Kerala 2012. 
159 Source: speech delivered in National Ayurvedic Conferences in Bangalore 2011, Trivandrum, Kerala 2012. 
 
Dr. M. S. Valiathan’s talk ‘A science initiative in Ayurveda’ in 
the Global Ayurvedic Festival, Trivandrum, 2012 
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document he suggests that even if breakthroughs in science were to demonstrate the validity of 
ayurvedic concepts160, the truth will be still elusive because of the holistic nature of ayurvedic 
knowledge.   
This position appeals to both the camps, the purists and progressivists because it not only 
extends the translation project but also respects the theoretical foundation of Ayurveda. However, like 
the other two approaches it focuses on classical texts and ignores metis. Medicine in practice is messy, 
it not only varies substantially from the texts and lacks uniformity, it also includes various other 
elements like spiritual practices, magico-religious practices, astrology, and so on. Ethnographies of 
medical practice (Langford 1999, Travick 1987) have showed how practitioners creatively borrow 
elements from various bodies of knowledge including biomedicine. After all, this is what the classic 
Charaka Samhita had exhorted to do, to learn  from various other ‘Shastras’ (sciences). 
The science of life shall never attain finality… humility and relentless industry should 
characterize your approach to knowledge. Further one should learn without jealousy, 
excellence of conduct even from the enemies because for the wise he world is the teacher 
while for the unwise it is the enemy…Knowledge.. coming even from an unfamiliar source, 
should be respectfully received, assimilated and utilized. Charaka Samhita VS: 8:14, Sharma 
2000) 
Such verses are quoted often in ayurvedic circles, oftentimes from practitioners trying to deal with the 
cognitive dissonance that arises in moving away from what is perceived as “true Ayurveda”.  
Though the new scientific approach is sympathetic to Ayurveda’s philosophy and seeks to 
legitimize ayurvedic theory in the language of an alternative science, like the other two approaches it 
is in search of universal principles, for which local variation is always a handicap that needs to be 
eliminated. The usual targets are the imprecision in the naming and identity of medicinal plants, 
variation in levels of active ingredients in plant material used, and variations in ayurvedic formulae 
from manufacturer to manufacturer. The attraction and hegemony of theory over practice is not 
limited to the context of Ayurveda. Imperialism is inherent in the universalist assumption of science 
that leads to the delegitimization of metis, points out Scott (1998). This is comparable to various other 
                                                 
160“If modern biology were to discover a molecular identity of dosas, if plant sciences were to find a biological basis for the anti-
dosa effect of herbs, if the biochemistry and immunology discover a sequence of chemical and immunological changes brought to 
pass by Panchakarma, human and drosophila genetics demonstrate the anti-aging power of rasayanas, if chemistry reveals the 
existence of metals in nanoform in bhasmas… No matter how complete and accurate the scientific accounts might be, the whole 
truth would still elude them because Ayurveda is more than the sum total of scientific studies. Instead, the philosophical 
tradition of Ayurveda would demand that we conceive the reality of Ayurveda as a whole, which expresses itself  not only in 
scientific insights, but also in innate disposition…(Valiathan 2006: 34). 
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areas of traditional knowledge, for example, the privileging of “scientific” expertise over farmers’  
skill  (Stone 2010).  
 Very few scientists who come from outside experts are trained in Ayurveda, but their image as 
harbingers of science gives them enormous power to pass judgments and dictate terms to their 
ayurvedic counterparts. Though there is some resentment about this among a faction of ayurvedic 
practitioners (see section 9.7), it does not come out into the open because such scientists are seen as 
the ambassadors of Ayurveda that have the power to 
take Ayurveda to new heights required for 
 effective participation in the globalization project. In 
fact, it is the globalization project that is imposing 
new pressure on the need to establish standards in 
botanicals, medicines, protocols, and so on. There is a 
significant difference between local commodification 
and non-local commodification in terms of its impetus 
to homogenization. When the product targets local 
consumers, variation is tolerated because it is the 
existing demand that creates the market. But a 
different scenario results when the demand is created 
by an outside market which demands homogeneity of 
identity. Just as the various regional curries get 
dissolved into a single ‘curry’ formula when it is sold 
to the West, all regional versions have to merge into 
one to be sold to the outsider as representing what is 
construed as one single Indian Ayurveda.   
In his keynote address to the 2nd World Ayurveda Congress in Pune in 2008, Dr. R. A. Mashelkar 
the Director of Central Council of Scientific and Industrial Research (CSIR), the apex body of scientific 
research in India, emphasized the need for “integrative Ayurveda” and advocated the opening of 
 
Presentation snapshot 
Confederation of Indian Industry, Global 
Ayurvedic Business Meet, Kochi 2010 
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premier ‘International Institutes of Integrative Ayurveda (IIIA) in the model of IITs and IIMs. The call for  
 integration has become shriller with 
increasing attention to globalizing Ayurveda.  
Pordié (2010) provides a comprehensive 
evaluation of the effects of globalizing 
forces, demonstrating how therapeutic 
evaluation project of traditional medicines is 
heavily shaped by biomedical parameters of 
efficacy and evidence. With the example of 
an Indian practitioner of Tibetan medicine, 
he points out how three interests are salient 
in shaping this project  of scientific 
validation: 1. Financial interest: motivated by perceived market value of scientifically validated 
traditional medicine, 2. Quest for legitimacy: to prove to the world that a hitherto undermined 
‘traditional’ practice is efficacious. 3. Intellectual property protection: A perception that patenting is 
important to safeguard knowledge from outside threat also accompanied by the perception that IPR 
rights help in generating income  (not necessarily an informed view of the legal meaning of IPRs). 
Pordié is concerned that commercialization driven therapeutic efficacy regime will make the medicine 
more expensive and less accessible to common people. A similar issue is brought up by Sujatha 
(2011:115-123) who notes, “subsidies for the export of raw herbs, digitalization of plant resources, 
standardization of ayurvedic formulas, and integrative research on herbal ingredients are all measures 
meant to enhance the ‘safety’ of herbal drugs for the western consumers; they have little to do with 
Indian consumers for whom accessibility and availability is the criterion”. Lack of standards is often 
touted as the cause for Ayurveda’s poor share in the five trillion dollar global neutraceutical pie. A 
higher level government official in Kerala complained that use of different texts for the same 
formulation was a problem, that a consensus has to emerge among the industry about standardizing. 
He attributed the inability of ayurvedic manufacturers to penetrate western markets to lack of such 
Eying the much coveted Global Neutraceutical Pie: 
Presentation Snapshot Arogya Conference Thrissur, 2009 
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standards. The golden standard of comparison is China’s success in exploiting the international herbal 
market, which is attributed to its adopting ‘progressive’ strategies of standardization.  
China has successfully promoted its own therapies over the globe with a science-based approach…. 
Global acceptance of Ayurveda is gearing up ….The increasing use of traditional therapies 
demands more scientifically sound evidence for the principles behind therapies and for 
effectiveness of medicines” (Patwardhan et al  2005: 465).   
The authors point out that various approaches taken by China including standardizing raw 
material, agricultural practices, are essential “to raise the image of ayurvedic medicines in the global 
business” (Patwardhan et al  2005: 468). Accusations of heavy metal contamination by Saper (2004) 
acted as a single largest motivation for the industry to get organized. Mandatory heavy metal testing 
for export was implemented in its aftermath. This also led to a substantial emphasis on the ‘herbal 
image’ of Ayurveda, which benefited Kerala, which has an overly herb-centric pharmacopeia. The 
ayurvedic community again got into a defensive mood after Saper hurled his second accusation in 2008 
(Saper 2008). In his keynote address in the 2008 Ayurveda Congress, Dr. Mashelkar suggested how to go 
about facing such a threat.   
What we should do is put our own house in order . How do we do that? First, encourage clinical 
research in ayurvedic institutions; second, create a complete ayurvedic pharmacopoeia of one or 
even two thousand products…; third, create an effective surveillance system, like the post-market 
surveillance systems for other traditional systems, including support from modern laboratories 
spread all over India; fourth, we must carry out multi-centric trials of ayurvedic biology; fifth, we 
must establish a presence in international scientific journals. There is no point in shouting; there 
is no point in getting angry. We must have a very strong presence in the world’s scientific 
journals…..(Mashelkar 2008: 369) 
An additional motivation comes from the need to protect this valuable knowledge from being 
taken away by others, the most cited issues being the western appropriation of yoga and the turmeric 
patent. Dr. Mashelkar, who had taken the lead in taking legal action against the US in the turmeric 
patent emphasizes on the significance of protecting ayurvedic knowledge from being misappropriated.  
Most often those involved in the scientizing project are not consciously against metis, but they 
tend to focus more on textual knowledge. Dr. Madan Thangavelu is a genome biologist researcher from 
Cambridge University who spoke in a recent conference in Kerala 2012. Expressing awe of ancient 
ayurvedic science which helped him to find the missing details in the theory of biology, he says,   
It was shocking that the knowledge and awareness about these ancient texts were virtually nil 
among people in Kerala, which was said to be the land where Ayurveda had its birth….It is also a 
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matter of concern whether in these times there are clinicians or qualified vaidyas who can 
interpret the wisdom in these texts correctly (Italics mine).  
Besides mistakenly identifying Kerala as a “land of birth” of Ayurveda, Dr. Thangavelu ignores 
the presence or significance of practical knowledge. Instead of considering the possibility of texts 
having drawn their strength from practical knowledge, he assumes a natural precedence and 
superiority of textual knowledge vis-à-vis practice.  
Medicines and clinical protocols are constantly improvised by doctors which may not always get 
formalized, but that does not mean it is less valid or that it does not exist.  This “partisan knowledge” 
is embedded in the holder’s passionate interest in a particular practical outcome in contrast to 
‘generic knowledge’ (Scott 1998). Scott points out that practitioners of metis do not pause long to ask 
why and how it worked, to define the precise mechanism of cause and effect; the intention is not to 
contribute to a wide body of knowledge but to solve the problem at hand. This problem solving 
approach is what ultimately leads to innovations, unlike the biomedical lab-centirc drug discovery 
process. In farming for instance, the invention and adoption of agro-scientific knowledge is deeply 
embedded in daily productive activities and socio-cultural interactions (Stone 2010). ‘Partisan thinking’ 
might appear to those who are in the effort to ‘scientizing’ Ayurveda as being un-systematic, 
unsophisticated, inconsistent. The founder of AyurVAID (Kerala based chain of hospitals established 
recently with American philanthropic venture funding), has put in enormous efforts to develop a 
standardized diagnostic format in line with the principles and guidelines laid out in classics. He finds 
fault with my use of the adjective ‘traditional’, emphasizing on the ‘scientificness’ of Ayurveda. He 
argues that ayurvedic doctors seldom go through the diagnostic steps systematically, which, he argues 
impedes transparency in clinical practice. His aim in developing the diagnostic format is to institute a 
systematic and transparent procedure, with a combined objective of documenting clinical evidence. He 
terms this approach as ‘process-driven ayurveda’, a slogan that was initially widely used in advertizing 
the hospital brand. While this approach has its own merits, it is important to understand why doctors 
do not go through the steps systematically. Doctors are not oriented towards documenting and 
generating evidence, because they are preoccupied in solving immediate health problems of patients. 
“The litmus test for metis is practical success”(Scott 1998: 323). Plans to make a systematic diagnostic 
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format, while may be extremely useful in some ways, might impede the efficiency of the doctor who is 
forced to give primacy to procedure rather than insight and intuition. Such diagnostic processes are 
often too messy to be translated in standardized language, naturally not transparent to an observer, 
and might be often a subconscious process even to the doctor.  
The Ayurveda Vs Science debate has been directly addressed by Trawick (1987) who defends 
Ayurveda  against the accusation that ‘traditional’ systems of thought are relatively less open to 
external challenges than modern scientific thought, based on the ethnography of a single ayurvedic 
physician. The physician in his search for the origins of disease consulted varied bodies of knowledge 
besides Ayurveda including Siddha, allopathy and folk medicine, referring to texts in various languages, 
Sanskrit, Tamil, Malayalam and English. Trawick points out that the physician,  
“puts the principles of these texts to work precisely by treating them as, in themselves, 
incomplete… In treating patients, he had a wide range of explanatory models of health, disease, 
and healing and a wide range of therapies to choose from. He avoided dependence upon a small 
set of rigid categories into which to force individual cases, and he treated patients with creativity 
and with sensitivity to their particular experiences of illness (Trawick 1987:1036).”   
Responding to the allegation of the Kerala Shastra Sahitya Parishad (a powerful organization 
from Kerala nationally known for its radical rationalist pro-science activism) that ayurveda is not 
scientific because it is considered divine and stagnant, one of the most renowned ayurvedic 
practitioner-scholars of Kerala demurs that such allegations are made by those who are distant to 
ayurvedic practical realities. He states that in his own 50 years of practice, he had never come across a 
view in any text or scholarly forum that held classical texts as divine or unchangeable. To illustrate 
how historically ayurvedic textual ‘redaction’ was renovation rather than re-writing, he cites 
Vagbhata’s quotation  yuganurupa sandarbho vibhagena karishyate – “I am writing this to suit the times 
and the examples which are contemporary, explanatory including new subject 
categories.”(Thirumulpad 2007: 35-36).  
Both Trawick and Thirumulpad are essentially emphasizing on the significance of practitioner 
metis in Ayurveda. Variability is Ayurveda’s best defense against  the accusation of it being static and 
unresponsive to new knowledge. “It is in fact the idiosyncrasies of metis, its contextualness, and its 
fragmentation that make it so permeable, so open to new ideas. Metis has no doctrine or centralized 
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training; each practitioner has his or her own angle (Scott 1998:332). Ironically, it is this “variability” 
that the ayurvedic community has attempted to shove under the carpet to confirm to expectations of 
standardization and homogeneity. The danger of this approach to metis is noted by Nichter, 
“Bioscience may diminish the importance of local practical knowledge not just by ignoring or 
suppressing it, but by appropriating and circumscribing funds of knowledge through acts of 
codification, standardization and theoretical unification” (Nichter 2006: 367).   
4.3.2 Formalization of education: disruption in the transmission of metis 
Unlike farming, in the deskilling of the ayurvedic vaidyan the industry has a minor role 
compared to the institution that is responsible for the skilling. As I pointed out earlier, the key 
difference between the cotton farmer Vs ayurvedic doctor is in the skilling process; farming is acquired 
informally by practice whereas the latter has a significant formal instruction component.  The 
traditional space of transmission of ayurvedic knowledge was the gurukula, i.e., residential master-
disciple mode of education taking place in the Guru’s house or in a space attached to Guru’s house. 
Formalization of ayurvedic education shifted the space of knowledge transmission from the Guru’s 
house to institutions where gurus were employees and the Guru-disciple relationship was therefore, 
impersonal and transient. Early attempts towards formalization began in late 18th century with the 
setting up of patashalas (schools), somewhat in lines of the gurukula  system.161 Though early 
education was modeled more in the lines of gurukula, the Court Physician appointed by the British in 
the Travancore kingdom intervened to influence a new kind of socialization that included instruction in 
modern physiology and anatomy (Wolfgram 2009). The next step was formalizing a curriculum and 
giving out certification in the form of titles akin to degrees162.  
                                                 
161 The first such institution was established in 1889 by Parameshwaran Moos in Trivandrum. Around 15 students were trained 
yearly. In 1902, Arya Vaidya Samajam an association of physicians came into being Calicut. It was patronized by the kings of 
Travancore and Cochin and Calicut and some of the most important vaidyans in the region. In the same year, another important 
organization called the Keraliya Ayurveda Samajam was started under supervision of eminent physicians. Before setting up of 
patashala, Samajam conducted early exams in three towns to award degrees to deserving practitioners. In 1913 a Sanskrit 
patashala was opened in Tripunithara by the Cochin Royal family.   
162 The Ayurveda Patashala in Trivandrum was taken over by the Government of Travancore. In 1910 the college began to impart 
a five-year regular course and those who completed the first four years were awarded LMC (Lower Medical Certificate) and those 
who completed all the five years were given Higher Medical Certificate. From 1917 onwards the degree course was titled 
Vaidyakalanidhi. Similarly the Keraliya Ayurveda Samajam began to award the diploma course Vaidyapadan. The Tripunithara 
Patashala began to give Vaidyabhushan degree. In 1925, Madras School of Indian Medicine began to award the degree Licentiate 
in Indian Medicine (LIM). In 1957 a special initiative was taken up by the Health Ministry to streamline the subject content of 
Ayurvedic courses in the State. Following this, ‘Diploma in Ayurveda’ (DAM) was awarded to those who completed the course. 
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With the establishment of Central Council of Indian Medicine (CCIM) in 1970, the transmission 
of ayurvedic knowledge came to be governed by a central regulatory authority. The CCIM drew up a 
uniform curriculum for the entire country, for the award of the degree Bachelors of Ayurvedic 
Medicine and Surgery (BAMS). This 5 ½  year program163 has become the single point of entry to 
ayurvedic practice. With certification of professionals becoming institutionalized, knowledge and 
practice outside institutions have been delegitimized and the traditional channel of knowledge 
transmission disrupted. In the struggle between purists (Shuddha Ayurveda) and advocates of an 
integrated system, the latter emerged victorious. Elements of biomedicine were integrated into 
ayurvedic education, including instruction in modern anatomy and physiology. This brought in a 
fundamental change in the socialization of the practitioners. Though this led to a subsuming of 
Ayurveda within allopathic paradigm in rest of India, leading most Ayurveda graduates to mix allopathic 
medicine in their practice, Kerala maintained what is best described “medical parallelism” that 
required practitioners to cultivate a “dual subjectivity”, that is, “comparable expertise in both 
disciplines” (Wolfgram 2009: 158). The extent of practitioners’ engagement with biomedical knowledge 
varies considerably, but it remains at the diagnostic level; treatment has stayed within the classical 
ayurvedic framework.  
The centralized framework also required standardization of curriculum which not surprisingly, 
worked against regional traditions. This is recognized by a reputed practitioner-scholar of Kerala, 
The kind of ayurvedic education which was in Kerala 50 years ago was just to suit the 
requirements and specialties of Kerala. In the beginning of formal education in Kerala, curriculum 
was centered around Keraleeya tradition, and parallelly a paramparya (traditional) system was 
also co-existing outside the institutional system. ….keraleeyata (the kerala-ness) of the  treatment 
tradition that evolved to suit the local realities (kaladeshochitha) was lost. Ashtanga Hridayam 
that was the basis of all the treatment in Kerala was removed from the curriculum. Medium of 
education became English (Tirumulpad 2007:35-36). 
I argue that centralized institutionalization of ayurvedic education and transition from the 
apprentice system to  modern education system was more damaging to ayurvedic metis than 
industrialization. It endangered transmission of metis in three significant ways.  
 
                                                 
163 Admission to the course was later limited to those who had studied biology at pre-degree level. 
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4.3.3 It created a break in the traditional channel of knowledge transmission 
Forcing the multiple community and regional traditions into a single centralized universal 
education system that cannot handle regional variations is the greatest disservice to ayurvedic metis, 
and therefore to local collective knowledge accumulated over centuries of experimentation. This 
attitude towards knowledge that favored  institutional education over informal learning and exchange, 
has also affected other areas like agriculture (Stone 2010). Inability to comprehend the value of 
knowledge that is not certified by prestigious institutions, privileging text over practical knowledge, 
(Scott 1998) are some of the common faults of the modern educational paradigm.  
In the early years of formalization of modern Ayurveda for metis-dense branches (for example, 
Marma, toxicology and eye-treatment), ayurvedic institutions in Kerala had used practitioners from the 
traditional background. Illustrious vaidyans without degrees were appointed as professors in reputed 
medical colleges. For example, a traditional Siddha Marma practitioner was appointed as a professor in 
Trivandrum Ayurveda College. One of his recipes for wound treatment (Murivenna), adapted and 
popularized  by the college continues to be 
the most important of all medicines in 
Kerala (Kerala Ayurveda Limited 2011). A 
small, but locally reputed doctor-
manufacturer I interviewed, said that his 
proprietary pain oil was based on a secret 
formula obtained from such a Marma 
vaidyan who was a visiting professor in the 
Trivandrum college hospital where he was 
doing internship in the mid-60s.  
With the freezing of registration for informally trained practitioners in the 70s, those outside 
the system got delegitimized164. Today, spaces and channels to bridge the traditional and the formal no 
more exist; the formal is assumed to have absorbed the traditional making the traditional irrelevant 
                                                 
164 In 1973, hereditary practitioners of Ayurveda were given chance to appear for an examination and on passing the examination 
were given ‘A’ class registration. Those who did not were denied the license. 
 
Annual joint regional conference of various unlicensed 
traditional practitioner associations, Ernakulam  
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and illegitimate. Transmission in the traditional style however continued outside formal institutions 
responding to popular demand for services. With increased symbolic value of Ayurveda, conflict 
between formal and informal streams has escalated; allegations of quackery have become more 
strident. Scott (1998) points out that the binary opposition between science and metis was an outcome 
of a history of competition between the institutions and personnel that sprang among these two forms 
of knowledge. In fact, I began my very first day of my field work in Kerala, in Feb. 26, 2008, with the 
witnessing of a state-wide ayurvedic dharna (sit-in) (see image). The central agenda was to protest the 
step-motherly treatment meted out by the State to Ayurveda (vis-a-vis allopathy). Another issue that 
some of the speakers were most concerned with was the increasing incidence of “vyaja vaidyans’  
 (quack doctors). The conflict between the 
degree holding practitioners and the paramparya 
vaidyans came to a head in early 2009 when the Kerala 
government allowed a relaxation of registration 
requirements favoring the latter in a notification dated 
June 4th 2009. On July 2nd 2009, Ayurvedic Aikya Vedi, a 
joint forum of students and teachers, went on a state 
wide agitation demanding a repeal. After a protracted 
battle that went on for two years, the government was 
forced to relent following orders from the Center and 
later from the Kerala High Court. A commission was 
constituted to evaluate claims of traditional 
practitioners and award license to genuine 
practitioners.  
  
Ayurveda Dharna (Sit-in), Collectorate office, 
Ernakulam  
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4.3.4 Shift in emphasis from practical learning to classroom instruction165  
A major difference between formal and traditional education is that the latter was more hands 
on. In the modern ayurvedic college, the primary identity of faculty derives from being classroom 
instructors rather than practitioners. They earn their livelihood from salaries paid by the institution and 
do not have the compulsion to establish a successful practice. Contrary to this, the gurukula was a site of 
active ayurvedic practice – including treatment and medicine making. Education was just a part of the 
whole set up, wherein instruction in classics would supplement practical education, and the students 
contributed to the establishment with their knowledge and skills. An illustration of such a gurukula is 
provided in biography of AVS founder.  
While examining a patient and deciding on the course of treatment…the guru would quote a 
verse from the chapter where the kind of symptoms the patient had were described and then 
cite the yogam, the specific formulation used to process the medicine for those symptoms. The 
student was expected to situate the verse in the chapter it belonged to, and be able to make 
up the medicine according to the formulation mentioned in it. A strict guru would often refrain 
from repeating the verse, if his student had not been quick enough to grasp it. Periods of study 
varied and so did their intensity; often, students could learn far more from a practical session, 
watching their guru examine, diagnose and prescribe than from hours of learning a text by 
rote.  Alertness, sharp observation, an ability to consistently relate verses from ancient texts 
to practical modes of application; these were the qualities that gurukula disciple had to train 
himself to develop (Krishnankutty 2001: 23).  
Formal education gave more importance to theory and less to medicine-making or medicinal 
herb identification, though both continue to be part of the curriculum. One major constraint is that of 
the time span. A traditional practitioner typically began learning from early childhood if the learning 
was within the family or at an average age of 12 under a Guru. It would take several years of 
apprenticeship before emerging as an independent practitioner. Before getting exposure to theory, 
they would be acquainted with a considerable amount of practical education including identifying 
herbs, medicine making, observing and participating in the diagnostic process. For students who came 
to medical college without any knowledge of Sanskrit or previous background of Ayurveda or medicinal 
plants, the five year term is too short to accommodate more than superficial exposure to all these 
areas of knowledge. The average formally educated ayurvedic doctor is therefore considered deficient in 
practical knowledge, especially, of plants and medicine making. This difference is often emphasized by 
                                                 
165 Discussion in this section is based on Based on narratives of traditional practitioners and of formally trained doctors from 
traditional practitioner families who were familiar with both formal and non-formal systems combined with information from 
speeches and discussions in conferences, and from secondary literature, biographical and historical work.  
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those who are familiar with the traditional system of education, traditional practitioners and formally 
educated practitioners who come from practitioner families166.  Raw-drug shop keepers too have a lot to 
say about this distinction without asking, especially because it is the decline of traditional practitioners 
that had affected their business. Interestingly, an awareness of the shortcomings of modern schooled 
practitioners is also widespread in popular culture167.  
But modern formal curriculum co-evolved with the industry; the centralized curriculum was 
formulated almost half a century after industrial production. In Kerala for instance, the founder of AVS 
was influential in formulating a formal educational program, shaped by his own good and bad experiences 
with the gurukula system.168 When AVS started industrial production in early 19th century, early 
attempts of formalizing ayurvedic education was already in place. The Arya Vaidyan Diploma awarded 
by AVS created a network of vaidyans who naturally became its extended arms. For Varier, it was part 
of institution building and strengthening of Ayurveda, formalizing it, creating a certification process, 
manufacturing medicines.  Did the interests and perceptions of the industry play into what was expected 
of the doctor? It is not easy to answer this question, it would require a careful historical analysis of the 
process of formalization of education169.  
Whether the industry had a hand in deemphasizing medicine-making in education or not, it is 
likely to have benefited from the decline in medicine-making skills of practitioners. In the pre-formal 
period majority of students came from traditional practitioner backgrounds, already exposed to 
medicine-making at home. Post 70s, with the expansion of formal education, there were more and 
more people coming from non-traditional backgrounds who did not have the advantage of traditionally 
                                                 
166 For example, an unlicensed eye specialist vaidyan who had studied from a traditional gurukula had an interesting story to tell. His 
father had sent his elder brother to a formal Ayurvedic system and he wanted to send him to a traditional gurukula to complement 
his education so they could practice together. His (late) brother’s scholarship and qualification and his own expertise in medicine-
making went very well, and they together set up a small clinic and vaidyashala. 
167The agricultural scientist who has no experience with soil advising the farmer is often caricatured in Malayalam movies. 
College educated Ayurvedic doctors’ plant knowledge similarly looked down upon. Not only traditional vaidyans and raw drug 
store keepers, knowledgeable consumers too harbor such images. Mary, a retired teacher in her mid 60s in central Kerala can 
recognize all the plants in her surroundings. Talking about her Ayurvedic doctor sister who was a high level official she said, “She 
may be an Ayurvedic doctor, but what does she know about plants, she studied in a college!”  
168 An  episode of carrying a heavy load for a guru without adequate food made him ill disrupting his studies for six months, but he 
was a dedicated disciple and, far from protesting, he enjoyed his privileged since it gave him greater opportunities to be with his 
guru, to observe and to learn from him (Krishnankutty 2001:24).”  
169 The Pathshala that P. S. Varier was designed to combine the best of old and new systems, as were the most pre-modern formal 
courses of training mentioned earlier. A close investigation will be required to identify the nature and manner of departure from 
‘the best in gurukulam method’.    
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acquired metis170. Formal training created more demand for ready manufactured medicines, and 
expansion in agencies.171 The agency distribution model (as discussed in Section 2.10),  took shape in 
the 40s and 50s, took wing in the 60s and continued spiraling in growth after the 70s, with the 
expansion of formal education. Some say the growth peaked in the 80s, some say it peaked in the 
90s.172 Agencies continue to expand as more colleges open and more doctors are churned out.173 
Manufacturers prefer doctors as agency owners, for they naturally draw more clientele. For the 
institutionally trained doctors with less hands on experience, the margins they get on dispensing 
factory-made medicines appear far more lucrative in relation to the drudgery of medicine making. 
Even if a doctor is inclined towards making medicines for self-consumption, setting up a manufacturing 
unit is no mean task. Though the equipment needed at small scale is simple, not all have the 
wherewithal to invest in a business that has low margin of returns. For women doctors, who constitute 
50% or more of the ayurvedic practitioner community in Kerala, capital is harder to come by even to 
set up their own clinics. For these reasons, it is uncommon to find formally trained practitioners 
without family background in the medicine making business.  
4.3.5 Disruption in the transfer of  practitioner’s personal metis  
The revivalist ideology considered practitioners’ secretiveness as one of the prime causes for 
the decline of Ayurveda (Leslie  1976). This argument was internalized by the ayurvedic community 
without any protest, despite the fact that much of Ayurveda was and continues to be fundamentally 
open-source. Perhaps underlying this fuelled and aided the confrontation of the more prestigious 
codified Ayurveda with metis-heavy non-codified traditions. (Like for instance the single-root 
practitioners in Kerala). This self-critical argument was repeated so often that it has become ingrained 
in practitioner psyche and continues to surface in everyday conversation. After a hair-rising account of 
his unsuccessful attempts to elicit a secret and powerful medicine from a vaidyan, a formally trained 
                                                 
170Based on practitioner recollections.  
171This would be an interesting correlation to subject to a quantitative study. Had I had this focus in mind from the beginning of 
the study, I would have put some effort to get these figures, but this data is not easy to get hands on.   
172 from narratives of elderly traditional practitioners.  
173While until recently only 300 Ayurvedic doctors were produced a year in Kerala, with 6 new colleges opening in the past 
decade, the annual figures have now touched around 600 within Kerala. Perhaps double that number of students from Kerala 
would be graduating from self-financing colleges in neighboring states and returning home to practice. There are self-financing 
institutions in states like Karnataka that are known to specifically target the Kerala population, because of the historical 
unwillingness of the Kerala government to allow liberalization of education policy.  
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ayurvedic doctor complained, “It is this attitude that caused Ayurveda’s downfall.  There were many 
reputed vaidyan families in this region, now they are no more, the secrets have died with them”.  
Negative perception of vaidyans’ reluctance to share knowledge arises from lack of 
appreciation of the significance of personal relationships between masters and disciples, a factor 
recognized by Hsu (1999) in the context of Chinese medicine. She identifies three modes of 
transmission ‘secret’, ‘personal’ and ‘institutional’, contending that ‘personal’ knowledge often gets 
subsumed under ‘secret’ knowledge.  
To what degree and what kind of knowledge was transmitted depended very much on the 
personalities involved….even if their personalities clashed, it was perfectly acceptable for mentor 
and follower to accept and reject each other on grounds of character and personality…Crucial was 
whether mentor and follower had faith in each other and could build a relationship of mutual trust 
(Hsu 1999:102).  
The gurukula provided the opportunity for a personal relationship between the guru and the 
disciple. The trust built in this relationship was critical in motivating the guru to transmit to the 
disciple, the valuable knowledge accumulated over a life time of practice including all tricks and 
secrets of the trade. The institutional set up does not provide the opportunity for such a relationship to 
develop. In the absence of guru-disciple transmission the knowledge generated during the life time of a 
vaidyan, remains with the vaidyan.  
Even fresh Ayurveda graduates recognize the significance of local practical knowledge that 
they fail to obtain in colleges. It is common to find Malayalee graduates from private medical colleges 
outside Kerala, attempting to gain access to ‘the Kerala tradition’ by doing internship with 
practitioners and hospitals in Kerala. Some prefer to do internships with practitioners reputed for their 
traditional knowledge. I came across one such student unofficially interning with an unlicensed 
traditional practitioner in a remote location. Dr. Jojy Thachil, the General Secretary of the largest 
ayurvedic practitioner organization in Kerala, AMAI (Ayurvedic Medical Association of India), said they 
conduct camps to provide training in Kerala tradition, meant exclusively to Malayalis who have had the 
misfortune of studying outside Kerala. 
In the institutional system, there is no robust mechanism to channel feedback to flow from the 
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individual doctor to the collective and back174. Research in the modern setting is concentrated in 
academic institutions that depend on government research grants, and are less connected to everyday 
concerns of clinical practice. This is not surprising given that even biomedical knowledge, despites its 
dependence on centralized knowledge production, shares a similar predicament.  “In the absence of 
physician-scientists175, the bridge between bench and bedside will weaken, perhaps even collapse…. 
would not only impede the process of questions inspired by a patient's condition becoming a research 
topic, it would also impede the flow of disease-relevant information” (Rosenberg 1999: 331). The Guru-
Shishya (student-disciple)  program instituted by the central department of Indian medicine in the 
recent past intends to bridge this gap between formal and informal, between academics and practice. 
It provides an opportunity for selected meritorious students to do their postgraduate education under 
senior vaidyans of repute including pre-BAMS era practitioners. A prestigious private institute in 
Bangalore has recently instituted a ‘Vaidya Scientist Fellow program’, however its objectives are 
different and not clinical practice oriented. It aims to train young ayurvedic teachers in modern 
scientific scholarship, with the aim of bridging the gap between ‘Shastra’ and ‘science’.  
4.3.6 Summing up 
In the gurukula system, the guru was the owner of the teaching institution; the disciples stayed 
with him176 in his house or in an attached residence. There was no instruction fee. The disciples provided 
labor and services to the guru. They assisted in everyday household work, and as apprentices, helped in 
medicine making, handling patients and administering therapies. Those who could afford compensated 
the Guru in kind, though it was not expected. For instance, Shankaran, a eye specialist practitioner, said 
that he stayed three years in the residence of a reputed Guru to learn medicine. Though there was no 
expectation of payment, being from a middle class farmer’s family, he could afford to make occasional 
donations of rice, vegetables and fruits harvested from their family farm.  
                                                 
174 It is easy to underestimate this, because the system of knowledge exchange that goes on between physicians is invisible. I 
have got a few glimpses of this exchange in doctors’ narratives of interactions with other doctors, especially in cross-referencing 
or exchanging information on difficult cases. Also, at a formal level, practitioner organizations like AMAI in Kerala have been able 
to provide the forum for exchange and knowledge generation, as evident by the Chikun Guniya protocol (Appendix C) But link 
between research funding and practitioner associations are poor, the reason why Ayurvedic professionals is slow to respond 
promptly to pressing contemporary problems, especially epidemics.  
175 The term “physician-scientist” denotes M.D.'s who devote all or a majority of their professional effort to seeking new 
knowledge about health and disease through research.  
176 Gurukulas are usually run by male vaidyans though their wives also could be vaidyans and be part of the establishment. 
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In the modern institutional system, the teachers are not autonomous; they are employees of an 
institution and are accountable to students. A reputed Ayurvedic practitioner-scholar who is also the 
principal of an Ayurvedic medical college in Kerala, points out that “collective responsibility” to students 
has led to deterioration of ayurvedic academy. “Teaching became just another job. Instead of preceptors 
(acharya) mediocre teachers (upadhyaya) flooded the field and teachers are no more ideal idols on high 
pedestals” (Agnivesh 2002: 230).  In the gurukula on the other hand, students were obliged to the guru 
for admission and the feeless instruction. From the modernist perspective, the subservient relationship of 
the student to a single guru might seem feudal and archaic. But it provided an atmosphere for a 
relationship to emerge that is often comparable to a parent child relationship. Whether it was 
authoritarian or democratic depended on the individual guru’s personality.  
To a certain extent there were barriers to universal access of advanced education in the gurukula 
system. In the modern system, caste and gender barriers were eliminated, but on the other hand, there is 
an economic barrier. The gurukula mode worked well for those coming from an economically 
disadvantaged background. In the institutional system, only a few meritorious students get access to free 
State subsidized education. The rest have to shell out a fortune (close to a million rupees/$ 20,000) for 
allegedly poor quality education in self-financing colleges outside Kerala. Besides social inequity in 
opportunity, this scenario has serious repercussions for practice. Doctor graduates from such colleges, 
like their counterparts in biomedicine, are under pressure to recoup the investment made, making them 
profit-oriented, thus making them vulnerable to lure of industry incentives.  
4.4 Post-script  
The analysis in this chapter was based on narratives of educational experiences of practitioners 
and significant others. Since ayurvedic colleges were not part of the study sample, I had not paid direct 
attention to the process of skilling177. Disquiet about the education system per se is often raised in 
professional forums. A recent nation wide survey of ayurvedic education showed inadequacy of 
practical knowledge (Patwardhan 2011). But would today’s practitioners agree with the analysis that 
unfavorably compares the modern institutional system with the gurukula system? Since I had not 
                                                 
177 an issue that came up as significant only during the later stage of analysis.   
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collected responses from the stakeholders on this issue that had emerged as significant post analysis, I 
had no answer to this question. Retrospecting on interactions in the field, I conjectured that the 
average modern ayurvedic doctor who wanted to move towards a more progressive and scientific 
system would be wary of the portrayal of gurukula system as superior to the modern institution. For 
example, in an article on gurukula system a reputed scholar, a principal of an ayurvedic college 
criticizes the “extreme conservatism of ayurvedic ‘elite’ that holds that ayurvedic wisdom cannot be 
imparted in colleges and universities” (Agnivesh 2002: 234). An earlier proposal by the CCIM to create a 
parallel stream of ayurvedic medical education, to  catch younger students and giving them more time 
(seven years) for a better exposure, had to be withdrawn after stiff protest from ayurvedic doctors. 
The reason for the protest becomes evident in this statement: “Ayurvedic experts who want to make 
drastic changes in ayurvedic academy may keep in mind that visiting the past may aid to strengthen 
the future, but opting to stay back there is historical regression, and will be detrimental to the future 
(Agnivesh 2002: 235).” 
Follow-up field work presented a surprise in the form of an expert panel discussion in the last 
session of the three day  Global Ayurveda Festival in Trivandrum in February 2012178. The subject of 
discussion was comparison between the gurukula and the modern college education system. The panel 
represented all the stakeholders - manufacturers, practitioners and academicians. The views of the 
panel were polarized. There was a clear difference between the two stakeholders, the manufacturers 
and the practitioners of Kerala as represented by the heads of the two organizations, AMMOI and AMAI 
respectively. The General Secretary of AMMOI (Ayurvedic Manufacturers’ Association of India), Dr. D. 
Ramanathan, also a proprietor-MD of Sitaram Ayurveda Pharmacy, expressed dissatisfaction with the 
quality of output of ayurvedic colleges. His main submission was that graduates from such colleges 
were lacking in practical knowledge of medicines, including knowledge of plant, raw drug and medicine 
identities and pharmacological knowledge. This he said was becoming a huge problem for 
manufacturers like him who have so far depended on the classical market to survive. He was visibly 
agitated with the status of affairs, and sounded distressed as he said “manufacturers like me would be 
                                                 
178 This was a surprise because in the three year period of my field work, I had attended five national conferences, business 
summits and several workshops, but had never come across this topic being taken up for public discussion.  
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forced to change our strategy to selling branded products”. Representing the practitioner body, Dr. V. 
G. Udaykumar, the General secretary of AMAI (Ayurvedic Medical Association of India) was unwilling to 
accept what he considered a sweeping comment on educational quality in Kerala. While admitting 
some inadequacies in the system, he argued that these should be addressed within the system, 
vehemently opposing the gurukula proposal as a move to go backwards. He argued against the creation 
of two parallel set of professionals, pointing that such a policy would be discriminatory.  
There was active participation in the discussion by a section of the audience. Three students, a 
few undergraduates and postgraduate students made emotionally charged comments airing their 
grouses about the education system. The AMAI General Secretary responded with surprise, re-
examining his earlier statement about the confidence in the quality of educational institutions of 
Kerala.  Owner-MDs of two reputed manufacturing companies179 came out strongly in support of the 
gurukula system. Both these companies are heavily invested in classical products and treatment, but 
are fairly open in their approach to the market. AVP has a new WHO GMP manufacturing unit, AVN has 
been leading in the re-invention of classical products. Dr. P. R. Krishnakumar, the proprietor of AVP, is 
a well respected figure in the Kerala Ayurveda circle is also known for his critical view of ayurvedic 
education. A few years ago, he  instituted a gurukula mode of education that admits young students 
between the age of 15-17 providing them with free education for eight years.  
In Section 4.3.4, I raised a question with regard to the possible role of the industry in shaping 
the skilling process on the premise that the industry would benefit by deskilling the practitioner. The 
panel discussion provided a divergent picture. Manufacturers of classical medicines were losing their 
market because of lack of adequate knowledge among the new generation of doctors. They wanted to 
reestablish the gurukula system of education to arm medical graduates with adequate training and 
knowledge, so that they would be able to maintain and grow Ayurveda’s classical therapy market. This 
was made further clear to me by Dr. D. Ramanathan, the General Secretary of AMMOI later in a 
personal interview. He reiterated his concerns, and pointed out that when Dr. P S Varier, the founder 
of AVS, had initiated the process of modernization of education, he had done it on the lines of the 
gurukula model. Though today, his company Sitaram Ayurveda Pharmacy is invested in celebrity 
                                                 
179 Arya Vaidya Pharmacy and Arya Vaidya Nilayam, both are based in Coimbatore but are manufacturers of Kerala origin. 
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advertizing for an OTC product, he claims his heart is in classical ayurveda. He got worked up talking 
about how the modern system of education was killing his business pointing out that there was a vast 
difference between the capability of average Ayurveda college graduates and traditionally trained 
vaidyans in their ability to attract patients. As an example he introduced me to a doctor whom he had 
recently hired to work in his hospital, Dr. Sreejith, a fresh graduate from a remote rural area who 
hailed from a traditional eye specialist vaidyan family. This doctor, in the very beginning of his career 
had already managed to attract a steady stream of patients,  a practice that graduates without such 
background would take years to establish. His family knowledge combined with the degree had 
equipped him with practical knowledge and associated confidence to treat critical diseases like 
diabetic retinopathy and macular degeneration, competing with allopathic surgeons. Among his 
patients was an European patient getting treated for Retinal Pigmentosa. Since the treatment was 
ameliorative, and this was the best cure the patient had found, he visited the hospital once annually 
for a 30 day course of treatment. For Dr. Ramanathan, this vaidyan was an illustration of how rightly 
trained ayurvedic vaidyans can establish clientele, maintain the therapy market and consequently 
create demand for classical products. It was this kind of doctors that he feels are getting rarer with 
deterioration in quality of education.  
But an ex-secretary of the Kerala ayurvedic practitioner body, AMAI, raised questions with 
regard to the industry’s intentions. Until recently, the industry had supported the State’s move to relax 
rules for letting unlicensed practitioners practice. “They do not care whether the professionals are 
qualified or not, as far as they have more doctors to sell medicines”. According to him, unlicensed 
practitioners are nothing but quacks, the State is driven by political interest and the industry by vested 
interest in the market. The non-institutionally trained, unlicensed, vaidyan respondents on the other 
hand feel that the schooled doctors are jealous of their ability to attract patients. At the end of the 
field work, the plot was certainly getting thicker and murkier.    
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4.5 Conclusion 
Vaidyan’s involvement in medicine making is important in keeping intact the process of what I 
refer to as ‘thinking medicine’, i.e., the cognitive processes that have hitherto contributed to the 
production of ayurvedic knowledge. The cognitive processes that goes into the making of the 
“ayurvedic physician a scientist” (Travick 1987), over several generations of practice and 
experimentation goes on to produce different cultures of practice. Divergence in practices, whether in 
term of protocols or formulations have their basis in this experimentation rather than being 
‘imperfections’ resulting from disuse or erroneous use. It was such a process that had led to the 
evolution of different regional traditions, Kerala tradition being one such outgrowth. Banerjee 
(2009:21) rightly points out that though heavily based in texts, ayurveda’s texts cannot be considered 
canonical, because while being closed at one end by its epistemology, it is open-ended to improvise 
from empirical situations. As a result, she says, “there is not only one Ayurveda, but many ayurvedas-
many traditions of practice that follow and contradict texts…and in doing so, contribute to further 
texts and parameters of practice.”  
Genome biologist Thangavelu is drawn to Kerala because of its fame as the place for excellence 
in Ayurveda, but his frame of excellence is ‘expertise in classical texts’, the absence of which shocks 
him.  Many ayurvedic practitioners from other parts of India travel to Kerala seeking a connection to 
the ancient classical antiquity lost elsewhere. The fact that Ayurveda in Kerala is closer to the original 
texts because of it being isolated from Mughal invasion (See Section 3.1) adds to this illusion. They fail 
to recognize the significance of the collective history of practice in shaping ‘Kerala Ayurveda.’  The 
revivalist framing of Ayurveda as belonging to a monolithic classical tradition, with its emphasis on 
theory laid out in the classics as the basis of the ‘Science of Ayurveda’ has played a formative role in 
the homogenization of knowledge in modern institutions. There is an implicit assumption that 
variations are errors to be eliminated. The globalization bandwagon provides the push factor that 
makes practitioners and manufacturers conscious and apologetic of variability. The political nature of 
barriers that hinder the international expansion of ayurveda is often ignored, accusations are routinely 
hurled at Ayurveda’s ‘lack of standardization’. The ayurvedic community, is quick to internalize the 
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blame; the ‘progressive’ among them exhort the ‘less progressive’ to shed their ‘traditional’ mindset, 
to march forward to meet the challenges of globalization.  
I argue that the systematic weakening of the skilling process through modern 
institutionalization is the fundamental factor that contributes to the deskilling of the ayurvedic doctor. 
Ayurvedic manufacturing industry is more a dependent than an independent variable. Paradoxically, 
rather than benefiting from the lack of practitioner metis, the industry appears to be suffering from 
the lack of it. They are afraid that like North Indian manufacturers they will be forced to shift towards 
branded products. Instead of moving away from the classical context like their counterparts, they seek 
to bring back to ayurvedic education its lost robustness, in the hope of creating a future market for 
their therapy products. When asked if the North Indian industry was forced to move away because of a 
weakened consumer base, Mr. Ranjith Puranik, the CEO of  SDL, refused to exonerate the industry. He 
pointed out “lack of commitment” as a reason for the easy caving in of large manufacturers. 
Manufacturers in Kerala continue to have the ‘commitment factor’ lacking in large manufacturers in 
North India. I argued in Chapter 2 that this was because they were not just medicine makers, but 
institutions that proffered therapy and education, and that the practitioner logic that governs them 
overrides the business logic that dictates the industry elsewhere. 
Irrespective of difference of opinion and conflict of interest, there is a consensus among the 
ayurvedic community that practical knowledge of medicine making and plant knowledge in addition to 
greater exposure to clinical experience is necessary for ayurvedic doctors to establish successful 
practice. There is no disagreement about the shortcomings of the current education system or on the 
virtues of the gurukula system. The difference of opinion is in the nature of reform. A section of 
industry calls for an alternative gurukula based system arguing that the institutional system has 
inherent limitations. On the other hand, a section of practitioners oppose the creation of an alternative 
system, contending that existing institutions can be reformed to incorporate the positive features of 
the gurukula system.  
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5. CH 5 COMMODIFICATION OF THE DECOCTION 
Ayurvedic medicines can be broadly classified as herbal and herbo-mineral. While the herbo-
mineral pharmacopeia dominates ayurvedic practice in rest of India, Kerala has remained faithful to 
the classical herb-centric pharmacopeia. Unlike the former which is mostly restricted to the expert 
realm, herbal formulations include both complex and simple forms. Historically, in Kerala, complex 
preparations like pills and vines used to be made by vaidyans or artisan producers. Simple and 
perishable forms of medicine like fresh juice, pastes and decoctions were made at home. Local raw 
material was sourced from surroundings; non-local material was purchased from  raw drug stores. One 
of the simple forms, the ‘decoction’ (kashayam) took the center stage in the ayurvedic pharmacopeia 
in Kerala. Owing to the simplicity of process and perishability of the product, it hardly made sense for 
a vaidyan or specialist to provide prepared decoctions. It is the decoction-centeredness of ayurvedic 
practice in Kerala, I argue, was responsible for familiarizing people with the processing of classical 
formulations, and consequently, acquainting them with raw drug ingredients. Not only did this promote 
familiarity with local herbs, but it also created a steady demand for non-local ingredients, leading to a 
flourishing retail medicinal raw drug market. 
 Biographies of two index plants, brahmi and kurunthoti, help us navigate through various 
levels of people’s relationships with plants, including every day use, seasonal medicinal practices, 
postnatal care, and classical ayurvedic use. They also provide a glimpse into the confusions that arise 
when customers are confronted with new commodity ‘forms’. The social life of brahmi shows 
traditional household use for infant care (Section 5.2). As a representative of widespread use in 
household and classical decoction, index herb kurunthoti demonstrates the centrality of decoction in 
Kerala pharmacopeia (5.7). Kurunthoti also plays an important role in popular health care of expectant 
mothers. With obstetrics being officially relegated to the realm of allopathy, culturally embedded 
ayurvedic pre and post delivery health care practices come into conflict with allopathic doctors’ 
beliefs. The exchange between two expecting mothers in 5.8, showcases the everyday turf battle 
between allopathic and ayurvedic systems of medicine.  
The dominance of the Kerala pharmacopeia by simple forms like decoctions and the consequent 
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popular habit and metis cultivated in processing such medicines posed a social barrier to capital 
intrusion180 (Capital in this context refers to large scale industrial processing of medicines). The turning 
point in ayurvedic practice, I argue, is the commodification of the decoction (Section 5.9). By the 
simple step of adding preservatives to the decoction, the physical barrier to capital posed by its 
perishability was irrevocably broken down. It was the first step towards deskilling the consumer. 
Though the medicine making skill per se is rudimentary, it had led the consumer to develop an affinity 
with classical medicines and the associated skill of plant identification.  
While the preservatives in the decoction remained invisible and less intrusive, with the 
progress of industrial production, traditional forms of medicine were increasingly being replaced by 
modern forms. In Section 5.3, index herb brahmi provides an illustration to the helplessness of the 
consumer caught between traditional habits and non-traditional commodities which takes us to the 
contested territory surrounding ‘form’ changes in ayurvedic medicine. A descriptive note on classical 
forms (Section 5.4) and the classical logic of ayurvedic pharmacology (Section 5.5) is provided as a 
backgrounder. 
Though the industry has been successful in breaking the barrier of habit and skill, as evident by 
the widespread market penetration of factory made decoctions, the culture of home cooking 
decoctions continues to co-exist. Consumers continue to invest time and labor in the pursuit of 
authenticity.  Section 5.9 shows how various new forms have evolved in the crowded space between 
the factory and home.  Instead of stopping the consumers from cooking decoctions at home, these 
commodities promise to aid them in the process.  
5.1 The unyielding Malayalee  
Varier had found it easier to persuade ayurvedic doctors to buy finished medicines than to 
convince consumers to stop making medicines at home. In an article in the AVS-run ayurvedic journal 
Dhanwantary, he lamented that people in general were still “not used to buying medicines or paying 
for them”, that “they have no idea whatsoever of the costs of manufacture”. “They do not understand 
                                                 
180 Kloppenburg (1994) identifies technological and institutional barriers to capital in the context of the commodification of the 
seed.  
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that medicines processed under the strict supervision of a trained vaidyan could be of a much higher 
quality than home-made ones” and are therefore reluctant to pay the price marked on them (Varier 
1908:52). Compared to his counterparts in rest of India, Varier was functioning in a different milieu; 
people in Kerala were in the habit of making medicines at home. The pervasive influence of classical 
Ayurveda in Kerala had created a unique culture of practice and consumption. Traditionally, 
practitioners would write a prescription that would either list the ingredients or just the name of the 
classical formulation; the raw drug shop keeper was expected to know the composition. People would 
buy whatever they could source locally from the raw drug shop and cook the medicine at home. In the 
early decades of 1900s, the modern working woman was yet to evolve. For women farmers and 
homemakers, cooking medicine was nothing but an extension of kitchen activity. Even an entrepreneur 
in the food market would have found the consumer equally recalcitrant to commodification beyond the 
level of raw ingredients. The boom in the market for branded ground spices is a post 70s phenomena. It  
is only in the past decade that branded rice and 
wheat flours have become popular. Distrust of ground 
spices and grains about poor quality ingredients or 
adulteration is still highly prevalent across India. It is 
common for people to ascribe health problems to 
adulteration of food (Nichter 1989, Sujatha 2007). The 
drudgery of chopping and grinding was what was making 
people vulnerable to branded ground spices. The hurdle 
in primary processing of raw drugs was overcome with the progress of mechanization; flour mills began 
to be popularly accessible since late 60s. People were able to make use of these facilities to get both 
their spices and medicines grounded. During my fieldwork, I have come across five flour mills in 
Thrissur and Ernakulam districts, that sported boards announcing separate facility for the processing of 
raw medicine ingredients181.  
 
                                                 
181 Two mill owner informants said that their  customers included vaidyans, consumers, and small scale manufacturers. 
 
A flour mill in Thrissur: the display board 
announces the facility to pulverize raw drugs 
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5.2 Brahmi, the memory plant 
From the day his daughter arrived home for delivery, Jacob and his wife have begun an 
elaborate preparation for postnatal care for both mother and child. Of the various tasks on Jacob’s list, 
highest on the priority is getting a brahmi sapling to plant in his garden. The herb ought to be ready for 
harvest by the time the baby is born, so that the new born baby is not deprived of its due; it is 
customary to feed the infant with a few drops of brahmi juice daily for the first couple of weeks. It is 
believed that it is essential for buddhi vardhana, ‘development of the intellect.’ Equally important for 
the baby at this time is Vayambu (Acorus calamus, the drug vacha in Sanskrit, meaning speech), for 
promoting healthy speech development. The practice is to embed a string of gold inside a 2-3 inch long 
piece of the dried rhizome, which is often done with the help of the goldsmith. This piece is grated on 
a piece of stone and the paste applied to the baby’s tongue once every day, for around a month. The 
quantity of gold expected to be used is minute, but sometimes people overuse it to make a statement 
of status. Mary, a rich housewife from Kottayam says, “Look at my son’s complexion, isn’t it glowing? 
we fed him with half a sovereign182 of gold with Vayambu.”  
Jacob and his wife are a small farming family in the interior midland region of Kerala. Very 
little is left of their original diverse home garden style of cultivation, all of the inherited two acres is 
converted to rubber cultivation. All they have now, like any city dweller, is a small patch of land 
around the house which is adorned with a number of potted plants, most of which are ornamental. He 
and his wife are regular consumers of medicinal plants like kurunthoti, cheroola, nilamparanda, all of 
which are available in whatever little left of the commons, untended roadsides and absentee house 
owners’ uncultivated yards. It is getting harder and harder to find many of these plants because of 
rubber cultivation and urban landscaping. Formerly, he used to depend on the raw drug shop only for 
non-local medicinal plants like Vayambu, but now he has to go there even for local herbs. 
Popular knowledge of medicinal plants in Kerala is closely linked to ayurvedic use, but at the 
same time it is also part of people’s repertoire of home remedies and cultural practices. Though half 
                                                 
182 = 4 gms. (1 sovereign = 8 gms).  Though gold is a pharmacological ingredient, the typical quantity used is ¼ to ½ gm. 
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the Kerala population is now urban183, but for the core large city dwellers, the rest continue to live in 
houses surrounded by small homegardens. These are not fashionable urban gardens dominated by 
ornamental plants, but abridged versions of the old homesteads tuned to multiple functional uses. Most 
medicinal plants are naturally growing weedy plants that are consciously maintained while a few are 
cultivated. On an average people are familiar with half of around 100 medicinal plant species found in 
the homegardens and commons.184 This is not surprising given that 52 species were being used just for 
postnatal care in South Kerala (Rajith et al 2010). In terms of herb use, Kerala is not exceptional; a 
recent study (Ved and Goraya 2007) estimated household consumption as 27% of the total consumption 
of herbal raw drugs in the country. In fact, in terms of number of species consumed, Kerala falls far 
behind the rest185. List developed with input from one informant, cross-checked with three other 
informants shows that 55-65 plants were part of the common knowledge of an average rural resident. 
Many of these are also popular because of their non-medicinal uses, as vegetable, spice, religious use186 
and so on. Knowledge of medicinal uses is less widespread. This is difficult to extract from a simple 
checklist because people typically depend on collective knowledge. Every village has a few people who 
can recognize almost every single plant in the surroundings.187 It is common to see patients being 
flooded by advice on home remedies from friends  and relatives. Articles in Malayalam health 
magazines188 and self-care booklets add to the household remedy repertoire. For example, during the 
Karkidakam month, print and television media overflow with advises and recipes of seasonal regimes.   
                                                 
183 The urban population spiked only in the last decade, from 25% (2001 census) to 47.72% (2011 census).   
184There is significant variation in the number of species depending on ecological habitat, proximity of forest and current status 
of habitat (extent of urbanization, nature of cultivation, etc.). Collectively the number would go far higher, 150-170. Certain 
species have restricted habitats, for example, aquatic herbs like brahmi, forest-species like thelli.  
185 Kerala: 98 Tamil Nadu: 104 Orissa: 130 Andhra Pradesh: 170 and Karnataka: 179.   
186While a few like tulasi have direct religious significance, wild flowers take a central part in religious/cultural occasions in 
Kerala The most significant is Onam Pookkalam, floral design made on the occasion of  the Kerala state festival Onam.  
187These are not necessarily vaidyans, but mostly likely to be people from background in families with medical practice, 
especially from castes like Velans, Ganikas and Ezhavas or those involved in collecting medicinal plants or working as assistants 
to vaidyans. They could also be others with exceptional interest. I encountered three such people, a taxi service runner who 
acquired his knowledge from hunting, a retired woman school teacher, another was a farmer cum petty salesman who used to be 
a land surveyor. There was no specific gender difference in the distribution of such knowledge.    
188 Every large media house has a health periodical, three of which are highly popular. They give equal space to all systems of 
medicine, but Ayurvedic products corner lion’s share in terms of advertisement. The most popular, Mathrubhumi Arogya Masika 
has a monthly readership of 826,000. 
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Jacob’s routine represents the typical routine of a farmer’s life in central Kerala189. Practices 
like this cut across all socio-economic classes. Their neighbor Leelamma, a landless laborer, follows the 
same set of practices, though she is ready to walk longer distances in search of herbs and to use less 
valuable substitutes rather than buying from the market. Practices associated with household use of 
brahmi revolve around the faith in its intellect-enhancing properties. For example, people in rural 
Ernakulam fry brahmi leaves in oil for applying on their heads especially for kids to help in ‘developing 
the brain’. The word brahmi is derived from Saraswati, the Goddess of knowledge.  
Like many other plants in the ayurvedic pharmacopeia, brahmi suffers from an identity 
confusion. The ayurvedic drug name refers to two different plants, Bacopa monnieri and Centella 
asiatica190, considered interchangeable in northern parts of India. Both are aquatic and widely 
distributed across the tropics, but botanically distinct. In Kerala, there is no identity confusion; Bacopa 
monnieri is the only brahmi. Centella asiatica191 is considered to be in the similar league, but with 
different properties and distinct therapeutic uses.192 Here onwards, unless otherwise mentioned, 
brahmi refers to Bacopa monnieri. In Malayalam, the Sanskrit name brahmi is the most commonly used, 
but it is also called Neer-brahmi (Neer=water). Bacopa monnieri (family: Scrophulariacceae), is an 
annual, diminutive193 aquatic ground creeper with bright green and tiny succulent leaves. It grows in 
wet lands and marshes, near streams, paddy fields and tank bunds. For much of Kerala which is water-
rich, brahmi is easily accessible. People in midlands and towns who do not have access the herb in 
their gardens194. But for people who live in cities, especially outside Kerala, following tradition is not 
an easy task both because of the absence of the cultural milieu and lack of access to the plant. For 
example Kavitha, a Malayalee Pune resident says she wants to follow at least some important 
                                                 
189 Typically women take charge of post delivery care, but it is not uncommon to find men equally involved. In this case Jacob 
was in charge because of his wife’s illness. Also being a farmer he was more familiar with plants than his semi-urban wife. In 
another family I interacted with in the same region, the lady of the house, a retired teacher, was in charge of all activities. Her 
bank employee husband’s herb knowledge was limited. The difference in knowledge appears to be larger between farmers and 
non-farmers than between genders. As a rule, processing medicine is a woman’s realm as it is considered an extension of the 
cooking activity, but men are involved in sourcing and pre-processing material.  
190Kodavan/kutangal in Malayalam and mandookaparni in Sanskrit 
191Centella asiatica is widely used in medicine and cuisine in South East Asia and has a worldwide market whereas Bacopa’s 
commodity life primarily stems from its Ayurvedic roots. 
192The classical triad of compendiums make a distinction between the two, but the north Indian practice follows from 
Rajanightantu (C. 14th Century CE). They are different in Rasas (bitter Vs astringent), the former is used to treat mental diseases, 
epilepsy whereas the latter has more of a rejuvenative effect, the former promotes fertility whereas latter has an abortive 
effect (Sivarajan and Balachandran 1994).  
193 grows around 10 cm. in height. 
194 One technique used is to grow the herb in the crevice of a dead palm tree trunk that acts as an artificial water body. 
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traditional practices, but does not know where to get the raw material, language being a significant 
barrier. She grows essential herbs like tulasi (holy basil) and panikoorka (Coleus spp.) to treat cold and 
fever. Brahmi is easy to grow, but is not part of her daily remedy repertoire. 
Brahmi’s commonplace appearance belies an extraordinary status in not only ayurvedic but in 
other Indian classical systems of medicine and in local oral traditions. Like any other ayurvedic herb it 
has multifarious capabilities, but what makes it indelible in popular culture is its ‘memory enhancing 
property’, a feature that has made it highly amenable to modern commodification.  However, its 
traditional use among the general populace in Kerala appears to be limited to child care and hair oil, 
both meant to promote intelligence.  
5.3 Is the capsule the same as the juice? 
A question on an online forum best describes the predicament of the clueless modern Indian 
who desires to follow tradition while living in far flung lands.  
 My grandmother told my mother to give brahmi to my baby as soon it is born. I googled and found 
that this plant is called Coastal Waterhyssop. Where can I get this plant/herb in USA? Is this plant 
available in India? If yes, I can ask my mother to bring when she comes. Let me know where my 
mother can buy in Chennai. My grandmother doesn’t remember who gave this to my mother when 
she was born or to her brothers when they were born, but she remembers someone gave it to 
them for sure. Rant.. No one remembers having this brahmi given to anyone born after my 
mother's generation and I am the first grand daughter in the family way
195
. Any help is highly 
appreciated. 
Equally poignant is the reply that in a nutshell describes the dilemma of the modern Indian who 
is caught between traditional practices and unfamiliar commodities.  
I think brahmi helps in memory power. i have seen it in ayurvedic shops here.. himalaya also has 
it, but in capsule form.. i don’t know how u will give to a newborn child in capsule form ? 
This is one of the most perplexing questions that plague the consumer who is caught in the 
crossroads between tradition and modernity; a perfectly straightforward question to which there is no 
straightforward answer. The manufacturer would no doubt argue that the tablet and the syrup are one 
and the same. Technically speaking, the capsule encloses the contents of a dehydrated extract of the 
juice. The consumer is a lay person for whom the juice and capsule can look so different that it is 
difficult to imagine they could be one and the same. It becomes even more problematic in the situation 
                                                 
195 in the family way = pregnant, euphemistic usage in Indian English. 
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above, where a drop of fresh juice is fed to the baby, for which it is near to impossible to gauge the 
safety of the transformed product, and to solve the question of dosage. The traditional consumer is 
also justifiably bothered about the safety of the capsule material and the colors used. Problems also 
arise because of differences in manufacturing practices. It is common for industries outside Kerala to 
use hydro-alcoholic herbal extracts whereas manufacturers in Kerala by and large have been resistant 
even to the use of aqueous extracts (see Section 9.6 for further discussion). But the infamy of the 
former affects manufacturers from Kerala to some extent. For example, a respondent at AVS said that 
despite using traditional processes to make brahmi capsules, they encounter consumers who suspect it 
as being made with extracts.  
In other parts of India, customers are accultured to medicines and habits of consumption driven 
by the industry, which in turn were heavily influenced by biomedical forms (Nichter 1989, Banerjee 
2002, Bode 2008). But in Kerala, up to recently,  manufacturers have stuck to traditional forms except 
for a narrow range of proprietary medicines. It is only in the past decade that external pressures have 
come to bear on ayurvedic manufacturing in Kerala. While the transformation of the juice to capsule is 
in fact the least contentious, many other changes are less straightforward. A host of form changes have 
gone more or less unnoticed elsewhere in the country, but in the conservative ayurvedic climate of 
Kerala some of the recent form changes have been actively contested by both practitioners and 
consumers. On one extreme are traditionalists for whom no alteration is justifiable. On the other 
extreme are modernists who consider all technologically feasible alterations as not only justifiable, but 
also superior. A mid-position is taken by manufacturers in Kerala who do not claim the modern form to 
be equal to the original, but argue that this is the form most ‘convenient’ to the consumer today. But 
who gets to decide which is the ‘right’ form? This question takes us to one of the central concerns of 
anthropologists studying commodification, that is “who has the power to control the meaning of the 
commodity” (Radin and Sunder 2005: 16). 
It is only after confrontation with the allopathic system in the last century that the form of 
ayurvedic medicine began to be influenced by extrinsic factors. With the industrialization of ayurvedic 
production, pharmacopeia began to be influenced by commercial logic. Urbanization and consequent 
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consumers’ demand for convenience had also a parallel role to play. In the pre-industrial era, the 
choice of form was shaped by the pharmacological logic, physical properties of the material, 
technological constraints in processing, and shelf life considerations.  
5.4 Classical forms 
Of the 23 different forms of classical medicines, around ten are most commonly used in the 
ayurvedic pharmacopeia. At a broader level they can be classified as herbo-mineral (rasa preparations) 
196 and herbal preparations. The pharmacopeia outside Kerala is predominantly focused on herbo-
mineral preparations197. Kerala pharmacopeia focuses on polyherbal formulations that vary in terms of 
complexity. Swarasa (juice)198 and Kalka (paste) are the most simple and direct199, but these can be 
made only when the fresh herb is available. The next in level of complexity are kashayam/kwath 
(decoction), sheeta phanta (cold infusion), and ushna phanta (hot infusion). these five together are 
known as pancha kashaya kalpana, i.e., ‘the five decoctions’. (Sarngadhar Samhita MK 1:1, Murthy 
1984: 51). However, technically, in classical Ayurveda, only the fifth is officially referred to as the 
“decoction.” The next in terms of complexity are choornams (medicinal powders), lehyams (jam-like 
preparations, literally ‘lickables’) made with herbs in a jaggery base, ghritams (ghee-based 
preparations), tailams (oils) and kuzhabmbus (thick oil). The most complex of the polyherbal 
formulations include various types of pills (vatikas, modakas, vartis) and fermented preparations called 
arishtams and asavams (hereinafter referred to as ayurvedic wines). 
 Diehard votaries of modernity consider form as being technology-driven and hence, old forms 
can be replaced with new, and traditionally prescribed procedures with new labor and time saving 
technologies. In the Arogya 2009 industrial exposition in Thrissur, a North Indian manufacturer proudly  
                                                 
196 Bhasmas and manduras ( calcined mineral and metal preparations), collyriums (anjanas), distillates (arka), ointments, nasal 
drops, guggulu preparations, Kupipakva Rasayana (medicines prepared by sublimation), Parpati (scale preparation), Pottali 
(metals cooked as bolus) and Pishti (fine powder of purified gemstones). Mineral preparations form 51.9% of the non-Kerala 
pharmacopeia whereas it is just 3% of the Kerala pharmacopeia.  
197 Mineral preparations form 51.9% of the non-Kerala pharmacopeia whereas it is just 3% of the pharmacopeia in Kerala.  
Further, the categories of formulations show that while the manufacturers are comparable on three categories (Ayurvedic vines, 
powders and tablets), Kerala manufacturers place far higher emphasis than the non-Kerala manufacturers on four categories: 
decoctions, oils, medicated ghees and jams. (See Table of comparison, Appendix H). 
198 However, boiling a dry drug in eight parts of water and reducing it to a quarter is also considered Swarasa. There are also a 
few complicated ways of extracting juice by the method of roasting. Roasting is done in many ways, firing medicinal paste 
wrapped in a ball of mud, firing a bird stuffed with medicinal leaves, and so on. 
199 Other simple medicinal preparations include, Mantha (thin gruel) and Panaka (diluted juice), porridges and soups, none of 
which are found in the commodity form.  
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showcased his ‘modern products’ mainly capsules and pills made by micro-pulverizing raw 
material. According to him the classical forms were product of an era that was limited by technology.  
He said, “it is ‘traditional’ backward mindset to continue to stick to them. Our medicines are far 
superior because in the micro-powdered form they are the most bio-available”. But ironically, his was 
one of the eighty stalls in the industrial exposition of which 90% were manufacturers from Kerala, 95% 
of whose product profiles would be obsolete in his eyes. In fact, the stall right across his was that of 
Santigiri Vaidyasala, who had gone further ‘backwards’ by selling medicine in its crudest form by 
establishing a network of raw drug franchisees200.  In Kerala, practitioners give primacy to classical 
ayurvedic forms that are governed by a pharmacological logic; modern scientific parameters can do 
only limited justice in explaining the rationale (for example, Kumar 2005, Vasudevan 2003).  
What is the logic that informed the 
choice of different forms? Choice of a 
particular form is obviously shaped by 
constraints imposed by the physical 
characteristics of the material. For instance, 
the best thing to do with a fresh leaf would be 
to express the juice, boil in water or grind into 
paste; juice cannot be squeezed of dry raw 
material; it is easier to convert tough roots 
into decoctions rather than to grind them into 
paste or powder. Resins call for different processes.201 Dr. P. S. Varier conjectures that  a combination 
of perishability and palatability led to the evolution of different forms. “Originally people would have 
been taking swarasa (juice) of  fresh herbs. Then when it became difficult to find, people started 
keeping dried herbs and roots, to make decoctions. That also marginally improved the taste by 
reducing the bitterness. But then they started asking for Mempodi (substance to enhance palatability), 
                                                 
200 This is despite the company being a large manufacturer of Ayurvedic and Siddha products. The marketing manager said they 
wanted to promote raw drugs because they would rather have people make medicines at home rather than consume decoctions 
with preservatives. The company run by a Hindu Ashram combines profit with service goals. 
201 There is an entire range of classical forms that are based on a resin called Guggulu.  
 
Color Coded classical medicines of AVS 
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like honey and sugar. That is how, other forms seems to have evolved” (Varier 1915: 66). 
Need for preservation must have been a critical variable. While all the simple forms are 
perishable, complex forms (oils, lehyams, powders, pills and ghritams) have a longer shelf life, ranging 
between one to two years. Vines and Bhasmas (calcined mineral and metal preparations) not only have 
no expiry date, they are expected to improve in quality with age (Sarngadhara Samhita (SDS) PK 1:51-
53, Murthy 1984). According to one interpretation, the North Indian pharmacopeia202 leaned heavily 
towards the herbo-mineral form because of its non-perishability203.  Among practitioners in Kerala, it is 
common to come across the perception that these preparations were powerful but complex to prepare, 
dangerous if not prepared properly or used in the right context and dosage. However, with increasing 
global interest in the heavy-metal free ‘herbal image’ of Ayurveda, such views are less commonly 
heard. 
 The nature of specialization and practice must also have played a 
role in the selection of form. The traditional pediatric practitioner in Kerala 
carried a palm sized wooden medicine pouch which contained several 
compartments, populated with pills so tiny that he used tweezers to handle 
them. For an itinerant practitioner, pills obviously were the most convenient 
to carry and to administer. Additionally, for a pediatrician, palatability and 
ease of administration were important criteria. Pills were also handy in 
emergencies. Some Vishaharis  (poison-healers)  were found to be carrying a  
large walking-stick look alike medicine chest full of micro-drawers for pills 
for emergency use (see image on the right). Annakutty, an ayurvedic 
veterinarian vaidyan, said she depended heavily on pills, it would be difficult 
to administer any other form of medicine to animals204.  
The ayurvedic classic Charaka Samhita defines dravya ( any substance including the drug) as 
                                                 
202 influenced by Tantric alchemic traditions from the 12th century, and by Persian Unani 14th century onwards.  
203 “There are many possible reasons why minerals displaced plants in northern India, and to some extent in eastern and western 
India as well. Incinerated minerals make good medicines because, by and large, they get better with age and so there is no 
expiry date and no danger of waste. There is no need for yearly expeditions to collect and preserve herbs, since minerals can be 
handed down from generation to generation. Their taste is no more neutral and they are less cumbersome to administer. They 
are also more powerful than all but the most potent (or poisonous) of herbs, and so small doses produce large effects faster than 
most herbal products can” (Svoboda 1992:263). 
204 Pills for animals are given hidden inside food, for example inside bananas for cows and elephants.  
 
Poison-healer Vaidyan 
with her emergency 
medicine chest 
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“that were actions and properties are located and which is the material cause (of its effect) (Charaka 
Samhita Su 1: 51, Sharma 2000).” A herb would qualify as a drug if it meets all the four criteria: of 
abundance (bahuta) so that it remains affordable, efficacy without side effects (yogyatva), 
transformability into various types of pharmaceutical preparations (anekavidha kalpana) so that it can 
be tailored to the ‘need’ and ‘convenience’ of the patient and finally, the potency to produce desired 
pharmacological action (sampad). Some other qualities expected of drugs are: they should be broad-
spectrum (bahudhoshaharam), easily digestible (laghupakam),   mood-alleviating (sukhasvadanam), not 
produce depression (natiglanikara),  should have pleasant smell, color, and taste 
(gandhavarnarasopetam), must not have any adverse effect (avikari) (Ojha et al 2004).     
Interestingly, convenience, one of the top reasons quoted by manufacturers in designing 
medicines today seems to have been an important criteria two millennia ago, though there is evidently 
a vast difference in the threshold of convenience. “Need” includes the constitution (prakriti) of the 
individual,  the type of disease, the strength and stage of disease, and many other factors that are part 
of the diagnostic framework. Digestibility is an important criteria. The classic on pharmacology 
mentions the order of difficulty in digestion for the five decoctions, in ascending order as, hot infusion, 
cold infusion, decoction, paste and fresh juice (Sarngadhar Samhita MK 1: 1, Murthy 1984). According 
to a doctor informant from Maharashtra, the choice of fermented vines over other forms were mainly 
due to digestibility; decoctions were hard to digest, so she would recommend them only to patients 
with good digestive power.  
As important as the drugs are the yogavahi (carrier or vehicle of the drug) and anupana 
(adjuant). Adjuants act as a catalyst to facilitate the action of the drug. They may enhance 
digestibility or bio-availability or mediate the action of the active ingredients in any other way.  Drugs 
are also classified into three groups based on the effect they have on each of the three dosas, as 
having stimulatory effect (prakopaka), depressing effect (samaka) and replacement (dhatuposhaka). An 
important cornerstone of ayurvedic treatment is the attention given to fattening (brhmana) or 
slimming (langhana) the body as per the requirement of the person and disease. Medicated ghee and 
oils are especially used in the former case and avoided in the latter case. Different routes of drug 
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administration, (mouth, nose, eye, ear, anus, urethra, vagina and skin) were another criteria for the 
selection of a particular type of formulation.  
Dr. Sheela Karalam, the Head of R&D of Oushadhi, the Kerala State ayurvedic  company 
pointed out that each form had its own pharmacological implication, and that the physician’s logic had 
to be applied in choosing a particular form of medicine. She provided a few examples. Decoction being 
not easily digestible, is not a preferred medication at the first stage of fever, whereas panakam (light 
juice), tablets or powders are preferred. When fever subsides, medicated ghee (like Indukantaghritam) 
or medicated jam is given to protect the patient from the damage caused by fever. Topical application 
of medicated oil is commonly preferred for external injuries and wounds, but it is not advisable in the 
case of suppuration; decoction is the most preferred form.  Fermented preparations are given 
commonly in the case of respiratory and digestive complaints, though they are also used in many other 
general conditions as well. A fermented preparation called Chandanasava is the most commonly used 
medicine for UTI. Much importance is given in ayurvedic treatment protocols to stimulating appetite 
and digestion. Arishtam (ayurvedic wine) is known to be producing Deepana, that is stimulating 
digestion at tissue and cellular levels. Ghritam (ghee) which is based in animal fat  in comparison to oil 
which is vegetable fat also is used for the same purpose. She also added that “the advantage of ghee is 
that it does not react with anything that it comes into contact, without losing its identity, compared to 
honey that reacts with other substances”.  
One major topic for debate is the use of various kinds of fats as solvents, mainly oils and ghees. 
Classical texts also recommend the use of various animal fats like tallow and fat from marrow, though 
their use is limited. This is a controversial point in Kerala because of the preponderance of the use of 
fats in the pharmacopeia, both for internal and external uses. It is common for ayurvedic practitioners 
to be confronted with questions on the rationality of the use of fats. An editorial in an ayurvedic 
journal (Agnivesh 2005) brings up this issue as one of the most troubling to Kerala ayurvedic 
practitioners. Though this issue has become more strident with the predominance of ‘lipid’ hypothesis, 
it has been around for long as evident by the narrative of Dr. Verghese Pattarumadom, an Ayurvedic 
doctor based in suburban Ernakulam. He narrates a hilarious incident that occurred when he was a 
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student in Trivandrum Ayurvedic College in the late 50s.  
An  allopathic doctor had written an article in a popular forum alleging that application of oils is 
nothing but superstitious and that it demonstrates how unscientific Ayurveda was. This naturally 
infuriated the ayurvedic community. An ayurvedic professor in his college known for his eccentric 
behavior, decided to take the writer to task. He invited him for a one to one debate on the issue, 
with the hidden agenda of subjecting him to an experiment.  He arranged his students to be 
accomplices. As soon as the doctor-writer got on to the stage, he had his students tie him to a 
chair. He then proceeded to apply on his head, an ayurvedic oil known for its extreme heating 
properties. Within a minute, his eyes began to turn red. In a few minutes, he began to sweat all 
over and was in a bad predicament. On the condition that he retract his statement, the professor 
allowed the students to apply on his head the counter-remedy, the cooling Ksheerabala oil, which 
got him back to normalcy. The doctor ended up publishing a retraction and a written apology.  
In cases where a ‘form’ would significantly influence the ‘content’, a modification that does 
not take this into account would certainly be problematic. Though certain forms and processes could 
be technology-driven and can be argued to replaceable, often forms might also be based on the 
foundation of the complex logic of ayurvedic pharmacology. According to modern pharmacology, plant 
chemicals can be either fat soluble, water soluble or soluble in alcohol. This would mean that different 
preparations lead to the extraction of different set of metabolites. Of the classical forms, juices, 
decoctions and infusions are water extracts of medicinal compounds; oils, ghee-based preparations and 
confectionaries function as fat-extracts; and, the self-fermented wines work as alcohol-extracts. The 
last two might also be based on water-extracted medicinal material. An understanding of the 
difference in medicinal qualities between these preparations must have influenced the design of 
various formulations. A telling example of the significance of processing comes from the story of the 
discovery of the malarial drug Artemisinin205. Reference to a Chinese classical text led the researchers 
to try the use of a low heat infusion  specified in the text, instead of the aqueous extract they were 
using. The resultant solution showed very high anti-malarial activity that finally led them to the most 
potent anti-malarial drug in the world today (Tu 2011). There are some research studies who attempt 
to understand the rationale of classical formulations by modern pharmacological parameters. For 
example, a study showed that the ayurvedic preference for milk decoction of raw drug pippali (Piper 
chaba) to the water decoction was ratified by researchers who showed that the former was 27 times 
more pharmacologically active (Sudha and Venkat 2004). Dr. A. Sindhu, General Manager, R&D and 
                                                 
205 A national project against malaria was set up in China in 1967. In the first stage, 2000 herbs were screened that resulted in 
640 hits. More than 380 extracts obtained from over 200 herbs were subjected to animal testing. Of these, Artemisinin showed 
pharmacological promise, but was week and inconsistent. 
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Technical Department of Arya Vaidya Pharmacy, said they engaged a biotechnologist from a University 
in Kerala to study Bilwadi Guliga, a pill that had to be wet ground for 30 days as per classical 
procedure. They were astounded by the findings that showed that the ground paste started to show 
remarkable pharmacological activity on the 29th day of processing (Thankamani et al 2005). For this 
reason, she said, they prefer to stick to classical procedures, however ridiculously pointless or 
laborious they might seem.  
5.5 Ayurvedic Pharmacology: A brief introduction206 
The material philosophy of Ayurveda, including physiology or pharmacology are  based on the 
evolutionary scheme of Samkhya (School of enumeration) (See Section 1.2.3). According to this 
scheme, the body which is the microcosm is a subset of the macrocosm, that is composed of five basic 
elements (earth, fire, water, air, and ether), and characterized by three qualities (inertia, equilibrium 
and activity). These are manifested as three doshas, loosely translated as humors (Vata, Pitta, Kapha), 
the proportion of which along with the qualities produce the prakriti or individual constitution. Illness 
is understood as the perturbance in these doshas. The physician is expected to use the three means of 
valid knowledge (See Section 4.1) in assessing the pathology in terms of these elements and to 
compose the right medicinal combination to correct the imbalance, based on the principles of Samanya 
(similarity) and Vishesha (dissimilarity).207  For example, a substance having Vata characteristics will 
increase Vata and decrease Kapha. As the material in nature is constituted of the same elements, 
logically, by the principles of similarity and contraries, substances can be used to manipulate the 
condition back to the desirable state. To address the bodily imbalance with the right combination of 
substances, the vaidyan follows a complex logic based in the theory of ayurvedic pharmacology laid 
down in the classics.  
The classificatory system of ayurvedic pharmacology is based on a synthesis of the two schools 
of Vaisheshika (atomism) 208 and Nyaya (logic), according to which the world is made of “six objects of 
experience” (See Appendix D). Ayurvedic pharmacology classifies medicines by taste (Rasa), quality 
                                                 
206 Based on Kutumbiah 1962, Svoboda 1992, Wujastyk1998   
207Substances having similar constituents/characteristics increase each other and those having dissimilar 
constituents/characteristics decrease each other.  
208 postulates that all objects in the physical universe are reducible to a finite number of atoms (Anus and Paramanus).  
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(Gunas), potency (Veerya), post-digestive taste (Vipaka), pharmacological action (Karma) and special 
effect (Prabhava) (Sarngadhara Samhita PK 1: 22-23, Murthy 1984:12).   
 Rasa (Taste), recognized by the tongue, is categorized into six types, sweet (madhura), pungent 
(katu), sour (amla), saline (lavana), bitter (tikta), and astringent (kashaya)  each attributed an 
elemental composition and a corresponding effect on the doshas. 
 Gunas(Quality)  are 41 in number and are classified into four. 1. Vishista consisting of sense-
objects (sound, touch, color, taste and smell) 2. psychological (intellect, desire, aversion, 
pleasure, pain, volition). 3. Guruvadya Gunas (physico-pharmacological) including ten pairs of 
physical attributes, heavy-light, hot-cold, dull-sharp, unctuous-dry,  and so on. 4. Paradya Gunas 
(Para-pharmacological) are abstract qualities, for example, primacy Vs unimportance, magnitude, 
and so on (See Appendix D.1 for complete list). 
 Virya (Potency): is classified into four pairs: hot-cold, unctuous-dry, heavy-light, and dull-sharp.  
 Vipaka (Post-digestive taste): The transformed state of the taste after digestion is called Vipaka. 
six tastes are reduced to only three post-digestive tastes, sweet (Madhura), pungent (Katu) and 
sour (Amla).  
 Karma (Action) refers to pharmacological action of a drug. The materia medica is divided into 
classes of drugs (Ganas) based on their Karma, 50 in Charaka Samhita (See Appendix D.3), and 36 in 
Sushruta Samhita. There are two additional classes, rasayana (rejuvenative) and vajikarana 
(aphrodisiacs).  
 Prabhava (Special effect): Action of a substance that is not explainable by the understanding of 
its constituents and qualities is called Prabhava. Two substances with similar properties may have 
different Prabhavas for reasons that cannot be explained.  
Some drugs act by the total effect of all these properties, some by one of the properties. 
Another concept considered in combining drugs is that of Virodha i.e., incompatibility. Drugs can be 
incompatible with each other in various ways, such as quality, taste, potency, post-digestive quality or 
action. They could also be incompatible with various other variables such as diet, place, time, 
digestion, dose,  and so on. Given this factor, diet regimen (pathya), forms an inseparable component 
of traditional ayurvedic treatment. In fact, Ayurveda considered food as Mahabhaishajyam, that is, the 
“supreme medicine” (Thirumulpad 2007). A related concept is that of Anupana a substance given along 
with the drug with various intentions. It is used as a simple vehicle or carrier of medicine or to improve 
palatability or to aid the action of the drug by improving absorption and digestibility or to ameliorate 
the drug’s side effects. Honey and milk are among the most commonly used adjuants. In Kerala 
pharmacopeia the Malayalam term Mempodi is often used to mean Anupana. But there is a difference 
of opinion in meaning, as Mempodi is a powder of one or more drugs that are used as adjuants that 
some scholars feel is equivalent to another classical concept, Prakshepa. This is an example for the 
evolution of regional nuances in practice that are likely to be perceived as unwanted variations in the 
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path of homogenization.  
The choice of medicine and the form would be based on various criteria, including the 
assessment of the nature of perturbance in the three humors, the constitution and temperament of the 
individual, the nature, strength and stage of disease, the constellation of symptoms, environment, 
season, digestive strength, age, and so on.  
Pharmacology of brahmi (Bacopa monnieri) according to API  P.1. Vol. 2 (2008: 37) 
Rasa/Taste Madhura, Tikta, Kashaya Sweet, bitter, astringent 
Guna/Quality Laghu, Sara Light, fluidity 
Virya/Potency Sheeta Cold 
Vipaka/Post-
digestive effect 
Madhura Sweet 
Karma/Action Kaphahara, Medhya, Rasayana, 
Svarya, Vatahara, Vishahara, 
Ayushya, Matiprada, 
Prajasthapana, Mohahara 
Kapha alleviating, intellect promoting, rejuvenative, 
beneficial to the voice, vitiated Vata alleviating, 
poison neutralizing, intelligence enhancing, fertility 
promoting, passion destroying. 
Brahmi is beneficial for Kushta, Jvara, Sopha, Pandu, Prameha, and Manasavikara, which can 
be loosely translated as tuberculosis, fever, edema, leucoderma, diabetes, and mental abnormality 
(API 2008). It is used in ten classical medicines209(out of 635 listed formulations in AFI 2008). Despite 
the numerous virtues of the herb, only around seven use brahmi as the primary ingredient. In Kerala, 
brahmi gets into a few more classical medicines besides those listed in the AFI210.  It meets Charaka’s 
criteria of being amenable to multiple forms; it is found in various forms including powder, pills, 
fermented preparations, medicated ghee preparations and herbo-mineral preparations. Of these, the 
most illustrious is Sarasvatarishtam, a brain tonic used to correct speech and enhance intelligence in 
children. The common uses, other than mentioned earlier, include treatment of speech disorders, 
amelioration of anxiety, degenerative neural diseases, post-stroke rehabilitation, and as a secondary 
drug to treat a variety of problems ranging from skin diseases to digestive disturbances. Ayurvedic 
diagnostics gives much importance to the role of stress in disease etiology. Brahmi is one of the 
common herbs that enter poly-herbal combinations as an anxiety-alleviator. 
                                                 
209 Sarasvatarishta, Panchanimba Churna, Brahmi Vati, Sarasvata Churna, Ratnagiri Rasa, Krimi Kuthaara Rasa, Balarka Rasa, 
Smrtisaagararasa, Brahmi Grita, Brihat Arbhacintamanirasa. 
210 Common medicines are Sapthachadarishtam, sarasvatarishtam, Brahma rasayanam, Brahmi doorvadi kera tailam, Chandanadi 
enna, Padoladi and thikthakam ghritams, manasamitra vadakam, Mahamanjishtadi, padolamooladi, and thikthakam kashayams.     
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Though its classical use appears to be relatively low, straightforward and non-glamorous, the 
commodity life of brahmi reveals a far more dynamic story, a story that also takes us through the 
confusions and controversies commonly encountered in the new era of commodification (See Section 
9.4-9.6). A focus on commodity lives of herbs like brahmi can be misleading because most herbs used 
by the ayurvedic industry are low-profile invisible ingredients in complex polyherbal formulations; very 
few have a distinct identity and social life outside them. Index herb kurunthoti is hence more 
representative of the trajectory of commodification of a typical ayurvedic herb.   
5.6 Kurunthoti: the star of decoctions  
Kurunthoti (the ayurvedic drug bala in Sanskrit) has a far less conspicuous presence in the 
commodity scene, which might seem surprising given its place in the ayurvedic pharmacopeia; not only 
is it used three times more often than brahmi in classical formulations211, it is used for a range of 
ailments. In fact, it is more representative of a 
typical ayurvedic herb than brahmi is. In ayurvedic 
pharmacology, however potent a particular medicine, 
its utility lies in its ability to play a supporting role in 
a polyherbal formulation. The multiple properties of 
kurunthoti makes it an ideal candidate. Unlike 
brahmi which is a celebrity all over India, kurunthoti 
in Kerala is like a next door neighbor who is always 
part of one’s daily life. It is this ubiquity that has earned its place in three commonly used proverbs, 
one of which helps in illuminating its centrality  in the Kerala ayurvedic pharmacopeia. Kurunthotikku 
Vatam Vannal (what will happen if kurunthoti itself gets afflicted with Vata?)212 Though kurunthoti has 
multiple pharmacological properties, it is most known for its Vata mitigating properties (See Appendix 
F for its pharmacological attributes). Typical Vata disturbances include rheumatism, joint pains, 
muscles spasms, sciatica, Parkinson’s disease, motor-neuron disorders and so on.  Kurunthoti is an 
                                                 
211 Based on analysis of formulations listed in Ayurvedic Formulary of India (AFI 2008). 
212 Though Vata is a humor, contextually it is used in a sense to indicate preturbance, just as the term Dosa is used both as humor 
and a perturbed state. This is perhaps comparable to the popular usage of terms ‘sugar’ and ‘cholesterol’, to refer to diabetes 
mellitus and hyperlipidemia respectively.  
 
Kurunthoti  
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indispensable ingredient in anti-arthritic medicines, both classical and proprietary. Its role becomes 
critical as arthritis accounts for almost two-thirds of patients in ayurvedic hospitals.213 It is an 
important ingredient in pain oils and massage oils used in therapeutic procedures. Commodification of 
Kerala therapy procedures in both tourist Panchakarma centers and domestic wellness  centers, must 
have significantly increased demand for this herb214. It is also an important rejuvenative, as its Sanskrit 
name bala indicates. It is considered to be especially effective for promoting muscle tissue, boosting 
strength, vigor and vitality. This makes it a popular ingredient in tonics and aphrodisiacs. Sida species 
have been subject to  extensive  pharmacological investigation. The most important alkaloids are found 
to be ephedrine, hypaphorine, vasicinone, vasicine and vasicinol (Ghosal et al. 1975). Because of its 
ephedrine content, it has been one of the plants banned by the FDA (Rados 2004). Bala being one of 
the most common ingredient in ayurvedic formulations, the ban poses a problem for manufacturers 
who seek to export products to the West.   
Kurunthoti is one of those plants that meets all the four of the  classical criteria discussed 
above (See section 5.4) to be selected as a drug. It is not only among the most potent, it is usable for 
multiple conditions and adaptable to multiple forms. Roots of the plant along with 4 finger-lengths 
(angulas) of the stem is the expected part to be used, though almost double the length is in use now. 
Indian pharmacopeia lists 53 classical preparations of which bala is an ingredient, 12 of which it is the 
primary ingredient (AFI 2008). There is no form which it doesn’t manifest215. In Kerala pharmacopeia, it 
is used in around 73 formulations. It is a prime ingredient in Dhanwantaram Kuzhambu and Bala tailam 
that are among the most commonly used in wellness treatments. Kurunthoti is also a principle 
ingredient in medicinal herb infusions used for therapeutic procedures like Njavara kizhi.  
As for the criteria of abundance, there is hardly any other medicinal plant that can compete 
                                                 
213Arthritis is primarily a geriatric disease. Due to lower mortality and fertility, Kerala has undergone a rapid demographic 
transition resulting in a larger epidemiological transition due to increased proportion of the aged to the population (Soman et al 
2011).The predominance of life style diseases (Joseph e al, 2000; Soman et al 2011) might have also been caused by the 
transition from farming to service. Sector-wise contribution to GDP of agriculture, industry and services are India (52%), (14%), 
(34%) (2003) and Kerala 14.5%,  24.6%, 60.9% respectively. 
214 Commodification of ‘brand Kerala’ in rest of India also has led to demand for Kerala commodities mainly medicinal oils and to 
a certain extent decoctions. Though classical, these were made only by manufacturers in Kerala. But in a polyherbal system it is 
difficult to identify individual growth trajectories, which not only requires historical quantitative data on herb demand in 
relation to other herbs, but also an analysis of demands for various medicinal formulations. In the case of Kurunthoti, the 
increasing internal demand for arthritic application can be a confounding factor.  
215 Of these 4 are fermented preparations, 2 are jam preparations, 9 are powders, 4 ghee preparations, 2 types of pills, 4 types of 
Rasas, one eranda paka? and the maximum use of it is part of medicated oils, 27 are oil preparations. 
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with kurunthoti. There is no wasteland in Kerala, wet or dry, coastal plains or elevated hill ranges 
where the plant cannot be found. It is especially luxuriant in disturbed habitats, like roadsides. Even 
now, despite intensive cash crop cultivation, it grows luxuriously in homegardens, unless meticulously 
weeded out. Kurunthoti is also interesting because of its widespread use, both popular and classical. 
Its independent identity at the household and the raw drug shop continues to co-exist with its identity 
as part of finished medicine. It has a vibrant social life as it passes through all the commodity chains, 
the forest, the commons and homegardens, providing insight into the dynamics of supply chain at 
various levels (See Sections 7.2.4, 7.5.1).  
5.7 Centrality of the Decoction in the Kerala Pharmacopeia 
The ayurvedic pharmacopeia of Kerala stands apart from the rest of India, in the importance 
given to two forms of medicine, the oil (tailam) and the decoction (kashayam). Kurunthoti figures 
prominently among herbs that are most commonly used in both these forms. In fact, it is so often used 
in both homemade and classical decoctions that it has become synonymous with the very identity of 
the decoction form. A popular Malayalam proverb says, kurunthoti illatha kashayamundo? (Is there a 
decoction without kurunthoti?). Kurunthoti decoction is considered a common home remedy for 
arthritis. When Sumathi, a bank employee in her mid-40s, developed a knee pain a year ago, she was 
not surprised because Vata problem was prevalent among her family members. She would consult the 
ayurvedic doctor if it were to aggravate216, but at this stage her treatment is limited to the episodic 
use of kurunthoti decoction and a topical application of an ayurvedic pain oil. In her homestead in 
rural Ernakulam, kurunthoti grows like a weed, she needs to do nothing but save a few plants from 
weeding.   
Kurunthoti is particularly important in the care of expecting mothers as indicated by another 
Malayalam proverb, Ayiram kurunthoti parichal 'avoo'nnu parayumpozhekkum peru (prasavam) 
kazhiyum. This literally means, “if you pluck 1000 kurunthotis, the delivery will be over just in the 
time you take to say “avoo!” (an exclamatory sigh)”, implying that the delivery will be effortless. It 
                                                 
216 In Kerala, Arthritis is one of those problems that are typically considered the domain of Ayurveda. For example, patient 
profile of AVP’s hospital for 2007 of 120 beds shows 45% are rheumatology patients.     
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should be noted that the proverb says ‘pluck’ not ‘consume’. It obviously implies consumption, but the 
effort that goes into plucking is part of the prescribed regime. Disguising life style recommendations as 
medicine is not uncommon in ayurvedic practice217. Kurunthoti  is consumed by pregnant women, as a 
decoction or as rice porridge cooked in the decoction. There are regional differences in the time and 
mode of consumption. Sumati says that in her hometown in rural Thrissur, the practice is to consume a 
decoction of a different leaf each of the nine months, one of which is kurunthoti. In some regions in 
Kerala, expecting mothers are required to consume kurunthoti decoction from the seventh month 
onwards. Sahasrayogam, the bible of Kerala Ayurveda, recommends seven decoctions for pregnant 
women, one of which is kurunthoti kashayam. The text also recommends a decoction with kurunthoti 
as one of the two prime ingredients for complaints of post-delivery fever.  
The typical home made decoction involves boiling a handful of kurunthoti root in water and 
letting it simmer overnight. The classical decoction on the other hand, is more elaborate, and requires 
close attention. A regular  decoction is made of one part of coarsely powdered drugs added to 16 parts 
of water, boiled and reduced to one-eighth of the original proportion218. The pot is not be covered with 
a lid; the rationale being that if covered the decoction will not be easily digestible (Sarngadhara 
Samhita MK 2:7, Murthy 1984:57). The idea is to allow the volatile material to evaporate. In other 
words, decoction is nothing but water extraction of active ingredients from medicinal raw material219.  
Kashayam also happens to be the term used for one of the six tastes (Rasa), “astringency”, 
perhaps derived from the typical taste of an ayurvedic herbal decoction. It is this connection that has 
given birth to a common usage, “your face looks like you have just drunk kashayam” used to describe 
an expression of disgust. Another popular usage of the term kashayam is in the verb form, “Kashayich,” 
to mean, “putting a lot of effort.” Preparing decoctions at home, though simple, is a task that takes up 
                                                 
217 A traditional vaidyan narrated this incident. He had prescribed a patient with a treatment that required him to consume juice 
of a herb to be freshly plucked from the forest every day. The hidden agenda was to make him walk a long distance every day, as 
being sedentary was one the root cause of his illness. The vaidyan said, “There was no guarantee he would have done it if I had 
told him to walk. People want medicines as short-cuts, modifying life style or diet is too much of work you know. The same is 
true with food prescriptions. If you get an emaciated patient for whom you realize require a bit of fattening up, and if you 
recommend to take more milk or ghee they will not do it. They expect the medicines to do all the work. The medicines are 
important, but in such cases they won’t work without some additional nutritional input. Prescribing a ghee-based medicine is a 
better way of getting some fat into them.”  
218 While water based decoctions are the most common, there are also other types like Ksheerapaka (decoction in milk) and 
Tandulajala (decoction in rice washings). 
219 Arishtam (a fermented form of Ayurvedic medicine) is also used in the same sense in the verb form Arishtich. These terms are 
an indicator to the ubiquity of Ayurvedic medicine making in popular culture. 
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time and labor. It is customary to cook decoctions on a firewood stove. Janakiamma talking to her 
daughter-in-law about her current medicine routine fondly recollects the decoction making process, 
“Once it is boiled, the decoction has to be left to simmer on the heat of the cinders over night, and 
then in the morning you can just boil it once and consume. But these days with gas you can’t do that!”  
This is however not a problem in most ‘modern’ Kerala households, where the gas stove and the 
fireplace continue to co-exist. In other parts of India, with the switch from firewood to gas, the 
kitchens in modern middle-class houses underwent a irreversible transformation. The messy traditional 
fireplace disappeared, and along with it, the suit-layered walls and roof. Vessels switched from clay 
and aluminum to swanky steel, housewives no more had to struggle scrubbing soot-layered vessels. But 
in Kerala, kitchens in modern middle-class houses usually have two parts, a swanky part meant for gas 
stove cooking and a less sophisticated anteroom providing for the fireplace and space to store 
firewood. The material used for walls, tiling and countertops tend to be likewise different, the 
traditional kitchen sporting more rugged and less showy material like for example, clay tiles for 
flooring. Perhaps one more symbolic representation of the Malayalee’s faithfulness to tradition.  
 “Keraleeya Chikitsa Kashaya Pradhanam” 
(“Kerala treatment is decoction centric)” is an often 
repeated saying among Kerala Ayurveda practitioners. 
Of the 1000 formulations in Sahasrayogam, the master 
recipe book of Kerala Ayurveda, 400 are decoctions. The 
pharmacopeia of Kerala is heavily dependent on 
Sahasrayogam.220  Manufacturers in Kerala make  around 
50-70 decoctions (17% of pharmacopeia) whereas the 
large and medium North Indian manufacturers make less 
than 4 (1.5% of pharmacopeia). (See Appendix E.1). 
Kerala pharmacopeia is also unique in its emphasis on 
medicinal oils.  
                                                 
220 Estimated proportion of dependence being anywhere from 40-70%. Analysis of product portfolio of one large pharmaceutical 
company showed 40% were based on Sahasrayogam. 
 
Decoction making demonstration by 
Production Manager, AVP, Ayurvedic 
Pharmaceutical workshop, Coimbatore, 2008 
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There could be regional variations in pharmacopeia on which there is no data available, but 
there is no report of decoction predominance in the ayurvedic pharmacopeia elsewhere in India. The 
closest suspect is the region adjacent to Kerala in Karnataka State. As mentioned earlier, the Secretary 
of the State’s Manufacturing association considered this region to be an extension of Kerala with regard 
to Ayurvedic culture. Analysis of secondary data available from a survey (Shivprasad and 
Chandrashekhar  2003),221 shows that the region’s pharmacopeia is in between Kerala and North Indian. 
It has a low proportion of decoctions like the North Indian pharmacopeia, but is more similar to Kerala 
in the importance given to medicated oils, jams and powders. It is also unique in that it has no 
medicinal ghees and has an over-emphasis on medicated wines that account for nearly 50% of the 
pharmacopeia. 
An exchange on an internet forum between a North Indian patient and a doctor from Kerala
222
 
shows the enormity of the difference between the pharmacopeia.  
North Indian Patient         Jan 19, 2011 
Hello Doctor, 
I visited a Kottakkal physician for my joint pains and a few other complaints recently. To my 
surprise, they have never heard of common ayurvedic preparations like Mahasudarshan and 
Kamadudha Rus which have been used in our household since my mother is an ayurvedic 
consultant with the Government. Not only are these readily available by Dabur and Zandu, these 
are widely used in Ayurveda as classical preparations. I could not make any sense of medicines 
available at the AVS as most of them do not have any reference/common name in Ayurveda. Could 
you please explain if Kottakkal AVS is a different branch of Ayurveda as it certainly does not 
seem to have much in common with the Ayurveda practiced worldwide. 
 
Doctor  from Kerala        Jan 20, 2011 
Hello, I have heard about these medicines but not used yet because there are a lot of medicines 
which have the same action of medicine specified…I think most of the ayurvedic doctors of Kerala 
or south India are not using this type of medicines because Rasa preparation if not purified clearly 
is very dangerous223… the main reason why these medicines are not used widely… other thing to 
tell you is that all ayurvedic medicines are not available in all pharmacies because there are 
thousands of medicinal preparation in Ayurveda…it's impossible to manufacture all..only 
those…needed…are manufactured...thank you. 
The patient is so confused on encountering an alien pharmacopeia that he arrives at a 
                                                 
221 Sample of manufacturers includes 17 industrial and 21 household manufacturers of erstwhile Dakshina Kannad district 
(including Udupi district)  
222 http://ayurvedictreatmentmethod.blogspot.in/2010/06/kottakkal-ayurveda-medicine.html 
223 Among practitioners in Kerala, it is common to come across the perception that these preparations were powerful but 
complex to prepare, dangerous if not prepared properly or used in the right context and dosage. In a meeting of traditional 
practitioners in Kerala, a vaidyan was advocating the use of a particular Siddha medicine, a herbo-mineral preparation as 
effective for a particular ailment. Speaking of it, he said, “I make all my medicines, but I wouldn’t dare to make Neet Marunnu 
(Malayalam term for mineral-based medicines). The process is very complicated and  you need expertise and experience in 
making them. The materials used are poisonous and therefore cannot afford to make mistakes. You have to be also careful about 
the source from which you buy.” 
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conjecture that AVS Kottakkal must be a different branch of Ayurveda.  
That Kerala traditional practice is principally based on prescription, depending on people to 
make medicines at home. Traditional practitioners’ narratives in Kerala reveal that depending on a 
service model primarily based on consultation is a practice neither uncommon nor recent224.  This is 
also noted by many local practitioner-scholars (for example, Namboodiri 2000, Thirumulpad 2002). An 
extensive interview of Ashtavaidyan practitioner provides a clear picture of historical practice. 
There were no dispensing pharmacies (vaidyashala) in former times. Therefore, all patients had 
to prepare their medicines like decoctions at their homes. We (Ayurvedic doctors) just had to 
prescribe the medicines with appropriate methods of preparation for each patient. Ayurvedic 
doctors had only a few prepared medicines at hand, like a few tablets and so forth [in former 
times]. All the other medical preparations, such as decoction (kashayam), medicated paste 
(lehyam), medicated ghee (ghritam), and oils were prepared by patients themselves. Their 
methods of preparation were also given along with the prescriptions (Yamashita and Ram 
Manohar 2007: 125) 
Thirumulpad (2002) points out that ayurvedic medicine in Kerala was focused on simple forms 
that people were expected to make at home using local resources, which made it less expensive. Even 
among herbal medicine forms, Kerala practitioners did not use much fermented medicine preparations 
unlike in the North. This was contrary to the classical textual expectation that patient to be wealthy 
enough to afford ayurvedic treatment. Abdulla, a traditional pediatrician from rural Thrissur said, 
neither his father nor he ever made medicines (See profile in Section 3.6.2). He was getting paid a 
consultation fee of ` 20-50 ($0.4-1) per patient that was more than sufficient for his livelihood. 
Medicine-making he felt was an unnecessary bother, a drudgery not justified by the returns. Back in 
the 1960s, the average consultation fee was a rupee. But unlike the allopathic practitioner they never 
‘asked’ for a fee, it was left to patients’ discretion; they could pay more or less depending on their 
affordability. People would also pay in kind, usually with farm produce. Consultation fees was 
considered adequate enough for vaidyans to their livelihood, but not to accumulate wealth. This 
changed gradually with the transition from the vaidyan to the doctor status, reports a doctor from a 
vaidyan family. He earned a pre-BAMS degree in the late 50s and his value began to soar when he 
changed from the local mundu to western pants; people began to pay double the consultancy money.  
The emphasis on simple medicines in classical medical practice in Kerala, therefore, is integral 
                                                 
224 Until late 19th century, be it in Britain or India, it was uncommon for physicians to earn their livelihood from consultation fee 
(Kapil 1988).  
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to the wide prevalence of household processing of medicine in Kerala225. The simple inconspicuous 
decoction seems to have played a significant role in connecting people to medicines and medicinal  
ingredients. The simpler of the decoctions, especially home remedies, are based on locally found herbs 
that are familiar and available to people. Classical formulations  on the other hand, also include 
ingredients that are non-local or non-seasonal for which people have to resort to the raw drug shop. 
Such widespread use of raw drugs must have led to the evolution of the raw drug shop as a key node in 
the traditional consumption of medicines. Though the use of decoctions appears to be uncommon in 
the classical pharmacopeia in rest of India226, it seems to be common in the medical systems in other 
parts of Asia, China (Zhan 2009), in Vietnam (Craig 2002), in Thailand and Indonesia (Esterik 1988).  
5.8 The curious case of kurunthoti decoction and two confused, young, expecting women 
In a pluralistic system, patients are often caught between the egos, ideologies and professional 
jealousies of doctors of different systems. The struggle is especially intense between allopathy and 
ayurveda; allopathic doctors given their historic status of privilege often have an upper hand in passing 
on their judgments and prejudices to their patients. Patients are constantly caught in this conflict. 
Some submit to the doctors’ authority and follow their advice in rejecting home remedies or other 
systems of medicine, whereas some choose to keep the doctors in the dark about their non-allopathic 
practices227. Kurunthoti’s biography reveals one such story of two young expecting mothers caught 
between two medical systems. Both modern young professionals who live outside Kerala have landed at 
their mother’s homes in Kerala a few months before delivery, they are exchanging notes on an online 
forum228. Kurunthoti decoction dominates the discussion.  
Comment by an expectant mother from a consumer’s forum 
So far I have not taken any ayurvedic medicines. But yes, people have been suggesting a lot. We 
have a good ayurvedic doctor who suggested some good tablets (for Garbha Raksha) which we can 
take since 7th month. But when we checked with my Gynaec, she asked me not to take it since 
she doesn't know how it will interact with the other prenatal Vitamins I take. But according to 
ayurvedic doctor, it doesn’t affect the allopathy medicines. However I did not take it, since I 
                                                 
225 As mentioned earlier, North Indian pharmacopeia is dominated by complicated forms, especially herbo-mineral preparations 
that could be made only by experts. In Kerala, simpler forms like juice of the herb and decoctions are processed by the 
consumers themselves, complex forms like vines and pills are invariably made by practitioners. (Said earlier?) 
226 It is however not clear whether there is a use of decoctions at popular level. The absence of evidence can be taken to mean 
absence of practice, but it might also mean lack of researcher attention to popular medicine.  
227 A common behavioral pattern of non-disclosure of CAM use to their biomedical practitioners (Robinson and McGrail 2004).  
228 www.indusladies.com/forums/pregnancy 
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wanted to listen to my Gynaec since she is the main doctor for my delivery…However I may start 
doing the following two things from 8th month onwards. One is Kurunthoti kashayam. i.e. Boil 
water using a medicinal herb and drink it. Second is External application of ayurvedic thailam (oil) 
like Dhanwantaram tailams for relief of body pain. These two are of no side effects at all. 
Regarding post-natal care, yes my mother arranged one lady who will take care of me and the 
baby during the initial months. This lady is experienced in post-natal care. My mom asked her to 
come by August 1st itself though my due-date is only on 24th…These days it is really really 
difficult to get these people and they ask a lot of money. My mother started searching for this lady 
from the time she came to know I’m pregnant, ha ha. Many other families were also looking for 
same lady for august but since we booked in advance and agreed to pay more, we finally got this 
lady. last time for my sister's delivery we tried for the same lady, but she was booked by someone 
else. These people demand a lot and needs VIP treatment. for e.g. she needs a car to pick her up 
from her home everytime !!! ha ha ... 
Response from another expecting mother from Kerala 
Yes, I'm at Kerala now. I'm working from home since last month, till end of June. From first of July 
I'm on leave. It's really good to be at home , eating mother's food…My Gynaec advised against 
Kurunthoti kashayam, since she said she doesn’t know what effect it may cause. Hence though i 
believe it is harmless (in fact i know 100s of women take it) i dropped the idea of having it…But 
she said I can use external application of ayurvedic oil. We bought "Dhanwantaram Thailam" from 
Kottackal. I'm applying warm thailam (oil) every Tuesday and Friday before taking bath (for 10 
mts) and take bath in warm water. I started only last week, but I can already see results. My body 
pain has reduced. 
In the above exchange, the first mother was told not to take the ayurvedic medicine by the 
allopathic practitioner. Since obstetrics/child delivery has almost entirely shifted to the realm of 
allopathy, people have become increasingly dependent on the advice of gynecologists and 
obstetricians, a trend that people from earlier generation criticize. Though she particularly mentions 
that she got some ‘good’ tablets prescribed by a ‘good’ ayurvedic doctor, she had no choice but to 
listen to the allopathic gynecologist on whom she was dependent for delivery.  However, note that she 
does not find it necessary to ask the doctor about using kurunthoti kashayam. This could be either 
because she thinks it is a home practice akin to food that does not fall into the ‘medicine’ category or 
because she has trust in a traditional practice that she suspects an allopathic doctor is likely to be 
unappreciative of. The second mother on the other hand, mentions this to her doctor who promptly 
advises her against it. A popular Malayalam health care monthly brings up this discordance for 
discussion (Manorama Arogyam 2012). The article presents a balanced perspective on the commonalties 
and divergence in the views of allopathic and ayurvedic doctors on the matter of post-delivery care. It 
points out that since 100% of the deliveries take place in hospitals where adequate care is provided, 
allopathic doctors are dismissive of the need for elaborate ayurvedic treatments, but in spite of it, 
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Malayalees by and large prefer to follow the ayurvedic post-delivery treatment even today. This is 
reminiscent of use of Jamu (traditional Javanese medicine) in Indonesia as a parallel system of 
postpartum care (Esterik 1988). Note also the comment from the first mother about the lack of skilled 
people for treatment and the consequent bargaining power enjoyed by the service providers. This has 
scarcity has resulted in the evolution of new forms of service commodification ( See Section 7.16) 
Ambika, a professor in an ayurvedic medical college in Northern Kerala said she had a tough 
time as her allopathic gynecologist was dead against her following the traditional ayurvedic regimen. 
This being the case, the plight of the average Malayalee is not surprising. Complaint about allopathic 
doctors’ hostile attitude towards Ayurveda is often heard.  Ayurvedic doctors feel that allopathic 
doctors’ attempts to indoctrinate patients as an important reason that contributed to patients moving 
away from ayurvedic medicine. Ayurvedic doctors also express their distrust with allopathic diagnosis 
and medicines, but unlike allopathic doctors who are dismissive of patients taking other medicines, 
they say that it is acceptable to take ayurvedic medicines along with allopathic, that they are 
complementary and not conflicting229. But the trend of advising against the use of traditional herbal 
practices is not universal. There are allopathic practitioners and nurses, especially of the earlier 
generation who are themselves rooted in such traditions and practice seasonal routines. Unlike 
allopathic doctors outside Kerala who prescribe ayurvedic drugs as a result of marketing done by 
pharmaceutical companies, in Kerala there are many who do it from their personal experiences. For 
instance, Jancy a farmer in her early 50s, was prescribed decoction of the herb Cheroola230 by an 
allopath for her chronic kidney complaints after allopathic interventions failed. There are also 
allopathic practitioners who refer patients to ayurvedic doctors. Dr. Vasudevan Namboothiri of 
Vaidyamadham Vaidyasala said, “Allopathic doctors have done much damage by spreading wrong ideas 
about Ayurveda through their patients. However, there are also a class of doctors, who are much 
enlightened whom we have a very good relationship with. They even refer patients to us, for illnesses 
                                                 
229 This has developed as a convenient, perhaps unconscious strategy to accommodate themselves within the dominant system 
challenging which might be counterproductive to them in the long run. Homeopathic doctors on the other hand usually proscribe 
the use of other medicines, contending their minute dosages are easily neutralized by other substances.   
230A herb well known for its diuretic properties, used for the treatment of urinary ailments and kidney stones. 
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that they think our medicines work better”. 231  
I got an illustration for cross-reference from a story recollected by one of the respondents, 
Anju, a retired nurse in her mid-60s. In her late 50s, she had consulted an orthopedic in a neighboring 
large, private allopathic hospital, after a bad fall. Following an x-ray, the doctor confirmed that she 
had a hair-line fracture after an x-ray. After weighing the pros and cons, the doctor told her, “given 
the location of your fracture (hip) and age, putting a plaster cast and getting confined to the bed for a 
month is difficult for you. I recommend that you visit Poosanampatti.” 232 She took the advice, and 
went through the procedure. Though she had to travel 70 km up and down twice for the treatment, she 
was back in action in a matter of three weeks233.  
5.9 Breaking barriers: commodification of the decoction  
Complexity of processing and perishability are important factors influencing commodification.  
Most of the classical forms already had a long shelf-life234; no advanced technology was required to 
turn them into shelf-ready commodities. The ayurvedic manufacturer who began to dream big by 
converting the small scale vaidyashalas into a centralized mass production, had little else to do besides 
convincing practitioners to buy from them. It was not difficult to convince them as artisan production 
was already in place, and the vaidyans were already accustomed to outsourcing the processing of 
complex medicines. Decoctions posed a problem, as they were highly perishable. They had to be used 
within two to four days of making, depending on the nature of ingredients and climatic conditions. The 
greatest challenge to mass production therefore was the polyherbal decoction. Given its centrality to 
medicinal practice in Kerala, unless decoction could be put on the shelf, the penetration of the 
manufacturer into the ayurvedic market would be limited. So, in early 20th century, when Dr. P. S. 
Varier of AVS took a small and simple step of adding Sodium Benzoate to the decoction to make it 
                                                 
231He said that they do send patients to allopathic or homeopathic doctors depending on the case. He usually prefers to send 
patients with acute infections to allopathic doctors.  During a consultation I witnessed him recommending a patient complaining 
of warts, to try homeopathic treatment instead. However, cross-referencing to other systems from Ayurveda to allopathy 
happens less often as usually patients make the choice based on the strength of the system.  
232 A place in Tamil Nadu bordering Kerala, reputed for traditional bone-setters. Treatment involves setting right the broken limb 
with the help of bamboo splinters, following an application of medicated oil. 
233 The cost of treatment was ` 300 ($6) (a tenth of allopathic treatment). Despite the cost of private taxi amounted to ` 1500 
($30), she saved half the money she would otherwise spend.   
234 Fermented preparations (Asavas and  Arishtams), medicinal jam-like forms based in jaggery (lehyams), ghee-based forms 
(Ghritams), Pills (Gulikas and Vatis). 
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shelf-stable,  the biggest step in commodification of Kerala Ayurveda was taken. It certainly met with 
opposition from the conservative practitioners, however it did not take much time to become an 
established practice. In the words of an eminent ayurvedic practitioner-scholar from Kerala,  
One does not have to roam the sunny fields or the grassy hill slopes anymore in search of the 
herbs! The involved process of grinding the ingredients and preparing the medicine by boiling, 
reducing to one fourth on a low fire…was done away with. The day we did away with the family 
‘kashaya kalam’ (the decoction pot) we became entirely dependent on the market and had to be 
satisfied with whatever it dished out (Agnivesh 2010:83).  
When Dr. P. S. Varier started production, he was talking about the difficulty in convincing 
people to stop making medicines at home and buying the market. But the Kerala ayurvedic market has 
come a long way since then. The market for finished medicines has expanded enough to accommodate 
thousand odd manufacturers. In the words of a reputed practitioner-scholar from Kerala,  
This convenience was cleverly maneuvered to make the preparation of medicine look like a 
bothersome inconvenience and the customer was gently persuaded to step back from the 
preparation of medicine (Agnivesh 2011:84) 
Traditional practitioners who used to only limit their consultations to prescriptions moved to 
medicine-making using new technologies like pulverizers and mechanized grinders. Two respondents, 
small practitioner-manufacturers from vaidyan families said they began to make and sell medicines 
when patients began to buy medicines from the market. One claimed that he was motivated following 
a moving account of a patient, a daily wager who had to take a day’s leave just for making medicines. 
Whatever be the stated reason, for  practitioners it must have made economic sense to cash in on their 
regular clientele, instead of letting them buy from elsewhere. According to Kabir (2002 cited in Harilal 
2008) average self-trained practitioners who could not compete with institutionally trained ayurvedic 
graduates, turned into manufacturers and salesmen of medicines.  
The first pre-packaged decoction came in 500 ml bottles that lasted for ten days, the typical 
dosage being 30 ml twice a day to be consumed directly. Another form of decoction soon emerged 
called kuruku kashayam, which was nothing but concentrated decoction that had to be mixed with 
water. This did not make much difference to the consumer, but made a big difference to the industry 
in terms of packing and carting, as bottles reduced to a manageable size of 200 ml. Most manufacturers 
prefer this format now, though there are some who continue to make the older form.  
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But as we can see from the continuing consumption from raw drug shops, factory medicine has 
not yet stopped people from  cooking decoctions at home. This is not surprising; a similar trend is seen 
in the food market. Despite the inroads commodification has made  ranging from spice mixes to ready-
made food, it is still common for people to make their own spice mixes. The reluctance of the 
Malayalee patient to consume and practitioner to prescribe factory-made decoctions contaminated 
with preservatives, allowed space for other forms of commodity to emerge.  A common commodity in 
this space is the kashaya churnam, i.e., “decoction powder”, powdered form of decoction that needs 
to be boiled for a short time. This segment is mostly dominated by small manufacturers, but a few 
large and medium manufacturers  do sell a narrow range of powders of commonly used decoctions.  At 
a further lower level of commodity is the kashaya-koottu , i.e., ‘decoction mix,’ finely chopped 
ingredients packed and labeled by formulation. Branded commodities are not common in this segment. 
The most common of the decoction mixes are those packed by retail raw drug sellers (see Section 6.1). 
There are also some disease-specific proprietary products from micro manufacturers who capitalize on 
family knowledge of traditional recipes, commonly aimed at urinary stones, hemorrhoids, etc. This is in 
a way nothing but an extension of the single-root (ottamooli) practice in the commodity form. 
Decoction powders and mixes are among the highest selling commodity for Oushadhi, the Kerala State-
owned manufacturer. For this company, the policy is more rooted in a sense of commitment than 
business. The marketing manager of Oushadhi is unhappy that these products eat into their profit 
margins; they could achieve better turnovers if they eliminated or scaled down such products.  
Another commodity in the space, invented and dominated by a single company, is the 
kashayam sookshma churnam, (decoction micro-fine powder) which is just another level of simple 
processing. Everest Pharma, a newcomer to ayurvedic manufacturing is the single handed inventor of 
this product category. The company began with decoction powders on the advice of the vaidyan (see 
page 80). The purpose was to aid patients to make decoctions at home by making the process less time 
consuming. The business model was successful;  Everest has now grown to a ` 20 mn ($0.4 mn) 
company. The product form continues to remain their mainstay. Their brochure, complete with a 
pictorial representation of the process, emphasizes on the marriage of convenience with tradition, 
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Everest Pharma developed the concept of kashaya sookshma choornam (KSC) after thorough study 
of all parameters and consulting many scholars of Ayurveda….KSC updated traditional kashayam 
into the instant age and hence considered a landmark in Ayurveda….KSC is the modern version of 
kashayam, better than the other forms available, suitable for present life.  
The absence of preservatives is emphasized, elevating it above the industrial decoction which 
is contaminated with a non-ayurvedic chemical. Everest Pharma displays on its website a newspaper 
report that summarizes several arguments and counterarguments regarding the appropriateness of this 
form (Davies 1995). There is an argument voiced by a few reputed scholars that the use of decoction 
micro-fine powder instead of the regular decoction mix can cut down the material requirement by 60%, 
that this would be less expensive for the patient and would help in conserving valuable medicinal 
resources. The dissenters including the Secretary of the Kerala Ayurvedic Medicine Manufacturers’ 
Association argue that the form is not recommended by the classics. They advice caution and they 
suggest that more research needs to be undertaken to ascertain its efficacy and safety. In the past 
decade, the decoction has got dragged to the next level of value addition in the form of ‘decoction 
tablet’. Unlike other forms, it has become a bone of contention between ayurvedic manufacturers and 
conservative Malayalee practitioners. The Kerala consumer is now faced with a new dilemma. Is the 
decoction tablet the same as the decoction? This issue is taken up for discussion in Section 9.2.  
5.10 Conclusion 
Index plants brahmi and kurunthoti provide a glimpse into popular culture of medicine and also 
showcase people’s involvement in processing classical medicines at the household level. To make a 
definitive statement on the reasons that have contributed to producing the distinctness in the medicine 
making in culture in Kerala Vis-à-vis rest of India, is not possible without a comparative investigation. I 
suggest that the nature of pharmacopeia in vogue, is one important contributor to this distinction. 
North Indian pharmacopeia is dominated by herbo-mineral preparations, that tend to be complex and 
have to undergo time-consuming processes of purification. As a result, medicine-making might have 
evolved as the province of the expert practitioner. Even the herbal pharmacopeia outside Kerala is 
skewed towards more complicated forms, fermented preparations, pills, and ghee-based preparations. 
Decoctions and oils are the least preferred. Kerala pharmacopeia on the other hand is not only 
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predominantly herbal, it also was centered around simple forms like oils and decoctions, heavily based 
on herbs from the surrounding commons. The ubiquity of the decoction in the ayurvedic pharmacopeia 
in Kerala made home processing of medicines a regular activity. The only challenge for the North 
Indian manufacturer was to wean off the practitioner; Kerala ayurvedic manufacturers had the 
additional task of breaking the barrier of household medicine-making. Commodification of the 
perishable decoction can be therefore considered the most important step in deskilling consumers, that 
was done with the promise of saving people from the drudgery of cooking medicine.  
Everyday involvement in making medicine binds lay people in a relationship with ayurvedic 
ingredients. Etkin (2008) in her discussion of Hausa medicine, discusses the importance of organoleptic 
(sensory) qualities in people’s evaluations of food and medicine. Consumers in Kerala, in being involved 
in the making of medicines, had developed familiarity with commonly used raw material and sensory 
qualities of medicines and medicine ingredients. In the process of making medicines, the pungent 
aroma of the decoction simmering on fire, the unpleasant astringent flavor of the decoction had come 
to be associated with healing; the smells and tastes conveyed a sense of comfort and reassurance 
absent in the experience of consuming factory-made medicine. This personal knowledge of and affinity 
with medicinal herbs, I argue, served to promote both active and passive conservation of medicinal 
resources in commons and homegardens. Accumulation of organoleptic knowledge of ingredients also 
made lay people knowledgeable of ingredients and therefore, perceptive of their quality. This in turn 
made them sensitive to minor changes in the ‘form’ of medicines. Distancing people from medicine 
making therefore deskilled them in several ways, an important effect of which can be seen on 
conservation of resources in homegardens and commons (for detailed discussion, see Section 7.4). But 
the metis and habit that developed due to the historical household involvement in medicine making has 
made the average Malayalee resistant to the deskilling effects of mass production. Though factory 
made decoction has made significant inroads, the process of commodification of ayurvedic medicine in 
Kerala is far from complete. Finished medicine still has to compete with home made medicine, and in 
the space between the older ‘slow’ medicine and the ready made ‘fast’ medicine, numerous other 
forms have emerged that offer a mid-way solution.  
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6. CH 6 UNPROCESSED AYURVEDA 
Raw drug shop: the  key node of pre-industrial Ayurveda 
If there is a single node that can be identified as key in the network of ayurvedic metis in 
Kerala, it is the raw drug retail store. From ancient times to up to half a century ago, these shops were 
the nerve centers of ayurvedic medicinal consumption in Kerala. The landscape of Kerala, both urban 
and rural, is dotted with retail raw-drug shops. Be it in the city of Kottayam, a town that is known for 
its gulf and rubber wealth, or in the capital city of Trivandrum, or in the financial capital Ernakulam, 
raw drug shops can be seen jostling for space amongst 
swanky textile shops and gold marts. For example, as we 
can see in the image on the right, in the heart of 
Trivandrum, a raw drug shop (shop in the extreme left 
corner) stands neck to neck with up market malls and 
textile stores. There is no statistics available on the 
number of raw drug shops, but in the seven districts that 
I traveled for field work235, the average density is one 
shop in every second or third village centre (within a 
distance of 5-8 miles). In a larger town, the number of 
shops range anywhere from 3 to 6, in a smaller town 2 to 
3 (See Section 2.8). In the past decade, with 
urbanization, many new shops have opened to occupy 
hitherto unrepresented villages or to match the demands of growing towns.  
Lack of attention to this market segment in social science research on Ayurveda is not 
surprising because elsewhere in India their presence is restricted to market centers in big cities and 
towns where they mainly cater to traditional practitioners and manufacturers rather than to the 
                                                 
235 Three in Central Kerala, Four in North Eastern Kerala, and one in Southern Kerala.  
 
Raw drug shop jostling with modern malls in 
the heart of Thiruvananthapuram city 
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general public.236 In Kerala, on the other hand, only a few large raw drug shops in markets cater to 
wholesalers; the rest cater to the retail market. Some wholesalers also have a retail front end. An 
ayurvedic practitioner from Rajasthan expressed his envy of Kerala practitioners because people in 
Kerala had access to raw drugs which made ayurvedic medicine affordable to patients from lower 
economic classes237. 
Following detailed ethnography of popular and traditional medicinal practice in coastal Tamil 
Nadu, Sujatha (2007) identified the raw drug shop as a key node in the knowledge network of ‘medical 
lore’. The presence of raw drug shops was noted in 18th century Punjab (Sivaramakrishnan 2006). In 
both cases, these appear to be a urban feature, present only in towns and cities. In fact, the ayurvedic 
raw drug market outside Kerala appears to be recent. Kumar (2001) points out that during the Moghul 
era, a class of druggists (attaris) had developed to supply raw drugs, extracts and compounded 
medicines to Unani practitioners, but ayurvedic practitioners had no such network; they had to source 
raw drugs from the grocer, villagers, forest-dwellers and other vendors.  
As discussed in the last chapter, in pre-industrial Kerala, household processing of simple 
medicines was common; non-local ingredients were sourced from raw drug shops. Medicines sold in  the 
shop are called Angadi Marunnu (‘market medicines’) because they were historically sourced only from 
the market238. In fact, the typical name of a raw drug shop is suffixed with Angadi (e.g., Angadi 
merchants). The shop is referred to as Angadi Kada, literally ‘market shop’. In some regions, it is also 
called ‘pacha marunnu kada’ (the fresh/raw medicine shop). If a businessman is said to be involved in 
‘angadi business’, i.e., ‘market business’ it is understood that he is into raw drug business. How raw 
drugs came to be the most representative of all commodities for market activity, is an intriguing 
matter that begs further investigation. But prima facie, it is an indicator to the historicity of the raw 
drug trade in Kerala, that appears to have been as old as spice trade. There is evidence of raw drugs 
                                                 
236Conversations with doctors from other parts of the country including Rajasthan, Karnataka, UP and Maharashtra and a 
pharmacognosist from Rajasthan who was familiar with raw drug market field revealed the lack of such widespread raw drug 
retail network. Inquiries with a few residents of Tamil Nadu, Karnataka and Maharashtra, substantiated this view.  
237“During my training in Kerala I found Jadibhuti (Hindi term for raw-drugs) shops everywhere. We have large shops only in 
major cities, people in rural areas have no easy access to raw drugs. I envy the practitioners of Kerala. I used to be working in a 
government hospital, and I have come across a lot of poor people who cannot afford medicines. If raw-drugs were available to 
people in rural areas, it would have made health care affordable to the needy”. (Dr. M. Gupta, participant, Global Ayurveda 
Conference, Jaipur, Dec. 2008/9). 
238 Even those collected locally ( e.g., Karimkurunji), but for a few exceptions (e.g., Kurunthoti), first enter the wholesale 
market, from where it may travel to any of the retail markets in the country.  
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being part of ancient transnational spice trade stretching from China to Greece. Evidence about 
medicinal plants being part of the global spice trade network between 10th and 12th centuries is 
available from the Geniza documents239 (Hall 1978)240.  
Islamic physicians who visited India between 14th and 19th centuries translated several 
ayurvedic texts into Persian and Arabic, and integrated therapies and drugs of ayurvedic practice into 
their system of medicine. This would have further expanded the import and export of raw-drugs 
between India and the Middle East. A Manipravalam (old Tamil-Malayalam) document between 14th to 
16th centuries241 provides a list of 42 raw drugs (Rajagopalan 2008)242. Another 600 year old 
Manipravalam manuscript collection (Alathur manipravalam) shows that by then though local fresh 
herbs were used, dependence on raw drug market was high  (Varier 2009). If non-local medicinal 
material had to acquire the status of spice, it would indicate the historicity of Kerala practitioners’ 
connection to the classical ayurvedic system and a consequent demand for a pan-Indian materia 
medica.  
The chapter begins with an ethnographic account of transactions in raw drug shops in section 
6.1. The number, complexity and variability of raw drugs makes selling a metis-dense activity. 
Moreover, consumption of medicine commodities unlike most others is expected to be mediated by an 
expert. Though this is the doctor’s role, raw drug shop keepers are expected to be knowledgeable 
about composition, processing and dosage. A discussion on the nature of knowledge and skills 
demanded of raw drug sellers in everyday transactions, is presented in section 6.2. Being at the cross-
roads of transition from raw to finished medicine, raw drug shops provide an ideal ethnographic 
vantage point. Section 6.3 documents the transition of consumption from home-processed to factory-
made medicines, the reasons for such shift and the implication for raw drug shops. It is surprising to 
                                                 
239 Geniza documents are scraps of paper, letters of correspondence, and figures of business transactions maintained by a group 
of Jewish merchants between 10th to 12th centuries, found hidden in a room in a synagogue at Fustat in Old Cairo. Fustat 
merchant families established branches of operation in the ports of Malabar and Coromandel coasts.  
240 This was the coastal trade route between Arabs, Egypt, India, China and rest of South Asia. There was also an Himalayan trade 
route that traveled both towards south and through Afghanistan to the Port of Petra on the Red Sea. This is probably how the 
famous Spikenard used by Mary Magdalene to anoint the feet of Jesus, traveled from the Himalayas to Rome through Arabians 
and Parthians (Thorley 1969). 
241The fact that market items included food that is considered subsistence in Kerala even today (e.g., jackfruit, plantain stem) 
suggesting the existence of a substantially urbanized civilization.  
242 The list ranged from plant material like turmeric, spikenard, ashwagandha, to animal derivatives like gorochona (stone taken 
from the gallbladder of a cow), civet cat secretion. 
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note that despite the inroads made by finished medicine, raw drug shops continue to co-exist. Section 
6.4 provides an analysis of factors that drive continuing raw-drug consumption. These include: 
predominance of decoctions in the Kerala pharmacopeia, narrow range of manufactured pharmacopeia, 
people’s perception of home-made medicine as authentic, and also economic considerations. 
Traditional-popular formulations, a category based in popular seasonal and  post delivery diet regimes, 
is an important segment that drives raw drug consumption; section 6.5 provides two illustrations.  The 
example of seasonal medicine porridge shows the vulnerability of this segment to commodification 
(6.5.1) whereas home-processing of post-delivery medicine (6.5.2) shows resistance to factory-
produced commodities. 
6.1 Key node of an ancient commodity chain: a descriptive account  
A routine week day in Thrissur, Central Kerala. The city has just begun to warm up in the 
morning sun. The market street located at the heart of the city is already teeming with people and 
traffic; the usual nightmare of a busy city street in India where all are equal in their claim to the right 
of way, irrespective of the direction they are heading to. Every half minute, a private bus zooms by, 
gulping in and spitting out hoards of people. For an unaccustomed pedestrian like me, it is a long wait 
to cross the street.  Across the street is a row of shops, all colorful and smart looking with the new flex 
boards and neon signs. One tiny spot catches the eye; at first glance, it looks like a piece of a 
vegetable market cut and pasted on a posh urban  landscape. As the swarming customers thin out, the 
shop becomes more visible - strange shaped roots and herbs are seen hanging from the roof, gunny bags 
stuffed and overflowing with roots are lying all around the shop spilling over to the pavement. By the 
time I try to make sense of the stuff, the shop has again collected a crowd. Perhaps it is the busiest 
shop on the lane, though in all likelihood, selling the lowest-priced goods compared to other shops on 
the street. Given the value of land in Kerala, it is a wonder that a business like this continues to thrive 
on such prime real estate. What makes it look even more outlandish is that its neighboring shop sells 
the priciest commodity in Kerala next to land – gold. Ironically, the board of the jewelers’ shop has 
extended over and literally swallowed the adjacent board. Is it metaphorically portending an ominous 
future? A mixed aroma of raw drugs envelop me as I approach the shop. The board announcing the 
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name of the shop, Country Drug Merchants, becomes visible only on entering the shop. It is an ancient 
hand painted board that appears in stark contrast with the adjacent modern flex boards. The shop is  
over a hundred year old, now run by the 
fifth generation of the business family. 
The shop has two faces, the retail one 
that opens out to the busy street and a 
wholesale outlet that opens out to the 
market. Significant business now comes 
from bulk door deliveries to pharmacies. 
Nevertheless the retail segment continues 
to attract substantial revenues because of 
continuing demand and high margins.  
In the shop, the activity is on at a hectic pace. The crowd of customers, around 10-15 in the 
small space in front of the ten feet long counter provides an ideal opportunity to hang around and 
observe without being intrusive. Of course, in the bustling of the street, the transactions are hardly 
audible, especially because the raw drug names are unfamiliar to me. Most of the customers are seen 
buying small quantities of raw material to make medicines at home. Practitioners do not prefer to buy 
from retail stores in such regions because of the proximity of the wholesale market. Retail prices can 
be two to three times the wholesale price.  
Customers without prescriptions typically ask for either single herbs or popular compound 
medicines. For example, customers are seen asking for vayambu, a rhizome which is usually used for 
neonatal care or for digestive complaints, or njerinjil for diuretic purposes. One customer asked the 
price for ekanayakam, a thick tree root. He exclaimed when he heard the price, that had gone up from 
` 25 ($0.5) to ` 75 ($1.5) within two years. He wanted a whole chunk, unbroken, preferably weighing 
less than a kilogram. The shopkeeper took a piece weighed it and said, “this is 1.5 kgs. Why don’t you 
take it, I will give it for 100 rupees ($2)”. After some hesitation, the buyer agreed for the deal. Many 
Raw drug shop adjacent to a gold jewelry shop, Thrissur 
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shop-keepers reported an increase in demand for this tree root, an anti-diabetic drug.243  
Specialist vaidyans who dealt with large volume of certain categories of patients had ready-
made formats for prescription. One customer, a patient under treatment by a traditional bone-setter 
for a fractured hand, carried a neatly printed prescription from his vaidyan, that read like this 
(translated from Malayalam, italicized words are names of raw drugs): 
K.  M. Chikilsalayam 
Mekkad – 68xxxx  
Phone:    Date:    Name:     
for kuzhambu (balm/ointment) 
Rock salt, chanchalyam, chenninayakam, kantharam, kanmadam,  kunthirikkam, shatakuppa, 
panchamampalukka, all in the quantity of one kazhanju (equivalent to 4.5 gm.), ground in the juice of the bark of 
drumstick tree along with arikkadi (rice washed water), mixed with two chicken egg whites,  in a spoon of honey 
and ghee (clarified butter) to be applied on the fractured area continuously, as and when it dries.  
Dietary Restrictions 
Do not take cold water, meat, fish, egg, butter milk, milk, curd, tamarind, tubers, legumes, oil- fried snacks.   
Office Hours: 7 a.m. to 1 p.m. , 4 p.m. to 6 p.m.  Sunday Holiday 
At the raw drug shop, it is more common to see prescriptions from traditional vaidyans rather 
than modern ayurvedic doctors. There are regional differences in this trend. In a small town in 
Thrissur, raw drug shop sellers reported that but for a small number of young doctors, most other 
qualified doctors regularly prescribed raw drugs. They attributed this to 
the fact that most of these people hailed from traditional vaidyan 
families. It is also a common practice to combine raw drugs with classical 
medicines in a single prescription. For example, one customer who was 
buying medicine for arthritis, had a prescription listing four ayurvedic 
classical medicine formulations, along with which she was also prescribed 
a raw drug, njerinjil, considered an important diuretic.  
The centerpiece of attraction in the raw drug shop is a large 
wooden medicine chest.  The chest, measuring six by three feet, is raised 
by one and a half feet from the floor on the support of six wooden legs. 
The box is divided into 64 small compartments of equal dimensions to accommodate the most 
important of the angadi (market) medicines. The compartmentalized chest is convenient for such 
                                                 
243 Kerala is one of the states in India reporting dramatic increase in the incidence of diabetes (Thankappan et al 2007). 
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purposes because it minimizes the requirement of moving around. The shop-keeper could hold the 
handy traditional weighing balance (velli kol, literally silver stick) over the box, the weighing bowl  
could be dipped into the chest and the excess material could 
be poured back by tipping the bowl. This would be especially 
useful for medicines with a large number of ingredients, some 
decoctions and certain traditional medicines like Angadi 64 
and Valiyangadi Kashayam, that require 64 and 48 raw drugs 
respectively. But today shop-keepers use their spare time to 
keep high-demand assorted stuff in packets so that they can 
save time during peak hours. The centrality of this box in the 
medicine business is visible by the Malayalam name of the 
medicine shop, angadi petti (angadi = market and petti =box). 
In fact, in Northern Kerala the dry raw drugs are called petti 
marunnu (literally, box medicine). With the advent of modern 
storage shelves, these grand chests have gone out of use. However, most shopkeepers are reluctant to 
dispose of the chest that stands as a symbolic icon of the  
long-standing business tradition.  
But most raw drugs do not yield to neat 
arrangement, so a typical look of a raw drug shop is messy 
and chaotic. They are spread all around the shop, in tin 
boxes, gigantic glass bottles and gunny bags.  The typical 
inventory consists of 150-300 dry  drugs, 5-20 fresh herbs, 
and 100-300 semi-processed and factory finished medicines. 
The drugs are not limited to herbs but also include minerals 
like five-salts, alum, asphalt and animal products like deer horns, coral, marine shells and ambergris.244 
The prices of medicinal drugs range from dirt cheap, as low as `10 ($0.2)/ kg for local fresh herbs and 
                                                 
244 A solid, waxy, flammable gray or blackish colored substance regurgitated by sperm whales. 
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roots to highly expensive ones like atividayam (Aconitum) at ` 4000 ($80)/ kg.245 The inventory is not 
limited to dry and fresh raw drugs, but includes a range of items like spices, dry fruits, semi-processed 
food like sago, arrow-root powder, millets like ragi and barley, oils used as medicinal base, incense and 
perfumes. Some shops also include pooja dravyam246 (material used for ritual offerings), on their 
nameplates. To the traditional assortment are added a large range of packaged herb powders/chunks 
either in single ingredient form or popularly used combinations. Not to lose on the growing market in 
finished medicines, many also take up ayurvedic pharmaceutical dealerships. 
The fresh medicinal herbs (pacha marunnu) sold in the shop are locally collected herbs and 
roots, mostly from commons and home-gardens, and occasionally from the forests. Though pacha 
marunnu kada has become a popular alternative name for the shop, and in some regions more in 
currency than the older name, fresh medicines here are a small number, ranging from 5 to 20 items.247 
At one of the shops in Idukki district, a medicinal plant collector delivering his daily collection to one 
raw-drug shop addressed the onlookers teasing the shop-keeper, “He calls his shop pacha marunnu 
kada? (fresh medicine shop)  What is there which is pacha here, everything is dry, he should be calling 
it onakku marunnu kada (dry medicine shop)!” Amidst people’s laughter, the shopkeeper sheepishly 
tried to defend himself, “I don’t have much space here to be able to keep them spread so that they 
don’t rot.” What the collector failed to note was that the local herbs are mostly available to people  in 
the rural region, and therefore does not easily acquire commodity status. For a herb to acquire a 
commodity status it has to be non-local, seasonal or rare. For instance, njerinjil, a herb common in the 
arid regions, has a market demand in the non-arid region. The number and quantum of fresh herbs is 
larger in urban centers where people have less access to  commons, farms and forests. In some regions, 
decline in the inventory of fresh herbs is owing to the near disappearance of collectors, but those 
located near wholesale markets have no dearth of suppliers. Two ST communities, Ulladans and 
Nayadis, who lived in marginalized areas in the non-forest regions of central Kerala were historically 
dependent (almost up to late 90s) for their livelihood on collection and sale of medicinal herbs. Now 
                                                 
245 Sale of high priced rare endangered material like Kasturi (Musk) and  Rakta chandana (Red Sandal) is banned.  
246 Pooja = worship, Dravya = material 
247 The most common are Aloe, Dantapala, Neeleamari, Kaiyunniyam. Others include fresh or partly dried barks of Nalpamara 
(the four ficus trees),  roots of Kurunthoti, Ramacham, tubers of turmeric, ginger, partly dried whole herbs like Cherulam.  
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they have better alternatives; the few remaining collectors supply only to the wholesale market. 
Despite proximity to forests, raw drug retail seller Raghavan was in short supply of fresh herbs owing to 
lack of reliable pluckers.  
The older generation of herb collectors are gone…there is enough money to make as a side-
income, but the new generation is not familiar with the plants. I do get some of my supply from 
the Mannan tribals. But they are not innocent any more, they have also become crafty now, like 
us. There is one single old-time plucker who supplies to all the shops in this region. Raman Kutty is 
his name.  
His narrative was interrupted by a sudden commotion. A person approached the making a high 
pitched announcement, and the idling shop keepers nearby had come to the pavement to watch him. 
“There he is, he has 100 years of life!248 That is Raman Kutty, the plucker I was talking about, and as 
usual he is drunk!”, said Raghavan. “It may not be advisable to talk to him now”, he said, afraid that 
he may utter some profanities. But as an afterthought, he added, “But probably it is very difficult to 
get him in his senses anyway; he is always drunk when he is in the market. He spends his entire day in 
the market region, everyone knows him and everybody is fond of him”.  
By 11 a.m. in the morning, Raman Kutty seemed to have already finished his day’s work of 
collecting and supplying raw drugs to local shops, and decided it was time to make merry. Surprisingly, 
despite his inebriated state Raman Kutty was well focused when it came to the subject of his trade, 
though once in a while he got caught in flights of fancy. When asked about his age, he said, “I am not 
sure, I feel like I am 16. But probably I am around 84.” The small crowd that had gathered around 
came to a consensus that he was  in the his mid 70s. His speech was not just eloquent because he was 
drunk, it showed a knowledgeable mind. His language was literary and spicy, peppered with proverbs, 
stories from mythology and Sanskrit verses. Today he is the sole plucker who supplies local raw herbs 
to the five raw drug shops in a migratory hill town in Idukki district. Migrated to this region from the 
plains at the age of 18, he took up this vocation learning the skills from the market and vaidyans. Two 
decades ago there were a dozen pluckers, but none is left now. Today forest regulations have also 
become problematic. “I used to collect from Marayur forest, but for the past 10-15 years they don’t 
allow me to take medicinal plants through the check post. They would have let me if it was Sandal, 
ivory, they might even accompany me”, he quips tongue in cheek. If there is excess collection, he 
                                                 
248 A common utterance made when one encounters a person who is the subject of a recent or ongoing conversation. 
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temporarily stores it with one of the shop-keepers. He takes it to the wholesale market when prices 
are better. “Look at this”, he picked up a root of  nagadanti, a giant tree from one such sack sitting in 
Raghavan’s shop. and asked the onlookers, “Can you imagine how difficult it is to pluck this out!” When 
asked if there is a steady income flow from this activity, he asked, “Why else would I be doing this?”. 
One of the onlookers, owner of a neighboring shop who was privy to the conversation, defensively 
interjected with a sentiment that was a mixture of fondness, respect and despair, “You don’t know, he 
earns more than this shop keeper here, though most of it goes into drinking”. Raman Kutty added, “I 
earn more than a wage laborer. But now you don’t even get labor to work on the farm, how will you 
get someone for this work?” When asked if he had plans to teach anyone the skills and tricks of his 
trade, he said with an air of resignation, “Youth these days are not interested in this kind of demanding 
work, they just want to make a fast buck”.  
6.2 Demands on knowledge  
Knowledge and skills required of the raw drug seller are comparable to that of the biomedical 
pharmacist, but unlike the latter which is highly standardized,  raw drug selling becomes a ‘high metis 
demanding activity’ because of the non-standardized nature of ayurvedic medicine and raw material. 
Customers do not always carry a prescription list, they tend to ask for standard formulations by their 
classic names. Some prescriptions mention the names of popular formulations without listing 
ingredients.  The shop-keepers are expected to be familiar with commonly used formulations and 
measures of each ingredient. They keep with them a couple of reference books to look up when in 
doubt, the most common being Sahasrayogam, a popular Malayalam ayurvedic recipe book (for details, 
see Section 3.4). It takes an experienced hand to apportion and dispense the raw drugs. Most 
customers hand out prescriptions that list anywhere from one to three dozen items, each of which has 
to be weighed in small quantities and wrapped separately.  In most shops the traditional weighing 
balance, velli kol (silver-stick) has given way to the digital balance, though traditional measurements 
(kazhanch and palam249) are still followed. Ashokan, a traditional vaidyan who owns a raw drug shop, 
reported with anguish that the Weight and Measures Department had heartlessly confiscated his old 
                                                 
249 Kazanch = 4 gm Palam = 48 gms according to Indian Pharmacopeia, 5gm and 60 gm. respectively in Kerala tradition. 
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balance, without taking into account its symbolic significance as a relic of a bygone era.  
Some of the raw drug items, like large roots and whole dried plants, have to be cut to size. A 
large round block of wood, 3 ft high and around 1.5 ft diameter length, sits at one corner of the shop; 
it is used as a table for crushing and slicing large roots and barks, done with the help of a heavy curved 
knife. It is a time-consuming operation. While small shops are managed by the storekeepers 
themselves, large shops have 2-3 helpers.  Some wrap the entire contents of a decoction together, 
leaving the customer to apportion it according to the dose while some patiently pack each dose 
individually. If a decoction is prescribed for ten days, this would mean ten different packets of the 
combination. Though this is tedious work, it makes for ease of use, and accuracy of dosage. At times 
customers ask for specific raw drugs, but may not be aware of the quantity required. After finding out 
its intended use, raw drug sellers recommend the dosage and mode of processing and consumption.  
They are also expected to have some knowledge of medicine. People often approach them for 
solutions to minor health complaints. Formerly,  many of the shop-keepers were also known to be 
vaidyans or as adept as vaidyans in their knowledge of medicine. Four respondents were in family 
business for generations and had naturally imbibed the knowledge of raw material and to some extent 
the knowledge of medicine. Two of the sampled shops were run by unlicensed vaidyans, who were 
affiliated to traditional practitioner associations for legitimacy. Though they did not openly advertize 
their services, locals were aware of their expertise and would frequent them for consultation.  
In medieval Punjab, raw drug shop keepers (attaris) were known to have played multiple roles; 
they also made medicines and competed with doctors in  providing consultation. They were often 
considered quacks because they lacked systematic theoretical training (Sivaramakrishnan 2006)250. But 
in Kerala, it is rare to come across such practice. Though there has been a demand from a small section 
of people in raw drug business for the right to prescribe, none of the respondents but for the unofficial 
vaidyans were sympathetic to the demand. Prescribing medicines is seen as a serious activity that 
needs theoretical competence. Besides, the raw drug shops had co-evolved with the vaidyans and have 
been in a symbiotic relationship with them; after all it was the vaidyans who sent them customers.  
Just as biomedical pharmacy degree holders are expected to be knowledgeable enough to 
                                                 
250 This is reminiscent of the account on apothecaries in 17th-18th century England (see Gevitz 1999 for details). 
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recognize prescription errors or potentially harmful drug interactions, raw drug shop keepers tend to 
be vigilant in handing out medicines. Mathew, the raw drug shop owner at Arimbur, once came across a 
prescription that appeared suspicious; the classic formulation had been altered substantially. It is 
customary for traditional practitioners to vary one or two ingredients in a formulation to individualize 
treatment, but it was rare for someone to make drastic changes. Concerned, he asked the customer to 
hold on and went to meet the doctor, an internee in the nearby ayurvedic hospital. He had assumed 
that the doctor being a fresher had made a mistake, but to his pleasant surprise, he found that the 
doctor had  intentionally substituted drugs to meet the patient’s requirement. To recognize such errors 
and to be concerned enough to follow up, would require a far deeper knowledge and involvement in 
medicine that being just a seller of raw drug commodities. Similar role is played by Chinese medicine 
pharmacists (See Zhan 2009:70-71). In another transaction, I saw a raw drug seller dissuading a 
customer from buying shilajit. On probing further, he found out that it was meant to treat a critical 
ailment for which he felt that the quality of material he stocked was not up to the mark. Instead, he 
recommended a pure herb capsule of a reputed North Indian manufacturer (which he did not stock).  
The raw drug seller not only has to be knowledgeable to do this, but to place professional ethics over 
business, he had to have a level of involvement in medicine close to that of a vaidyan251.  
Respondents who had newly set up shops said they had acquired basic knowledge of raw drugs 
and medicine while working as salesmen in raw drug shops. Keshavan said that in addition to that, he 
studied the whole book of Sahasrayogam diligently to equip him for the business. 
Knowing medicine is essential for managing the business, for growing your customer base. 
Occasionally customers ask your opinion on minor illnesses. Quite often they expect you to advice 
on the manner of medicine preparation and consumption. If you are knowledgeable, they will 
respect you. It helps in developing a personal relationship with the customers.  
This shop-keeper, in his mid-40s represents a generation for whom aptitude or family 
background in medicine did not always mean a opportunity to learn medicine. Raw drug business 
provided the closest alternative252. 
Though a certain amount of complexity of knowledge is common to all trade, identification of a 
                                                 
251 It was evident that the gesture was not intended to build long-term good will either; the customer in question was a transient 
Tamil laborer.  
252 Given the entry criteria in the institutionalized era that emphasized standardized school performance.   
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couple of hundred dry raw drugs especially in the form of roots and barks, calls for a far greater 
expertise. This knowledge is essential to be able to assess the quality and value of material, to 
recognize adulterants and substitutes. The experience of a couple running a large raw drug store in  a 
town in eastern Kerala illustrates the significance of such knowledge. Lakshmi and Sridharan had come 
to settle in this migratory town two decades ago, with the idea of setting up some business. They took 
the advice of an experienced local elder and set up a raw-drug shop. Since they knew nothing of the 
business, they hired a knowledgeable helper. It took them a few years to realize that they were being 
royally swindled. After chasing him away and decided to learn everything on their own. Lakshmi said, 
“It was an uphill task; neither of us are from a family with any background knowledge of medicine. It 
took us almost two to three years to get a minimum hang of things.” 
On the other hand, demand on knowledge and skills on the sellers of ayurvedic finished 
medicine is close to nil253. But recently the excise department in Kerala raised a demand that ayurvedic 
doctors should be present in shops that sell ayurvedic vines, a demand that drew the ire of the 
ayurvedic community and led to a long-drawn conflict culminating a state-wide sit in demonstration in 
December 2008. The excise department’s objection is based in a widely known problem of ayurvedic 
arishtams being used as a cover to sell illicit liquor. Several other concoctions are also sold in petty 
shops (petti kadas) in remote regions, sometimes in innovative forms and names (e.g., ‘Asava soda’). 
My first encounter with this practice was during the pilot study when I went to a remote rural shop at 
the edge of the Vazhachal forest, accompanied by the taxi driver. Surprised seeing a general store 
sporting a board of ayurvedic medicines in such a remote region, I went to speak to the shopkeeper 
who vehemently denied, “No! no! we do not stock any ayurvedic medicine here!”. Though I was 
puzzled at this reaction, I assumed it was a language difference I was misreading (Thrissur Malayalam 
has a distinct accent and vocabulary). As we walked back, a an inebriated assistant from the shop 
began to follow us, screaming at us. Before I could blink, the taxi driver told me to rush back into the 
car and we drove off. He later explained that we must have been mistaken as informants or journalists.   
Though the Excise Department has a valid argument, manufacturers feel that it is used as an 
                                                 
253Handling of inventory is fairly automatic and fully supported by the manufacturer. In fact, there are very few businesses that is 
as less demanding for a investor without background knowledge, except for low-end businesses like Kerala Milk Corporation 
outlets or high-investment businesses like garment and footwear.  
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instrument of harassment; even establishments of repute are subject to raids. The problem is traced to 
the very origin of the four decade old licensing regime that made it mandatory for ayurvedic doctors to 
obtain SP7 license. Ayurvedic practitioners’, manufacturers’ and hospital management associations 
have submitted memoranda requesting the government to protect ayurvedic interests. One main 
argument put forward was the impracticality of implementing the rule given paucity of qualified 
pharmacists (Editorial 2010b, AMAI 2010). But in the past decade, there is a steady rise in the number 
of institutions offering diploma and degree programs in pharmacy, and it will not be surprising if over 
the next decade formal qualification in pharmacy will be considered a requirement for vending 
medicines in an ayurvedic pharmaceutical agency. In mid 2010, a compromise was reached by the 
excise department which agreed to give five licenses to each ayurvedic doctor and to allow existing 
sellers in the agency to continue provided they pass a qualifying test.  
6.3 Old Medicine in New Bottles: Transition from unprocessed to processed 
A large raw-drug shopkeeper at Adimali has just redone the shop, lining up all the available 
space on the walls with wooden shelves. The shop owner is proud of the new modern decor. Colorfully 
labeled and branded bottles stand in neat rows in stark contrast to the messiness of the roots and barks 
spilling around the shop. They stand as living testimony to the shift in consumption from unprocessed 
to processed medicine, from home to the factory. Raw drug shops typically used to sell a few dozen 
bottles of the more complicated formulations, usually manufactured by local pharmacies and vaidyans. 
But gradually with shift in consumption towards finished medicine, they could no more rely on raw 
drugs as their main source of income. Today, the inventory of finished medicines in a raw drug shop 
ranges anywhere from 50-300.  
Though modern ayurvedic factories in Kerala began to roll out bottles of medicines in the early 
part of the 20th century,  it took several decades for them to overtake raw drugs. While there were 
numerous companies manufacturing ayurvedic medicine by the 1950s, widespread expansion in 
pharmaceutical agencies occurred only post 80s. Since then, there has been a steady shift in the 
consumer base towards finished medicine. Some raw drug sellers try hard to attract clientele by 
arranging traditional vaidyans to consult in their shops on a weekly or bi-weekly basis, but such 
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vaidyans themselves have become an endangered species. Shops that rely solely on raw drugs do exist, 
but they are increasingly becoming rare. All raw drug seller respondents had shifted part of their  
allegiance to finished medicine. Of the sampled shop-keepers 60% had taken up exclusive agencies of 
ayurvedic companies. Others preferred to maintain their freedom to stock multiple brands.  
It is rare to find a raw-drug shop owning an agency of a large manufacturer. Medium sized 
manufacturers are preferred because they offer better commission (25-30% compared to 18-20% 
offered by large companies). Established shops have a better candidature to pharmaceutical 
agencies254. A shop keeper in suburban Kochi who has not preferred to take up franchise of any 
pharmaceutical said, “I prefer smaller pharmacies because many of them are from families of local 
traditional reputation”. He keeps products of Bindu pharmacy, an old local pharmacy disinterested in 
expanding its scale of operation.255A factor that a business analyst may consider retrograde, in his eyes, 
becomes an attribute of authenticity and commitment to real tradition. “Often, people want to grow 
and as they do, they lose control over quality. If you taste their medicine three times, they will differ 
in taste.” His shop is dominated by a different range of commodities that fit in various points on the 
continuum between raw drugs and factory finished medicine. Such products can be collectively 
referred to as semi-processed medicines. 
Typically sold in sealed transparent 
polythene covers these come in various 
forms ranging from crude unbranded 
packets with hand-written labels to neatly 
sealed sachets with well-printed labels. 
Many are sachets hung on strings from the 
roof, adding to the overall messiness and 
colorfulness of the shop. Some are single-herb items one step removed from raw-drugs; processed in 
more convenient forms, mostly large roots and barks disintegrated into small chunks. Manufacturers  
                                                 
254An established shop-keeper said that he wanted an agency of a reputed manufacturer, but he was not inclined to pay the 
deposit of ` 20,000 ($400). The manufacturer refused to give at a concessional rate. Later when the company tried to run its 
agency in the town and failed, they offered him the agency unconditionally without any upfront payment.  
255With an estimated turnover of around 10 million rupees ($0.2 million).   
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 avoid fine grinding the raw materials, so the  
user is still able to identify and evaluate the quality 
of each component. Fine grinding results in powders 
and pastes, where it is impossible to detect 
substitution, adulteration or sub-standard quality 
drugs. Most of such products are produced by micro-
units, i.e., those with a turnover of below ` 2.5 mn 
($50,000). Of late, many women’s self-help group co-
operatives256 have also entered this segment. Another 
set of packets consist of raw drug combinations of 
classical decoctions. Such products save the time of apportioning and weighing, but at the same time 
remain transparent to the consumer unlike finished medicine.  Some are traditional products typically 
not found in the manufactured pharmacopeia.  
In this category, one ubiquitous commodity has emerged from a routine cultural practice 
unique to Kerala. A common sight that catches the attention of visitors in Kerala is the colored water 
served in hotels along with meals. Malayalees are historically accustomed to drinking boiled water 
because of the high water tables that characterize much of the State. One of the most commonly used 
herbs, karingali gives the water a rich pink hue and it is a favorite among hoteliers for a unique feature 
that adds authenticity to the water - the bark releases color only after the water  reaches boiling 
point. Though some of the tourists get suspicious of the colored water that appears more synthetic 
than natural, many are fascinated. The colorful glass becomes a part of their memoir collection in their 
Kerala picture album. For the more Ayurveda-inclined, it symbolizes the ubiquity of Ayurveda in 
everyday life in Kerala. Today, this simple household practice, has evolved a new product category 
Daha Shamani (thirst quencher), now a regular in the product portfolio of small and large 
manufacturers in Kerala.  
There are also various medicine mixes, the most common being those meant to treat urinary 
problems and hemorrhoids. But there are also some that address serious disease like for example, 
                                                 
256 Including many units of Kutumbashree, micro-credit women’s groups organized by the Kerala government.  
 
Semi-processed ayurvedic products: those 
hanging from rooftops of this raw drug shop 
 223 
 
diabetes (see image below). For problems like urinary stores, people routinely used to consult  
traditional single-herb vaidyans, not ayurvedic 
practitioners. Today, either because such vaidyans are rare 
to find or to save the trouble of traveling long distance, 
people find it convenient to consume such products. These 
are not typically advertized. Shop-keepers play an important 
role in pushing them. However, respondents said they have 
to be careful because it is important to maintain good will; 
they are dependent on a loyal customer base for their 
survival. Chandran, who keeps a large number of semi-processed products in his shop, says he is wary 
of this class of products. He exercises his judgment and purchases only from a few reliable 
manufacturers whom he is comfortable with, because there is a much fraudulent stuff peddled by fly-
by-night operators. Pointing to a bunch of semi-processed products made by a new company (VS), he 
explained,  
This family was a neighbor of K. pharmacy (a manufacturer of repute). Both families have the 
tradition of ayurvedic medicine, but this person was not into Ayurveda. He took up an employment 
as a marketing manager in a company in Bombay. Recently he met with an accident after which he 
decided to settle here, and set up his own ayurvedic company. The family had a lot of ancient tali 
ola (palm leaves) at home. Nobody knows this, but in fact the K. pharmacy had got many of their 
recipes from this family. Look at this product for example (picking up a decoction mix for 
hemorrhoids), I am sure this will be effective because it is based on such traditional knowledge. It 
also works out cheaper than products of established companies. Not everybody these days want to 
go the vaidyan and consult, so they find it convenient when medicines are packed in this fashion.  
The older raw drug sellers have plenty of such stories to tell. Their narratives also point to a 
distinct pattern in consumer preference. There seemed to be prime importance for local brands that 
are built over the traditional reputation of a vaidyan family. In regions where there is no local 
pharmacy worth its name, other factors came into play, like the history of distribution and doctor  
preference. For example, in a migratory town in eastern Kerala which has no established historic family 
vaidyan tradition, a particular brand was found to be popular. Further inquiry revealed the reason. The 
largest local distributor, who until recently was the sole distributor of ayurvedic products had a long-
term liaison with the manufacturer concerned, which created brand loyalty in the long run. Customer 
 
A proprietary decoction mix for treating 
diabetes, named ‘Prameha Shamani’ 
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preferences also varied in terms of preparations, one company was known for their arishtams, another 
for their oils and a third for a particular product. Some such preferences are rooted in old memories of 
the fame of a particular product or reputation of a particular family in treating certain illnesses. But 
raw drug sellers acknowledge that ayurvedic doctors have begun to play an important role in 
influencing patient preferences. One raw-drug shop keeper said tongue-in-cheek, “different doctors 
have preference for different brands,” obliquely poking fun at the promotional technique. One shop 
keeper reported the practice of the “letter pad technique257”  
Some shop-keepers these days print letter pads with addresses and leave with the doctors. After 
giving out a certain quantum of prescriptions, come and demand money from the shop, like 1000-
2000 rupees ($20-40). But I don’t get into that kind of business. Very few customers fall for such  
techniques. Most people tend to have long-standing loyalty to a shop. They don’t necessarily buy 
from the address on the letter pad. Why should we pay the doctor for no reason?   
Despite stories of decline, it is remarkable that raw drug shops continue to do brisk business in 
the face of rapid proliferation of finished medicines. The high margins involved in retail raw drug 
business258 (50-200 % Vs  20-30% in finished medicine) compensates for various other drawbacks: the 
scale, labor intensity, slow movement, storage loss. There are mixed reactions from sampled retailers 
on the present and future of raw drug trade. Equal numbers of them are both pessimistic and 
optimistic about the present and future of raw drug retail market.  
That it is still considered a viable business option is evident by the fact that four respondents 
had established their shops within the past decade259. Verghese, who runs a shop in the inner row of 
the main street in a large town in Central Kerala, is one such newcomer to the business. He had 
opened the shop two years ago using his seven year experience as salesman in a raw drug shop. Though 
he has an agency of a medium scale manufacturer, raw drugs are his mainstay. He claimed his business 
is actually growing every day rather than declining. It certainly showed; when others were in the 
process of discarding the traditional chest, he had upgraded his from 64 to 100 compartments. 
Kumaran, whose shop is located in the inner lane of a busy main street in the suburb of Kochi, is from a 
third generation raw-drug business family. He stocks several brands of finished and partly processed 
                                                 
257 I came upon this in my last visit to a shop in a migratory region, I could not follow up to see how widespread this practice was, 
and whether it was prevalent in other regions.  
258Menon’s (2003) study shows an average retail margin of 65% for forest plants and 55% for non-forest plants with margins for 
some raw drugs going up to 400%.  
259 New shops are established either in newly urbanizing villages or in expanding towns.   
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medicines, but a little more than half his turn-over continues to comes from raw drug sales. Though his 
business is upbeat, overall use of raw-drugs must have certainly declined as many other shops had 
closed.  During  his grandfather’s era there were eight shops in the region, all except his had closed 
down forty years ago. Another interesting case is that of Shaji, a raw drug seller in interior Thrissur, 
despite having a D. Pharm diploma is not keen on running an allopathic drug shop. He feels there is 
sufficient business in Ayurveda. His father’s shop located in the nearby town continues to substantially 
depend on raw drug retail. His own shop is just six years old, and yet to establish a regular clientele 
base. A substantial part of his clientele comes from the local government dispensary. He supplements 
his business with the small manufacturer’s agency. He is disadvantaged not only because he is located 
in an interior village, but also because he has to compete with the State’s largest wholesale market 
located just 9 km away. But he makes good use of this opportunity and doubles up as a wholesale agent 
to doctors and small manufacturers, also value-adding by supplying pre-processed raw material260. 
Commonly cited reasons for decline in retail consumption of raw drugs are: declining medicinal 
knowledge among consumers, the modern consumer’s demand for ready-made medicine, decline of 
traditional practitioners, ignorance of raw drugs making modern practitioners rely excessively on 
standard formulations, commercial incentives to prescribe certain brands, and rise in the trend of 
doctors making medicines to corner additional profit. In Idukki district, the transition I observed  
between two visits in the interval of two years was phenomenal. In two small shops, the proportion of 
turnover from raw drugs to finished medicine had come down from 50-60% in Oct. 2008 to 20-30% in 
Nov. 2010. But during the same period, hardly any change was perceivable in Thrissur district261 where 
even formally trained vaidyans continued to prescribe raw drugs. Even in the capital city Trivandrum, 
between 2008 and 2011, there was no decline in raw drug sales, and the shop-keepers were upbeat 
about the retail market.  But in both these places, the erosion of retail customer base might have gone 
unnoticed because of rise in small scale wholesale consumption that has arisen with the proliferation of 
hospitals, therapy clinics and massage centers.  
                                                 
260 Usually nothing more than fine chopping/coarse grinding. He sources local plants like Kurunthoti through six regular pluckers, 
all in the age group of 60-70. They earn ` 150-200 ($3-4)per day but this is not attractive to younger people, as wage labor 
fetches ` 350($7). He also cultivates some critical medicines that is in short supply in the market.  
261 considered the cultural capital of Kerala.  
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6.4 Factors that drive continuing consumption of raw drugs 
Continuing consumption of raw drugs by Kerala consumers, despite the penetration of finished 
medicine in the ayurvedic market begs for explanation. Based on interactions with various respondents 
including raw-drug shop dealers, consumers and practitioners, five factors can be considered important 
in driving continuing consumption of raw drugs: 
1. Predominance of decoctions in the Kerala ayurvedic practice (for detailed discussion, see 5.6, 5.7).  
2. Consumers’ perception of home-made medicine as authentic: Perceptions of authenticity of home-
made medicine is perhaps the most significant of all reasons why people shop for raw drugs. When 
people buy raw ingredients of classical formulations, the cost is almost equal to or marginally lower 
than prepared formulations262. A larger majority of consumers of raw-drugs are from the older 
generation, typically age 50 and above who share a traditional value for home-made medicine similar 
to many who swear-by home-made food. They do not trust the industry to use the right quality and 
quantity of ingredients. Typical response from such consumers is, ‘When you buy raw-drugs, you are 
personally able to evaluate the quality of the raw material, and when you cook it at home, you are 
sure that the right procedure is followed’. There is someone at such households familiar with the skills 
of medicine cooking, and has the time and patience to devote to such a cumbersome task. This 
someone is almost always a woman; medicine cooking happens to be just an extension of the routine 
kitchen work involving the same processes of grinding, boiling, and cooking. Not surprisingly, ayurvedic 
manufacturers refer to their factories as extended kitchens. Though it is the woman who cooks the 
decoction, men usually buy raw material from the market, quite often traveling long distances in 
search of authentic sources. For example, one young gentleman was found traveling from Kuravilangad 
in Kottayam to Kaladi in Ernakulam (70 kms.) for purchasing raw drugs for postnatal care, clubbing a 
trip to visit a distant relative. Though there is no dearth of shops in his neighborhood, a reliable 
personal source had recommended the shop in Kaladi.  
3. Requirements for medicines that are not commonly manufactured: The ayurvedic finished product 
portfolio is far smaller than the pharmacopeia. The largest of the manufacturers produces around 500 
                                                 
262 For example, a seven-day dose of Dhanwantaram Kashayam costs ` 85 ($1.7) whereas the raw drug mix for the same cost `80 
($1.4). Note that the former does not include the cost of fuel and labor of cooking decoction at home.  
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formulations, the others make an average of 300-400. Ayurvedic texts consists of far larger number of  
formulations. The most commonly referred Ayurvedic recipe book in Kerala mentioned earlier, 
Sahasrayogam, literally means ‘thousand formulations’. Likewise different texts have different 
formulations, the total with all variations are put to around 75,000 (API 2008). Texts approved as 
official pharmacopeia by the Central Drug and Cosmetics Act are 56, there are also many local texts 
that are not approved and popular recipes that are not part of texts. Furthermore, industries produce 
standard formulations based on one particular text. Formulations vary between texts and the version 
preferred by the doctor might not be the one commonly available in the market. Furthermore, 
practitioners might also want to tweak an existing formulation to suit individual patients’ requirement.  
4. Flexibility to manipulate formulations to meet budget constraints: Making medicine from raw-drugs 
is sometimes more economical than buying finished medicine because of greater flexibility in tailoring 
the formulation to the patient’s pocket. Even Charaka Samhita which is accused of being affluent-
focused has mentioned ways to tailor the treatment to meet the needs of poorer patients (Valiathan 
2003). Doctors in government dispensaries and those who practice in rural areas, tend to prescribe 
either all or at least part of their prescription in the form of raw drugs. A doctor in Ernakulum, while 
talking about the increasing expensiveness of ayurvedic medicine said that he always tried to tailor the 
medicine to the affordability of the patient. When asked about rising prices of medicines and impact of 
tourism selling on the lower income patients, he said,  
The advantage of Ayurveda is that, if the doctor is sensitive and service-minded he can see to 
it that the medicine remains affordable to the poorest among the poor. This can be easily done 
by prescribing raw-drugs instead of finished medicine, and by using cheaper acceptable 
substitutes when raw drugs themselves become expensive.  
In this context, many raw-drug shop keepers blamed modern degree holding doctors’ poor 
knowledge and over-reliance on standardized formulations for killing their market.  
5. Resistance to commodification from the traditional-popular practice: An important category of raw 
drug consumption is devoted to what I term traditional-popular medicines. These lie in the boundary 
between medicine and food, and are widespread in the popular culture of Kerala, deeply rooted in 
household traditions. Their consumption is not necessarily mediated  by the vaidyan. They are either 
based on oral traditions or on officially approved local texts (e.g., Sahasrayogam) or unapproved local 
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texts (e.g., Chikitsa Manjari). Consequently, this segment has been most resistant to commodification, 
and hence a critical contributor to the maintenance of retail raw drug business.  
6.5 Traditional-popular formulations: Two examples 
The most important in this category of consumption are seasonal practices and special diets. 
Important among the former are those followed in the season of Karkidakam (July-August), and among 
the latter, post-delivery care diets.  Four popular diet routines during Karkidakam are Karkidaka-Kanji 
(medicinal rice-porridge), Kozhi Marunnu (Chicken-medicine), Attin Marunnu (Goat-medicine), Pathila 
curry (a vegetable curry made with 10 medicinal leaves). Besides this, there are several other routines 
that vary across regions and communities like various types of leaf-curries, and several types of 
medicinal rice. There are also a few that have no proper name, but are referred to as combination of 
Angadi (market)drugs. For instance, Valiyangadi Kashayam with 48 raw drug ingredients literally 
means, “big market drugs kashayam.” Angadi 64, is a combination of all significant 64 raw drugs mostly 
used for post-delivery care. Most such products are not found in the finished product market. Some are 
available but restricted to small local pharmacies with limited spread (e.g., Attin Brath, Ulli Lehyam). 
Some products, though commodified by large companies, are of recent origin, and are yet to displace 
the culture of home-making (e.g., Tenginpookuladi, Ajamamsa Rasayanam). They are almost an 
extension of regular cooking, and unlike medicine-making that is  specialized and occasional, these 
have stayed fresh in people’s memories because they are seasonal routines. They are typically required 
in large quantities because they are consumed by entire households unlike medicine which is restricted 
to the afflicted few. The scale makes it more viable and more meaningful for home processing.  
Traditional-popular formulations have helped keep the culture of medicine making alive in 
Kerala homes, contributing a large extent to keeping the retail raw drug segment alive and kicking. In 
the past decade, many small and medium manufacturers have begun to produce commodities to tap 
this market. Two case studies provide a glimpse into the transformation this market is undergoing. The 
first, commodification of the medicinal rice-gruel is an example of the emergence of new commodities 
in the segment, whereas the second case illustrates a conservative attitude of a typical farming family 
in Kerala that finds ways to resist such commodification.  
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6.5.1 When the month of famine becomes a month of profit 
In recent years, the State has been aggressively promoting monsoon tourism as part of its 
Ayurveda tourism campaign. Monsoons in Kerala are among the harshest in the country bringing down 
around 300 cm precipitation in 3-4 months. But it is neither the charm of the monsoon nor the leanness 
of the season that is the motivating factor behind the campaign. Karkidakam, the peak monsoon season 
from July 15th to August 15th has a special significance in ayurvedic practice in Kerala. It is considered 
the right season for wellness treatment263 and also a season when people are expected to follow 
specific medicinal diet regimes.264 Different reasons are attributed for the ayurvedic significance of the 
season, all of them equally convincing. Firstly, since the season is considered to be the most conducive 
for the spread of infectious diseases and hence, naturally leading to emphasis on preventing health 
care practices265. Secondly, this is one of the most relaxing times during the year for people centered 
around a farming economy. After sowing rice, the fields are left to the care of the rain gods; the only 
chore left is occasional weeding. Torrential rains make any other activity impossible, therefore it is 
also a lean time for wage laborers. Thirdly, and most importantly, karkidakam  is considered the 
“famine month” (panja maasam) during which period food grains from the previous harvest would be 
depleted and tuber crops hardly available.  For the working class, lack of wage labor worsens the food 
security situation. Some suggest it is this food-paucity situation that has led to the development of 
diverse food diet prescriptions, many of which include rare resources, mainly those collected from 
forests and uncultivated commons.266 All these reasons must have together contributed to the emphasis 
on Ayurveda in the karkidakam season. Some of these conditions might have become irrelevant in 
today’s lifestyle that is unaffected by seasonal contingencies of a subsistence agrarian economy. But 
the cultural practices stay and provide an avenue for new commodities to emerge. It is ironical that 
the medicine-cum-diet regime created for the famine month has led to a boom time for Ayurveda 
business. Raw drug store keepers say that monsoon time was historically a peak time for their business. 
                                                 
263 Sukha Chikitsa, Sukha=well-being/pleasure, Chikista=treatment. 
264 The classics of Ayurveda do not mention a particular season for wellness treatment.  
265The disease-proneness of this tropical rain-forest region is probably high during this period, the combination of summer heat 
and humidity providing a breeding ground for infectious diseases. 
266 It is also interesting to note that that their Tulu speaking neighbors across the border who share the same ecological biome, 
attribute similar significance to this month, prescribing diverse nutritional practices and medicinal regimes. 
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Today, there are many other stakeholders rushing to cash in on the increased affordability of the 
expanded middle class combined with the decline of traditional household knowledge and skills.  
Among the many dietary practices adapted during this month, one that has remained in the 
household realm is the consumption of marunnu kanji or oushadha-kanji. Marunnu in Malayalam and 
oushadha in Sanskrit both mean medicine; Kanji means rice gruel. The Production Manager of the 
State-owned Oushadhi claim it was they who first introduced a ready-made kit. Within three years 
after the introduction, that is in 2007, 40 different brands had entered the market. The sales had gone 
up from ` 50 mn ($0.1 mn) in 2006 to ` 55 mn ($1.1 mn) in 2007. In 2006 An estimated 500,000 kits 
were sold. In the same year, manufacturers and hospitals estimate a total business of ` 500 mn ($10 
mn), including the cost of in-patient treatment. This is almost 1/5th to 1/6th of the total annual market 
turnover in Kerala (Anoop 2006). In 2010, the monthly turnover of the kits has risen to ` 200 mn ($4 
mn) (Ajayan 2010).  
A typical kit contains medicines with or without rice for a week’s or fortnight’s consumption. 
The contents are typically in the raw form, with each ingredient separately packed in individual 
packets. The number of medicines vary, but most kits include around 20 odd herbs. The price ranges 
from ` 30 ($0.6) to ` 100 ($2) based on brand and composition. High-end packets include the medicinal 
rice njavara (one of the index plants). A variety of sellers have entered the fray. Almost all large and 
medium ayurvedic companies have their own versions. Branded rice sellers have found it a great 
opportunity to value add to their product. Small scale food 
producers, self help groups and rural co-operatives have also 
added the item to their product list. Unlike finished medicine, 
the kit provides people with ready ingredients to be made at 
home. The time and hassle of  purchasing and measuring each 
ingredient is saved and for those without traditional know-how it 
solves the pain point of figuring out the right recipe. Recently, a 
medium scale Ayurveda manufacturer Pankajakasthuri took the 
medicinal gruel to the next level of commodification with ready-
Karkidaka Kanji  Kit with rice 
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to-eat kits packed in  aseptic pouches.  
Expansion of the commodity market for the medicinal gruel does not necessarily mean decline 
in consumption of raw drugs. Among those who buy such commodities are  those who had long stopped 
following the seasonal routine. There is a large section of  population which is short of knowledge 
or/and time, but are eager to maintain traditional cultural practices and can afford to buy such 
commodities. Sheela, a 40 year old a bank employee from suburban Cochin said she could not afford 
the time to make this from scratch. “Of course, if I wanted to make it I could have always ask others 
for the recipe.  But the problem is that the process is so time consuming. One doesn’t even have time 
to cook normal food these days. I was very happy when I saw the Karkidaka Kanji kit in the market”.  
The Nair family from rural Thrissur on the other hand is totally against the idea of buying the kit. Mrs. 
Nair asked, “Why pay the companies when you know how to make it anyway? Such things are either for 
lazy people or for those who are so rich that they don’t mind throwing away money.”  
Medicinal porridge has begun to appear both in commodity and non-commodity form in many 
other ways. In suburban Kochi, an ayurvedic agency owner had erected a large banner announcing he 
would deliver Karkidaka Kanji and Pathila curry (a vegetable side dish made with 10 medicinal leaves) 
on order267. In suburban Thrissur, a push cart vendor was found selling two other seasonal diet 
preparations268. By virtue of being in the category of 
food, such products have also begun to appear in 
some restaurant menus during he season.  The 
medicinal gruel also circulates outside the 
commodity realm. Recently, the PTA of an 
elementary school in Northern Kerala decided to 
serve the gruel to students, to “save a traditional 
practice from extinction… in this era of fast food 
and tin food culture” (Asianet Television 2012).  
                                                 
267 The charges were nominal, meant to cover just the expense of material and labor.  He claimed that this was a goodwill 
gesture to promote the cultural practice. This was his first attempt, he had got only 50 orders and was hopeful of adding more 
customers in the future.  He also offered free consultation and medicines at concession rates during this period, for which he had 
to spend some money from his pocket.  He spent about ` 20,000 ($400) for medicine and doctor’s fees, but earned the good will 
of about 500 customers which he expected to provide long-term returns.   
268 Kozhimarunnu = medicated chicken curry. Attinmarunnu =  medicated mutton (goat) curry. 
 
Medicinal porridge served at the Oushadhi 
Panchakarma Hospital canteen. 
 Photo: K.C. Sowmish (The Hindu news report) 
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It has become a trend among some Hindu temples in Kerala (The Hindu 2012) to offer medicinal 
gruel twice or thrice a week during the season. This is not surprising given the historical connection 
between medicines and temples in Kerala.  Firstly, while temples for the Hindu medicine god 
Dhanwantari is unheard of in the rest of the country, in Kerala there are four major Dhanwantari 
Temples.  Secondly, many temples in Kerala offer medicine to devotees as prasadam (consecrated 
offering for devotees’ consumption)269. Murali (2005) mentions that two of the temples also had 
vaidyashalas (pharmacies).  
A media report (Hindu 2008) carried a complaint from the General Secretary of the Kerala 
Ayurveda Labor Union that “image of Ayurveda” was being misused for unbridled commercialization of 
the traditional gruel. Pointing out that the gruel originated as an alternative diet for the poor during 
the famine month, he complained that it has now become a ‘fashionable health diet’, sold at 
exorbitant prices. He complained there were too many companies coming out with porridge kits, the 
ingredients were not always listed. His complaint to the Kerala Ayurvedic Drugs Control Department 
was ineffective as there was no regulation to check the proliferation of such products. This is because 
commodities like Karkidaka Kanji fall in the grey boundaries between food and medicine.  Differential 
tax for ayurvedic medicines (4% compared to 12.5% on food products and cosmetics) is an issue that 
quite often drags the question on the meaning and categories of food and medicine into the legal 
realm. Ironically, Oushadhi, the ayurvedic manufacturer which introduced the concept into the market 
was the first to feel the brunt of this vagueness. Though the product was a runaway success, the 
company, despite being state-owned, got caught in a legal bind; the revenue department considered 
Karkidaka Kanji a food item, and slapped extra tax with retrospective penalty270.  
6.5.2 Borrowing skill from the factory to cook medicine at home   
Elisa, the pregnant daughter of Mr. and Mrs. Jacob, a farmer’s family in Central Kerala, had 
come home for delivery. In Kerala, like in many other parts of India delivery care of daughters is 
considered a right and responsibility of her parents. The expecting daughter is ceremoniously invited to 
                                                 
269 For example, Thakazhi temple gives medicinal oil, Thiruvizha temple in Aleppy gives medicine for mental problems and Sri 
Krishna temple in Kaladi stomach related problems.  Two other temples, Maruthorvattom in Aleppy and Nelluvaya, Thrissur, gives 
Mukkudi (a special combination of herbs) to treat stomach problems; both have legends that connect them to Ashtavaidyans.   
270 As told by the Marketing Manager of Oushadhi.  
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her parental home on the seventh or eighth month of pregnancy.  During this period, much emphasis is 
laid on nutritious food; in some regions consumption of various medicinal herbs are recommended. The 
greatest emphasis however is on post-delivery care  that besides oil massage and bath includes 
consumption of a variety of medicines. Among the various medicine-diet practices, post-delivery care is 
one of the most  colorful both because of its  complexity and the mood of celebration that surrounds 
the  household that is engaged in the process. Though it is managed almost totally by the women of the 
household, men participate in procuring raw material and also labor, if pre-processing is done at 
home271. A typical protocol in central Kerala consists of seven medications272 of which two are readily 
available classical decoctions part of the mainstream ayurvedic pharmacopeia.  
Two others, the medicated goat-jam and coconut-
inflorescence jams were not in the market until recently. 
Since it has been popularized by Kandamkulathy Vaidyasala, 
a manufacturer based in central Kerala, a few small and 
medium sized companies have added them to their  product 
portfolio. Onion jam and medicated goat broth are 
occasionally  seen in regionally restricted circulation, made 
by enterprising small local pharmacies. Such formulations do 
not figure in the official pharmacopeia, and are therefore 
registered as proprietary medicines, despite being based on 
traditional knowledge. These are still part of widespread 
household practice, but more and more households are 
lacking in the knowledge and skill of making them.   
                                                 
271 There are minor regional and community variations in the protocols followed, but overall similarities cut-across these 
differences. Typically post partum care begins from the end of the first week after delivery lasting for two more months. Since 
Elisa had a caesarian section, they had to wait for a month to begin associated internal medicine. 
272 The new mother has to first consume a combination of two classical restorative vines, Dashamoola Jeerakarishtam for 5-7 
days. A medicinal jam made from ginger and onion, Ulli Lehyam aimed at shrinking the stomach flab, is also consumed during 
this time. Following this Dhanwantaram Kashayam,  is consumed for a week. The next in line is a jam-like preparation made of 
medicated goat meat called Ajamamsa Rasayana, which is consumed for a month. This can also take a simpler form as Attin 
Brath (Goat Broth). And then, the first medicine is repeated for a week, following which Idimarunnu, another medicine is 
consumed for a week. The final touch to this elaborate medicinal ritual is Thenginpookuladi Rasayanam (jam with coconut-
florescence as the main ingredient), which is consumed for a month or two.  
 
Full page ad for a post-delivery maternal 
care medicine, Attinbrath (medicated 
goat broth) in a popular Malayalam 
health care magazine 
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Elisa’s parents wanted to make at home everything except the fermented preparations. But the 
medicated goat-meat jam (Ajamamsa Rasayanam) was complex. Given its importance as a restorative 
medicine, they did not want to buy it from the market. Though usually it is the women of the 
household who took the lead, in this case due to his wife’s delicate health condition Mr. Jacob had to 
organize everything. He said, “If my mother was around she would have known how to make. An option 
is to consult a traditional vaidyan, but then we still have to make the whole thing. It is not enough to 
have the recipe. Unless you have experience making these kind of things, it is not easy.” So they found 
an idea middle ground; they hired a foreman from a nearby medium scale Ayurveda manufacturing 
company, to cook the medicine at home. Jacob went hunting for the items that the ayurvedic cook 
asked him to buy. First, he had to buy a goat that weighed around 5-6 kilograms. To buy the raw drugs, 
he went to the wholesale shop in a neighboring town as he did not have much faith in local retailers. 
But the shop-keeper tried to push powdered raw drugs. Jacob did not fall for it, though he justifies the 
shop-keeper’s behavior as being motivated by the desire to cut down on the labor of cutting and 
packing each ingredient. Together the material cost him ` 400 ($8). He hired a farm hand to chop the 
koovalam root and crush into smaller bits with a heavy iron pound. She took a whole working day for 
the job, and had to be paid ` 150 ($3). The next step was to get the rest of the 20 raw drugs crushed 
into fine pieces. Formerly they would have had to manually chop them into small pieces and crush 
them using a wooden pound. Now the electric dry grinder does the job. When quantities are large, the 
job is outsourced to flour mills that specialize in medicine disintegrating and grinding273.  
The first step in the preparation of the formulation is to process the goat meat to produce 
broth274. Once the broth is prepared, the expert takes over. He adds jaggery, honey and ghee to the 
broth, and constantly stirs the mix on low fire for about 6-7 hrs till it reaches the right consistency. 
And then, powdered raw drugs are stirred in and the dish is kept away to cool. Only a seasoned hand 
can identify the right consistency. If the product gets under-cooked it will putrefy fast, if it is 
overcooked it will become hard and inedible. The rightly cured end product can have a year’s shelf life 
                                                 
273 Since early 90s, beginning with the introduction of the mechanic pulverizer. Mills that typically grind flour and Masalas in this 
region, sport a signage on their boards announcing ‘medicines will be disintegrated and ground here.’ 
274 Typically this involves boiling the meat in water and then simmering it on moderate fire to reduce the water to an eighth of 
the original quantity, an activity that takes 3-4 days. These days one can also hire machines to extract broth.  
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without refrigeration. The expert and his helper were paid ` 500 ($10) and some drinks for their 
trouble. The end product, Ajamamsa Rasayana (medicated goat-meat jam) was around 8-9 bottles (4-
4.5 kilograms) all of which would be fed to the delivered girl within 3-4 months after delivery.  His face 
radiated with satisfaction as he narrated the story,  
I am very happy with the product since all the raw material has undergone my scrutiny. The shops 
put a lot of jaggery and save on the meat.  I am not very sure of their raw material quality.   The 
guys from the raw drug shop also told me that it is best to make this at home, so that nothing 
would be compromised, after all this is a very important medicine.  
The material and labor that went into making of the medicine together cost him around ` 5000. 
This being a classical ayurvedic product, would have been available at half the cost in the market (` 
500($10)/kg). Jacob considers this as a definite indicator of the branded product’s poor quality. But he 
fails to take into account economies of scale. The price Jacob paid for his raw drugs is likely to be two 
to four times higher than what the pharmacy pays for bulk purchase275.  But at the same time, the 
superiority of personally supervised homemade product is undeniable, not to mention the additional 
fizz it adds to a celebrative atmosphere. In planning and engaging in this activity, the family is 
producing much more than medicine.  The medicinal food certainly has a nutritional value, but the 
process of making and consuming it has an equally strong ritualistic and symbolic value. Home-made 
medicine emphasizes the centrality of ‘home’ as a site of authentic consumption and also expresses 
parents’ love and care for daughters who have left their home. This is comparable to the construction 
of meanings and identity of home-made food.  
Homemade has some singular qualities absent in market-made products… some of these 
imperfections of homemade food mark its singular quality in relation to the homogenizing, serial 
quality of market-made food. Hence, while the capitalist system appropriates food products and 
makes them into mass commodities, the production processes result in a loss of domestic 
meanings. The love of family associated with homemade signifies an opposition to the commercial, 
instrumental interests of the market ( Moisio et al 2004: 368). 
  
                                                 
275 Customers buy mostly in traditional weights (5-60 gm.). Given the number of ingredients that go into a single medicine, it is 
hard to track the per kilo price.  
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6.6 Conclusion 
Being a key node of traditional ayurvedic consumption, the raw drug shop provides a glimpse 
into the pre-industrial culture of ayurvedic practice. Sujatha (2007) writes that the raw drug store 
keeper in Tamil Nadu is a vaidyan or a person knowledgeable about medicinal substances and their 
properties; the store is a meeting-point for folk, professional practitioners and the common people, a 
site of consultations and exchange of information. This would be true of the raw drug shop node across 
India, except that in Kerala it is diffused across urban and rural regions, catering to end consumers 
unlike other regions where they are concentrated in urban centers and focused on practitioners. 
Though the role of the raw drug shop has been on the decline since industrialized production of 
medicine, it still cannot be written off as irrelevant in the Kerala ayurvedic milieu. It not only 
continues to hold ground, but is flourishing in regions like Thrissur and Trivandrum. Raw drug shops 
today rely heavily on two classes of consumption: home processing of classical medicine and 
traditional-popular medicine.  With the former being increasingly displaced with finished medicine, the 
latter remains the mainstay. Though new commodities like the packaged medicinal rice kits are rushing 
in to occupy this space, they are not yet able to displace household level practices. Resistance to 
finished commodities is still vibrant as illustrated by Jacob’s family which went to great lengths to 
undertake the laborious process of cooking post-delivery medicine at home. Though there is a positive 
correlation between the decline of raw drug consumption and the progress of finished medicine, rather 
than one causing the other, both appear to be linked to other factors. I have identified the most 
important contributors to decline as being, on one hand, the gradual replacing of traditionally trained  
practitioners by institutionally trained practitioners, and on the other, the reluctance of the urban 
consumer to devote time and labor to cooking medicine. Of various factors that continue to drive 
consumption of raw drugs, consumers’ perception of home made medicine as authentic may not last 
for long, but tailoring medicine to suit one’s pocket is a requirement that is likely to have continued 
relevance, especially for lower income families. Another most important factor that would determine 
the continuity of raw drug consumption is prescription practices of ayurvedic practitioners, which in 
turn is linked into several other factors as already discussed in chapter 4.  
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7. CH7 ALIENATION AND DESKILLING IN THE SUPPLY CHAIN 
Alienation induced by industrial commodification has adverse affects on both ends of the 
supply chain –  the product and the resource base, in addition to affecting those involved in the 
transaction. In the Global Ayurveda Festival in Kerala in early 2012, the secretary of ayurvedic 
Manufacturers’ Association of India stated that availability, price and quality of raw drugs were the 
biggest problems plaguing the ayurvedic industry today. Aspersions are often cast on the product 
quality of ayurvedic medicines alleging widespread adulteration and substitution (for example, Dubey 
et al 2004). This is linked to unsustainable collection and overexploitation of resources. An estimated 
81% of the species used in the Indian medical systems are collected from the wild (Ved and Goraya 
2007). This has raised conservation concerns276 that led to the formulation of policy guidelines for 
medicinal plant collection and farming in 2009277. Another angle of concern is the exploitation of 
medicinal plant collectors by middlemen. In the national context the collectors’ share is found to be 
lower than 33% (Subrat et al 2002). In Kerala too, there is allegation of similar exploitation (e.g., 
Harilal 2008, Menon 2003), but studies show that collectors get a fair share of the wholesale price, i.e., 
42-55% (Sasidharan and Muraleedharan 2009) and 15-50% (Abraham 2003).   
The chapter begins with a brief overview of the upstream supply chain in Section 7.1. Section 
7.2 discusses the consequence of increased distance between raw material source and production. 
Index plant koovalam provides insight into issues that affect large scale production (Section 7.2.1) and 
also showcases small manufacturers’ attempt to use their knowledge to get access to genuine raw 
material (Section 7.2.2). The ‘morally ambiguous aura” caused by large scale production is conducive 
to “myth-making” (Appadurai 1986); the resultant information asymmetry creates room for rumors 
regarding the quality of factory produced medicines (Section 7.2.3). Index herb kurunthoti provides a 
glimpse into problems that arise from confusion in plant identities, especially in the context of mass 
production (Section 7.2.4). It also shows the knowledge-intensive role of large fresh herb traders and 
                                                 
276 86 medicinal plant species from Kerala find mention in the national Red List, 50 of which are endemic and also have a global 
Red List status (FRLHT 2011). According to the Kerala State Medicinal Plant Board, only 22 in Kerala are endangered.  
277Good Agricultural Practices (GAP) and Good Agriculture and Field Collection Practices (GACP) based on 2003 WHO guidelines 
adapted by National Medicinal Plant Board and AYUSH, as of now, meant for self-certification.  
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their influence in the construction of raw material identity.  
Significance of people’s stake in promoting conservation is well acknowledged both by those 
who argue for privatization of resource and those who defend common property regimes. The former 
hold that commonly held resources are vulnerable to overexploitation (e.g., Andreoni 1988). Three 
decades of work instigated by Hardin’s (1968) infamous paper showed that much of the commons were 
wrongly assumed to be open access; they were governed by collective cultural regulatory mechanisms 
that came to be known as ‘common property regimes’ (McCay and Acheson 1990, Vollan and Ostrom 
2010). To understand the problem of overexploitation of medicinal plant resources, it is important to 
understand the status of cultural control over collectively held property.  
It is useful to differentiate between stakes people hold in medicinal plant resources as 
‘cultural’ and ‘economic’ though there is some overlap between them. I refer to “cultural stake” as 
that which derives from the meaning a plant holds in people’s lives with respect to its various cultural 
uses including religious, food and health care. “Economic stake” derives from the value of the 
medicinal plant as a market commodity disengaged from its use value. I argue that cultural stakes are 
central to the conservation of medicinal plants in both forest and non-forest regions, though the stakes 
involved and sources of alienation are different. Distancing of people from these cultural stakes has 
made room for overexploitation. In the forest region, alienation of people from forest resources and 
decline of Vamsheeya Vaidyam (tribal medical systems) and in the non-forest region, decline of 
traditional vaidyans, and home level processing of classical medicines are proximate causes. These are 
in turn influenced by macro-socioeconomic factors like urbanization, change in occupational and land 
use pattern, and so on. Collectors having economic stake in resources per se is not conducive to 
conservation unless the stake is long-term, which is possible only if the property be controlled by a 
finite community. In the forest a certain degree of exclusivity has been created by restricting 
collection rights to Scheduled Tribe co-operative societies, which ensures fair prices to collectors and 
forces traders to pay better prices. But their inability to gear up to a competitive market situation 
makes room for illegal exploitation. In section 7.3.1, examples of two successful societies show that 
the mechanism can be effective given captive labor and dynamic leadership.  
 238 
 
Discussion in sections 7.3.2-7.3.4 illustrates the superiority of cultural stakes over economic 
stakes. The Kani-CSIR benefit-sharing  model, an internationally acclaimed model initiated by scientists 
from CSIR (Council for Scientific and Industrial Research) to commodify exclusive tribal knowledge is 
compared to a participatory training cum certification program for tribal healers. The success of the 
latter shows that combining cultural and economic stakes creates internal incentives that ensure long 
term sustainability. Ethnobotanical approach on the other hand, relies on an external revenue model 
that has an additional disadvantage of being potentially conflict-generating.  
Non-forest commons are devoid of coherent common property regimes and hence inherently 
vulnerable to overexploitation. But some extent of cultural regulation was present in the form of 
traditional rules of harvesting that are flouted in the industrial production era (as discussed in section 
7.2.1). In section 7.5.1, index plant kurunthoti illustrates conditions that can promote or hinder the 
development of long-term economic stakes.  Farmed medicinal plants constitute an insignificant part 
of the supply chain, but much attention has been heaped on this segment in the past decade. Section 
7.6.1 describes factors that contribute to making medicinal plant farming unviable in Kerala. Section 
7.6.2  provides a brief account on three major types of farmers. Farming in the forest has different set 
of constraints and potentials which is described in Section 7.6.3, further illustrated by the ethnography 
of the index herb kattupadavalam. Ethnographic evidence in Section 7.6.2 shows that variability of 
material and complexity of ayurvedic medicine production are factors that inhibit direct connection 
between ayurvedic industries and collectors/farmers. The newly initiated ayurvedic industrial cluster, 
the Confederation for Ayurvedic Renaissance (CARe Keralam), promises to build a bridge between 
manufacturers and suppliers (See Section 7.7). 
7.1 Upstream supply chain: An overview 
According to a recent extensive survey of consumption of medicinal plant use (Sasidharan and 
Muraleedharan 2009), 400 species are regularly used by the ayurvedic industry in Kerala278. Of these, 
230 are used in quantities above 1000 kg. annually. Ayurvedic plant material is classified into dry raw  
                                                 
278 Of the total 6000 plants identified as medicinal value, 2400 are used by various ISMs, of which Ayurveda uses 66% i.e., 1587 
plants. Of the 960 medicinal plants found in trade, 72% (688) are used by the Ayurvedic system. Of the 491 that used in the 188 
surveyed herbal industries, 117 were consumed in quantities over 100  MTs ((Ved and Goraya, 2007). 
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drugs (petti marunnu) and fresh herbs (pacha/pari 
marunnu). The estimated contribution of each is 
almost equal in value279. The dry raw drug market is 
mainly centered around non-local commodities and 
is concentrated in the wholesale markets. There are 
6 major, 21  medium and 37 minor  markets spread 
across the country (Subrat e al 2002). In Kerala, 
there are major raw drug markets in Thrissur and 
Cochin and minor markets in Kottayam, Kozhikode, 
Badagara and Trivandrum.  
Between the medicinal plant gatherers and the industry there is a chain of agents, beginning 
from small aggregators to large wholesalers. Manufacturers source non-local dry raw drugs either from 
the wholesale markets in Thrissur or through agents who source material from other raw drug markets 
in India or through commission agents who have direct access to the point of origin280. Traders can be 
classified into two: dry and fresh herb traders, though some combine both. The former aggregate 
material from across the country; the component of local material in their trade is minor. They are 
rarely connected directly to the point of origin of the herb. The major markets are dominated by 4-6 
large dry raw drug traders who have been in business for several generations.  
Fresh herb suppliers are a specialized set of actors who are much more than traders; they are 
closely connected both to the source and production. There are around 20-24 large fresh herb traders 
in the Kerala market. Many of them have personal relationships with manufacturers that go back to the 
beginnings of industrial era. For established manufacturers, trust in such relationships continues to be 
the most important modulator of raw material quality. Given their perishable nature, fresh herbs come 
to Kerala mostly through a local supply chain that includes Kerala and immediate neighboring states, 
mainly Tamil Nadu. The major fresh herb gateway from the neighboring State Tamil Nadu is 
Kozhinjampara (in Velanthavalam) in Palakkad district. 
                                                 
279 Typically, non-local items are high priced and used in low quantum; the local are low-priced, used in large quantities.  
280 One manufacturer sourced the bark of Saraca asoka from Bengal and the root of Salacia reticulata from North Karnataka. 
Oushadhi, the State owned company often sources material through Forest Departments of other states.  
 
Raw Drug Market 
 240 
 
Based on source, the local supply chain can be 
classified into two: forest produce supply chain and non-
forest produce supply chain. The forest belt that accounts 
for 29% of Kerala’s land area, stretches from Trivandrum in 
the South to Wayanad in the North along the Western Ghats, 
traversing through six Eastern districts. As per the regulations 
of the Kerala State, collection of forest produce is the 
exclusive monopoly of members of Scheduled Tribe 
communities. The SCST Federation (Schedule Caste and Scheduled Tribes Federation), a State level co-
operative organization, with its 4 branches and 36 affiliated co-operative societies (Girijan Service Co-
operative Societies, GSCS) is the nodal agency for collection of Minor Forest Produce (MFP) from the 
forests of Kerala. The Kani community in Southern Kerala also participates in a direct market in Kottur 
(Kani Chantha) twice a week. Most of the forest collection is dried and stored in the four branch depots 
and annually auctioned to manufacturers and traders through the Federation. Fresh herbs required in 
large quantities are directly supplied to manufacturers on order (e.g., karimkurunji (Nilgirianthus 
ciliatus). Some enter the raw drug wholesale market legally through auctions or illegally through 
middlemen. A single herb might enter both dry and fresh commodity chains, depending on whether the 
use is local or nonlocal, immediate or long term (e.g., kurunthoti roots). Perishable fresh herbs from 
Kerala or neighboring states like Tamil Nadu are consumed directly (e.g., brahmi). Typically, 
production in companies follows a routine annual plan made to suite material availability, especially 
fresh herbs with seasonal constraints. Production of decoctions and oils that require bulk fresh herbs 
are arranged during monsoon and post monsoon when they are available in plenty. The fresh herb 
season starts in June after the monsoon arrives and stretches up to mid March, the peak season being 
July-September. 
Non-forest supply chain obtains medicinal raw material from commons and homegardens that 
are source to around 80-100 of the around 400 species in use. In terms of value, they account to nearly 
Unloading fresh herbs from the truck 
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50% of the resource used by the industry281. There is some amount of overlap between forest and non-
forest sources (e.g., wild brinjal varieties like puthari chunda). Non-forest supply chain also includes 
an insignificant portion of farmed herbs, less than 8% according to Sasidharan and Muraleedharan 
(2009). These enter the market  mainly through fresh herb traders and hill produce (malancharakku) 
traders. According to manufacturers’ estimate 5-15% of material is bought directly from households 
including gatherers and cultivators. Sasidharan and Muraleedharan (2009) give a species-wise break up 
for the 230 most heavily used species in the Kerala ayurvedic industry as follows: 92 from forest; 34 
from non-forest areas: 40 sourced from both forest and non-forest; 10 sourced from cultivation; and 30 
items were from outside Kerala, mostly North India.  
The knowledge base of fresh herb suppliers is far more complex than dry drug traders, because 
of their connection to the source, perishability of material and complexity of ayurvedic medicine 
production schedules. The domains of knowledge that concerns this node include knowledge of identity 
of herbs, quality, availability and location, knowledge of the market and skills of negotiation, skills in 
strategizing and organizing collection according to complicated production schedules. A typical large 
fresh herb trader collects around 200 different kinds of material of around 100 plant species and they 
have to identify different parts of the plant, in both fresh and dry condition, the locality they grow in, 
and various conditions of maturity in the wild. With the decline of professional collectors, such 
knowledge is now concentrated only with aggregators.  
7.2 Implications for Production 
The crisis in quality arose in the exigencies of mass production that led to increasing distance 
from the source of raw material. In the golden jubilee souvenir of the AVS, a vaidyan writes about 
“ayurvedic ‘doctors’ emerging from modern courses who get infuriated if addressed as Vaidya…Many of 
these ayurveda doctors don’t identify medicinal plants – they say it is the duty of pluckers. If they 
don’t know how will they make medicine in pharmacies?” (Nair 1954:42). Ali, a fresh herb collector-
aggregator says that when he began collecting herbs in his early teens (early 1950s) he had to struggle 
                                                 
281  Estimate based on accounts of 3 of the largest manufacturers in Kerala. According to Sasidharan and Muraleedharan (2009), 
the fresh herb category accounts for 51.4%, entirely met by supply from Kerala and Tamil Nadu.  
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to acquire the knowledge of herb identification; the knowledge of medicine making vaidyans in 
vaidyashalas was superficial. He picked up all his knowledge and skills from an elderly woman who 
agreed to let him tag along with her on her medicinal plant collection trips.  
A century of pre-industrial artisanal production282 seemed to have already had its toll by the 
beginning of industrialization as evident from the founding day address of AVS in  1902.  
We have reached a stage where it is generally only those who work for daily wages who now 
gather, stock, sell, buy, process and use these raw materials, mainly herbs…..Apart from this, 
because of a growing lack of familiarity with them, innumerable medicinal plants and roots have 
now become impossible to identify…..Since outsiders to the system are thus being given total 
responsibility and vaidyans themselves refuse to take any….vaidyans themselves are in the process 
of losing all acquaintance with the medicines they prescribe.(Krishnankutty 2001:49).  
Industrialization led to greater concentration of production and as the scale increased, so did 
the physical distance from the production center283. But in the early era of industrialization herb 
collectors were closely linked with manufacturers in a one to one relationship, many of the old timers 
have continued to depend on these long-term ties. AVS, since its inception has been faithful to 40 
families who meet all their fresh herb requirement and also handle complex inventory management, 
i.e. providing combinations of fresh ingredients tailored for individual formulations. Large pharmacies 
like Vaidyaratnam, AVP, Oushadhi, KAL continue to have one to one relationship with a few old 
generation collectors. However, all these collectors including the families supplying to AVS have 
evolved with the industry to become large scale aggregators who employ daily wagers to do the 
collection. Many have organized themselves as medicinal collectors’ societies. There are very few 
household level individual collectors left except in regions with high concentration of ayurvedic 
industries (e.g., suburbs of Thrissur). Due to unavailability of regular gatherers, most companies rely 
for their fresh herb supply on commission agents who have the capacity to organize labor for large 
scale collection.  
Increased distance between collectors and medicine makers is alleged to be leading to 
overexploitation of the former by middlemen. But research findings on price spread, as mentioned in 
the introduction above,  are inconsistent, This could be either due to variation in the nature of raw 
                                                 
282 Harilal (2008) divides Ayurvedic production phase in Kerala into three phases: up to 1830s – service dominated production; 
1830s-1880s – period of petty commodity production, and 1880s-1920 – shift from service to industry. 
283 Locally sourced herbs like brahmi and koovalam are increasingly sourced from neighboring states Tamil Nadu. 
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material284 or failure to account for fresh Vs dry and temporal price variations, and wastage component 
in calculating traders’ margins. Besides these, an inherent expectation of marginalization of medicinal 
plant collectors, appears to be leading to selective bias. For example, Menon (2003) and Harilal (2008) 
have alleged overexploitation of collectors based on retail raw drug margins instead of wholesalers’ 
prices285, ignoring the narrow margins between wholesaler’s purchase and selling prices286. Traders get 
much attention as ruthless exploiters who eat into production margins and shortchange the already 
marginalized plant collectors, but their role as knowledge mediators is almost always ignored. Though 
the industry complains of losing a large chunk of margin to them, it is at the same time highly 
dependent on their knowledge and skill sets.287 Some manufacturers also depend on them to provide 
aggregated material tailored for individual formulations. This dependence on knowledge-intensive and 
reliable services provided by traders combined with long-term trust based relationships makes the 
industry reluctant to accept raw material directly from collectors and farmers. 
7.2.1 Koovalam: the icon of Industry’s profligacy  
Madhavan vaidyan, a 70 year old traditional practitioner from Idukki district, gets worked up 
whenever he talks about the quality of raw material used by ayurvedic manufacturers.  
When I was trained in medicine by my uncle, we were expected to follow strict rules in harvesting 
medicinal plants. For koovalam, the rule was that the bark of the root which goes to north to be 
harvested without the aid of any iron (metal) tools, before sunrise, without clothes, after bath. 
This was probably to restrict overharvesting.  Of course, we were not following all the rules, it 
was not practical, but we cut only northerly roots because medicinal properties are supposed to 
be greater in them. We are vaidyans, and unlike medicine making industries, we want the best 
quality medicine. It is only if we are able to cure that we can build trust in our patients, on which 
our livelihood depends. But nowadays medicine makers do not follow such rules, that is why you 
will not get quality medicine. Forget northerly root barks, industries no more use even roots, first 
they switched to heartwood, and now they use any part of the wood they lay hands on.  
                                                 
284 in terms of rarity, habitat, demand, perishability, and so on. For example, unlike an abundant herb like kurunthoti that is 
collected in large scale, rare herbs are affected by information asymmetry and are more conducive to overexploitation. 
285 Retail raw drug market is a different offshoot of the chain whose prices are affected by different set of conditions.   
286 Menon’s study of price spread for 79 non-forest and 19 forest plants shows that the wholesaler’s profit margins are narrow and 
the collector is given a fair share of the selling price, but when retail raw drug shop are included, margin spread goes up to 500%.  
287 Veteran local researchers have not been able to make much headway with this set of actors. While their secretiveness is the 
main cause, their inaccessibility to researchers gets compounded by the prejudiced perception of them as ‘exploiters.’  
Economists and forestry researchers tend to be interested in sensitive and closely guarded information like prices and sources of 
material. The dubious legality of sources further complicates matters. While these are issues to be investigated, there is also a 
need for ethnographic attention that goes beyond issues of legality and exploitation. There is a wealth of knowledge and 
information hidden among actors at this node that can give insights into a variety of issues critical to both raw drug quality 
control and natural resource conservation. A few interactions, though brief, has led me to believe that long-term interaction 
based on trust and respect with appreciation to their knowledge and role they play, can provide access to this enigmatic set of 
actors. Given their centrality in the supply chain, such knowledge could be used to make them co-participants in conservation, 
with a combination of incentives, sensitization and regulation. 
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He said this with a resigned gesture of hand, and a note of despair in his words. Koovalam 
(Aegle marmelos, family Rutaceae; bilva in Sanskrit), is a medium sized (up to 10 m. in height) thorny 
tree with tiny leaves and large apple sized fruits most commonly found in temple premises. It is native 
to India, grows wild in Sub-Himalayan tracts from Jhelum eastwards to West Bengal, in Central and 
South India. Its cultural significance surpasses its importance in the pharmacopeia. In fact, there is far 
less popular awareness of its medicinal properties compared to its religious significance288. Various 
parts of the tree including the fruit, root and the stem bark enter into the making of 70 odd classical 
ayurvedic preparations. The most important part is the root. Bilva belongs to an important class of 
ayurvedic drugs called Dashamoola (“ten roots”).289 It is an ingredient of some of the most popular 
ayurvedic medicines like Dashamoolarishtam, Vilwadi Guliga and Chyawanaprash. There is no better 
ayurvedic drug than koovalam to bring forth vaidyans’ ire on industrial production. Large scale 
extraction of this tree root over the years resulting in scarcity has driven the industry to using heart 
wood in place of the root or stem bark, a fact that manufacturers openly  admit290. Though this is 
considered acceptable by the industry, vaidyans are apprehensive. Not only practitioners, regular raw 
drug consumers in Kerala are concerned291. The Indian Pharmacopea lists the fruit, root and stem bark 
as different drugs with variation in pharmacological  properties between one part and another (See 
Appendix F), a distinction which is also supported by pharmacological findings (API 2008).  
7.2.2 Exclusive paths of circulation 
Manufacturers buy koovalam from two sources, from the raw drug market directly or through 
local raw drug agents who procure it from major markets in North India. One of the biggest local 
markets for koovalam (and other fresh herbs) is the market in Kozhinjampara, a sleepy little village in 
the Palakkad pass in the eastern border of Kerala. The raw drug market is so secretive that very few in 
the local market were aware of its whereabouts. The trade happens surreptitiously by the side of the 
                                                 
288 Its leaves are considered a favorite of the Hindu god Shiva. In Buddhism, it is a representative to the eight fold principle for 
right action. As per astrological tradition each, koovalam represents the constellation of Chithira.  
289 People in their 50s and plus can list Dashamoolas with ease because many had gone to indigenous pre-schools run by the Kalari 
master. Enchuvadi, the native multiplication table which was in vogue in the traditional preschool system also provided such 
facts to memorize that were later found in print as ready reckoner booklets.  
290 One large manufacturer followed the convention of using double the quantity of wood in the place of root.   
291 For example, Jacob needed koovalam to make post-delivery medicine (see Section 6.5.2) knew that raw drug stores mostly 
sell heartwood, so  he located a tree in the neighborhood in the event of unavailability in the market.  
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state highway, in the truck stand. There are neither shops nor carts to house the material. Bundles of 
koovalam roots and wood along with a dozen root crops and some green herbs arrive and accumulate 
on the side of the road. Once the stock arrives a spring balance is hooked on to a branch of a tree to 
weigh the bundles; the balances handle up to 100 kilos of load.  Weighed raw drugs are then kept in 
bundles on the road side, to be transported to the Thrissur market or to pharmacies in truck loads. On 
an average 2-3 trucks (6-12 tons per truck) of material leave Kozhinjampara in a week. Two to three 
wholesalers and a number of small scale dealers handle the trade, most of whom supply directly to  
pharmacies. The traders refuse to quote prices, instead asking the consumer, “how much are you 
willing to pay?” From other respondents (i.e., 
manufacturers and commission agents), I found that 
koovalam roots are sold for ` 12-15 ($0.24-$0.3) and the 
heart wood for ` 6 ($0.12) per kg. The source of koovalam 
is difficult to trace given the secrecy, but according to 
vaidyans who are knowledgeable of local ecology most of 
Kerala’s supply comes from neighboring Tamil Nadu.  
What is interesting about the commodity life of 
koovalam, is the exclusive channel in which it circulates outside the wholesale market. Popular 
awareness of the tree’s value in the ayurvedic market is not widespread. Timber merchants take 
advantage of this information asymmetry; they buy the wood at firewood price (` 2.5 ($0.05) per kg), 
and sell it at ` 15 ($0.3)/kg in exclusive markets. Usually, such trees become available when land gets 
cleared for construction, an opportunity that knowledgeable middle men make good use of.  Of late, 
the operators of earth-moving equipment (commonly known as JCB drivers) have become an important 
class of participants in the trade. 
Traditional practitioners and many small pharmacies are reluctant to switch to using any part 
other than the root. Those whose production is mainly meant for treatment depend on a tree or two in 
their own farm or they keep an eye on koovalam trees growing in the neighborhood. When they come 
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to know that a certain patch is getting cleared for construction, they place an order in advance292. For 
instance, Gopalan Vaidyan, a small manufacturer based in central Kerala, has three distribution 
outlets. He requires larger quantities which he manages to get from a small supplier who deals in a 
narrow range of raw material. He bribes the delivery guy to get just the root portion of the tree at one 
an a half times the market price. Practitioners and small manufacturers are able to source material 
through exclusive channels because they require small quantities and because price is not a deterrent 
for them; they pass on the burden to consumers. The selling point is the quality and authenticity of 
their medicines in the local market. Much of the consumption is closely linked to their treatment; they 
do not have the obligation to meet demands from regular buyers. This means that when they do not 
find the right material they are not compelled to make the medicine293. Keshavan Vaidyan, a micro-
manufacturer based in Suburban Ernakulam said he does no produce medicine when material is not 
available. “But large scale manufacturers are not like that. They will use the wood, or any other part 
of the tree or low quality material and continue to make the products.” The compromise large 
manufacturers make on material is an issue often raised by small manufacturers. A random visit to the 
warehouse of a pharmacy in a reputed hospital in central Kerala revealed a large stash of koovalam 
roots. The manager said “There is no real scarcity for koovalam roots.  If you really want it you can get 
it, but you should be ready to pay the price.”  He makes a logical point; though koovalam does not 
grow naturally in Kerala, it is abundant in North India where it is cultivated for fruits.  Twelve varieties 
are cultivated in North India for fruits294. Surprised at the information about its widespread availability 
in North India a small manufacturer pointed out, “The real problem is perhaps not of availability, but 
disinterest in paying for quality. When heart wood is available at half the price, why bother about the 
root?”  
                                                 
292 A common occurrence; the construction boom that began in the 70s (Gopikuttan 1990) shows no abatement. A single tree root 
weighs several hundred kilos. Four years ago when Keshavan vaidyan heard about a tree being cut 15-20 kms. away from his 
house, he rushed to collect some roots. The stock will last two more years. Philippose vaidyan  knew the plot two blocks away 
from his house was sold to build a house, he put in a word with the contractor to let him know the schedule. Since he took care 
of the labor himself, he had to pay a small price for the material.  
293 At the same time, there are also a few medium and small scale manufacturers who allegedly make low quality medicine, price 
them very low, push it through small unlicensed traditional practitioners for a higher commission.  
294 I asked several practitioners and manufacturers about the discrepancy between this story of plenty in the North and scarcity in 
Kerala, but got no satisfactory answer. In Kerala, people are aware of its religious and medicinal uses, but have no inkling of its 
use as an edible fruit.  
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7.2.3 Myth-making and the morally ambiguous aura of commodification 
For practitioners like Keshavan Vaidyan and small manufacturers like Gopalan Vaidyan, 
koovalam is an ideal beating stick to use against the large industry. However, while they legitimately 
brag about the authenticity of their medicine, they do tend to exaggerate the profligacy of the 
manufacturers. Plenty of yarn gets woven around the theme of industrial substitution and adulteration. 
This does not mean that industries can be given a clean chit on quality grounds.  But the general 
tendency to trust traditional practitioners and distrust large manufacturers may blind one to the 
interests of the former. Madhavan vaidyan is right about koovalam. But I start getting skeptical when 
he says, “there is not enough production of nellikai (gooseberry) for the amount of Chyavanaprasha 
Dabur makes” This is a statement often heard on various forums, politicians’ speeches tea shops and 
dinner tables.  
It is one of those folk tales that attain a status of fact by mere repetition. Even if the vaidyan 
is right about Dabur’s not using sufficient gooseberry, dearth of material is an unlikely reason295. As 
part of his invective against the industrial production that is almost the standard subject in every 
conversation, the vaidyan runs ‘the taste test’. I know it is coming when he starts turning a lid in the 
middle of his invective. He would soon pour the dark liquid into his ounce glass, and ask, “Now drink 
this and tell me, does the Kutajarishtam of Kottakkal296 
taste like this?”. After a few minutes during the 
interview, he would ask,  “Doesn’t the taste still linger 
on your tongue?”  In the absence of external objective 
parameters, organoleptic qualities (color, consistency, 
taste, smell) are the only measure. An expert vaidyan 
can assess the quality of medicine by these standards, 
taste being the most important of  them. I would take 
                                                 
295 Not many of them are aware of the thousands of acres of Amla production in some of the neighboring states like Tamil Nadu 
and parts of Northern India in addition to supply from the forest. Pratapgarh district in Uttar Pradesh produces 90% of the 
country’s gooseberry requirement, which is a mind boggling  10,82,000 MT  in 12,830 Hectares.   
296 AVS is the favorite target despite being a trust owned company with 45% of turnover devoted to charity. Though there are 
some small and middle range players with dubious reputation, AVS becomes the default villain by virtue of being the largest and 
therefore an icon of large industry.  
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the vaidyan’s word when he distinguishes the genuine taste of Kutajarishtam  from the factory made 
one, but when it comes to what goes on in the factory his knowledge is based on hearsay. Note that it 
also acts as a great sales pitch for him. Every now and then Madhavan vaidyan picks up the issue of 
pricing - another stick to beat the industry with. He points at a particular wine preparation and says 
the raw materials are very expensive, “Production cost per bottle comes to 50 odd rupees, but 
Kottakkal (i.e., AVS)297 is charging only ` 48/- Now you tell me. How can they sell it so cheap?” 
Implying that if the medicine is cheap the ingredients had to be of low quality. Like Jacob who comes 
to the same conclusion by comparing home made medicine to factory made products (see Section 
6.5.2), he too fails to take into account the economies of scale298.  
But having said this, the vaidyan does have a genuine problem. He is no doubt using high 
quality raw material personally supervised; it will be indeed surprising if large scale industrial 
production can meet such exacting standards. But unfortunately he has to compete with what he 
considers poor quality products given his scale of practice, he cannot afford to have too low a profit 
margin. One has to understand the context under which such legends get woven. The ‘morally 
ambiguous aura” (Appadurai, 1986) of mass production provides a fertile ground for distrust. No one 
really knows what goes on behind the closed doors of the industry. This is not different from popular 
skepticism regarding quality of processed food from factories vis-à-vis home made food. The legend of 
the missing gooseberry represents this mistrust. Blockbuster products of big companies tend to be the 
most likely candidates to be chosen for the villain’s role. Not surprisingly, Dabur’s Chyawanprash 
becomes the icon of adulteration. Of the 48 ingredients in Chyawanprash, the most important is 
gooseberry. The allegation is that there is more jaggery and less gooseberry in the product, which is 
either done for a better margin or for palatability or for both.  
Though allegations of adulteration are commonly leveled, they are rarely backed up by 
evidence. In a workshop conducted by the Kerala Agricultural University on medicinal plant farming, a 
research scientist from a premier institute alleged widespread adulteration, saying that 16 medicinal 
                                                 
297 Arya Vaidya Sala is popularly also referred as Kottakkal though it is a name of the town. 
298 He buys from a minor raw drug wholesale market and in small quantities, so he does not have much of a bargaining capacity. 
Chencheril with his larger production size gets it cheaper. Jacob who buys from the retail raw drug shops to make medicine at 
home pays a 50-200% margin. AVS with four times the turnover than the next four large manufacturers, has the highest 
bargaining capacity and therefore can price their products low.   
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ingredients were affected by substitution. His allegation was dismissed as exaggeration by an eminent 
ayurvedic practitioner who had formerly worked in one of the largest industries. Finding fault with the 
scientists’ claim that atividayam (Aconitum) was being adulterated with eratti muthanga, he pointed 
out that it was recommended in classics and despite their botanical dissimilarity recent research 
showed them to have similar fingerprint. He then pointed out that “Kerala market situation is unique; 
95% of manufacturers are vaidyans. Quality control is therefore inherent in the system”. In a personal 
interview, the General Secretary of the ayurvedic manufacturers’ body, AMMOI, agreed that allegations 
do have some substance but, “they tend to be way too exaggerated; such unfounded rumors are 
damaging the reputation of the industry”.   
But there is unlikely to be smoke without fire. Finding out the nature and extent of 
adulteration is investigative work that is beyond the scope of this work. Based on interaction with R&D 
scientists, production and purchase managers of big and small manufacturers and narratives of 
practitioners outside the industry, the most common sources of compromise in raw drug quality299 can 
be identified as 1. genuine but lower grade material (many of the raw materials are traded in three 
grades) 2. undetected adulteration that escapes sample testing  3. substitutions considered accepted 
because of widespread use 4. identity confusion.  The biography of the index plant kurunthoti throws 
light on some of these issues.  
7.2.4 Kurunthoti’s identity crisis and its implications 
Despite being commonplace, kurunthoti (bala) is among the most misunderstood of plants in 
the ayurvedic pharmacopeia. Traditional practitioners interviewed said there were 21 varieties of 
kurunthoti, a fact corroborated by botanists (Nesamony 2005). But only 2-4 are recognized as 
important in the pharmacopeia in Kerala.300 As for industry use of bala in Kerala, there is a consensus 
on using Sida rhombifolia spp. retusa (Vs Sida cordifolia in North India).301 The identity crisis that 
kurunthoti enjoys and suffers gives a window into the confusion that surrounds the complex project of 
                                                 
299 According to Sasidharan and Muraleedharan (2009), the reasons for raw drug substitution are : mistaken identity, 
indiscriminate naming, biased interpretation of Sanskrit names, lack of expertise in identifying and increasing price. 
300 Seven are identified by Nair and Rekha (2007) five by Nesamony (2005) A survey of Kerala industry (Sivarajan  and 
Balachandran 1994) found four varieties were used as ingredients in medicine, but two had gone out of vogue. This raises a 
question if industrial commodification has led to the reduction in the variety of raw material used.  
301 I have not gone beyond practitioners narratives to double check the identity of species in use.  
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translation between local, textual, pan Indian, and botanical taxonomies. Modern botanical 
nomenclature is based on impersonal morphological features whereas ayurvedic classification is based 
on pharmacological and other functional attributes of the plant. To give a few examples, 
 Pharmacological properties: bala (strength), ashoka (relieving from sorrow/pain), bharngi (cough-
dispelling), iswari (power to neutralize snake poison, referring to Lord Shiva’s ability to do so), 
kasamardah (suppressing cough) 
 Taste and smell: amalaki (acid taste), kiratatikta (wild plant with bitter taste), asvagandha (horse 
smelling) 
 Physical attributes: akhukarni (‘rat-ears’) hamsa padi (feet of swan), dughdika (having latex 
inside), kokilaksah (eyes of cuckoo), mandookaparni (frog-like leaves)  
 Habitat: kutaja (growing on top of hills) 
 Other characteristics: duralabha (not easy to handle), durlabha (not easily available), apamargha 
(hinders the path of pedestrians).  
The same drug can have multiple names, as names can be describing different attributes of a 
plant, different parts or  multiple pharmacological properties. Together these help in providing a brief 
profile of a plant, and in the absence of illustrations, provide valuable clues to the identity of the plant 
mentioned in classics. A good example is the plant drug Sahachara, which has seven names, “occurring 
in fully exposed habitats”, “gregarious”, “spiny”, “pain-causing”, “living in oppressive conditions”, 
“refers to certain seedling establishment characters in mangroves”, “referring to certain air-sucking 
characters, probably breathing roots in certain mangroves”. Radhika (2011) has done an extensive 
review of drug manuals and dictionaries and located 40 synonyms for bala, viz., strength promoting, 
grain-like seeds, yellow flowered, strong fibrous stemmed, fruits that ripen in winter and so on.  
The problem gets further complex because the same name can be used for multiple herbs, 
firstly because of the commonalty in physical and pharmacological properties, and secondly, due to 
unintended regional variations. This might seem messy from the modern expectation of ‘universality’ 
and ‘uniformity’, but these names were meant to carry local, contextual and functional information 
useful to the practitioner. Local relevance and functionality are prime factors that inform the logic of 
classification of flora among indigenous people (Scott 1998). Botanical classification on the other hand 
emerged from a universalist position, where plants were taken to the expert realm of a ‘science’, and 
removed from their local context.  
The species concept permitted the unification of knowledge concerning flora and fauna, 
minimizing distances between near and far, between Europe and America….Nature, in short 
became a structure of data whose objective was not to appreciate but to process local 
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peculiarities into information using the botanical system best able to homogenize diversity 
(Lafuente and Valverde 2004: 137).   
There are also names that convey nothing about the identity of the plant (e.g., brahmi) or too 
general to be useful (amrita – rejuvenating), but preserved mainly through usage, the survival of which 
depended on the continuity of the language and he medicinal tradition. Most Malayalam plant names 
have little significance in terms of pharmacological characteristics302. But practitioners based in Kerala, 
even doctors trained in modern institutions are equally or more at ease with Malayalam than Sanskrit 
names, which is perhaps not the case everywhere else in the country303.   
In the effort to standardize production, local variations might appear as errors or unwanted 
differences that had to be smoothed over to enable standardized production. But local variations are 
integral to the classical pharmacological framework which provides for substitution of less available 
herbs with more abundant ones and for adaptation of the pharmacopeia to suit local conditions. This 
was aided by the classification of medicinal plants in Ganas (drug classes based on pharmacological 
action). But dealing with local variations in the context of mass non-local production is obviously a 
thorny process. Varier was worried about the ignorance of individual vaidyans, which he felt could be 
rectified by them coming together, standardizing production and making the process error-free. But 
ironically the solution he envisaged had a greater potential for errors that he may not have then 
foreseen. The nature of error in centralized production is different, and perhaps more problematic 
because of its potential to be viral. Minor misinformation in the interaction between a set of a 
collectors and an influential large manufacturer can snowball and attain the status of universal 
standard. Once a commodity chain grows around this mistaken herb, it can influence the standards in 
rest of the market. For example, takaram, a high elevation plant costing ` 300/kg., ingredient of 
formulations like Bilvadi Tailam, is wrongly substituted by a local aquatic plant costing ` 20/kg. The 
supplier had introduced it knowingly or unknowingly which was unknowingly accepted by one of the 
leading manufacturers that went on to become an established standard.304 Role of large scale raw drug 
                                                 
302 Except for a few plants like panikoorka (“fever plant”), some names refer to physical features, like color of flowers (e.g., 
vellila, chembarathi). Some popular drugs have become default local names (e.g., brahmi, tulasi, ashoka).   
303 PG students and doctors from Karnataka and Maharashtra participating in a workshop in Kerala were annoyed that instructors 
(production and R & D personnel of a large company) were using Malayalam instead of Sanskrit herb names. In today’s Sanskrit-
centric homogenized image of Ayurveda this would tantamount to ‘ignorance’.  
304 Told by Vasudevan Nair, botanist and consultant to Arya Vaidya Pharmacy in a workshop. Aug. 2008. 
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trader-collectors has been very important in the process of raw material selection, in their ability to 
persuade buyers to accept their version of drug identities, sometime based on genuine knowledge, 
sometimes to suit their convenience. But trader-collectors are not necessarily less rooted than 
manufacturers, many have grown with them, and the knowledge that exists today is co-produced. Many 
are carriers of traditional use-knowledge, as they themselves had picked up the knowledge from the 
vaidyans. But unlike vaidyans, they are likely to be influenced by commercial considerations in the 
choice of a particular plant or substitute.     
Ashoka (Saraca asoka) one of the most widely used tree barks, 
is often substituted by the barks of arana tree (Polyalthia longifolia), 
the name of which in common usage is also ashoka. There is 
widespread discomfort about the use of this drug as there is no 
resemblance between the plants by ayurvedic or botanical standards. 
The real ashoka is in short supply, and therefore expensive. Two 
traditional practitioners said they stopped making Ashokarishtam, 
because of the unavailability of real ashoka. Despite it being an 
important drug (used in gynecological complaints), there has been no 
mechanism to systematically address the confusion. Some 
manufacturers of repute sheepishly admit using arana, conveniently going by the informal consensus.  
By virtue of being large scale raw drug buyers, thereby influencing the supply chain, the 
industry has indirectly induced some extent of homogenization. But the roots of traditional use have 
been so strong that even a century of industrialization has not been able to homogenize the usage. For 
example, for the drug paphanah, though Pavetta indica is the most common, three different species 
are in use. For the drug prsniparni, Desmodium gangeticum is the most commonly used, but two other 
species of Desmodium are also used. Neither the industry nor the State in Kerala has attempted 
universal standardization of ingredients. Each manufacturer began with their family tradition and local 
knowledge, and as they grew in scale they made their own in-house standards based on their historical 
usage. For this reason, they are reluctant to follow standards laid out in the Indian Ayurvedic 
 
A badly stripped Ashoka tree 
in a public garden 
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Pharmacopeia and Formularies. However meaningful be regional variations in usage, with increased 
pressures on standardization, the demand for homogeneity continues to escalate. Large manufacturers 
have experts in their R & D department for creating standards. But small and micro-pharmacies lack 
these resources305. In the middle of an interview, Dr. Vasu, an ayurvedic doctor and proprietor of a 
small pharmacy in Central Kerala, excused himself to take an urgent phone call. The caller was asking 
his advice on the choice of the right variety of kurunthoti. A long discussion ensured. Keeping down the 
receiver, the doctor commented, “this is the trickiest problem for us to handle. For small pharmacies 
like ours it is very difficult to decide which is the right plant. We would really like to get some 
technical support here. I really hope CARe (the ayurvedic cluster project, see Section 7.7) will be able 
to streamline this process.”  
7.3 Medicinal plant resources in the forest: Cultural Vs economic stakes  
STs were historically dependent on the forest to meet everyday needs ranging from food to 
medicine, ritual to entertainment. Though they had no marked territories, they had informal common 
property regimes to manage people’s relationships with resources. Some even had designated leaders 
to oversee the forest306. The unwritten rules on harvesting territories meant that people had long-term 
stakes in the conservation of resources that they saw as critical for not only their immediate survival 
but also for future generations. Though various regional kings in the past did interfere with their lives 
to a certain extent nothing was as disruptive as colonial intervention (Aravindakshan 2011). British 
encroachment of forests to rehabilitate soldiers in the early 19th century and large scale acquisition and 
clearing of forest land for tea plantation in the mid 19th century displaced most of the ST communities. 
In the late 19th century, Forest Department of the colonial government began to take control over the 
forest with an eye on revenue. Slash-and-burn agriculture was prohibited by the 1882 Madras Forest Act 
and hunting was restricted by the 1879 Nilgiri Game & Fish Preservation Act (Anderson 2000). The post-
independent Indian State continued with similar policies alienating forest-dwelling communities from 
                                                 
305 With listing ingredients on the label becoming mandatory (both Sanskrit and Botanical names), a new problem has arisen. A 
small company listed  on its label ‘Sida cordifolia’ though they were using Sida rhombifolia. Not all small pharmacies have 
expertise to identify botanical varieties of herbs, hence they use generic catalogues for the purpose. The part-time botanist 
consultants they hire are average botany graduates who are not trained in complex pharmacognosy.  
306 For example, the Muthuvan community had a designated forest supervisor for each hamlet called a ‘Kani’, who was the 
decision maker when it came to matters concerning the forest. 
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their land. Forests’ value as a source of revenue escalated with industrialization. The plan was to grow 
large-scale plantations of quick-growing high yielding tree species (like eucalyptus, teak) to replace 
inferior, slow growing ones and to earn revenue by supplying raw material to wood based industries  
 (Guha 1983). In a personal interview, the King of Mannans in 
Kozhimala, Idukki district, pointed out that the forest 
department’s project of farming inside the forest was at the root 
of its destruction.   
 The next threat to the STs came ironically from the 
conservationist ideology that saw forest-dwellers as a threat to 
forest resources. As forest after forest was declared protected, 
they were forced to the peripheries. Today 28.4% of the Kerala 
forest is protected as biological parks and wild life sanctuaries.  A 
less visible alienation was caused by the denial of rights to use 
forest resources, forcing dependence on the market. This in turn made cash income a necessity for 
which they had to either trade forest goods or/and work for wage labor gradually alienating them from 
knowledge and values associated with forest resources. Forest resources were used not only for 
subsistence, but also for exchange. Anderson’s (2000) study in the Nilgiri forests in Tamil Nadu 
contiguous to Kerala shows intricate reciprocal exchange relationships between communities based on 
barter. Market-driven commodification in the late 18th and early 19th centuries transformed tribal 
relations; monetary transactions replaced relations of reciprocity, economic stakes replaced cultural 
stakes. Demand from ayurvedic and other industries increased economic stakes of forest resources. At 
the same time, increasing dependence on biomedical health care307 led to diminished cultural stake in 
medicinal plants. This led to a conducive atmosphere for overexploitation. For the younger generation 
medicinal herbs have become mere ‘commodities’ to sell for cash.308 The alienation is compounded by 
the fact that they are suppliers to a medical system they are seldom users of.  
                                                 
307 Though ST communities’ access to professional health care is poorer than the general population in Kerala, biomedicine has 
made sufficient inroads. Abraham (2003) finds that though 84% depend on herbs for home remedies, at the next level their 
dependency was 94% on allopathic medicine,  15% on Ayurvedic medicine and 8% on tribal medicine.  
308 Based on narratives of vaidyans and other elders from ST com\munities regarding generational value differences.  
 
The late Mannan King of 
Kozhimala 
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Despite their alienation from forests, the central source of livelihood of most ST communities 
in India comes from collection of minor forest produce (MFP) or non-timber forest produce (NTFP). 
Across India, there have been allegations of widespread exploitation of forest collectors by middlemen. 
The secretiveness of the raw drug and the consequent lack of transparency in prices makes it 
conducive for such exploitation (Joshi 2003). Kerala government took a radical step when they granted 
monopoly of collection of NTFPs to the STs in 1978. Girijan309 Service Co-operative Societies (GSCS) 
were formed that aimed to protect them from middlemen. These were soon brought under a nodal 
regulatory body, the Kerala State Scheduled Caste and Scheduled Tribe Development Cooperative 
Federation Ltd. (Hereinafter referred to as the Federation).  
Despite the legally restricted access, and 
a substantially improved regulatory 
environment310, illegal channels of trade 
persist311.  Small middle men traders who are 
market-savvy and have the ability to advance and 
extract credit make use of these skills to gain 
access to forest resources. Some of these also 
happen to be official agents of the collection 
societies.  The GSCSs focus mainly on items that 
they can easily market, unlike private traders 
they do not try to utilize the full potential to maximize profit. Of the total 145 plants in the list of 
forest collection, only a total of 60 are collected somewhat regularly, with each society collecting 15-
20 items. But 80% of the total collection comes from eight items. The bureaucratic organization of the 
Federation and lack of initiative and market sense of the GSCSs renders them too weak to be 
competitive in a market situation. The centralized annual price fixing done by the Federation is not  
                                                 
309 Literally, ‘hill people’ this term is used as a generic term to refer to those designated as ‘scheduled tribes’.  
310 Many flourishing private contractors of the pre 1980s era had gone out of business, some of them continuing to be marginal 
traders. Elders in ST communities also report that forest officials in general used to be high-handed and exploitative earlier and 
that they have now become less corrupt, more humane and friendly.  
311 Reports of illegal trade are high in forest peripheries easily accessible to traders in buffer zones. To a certain extent goods are 
also reportedly smuggled through official checkpoints with or without the connivance of forest officials.  
 
A Medicinal Plant Collector 
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flexible enough to respond to the 
market. However, despite their weak role, 
by providing a fair price to collectors, the 
GSCSs have been relatively instrumental in 
forcing other traders to pay equivalent or 
higher prices. Abraham (2003) in her study of 
20 select forest plants show that societies 
pay on an average 77% of what the private 
traders pay. All said and done, it does 
appear that illegal exploitation remains fairly in check because the economic stakes are low; there are 
few high value herbs that are lucrative enough to warrant smuggling. Prices remain so low that 
medicinal plant collection, even when fair prices are paid, is not a preferred way of earning livelihood 
except for the most marginalized among tribal communities.   
Therefore, Kerala forest resource suffers more from under-exploitation than overexploitation. 
The contribution of collection from the forests of Kerala to the ayurvedic industry is negligible. The ` 6 
billion ($ 120 mn) worth ayurvedic industry in 
Kerala is likely to consume a minimum of ` 2 
billion ($40 mn) worth raw material annually312. 
The  total annual collection value from the 
Kerala forests in 2007-08 was a mere ` 26 mn 
($0.5 mn), that is 1.3% of this consumption. The 
recent hype of Ayurveda and of the State’s 
potential to earn revenue from export of herbs 
and herb commodities, made the Kerala State 
government to sit up and worry about under-
exploitation. In the late 2000s, a policy proposal was made to step up MFP collection through enabling 
                                                 
312 Estimated based on manufacturers report of raw material part of the turnover being 35-45%. 
 
On a market day: raw Drug Collection Agent, Kottur 
 
Commuting from interior forest regions to the market 
to sell raw drugs, Kottur 
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Vana Samrakshana Samitis (VSS, “forest protection committees”)313, breaking the monopoly of the 
current Federation system314.  The target annual turnover was ` 1500 mn ($30 mn), 60 times that of the 
current average turnover. Though very few have the business acumen to deal with such an aggressive 
market, most GSCS functionaries come across as committed and concerned. Most of them are worried 
about the government proposal. VSSs are the ground level local administration of forests that are 
theoretically people’s committees, but they are literally under the wings of the Forest Department. 
They might be successful in increasing revenue, but this might open the floodgate to exploitation.315  
7.3.1 Long-term economic stake in restricted territories   
Despite all the hurdles, there are a few pockets of collection that demonstrate the significance 
of long-term economic stake. The primary pre-requisites for success appear to be territorial exclusivity 
of collection area and the dynamism of the leadership of the concerned Society. Most GSCSs were 
weighed down by the centralized bureaucratic organization, working like government entities that care 
little about profit making. An exception is the Kurumba GSCS in Mukkali that has the advantage of a 
captive community – most  of the Kurumbas live in the land locked forest, without access to any other 
means to earn cash income316. This is the only GSCS in the study sample that openly criticized the 
Federation as bureaucratic. Prices were fixed once a year at the center making it inflexible to compete 
with market prices317 that allows private traders to take advantage. Unlike societies, traders do not 
worry about the risk in paying an advance. The equation becomes worse when traders also act as 
creditors using it as a leverage to get access to forest resources. They are also know to make payments 
in tobacco and alcohol.  On the other hand, the annual auctions were non-transparent; there were only  
limited number of regular participants every year with high potential for cartelization.   
The Kurumba GSCS decided to bypass the Federation; it neither auctions its collection through  
                                                 
313 Equivalent to VFC (Village Forest Councils) local administration body of the Forest Department that includes forest dependent 
general population of a given forest locality with an elected president and a forest guard or forester, as its secretary, established 
under the institutional framework of Joint Forest Management (JFM).  
314 Most GSCSs were worried about this sword hanging over their head, but the proposal never saw the light of the day.  
315 For example, one year, a GSCS failed to arrange collection for kadukka fruit, an item that they usually purchase for ` 6 
($0.12)/kg. The forest office got it collected for ` 2 ($0.04)/kg refusing to share any part of the profit with the collectors. 
316 It has 600 members, i.e. 1/3rd the population of members of the Kurumba community who live on the fringes and inside the 
Silent Valley Forest sanctuary, the most protected of all the sanctuaries in Kerala. The society has collection grants for the 
Attapadi and Mannarkad forest ranges that are outside the protected area.  
317 Since the society depends on the advance given by the Federation to pay the collectors, it would be risky to pay a higher than 
fixed price, because by the time they are ready to sell it  the prices can again go down.  
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the Federation nor does it stick to prices fixed by 
them. The society supplies most of its collection 
to four of the five largest ayurvedic pharmacies 
excluding the State owned company318. During 
the time of this interview, in June 2010, they 
were in negotiations with AVS, demanding a 
higher price for padakizhangu, which the 
company had not yet agreed to. The staff is 
constantly in touch with the fluctuating market 
striking hard bargain with buyers like regular 
traders do319. The society claimed they used the 
maximum potential of the forest which left little 
room for illegal collection because they paid 
prices that traders were unlikely to match. 
According to them, the only item that could get 
illegally traded to a certain extent was 
adapathiyan320.  
Pottomavu GSCS is one of the ten 
societies that are part of the Trivandrum branch of the Federation, which though not as market-savvy 
as the above, is fairly dynamic and has the advantage of territorial exclusivity. It has been into 
medicinal plant collection since early 70s and had won the award for the best GSCS last year (i.e., 
2008), proudly claims the society president Tulaseedharan Kani. The members of the society, 80 odd 
families of the Kani community who live in this interior hamlets in Palode forest range derive 70% of 
their livelihood from collection of MFP321. Recently, Ayurdhara Pharmaceuticals, the ayurvedic 
                                                 
318 This is paradoxical – the  original intention was to channel the supply of collection societies to the State company. 
319 Recently they collected cheenikai at a price higher than that fixed by the Federation, despite being warned that the 
employees might end up bearing the losses. They nevertheless went ahead and earned a neat profit.  
320 Because of its high-price (` 350-500 i.e., $7-10/kg) and convenience to smuggle; a forest dweller could smuggle a piece of 
root in a shopping bag while going to town without attracting attention.  
321 Around 130 people are involved in the collection of forest produce through the society. The society collects 20-27 items in a 
year, and the average annul turnover is between 200 to 300 thousand rupees ($4000-6000). 
 
Group of elderly Kani women pre-processing 
Kurunthoti for Ayurdhara: Pottomavu forest  
 
One of the Kani women from the above picture 
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manufacturing unit run by  SCST Federation has engaged them in pre-processing (cleaning, cutting and 
drying) of kurunthoti to enable value addition at the source. This is mainly done by elderly ladies of 
the community.  
The society secretary who is not a Kani322 is appreciative of the community’s sensitivity. “The 
Kanis are extremely sensitive ecologically, and their harvesting practices are consciously sustainability 
oriented, it is not something we need to tell them to do”.  ST communities vary in the cultural stake 
they hold in forest resources depending on to what extent they preserve their cultural identity and 
traditional ethos. Each community’s relationship with the forest is different, partly determined by its 
own history and partly by the impact of post colonial policies323.  
7.3.2 The case of Arogyapacha: economic stake in competition with cultural stake 
A hitherto obscure plant Arogyapacha (Trichopus zeylanicus) brought international fame to the 
Kani community and to a team of scientists, when they received the Equator award in 2002. Unlike  
much ayurvedic knowledge which is published or openly shared, medicinal knowledge among tribal 
communities is oral and exclusive, often closely 
guarded. Scientists of the CSIR lab who were 
working on an ethnobotanical project in the 
region managed to wrest one such secret from 
three Kani youth who were assisting them with 
fieldwork. Kuttimathan Kani (image on the 
right), the leader of them made headlines when 
he accompanied the co-awardee Dr. P. 
Pushpangadan to Johannesburg to receive the 
equator award.  
                                                 
322 One staff member of GSCS is always from the Scheduled Caste.  
323 Whether a community has access to land and a history of settled cultivation (e.g., Kanis in Trivandrum, Muthuvans in Idukki), 
historically displaced and forced to work for daily wages (e.g., Paniyans in Wayanad), lives in protected forests with minimal 
access to resources (e.g., Muthuvans in Lakkam Kudi), lives deep inside the forest (e.g., Kadars in Vazhachal, Kattunaickans in 
Wayanad), moved to cash crop cultivation (e.g., Muthuvans in Idukki), struggling for basic land rights (e.g., various STs in 
Wayanad and Pathanathitta), substantially integrated with the mainstream (e.g., Mannans in Idukki) or isolated (e.g., Muthuvans 
in Idukki), reputed for its medicinal knowledge (e.g., Kuruchiyars,  Muthuvans and Kanis), large (e.g., Kanis with a population of 
20,000) or small (e.g., Kurumbas with a population of 1500).   
 
Kuttimathan Kani of the Arogyapacha fame talks 
about cultivation related problems 
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The scientists led by Dr. P. Pushpangadan, an ethnobotanist from CSIR worked on the chemical 
pharmacology of the herb and with the help of an ayurvedic expert designed an ayurvedic medicine 
called Jeevani for which they obtained Indian and US patents. With the help of an expert 
pharmacognosist, the herb was identified as an ayurvedic classical drug varahi (Sivarajan et al 1990).324 
Following this, they granted license to Coimbatore based Arya Vaidya Pharmacy (AVP) for production, 
after signing a benefit-sharing agreement with the Kanis, who were expected to get 50% each of the 
license fee and royalties obtained by the product sales. However, the project met numerous hurdles on 
the ground. A group of Plathis, officially designated Kani healers who were not consulted during this 
process, wrote a letter to the chief minister objecting to the deal. They felt it was unfortunate that 
the secret leaked, but now since it had, they did not want it to be leased to a private company. They 
were not interested in monetary benefit. Instead they wanted it to be shared as a free good for the 
benefit of the public. To use Kopytoff’s (1986) terminology, moving the plant from the “sacred sphere” 
to the “commodity sphere” must have felt unconscionable within the Kani cosmology. After overcoming 
several teething troubles325, the project finally took off in 2005. Jeevani came to market, but did not 
last long. It ended up in a series of controversies; the CSIR scientists drew much flak in the process. Dr. 
S. Rajasekharan, the ayurvedic scientist who designed the drug is reluctant to talk about it. He is 
distraught; what they intended as a benevolent act had backfired, making them villains. The unethical 
way in which the information was accessed made them easy targets for criticism, but there were other 
factors at work also common to other well known ethnobotanical fiascos326. The root of the problem 
lies in the larger context of the exchange “once you begin to dance with the devil, you are more likely 
to be seen as a sinner (Brown 2003: 125).”  Ethnobotanical researchers had supplied valuable 
information to industrial bioprospectors, subsidizing commercial drug exploration. The IP heavy 
regimes of the industrial world along with technological changes thwarted free flow of information as it 
“crossed the line from reciprocal exchange to industrial larceny” (Brown 2003:106).  
The biggest hurdle in the Jeevani case was set up by the Forest Department which had sole 
                                                 
324 Many herbs mentioned in the Ayurvedic classics remain unidentified.  
325 Amidst this, there was a ruckus in the Kerala parliament saying the royalty share was not fair. So the government issued an 
order to put the project on hold, asking the parties to rework the royalty agreement. 
326 The most infamous of them, ICBG-Maya project in Chiapas and Shaman Pharmaceuticals had landed into similar trouble, 
despite the inordinate effort made to take consent and share benefits with the communities (Brown 2003).  
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control over the forest land and resources; the community had no say in the matter. It refused 
permission to transporting the herbs out of the forest, despite being in the know that they were 
cultivated327. The objection of the Forest Department is not unfounded. Cultivation becomes a 
legitimate front to smuggle medicinal herbs out of the forest (e.g., kattupadavalam case, Section 
7.6.3). A lucrative grey market had developed around the herb following its fame, far before Jeevani  
entered the market. The leaves of the plant were being smuggled out in undetectably small quantities 
and sold at ` 100-150 per kg. However genuine be the intention, creating blockbuster herbs have the 
inevitable impact of magnifying individual economic stakes that tend to overtake the community’s 
cultural stake328. Ironically, the fact that it is secret knowledge itself brings unwanted attention 
creating an inflated commodity value329.  
The limited ability of herbal formulation patents to maintain exclusivity is downplayed by all 
the parties involved. Patents on plant formulations tend to be as weak 
as copyrights. Once secret knowledge is made open, nothing can stop 
others from creating modified versions. In the case of Arogyapacha, 
this problem was further compounded. Re-designated as an ayurvedic 
herb, it was dragged into an open source system330. Since AVP’s license 
for Jeevani expired, they have come out with a new product, 
Punarjeevani, literally meaning “Jeevani again” (image on the right).  
 Patent would make practical sense only if it was viable  for the company to legally exclude 
other uses, not a likely scenario for ayurvedic companies331. The inherent replicability of biological 
material poses another problem. There is no guarantee that the original owners of knowledge will 
benefit from the sale of the material. Arogyapacha had an initial advantage in being endemic. But it 
did not stop AVP or other pharmacies from sourcing it from the other edge of the forest in the  
                                                 
327 If the Department was genuinely concerned, it could have appointed supervisors to oversee harvesting and transport.   
328 E.g., This occurred when Sarpagandhi (Rauwolfia serpentine) was extracted for anti-hypertensive alkaloid Reserpine. 
329 Tribal medical knowledge carries an aura of mystique for the mainstream, representing all that is pristine, untainted and 
magical. Compared to regulating researchers policing the curiosity driven public is near to impossible (Brown 2003).   
330 The scientists were perhaps aware of the tenuousness of its exclusivity. Kuttimathan said that before Jeevani took off, during 
the controversy, they were approached by a company from Bangalore that promised higher royalty, but the TBGRI scientists  told 
them to stick to the deal as their exclusive control over it would not last long. 
331 Biomedical pharmaceutical product’s commercial logic cannot be applied to Ayurvedic products because profit margins are 
too low in the latter to justify the cost of litigation and the borders of the patent too fuzzy. The most important instrument for 
intellectual property here is the trademark, and surprisingly but for the drug registration that was valid within India, it had no 
specific trade mark protection inside or outside the country.  
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 neighboring state of Tamil Nadu, also a Kani habitat. The herb is also 
available in any medicinal plant nursery and is now growing in innumerable 
medicinal gardens. If a lucrative market develops, there is  no law to stop 
it from being cultivated in large scale.   
 
7.3.3 KIRTADS332 model: Economic stake built over cultural stake 
Dr. Vishwanathan Nair is an anthropologist who has been 
researching ethnomedical practices of the STs of Kerala for the past four decades. During his study he 
had realized that their traditional medical knowledge was fast disappearing. When he became the 
Director of KIRTADS333, the State government Institute meant to promote research and development of 
the Scheduled communities, he implemented an idea that he had been toying in his mind for long; to 
reinvigorate tribal medicinal knowledge by providing a platform for bridging the otherwise broken 
chain of knowledge transmission. He began with a pilot venture in 1993, with the setting up of a Tribal 
Medicine Center in Wayanad in the  North-Eastern tip of Kerala; 30 regional healers were identified and 
organized under a Chief Tribal Healer334. They were paid honorarium, transport and accommodation 
cost to instruct ten selected ST youth in a one year certificate program. After completion of the 
program, the students were certified by KIRTADS as vaidyan. Senior healers of the community335 were 
also awarded the certificate after an interview and practical assessment of herb identification skills. 
Meanwhile Dr. Viswanathan had managed to get the Chief Minister’s backing for the program, which 
was critical as they had to face protest from a section of ayurvedic practitioners who questioned the 
validity of the parallel certification. The program drew tremendous response and was soon extended to 
all tribal communities in Kerala. Around forty ST healers were appointed as instructors.  
Essentially what Dr. Viswanathan did was to provide an institutional mechanism to enable STs 
to commodify their knowledge without losing intellectual property to the outsiders. Unlike the 
                                                 
332 Kerala Institute for Research Training and Development Studies of Scheduled Castes & Scheduled Tribes 
 
333 Kerala Institute for Research Training & Development Studies of Scheduled Caste and Scheduled Tribes. 
334 The core curriculum was tribal medicine. Students were exposed to biomedical knowledge on health and medicine through a 
paper on community medicine. More emphasis was given to practical learning; they had to identify at least 500 medicinal plants 
and in the last phase, they had to apprentice with prominent tribal healers.  
335 During this period, the NGO led by Nair identified and prepared a directory of 240 tribal healers. 
 
Arogyapacha for sale in a 
medicine nursery 
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arogyapacha project, neither Nair nor the Institute has courted limelight. It was a low-key project that 
was executed on a shoe-string budget, just enough to meet the operation cost and to provide minimal 
incentive for the healers.  It was also genuinely participatory; the healers who were appointed as 
faculty were put on an equal footing and given a free hand in planning and running the program. Their 
right to secrecy was acknowledged and respected; no attempt was made to pry into their medicinal 
knowledge. They were given the freedom to choose what they wanted to teach.336  
 In 1996, the government agreed to the Institute’s 
recommendation to set up an annual grant to assist tribal 
healers in raising medicinal plants and to improve facilities for 
preparing and dispensing medicines. The Institute provided 
know-how, financial and moral support for the healers to set 
up clinics with the help of which many have established 
successful practices. They get as many patients from the 
mainstream as from within their community if not more. The 
more reputed of them get visitors from across Kerala, some 
attracting patients from outside the State337. Of the 9 tribal healer informants from five 
communities338, 7 were KIRTADS certified, two of which are young alumni of the healers’ training 
program. Among the senior healers, one had built a full-fledged nine bed inpatient hospital, two others 
were attracting patients from neighboring towns and cities. Both the junior healers interviewed had 
established successful practices. One practices in a remote interior hamlet inside the forest in 
Wayanad attracting 100-200 patients a day, employing 40 herb collectors to make medicines (see image 
of the clinic-pharmacy above). His pharmacy assistant allowed me to take a photograph of the premises 
but pleaded, “Please don’t publish the photograph, we don’t want any more crowd. We are already not 
able to handle the crowd”. Another junior healer stated that despite being a healer’s son he would not 
have been able to become a vaidyan without this opportunity. He said, “As per our community ethics, I 
                                                 
336 Also whom to impart with knowledge that they considered secret. This was important given that several communities were 
involved, some of which had cultural barriers to share secret knowledge with outsiders.  
337 For example, the late Valli Amma, an elderly woman vaidyan from the Kurumba community attracted patients from cities 
outside Kerala, like Bangalore. 
338 One each from the Kadar, Urali, and Kuruchiyar communities, two Muthuvans, and three Kanis. 
 
A flourishing clinic of a KITARDS 
certified Vaidyan from Kuruchiyar 
community, Wayanad 
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would not have been able to put an economic value to the service, but the training made it possible to 
see the process in a different light”. It was important not just because it opened up a means to 
livelihood, but also because it bought in a lot of much needed self esteem to the community. He said, 
“For the first time the mainland people (Nattukaru) are treating us with respect. They call me vaidyar, 
pay the money we ask, observe whatever we asked them to do.” The success of the program is evident  
by the fact that almost all certified healers have  
youth from their own communities apprenticing with 
them (See Appendix G for practitioner profiles). 
More often than not tribal medicinal 
knowledge gets exploited without any benefit 
accruing to the community.  For instance, one of the 
widely advertized proprietary ayurvedic products 
from Kerala, Haridra, an anti-hemorrhoid product 
marketed by DuCare carries the slogan “a unique tribal formulation for piles”. An ayurvedic 
practitioner was found advertizing his expertise in tribal medicine. Muthu vaidyan had an interesting 
story to tell about a conman who went around conducting ‘tribal camps’ across Kerala recruiting tribal 
healers to travel with him. He spent almost a year and a half with the program; the camps drew on an 
average of  800 people per day. He moved away after he realized it was a money making racket that 
had little regard to people’s health339.  
The TBGRI ethnobotanical approach saw tribal knowledge as just a source from which 
knowledge of plants had to be taken and validated within the ayurvedic framework. In fact, the herb 
was de-identified from the culture when it was named as arogyapacha (the health herb) and classified 
as an ayurvedic drug. Citing Charaka’s advice to ayurvedic practitioners to gather knowledge of herbs 
from shepherds and nomads340, Dr. S. Rajasekharan, said the traditional path of drug discovery was 
scuttled by the artificial freezing of the ayurvedic pharmacopeia. The Indian Drugs and Cosmetics Act 
                                                 
339 As there was no time to take  case history or to make medicines, he was forced to give standard prepared medicines. Patients 
were charged exorbitant amounts of money, doctors were paid a small commission. The itinerant camp mode was convenient to 
escape long term accountability.  
340 Charaka Samhita Ch.1 su: 120-121: Oushadha nama roopakhyaam jaanathe kyajapa vane, avipashchaiva gopashcha ye cha 
anye vanavasinatha ‘the goat herds, shepherds, cowherds and other forest dwellers know the drugs by name and form…” 
 
Krishnan Vaidyan from the Muthuvan Community, 
Lakkam Kudi, Marayur 
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(1940) limited innovation to herbs mentioned in the approved classical texts. Just as biomedicine 
wanted ayurvedic plants for discovering new drug entities, Ayurveda looked at tribal medicine as a 
source of knowledge, without respect to its larger framework. It is perhaps this lack of respect that 
was behind their resistance to the KIRTADS certification of ST healers as vaidyans.  
7.3.4 Comparing the ethnobotanical benefit-sharing model to KIRTADS model 
The ethnobotanical benefit-sharing approach is based on an external revenue model. For it to 
be financially sustainable, herbs have to have proven pharmacological value within a biomedical 
paradigm341. The financial viability of such a model is not always guaranteed; the costs of drug testing 
are high and the rate of success very poor as evident by the Shaman pharmaceutical experiment 
(Brown 2003). Benefit-sharing becomes a complicated exercise as knowledge tends to be shared across 
communities. Often within communities that lack a coherent authority structure, representation 
becomes a knotty problem becoming an unwanted source of conflict. Hyped up herbs create a 
conducive atmosphere for illegal exploitation chains to develop. This is reminiscent of the “tribal 
zone” situation (Ferguson and Whitehead 1992), except that the valuable goods belong to the people 
themselves and the bone of contention is intangible intellectual property. The problem is exacerbated 
due to the involvement of large capital. Contrary to scientists’ self-perception of benevolence, the 
unequal interaction brings into relief the wide disparity in monetary compensation between the parties 
involved, giving rise to the perception of exploitation (Brown 2003).  
Ethnobotanists, in their zeal for forest conservation promoted the idea of forest biodiversity as 
being source of valuable medicines (Brown 2003). This concept of wealth ignores the inherent 
economic value of medicinal herbs as local health resources, instead focusing on their elusive and often 
undependable cash value brought by selling to outsiders, especially biomedical pharmaceutical 
companies. It does not take into account the potential losses to the community in the event of the 
herb’s escalated exchange value which might not only make it unattainable for internal use but also 
threaten its very existence in the wild. The KIRTADS model on the other hand recognizes, strengthens 
and equips indigenous knowledge to adapt to a commodity friendly model. Most importantly, it allows 
                                                 
341 Discrepancy in cultural capital allows scientists to claim intellectual capital over indigenous knowledge(Brown 2003). 
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the traditional knowledge holders to capitalize on it value without diluting its secret, thereby giving 
them long-term control over intellectual property.  
Cultural stake in medicinal plants as source of health care now gets tied to the pursuit of 
livelihood. In other words, economic stake and cultural stake merge to form a sustainable model that 
combine the goals of conservation and resource utilization remarkably well.  Vaidyan Shankaran Kani 
goes to the forest to every Tuesday to collect herbs along with four assistants, each paid ` 200 ($4) per 
day, equivalent to an unskilled laborer’s wages. When they collect herbs they are careful to partially 
extract roots and barks to allow them to regenerate. These resources have to not only last for their life 
time, but also for future generations. When Ganeshan, a wealthy businessman in Adimali had a problem 
with chipping nails that all other medical systems failed to find a cure, he went to Shankaran as a final  
resort. The vaidyan told him it was a calcium 
problem342 he could address, but he had to 
wait until his next trip to the forest. The 
medicine was a lichen that grew on the top of 
a particular tree; he knew exactly where to 
get it from. Tribal vaidyans make very few 
ready made medicines, the rest are prepared 
as and when the requirement arises. Keeping 
an eye on medicinal plant resources in the 
wild is a habit tied to the interests of their 
vocation. Naturally, they are also tuned to notice dwindling of useful resources. Shankaran pointed out 
that he had come across ‘Kachodakkar’ (traders) collecting medicinal plant material in the forests 
looting the resource without any regard to its conservation343.  
                                                 
342 Shankaran has nothing more than primary school education. His knowledge of calcium comes from his exposure to basic 
community education provided by KIRTADS (Kerala Institute for Research Training & Development Studies of Scheduled Caste and 
Scheduled Tribes). 
343 Such incidents were more common where forest-dwelling communities had neither cultural nor economic stake in resources, 
and also in buffer zones that were easily accessible and difficult to guard. The Federation worked through agents who were 
adept non-tribal tradesmen, some of whom  misused their position. It is difficult to track such cases for obvious reasons,  but I 
did meet one collection agent who had hired casual workers to harvest large quantities of Shatavari with little regard to 
conservation. He operated in a region where the ST communities had access to cultivable land and were well to do. Having no 
stake in MFPs they were naturally oblivious of such activities. 
 
Shankaran Vaidyan at his clinic, the board lists names 
of medicines available with prices 
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7.4 Non-forest medicinal plant resources: Cultural stakes 
The non-forest supply chain includes medicinal plants collected from private farms and 
commons.  Ethnographic description of household involvement in medicine making in Kerala in the last 
three chapters shows how this helped to maintain people-plant relationships. But unlike forest regions 
where cultural stake and economic stake directly compete, the general population has no direct 
monetary stake in the resources. It is only the marginalized, usually the landless who have been using 
medicinal plants as a resource to earn their livelihood. Commons are uncultivated land between farm 
lands not owned by anyone. Unlike the forest, here there were no historical common property regimes 
to regulate access. Resources survived only because the intensity of use was low, though most 
medicinal plants and trees were safeguarded by traditionally prescribed rules of extraction. Though the 
rules emphasized the medicinal value of specific roots (e.g., koovalam – roots  growing in the northerly 
direction), they were perhaps made to ensure sustainable extraction344. Pressure on plant resources 
must have been an old story; the 16th century treatise Bhavaprakasha lists Abhava varga, i.e., a class of 
substitute drugs for rare or unavailable plants. Substitutes are  suggested for 44 medicinal herbs in the 
three important classics from 16th to 19th century (Venkatasubramanian et al 2010).  
Mass production and increased demand for finished medicine in the past few decades has led to 
large scale extraction from the commons, flouting all traditional rules of harvesting. This would still 
not have been a problem if not for the fact that expansion in the urban sprawl and spread of intensive 
cultivation had meanwhile shrunk common spaces considerably. The biggest culprit is rubber which 
gobbled up all previously uncultivated areas especially hilly lands, meadows, poorly irrigated lands345. 
The only common spaces now left are road sides, river banks, and buffer regions of forests. Recently, a 
brand new threat has begun to loom over the most critical of the remaining commons, the roadsides.  
                                                 
344 Similar rules for extraction have been found to be prevalent in many indigenous cultures (Sheldon et al 1997). 
345 Area under rubber cultivation expanded to 627% from 1955 to 2000, now accounting to 20% of the cultivated land. 
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Weedy growth on the roadsides includes 
 medicinal plants 
Harvesting kurunthoti from the roadside  
post monsoon 
 
In my last visit to the field in early 2012, I heard a small manufacturer complain in a  business meet, of 
acute raw material shortage as a side-effect of NREGS (National Rural Employment Guarantee Scheme). 
The project deploys casual laborers across Kerala for road side beautification work, who mercilessly dig 
up all biomass without leaving back any roots. That this problem is not as trivial as it seems is evident 
from the fact that it has already attracted media attention (e.g., Viswanath 2012).  
In many regions, private farms are an equal or more significant source of medicinal plants, 
especially because the predominant system of traditional farming in Kerala is the homegarden system. 
Unlike monocultures that leave little room for diversity, a homegarden is a multifunctional farm, a 
combination of passive and active cultivation.346 Several medicinal plants are weeds that come up 
naturally and maintained passively (e.g., kurunthoti). A few are intentionally cultivated (e.g., 
panikoorka). Some are used for both food and medicine (e.g., kodakan) or other cultural purposes 
(tulasi, a sacred plant). Some medicinal trees like venga are maintained within homegardens for their 
timber value, some for fruits (e.g., njaval, tamarind). Homegarden cultivation promoted multi-
functional thinking that often involved long-term planning, a thought process absent in monoculture 
cash crops (Thomas 1999). As people moved from agrarian to salaried employment, such thinking lost 
relevance because most commodities could be bought from the market. Medicinal plants in 
homegardens also got sidelined due to transition in farming from extensive to intensive cultivation, 
                                                 
346 The term ‘horticulture’ is commonly used for such systems, but in India the term would mean ‘fruit and vegetable cultivation’  
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especially towards monocultures of cash crops347. The biggest culprit again was rubber. The Kerala 
Rubber Board’s policy required cultivators to clear the farm land of every other plant as an eligibility 
requirement for subsidy. There were also other attitude shifts from ‘traditional’ to ‘modern’, like 
change in preference from functional gardening to modern landscaping centered around fashionable 
ornamental plants. Another cultural practice that was critical in conserving plant species are 
sarpakavus (literally, snake groves), small patches within the farm reserved as a sacred habitat for 
snakes348, that have significantly declined due to weakening of religious and cultural beliefs.  
Dissociation from medicine making has distanced people from knowledge of medicinal values of 
flora. More than monetary loss, lack of knowledge among people does not augur well for conservation 
within farms. Savvy middlemen make a fortune out of this ignorance, buying trees like koovalam for 
timber or firewood value (See section 7.2.2). Talking about the lack of availability of an important 
medicinal tree root, a respondent from a medicinal plant collection society said, “Palakapayyani (one 
of the Dashamoola trees)  was common in the farmsteads till recently, but it is now hard to find 
because greedy medicine pluckers went around homesteads indiscriminately pulling out roots of 
immature trees, paying pittance to the owners.” They could do this because the farm owners had no 
knowledge of the medicinal value of the tree or of its trade value as a raw drug.  
 A good example for the significance of cultural values in conservation is the index herb 
koovalam, the poster child of ayurvedic industry’s threat to medicinal plant resources. Destruction of 
koovalam is usually clubbed with the larger story of exploitation of forest resources, but a closer look 
reveals a different story. In Kerala, koovalam happens to be more of a cultural tree than a forest 
tree349, a fact that is seldom recognized. Due to its religious value, it was historically grown in home 
gardens, sacred groves and temples. According to a large manufacturer’s estimate, the scarcity of 
koovalam is a two decade old story. But popular narratives push the time frame further backwards to 
                                                 
347 An analysis of homegardens in Kerala (Peyre et al  2006) finds that 50% of all respondents followed traditional homegarden 
management practices, 33% had moved towards cash crop production and use of external inputs. 
348 Found across India in various forms, such ‘sacred groves’ have been found to harbor threatened species that are not found in 
protected forests and also have medicinal species in greater abundance than forests (Bhagwat et al 2005). 
349 This species is globally distributed across Indo-Malesian region, it grows all over India in nine States, but is densely distributed 
only in dry and moist deciduous forests of the Eastern and Western Ghats with a mean annual rainfall of 50-200 cm. Though it is 
present in Kerala, it is sparse in the wild because of heavy rainfall of annual average being over 300 cm. Inquiries with traditional 
practitioners familiar with the forest ecology, and knowledgeable of the past few decades, reveal that forests in Kerala was 
never an important source of the drug. It does not also figure in the SCST Federation’s list of 145 forest plants allowed for 
extraction. 
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the 1960s.350 Added to koovalam’s woes is an unfortunate 
misunderstanding of a popular proverb351 that lists four events 
as ominous for the land and the land owner, one of which is the 
perishing of koovalam. The intention of the proverb must have 
been to remind people to take special care of the tree, 
considered an integral part of the homegarden. But 
paradoxically, the proverb seemed to have become counterproductive. Afraid of adverse consequences 
of its destruction, people thought it wiser to avoid planting the tree in their homesteads!  
7.5  Non-forest medicinal plant resources: Economic Stakes 
A noteworthy trend in non-forest areas is the transition from professional collectors to daily 
wagers352. This development is not entirely new as noted by PS Varier in his foundation address in the 
beginning of 1900s, but it has increased in magnitude. Fresh herb trader Abdullah says that in the past 
they could hire knowledgeable collectors; they had to be only given a item list, they knew the identity 
and location of herbs. Now they hire casual laborers, who are trained on the spot to identify a few 
herbs, usually one at a time. Be they professional collectors or casual laborers, it is unlikely that long-
term economic stakes work in an open access situation, whether today or in the past. I observed an 
instance where the fresh herb agent refused to supply the bark of ung (a tree) to a small manufacturer, 
telling him that the bark extraction is killing all the trees, suggesting he use the leaves instead. Though 
this suggests a likelihood of some long term economic stakes for professional collectors or traders, my 
estimate is that this is likely to be negligible given the historical lack of exclusivity in collection 
territories. 
Economic stakeholders of non-forest resources are marginalized people who earn their living by 
selling medicinal herbs. There are a variety of collectors in non-forest areas. There is a large body of 
                                                 
350A retired school teacher says that in her childhood (in the mid-1960s), she used to harvest roots from a koovalam tree in the 
neighborhood commons. Despite the fact it was not a popular home remedy, the paucity of resource and population pressure 
combined led to overharvesting to such an extent that one fine day the tree collapsed. 
351 Nari karanjidam, narakam nattadam, koovalam kettidam, nakham vetti ittidam okke nashichidum – the  land on which a 
woman cries or a lemon tree is planted or koovalam has gone bad or nails are cut and dumped, will surely perish. 
352 Two STs, Ulladans and Nayadis were among such professional collectors, are now found only near Kottayam wholesale raw 
drug market. 
 
Koovalam (Aegle marmelos) 
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casual laborers, mostly displaced laborers, women from lower income families who need to work close 
to home on a flexible schedule, disabled and elderly people who cannot do other jobs. Here are 
profiles of four respondents that represent some of the common categories of collectors. 
 Full-time collector: Thankamma, a lady in her mid 50s who lives in the outskirts of Thrissur is a 
regular collector supplying to a large Ayurveda pharmacy in the nearby town, an occupation she 
started in her teens. She used to pluck a number of medicinal herbs from the commons, from river 
shores, road sides and private farms. The earning rarely matched a daily wager’s income, but was 
a good fallback option. She stopped the job when she started going for full time wage labor. Now 
four decades later, she turns to herb plucking occasionally. The pharmacy sends word to her if 
there is a requirement for a small quantities of a particular herb, for example 50 kilos of 
brahmi353.  Though it is not much rewarding354 she is glad to have the option to make up for days 
of unemployment. The work is not heavy except for herbs like kurunthoti that are difficult to 
uproot.  
 Full-time collector committed to a singe buyer:  Yohannan, a 72 
year old, partially disabled, house painter, shifted from part time 
to full time collection as he grew older. He was introduced to the 
trade in his youth by a vaidyan cum raw drug wholesaler, who also 
taught him how to identify plants. He was supplying to him till 
recently, but now the vaidyan is no more and his children have 
become allopathic doctors. Now he mainly supplies to a local raw 
drug dealer, who gives him the same price he would get in the 
Thrissur market. It fetches him ` 150-200 ($3-4) equivalent to a 
day’s wages of an unskilled woman laborer. On the day of the 
interview he had four bundles of plants, kadaladi (3 kgs), tulasi (4 
kg.), kurunthoti (around 5 kgs), and cheroolam (2 kg.), these 
would fetch an average of ` 18-20 ($0.36-0.4) a kilo.   
Full time free-lancer:  
Keshavan does both the collecting and selling himself.  When he finds a cache of medicinal plants 
he goes around enquiring among pharmacies, also collecting information on future fresh herb 
                                                 
353 Whenever there is a long period of unemployment she calls up the pharmacy (thanks to the mobile  phone) to check if there is 
a requirement. The pharmacy also contacts her once in a while with specific requirements.  Sometimes when she is lucky, like 
she was last week, she manages to earn above ` 200 ($4) for a day’s work, which is higher than her regular daily wage of ` 150 
($3). But there are also occasions when she earns only 50 or 100 when the quantity required is small.  
354 Market prices are highly fluctuating, the average price for a kilo of fresh brahmi in the wholesale market ranges from `10- 20 
($0.2-0.4). Prices vary depending on season, criticality of requirement and quality. Thangamma gets ` 5-15 ($0.1-0.3) per kilo. If 
she sells to an agent she would lose ` 2 to 3 ($.0.04 to 0.06) 
Yohannan 
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requirements. He has a number of buyers in Shoranur town, which has three medium sized  
manufacturers and two ayurvedic medical colleges and a couple of resorts in the town. When I 
met him he had just spent two hours collecting 25 kilos of roots of the castor plant from the banks 
of the Nila river, a collection that is worth ` 250-400 ($5-8).  
Farmer cum part-time collector (image on the right) 
When I met Ahmad, he was on his way to the wholesale 
market in Thrissur, trying to find a buyer for 30 kilos of 
barks of the Athi tree, he hopes it would fetch him ` 7 to 
15 ($0.14 to 0.3) per kilo. The source of the resource was 
his own farm; a large branch of the tree in the farm had 
fallen during the previous day’s thunder storm. Though 
an average farmer, being medicine-literate he regularly 
suppliers material sourced from farmsteads, e.g., 
drumstick tree bark and root of koovalam.  
 
7.5.1 Kurunthoti: A contrast between long term and short term economic stakes 
Long-term economic stake also  comes into effect in open access spaces in the event of 
absence of competition. I observed one such situation in the forest supply chain of the index plant 
kurunthoti355. In terms of quantum of collection, kurunthoti is the largest among the MFPs collected by 
the Federation (363.6 tons in 2006-7).  Four GSCSs from the sample account for 70.4% of the collection. 
The largest contribution comes from the North-Eastern tip of Kerala, from the district of Wayanad. Two 
GSCSs (Meppadi and Sultan Battery) account for 65% of the total collection.356 But kurunthoti’s 
presence in the forest supply chain is deceptive. Though the collection flows through the forest 
channel, it is the collectors and not the source that makes it a forest produce. Almost all the material 
comes from non-forest commons around the peripheries of the North-Eastern forest ranges of the 
Western Ghats in Kerala. During the season, collectors descend on the picturesque rural landscape like 
a locust army. The entire collection of the two societies is geared to meet the annual orders of Arya 
                                                 
355 Though Sida species are available across the country, Kerala depends on local collection because of the variety specificity 
(Sida rhombifolia spp. retusa) and also due to abundant availability it was a more economical option. 
356 166 tons  and 118.8 tons respectively in 2006, and 115 and 128 tons in 2008-9.   
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Vaidya Sala.357  Both societies claimed that the collection did not have any visible effect on plant 
resources because they change the collection site every other year. The resource is so abundant that 
they claim they are limited by demand rather than supply potential. This is not surprising given that 
the regeneration rate for Sida spp. was found to be 100% if the removal rate was below 75% 
(Muraleedharan et al 2005).  
More importantly, the harvesting is typically done annually between Oct-December post the 
flowering and fruiting of the plant. In most other regions of Kerala, the collection is between August-
October, when the soil is soaking wet and the roots are easiest to pull. Here, there is a conscious 
decision to wait for the fruiting season to get over. Both the GSCSs and the manufacturer (AVS) who 
buys from them have a long-term stake in the resource. Other factors also work in kurunthoti’s favor. 
Unlike other parts of Kerala where Karkidakam (July-august) is the lean period for labor,  in this region 
Nov-January is the right time to mobilize a large labor force. So far, the GSCSs have been fortunate to 
get an exclusive catchment to collect the material and since only the most marginalized resort to 
medicinal plant collection, there has been no significant competition. But  of late, there is a fear of 
private contractors entering the space. The Meppadi GSCS secretary says that she plans to petition to 
the Federation that STs be given monopoly of collection. But this argument has no locus standi as there 
is no law to regulate harvesting of resources in non-forest commons; monopoly of tribal collectors is 
restricted to forest produce. 
 Kurunthoti’s commodity life illustrates the problems that arise in the context of short-term 
economic stakes. Upputhara is a busy town with around hundred shops catering to the largely rural 
agrarian population of the Panchayat in the hill district of Idukki.358 Rolling tea gardens dominate the 
landscape accounting for nearly 60% of the cropped area. Other important crops are rubber, pepper, 
coffee and cardamom. Medicinal plant collection hardly has any place in the region’s economy. Though 
it is abundant in forest resources, raw drug markets are far away, and much of the forest in the region 
is part of the State Reserve Forest.  
                                                 
357 The material is sold at a price of ` 27 ($0.54) to AVS which sends around 12-14 trucks to each of these two societies for 
collection. If the material fetches a better price, the difference is paid to the pluckers.  
358 Upputhara, a village Panchayat with a population of 30,000 is located on the bank of Periyar river in the district of Idukki. It is 
a migratory region where settlements began in early 20th century with a group of Christian families from Kottayam acquired 
license from the Travancore government to establish tea plantations (Nair and Ramkumar 2007). 
 274 
 
 In the past three years, there is a new development. By the end of monsoons, in the month of 
August, a raw drug collection center springs out of nowhere. As the day progresses, stacks of fresh 
herbs and roots begin to accumulate around the shop. Kurunthoti roots dominate the stacks that 
consist of around ten different herbs roots. The traders, 
Suleman and Sayyed  are reluctant to speak. 
 Though they claim they trade in herbs collected from the 
commons, some of the material is most likely sourced from 
forest land. They pay `10 ($0.2)/kg. of freshly collected 
kurunthoti root359. Once they accumulate a mini-truck load 
(3-4 tons), they sell the material to larger agents in 
Kottayam and Thrissur360. These traders are routine dealers 
in various types of waste – paper, plastics and metals. They are adept at identifying emerging niches; it 
works well for them to diversify. They move into medicinal herb trade in the post monsoon season 
when the earth becomes soft and it is easy to pull out roots.  
Such fly-by-night operation has been catching up in various parts of Kerala of late, owing to 
spiraling demand for bulk quantities of some local raw drugs like kurunthoti. Unlike traditional 
collection agents they have no long term stake in these resources, they switch their trade to suit the 
market. It makes sense for them to maximize their profit; there is no scope for sustainability here. 
Same is true with collectors – a  motley crowd of people including marginalized laborers, women, older 
men, displaced laborers, and school children from poor families using their spare time to make some 
pocket money. Most of the displaced laborers are from locked out tea-estates and factories, a regular 
feature in Marxist Kerala.  
Kurishu Michael, one such displaced estate worker, came to know about a medicinal plant 
collection agent in a nearby town when he was hunting for a job. The agent familiarized him with the 
commonly required plants, of which he selected three items that would fetch the best returns 
                                                 
359 Roots are collected along with leaves to check herb identity. Before weighing they cut the rest of the plant retaining roots 
along with 5-10 inches of the stem. The hardy stem and roots without leaves stay fresh for almost a week. 
360 When the prices are not attractive they dry it so that they can sell at a premium. A  kilo of dried material fetches about ` 40-
60 ($0.8-1.2). It takes  around 4-5 kg of wet herb to make a kilo of dried material.  
 
Seasonal Fresh Herb Traders, Idukki Dt. 
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including kurunthoti. His range of collection is around 25 sq. kms. 
from around his residence. Though all the three herbs are found 
in proximity, he finds it easier to collect one a time, and while 
picking one, he identifies sources for the other herbs. The 
distribution and biomass of herbs is an important factor 
influencing collection, besides its market value; it is a 
determinant factor in returns per unit of time361. He collects 
other herbs from the commons, but prefers to collect kurunthoti 
from farm land; in spite of the rain uncultivated earth is far 
tougher to dig up. A four acre farm can fetch an average 60 kg of wet herb. If the farm is small he has 
to visit 4-5 farms a day; it is not always easy to get permission from the landowners. Though they do 
not care about the value of the material being plucked, most of it being weedy growth, they are 
uncomfortable with letting unknown people into their property. He gets  around 40-50 days 
employment in the season, earning ` 300 ($6) a day. 
 Even those with best of intentions find it difficult to stick to their goals of conservation in an 
open access situation. ESAF (Evangelical Social Action Forum), development outfit of a Christian 
evangelical group headquartered in Thrissur, discovered a niche in the growing medicinal plant market 
in 2006. They now gross an annual ` 5-6 mn ($0.1-0.12  mn) from medicinal plant collection alone, 70% 
of which is contributed by kurunthoti. Their primary collection is focused around 7-8 herbs involving 
around 300 collectors, mostly from women’s SHGs. They claim their presence has made a difference in 
the local market to force traders to give equivalent prices. As a voluntary organization without sole 
aim of commercial gains they expected the collection to be sustainable. But once they get into trade 
they have realized a few things. They initially burnt fingers being generous to collectors failing to take 
into account wastage rate362. Their primary focus is to organize livelihood resources for people, but the 
labor supply is not dependable, and they ended up sourcing from traders. To stay as a recognized and 
trusted supplier it was important to maintain schedule commitments. For the same reason, they were 
                                                 
361 Also noted by Muraleedharan et al (1997) who found density and distribution as limiting factors in NTFP collection.  
362 The wastage rate was very high, up to 40%. So they ended up getting a dry weight of 6:1 instead of the expected 4:1. 
Fresh herb transport on bike from 
wholesale market to factory, 
Thrissur 
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unable to stick to sustainable collection; plants were often collected before flowering. In an open 
access situation, it made no sense to follow rules of sustainable harvesting. “If we did not collect, 
someone else would” sighed a staff member, with frustrated resignation.  
7.6  Medicinal plant farming in Kerala: Problems and prospects 
7.6.1 Factors contributing to unviability of medicinal plant farming in Kerala  
Dr. M. S. Swaminathan, the architect of Green Revolution suggested that the North Eastern stretch of 
Kerala be “converted into a bio-valley based on the cultivation of medicinal plants” (Hindu 2009). 
Thriving ayurvedic industry and the tropical vegetation together create a mirage of ‘green Kerala’ as 
an ideal haven for medicinal plant farming. But several factors contribute to making medicinal plant 
medicinal plant farming unviable in the State, the most important of which are the following: 
1. High cost of land and labor and competition from high-margin cash crops:  Kerala’s excellent 
track record in land reform and equitable distribution has reduced the average size of land holdings to 
less than 0.4  ha. 90% of holdings are less than half a hectare in size363. High land prices coupled with 
high cost of labor makes farming an unviable proposition. Only crops with low labor inputs or those 
with high profit margins can survive. In 2009-2010, the farming sector contributed only 11.47% of the 
State’s GDP. Food crops account for merely 12% of gross cropped area, the rest devoted to high-margin 
cash crops364 (Kerala State Planning Board 2010).  Recent water wars with Tamil Nadu has brought into 
relief Kerala’s dependency on neighboring states on rice and vegetables. Labor is not just expensive, it 
is unavailable. A fresh herb trader asks a valid question, “We are not even getting laborers to pluck 
herbs that are freely available, how are you going to get anybody to do farm work?” He complained 
that the National Rural Employment Guarantee Scheme was worsening the situation.  
2. Price volatility and competition from free wild resource: Medicinal plants have not reached the 
stage of open commodities. There are no established marketing channels; prices are volatile because of 
unpredictability in demand and supply. Availability of free forest resource makes prices too low for the 
already unviable farming sector to compete. It is therefore not surprising that an estimated 8% is all 
                                                 
363 200 thousand farms are between 1 and 2 ha., 75, 651 between 2 and 4 ha., 16008 bet. 4 and 10 ha., 2735 above 10 ha. 
364 Rubber, coconut, banana and spices. 
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what ayurvedic industry sources from cultivation (Sasidharan and Muraleedharan 2009). Even among 
the 19 species listed, most are historically cultivated for other markets, like spices (e.g., ginger, 
turmeric), cosmetics and perfumes(e.g., kacholam, inchipullu, ramacham), dye (pathimukham)365.  
3. Non-standard material use and complexity of  medicine production schedules: The most 
important commodity in the medicinal plant market is ‘information’. Though all trade thrives on some 
amount of information asymmetry, it plays a critical role in medicinal plant trade. Complexity and 
variability of material makes it difficult for an average farmer to understand market demand. Firstly, 
manufacturers patronize different species/varieties.366 Secondly, production scheduling is complex 
because of the number of ingredients that go into a single medicine. Raw material schedules have to 
be coordinated based on seasonal availability of fresh and perishable material. Since it is too complex 
for manufacturers to handle, they let the agents do it for them. Traditional suppliers have a high 
degree of accumulated metis. They are not mere suppliers, knowledge-intensive material managers. 
Individual farmers bringing in discrete material poses a problem to large manufacturers.  
Biju has been growing neela-amari (Indigofera tinctoria)367 for 25 years in an acre of land. As 
the chief ingredient of the most popular ayurvedic hair oil of Kerala, Neelibhringadi, the herb is always 
in bulk demand from ayurvedic manufacturers of all sizes and hues including those who specialize in 
cosmetics. Growing is easy, the yield is good and if there is demand, he can even do multiple 
harvesting (up to 3 times) garnering up to 5-6 tons of yield368. But he says, “it is not the growing but 
the marketing that is complex”. He could venture into this only because of insider understanding of the 
market requirement that he acquired in his youth as a helper to his uncle who supplied the herb to 
pharmacies. But despite that, it is a struggle. First hurdle is variability of material. There are two kinds 
of  amari, blue and white, that give blue and green tint to the oil respectively. Two large 
manufacturers to whom he tried supplying to were found to be using the white variety due to historical 
low-priced supply from Tamil Nadu (` 8 - 14 ($0.16-0.28) Vs ` 20-40  ($0.4-0.8) for the blue). 
                                                 
365 Koovalam and Ashoka are listed, but these are unlikely to be cultivated on a commercial scale. If the total demand for the 12 
herbs are added up, it amounts to 866 tons, that is a mere 4.3% of the 230 heavily used medicinal fauna. 
366 E.g.,  three varieties of Chittaratha are in use. Certain varieties of Vayambu are not preferred because they are too fibrous.  
The gooseberry is preferred for Chyawanaprash is the pulpy variety whereas the juicy variety is preferred for oils.  
367 A branching shrub that grows up to 2 m. high. The whole plant is used as the source of the drug ‘Nili’. 
368 Though theoretically per acre yield could go up to 15 tons, 5-6 tons is what one can practically expect to get. One year he lost 
the entire crop due to a virus infection.  
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Though they know blue is the right variety, they do not want to upset 
their established production style369 and alter the product’s look and 
feel, not to mention that it would also affect their profit margins. The 
proprietor of Kalan Pharmaceuticals, Dr. K. P. Jose, says that he 
initially tried to raise a ruckus about the color discrepancy of products 
in the market, but eventually yielded to the request of significant 
others to avoid making life difficult for other manufacturers. His company is one of the offshoots of the 
Kalan vaidyan family of Nellayi whose brand name is synonymous with the classical hair oil.  
Production schedules complicate the matter further. Despite widespread use, buyers are 
elusive. Neela-amari is required along with other raw materials like bhringaraj, uzhinja and fresh 
gooseberry. Bhringaraj is a highly perishable fresh herb, unlike amari which has a longer shelf life. The 
movement of the most perishable herb determines the movement of the rest.  Those who have the 
capacity to supply all the material get the call, and naturally, it is always those with greater muscle 
power. Given all these factors, once in 5-6 years Biju gets lucky and gets a good money for his crop. He 
makes his living supplying to two large pharmacies regularly, but it is an uphill task. Despite being 
among the largest, Vaidyaratnam sticks to its traditional style of production tuned to the supply of 3-5 
kilos provided by women pluckers who collect it from the commons. The company is not in a position to 
take in large quantities and finish large batches. The second is the State pharmacy to which he is a rate 
contract supplier, the only silver lining amidst dark clouds. He has quoted  `40 per kilo for the current 
year, but he says even at that price it may not be viable because their scheduling may not match the 
supply. He has 5-6 tons of standing crop that he is willing to sell at ` 12-14 ($0.24-0.28) per kilo, but 
there are no buyers. This is a handicap for farmers, unlike a free resource that can be collected as per 
choice, they are forced to sell when the time of harvest comes. Often, their helplessness is exploited 
by traders who use the opportunity to bargain for lower prices. Some agents buy small quantities (10-
25 kilos) from Biju, which he suspects are meant for small manufacturers. Despite knowing the market 
so well for so many years, with his farm located right in the hub of ayurvedic manufacturing, he is 
                                                 
369 Manufacturers also have futuristic considerations. They would be in trouble if they were to alter the production and fail to get 
the material in the future. They feel it is wiser to stick to a material that is available in plentiful and is low priced. Whatever be 
the raw material price, a classical product has limited price elasticity.  
 
Neela amari, Indigofera 
tinctoria 
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unable to make direct contacts even with smaller pharmacies. He says, “I think manufactures are not 
comfortable with small suppliers like me, they would like each supplier to be responsible for large 
number of items”.  
4. Unpredictability of price and quality: Manufacturers also have to deal with quality issues. Unlike 
collected material that they can sample, choose and discard at will, in agreeing to buy farmed material 
they are taking a risk. Most lack the capacity to get into a full scale backward integration, to supply 
the know-how and supervise the process to ensure quality. Dr. K. Anil Kumar, Executive Director of KAL 
narrated the company’s bitter experience with contract farming. Out of commitment towards 
medicinal plant farming, they had made a buyback agreement with farmers in Karnataka for growing 
ashwagandha, but suffered heavy losses because the farm produce was of poor quality. The farmers 
had to be paid to meet their commitment but the material could not be made use of370. Such 
experiences make manufactures wary of long-term commitments. Price is another deterrent; making a 
prior commitment takes away the manufacturers’ freedom to buy raw material at the lowest price. 
Ayurvedic manufacturers do not have a high profit margin like biomedicine; cost of raw material 
accounts to 35-45% of the turnover. Adding the cost of labor intensive production and distribution, this 
leaves little room for maneuver.   
4. Agronomical barriers: Farming medicinal plants have several other challenges in terms of 
cultivability. Firstly, agronomical know-how of medicinal plants is still in its infancy. Of around 400 
plants used, only around 30 are amenable to cultivation. Secondly, even if cultivable there can be real 
and perceived differences between farmed and wild plants in medicinal quality (Sheldon et al 1997) 
and other features like for instance, shelf life371. Thirdly, a whole class of medicinal sources like trees 
and other plants and creepers with long maturity period are unviable to grow on prime farm land. 
Maramanjal, a woody creeper takes 9 years to reach maturity. Trees like koovalam need 9-10 years and 
Ashoka 15 years to be ready for harvesting372. Herbs that pass these hurdles like brahmi or tulasi 
happen to be low-priced, high-labor intensive crops. Some or all of the factors have to come together 
                                                 
370 The details were filled in by pharmacognosist  Dr. Sarala Samuel, Senior Manager R&D, KAL who also showed me samples of 
the various grades of Ashwagandha. It was not the farmers’ fault, the agronomy of the plant was unsituable to the region.  
371 E.g., the shelf life of the wild Shatavari tuber is one year whereas the cultivated crop stays not more than 2-3 weeks. 
372 Hence unviable unless grown in waste lands. The potential in Kerala is not high given that only 2.4% of the total available land 
is cultivable waste, 0.6% is barren and uncultivated land.  
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to make the plant a viable crop, which rarely happens. Koduveli 373 is one such rare plant. Its bulk 
demand for production of ayurvedic soaps and rarity in the wild keeps the price high and stable. Of 
late, it is growing in popularity for boundary cropping with crops like pineapple and tapioca; the acidic 
medicinal tuber that makes harvesting and purifying an arduous task is useful in keeping rodents at 
bay. And being a shade-tolerant crop, it falls into the narrow range of crops that can be intercropped 
with rubber. While viability in Kerala is low, other regions in India may be better suited for medicinal 
plant farming374. For manufacturers like Himalaya and natural extract companies who use a few herbs 
in large scale, contract farming becomes a viable option.  
7.6.2 Types of farmers 
Despite lack of viability, there are a variety of actors who participate in medicinal plant 
farming in Kerala that include: 1. End users who produce for their own consumption 2. Traditional 
suppliers historically linked to the supply chain and 3. New subsidy farmers (since mid 90s).  
1. End users who produce for their own consumption: This category includes practitioners375, 
manufacturers, household users, medical colleges and recently, spas and resorts. Some farms are 
maintained mainly for demonstration376. Of late, it has become fashionable for ayurvedic resorts to 
boast of medicinal gardens to boost their claim to authenticity. Some of them also have a requirement 
for a few fresh herbs for medicines that are freshly made for administration of therapies (see Section 
9.3). Most medium and large manufacturers boast of vast medicinal plant farms (for example, AVS has 
a 200 acre farm). The average contribution of such farms to production ranges between a paltry 1-5% 
of total requirement.377  But given the hurdles, some achievements are substantial. For example, AVS 
has achieved self-sufficiency in four plants including brahmi (60-70 tons in 10 acres). It has also 
involved around 100 small farmers to achieve a yield of 3-5 tons from 8 plants.378  
                                                 
373 The plant gets mature in 18 months, yields an average of 3 tons of dry tuber per ha., fetches ` 80-120 ($1.6-2.4)/kg. 
374 E.g., plants like Tulasi and Brahmi are cultivable in Tamil Nadu due to abundant land and supply of cheap labor.  
375 Shanta, a single-root practitioner in remote rural Idukki, grows 10-15 plants  in her 5 cents land, for the rest she depends on 
the commons. Annakutty, a veterinary specialist won annual farmers’ award instituted by a large manufacturer.  In her half an 
acre homegarden she has cultivated with great care around 70 medicinal plants and trees.   
376 These are maintained by most medium and large manufacturers, educational and research institutions. Some are very large, 
for example AVS has a demonstration plot of 8 acres with 700 species of plants. 
377 Estimates of three large and three medium sized manufacturers. 
378 Ramacham, adapthiyan, chethikoduveli, palmuduku, shatavari, pichakam, chengazhnir kizhang, kattuapadavalam. These are 
intercropped with coconut/ arecanut or grown in homegardens with other mixed crops. AVS promises to pay a fixed base price or 
the market price whichever is highest.  
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 2. Traditional suppliers: Perhaps the only exclusive ayurvedic commodity sourced historically from 
cultivation is the index plant njavara, a medicinal variety of rice. Njavara, that was marginalized like 
many other traditional varieties of rice has bounced back post tourist commodification of ayurveda (see 
Section 9.3.3). But only a small group of farmers grow the variety, most of them concentrated in 
Palakkad district. Most other traditional farmers of medicinal plants either grow monocultures of 
established crops like ginger and turmeric or homestead farmers who do mixed cropping of small 
quantities of niche herbs in small homegardens. Such farms are typically found near areas with high 
manufacturer concentration.379 Some supply to pharmacies directly, but most supply to fresh herb 
contractors who tell them what and how much to farm380. The most important of the farmers, 
especially those who do high value niche farming are those in the business of fresh herb collection and 
selling. They may not be often recognized as farmers, but by virtue of their access to critical 
information on demand and supply they are at an advantage. At the lowest rung are fresh herb 
collectors who grow a small number of plants in their backyard381. Ahmad, a larger fresh herb  
collection agent grows a hectare of the forest herb 
karimkurunji along with a few other trees382. Abdulla’s 
family, a fresh herb supplier for three generations 
cultivates koduveli and pichakam in two acres of land. 
Mohammad, a large fresh herb aggregator grows small 
quantities of high 20 different high-value herbs and trees in 
an acre of home garden space.383 Shaji, the raw-drug shop 
seller in Thrissur who doubles up as a fresh herb agent 
(mentioned in Section 6.3) cultivates a few critical medicinal plants. He planted a tree of neermaruthu 
                                                 
379 Given the low margins, proximity to manufacturing center is a determining factor in viability. The greatest concentration of 
traditional medicinal plant farmers are found in Thrissur and Malappuram. For example, a farmers’ co-operative society near 
Kottakkal that I interacted with, had 30 farmer members, the largest of whom had 5 acres of medicinal plant farm. Two types of 
herbs are generally farmed, viable ones like Chethi Koduveli that fetches ` 80-120 ($1.6-2.4) per kg and those unavailable in 
large quantities in the wild like Tulasi, Pichakam, Chengazhneer, Neelaamari. 
380 Farmers and manufactures both lose substantially on the margin, but this is the only viable manner in which farming gets 
organized to produce what is required, and avoids the problem of growing medicinal crops that have no buyers. 
381 For example, fresh herb collector Johannan grows a few plants in the backyard of his 10 cents land along with other 
vegetables. These include trees like Karinochi and plants like Tulasi, Vellakunni, and Ummam (Datura).  
382 His farm is 40 minute of walk from his house on a hilly land unviable for any other crop. Karinkurunji  is a small gregarious 
plant that needs shade to grow, but does not need much care. The low price (` 8-10/$0.16-0.2) per kg of fresh herbs) makes it 
viable only for a fresh herb supplier.  
383 For example, he could supply 25 kgs. of fresh Pichakam flowers at the price of ` 250-300 ($5-6) per kg. 
 
Karimkurunji farm, Malappuram  
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15 years ago observing that the market variety derived from the purple-flowered variety was the wrong 
source. He said, “Since it is a cardio-protectant, it is critical that the vaidyans have the right 
material”. A single tree meets his requirement; the bark grows so fast that it can be peeled every 
month.  
3. New farmers: In the mid and late 90s, with the growing popularity of tourist Ayurveda and the rising 
sound bites of a global herbal market, medicinal plant farming began to get policy attention. In Kerala, 
the first major policy drive in Kerala was in 1995 leading to the emergence of the first subsidy 
medicinal plant farmers. The National Medicinal Plant Board set up in 2000 initiated a subsidy program 
and prioritized list of medicinal plants for farming. The Kerala State Medicinal Plant Board (SMPB) has 
executed this along with several other promotional schemes that led to cultivation of medicinal plants 
in waste land, school gardens, jail premises, government hospitals, worship centers and so on. Over a 
period of nine years (up to 2009-10), subsidies had been awarded to 104 projects that led to medicinal 
plant cultivation in 2500 acres. The initial lower limit for subsidy eligibility was 5 acres which was 
revised in 2006 to accommodate small farmers provided they pool their land together. This policy has 
led to the formation of many medicinal plant farmers’ collectives.  
But subsidy schemes can lead to steep price drop and kill the market for farmers and collectors 
(e.g., the fate of aloe vera in Tamil Nadu)384. The mid 90s subsidy drive of the Kerala government had 
led to a glut leading to a price crash (Suneeta and Chandrakant 2000).385 The farmers find that when 
prices drop manufacturers refuse to honor the contract. However, officials in the SMPB are upbeat 
citing the success story of Vanamoolika, an NGO that involved tribal people to cultivate medicinal 
plants in 144 acres of land in Wayanad buying back raw material worth ` 300,000 ($6000) for their 
ayurvedic/herbal product unit386. Though the project team at Vanamoolika is committed, returns are 
too low (` 2000 or $40 per acre) to make the project sustainable or replicable. Of the four subsidy 
                                                 
384 This hardy cactus plant  is not only used in Ayurvedic medicines but also in cosmetics and neutraceutical industry, and has a 
good demand. Given its high yield (22 ton of biomass/ha) and ease of growing, several farmers took it up. Soon the price dropped 
from ` 8 ($0.16) to ` 2.5 ($0.05)per kilo. 
385 In 2010 AVS launched a scheme with NABARD funding to propagate two plants (including kattupadavalam) with a target of 
covering 200,000 households in 3 years. If this is successful, tribal who collect/farm this plant may be he losers.  
386 Vanamoolika in Wayanad with the use of subsidy of ` 300,000 ($6000) for 3 years (2006-9). 
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farmers interviewed387, two were successful in growing plantations of gooseberry388 though they were 
not successful with other plants. Another farmer from a vaidyan family said that he found the subsidy a 
good opportunity to explore the commercial potential of an activity that was until then a hobby. But he 
found that the only crop viable in the market was koduveli. The most successful of the lot was Abdulla, 
the fresh herb trader mentioned above, who is already a well established medicinal plant farmer. 
Talking about the new subsidy farmers, he said that for most of them, the passion lasted only as long as 
the money lasted.  
Farmers are required to have a buyback contract from a manufacturer in order to be eligible 
for subsidy. But some of the farmers participating in the subsidy promotion workshop organized by the 
Kerala Agricultural University complained that manufacturers do not honor the contract. A silver lining 
appeared when State pharmacy Oushadhi took the initiative to earmark 25% of its raw material 
requirement (Since 2007-8) from farmers at tendered price or market price whichever is higher389. 
Oushadhi found it easy to take this step as it did not have the constraints of a commercial company390. 
But reportedly some trader-farmers use it as a front to supply herbs that are not cultivated391. There is 
no mechanism to double check the source of each supply load. 
Even without the lure of subsidy , there are a sizeable number of entrepreneurial farmers in 
Kerala open to new ideas, but after a few bitter experiences they are cautious. Formerly hyped up 
herbs lead to disastrous farming fads. The safed musali hype in which many farmers burnt their fingers 
planting an unknown medicinal crop with a hyped up market is an extreme example of how information 
asymmetry can lead to disaster.392  
                                                 
387 Of the six I selected to track down for an interview, two were suspiciously elusive.   
388 One farmer had 17 acres of gooseberry under subsidy, which is also a certified organic farm.  He started farming in 2002 and 
supplied 12 tons of gooseberry in (2008-9) to AVS at ` 17 ($0.34) per kg. He cultivates the juicy variety which is not used for 
Chyawanprash but mainly for oils like Neelibhringadi.  
389 Reportedly risen to 50% now as informally told by a respondent from Oushadhi in March 2012.  
390 But a veteran supplier said the company was struggling to juggle farmers’ deliveries with the production schedule. 
391 E.g., a farmers’ co-operative was found supplying 9 herbs on contract, all from homestead and forest peripheries.  
392 The hype was kicked off by some companies in Hyderabad who created a rumor of the herb’s potential and made a fortune 
selling high priced saplings promising buy backs. When the time came to harvest, the companies had vanished. Because of the 
huge glut in the market, prices crashed. People lost both the opportunity cost and the investment made. Homestead farmer Siju 
says he burnt his fingers but he had invested only a small amount. Many others got into debt. This is not different from other 
farming hypes in Kerala like cocoa and vanilla. A farmer noted another instance of a manufacturer selling a Koduveli cutting for 
`10 ($0.2) with a buy back offer, when the per kg prices were only ` 10 ($0.2)!  
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7.6.3 Economic stakes in the forest: farming Vs collection 
Statements about laziness of the STs and their reluctance to farm were heard from various 
quarters. A large manufacturer who made a sincere attempt to get herbs cultivated on contract by 25 
select tribal families, was disappointed with the results. The general assumption was that the STs were 
marginalized, that they needed cash income and hence they ought to be ready to take up any cash 
bringing activity. However, interactions with various ST communities revealed several contradictions. 
Constraints for farming were different for each community depending on its access to land, familiarity 
with cultivation, access to cash crops, need for and alternatives to earning cash income. The following 
situations were most commonly encountered in the sampled regions.  
 For relatively isolated tribal communities restricted to forest territories, MFPs are the only source 
for cash income. But paradoxically plants that grow easily in the habitat are those that are 
abundant in the forest, and those that are economically viable do not grow in the forest393.  
 The most marginalized of the STs are those who depend on MFPs for their livelihood, but cannot 
participate in cultivation because they are landless or have leased their land to non-tribal 
cultivators394.  
 NGOs/government officials/pharmaceutical companies who interact with STs persuading them to 
cultivate medicinal plants find that their projects fail because tribal people are ‘lazy’ or 
‘disorganized’. Anderson (2000) in his study of ST communities in adjacent regions in Tamil Nadu 
notes that NGO workers with a certain idea of ‘development’ get frustrated with tribal people who 
do not meet their expectations. Accounts from tribal elders reveal that their requirement for cash 
was limited, they had little motivation to devote their valuable time to earning.  
 Rationale for MFP collection cannot be understood purely in economic terms. Many who engage in 
MFP collection do so because it is work they can do on their own terms unlike wage labor; there is 
no boss to please and they are in control of their schedule. Local traders recognize this. Babu, a 
forest produce collection agent says, “tribal people are happy to work when they get a contract 
because they prefer the freedom and flexibility to wage labor”. Some of them also use the 
opportunity to travel into the forest for recreation, socialization and adventure. Mani, in his early 
                                                 
393 For example, GSCS at Pottomavu  unsuccessfully tried growing two forest plants that was in demand and not widely available 
(kattupadolam and Maramanjal). Both are conducive to farming. The former has a restricted habitat and is in short supply; the 
latter is banned from harvesting because it is endangered. But both are tough candidates for farming. They are hardy and 
luxuriant in their natural habitats, but are reluctant to grow elsewhere. Maramanjal , a woody climber, for instance, has a 9 year 
harvest window. All efforts to grow the climber through vegetative propagation has failed.  
394 E.g., Maniyarankudi hamlet (Vazhathopu GSCS, Idukki); Urulanthanni hamlet (Kuttampuzah GSCS, Ekm).  
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20s enjoys going with a group of his friends for the collection of karimkurunji during summer, a  
gregarious forest plant harvested in large quantities. They hire a jeep and go into the deep forest 
combining work and recreation. But there are also reportedly some youth who have no affinity to 
the forest, who prefer wage labor and are drawn towards an urban life style.  
 Communities historically accustomed to settled cultivation like Muthuvans and Kanis are not much 
dependent on NTFP cultivation for livelihood because of cash crop alternatives that are more 
lucrative. They live in forests and forest peripheries where the soil and climate are ideal for 
cultivation of spices such as cardamom, pepper, and coffee. Some of them have even begun to 
cultivate rubber. As mentioned earlier, the farming economy of medicinal plants has several 
limitations – very few of the herbs/trees are cultivable, most of them are low priced, and both 
market price and demand tend to highly unstable.  
One successful story of farming: index herb kattupadavalam  
For medicinal plant farming to be a viable proposition in the forest, the preconditions are 
these: 1. the community should have access to cultivable land and should be accustomed to farming 2. 
the plant should have a consistent demand and stable price 3. It should either have profit margin 
equivalent to or better than other cash crops or it should be easy to grow requiring low input or/and 
labor demands.  For example, Muthuvans in Kurathikudi hamlet in the Mankulam forest region in Idukki 
district were found to be growing manjakoova in their gardens, which had a good and stable price 
because of its use in the cosmetic industry. They were growing it of their own accord despite the fact 
that it was available in the forest in plentiful, solely for the ease of harvesting. It was a low 
maintenance crop; all they had to do was to plant it in their yard, which being inside the forest was its 
natural habitat. Another feature that added to its viability was its long harvesting window — allowing 
flexibility to harvest when the prices were high or when there was a need of cash. However, such 
events of farming are sporadic and the scale too insignificant to be of any consequence. 
Kattupadavalam is the only medicinal plant that has been farmed in large scale in the Kerala forests 
thus far. Though the circumstances that led to its farming are political, it provides valuable insights 
into variables that affect the viability of farming in the forest land. 
Outside the run-down building of the Devikulam GSCS in the town of Munnar, a farmer lands up 
with a cart load of produce (see image below).  The material is a collection of dried creepers, each 10-
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20 feet long with all its parts intact. Kumar, the assistant at the society, gets into a laborious process 
of checking to screen for un-dried material that if left could rot the whole bunch.  
The creeper is Trichosanthes cucumerina var. 
cucumerina, of the family Cucurbitaceae. Though a close 
relative of padavalam or snakegourd, Trichosanthes 
cucumerina var. anguina, a common local vegetable, very 
few have heard of its bitter cousin in the forest, 
kattu/kaipanpadavalam (wild/bitter snake gourd). 
Kattupadavalam, like many other plants has multiple uses 
in the ayurvedic pharmacopeia395. (For details on its 
ayurvedic pharmacology, see Appendix F). The drug 
source is the whole plant without fruits. The Sanskrit word patolah from which the local word derives 
indicates its inclination to sprawl on the ground. Unlike the other index plants, it is used in relatively 
few medicines, but because of its rarity it commands a better price.396 
Though it has a wide habitat, most of the Kerala ayurvedic industry’s 
requirement is met from the restricted high-range forest habitat397 
that falls into the collection areas of three GSCS, Devikulam, Adimali, 
and Kothamangalam of which the first contributes lion’s share of the 
herb.398 What is intriguing is that for the past three years (as at early 
2008) their entire collection was sourced from cultivation in tribal 
hamlets. Given the travails of medicinal plant farming among tribal 
communities, this seems like a puzzling phenomenon. Investigation 
shows that the circumstances that led to its farming are fortuitous.  
Though not representative, its biography provides valuable insights into stakes involved in 
farming. The Munnar GSCS staff members are eager to share their story of initial frustration and 
                                                 
395 It is useful in skin and digestive diseases, respiratory problems, cardiac debility, ulcers, inflammations, intermittent fever, 
alopecia, boils and general debility. In higher doses it is emetic and purgative (Warrier et al 1996: 323) 
396 It is 6 times more expensive than Kurunthoti but 1/10th of its demand (133 tons in Kerala according to Sasidharan and 
Muraleedharan (2009), country requirement is 622 tons (Ved and Goraya 2007).  
397 Munnar-Marayur in the Eastern high ranges (alt. 3000 - 7000 ft.) of Central Kerala. 
398 One large manufacturer reported that they were sourcing part of their requirement from Gujarat.   
 
Farmer unloading Kattupadavalam produce 
Girijan Service Society, Munnar 
 
Farmer Ayyappan, Marayur 
Kattupadavalam
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eventual success. In the summer of 2005, the plant’s commodity trajectory took a unique turn when 
they were denied the annual extension of lease because of interpersonal differences; the lease for 
their collection area was given to another GSCS. Ironically,  theirs was the first of the Societies to get 
into the medicinal plant collection, a success story that had inspired the government to extend the 
experiment to the entire State. The team of committed people which was behind its inception was 
upset at this turn of events. The ST communities they served were substantially dependent on forest 
produce for their livelihood, the most important of which was kattupadavalam. The staff did some hard 
thinking and quick experimentation and realized it was easy to farm the herb in the forest region 
where the tribal people lived. It grew naturally in the high altitude region, on hill slopes, on well 
drained land with occasional irrigation. It needed hardly any input and was free of natural pests and 
predators. Three years ago (as at 2008) they put the idea to test; the experiment was a resounding 
success. Now the vine is grown in three tribal hamlets, Lakkam, Vattavada, and Gundala, each with an 
average of 60-70 farming families (See Appendix H for profiles). Farmers dry the plants and give it to 
the society’s agent in Marayur399.  All their collection is directly purchased by large ayurvedic  
manufacturers. In 2008, the society sold the material at ` 130 ($2.6)/ kg of dried material, while they 
bought it from the farmers at ` 90 ($1.8). The difference includes the agent’s commission (5%), cost 
adjusted against storage loss400, transportation cost401 and the society’s commission (10%). The viability 
of this vine for farming in this region is because of certain features that give it an unique edge.  
1. Restriction on gathering: A major factor that commonly impedes cultivability of forest plants is 
competition from the low-priced the freely available resource. Though political factors motivated 
the restriction of harvesting in this case, it gives a working example of how restrictions on 
harvesting of a wild resource can enhance its farming viability.  
2. Restricted availability and consequent high price: Though the herb is not endemic, its availability 
in large quantity is restricted and it has been slow to respond to cultivation efforts elsewhere. 
Because of these factors, the price remains high, around four times the price of an average herb 
like kurunthoti. The average medicinal plant that is cultivable in the forest is low priced (for 
example, Karimkurunji is ` 8 ($0.16)/kg. of wet herb, Chunda is ` 5 ($0.1)/kg).  
3. Ease of cultivation – Strangely for a herb that is so reluctant to take roots elsewhere, it behaves 
differently at home. It is hardy, grows luxuriously similar to its vegetable counterpart. It needs 
almost no labor or other input, no irrigation and no weeding.  Most critically, the plant is not only 
                                                 
399 The local Vana Samrakshana Samiti (VSS) and ESAFI, an NGO also act as collection agents. 
400 The crop reduces to 15-20%  when dried. It is important that the fruit is removed before drying because they are slow to dry, 
and if unnoticed can spoil the entire bundle. The average storage loss is 10-20% due to incomplete drying. 
401 It travels 7-8 hrs to the destination, at the transpor cost of ` 12,500 ($250)/ truck load (2500 kg), i.e.,  ` 5 ($0.1)per kg.  
 288 
 
relatively pest-free, it is unattractive to forest animals. This bitter plant they consider a godsend; 
not even the goat with its proverbial appetite to anything green was interested.  
4. Short maturity period and long harvest window – It only takes 6 months for the plant to grow and 
be ready for harvest (from the sapling). If the prices are down in the harvest season, the plant can 
be harvested anytime in the next 2-3 years; the biomass would only increase.  
Overall this is a success story that does not seem to have too many loopholes, but  there are some 
looming concerns. The GSCS staff said there was hardly any illegal collection when they were collecting 
from the forest, but paradoxically, cultivation provided an easy cover for illegal forest collection (an 
informal estimate being 20-30 tons annually). Secondly, there are rumors that farmers in Kodaikanal, a 
hill resort in Tamilnadu known for vegetable cultivation, have begun to cultivate the crop. If farming 
picks up in such regions, the exclusivity enjoyed by the ST farmers may not last. It could also lower 
prices making it less viable for small scale cultivation. Though it grows easily in the high-altitude 
Munnar-Marayur region, it is no competition for cardamom which has a market price six times higher.    
7.7 Ayurvedic Industrial cluster: potential to bridge the producer-supplier gap  
The Confederation for Ayurvedic Renaissance - Keralam (CARe Keralam), a project initiated by 
Department of Ayush under the Development of AYUSH Industry Cluster Scheme in mid 2000s formally 
began operations in mid 2011 with 108 members. This is the first ayurvedic cluster in the country, 
following which many more have been approved. Among its several objectives to empower the 
manufacturing sector in Kerala, an important aim is to break the monopoly of traders and enable 
manufacturers to procure raw material directly from farmers 
and collectors. As a step towards this objective, in July 2012 
it entered into a memorandum of understanding (MoU) with 
the farmers’ consortium set up by the State Medicinal Plants 
Board (SMPB) and Horticulture Department of Kerala, to 
procure medicinal plants. This is a significant development to 
bridge the distance in relationship between the supply and production nodes. While it certainly has 
stepped in the right direction, its success in breaking the monopoly will depend on its ability to provide 
an effective replacement to the fresh herb trader, in other words its ability to get a grip on the 
complexity of inventory management.  
CARe Keralam complex, Thrissur 
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7.8 Conclusion 
Medicine production in the industrialized era is mainly characterized by alienation of medicine 
maker-collector relationships that in turn has repercussions for quality of medicine  produced, 
conservation of resources and livelihoods of people. Mass production requires large scale supply of raw 
materials that naturally increases the distance of medicine producers from the raw material. This 
distance creates space for a number of problems to crop up. These include identification errors, 
adulteration, and various other issues associated that have adverse affect on raw material quality. 
Small scale manufacturers and practitioners making medicines to meet their clinical requirement are 
able to circumvent some of these problems. They are able to make use of their knowledge to access 
quality resources creating exclusive channels of circulation. The other side of the coin is the alienation 
in collectors’ relationship with plants which has to be seen in the larger context of people’s 
relationships with resources in general. These relationships are best understood in terms of the stakes 
people hold in the resources, that can be differentiated as cultural and economic. Cultural stakes work 
better for conservation whereas economic stakes work as far as stakes are long-term and there is 
territorial exclusivity in harvesting.  
For collectors in the forest, medicinal plants historically carried dense symbolic value as part 
of their health care system. But with decline in their health care systems owing to official health care 
policies and cultural integration with the mainstream  combined with alienation from their own 
habitats, forest-dwelling communities have lost much of their traditional cultural stake in the forest. In 
this context, they end up being mere suppliers of herb ‘commodities’ to ayurvedic industry, a medical 
system that they hardly have any access or affinity to. This situation of absence of cultural stake and 
escalation of economic stakes is conducive for resource overexploitation. Ethnographies of successes 
and failures show both potentials and shortcomings of the government’s policy of allowing monopoly 
over collection of minor forest produce to tribal co-operative societies. Comparison between the 
ethnobotanical benefit-sharing model and the KIRTADS participatory training model demonstrate the 
superiority of cultural stakes over economic stakes in contributing to both livelihood and conservation. 
In non-forest areas, various factors associated with urbanization and shift in farming patterns away 
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from homegardens to cash cropping monocultures are some of the factors that have  alienated people 
from medicinal plants. There is no direct replacement of cultural stake with economic here; economic 
stakeholders here are a minority of marginalized people. However, shift from long-term to short-term 
economic stake because of transition from full-time professional pluckers to casual laborers recruited 
by middlemen poses a serious threat to conservation. 
Medicinal plant farming has been considered the best way forward to conserve forest 
resources, but the growth in this segment has been slow. This is especially true in Kerala where  the 
farming sector has low viability owing to high cost of land and labor and preponderance of high-margin 
cash crops like rubber and spices.  Ayurvedic manufacturers are often blamed for not being open to 
purchasing material from farmers, but several practical factors impede the transaction. The most 
important of this is the information and knowledge intensity of raw material sourcing and handling 
activities. While fresh herb traders are seen as exploitative, their role as knowledge-intensive actors is 
often ignored. Manufacturers heavily depend on the collective metis that these actors hold and are 
bound in trust-based relationships that go back from a few decades to a century.  
The newly initiated ayurvedic industrial cluster project promises to bridge the gap between 
manufacturers and grass root suppliers to enable manufactures better control over price and quality. It 
aims to break the monopoly of raw drug traders and provide a better bargaining power to the industry, 
to enforce better conservation practices, and to encourage farming of medicinal plants. The success of 
this institution will depend on the extent to which it is able to supply knowledge-intensive services that 
the fresh herb traders have provided for almost a century now. Fresh herb collectors are perceived as 
exploitative; but their role as strategy managers is seldom acknowledged. Years of accumulated metis 
and hard work goes into the knowledge of raw material, reconnaissance and maintenance of a mental 
data base of resources, being constantly abreast of market knowledge and the ability to mobilize labor 
on a short notice. This role combined with their ability to take advantage of the high degree of 
information asymmetry in the ayurvedic commodity chain allows them to make high margins of profit, 
to the disadvantage of both manufacturers and collectors/farmers.  
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PART THREE 
NEW WAVE OF COMMODIFICATION 
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PROLOGUE 
The issues that were discussed in Part I and II centered around an older phenomena surrounding 
industrial era commodification. But what had attracted me to Kerala in the first place, was the 
contemporary phenomena of commodification that appeared markedly different from the earlier 
processes. This “new wave of commodification” surrounds the commodification of ‘services’, in 
contrast with the industrial era focus on ‘pharmaceutical commodities’. This shift of focus can be 
considered “paradigmatic” because it also changed the framework of ayurvedic commodification from 
“illness” to “wellness”.  
The Marxist perspective on commodification used as the analytical framework to analyze 
industrial era commodification, is also useful in comprehending and analyzing the course of new 
commodification processes. A brief recapitulation of the former analysis will help in taking the 
argument forward. I had argued that ayurvedic medicine manufacturing industry in most of India had 
managed to break most of the natural and social barriers of the commodity to expand its catchment 
area. Though industry in Kerala had by and large managed to take ayurvedic medicine to the market 
working within the constraints of the classical commodity, some ‘social’ and ‘physical barriers’ 
(Kloppenburg, 2004) had to be broken, even if partially. At a social level, practitioners and consumers 
had to be convinced to stop making medicines and buy from the industry. The main physical barrier, 
the perishability of the decoction, was broken by the simple step of adding preservatives to extend its 
shelf-life (See Section 5.9).  
But unlike in rest of India, commodification of ayurvedic medicine in Kerala had not sidelined 
the ayurvedic practitioner and therefore had not disrupted the integrity of ayurvedic practice. As I will 
elaborate in Chapter 8, western tourist interest in select elements of ayurvedic practice had drawn out 
some of the elements of such an integrated practice, especially the cleansing therapies (Panchakarma), 
and had paved the way for their commodification. What had looked as a passing fad in the late 80s, 
grew beyond expectation and snowballed to such an extent that Ayurveda was taken up by the State as 
one of the key selling points in promoting its newly burgeoning tourist sector. After the late 19th 
century industrialization, this was the first major twist in commodification of Ayurveda. Ironically, 
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Kerala which had resisted some of the earlier pressures of commodification, had now taken the center 
stage in the new market.  
The most important external factor in breaking traditional cultural barriers was the entry of 
non-traditional stakeholders into the ayurvedic market, both in Kerala and at the all-India level. These 
newcomers were unconstrained by the practitioner ethos that had kept commodification of Ayurveda in 
check in Kerala. They had little regard for the sanctity of the therapeutic context, and therefore had 
no qualms in breaking the barriers of convention. Such stakeholders sought to break traditional 
boundaries of ayurvedic commodities, venturing to create new meanings and contexts. By doing so, 
they also opened up opportunities for existing stakeholders. Many small traditional practitioner families 
and new doctor-entrepreneurs who could not participate in the manufacturing segment, found it easy 
to participate in the service market that required far less capital and labor investment. The service 
market also provided for a wide range of opportunities beginning from household enterprise to five star 
enterprise, as is typical of all other services in the tourist market.  
What initially looked like a dangerously corrupting trend had eventually gone on to create a 
dynamic atmosphere in an otherwise stagnant ayurvedic market. Though the traditional stakeholders, 
the manufacturers and other therapy-centric groups were slow to respond, by the middle of 2000s, it 
was clear that the temptation to exploit the new segments and new formats of selling had become 
impossible to resist. Large business houses who were hitherto oblivious of Ayurveda had begun to enter 
the market in a drove. Given the importance of tradition as a marker for authenticity in this market, 
and the complexity of technical know-how, the newcomers sought out traditional stakeholders to forge 
joint ventures. In 2002  the FMCG giant Hindustan Lever forged ties with Arya Vaidya Pharmacy, 
Coimbatore to create a new format of therapy centers. In 2004 an old manufacturing house was 
acquired by an NRI owned international health care business group based in US, leading to formulation 
of various new strategies including a network of wellness centers. In 2008 the Indian multinational 
business conglomerate Aditya Birla group acquired majority stake in a resort chain owned by a vaidyan-
family to establish wellness centers across India. These developments might have worked as ice-
breaker for the traditional stakeholder, who found they could make use of the capital and the 
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opportunity for innovation, without sullying their own hands. Such joint ventures and tie-ups opened up 
new segments and spaces for the commodification of not only ayurvedic services, but also for ayurvedic 
medicines, either as integral part of service or as commodities in their own right.   
In addition to attracting foreign and domestic tourists, Kerala Ayurveda had begun to acquire a 
brand value of its own in the domestic and global market of Ayurveda, both in medicines and services. 
As if to make up for the colonial West that had delegitimized the system, the tourist West was playing 
the role of a re-legitimizer. Across the country, clinics, practitioners, hospitals and manufacturers had 
begun to proffer Kerala Ayurveda.  Not only was service taken out of the therapy context, outside 
Kerala, Kerala Ayurveda itself got dragged out of context and became highly vulnerable to intended 
and unintended diversions. The traditional checks and balances were no more in operation. Consumers 
outside Kerala who had no cultural knowledge of the practice, had no vantage point from which to 
gauge authenticity. This resembles others situations of commodities being commercialized out of their 
context, for example qat (Cassanelli, 1986). Just as western consumers of Congolese Soukouss music 
(White 2000) and the consumers of oriental carpets in the United States (Spooner1986) who depend on 
erroneous measures of authenticity, new consumers of Ayurveda were struggling with information 
asymmetry. To use Appadurai’s (1986) conceptual framework, the new market had created a 
“diversion” from its regular “path”, and created a new “commodity context” for the selling of 
therapies outside its traditional context, the doctor’s clinic. In the following chapters, I analyze the 
various complex paths this diversion has taken. Chapter one will be devoted to the discussion of the 
commodification of services, mainly focusing on the developments in the tourist market in Kerala. The 
chapter will also include a brief account of ramifications of tourist selling on the domestic market and 
its influence in other parts of India, especially with regard to commodification of ‘wellness’. New 
developments in the commodification of ayurvedic medicine commodities will be discussed in chapter 
two. The discussion will cover a gamut of new commodities ranging from form-changes of classical 
medicines to medicine commodities that have co-evolved with commodification of services.   
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8. CH 8 FROM ILLNESS TO WELLNESS: SERVICE COMMODIFICATION  
The new wave of commodification might prima facie appear to have created a major deviation from 
the way Ayurveda is practiced and consumed. Judging the extent of deviation from the vantage point 
of modern Ayurveda can be misleading, given that it is significantly influenced by a century of 
pharmaceuticalization. Medicine is just one of Ayurveda’s four-pronged approach to treatment, the 
others being, cleansing (Shodhana), modification of diet (Ahara) and life style (Vihara). Unlike 
pharmaceutical commodification where it serves the interest of the capital to circumvent the 
ayurvedic physician, service commodification has the potential for a closer patient-physician 
interaction. Service commodification surrounds ‘therapeutic procedures’, and to a certain extent 
includes diet and life style advice in the form of  ‘expert consultation’ bundled with ‘therapy 
packages’. In a way, it brings the patient under the authority of the physician, who gets to be 
respected not just as a prescriber of medicines, but of diet, life-style, and spiritual-psychological 
advice. Though like any commodification, it has led to intended and unintended misinterpretations, it 
has also brought attention back to Ayurveda in its holistic integrity. Likewise, the shift in focus from 
illness to wellness is also in keeping with the spirit of Ayurveda, which in imitating the biomedical 
model, had got skewed towards a disease-centric approach402. While Kerala experienced an 
intensification in the commodification of existing practices, elsewhere in India Ayurveda witnessed a 
paradigmatic shift. Kerala Ayurveda attained a brand value and spread to rest of India. In Kerala, new 
contexts and categories of commodities were created, bringing in new opportunities, challenges and 
controversies. These developments can be classified into four major categories:  
 New consumers: Tourism generated new categories of consumers who brought with them 
expectations that quite often did not match with conventional ideas of what constituted ayurvedic 
treatment.  
 New category of commodities: Therapeutic procedures and other services, the most important of 
them being Panchakarma and related therapies, emerged as commodities in their own right.  
 New spaces: The move to ‘tourist spaces’ eventually spurred the growth of ‘wellness spaces’, from 
thereon spreading to ‘biomedical spaces.’  
 New stakeholders:  This era marked the entry of new stakeholders, initially from the hospitality 
segment, eventually including a wide variety ranging from doctor-entrepreneurs to large business 
                                                 
402The disjunction between the philosophical orientation of Ayurveda to wellness and modern institutionalized Ayurveda has been 
noted by a few scholars (For example, Alter 1999).  
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houses.  
Section 8.1 opens with excerpts of discussions from an online travel forum to showcase new 
consumers caught in the crossroads between medicine and tourism, treatment and relaxation, illness 
and wellness. A brief note of the rise of ayurvedic tourism in Kerala is presented in Section 8.2, 
followed by a description of Panchakarma, the centerpiece of the new wave of commodification in 
Section 8.3. The discussion of new spaces and stakeholders is clubbed together in Section 8.4. Four 
new categories of services that have recently emerged are classified and discussed. The participation 
of traditional stakeholders in new service commodification is discussed in Section 8.4.1. This is 
followed in Section 8.5 with a discussion of ‘identity crisis’ faced by various stakeholders as they enter 
unfamiliar spaces and deal with unconventional formats. Section 8.4.2 throws light on their struggle to 
construct authenticity, with focus on major themes, i.e., tradition, nature, spirituality and yoga.  
Section 8.5 focuses on the new booming industry of paraprofessional training and two related issues, 
i.e., the sidelining of traditional Kalari martial art practitioners (8.5.1) and spread of unregulated 
Ayurveda across the globe (8.5.2). In section 8.6, four salient consequences of service commodification 
are discussed: menu/package mode of selling therapies (8.6.1), emergence of Brand Kerala in Ayurveda 
(8.6.2), emergence of a domestic wellness segment (8.6.3) and expansion of the therapy segment 
(8.6.4). In section 8.7 I trace the evolution of service commodification and its historical roots in the 
wellness tradition of Kerala.  A general discussion is presented in Section 8.8 which is followed by 
conclusion in Section 8.9. 
8.1 Resort or hospital? Clinic or spa? : New spaces, new consumers, new questions 
Excerpts from an internet discussion forum403 illustrate the issues and problems new consumers have to 
tackle in their new found pursuit of Ayurveda (Italics are mine).  
Exchange on internet discussion forum: 1 
A non-resident Indian who wants to take his mother to ayurvedic treatment in Kerala for stress and 
weight loss has put in a request for recommendation and suggestions have poured in. A non-resident 
Keralite from UK who spent 4-8 weeks thrice in the past five years in a couple of treatment centers, 
                                                 
403 www. indiamike.com 
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after having located the centers with the help of friends and family, advises:    
There are many 'resort style' ayurvedic places that have cropped up to cater for western tourists. 
All well and good but if the quality of treatment is the number one priority, I suggest that you 
seek out a traditional place respected by the locals. Many of them lack western style comforts 
and are basic and might look grubby to westerners. Not all speak English but there will be some 
and you can get by. 
A British citizen living in Chennai points out “there are so very many hotels/resorts in Kerala 
offering Ayurveda at various levels of seriousness varying from sham to completely sincere and 
genuine”. She relates her positive experience in a German-owned beach resort in Kerala where the 
tariff is reasonable because the resort has no swimming pools or air-conditioning, focuses mainly on 
treatment, “takes Ayurveda very seriously”. Another respondent recommends “a place to avoid”, 
describing his/her bad experience.  
The very first time I went to an ayurvedic clinic, it was in Goa...I was seduced by the title 'clinic' 
as opposed to rejuvenation centers. I was there for two months and was very lucky that i had an 
excellent doctor and one of the most experienced therapists..but it quickly became apparent that 
they were moving away from ayurvedic principles to the 'lets make as much money as possible' 
principle. 
An Italian who has just returned from a week’s rejuvenation in a resort in Kerala recommends 
the place, saying the location was not great, packages were expensive, and there was no time to have 
fun between them, “not good for a holiday,” but he says “it is probably the best place for Ayurveda”. 
A Polish citizen recommends that he look for Ayurveda in hospitals, warning against massage parlors 
that like in many other parts of the world are “camouflaged brothels”.  He says,  
I have found the heavy handed hospital massages tough to handle while being administered, but 
the soothing effect that hangs around for the next couple of days is good, compared to the feel 
good but later feel just normal massages I have received from touristy places.  
Exchange on internet discussion forum: 2 
A complex query is raised from a Portland resident planning to go on a six month trip to India. She says 
going to India was her childhood dream, but she is highly confused between her priorities. On one 
hand, she wants to visit all the hot spots including the Taj. On the other hand she wants to spend five 
months at an Ayurveda resort, the main reason why she wants to go to India. In addition to that, before 
going home she wants to go on a three week pilgrimage. “I'm fairly ill and am looking for a very good 
resort where I can just begin to get better physically and emotionally. It's something I definitely can't 
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afford in the US. I need pretty intensive in-patient care”. She has identified two resorts, but is not 
happy with their location. Her priority is to get well; she knows she should not be picky about the 
location, but she is afraid of getting homesick for the mountains. The one in her preferred location, 
the Himalayas, is too expensive for her budget which is limited to $20,000 for the entire trip. She 
wants to know if there is anyone who had done ‘medical tourism’, and what the ‘results’ were. The 
first response from an Indian resident is matter of fact, 
I think you should ask yourself first that what is your priority? ayurvedic treatment? Or, the luxury 
of a resort? because I don't think they would come together. If you find anyone offering you the 
same. ..You could bet that is just a touristic destination which has nothing to do with either 
ayurvedic medicines , or the real pleasure of staying in a resort. 
A respondent from Brighton also asks her to make up her mind if she wants “a resort or 
Ayurveda.” He is soon going to a hospital in Kerala recommended by many people, which he says “has 
been around for more than 80 years”, and is a “real deal”.  He once had a bad experience with a clinic 
that the manager was trying to make into a resort “at the expense of ayurvedic principles”. Too many 
places are popping up with therapists without much training; he had heard that a “true therapist” 
should train for five years “before being let loose on a patient”. Another respondent from Switzerland 
suggested AVS hospital as the “non-profit” hospital, a "real deal" in Ayurveda to which people come 
from all over the world for treatment. A British citizen living in India with considerable experience 
points out that every hotel in Kerala offers ayurvedic treatment, which is limited to a relaxing 
massage. But there are resorts that take Ayurveda seriously, employ qualified doctors, but he insists, 
“They are still resorts, not hospitals”. Sympathizing with her ‘not wanting to be confined to bed’, he 
recommends a beach resort in Kerala that has a section devoted to Ayurveda.  
The only person really qualified to give you a recommendation would be an ayurvedic doctor, but, 
should you decide on Kerala, you might enquire into K., it’s a bit of a quirky place to stay, but the 
owners also run an ayurvedic medicine processing factory, so they are certainly more than 
massage merchants.  
Another experienced respondent from UK writes 
It depends what sort of treatment you want. There are a lot of charlatans in Kerala without any 
qualifications selling “ayurvedic” treatments. The state government is actively trying to shut down 
fake ayurvedic practitioners, but there are still too many ... If you are fit and well and you are 
looking for ayurvedic fun and relaxation it doesn't really matter where you go, but if you have an 
existing condition you really must make sure your practitioner is fully qualified or you could come 
to harm. I don’t have any medical reason for having ayurvedic treatments, but I really enjoy going 
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to M’s ayurvedic Clinic in Kochi. They have a general practitioner who will look after aches and 
pains and give you the most amazing massages, and a specialist in headache, migraine and sinus 
problems. 
The queries in the above forums showcase the dilemma of the “new consumer” who is in search of  
“authentic Ayurveda”. The responses provide a bird’s eye view of the “new spaces” and “new 
categories of commodities” that have emerged in the market and the consequent confusion. The 
discussion also showcases the international nature of the emerging clientele. The exchanges expose a 
wide gamut of issues that surround the new wave of commodification. Unlike with medicine 
commodities where traditional consumers are caught in  bind between a new form and the old, here is 
a consumer who has to decide what is authentic without having any cultural knowledge to fall back on. 
Discerning authenticity is complicated because the consumers themselves here are non-traditional; 
consumption does not fit into the traditional ‘therapeutic’ category.  These are consumers with little 
traditional experience with Ayurveda, they do not know what they are looking for, and like the 
Portland tourist above, are quite often not sure what they want. They are dependent on experienced 
people to recommend an “authentic place”, but they have come up with expectations that themselves 
are in conflict with traditional parameters of authenticity. Spitzer (2009) in his study of Ayurvedic 
tourism in Kerala finds that many practitioners are disgruntled having to face such unconventional 
expectations. A practitioner he quotes differentiates between local patients who come to take some 
decoction and undergo treatment, the North Indians and NRIs request specific treatment, commonly a 
massage or a fancy procedure.  
Within a short time, one can also see the evolution of the discerning consumer. The 
experienced tourists contrast tourist style Ayurveda which is business-minded and goes against 
ayurvedic principles, contrasting them with serious treatment oriented hospitals. They talk about 
dubious quality, unqualified therapists, disguised brothels, and so on. Unlike the consumers of oriental 
carpets who are easily misled by tradesmen (Spooner 1986), here internet forums provide for 
exchanges between consumers undermining the authority of the middlemen in setting standards or 
obfuscating information. Emphasizing the importance of information and lack of it, in the creation of 
authenticity, Appadurai (1986:43) points out, “much of the institutional structure and cultural form of 
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the bazaar is a double-edged sword which makes information hard to get”. Internet provides a 
powerful forum for savvy consumers to overcome the information barrier.  
An interesting new business model attempts to provide a solution in the form of “Ayurvedic call 
center service” to guide the confused consumer. Recently, one of the largest Indian multinational 
firms, the Tata business group tied up with the oldest ayurvedic organization in Kerala, the Keraleeya 
Ayurveda Samajam to form Traditional Medicine Resource Centre (TMRC), a consortium of eminent 
institutions in Ayurveda, to propagate Ayurveda and guard against “quackery”. The news paper report 
on the launch proclaims, “Quack ayurvedic practitioners in the state will not have an easy time 
hereafter. A call centre identifying genuine ayurvedic centers and doctors will start functioning near 
Shoranur soon”(Financial Chronicle 2012).  
What makes the determination of authenticity most complicated is the disjunction between 
consumer expectations and conventional formats of practice. Even apparently serious treatment 
seekers are looking beyond disease cure to enhancing wellness. The western tourist above who wants 
to combine serious treatment with tourism, desires to undergo treatment in a particular kind of a 
location and ambience. Though most of the respondents ask her to choose between tourism and 
treatment, one respondent recognizes her need of being treated without being confined to the 
hospital bed. Such patient-consumers are trying to address a health problem that has a psychological 
component and justifiably expect the treatment ambience to be relaxing. Trapped in stressful work 
schedules they want an opportunity to let go. Those who target this market have come to recognize 
this requirement and not surprisingly, even serious therapy groups are beginning to accommodate such 
needs. By conventional parameters, such a ‘diversion’ can be interpreted as ‘distortion’.  But the very 
idea of ‘serious hospitals’ focusing on ‘treatment’ arises from a conventional mindset of viewing health 
care as just a matter of treating disease by confining the patient to a hospital bed. Ayurvedic disease 
etiology, unlike biomedicine, lays an overwhelming emphasis on psychological causes for most diseases, 
and it can be rightfully argued that such trends are not inconsistent with the philosophy of Ayurveda. 
However, even new customers attempt to draw a line between hospitals and resorts in determining 
authenticity. Though theoretically it may be possible to make a genuine and appropriate combination 
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of the two, in practice, the stakeholders of tourist focused Ayurveda and therapy centric Ayurveda 
tend to be different, with the former guided by commercial interests and the latter rooted in 
practitioner ethos. Though it is rare to find them going together, such a possibility cannot be ruled out.  
8.2 The Rise and rise of  Ayurvedic tourism in Kerala 
The origins of this new wave of commodification of Kerala Ayurveda goes back to early 80s. 
Western tourists who had been frequenting the Kovalam beach since the 1970s404, had been sampling 
various cultural commodities like Kathakkali, Yoga, Kalari and ayurvedic massage. By the mid 80s, 
tourist interest snowballed and ayurvedic massage parlors  sprouted everywhere405. In the initial phase, 
there was an unchecked growth of massage parlors engaged in illegal drug and sex trade in the guise of 
Ayurveda. In the early 90s the state cracked its whip by making it mandatory for centers offering 
ayurvedic therapies to be manned by qualified doctors and by implementing strict policing. The trend 
soon spread to all other tourist regions in 
Kerala406. The key focus in ayurvedic tourism 
was on the Kerala tradition of Panchakarma. 
The first of the exclusive ayurvedic resorts, 
Somatheeram was founded in 1985 in Kovalam. 
The founder of the resort had played a 
formative role in the aggressive tourist 
marketing of Kerala Ayurveda. In the late 80s, 
he provided hospitality to an international press 
contingent to Kerala, getting them to write 
articles on the subject. In the mid 90s, realizing the business potential, the Kerala government added 
                                                 
404 Kovalam beach was a historical western tourist hot-spot. Its history goes back to the 70s when it was accidentally discovered 
by Hippie travelers on the way to Ceylon. It already had a dubious distinction for drug and sex trafficking.  
405The details of progression of this early stage of development of the Ayurvedic massage market is unexplored. 
406 The most prominent being the Varkala beach in Trivandrum, backwater regions in Aleppy and Kumarakom, to the historic city 
of Fort Kochi and to some extent to hill resorts in Thekkady and Munnar hill station. 
 
Ayurvedic tourist centers proliferate,Varkala beach 
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Ayurveda as a key selling point to its official tourism campaign.407 Co-incidentally, Kerala’s value had 
risen owing to the decline of Kashmir in the tourist circuit, and  the industry-starved state had just 
begun to realize the importance of the tourism segment to the economy. This was also a time when 
‘medical tourism’ had caught up. Though the focus was on biomedicine, Kerala saw an opportunity to 
ride the wave by creating a niche of “ayurvedic health tourism”. The tourism industry today credits the 
State for its aggressive and imaginative tourism campaign, for  the special thrust given to Ayurveda, 
ironically the same reason why the State stands discredited by some of the traditional stakeholders of 
Ayurveda.  
In 1998, the State Tourism Department introduced a scheme of self certification for tourist 
centers offering Ayurveda (Green leaf and Olive leaf certification). This move took Ayurveda from the 
medical to the tourist realm, a step that many traditional stakeholders of Ayurveda find objectionable. 
Today there are 39 Olive and 64 Green Leaf centers. In addition to this, wayside motels to five star 
hotels all boast of excellence in Panchakarma treatments, and the rates vary accordingly. The cost of 
an hour of treatment for a tourist can range anywhere from $8-$60408. Many of the resorts offer 14-21 
day packages of Panchakarma treatment with accommodation that may cost anywhere from $60 to 
$2000 per day. An NRI blogger quips, “soon they will be selling it along with parippu wada (a popular 
snack) and chay at the chayakkada (tea stall)” (akin to saying, selling with burger and coffee at the 
coffee shop).   
 
 
An Ayurvedic beach resort, 
attached is a restaurant and a 
beer and wine parlor 
                                                 
407 The State’s “God’s own Country” tourism campaign won several national and international awards, including seven times 
national award for Best Tourism State. Recently, in March, 2012, its new campaign “Your moment is waiting” has got the Golden 
Gate Silver Award at ITB Berlin. Germany, clearly the most important country in terms of demand for Kerala Ayurveda (NDTV 
2012), is targeted with a special Ayurveda promotional in April, 2012. 
408 Comparable treatments would cost $2-$4 in a regular Ayurveda clinic. 
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The State effort did not go in vein. Foreign tourist arrival increased nine fold in the past two 
decades.409 The contribution of tourism to the State’s GDP went up from 0.25 to 7.7%. At the same 
time Kerala’s share in foreign tourist arrivals went up from 4.97% to 11.16%. Though the ratio of 
domestic to foreign tourists is 12:1, revenue earnings are equivalent.410 Ayurvedic tourism earned 
Kerala ` 60,000 mn ($1.2 billion) in 2007-8. Around 1,45,000 foreigners tried out Ayurveda in Kerala 
(Singh 2009). A study of international tourists who visited Kerala between 2001-2003 found that 13.8% 
had come to Kerala mainly for Ayurveda treatment, 1.9% for Siddha and Unani, 17.6% for spa, 6.2% for 
yoga/meditation (Jyothis  and Janardhanan 2009).411   
8.3 Panchakarma – the new commodity  
 Brian, a 40 something tourist from Germany is visiting India for the second time.  He had never 
heard of Ayurveda before this visit. His idea was to explore all the unique features of Kerala; his list 
includes Kathakkali (the dance art), Kalari, and Panchakarma. The medium range hotel in which he 
stays does not offer ayurvedic services, so he chose an independent Panchakarma center. The center, 
located within a star hotel complex, 
caters to residents of hotels and 
resorts that do not provide 
ayurvedic services. Brian bargained 
for a packaged deal that included a 
Kerala special Abhyanga (whole 
body massage), Shiordhara and 
Elakizhi that together cost him ` 
4800 ($120). He had to consult a 
doctor, but that was just a 
formality. Brian’s experience is 
                                                 
409 From 66,139 in 1991 to 5,98,929 in 2008. Domestic tourist inflow increased 8 fold from 9,48,991 to 75,91,250. 
410 1. Average length of stay for a foreign Vs domestic tourist is 16 Vs 6 days. 2. According to an estimate given by a tourist 
official, an average backpacker spends ` 6000 ($120) whereas an average Ayurveda tourist spends ` 90,000 ($1800).  
411 biomedical treatment: 15.6%, Cosmetic surgery:10.5%, dental care 7.6%, eye care 7%, &  recreation 20.3%.  
 
 
Panchakarma Center Ads Abound: Varkala beach cliff 
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representative of the quintessential foreigner sampling exotic treasures of Kerala on a tourist trail, on 
which Ayurveda had become a routine stop. The Panchakarma that Brian is so excited about, literally 
means ‘five actions’. It is part of Shodhana, one of the four modes of ayurvedic treatment which 
focuses on cleansing the body412 by eliminating the doshas accumulated in various parts of the body. 
Like the majority of the tourists, Brian would go nowhere near the actual Panchakarma, which 
comprises five procedures he would be unlikely to find pleasant. These include therapeutic vomiting 
(vamana), Purgation (virechana), nasal application of medicine (nasya), enema (vasti) and blood-
letting using leeches or incisions (rakta-moksham). All five procedures can be performed, or some can 
be chosen, based on individual requirements.  
The procedures offered in the name of Panchakarma are preparatory procedures literally 
meaning “preceding procedures” (poorvakarmas). These are classified into two: Oleation (snehana) and 
Sudation (swedana). The former is further classified into external and internal oleation. The theory is 
that oiling and sweating will open all the channels in the body and release accumulated doshas. If the 
body is subjected to purification without preparation, the doshas will eventually get firmly embedded 
in the tissues, aggravating the problem and weakening the body.  There are over 40 procedures 
employed to induce oleation and sweating which can be performed individually or in combinations as 
required. Kerala came to be known for Panchakarma for not only preserving such procedures, but for 
using them as part of treatment-protocols. Dharas (procedures that involve the pouring of oil over the 
body) are used to treat mental disturbances, insomnia, nasyams (nasal cleansing procedures) for nasal 
congestion, sinusitis, and so on. There are also a less heard of class of procedures known as 
Paschatkarmas, meant to be followed after the administration of Panchakarma. While full-fledged 
hospitals offer therapies as per requirement, resorts, hotels, spas and tourist oriented centers offer 
anywhere from 5 to 20 procedures413.  
                                                 
412The other three: Shamana (palliation using medicines), Ahara (dietary management) and Achara (life style management). 
413 The most popular are Uzhichil, body massage with medicated oil;  Pizhichil, subjecting the body to a constant flow of 
medicated warm oil; Ela Kizhi, application of medicated oil with a bolus filled with herbs, Njavarakizhi, application of medicinal 
rice bolus; and Shiro Dhara, rhythmical pouring of oil or medicated buttermilk on the forehead.  
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Brian was obviously unaware of all these intricacies. For him Panchakarma was synonymous to 
Ayurveda which was synonymous to a massage tradition, all originating in Kerala. Though Panchakarma 
is part of the pan Indian ayurvedic classical 
tradition, it is only in Kerala that it has survived  
and thrived. So in the post-tourist selling era, it 
has come to known as a tradition of Kerala, 
referred to as Keraleeya Panchakarma. Not only 
foreign tourists, but most Indians who have 
never heard of Panchakarma earlier in their lives 
mistake Kerala as the site of its origin. At the 
Global Ayurveda Summit in Kochi in 2010 a 
speaker said,  
In the pre-80s the place identified with Ayurveda used to be Sri Lanka, …today the top of the mind 
recall for brand Ayurveda is Kerala. For many, Panchakarma has come to signify Kerala Ayurveda, 
for some, it is simply Kerala Treatments not even Ayurveda.  
This misunderstanding irks some North Indian ayurvedic practitioners like Dr. Sukumar who 
grumbles, “What is so special about Kerala Panchakarma? Now people think it was Kerala that invented 
Panchakarma. But it is already all written by the ancient sages, mostly from north India. It went to 
Kerala much later.” Though he is right about it being a generic classical tradition, he fails to 
acknowledge the importance of metis. When ayurvedic doctors from all parts of India flock to Kerala 
they seek to imbibe collective practical knowledge that goes far beyond the text. Scholars across the 
country have appreciated Kerala’s role in preserving and improvising on the classical tradition. In the 
concluding ceremony of a national workshop, the Advisor of Ayurvedic Division in, Department of 
AYUSH, said with much emotion, “We are thankful to Kerala for preserving this glorious tradition.”A 
North Indian scholar from a premier national institution of Ayurveda dedicates his book on 
Panchakarma to “Ayurvedic practitioners of Kerala who kept the Art and Science of Panca Karma 
Therapy alive in some form and who continue to inspire rest of the profession to revive this great 
science in its original form” (Singh 2008). Though Kerala’s Panchakarma prowess got popular attention 
 
Miniature model of Ayurvedic Therapy displayed at 
Ayurvedic Industrial Exposition, Thrissur,2009 
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post tourism, it was common knowledge in national ayurvedic scholarly circles. For instance, a mid-
1960s medicine catalogue of AVS has a three page description on Panchakarma therapies in a section 
entitled “Special Treatments: Kerala specialties in methods of rejuvenation and care”. The description 
emphasized the “individuality of Kerala practice since time immemorial.”  
8.4 New Spaces and new stakeholders 
New spaces and new stakeholders are mostly co-produced. These can be classified into four 
broad categories, though they have many overlapping features: independent centers, hotels attached 
with ayurvedic facilities, exclusive ayurvedic resorts and spiritual resorts. The center Brian visited 
(APC) is located in a strategic place between a number of luxury hotels, many of which do not offer in-
house ayurvedic services or are limited in the range of services they offer414. Though it is mandatory to 
keep a doctor on rolls, casual conversations revealed that many proffered treatments off the menu 
without involving the doctor. They evidently did not share the ayurvedic practitioners’ sentiment of 
them being ‘clinical procedures’ with ‘therapeutic significance’; they were considered harmless 
recreational experience for the curious tourist. A common objection raised with regard to tourist 
selling of Ayurveda, is this disregard to the ethos of medical practice. For most ayurvedic practitioners, 
the seemingly simple preparatory procedure is a serious affair, to be regarded with the same respect as 
a surgical procedure, each with strictly specified indications and contraindications415. They are worried 
that flouting these norms, is not only against professional ethics, but could also harm Ayurveda’s 
reputation in the long-run416. Strict implementation of regulations had substantially streamlined 
ayurvedic service providers in foreign-tourist frequented regions. But domestic tourists focused regions  
 (e.g., Thekkady hill resort) sport a different landscape dotted with numerous small massage parlors, 
some with dubious reputation. Vendors follow tourists around, proffering massages, quoting rates, not 
much different from curio vendors.  
                                                 
414 It offers 9 different procedures including 5 varieties of massages (ranging from ` 300 ($6) -1500 ($30) per 40-60 mts session). 
415 For example, Shirodhara (procedure involving pouring medicated oil over the head) is contraindicated in the contexts of 
pregnancy, severe neck pain, low blood pressure, epileptic patients, brain tumor patients, people who have aversion/allergy to 
oil, those who have scalp rash, and those under the influence of drugs or alcohol.  
416 Occasionally, one heard rumors floating of procedures that had misfired. For example, one was about a wrongly performed 
massage that had created adverse effect on a patients with a history of spinal degeneration. 
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 In the post-tourist era, hotels and resorts have become a common space for the consumption 
of Ayurveda. The trend that started from resort hotels 
in tourist regions in Kerala has spread across the 
country, both to tourist regions and business hotels in 
large cities. “In Kerala, too many spas are trying to 
stitch the Ayurveda element into the outfit (Jhaveri 
2006)” A significant development in the past decade is 
the rise of tourist brands specializing in ayurvedic 
spas417. The first known ayurvedic spa brand is the Jiva 
spa from the Taj group which was launched in 2004418. 
Taj Garden Retreat at Kumarakom operates a full-
fledged ayurvedic center offering both therapeutic and 
rejuvenative treatments and massages. ‘Ayurvedic 
therapy’ has definitely made a long journey from the 
bare clinical settings of a hospital to a luxury hotel. 
Ayurvedic practitioners are uncomfortable with this 
transition, common reactions being that such trends are 
“prostituting an esteemed tradition”, making “Ayurveda more of a business and less of a service”.  
There is a segment of tourists unlike Brian, who are already familiar with Ayurveda, more often 
than not because of its affinity with Yoga. Such tourists tend to be serious seekers of Ayurveda who 
have done their homework either by reading or going through formal classes as part of their Yoga 
courses. The favorite haunt of such tourists are exclusive ayurvedic resorts. There are over 100 high-
end Ayurveda resorts in Kerala that cater to high-end consumers, offering both therapeutic and 
rejuvenative treatments. For example Somatheeram, which calls itself the world’s first Ayurveda resort 
(estb. 1985), employs 20 doctors and 90 therapists. Of its annual 6000-7000 customers, 98% are 
Ayurveda-focused. 60% of their ayurvedic customers come for serious therapy, 95% are foreigners, 
                                                 
417 A review of business news shows that ‘spa concept’ in India picked up momentum only in the early 2000.  
418 The group has 17 Jiva spas now, exclusive Ayurvedic Centers are run in two of their hotels, both in Kerala. 
Massage centers proliferate, Thekkady  
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mainly Europeans (Moosath 2006). Though large resorts are owned by business groups, there are 
exceptions. For instance, Kairali419 in Palakkad, known for its therapy focus, was founded by a doctor 
and his biotechnologist wife, who modeled it after their treatment center in Delhi. They made a 
conscious move away from the conventional hospital to create a “resort-cum-healing” where comforts 
were given as much importance as the treatments (Dhar 2012)420.  There are also many mid-range 
treatment centers run by established hospital owners or ayurvedic doctors with access to some capital. 
Andrew, a professional biker from Germany had chosen one such small resort run by a traditional 
Vaidya family in interior Thrissur district. After a bad fall that rendered him paraplegic, Andrew 
resorted to ayurvedic treatment, after all other medical interventions failed. Recovered enough to 
walk on crutches after a year’s treatment in a reputed Ayurveda resort-hospital in Bangalore, he was 
looking around for a cheap and authentic place in Kerala for continuing his treatment. He zeroed on 
this resort because of its German connections421. When I met him, he had been there for six months 
and had recovered sufficiently enough to resume biking.  
8.5 Marriage between the old and new: traditional stakeholders in non-traditional spaces   
Though initially shy and reluctant, many established ayurvedic groups including manufacturers, 
have one by one, directly or indirectly, entered the tourist market. These include a range of actors, 
traditional vaidyans, individual doctors, clinics and hospitals, and Kalari martial art training centers. 
They operate in different formats, four of which are most common: 1. Independent small/medium 
Panchakarma/wellness clinics, 2. Partnership model 3. Exclusive ayurvedic resorts and 4. Tourist-
focused treatment centers. The most common are the first category. Though it is rare for reputed large 
groups to start branches in tourist centers, many local hospitals have begun to open branches in tourist 
areas. Established doctors with some spare capital too jumped into the fray.  
In the late 90s, and early part of this decade a new partnership has emerged between two 
parties who had hitherto nothing in common – hoteliers and established stakeholders in the Ayurveda 
                                                 
419 Featured as one of the top 50 wellness destinations in the world, by the National Geographic Traveler.  
420 The only addition being a 50 acres of lush Kerala green ambience to take care of relaxation requirements. 
421 The vaidyan’s eldest son, runs an Ayurveda spa center banking on his traditional background despite being unqualified. This 
connection helps the resort to get a few German clients every year. The traditional family farm already had a medicinal garden. 
With a small investment on low-cost bamboo huts, it exudes the ambience of a local and authentic luxury resort.  
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segment. These range from small partnerships to large networks. The partnership framework has 
enabled the most conservative of the lot to enter the tourist market. This model works to the 
advantage of both the parties. Hoteliers get an easy plug-in option that provides them both technical 
expertise and a authentic traditional brand. Ayurvedic partners can keep their hands clean and minds 
free from running an unfamiliar hospitality business. Additionally, it provides them space to market 
their medicine commodities to a global audience and also serves as a catchment for their regular 
hospitals. A common network partnership to be spotted in tourist regions is a brand, Sukham (i.e., 
wellness), a joint venture between Abad chain of hotels and Kandamkulathy Vaidyasala, In early 2009, 
the  company was planning to introduce a novel format, “Ayur-tour”422 coordinating between their 
various centers to enable tourists to undergo treatment on the move so they would not lose on sight-
seeing – a program most unlikely to meet the approval of traditional stakeholders who have already 
been objecting to using beaches as treatment places, let alone traveling between them. Part of the 
traditional prescription for ayurvedic treatments in Kerala, especially in the context of seasonal 
wellness treatments is “nallirikka”, which literally means “good rest.”  
AVP, a large manufacturer, established a trust in 1998 to  “set up ayurvedic centers across the 
globe in Hotels, Resorts and other Institutions”.  It went on to build partnerships with several large 
hotel groups. Its much advertized partnership was with  Hindustan Unilever, top FMCG manufacturer in 
the country in 2002, to create Ayush Therapy Centers (HUL 2002). Another large manufacturer 
launched the Harmony brand in 2005, targeting spas and high-end hotels. It announced the formulation 
of ‘protocol-based’, ‘ready-to-install’ ‘ayurvedic experience packages’(Pankajakasthuri 2005). A recent 
headline news-maker in the resort segment is the entry of Yash Birla group423, an Indian multinational 
company.  It acquired majority stake in Kerala Vaidyashala in 2008, to establish Birla Kerala 
Vaidyashala (BKV),424 a combination of day care treatment centers and ayurvedic health resorts.  
Very few of the established Ayurveda stakeholders have openly entered the resort market. One 
boldly advertised resort is Keraleeyam by SD Pharmacy, a medium scale manufacturer. They advertise 
                                                 
422 As told by the General Manager of the company.  
423 A 35 billion dollar Indian multinational conglomerate corporation headquartered in Mumbai, India. 
424 Kerala Vidyashala  is a new generation tourist-oriented establishment started by an entrepreneur from a traditional vaidyan 
family in North Kerala.  
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a “3000 year old ayurvedic rejuvenation massage” without scruples, and have even gone far beyond 
their traditional forte to offer tour packages. Some other reputed resorts run by established Kerala 
based manufacturing groups are Ayurvedagram in Bangalore (KAL), Ayurveda Spa (Deseeya Pharmacy),  
Ayursoukhya (owned by a group of NRKs, managed by Kandamkulathy Vaidyasala).  
The last category is the most difficult to discern. In being treatment centers these overlap with 
the first category, but in being resort-like they overlap with the third category. However, unlike the 
first these are not typically found in tourist areas, and are not visibly tourism-focused. For example, 
though the treatment center run by the Nagarjuna group in Kaladi is oriented towards wellness 
packages and foreign customers, they make it a point to call it a therapy center. At the same time it 
gets recognized as the best Ayurveda Center for award in ‘tourism segment’425. Narayanan Namboodiri, 
Assistant Marketing Manager of Nagarjuna Ayurvedic Group says, “it is not a spa, many foreigners come 
here, but they all come for treatment”. That there is a niche for treatment as an offshoot of tourism is 
evident from the strategy followed by the large tourist business group CGH Earth. A pioneer in tourist 
development in Kerala, the group has also invested in the therapy market, strictly differentiating 
between the two. Kalari Kovilakam is a therapy center where “every single thing is done by the book,”  
whereas the Ayurveda spa in Karwar beach, Karnataka is a “time-pass resort (Dominic 2010)”.  
8.6 Identity crisis and the manufacturing of authenticity 
The boundary between the hospital and the resort is no more sacrosanct. The first concrete 
demonstration of this was the Tourism Department stepping into certification of Ayurvedic Centers. Of 
the total 103 certified centers, at least 20 appear to be conventional treatment centers.  Of these, 
around six are run by well established stakeholders including two from Ashtavaidyan families. This 
shows their aspiration to exploit the tourist generated market and willingness to cater to non-
conventional expectations.  A resident from Kerala might be able to distinguish between a spa and a 
treatment center not because of what they say they are offering, but because of their local knowledge 
of the institution’s history. For an unfamiliar customer seeking authentic Ayurveda the scenario can be 
quite confusing. Not surprisingly, the sellers of Ayurveda  are caught in an identity crisis in their 
                                                 
425 It won an award as the Best Ayurvedic Center in 2004 by the State Tourism Department. 
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attempt to strike a balance between the conflicting ethos of the hospital and the hospitality segment. 
While most ayurvedic resorts portray themselves to be serious enough to be considered a treatment 
center, many middle and upper crust  hospitals attempt to acquire some of the attributes of a resort. 
On the whole, the struggle is to remain attractive to the typical tourist, but still rise above the identity 
of a mere spa, to be considered at par with an ayurvedic hospital for the quality of therapeutic 
services426. Attempts to reconcile the contradictions that arise in the ‘morally ambiguous aura’ caused 
by ‘diversion’ of the commodity (Appadurai 1986) lead to struggles at meaning making. Some try to fit 
in all categories. For example, a spa run by an American woman exclusively for women tries to position 
itself as a combination of a home, a clinic and spiritual retreat, trying to distance itself from the 
commercial feel of a spa. “R.A… is not a spa or resort, but a retreat—a “guruless” ashram and 
ayurvedic clinic, dedicated to providing a nurturing space for healing and learning… located in a 
village-like neighborhood..along with the personal connection you’ll enjoy with .. make Rasa Ayurveda 
your home in Kerala”. Some others attempt to defy categorization, “So is it a spa? A Palace hotel? An 
ayurvedic hospital? An ashram? Kalari is beyond these simply because it is a little of all of these.” 
Another savvy resort invokes the mantra of individualization to transcend all boundaries, “Whether you 
are looking for ayurvedic treatment or a weekend get-away… AB Health Resort has a whole range of 
programs to suit every individual’s need. A cornerstone of ayurvedic  thinking, “individualization” 
opens the floodgate for commodification. It marks everything as distinct and exclusive and hence 
incomparable. In this perplexing scenario, it becomes very important for sellers to establish their 
authenticity. Analysis of advertisements and brochures, location and customer positioning, points to 
three major themes as being the most exploited in sellers’ attempts to manufacture authenticity – 
tradition, nature and location, spirituality combined with yoga. 
8.6.1 Tradition as the prime-marker of authenticity 
Though tradition has always been important brand marker in the Ayurveda market in Kerala, in 
the manufacturing era, the emphasis was on science and modernity. In the marketing of services, 
                                                 
426 Chronic diseases like sinusitis, migraines, allergies, hemorrhoids, hypercholestremia, IBS, early stages of hypertension, 
insomnia, anxiety, etc., are conditions that might be ameliorated, if not cured, with a period of cleansing (detoxification being 
the favorite term), break from routine, diet and life style modification and mental relaxation. 
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modernity and science has taken a backseat with tradition coming to the forefront. One or more of the 
following reasons could be contributing to this trend,  
 The western tourist consumer seeks the traditional and the exotic, not the modern or 
scientific. 
 Unlike local people, foreigners need to be presented with convincing credentials.  
 In the service market, it is uniqueness and exclusivity that sells, not uniformity and 
standardization.  
Unlike traditional stakeholders from established traditions like Ashtavaidyans,  erstwhile title 
holders, royal physician families, and old manufacturers, newcomers have to struggle to convince 
others of their legacy. Besides the legitimacy of a formal degree, it has become important to have 
pedigree. Since ayurvedic practice in Kerala cuts across classes and castes and religions, ‘family 
tradition’ can be found even in nooks and corners of the state, traced back to unknown periods in 
history. Kalari Kovilakam a new age therapy centric ‘palace resort’ traces its history back to a 
historical royal legend. Sanjeevani Ayurveda claims their genealogy to an unbroken tradition of six 
generations going back to a royal physician. Claiming ‘250 year of tradition’ Chavarcode family in 
Southern Kerala claims to follow both ‘classical’ as well as ‘traditional’ approaches. New generation 
hospitals who have no tradition to boast of, hire someone with traditional cultural capital or simply fall 
back on the generic ayurvedic heritage. When family traditions do not go far back, access to “secret 
formulae” from “ancient palm leaves” are cited.  Though the family vaidyan history may be legitimate, 
there can be vast differences in the level of expertise inherited and in the caliber of the inheritor. 
Distinguishing between the real graduate and the drop-out student, without local knowledge of the 
vaidyan’s or the family’s historical reputation, is near to impossible.  
A backwater ayurvedic resort traces itself to the ottamooli (single-root/dose) tradition of 
Kerala offering one-day rejuvenation treatment based on “a magical combination of herbs”. It cites a 
fascinating anecdote of how a royal toxicologist in the family a century ago had developed a single shot 
remedy to increase the immunity of royal family from poisoning and increase their life span.  While this 
might appeal to a foreigner, it is ridiculed by locals as downright ‘quackery’. People in Kerala scoff 
when the word paramparya (tradition) is specifically advertized. In fact, it is the labeling that rouses 
suspicion; those who market tradition are suspected to be quacks falsely laying claim to authenticity. 
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By their logic, vaidyans, if traditional, are locally known and therefore have no need to advertize. This 
however is not a new development for Ayurveda which has a two millennia history of commodification. 
Several references are available in ancient and medieval literature in Kerala and various other parts of 
India that mock vaidyans who cheat public and make money. Charaka Samhita warns against quack 
vaidyans who advertize their wares in public. There is mention of prevalence of ‘muri vaidyans’ 
(quacks) in literature in 14th century Kerala. A remark is made in an humorous art form of medieval 
Kerala (called chakkiyar kooth) that the vaidyan and the Kala (god of death) are from the same breed, 
but the former is more cruel because he also takes money (Varier 2009). 
Resorts away from the usual tourist circuit bank upon local cultural heritage hitherto 
unmarketed. For culture-tourists they serve as more legitimate markers for authenticity than generic 
images of nature, demonstrating the rootedness and localness of the institution. For example, the 
Nagarjuna Ayurvedic Group’s center in Kaladi is the birth place of Shankaracharya, the Hindu revivalist 
guru, where according to the brochure, “the vibrations of the past are still felt…the sacred place 
exudes serenity and sanctity, instilling divine and spiritual thoughts into one's mind427”. The Silent 
Valley resort boasts about its location in Pulamanthol of the Ashtavaidyan fame as “the land of 
Ayurveda” where “tradition and culture meets”, a place where sage Vagbhata spent his last days428. 
The Kerala style of architecture helps to create an authentic ambience of tradition.  There is a 
wide range to choose from; ordinary tiled houses for the lower-end, elite houses (nalukettus429) in the 
mid-range; royal palaces and illams/manas (Namboothiri Brahmin houses) for the high-end. An 
ayurvedic resort founded in 2001 by modern entrepreneurs without having tradition or location to cash 
on emphasize on  the “century-old building… constructed in the nalukettu model. The nalukettu is the 
traditional upper-class homestead(tharavadu), a quadrangular mansion with a centrally open 
courtyard, corridors, massive pillars and dorm windows typical of Kerala's Architectural Style”. Another 
resort located at an off-beat river bank describes itself, “The construction of the nalukettu building, 
the aristocratic  bungalow of ancient days is strictly sticking on to the vaasthu (ancient Indian science 
of architecture) technology, but compromising with all modern facilities”. This  comes especially handy 
                                                 
427 Nagarjuna Ayurvedic Group, promotional leaflet, n.d. 
428 Silent valley Resort, promotional leaflet, n.d. 
429 Quadrangular houses surrounding an open courtyard in the center, a unique Kerala style of architecture.  
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in creating a Kerala ambience elsewhere. KAL’s high-end resort in Bangalore declares,  
Drive away from the City lights…As you drive in through the Classic gates of Ayurvedagram, you 
enter a whole New World of ethnic charm. Taking you back by over 75 years to Kerala's antique 
Nalukettus, Kovilakams (Palace), Manas & Illams- the traditional homes of Kerala. We have 
carefully transplanted these ethereal homes of Kerala's high & mighty, brick by brick, woodwork 
and all, to Bangalore, and recreated the royalty of Kerala, exclusively for your unique 
experience430.  
8.6.2 Nature: a natural selling point for a herbal tradition of medicine 
Tourism is primarily a business built around selling a geographical location either for its natural 
attractiveness or/and for its cultural significance. 
Kerala tourism had historically focused on the scenic 
beauty of its tropical beaches, backwaters and tea 
gardens. The theme of Ayurveda as a ‘herbal’ 
medicine rooted in ‘Nature’,  oriented to wellness 
and rejuvenation has become comfortably ensconced 
within this framework. This goes down well with both 
the foreign tourist and the average urban Indian 
wanting to have a respite from crowded and polluted 
concrete jungles. The publicity literature of ayurvedic 
resorts overflow with imagery of nature and ecology. “Rejuvenation in nature’s own way” proclaims 
one brochure with the image of lush forest and waterfalls pasted over a traditional Kerala bungalow.  
Another medium scale ayurvedic medicine manufacturer stretches the nature theme to its 
maximum capacity, “Escape to a healthy change…be close to nature….leave behind the maddening rush 
of city life, never ending deadlines and the strenuous schedules…enveloped by pure raw nature… Clear 
air, misty mountains, soothing music of rivulets and the chirruping of rare birds will transcend you to a 
world of peace and humanity…” The wellness center, whether it aims at tourist or to domestic 
customers, sells along with Ayurveda, the surroundings and the ambience. The best and most expensive 
therefore are situated at picturesque surroundings. The most favorite location, the backwaters in  
                                                 
430 Kerala Ayurveda Pharmacy, promotional leaflet for Ayurveda Gram resort, n.d. 
“Return to Nature” 
Hoarding of Somatheeram Ayurvedic Beach 
Resort 
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Kerala are a network of interconnected canals, 
rivers, lakes and inlets comprising of five large 
lakes and 38 rivers, that provide 900 km of 
waterfront opportunity. While a large 
manufacturer like Nagarjuna can afford to have 
a treatment center on the bank of a major river, 
PS, a small traditional player with a clinic in 
interior Ernakulam has invested in a modern 
hospital building, overseeing an inconspicuous 
lake. Ironically, backwater-front properties that were the least attractive431  have become 3-4 times 
more expensive than prime road-front properties.432 In Kumarakom for instance, a piece of land worth 
` 250-300 ($5-6) per cent two decades ago,  now costs ` 200,000 ($4000) to a mn ($20,000), an 80-400 
fold increase.  
8.6.3 Spirituality and yoga: natural bedfellows? 
An element not traditionally associated with Ayurveda in the domestic market, but is often 
found  packaged with tourist Ayurveda, is spirituality. The only group known for such packaging earlier 
was Maharishi, which along with selling transcendental meditation to the western market, developed 
its own export-version of Ayurveda (Jeannotat 2008). Popular practice of Ayurveda, contrary to 
western imagination, is far from being steeped in spirituality. But tourist resorts in Ayurveda make it a 
point to emphasize on the spiritual dimension of Ayurveda, which is most often taken care of by 
including yoga and meditation in the menu. Western expectations are known to play an important role 
in shaping Ayurveda in the West, for example an overemphasis of spirituality in the United States partly 
owing to regulatory barriers to medical practice (Reddy 2002).  
There is no historic link between Ayurveda and Yoga in the classics nor has there been a close 
association between them in everyday practice in India. But for outsiders besotted with Indian 
                                                 
431 They were flood-prone and due to frequent sea-water intrusion, unviable for cultivation.  
432Property prices were already high in Kerala owing to high population density coupled with insatiable demand from a rich Kerala 
Diaspora. Traditionally, the highest priced were core urban land and road-front properties. 
 
Backwaters: the upmarket ayurvedic tourist 
destination 
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spirituality they appear to be closely related. Not only do they share a common homeland, they are 
apparently complementary; both aim at enhancing health. Formerly, the likelihood of people who were 
exposed to yoga and meditation stumbling on Ayurveda would have been rare. But today Yoga and 
Ayurveda are often found packaged together. Organizations focused on Yoga have begun to package 
ayurvedic commodities along.  Likewise those in the ayurvedic business ride on the popularity of Yoga 
to gain access to an established catchment of western consumers. It has become common for ayurvedic 
practitioners to talk about yoga as if they had always been closely interconnected. In a publicity 
brochure, Nilayoram resorts claims that “Ayurved and Yoga are sister sciences”, tracing their “common 
ancestry to the ancient  seers”. The brochure belabors on the theme drawing a long list of similarities 
between the two, arguing that “Ayurveda deals more with health of the body, while yoga deals with 
purifying the mind and consciousness, but in reality they complement and embrace with each other433”. 
Much effort is being put into justifying  the relationship to make up for the lack of a natural link. It is 
likely that the historical disconnect between the two would be soon forgotten, and any reminder of it 
might meet with disbelief or disapproval. 
The domestic market space of spirituality has undergone an expansion in the last two decades. 
Institutions and gurus in this space find it advantageous to partake their share of brand Ayurveda. 
Spiritual entities are of two kinds, low profile traditional spiritual organizations rooted in local 
communities and high profile ‘new age’ spiritual gurus. Both of these activities are relatively low key in 
Kerala compared to rest of India. The most prominent spiritual entities in Kerala are Santigiri Ashram 
and Mata Amritanandamayi’s Ashram. Interestingly, both hail from subaltern communities, began as 
low profile institutions that acquired international stature434. The former through its manufacturing 
unit Santigiri Ayurveda and Siddha Vaidyashala has been a mainstream stakeholder given the Ezhavas' 
historical association with medicine. The latter participates in Ayurveda by selling products under its 
recently launched brand  Amrita Life.  Both follow the Kerala model of focusing on classical 
pharmacopeia. Post the recent liberalization of education, both have entered the ayurvedic education 
market in the past decade (Santigiri in 2001 and Amrita in 2004).  
                                                 
433 Nilayarom Ayurvedic Resorts, promotional leaflet, n.d. 
434 The former established in 1964, derives inspiration from the Ezhava spiritual leader Kumara Guru. The latter, 
Amritanandamayi popularly known as Amma (i.e., mother) hails from a fishing community.  
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As far as ayurvedic market in Kerala is concerned new age spirituality does not have much 
traction. Authenticity is mainly constructed around established ayurvedic stakeholders. But in other 
parts of India, where there are no claimants for ayurvedic tradition, modern spiritual gurus have begun 
to wield extensive influence. Most notable are two new age gurus, Sri Sri Ravishankar, an elite oriented 
guru  and Baba Ramdev who is a guru of the masses. The popularity of both are linked to the teaching 
of Yoga, though their modus operandi presents a stark contrast. Ravishankar’s Art of Living Foundation 
propagated a proprietary format Sudarshana Yoga taught through highly priced ‘art of living’ workshops 
and ‘satsangs435’. Ramdev on the other hand garnered mass following from his open-source model of 
teaching Yoga on television. Both have jumped on to the Ayurveda bandwagon, with distinct 
approaches and aggressive marketing strategies. Ravishankar’s Ayurveda remains elite, the language 
and the format designed to appeal to the export market, especially to the western consumer. The 
image below shows the company’s presentation listing international certification markers at the 
international conference in Bangalore in December 2009. They were hosting the ‘international delegate 
session’ in their grand auditorium at the Headquarters in Bengaluru.  
Ramdev on the other hand has made big strides in 
domestic Ayurveda, producing affordable classical and 
traditional medicine commodities. His ayurvedic 
establishment has seen a meteoric rise in the past two 
decades, now an empire of 1049 Patanjali Arogya Centers 
(medicine franchises) and 794 Patanjali chikitsalayas 
(branded clinics). Ranjit Puranik, owner-CEO of 
Dhootapapeshwar, General Secretary of Ayurvedic Drug 
Manufacturers Association (2002-2010), feels that he has 
done “yeoman service” in restoring faith in Ayurveda  in 
North India.  
Though spirituality, yoga and Ayurveda appear to be natural bedfellows, as far as the selling of 
                                                 
435 (sat= truth, sang= community) A format of religious fellowships common to many religious organizations in India.  
Presenting credentials: A Sri Sri Ayurveda 
rep. in International Delegate Assembly 
World Ayurveda Congress,Bengaluru, 2009 
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ayurvedic commodities are concerned, the spiritual gurus are no doubt riding over a wave of popularity 
generated by the post-tourist commodification of Ayurveda. At the same time, by doing this, they are 
also creating a new clientele for Ayurveda among their followers by providing a stamp of recognition 
that Ayurveda outside Kerala sorely lacked. These set of actors have a distinctive advantage in making 
claims to authenticity; they are implicitly perceived to be operating within a ‘sacred’ ‘non-commodity’ 
sphere inherently untainted by commercial logic. 
8.7 New Practitioners: the spawning of paraprofessional training institutions 
The proliferation of Panchakarma in resorts and hospitals has created an unprecedented 
demand for paraprofessionals. This has led to the gradual formalization of a once purely informal skill. 
Practitioners mainly depended on Kalari martial art trained masseurs for assistance with massage and 
other clinical procedures. In the 70s a formal training program was created to meet the requirement of 
government hospitals in Kerala. For a long time the only course to train paraprofessionals was run by 
Government College in Trivandrum, with a capacity of 30 seats. 
Since 90s, various small and big private players began to respond to 
the requirement of paraprofessional training. A prime-mover both 
in the training and tourist services market was the Christian-
missionary owned Sahyadri, which started Ayurvedic Nurse training 
in 1994, producing 480 students by 2006. It forged a partnership 
with a Kerala-based luxury hotel chain in Goa to offer wellness 
treatments. Paul and Mary who studied in the first and the second 
batch graduating from this institution were happy to have chosen 
this path. Armed with eight years of experience, Paul436 is 
optimistic of finding a position abroad. Mary437 had a good career until she moved back to Kerala after 
marriage, to a remote location without tourist activity. Nagarjuna was the first and remains the only 
                                                 
436After a B.A and a diploma in computer application course failed to land him a job, he decided to try this option. For the first 6 
months, he worked in an Ayurveda hospital. After 4 years of working in various hotels in Bombay and Delhi, he now works at a 
five star hotel in Kovalam and is paid ` 8000 ($160) per month besides free boarding and lodging.  
437 She passed the Ayurvedic nurse program in 2001. When she joined, the fee was a mere ` 5000 ($100). The entry requirement 
was just a higher secondary pass certificate. With demand for the course going up, a biology requirement has been added. All of 
Mary’s 15 classmates found immediate employment. Mary worked at the five start hotel Leela in Goa for two years before 
marriage, at a salary of ` 5000 ($100) per month. This was considered a good deal as accommodation and food were taken care 
of and moreover, she was earning an equal amount of money from tips. 
 
Poster ad for Sahyadri’s 
Panchakarma therapy course  
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one among the large manufacturers to enter this market. The diploma program they introduced in 2002 
was so popular that they were training three batches a year, with intake ranging from 30-50 a batch. 
By early 2008, they had trained around 600 therapists. Given the brand name and the rigorness of the 
program, therapists trained by the Institute are sought after. Another medium sized manufacturer 
Pankajakasthuri’s tourist brand ‘Harmony’ is a business model centered around training therapists.  
Given Kerala’s expertise in exporting biomedical nurses across the globe, the concept of 
ayurvedic nursing did not take much time to take root. Ayurvedic nursing demands far lower 
investment, and caters to a lower income group. Also, it provides opportunity of training to both 
genders unlike biomedical nursing which has been traditionally woman-centric. Majority of the 
candidates for these programs are from lower socio-economic strata who are on the look-out for quick 
jobs438. Ayurvedic nursing also carries the potential of going abroad, a common aspiration among 
Keralites accustomed to labor migration to foreign countries. Absence of state control and 
standardization coupled with increasing demand from the service segment (both tourism and the 
expanding hospital segment), provided a fertile breeding ground for a variety of entrepreneurs. 
Soukhya, one such training institute located in Thodupuzah in Idukki district439 is among the pioneers 
who has made it big.  The Institute was constituted solely for this purpose by a retired Government 
ayurvedic doctor who in his association with Nagarjuna’s training program, was inspired by their 
model440. The Institute has a good reputation; students are well placed, not only in Kerala but also in 
cities like Bombay, Hyderabad and Bangalore. In fact, the demand was so high that they have 4-6 
institutions visiting annually for campus recruitment. The manager of and the four masseurs employed 
in the tourist center Brian visited were all alumni of this institute. Two similar Institutes (Ashramam 
and Ayushalaya) opened in the district inspired by their  success, have also grown substantially big.  
Unlike Nagarjuna and Sahyadri, who have traditional reputation in the ayurvedic community, 
new institutes like Soukhya find it important to have some official seal of approval which is 
                                                 
438 Some of the typical job alternatives for youth from this class are office administration, tailoring, barber/beautician, computer 
hardware, or specifically for men, plumbing, welding, smithy, lift operation, fire technology, draftsmen.  
439 Interview with Office Manager, Soukhya, 05/10/2010 
440 The manager of and the four masseurs employed in the tourist center Brian visited were all alumni of this institute. The fee 
for the course was ` 12,000 ($240). With three batches in a year they had rolled out around 250 students by early 2010. They did 
not employ permanent staff; three Ayurvedic doctors were employed as visiting faculty. The institute was residential, most of 
the students were non-local Keralites. The minimum entry requirement is higher secondary, but they get diverse students many 
with undergraduate degrees. In one batch, they even had a retired lawyer. Many Christian nuns come for training. 
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conveniently obtained from the Bharat Sevak Samaj (BSS)441. As of early 2010, over 70 institutes had 
obtained approval for conducting 6-12 month certificate courses in Panchakarma, ayurvedic therapy 
and nursing.442  In addition to this, there are around 10-20 small institutes at the lower end of the chain 
that give 3-6 months training without any formal connections, with lower fee and lower entry 
requirements. There are also several individual doctors who have turned entrepreneurs overnight. For 
example, in early 2008, when I met Ravikumar, an ayurvedic doctor in a rural town in central Kerala, 
he was busy hatching plans with a traditional Kalari practitioner to begin an ayurvedic nursing program. 
It does not require much investment, he said. All he had to do was to spruce up the already existing 
Panchakarma room, and add another room for conducting classes. Though the State government has 
given approval to few more ayurvedic medical colleges to run ayurvedic nursing/therapist courses, 
there has been no attempt so far to regulate para-professional education. During the Global Ayurveda 
Summit in Kochi held in March 2010, there was much discussion on the shortage of therapists.  Despite 
the mushrooming of training institutes, the current supply of around 1500 therapists a year hardly 
meets the estimated annual domestic demand that exceeds 20,000 (Sangeetha 2010). In his inaugural 
address at the Summit, the Chief Minister of Kerala promised that a policy would be soon formulated to 
promote the education of Ayurvedic therapists.  
8.7.1 The sidelining of Kalari martial art practitioners 
 In this particular market, the Kalari martial artists find themselves in an awkward position. As 
traditional suppliers of ayurvedic services, they continue to play a significant role. Some therapist 
training institutes have been reportedly using Kalari practitioners to do the skill training. However, 
instead of being key players in the emerging market, they are relegated to the periphery, and are in 
danger of being further undermined. Within the current Ayurveda-centric market they cannot claim a 
legitimate place. This was not the case until recently, when bone-setters from this tradition had a 
legitimate status as experts.  Formally trained doctors respected their skills; many admit that such 
skills are difficult to acquire from classroom instruction. But with the escalation of the commodity 
                                                 
441 A national development agency promoted by the planning commission, Government of India, works as a certification 
organization for approving syllabus and conducting examination for vocational courses. 
442 Of the 70 institutes, around 10-15 are independent training institutes. The rest include the full range of players in the 
Ayurveda market ranging from manufacturers to resort owners, medical colleges to martial art training institutes.  
 321 
 
value of Ayurveda, there has been a sea change in perceptions. The tourist market grew around 
ayurvedic massage,  of which the most popular was Kerala special massage (uzhichil), a contribution of 
the Kalari tradition. When the demand extended to practices that were a joint realm of Ayurveda and 
Kalari, tension began to build up. Eventually, rampant malpractices brought in regulation; registered 
ayurvedic doctor’s presence became mandatory. Unfortunately for Kalari practitioners, Kalari 
massages did not evolve as a distinct commodity category outside the ayurvedic fold. 
In the early years of formalization of modern Ayurveda, for metis-heavy branches (Marma, 
toxicology and ophthalmology), ayurvedic institutions in Kerala had used practitioners from the 
traditional background to formalize the curriculum. Illustrious vaidyans, despite not having degrees 
were appointed as professors in reputed medical colleges. For example, a traditional Siddha Marma 
practitioner was appointed as a professor in Trivandrum Ayurveda College. One of his recipes for wound 
treatment (Murivenna), adapted and popularized  by the college continues to be the most important of 
all medicines in Kerala (Kerala Ayurveda Vaidyam 2011). A small, but locally reputed doctor-
manufacturer I interviewed, said his proprietary pain oil was based on a secret formula obtained from 
such a Marma vaidyan who was a visiting professor in the Trivandrum college hospital where he was 
doing internship in the mid-60s. The significance of metis in the area of musculo-skeletal issues is well 
illustrated in this narrative of Sudhakar, a college professor in his late 30s who landed in a prestigious 
ayurvedic hospital with a severe back pain.  
The patient was a non-Keralite, the hospital was a prestigious Kerala ayurvedic hospital outside 
Kerala. Despite the severity of his condition and despite the warning of his friends and family, 
KS decided to go to an ayurvedic hospital because of his historic experience with various 
indigenous systems of medicine. Only those who supported him in his decision he said were 
Keralite friends who had recommended this hospital. When he admitted he was barely mobile 
and was in excruciating pain. When his symptoms did not come down after a week, the doctors 
lost confidence and recommended that he visit a allopathic specialist. KS asked them to take 
him to an orthopedic surgeon, who recommended surgery. KS was unwilling, he asked for 
traction instead, and asked for it to be arranged in the ayurvedic hospital. However, after the 
procedure was done, KS was disappointed with the doctors and felt no much in spending his 
money on the hospital. When he was about to leave, a therapist who heard about this 
unsolvable case, got curious and came to visit him. The therapist who was in mid-30s had 14 
years of experience, and he said he was willing to treat him, but the hospital protocols won’t 
permit. KS being willing to take the risk, he agreed to perform the therapy behind closed 
doors. He brought with him an assistant with a hefty build to lift KS, and directed him to 
perform some kind of manipulation. Following this, he gave him a therapeutic massage, which 
he said significantly ameliorated his condition. The therapist continued with his therapeutic 
massage sessions at home, until KS fully recovered.    
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Lambert (1997) feels that the official status of Marma as part of a legitimate branch of 
Ayurveda in Kerala was instrumental in preserving the martial art tradition. She contrasts it with the 
absence of official patronage in Rajasthan which led to the decline of the ‘Pahalvans’, the wresters 
who also used to practice as bone-setters. Formalization might have legitimized the practice and to a 
certain extent absorbed traditional skills. But at the same time it sidelined practitioners outside the 
formal system. Today, spaces and channels to bridge the traditional and the formal no more exist; the 
formal is assumed to have absorbed the traditional, making the traditional irrelevant and illegitimate.  
Though well intended efforts were made to incorporate traditional knowledge, the very format 
of formal learning was inimical to the learning and transmission of these skills. Hence, it failed to 
produce effective counterparts. Consequently, transmission continued in the traditional format outside 
institutions responding to popular demand for services. However, Kalari Marma practitioners lost 
official legitimacy, financial and moral support. This has affected bone-setters hailing from the Kalari 
background. For example, the patient who was buying raw-drugs for a fracture treatment (see Section 
6.1) was visiting Rajan, one such traditional bone-setter. Being unlicensed, this practitioner maintains 
a low-profile. It was quite a task to unearth his clinic, which was run in a house in a remote rural area 
in Central Kerala, well hidden in a thickly housed residential area. There were no boards or any sign to 
indicate the existence of such a vaidyan. For the sake of legitimacy, he practices along with a retired 
ayurvedic doctor, displaying only the latter’s name plate. His clinic draws 50-100 patients a day, who 
mainly hail from the surrounding three districts. Domestic demand continues to be high for such 
services which continue to circulate in exclusive channels mainly by word of mouth publicity, far away 
from the public gaze. Unlike Rajan,  Kannan vaidyan in another remote village in central Kerala 
functions on a far smaller scale. Now in his mid-60s, he lives a nomad’s life travelling from city to city 
responding to random service calls, mostly from patients’ families. Sometimes he also gets calls from 
ayurvedic doctors to assist them in treating difficult cases.   
Kalari practitioners’ problems are similar to that of informally trained ayurvedic practitioners 
who had been delegitimized in the process of professionalization of the indigenous medical systems. At 
the same time, it should be noted that it is ‘participation in the market’ that is at the root of their 
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problems. The traditional checks that guarded professional boundaries and ethos do not work in the 
new market. Kalari was primarily studied as a passion and as a hobby, not for getting a job or making 
money. Some basic skills like fixing sprains, dislocations and fractures were commonly taught Kalari 
training to address their everyday occupational hazards. It is common for Kalari trainees to leave half-
way; some learn skills useful in doing minor massages, ending up as assistants to Kalari masters or 
vaidyans. Many do it just as a social service and hobby, not expecting returns. For example, Savita, a 
young woman from a lower middle class family in an interior village in central Kerala, had a few years 
of Kalari training as a young school girl. Now a nursing student, in her free time, she helps out 
neighbors in cases of minor sprain or a simple massage for aches and pains, without taking payment. 
Only those with special aptitude went on to learn advanced techniques and medicine preparation.  
Those who did well had people queuing up for service; ayurvedic vaidyans often referred their patients 
to them. Mohammad Gurukkal, a Kalari practitioner who runs a small institute in interior Thrissur,  
talking about opportunities and lack of it for Kalari practitioners said that traditionally most learnt 
Kalari as a hobby. Some like him who continued with passion went on to become teachers. “Now many 
are going to the Uzichil (massage) business, may be some of my half-learnt students (cheats!) might 
also go, I have no idea”. He was also dismissive of the qualification of the so-called certified masseurs. 
“One cannot teach massage like that in six months or even a year. This is something that we teach very 
slowly over time, as a part of a discipline.” Commodification pressures leads to demand for formal 
certification that consumers in the market can use to gauge authenticity of a practitioner. The 
traditional curriculum in Kalari is organized by levels, ranging from wrestling to full-fledged sword 
fights. Though students are internally graded by accomplishment of each step, certification is not 
formalized (unlike ‘belts’ in Karate). In time, as a profession Kalari may be forced to institute visible 
certification markers to guard its boundaries. 
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8.7.2 The battle for legitimacy in transnational spaces 
Ayurvedic tourism has also opened up lucrative opportunities for training professionals from 
abroad including foundation programs for non-professionals. There is also demand from ayurvedic 
doctors across India for training in Kerala special treatments. Almost all manufacturers and resorts 
have opened a Trust or branch for training443. Most of the high-end and even some of the mid-level 
training institutes target Europeans as the primary clientele; the course fees are listed only in Euros.444 
Training courses are not just run by large and reputed establishments. There is small scale brisk 
activity, especially in tourist regions and cities near tourist regions. Dr. Sridharan, an ayurvedic doctor 
from a vaidyan family runs a tourist oriented ayurvedic massage center in the historical city of Fort 
Kochi. He proudly shows his book full of recommendations from his trainees – around 30 odd trainees, 
most of them from European countries. He  charges a fee of `14,000 ($280) per student for a monthly 
course445.  
However, while it works as a lucrative market for local entrepreneurs in the short run, there is 
a less recognized indirect impact. When Ayurveda travels out of its context, as a commodity to 
transnational spaces, given the lack of official recognition and consequent lack of regulation, it is 
vulnerable to diversions. Vijaykumar (2010) provides a neat classification of ayurvedic practice in UK 
based on his own experience as an ayurvedic doctor in UK. He classifies the services into four 
categories: widely prevalent Ayurvedic clinics run by North Indian doctors that do not offer 
Panchakarma; resorts that have doctors and therapists from other parts of India who provide no 
classical treatment; half a dozen illegal institutions that employ Keralites or those trained in Kerala 
who are into full-fledged Kerala ayurvedic practice including Panchakarma; and finally centers run by 
Germans and British, post short-term training in Kerala, which sell services as independent 
commodities.  
                                                 
443 For example, Kerala Ayurveda Pharmacy’s Kerala Ayurveda Academy, AVP’s Arsha Yoga Vidya Peetam,  Somatheeram resorts’s 
Ayurveda Academy, Birla Kerala Vaidayshala’s (BKV),  BKV Institute of spa. 
444Somatheeram resort charges 2000 Euros for a basic Panchakarma course for 20 days, excluding boarding and lodging 
(accommodation costing Euros 70 to 270 per day in the season).  Greens Ayurvedic Hospital has targeted at a predominantly 
North-American clientele in introductory Ayurveda (50 from USA, 49 from Brazil, and 10 from Canada between 2005 and 2009). 
445 This is equivalent to a government Ayurveda doctor’s basic monthly salary. 
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Formally qualified practitioners attempting to 
establish practice abroad, mostly Indian doctors and a 
handful of European CAM practitioners are concerned that 
such practices would endanger their interests. Many local 
CAM professionals in Europe and US with a few months 
training set up ayurvedic treatment centers or add it as 
an item in their spas or integrate with other CAM 
specialties. An agitated ayurvedic doctor from Kerala 
writes,  
Many westerners come to India nowadays to get short 
ayurvedic courses, so that they can return back to 
their country and term themselves ayurvedic experts. 
As in many countries there are no standards in 
ayurvedic medicines whoever can pronounce vata 
pitta kapha clearly and loudly and chant one or two 
mantra or can change their name or let their beard 
grow or put a long sandal paste dot on their forehead 
can become great ayurvedic experts (Ajit 2007:48-49). 
And he warns, “If we do not wake up before it becomes too late Ayurveda will go the same way Yoga 
has gone in west (Ajit 2007:48-49)”.  Qualified practitioners are afraid that such practices might 
damage the reputation of Ayurveda, making it further difficult to get official recognition.  A Latvian 
Ayurvedic practitioner presenting a paper at the Global Ayurveda Conference in Bangalore calls this 
‘pseudo Ayurveda’ which he says led regulators to apply cosmetic industry controls on Ayurveda446.  
The growth of Pseudo Ayurveda in Europe, in the long run, is detrimental to the interests of the 
authentic Indian ayurvedic science and the industry. The lack of coordination and standard course 
programs leads to a number of organizations all over India, offering so-called ‘Indian Ayurveda’ in 
short term 3-6 months courses to lure foreigners. This promotes Ayurveda but robs the medicinal 
aspect; this mix is further diluted with the perceptions of the western promoter and Pseudo 
Ayurveda…finally negative publicity for Original Ayurveda. It also very negatively impacts qualified 
Indian doctor’s chances in European nations, who have to compete with 3-6 month educated but 
5-7 years practiced local European quacks. This is the main reason Ayurveda is largely perceived as 
a lifestyle in the West and not a medical science and Industry struggles to cut ice with them trying 
to market ayurvedic medicine (Bhasin 2010).  
                                                 
446 His persistent campaigning with the State in Latvia that has led to an Indo-Latvian Health agreement on Ayurveda.  
Presentation by European Association of 
Ayurvedic professionals 
Arogya Conference Thrissur, 2009 
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 So far perhaps the only full-fledged and legitimate program in the western hemisphere is 
Ayurveda Point in Italy, a training institute founded in 2001. It was born from a joint venture between 
Dr. Antonio Morandi, an Italian ayurvedic scholar-cum-biomedical doctor and SNA Pharmaceuticals, a 
medium sized manufacturer group from an Ashtavaidyan family. SNA provides technical support to run 
a full-fledged Ayurvedic training for biomedical doctors in Italy and a 4 year course for therapists. The 
internship is done at their hospital in Kerala. The program is officially recognized in Italy, and 
biomedical doctors are allowed to practice other systems. During 2008-2009, there were a few other 
proposals of joint ventures of local entrepreneurs with various European countries.  However, 
expansion outside the country is slow, both due to 
regulatory barriers in other countries and the 
reluctance of traditional stakeholders to enter into 
grey areas or to bend to suit the regulations. There is 
increasing pressure on Ayush authorities to provide 
technical support in designing a curriculum and to 
evolve a certification procedure for professionals 
abroad. But there is much disagreement between 
various stakeholders as to the modus operandi. In the 
international delegates session at the World Ayurveda 
Conference in Bangalore in December 2010, this 
surfaced as a significant bone of contention between 
officials from the Ayush ministry and foreign delegates.  
Foreign professionals are irked at the 
insistence of Indian authorities that they meet the same requirements as Indian professionals. They 
find the Indian curriculum and evaluation system classics-heavy and exam-oriented. They expect the 
freedom to tailor the curriculum to suit local realities and needs. In Europe, the predominant approach 
appears to be to allow integration of Ayurveda with biomedicine, to let already qualified doctors to 
acquire knowledge in alternative medical systems. This is another area of difference that surfaces 
Presenting the European point of view  
International Delegate Assembly, World 
Ayurveda Congress, Bengaluru, 2010  
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between European and Indian practitioners. The former insist that unlike India their countries have no 
historically recognized status for Ayurveda; the best way to gain recognition in their biomedical 
dominant countries is to allow for integration. But at the same time there are other interest groups 
among them, like CAM professionals based in various alternative medical systems including European 
herbal systems, who are resentful of allopathic doctors monopolizing Ayurveda447. Used to the model of 
mixing and matching medical practices from across the world, they feel no need for 
compartmentalization and regulation.  
8.8 New modes of Commodification  
With the entry of new stakeholders and consumers, new formats of commodification emerged, 
of which three are salient. 
 A la carte Panchakarma: Disassociated from their clinical context, services have attained a 
commodity status of their own, and are being offered in attractive packages or as individual items 
that can be ordered off a therapy menu.  
 The emergence of Brand Kerala: A Kerala brand in Ayurveda has emerged and spread to rest of the 
country. It began with Kerala Panchakarma which continues to be the key attraction, but has 
expanded to become Kerala Ayurveda.   
 Expansion of the wellness segment: A new category of ayurvedic practice and consumption has 
emerged as the concept of wellness treatment has taken wings and spread from Kerala elite 
practice to tourism and further on to the domestic sphere. Wellness treatment hitherto affordable 
only to the elite have emerged as mass commodities accessible to all classes, tailored according to 
individual need and pocket size.  
  
                                                 
447 As learnt from an Italian CAM practitioner, a participant in Global Ayurveda Conference, December 2010, Bengaluru.  
 328 
 
8.8.1 A la carte Panchakarma 
When Brian inquired about treatments available at the Panchakarma center in Kumarakom, he 
was asked to look down at the print-out stuck under the glass table, a menu with nine treatments.   
General Body Massage 45 minutes ` 750 
Kerala Traditional Massage with herbal steam bath 60 minutes ` 850 
Special honey massage 60 minutes ` 1000 
Njavara kizhi 45 minutes ` 1450 
Shirodhara 60 minutes ` 1500 
Head Massage 25 minutes ` 450 
Elakizhi 40 minutes ` 800 
Face and head massage 30 minutes ` 550 
Herbal Steam bath 20 minutes ` 300 
He was also given a small brochure which described the Kerala special treatments illustrated 
with tiny pictures. He read that and looked at the menu, picked up three that seemed the most exotic 
of the lot, and bargained for a better price for a combo. Not much different from ordering a meal in a 
restaurant. Thick accented broken German-English and nasal accented broken Malayalee-English did 
not come in the way of a successful bargain. Such treatment menus have become a common sight in 
the new wellness centers. Brian was little aware of the storm that was brewing among the ayurvedic 
fraternity in Kerala over such gross misuse of an ancient and respected tradition. “Ayurveda is being 
misused for serving tourists” was a common refrain heard at every single occasion, conferences, 
practitioners and industry meetings. At the  Ayurveda Summit in Kochi in early 2010, many speakers 
expressed concern at the unhindered spread of Kerala massage across the country. The State tourism 
secretary said it is not only bad for Ayurveda, but also “for the image of Kerala”. Even those who 
participate in the tourist market have reservations. Marketing manager of a manufacturer who had a 
tourist-friendly treatment centre said, “Ayurveda was being misused by unscrupulous elements. It is 
getting a bad name for Ayurveda…I am afraid serious local consumers might move away from Ayurveda 
if this trend continues.” Though this seems farfetched, this sentiment is often expressed. Established 
Kerala stakeholders want to tread cautiously for fear of losing credibility in the eyes of the 
conservative Kerala consumer. But ironically many among the critics have also become direct and 
indirect, willing and reluctant stakeholders in the market. Dr. Abraham is a 65 year old doctor from a 
traditional vaidyan family, who runs his clinic-hospital in interior Kochi. A French tourist, dissatisfied 
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with the touristy outfits in the tourist areas, landed up in his place through some reference for 
‘authentic’ Panchakarma.  
She had come in search of authentic Ayurveda. She had done some reading and had her own 
notions. She wanted Panchakarma done. And my! you should have seen her bargaining. She said 
she will buy 5 treatment procedures if we offer a 6th free, not different from how we buy fish. 
Anyway, what did we have to lose, we threw in a Ayurveda facial treatment, and she was 
satisfied.  She stayed for a 21 day package, and Lord! her demands were so high - we have cooked 
every vegetable available in the region for her. She also had this notion that the same set of 
masseurs had to do the treatment. Ours is a small place, we don’t necessarily have regular 
people. When one has a health or personal problem, we have to find a replacement. But she would 
throw a tantrum if a different masseur turned up!  
The doctor is contemptuous of the tourist, but at the same time his joy at receiving an 
international guest is palpable. He can now boast that a westerner had come to his clinic in pursuit of 
authentic Ayurveda. Though he claims being averse to tourist commodification, his brochure provides a 
list of packages ranging from rejuvenation to obesity care. The brochure states that their nursing home 
is located “in a typical Kerala village on the banks of a paddy field and waterway.” His rural location 
instead of being a handicap, adds to the authenticity of not-being touristy. However, he squarely 
places the blame of the new avatar on his son, also an ayurvedic doctor, saying “the new generation 
does not want to lose opportunity in the name of principles”.  
Besides the menu mode, the other ubiquitous post-tourist development is the “package” 
model. An ayurvedic wellness or treatment course involves a combination of treatments, commonly 
referred to as ‘package’. Such packages are typically classified as rejuvenation packages, wellness 
packages and treatment packages. Average duration of a package ranges between 14-28 days. Of the 
disease treatment packages, the most common are aimed at arthritis and obesity (See Appendix I for  a 
sample wellness package). They are available at various price ranges.448For spas and resorts, Ayurveda 
is nothing but a commercially attractive venture. Even a traditional stakeholder like SD Pharmacy 
which offers consultancy for ayurvedic spas extols the commercial benefits of an ayurvedic spa as a 
business with, “low capital investment, low gestation period with excellent profitability from the very 
                                                 
448 A weekly package in Somatheeram in the peak season ranges from 1100 to 4000 Euros (at 160-570 Euros per day =` 10,000-
34000/ $200-680) for a basic room, going up to 2400 to 8000 Euros for a luxury room (at 340-1140 Euros per day= ` 20,000-
70,000/$400-1400). In the off-season the rates come down by 20%.  In Keraleeyam, (a resort run by a traditional mid-level 
manufacturer), the costs are moderate, 426-630 Euros (60-90 Euros a day= ` 3600-5400/$72-108) depending on type of package 
and nature of accommodation. Thanneermukkam, the Kerala State Tourist Department Resort offers 15 treatment packages for 
diseases ranging from migraine to Parkinson’s to psoriasis, diabetes to infertility. Accommodation here is relatively inexpensive 
25 to 50 dollars a day (` 2500-5000/$50-100 per day) including boarding, lodging and treatment excluding food. All prices 
mentioned refer to a period between 2008 and 2010.  
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1st or 2nd year of operation…very short off-season since Ayurvedic Rejuvenation Therapies can be 
conducted round the year”.  
Saroja, who works in Bombay visited her hometown in rural Thrissur two years ago, went to a 
local traditional hospital with regard to her arthritic problem. She was in for a shock when she was told 
that she would require a treatment package of 21 days at the cost of ` 35,000 ($700). “My family and 
relatives have been consulting the father of the current manager of the establishment since my 
childhood. So I’m not able to digest this development! Everything is sold in terms of packages, and that 
too for exorbitant costs! ” she exclaimed, rolling her eyes, evidently still not totally out of shock. 
Though the hospital is run by a vaidyan family establishment, the stewardship had passed on to a 
shrewd businessman-son who though not a doctor himself was adept at capitalizing on his father’s 
legacy. While offering treatments on a menu to be selected at will by the consumer can be considered 
a brazen flouting of ayurvedic principles, the same cannot be said of the package model.  Classical 
Ayurveda does not talk about disease or wellness packages like arthritis or anti-stress packages. But 
not all package selling is driven by commercial logic. It is possible for serious therapy-centric hospitals 
to prepare systematic protocols aiming at certain ailments, especially chronic ailments like arthritis, 
back pain, chronic fatigue and so on, that take time to heal. Ayurveda offers a perfect format for 
commodification – the minimum period stipulated is seven days that can be extended in multiples of 
seven. Treatment is begun at low intensity and gradually increased in strength, leveled, and then 
tapered down systematically. In fact, one of the members on a discussion forum pointed out that the 
minimum time is seven days, “if anyone offers shorter term than that, then he is a quack”.  
One test to see if commercial logic dictates supersedes treatment logic is to gauge the 
approach. Serious therapy places rarely suggest long-term protocols without gauging the patient’s 
response to initial steps of treatment.  Vaidyamadham Vaidyasala gives an advance warning in their 
brochure, that no inpatient would be admitted in summer, a season inappropriate for ayurvedic 
treatments, and further sternly states that “no patient will be admitted immediately after the first 
consultation even if accommodation is available. The patient is first required to start treatment as an 
outpatient and the admission will be considered only after a month’s treatment based on the 
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feedback.”449  
It would be erroneous to heap all credit for the proliferation of the package model on tourist 
demand. An equally significant contribution comes from shift in demand in the therapy segment, from 
outpatient to inpatient treatment. With women going out to work and joint families disintegrating, 
home based services are no more available. Given the paucity of labor supply in Kerala, it has become 
near to impossible to get paid assistance at home. A case in point is the emerging market of 
professional post-natal service for mothers. Traditional service-providers were women from two 
communities (Vannan and Velan). Given their scarcity today (see section 5.8), new business models 
have emerged. Initial service-providers were professional temping services which specialize in 
providing home nurses for geriatric care. In the past decade, ayurvedic service providers have begun to 
offer post-delivery packages. In mid 2011, an Ayurveda wellness hospital in Trivandrum went a step 
ahead offering a 14 day package ‘delivered at home.’  
Commodification of biomedicine has already made people suspicious of doctors and hospitals. 
It is common to find Malayalees refusing to go to hospitals worried they would be forced to undergo 
unnecessary and expensive testing or surgical procedures. Now there is a fear that Ayurveda is going 
the same way. Unlike allopathic treatments that to a certain extent are verifiable, Ayurveda, with its 
subjective parameters and individualized therapies has more vagueness at its disposal. The package 
model allows far greater opportunity for reinventions and diversions than pharmaceuticals. A cursory 
survey of treatments offered shows that hospitals and resorts have graduated from simple therapy or 
rejuvenation packages to conjuring up new categories straying away far beyond conventional 
boundaries. For instance, one new generation hospital announces “memory fitness package” with a 
catchy slogan, “update your memory without chips”!    
                                                 
449 Vaidyamadham, e-brochure, http://vaidyamadham.com/html/0700fram.htm 
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8.8.2 Emergence of Brand Kerala in Ayurveda and Panchakarma  
As people from various parts of India visiting Kerala450 got introduced to massages or 
treatment, brand Kerala Ayurveda emerged and spread like wildfire across the country. So when in mid 
2005, Mr. Ramesh Vangal, a  US based businessman of Indian origin,  the owner of Katra Health Care 
acquired majority stakes in Kerala Ayurvedic Pharmacy Limited, he renamed it Kerala Ayurveda 
Limited. He rebranded the products that was earlier known by the acronym KAPL, as “Kerala 
Ayurveda”. In a recent founder’s day ceremony, he points 
out, “we have got to revamp, you see the branding is 
completely different. We are delighted that we actually 
have the name Kerala associated with our brand name 
because we would like to be your representative in terms of 
Kerala and Ayurveda”. An ex-President of Pepsico Asia-
Pacific, he talked about his role in popularizing Pepsi in the 
country in the same breath as he talked about popularizing 
ayurveda. “In the last two and a half years I have been involved in Kerala  Ayurveda. We have now got 
a US presence, five clinics doing well. We have four academies in the US. (Vangal 2009:6)”  
The initial spread was in tourist spaces, but it did not take much time to get mainstreamed. 
Ayurvedic doctors in large cities began to add Kerala Ayurveda, especially Kerala Panchakarma to their 
clinics, either by hiring people from Kerala, or by getting themselves trained in Kerala or just as a mere 
branding strategy. The initial spread was to the middle and upper middle classes in big cities, but from 
there the trend spread to small cities and towns451.  It was easy for ayurvedic doctors to  value add to 
their practice by incorporating these therapies, all they needed was an additional room for treatment 
and some low-cost equipment like a massage table. Take for example, Dr. Mahesh Gupta, an ayurvedic 
doctor who has set up a clinic called  Keraliya Ayurvedic Spa and Panchakarma Center in Udaipur, a 
important tourist town in Rajasthan. He and his five other associates all ayurvedic doctors who have 
                                                 
450 Domestic tourist to foreign tourist ration stands at 12: 1 
451The following account is based on a fortnight’s stay and speaking to friends and acquaintances in Pune, Bangalore and Bombay, 
and from chats with doctors and students at three national level conferences and workshops.   
 
Rebranded ‘Kerala Ayurveda’ products 
of KAL 
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founded the establishment were early birds to catch on local demand that had picked up in the late 
90s. Denouncing the trend of unqualified people running massage centers that he said was creating 
badnam (infamy, in Hindi) to Ayurveda, he claimed that theirs was the only second authentic Keraleeya 
center in the region. The first one was a center run by Keralites, which he said mainly focused on 
providing services to people from Kerala452. Dr. Gupta was not using the Kerala brand in vein; he had 
undergone training in four different places, all traditional places of excellence453. He enthusiastically 
reeled out names of medicines and treatments in Malayalam, a substantial accomplishment for a Hindi 
speaker. He now offers a two month certificate course for therapists, which also helps to meet their 
inhouse personnel requirements. I asked him if the Kerala name was just hype, after all Panchakarma 
was also part of classical Ayurveda. He emphatically countered, “No, no, it is indeed very effective for 
treatment and rejuvenation.” Though located in a tourist town, his focus is on treating locals. There is 
much demand, especially from arthritis patients. 
Foreigners fundamentally come for relaxation, not for treatment. But local people are interested 
in treatment mainly for chronic diseases. There is enormous demand for Panchakarma. We have a 
range of prices, from ` 200-300 ($4-5) to ` 1000 ($20) per session depending on the level of 
income. I specialize in sciatica. I have great success in treating insomnia and depression combining 
Shirodhara, aromatherapy and reflexology. I can cure insomnia in two days without medicine.  
Since the main revenue earner for therapy is service, which is mediated through the 
practitioner, low margin classical products make more economic sense than proprietary medicines. Dr. 
Gupta listed three Kerala brands in terms of popularity – AVS, AVP and Nagarjuna, three of the top five 
manufacturers in Kerala. This shows a new trend, the circulation of conventional classical ayurvedic 
commodities through unconventional channels built on a service-centric model inspired by tourist 
Ayurveda.  
Even in the city of Pune,  one of the four pockets of classical Ayurveda454, Kerala Ayurveda has 
taken firm roots. According to Neha, an IT professional, it has become fashionable for middle class 
people to go for wellness treatments that ranged anywhere from an hour’s beauty treatments to a 
fortnight’s anti-stress treatment. Unlike tourists, locals have the advantage of availing treatment 
                                                 
452 Before tourism made Kerala Ayuveda popular, there were clinics and agencies of Kerala manufacturers in large cities that 
aimed at catering to the Kerala Diaspora. Non-Keralites rarely visited such centers.    
453 Vaidyamadham, Keraliya Ayurveda Samajam, Arya Vaidya Sala and Indian Institute of Panchakarma.  
454Mr. Ranjit Puranik, General Secretary of Ayurvedic Drug Manufacturers Association (2002-2010), identified four regions as being 
rooted in classical culture besides Kerala, i.e., Pune and the Nasik belt in Maharashtra, Varanasi in Uttar Pradesh, Surat-Baroda 
belt in Gujarat, and South Kanara in Karnataka.  
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sessions; they could tailor it to suit their works schedules and they did not have to worry about 
boarding cost. She says, “take a look at the weekly Sunday supplement of Sacral  (A Marathi  daily). 
You will see that it is full of Kerala Ayurveda advertisements”. A traditional Ayurveda  user, she was 
skeptical of the new developments “aimed at taking advantage of gullible customers”.   
Ayurvedic wellness services have also become popular in the IT capital Bangalore. Shailah, an 
IT professional in her early 40s, a native of Andhra Pradesh, tried ayurvedic massage at a high-end 
ayurvedic resort in Kerala during a summer vacation. She found it so rejuvenative that she identified a 
place offering Kerala treatments in Bangalore and enrolled into a fortnight’s program during Christmas 
vacations. Vineet, a business professional in Bangalore in his mid 30s was troubled by a chronic lower 
back pain. He went to the branded Ayush Therapy Center attracted by their advertisement on a bus 
shelter painted all over with attractive images of Panchakarma. The treatment eased his troubles 
considerably. He was advised to use two classical ayurvedic medicinal oils that he now continues to use 
at home. Note here the expansion of the catchment of classical products to include non-traditional 
users. Chandrashekhar, a retired school teacher in a rural town in Southern Karnataka bordering 
Kerala, had recovered from a trans-ischemic attack five years ago. But he had persisting numbness in 
an arm for which he decided to try out services offered by a local Ayurveda hospital. The masseur who 
did the massage was traditionally skilled as part of his garadi (local gymnastic tradition)455. He skillfully 
manipulated the afflicted nerve and in three sessions, the pain disappeared. The ayurvedic hospital he 
visited grew out of a clinic started around 15 years ago. The Panchakarma unit was added only a 
decade ago, just when its fame had begun to diffuse across the border.  
Developments like this are not limited to the neighborhood of Kerala. Dr. Rajkumar, an 
ayurvedic practitioner hailing from Uttar Pradesh runs an eco-shop offering Ayurveda treatment to 
customers in Wardha, a small nondescript town in Northern Maharashtra, known for its historical 
association with Gandhi. Since 2005, he has a new sign on his board, “Kerala style massage treatment 
offered.” The demand for his services is so high that he struggles to find an empty slot for an interview 
                                                 
455In this region, such massages were done by traditional vaidyans or masseur-experts to treat sprains and fractures and even 
paralysis. A neighbor of his who was bed-ridden with post-stroke paralysis had recovered after such treatment.   
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appointment.456 Curious to explore Kerala style massage and Panchakarma, he took a year’s training 
from Sahyadri. He reeled out a few Malayalam words with great enthusiasm. “I can even sing a song in 
Malayalam”, he sang a Christian devotional song which he learnt visiting a classmate’s house.  
Even State governments have succumbed to the Panchakarma hype. In 2002, Tourism 
Department of Andhra Pradesh State entered into a joint venture with Santigiri to set up 15 Health 
Centers in the state. In September 2009, Himachal Pradesh government announced its plan to 
implement to implement Panchakarma treatment in 20 hospitals. The Health minister, an ayurvedic 
doctor himself, announced “Himachal will study and learn the functioning of Panchakarma centers in 
Kerala and will start it in 20 hospitals of the State with active participation of State Tourism 
Department. Moreover, implementation of this system will go a long way to attract tourists”.  
8.8.3 The emergence of a domestic wellness segment 
The most spectacular of all the impacts of tourist interest, less visible and underrated compared to the 
global expansion, is the emergence of a domestic wellness segment.  Ayurvedic stakeholders of various 
hues have developed strategies to tap this market. In fact, by participating in this new business, a 
large number of ayurvedic professionals have become stakeholders in the very process that they are 
critics of. Most important in the initial phase of expansion are large non-ayurvedic business groups.  
They rushed in to capture the wellness market unhindered by the conservative ethos of ayurvedic 
stakeholders that limited their expansion to therapy-centric hospitals. Over time, some traditional 
groups began to expand into the market of wellness, either through joint ventures or networks of 
wellness clinics.  The most important of these are: Lever Ayush Therapy Center with 43 centers, Birla 
Kerala Vaidya Shala (BKV) with 27 centers and Kerala Ayurveda with 11 centers. All of these are new 
generation enterprises,  either joint ventures with or acquisitions of traditional stakeholders. The first 
is a joint venture between a large Kerala-origin ayurvedic manufacturer and a multinational company 
firm. The second is run by one of the largest business conglomerates of India that acquired an 
ayurvedic company from Kerala, and the third is run by a Kerala origin ayurvedic manufacturer 
                                                 
456 The only slot available was 6.30 a.m. a week later on a Sunday. Majority of his clientele were elderly people suffering from 
arthritis, back pains and joint pains. His charges were nominal, a mere ` 150 ($3) per session. He restricted his services to 
massage treatments, uncertain of getting sufficient clientele to recoup his investment for upgrading his facilities. 
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acquired by an US based health care group (for details, see Section 8.5).  
Besides those specifically branded as wellness centers, it 
has become now fashionable for regular hospitals of all 
sizes and hues to offer wellness treatments. As mentioned 
earlier, the market for disease treatment is far restricted 
compared to that of health maintenance or enhancement. 
Both the post-tourist modes of commodification and the 
changing health requirements of patients are providing 
new ideas for entrepreneurs to expand the market for Ayurveda. In a discussion session in the Global 
Ayurveda Festival in Trivandrum (February, 2012), Dr. Ramesh Varier, owner MD of AVN, an ayurvedic 
doctor himself, responding to a speaker’s complaint of underpaid doctors said it was not the State’s, 
but the  ayurvedic physicians’ responsibility “to create demand” for their services. He first stated that 
Ayurveda’s two main objectives were primarily to: 1. maintain health and prevent disease, and 2. To 
treat disease. And then he rhetorically asked his colleagues in the audience “are we observing the first 
objective as ayurvedic physicians?” Answering himself with an emphatic “No!” he added, “the general 
notion amongst the public is that when I am sick then only I approach the doctor”. He said that it is 
important that doctors create awareness among the public about Ayurveda’s health maintenance 
objective, “If you can create that, even healthy people will walk into your clinic, not necessarily only 
sick people”. He narrates his own efforts in the direction. Patients visiting his clinic are routinely 
subjected to prakriti (constitutional) analysis and are provided with ‘scientific data’ recommending 
further investigations. They are also provided with dinacharya (daily regime) and ritucharya (seasonal 
regime) recommendations. Taking into account the ayurvedic concept of decadal decline in the status 
of health, he also initiated age-specific Rasayana (rejuvenative tonic) recommendations. As a member 
of CCIM, he had noticed the absence of patients in ayurvedic college hospitals across the country, 
outside Kerala. He has conscientized other CCIM members to take initiatives to popularize Ayurveda 
among the public. He mentioned a recent initiative in which an ayurvedic college in Bangalore to 
organize ‘swarnaprashana’ a program to build immunity for children that had 200,000 subscribers.  
 
Ayush-Lever Wellness Center, Fort Kochi 
 337 
 
8.8.4 Expansion of the Service Market in Kerala 
There has been an unprecedented expansion in the ayurvedic therapy segment in Kerala in the 
past two decades, some of which is the expansion of the conventional hospital segment. Ayurvedic 
hospitals had begun to come up in the early 70s and had attained a significant growth momentum by 
the 80s in response to increased urbanization. As joint families broke down, people could no more rely 
on home based services for treatment management. Both public and private sectors have grown to 
respond to this requirement. Today the government infrastructure for Ayurveda consists of  871 
institutions (124 hospitals, 747 dispensaries) with 4020 beds and 160 NRHM (National Rural Health 
Mission) dispensaries. Ayurveda has 2/3rd the number of allopathic institutions but less than 1/10th in 
terms of number of beds. It treats 2.2 mn outpatients a year, a little less than half that of allopathic 
system, but the inpatient number is negligible (See Appendix J.1).  
The number of private ayurvedic hospitals as of 
March 2004, was 4332, with a bed size of 5502. 
The private system employed 6000 doctors and 
treated 9.5 mn outpatients and. 0.2 mn 
inpatients457, four times that of the public system 
(Department of Economics and Statistics 2004) 
(See Appendix J.2).  
Two trends can be noted in the 
expansion of  private sector Ayurveda in Kerala: traditional and non-traditional though these are not 
mutually exclusive categories458. Traditional stakeholders tend to expand linearly, increasing in size 
and reach while continuing with their focus on treatment. Almost every ayurvedic manufacturer who 
had a hospital has scaled up by adding rooms and by expanding into branches. Change in this segment 
is mainly restricted to improved facilities. For some, it means nothing more than adding a few luxury 
air-conditioned suites to their otherwise Spartan establishments.  
                                                 
457 4825 allopathic institutions employed 15,000 doctors, treated 39.3 million outpatients and 4 million inpatients. 
458 Based on practitioners’, hospital owners’ narratives and secondary data from press releases, brochures, advertisements. 
 
100-bedded district government hospital, 
Thodupuzha 
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Some go a step ahead with establishing new swanky 
hospitals to cater to ‘modern’ clientele. While some 
of this growth might be a natural response to 
urbanization, it is likely that some has been caused 
by the growth spurt in the service market post-tourist 
commodification. The largest of the hospital 
establishments in this category belong to top 
ayurvedic manufacturers459. The proportions of 
foreigners treated in these hospitals is substantial: 
30% in AVS, 24% in AVP and 30% in Vaidyaratnam. 
Medium scale manufacturers have also expanded their hospitals460. Another set of traditional 
stakeholders are treatment-focused groups, who have also seen considerable expansion461. Groups that 
have started private medical colleges post liberalization, beginning early and mid 2000s are other large 
scale contributors to the expansion462.  
Non-traditional stakeholders who have entered the market on the other hand tend to be 
heavily influenced by the new era of commodification.  This category includes a variety of 
stakeholders, old and new, big and small, ranging from ayurvedic doctor-entrepreneurs to hereditary 
practitioner families, from non-ayurvedic businessmen to biomedical hospitals. Most visible are large 
luxury hospitals aimed at the upper crust of the society, to NRIs and foreigners463. These hospitals are 
distinguishable from the traditional in that they appear somewhat touristy in their approach. They 
advertize heavily in print media with emphasis on treatment and wellness packages.  
                                                 
459 Arya Vaidya Sala’s (AVS) which started with a small hospital in 1954 has now grown to 160 beds. In the past decade it opened 
branches in two other cities in Kerala, one of them 80-bedded and a 35 bed hospital in Delhi. Arya Vaidya Pharmacy which 
started as a small  hospital in 1957 has grown to 120 bedded hospital. Vaidyaratnam, one of the earliest to start  a hospital (in 
1910) now has a 150 bed medical college hospital. They opened a ‘modern’ 53 bed hospital in 2001 to specifically target IT 
professionals. In 2007, they went a step ahead and opened a branch in the IT city, Bangalore.  
460State-owned Oushadi ventured into treatment for the first time with a 30 bed Panchakarma center in 2004. Dhanwantari 
(estb.1933) has over the last decade established seven hospitals, the largest one being 20 bedded. 
461 For example, Pam Labs has grown from 4 bed in 1954 to 100 beds, Nangelil Hospital from 10 beds in 1980s to 100. Kerala 
Ayurveda Samajam has grown into a 100 bedded hospital and 7 branches with 15-60 beds each.  
462 The largest of these, Santigiri, has a 150 bed hospital (in addition to another 100 bed hospital in Palakkad), and the other four 
have around 100 each, that are attached to the Ayurvedic medical colleges.  
463 Some examples are Sreedhariyam eye hospital which grew from an 8 to 260 bedded hospital and 8 branches across India in 6 
years (estb. 2004) established by a eye specialist practitioner family. Punarnava (1993 estb.) with 175 beds in three hospitals in 
and around Kochi established by a team of Ayurvedic doctors. It also runs tertiary care in Ayurveda for a large private biomedical 
hospital. Ahaliya and MAHAR both with 100 beds each were founded in the early 2000s.   
 
Giant hoarding of Krishnendu Ayurvedic 
Hospital on NH 47, Kayankulam 
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Certain new formats have developed in the service market, the most notable being 
clinic/hospital franchisees and high-profile hospital chains. These categories are exploited by both 
traditional and non-traditional stakeholders. For example, treatment brands floated by two 
manufacturers, Soukhya of Kandamkulathy Vaidyasala and Jeevanam of Pankajakasthuri are promoted 
through weekly consultation sessions on Malayalam TV channels. Though the format is new, they are 
simply extensions of the existing agency model. On the other hand, the kind of franchisee the Earth 
Group of hospitals has initiated is certainly a departure from the norm, in terms of being blatantly 
market-focused rather than therapy-focused.  Dhatri, a new generation cosmetic-focused manufacturer 
from Kerala has announced a chain ABS (Ayurveda, Beauty and Slimming) clinics in 2009. Beginning with 
three, the company announced its intention to expand to 200 clinics by 2015.  
As for high-profile hospital chains, the most notable is AyurVAID which made news in early 2008 
when it got venture funding from a US philanthropic organization for its proposed hospital chain. It 
claims to be “a pioneer in rigorous process and documentation driven classical Kerala Ayurveda 
treatment services that has been appropriately and seamlessly integrated with modern medicine”. 
Their ambition is to create 40 hospitals in this model. It is headquartered in the IT up-market region of 
Bangalore. In 3 years, AyurVAID has grown to 6 hospitals with a collective bed size of 160. Mr. Rajiv 
Vasudevan, the founder-CEO claims that the intention is to judiciously blend profit and non-profit 
ideals; differential branding is done catering to different segments of the economy464.  
Another important development is the expansion of Ayurveda into biomedical spaces, certainly 
an unusual ‘diversion’ from its regular path. Almost every large allopathic hospital in Kerala has opened 
an Ayurveda wing. Some notable examples are Amala cancer hospital, Karithas, Matha and KIMS. 
According to a survey, 105 institutions have both allopathy and Ayurveda (Department of Economics 
and Statistics 2004)465 The biomedical sector’s new found fascination for Ayurveda is also visible in the 
national level. Apollo group of hospitals, one of the largest and the most elite in the national 
                                                 
464 Four AyurVAID hospitals are targeted at the upper crust; two are called AyurSEVA hospitals targeted at the lower economic 
strata, one of which is located in Dharavi, Mumbai, Asia’s largest slum. (Source: personal interview 2010) 
465There are 47 hospitals with homeopathy and Ayurveda, 18 with all 3 three systems and another 11 with Ayurveda and other 
combinations. Ayurvedic hospitals opening allopathic wing is rare, one example is PAM labs, Ernakulam.  
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biomedical sector recently attempted to forge ties with AVS that did not work out466. A few ayurvedic 
practitioners who had colleagues working in allopathic hospitals were critical about the trend. Firstly, 
they said it was plainly oriented to profiteering. One of them pointed out, “the hospitals wanted to 
make sure no patient would escape their clutches”. Secondly, their value system and expertise were 
not suitable to Ayurveda and is likely to lead to compromising ayurvedic principles. Thirdly, they 
pointed out that there was no communication between the two medical systems; ayurvedic doctors had 
a subordinate status and were expected to do nothing else than take care of patients sent to them by 
the allopathic section.  
8.9 Going to the roots of wellness commodification 
When Pune resident Neha says that “all these massage parlors in the name of Ayurveda are 
fooling people”, she is representing a popular perception of ayurvedic massage as nothing but a 
corruption of Ayurveda. This perception results partly from the way the services are peddled, and 
partly from her unfamiliarity with the non-medicinal facets of Ayurveda. Few outside Kerala are aware 
how rooted the wellness treatment has been in classical ayurvedic practice in Kerala. In the absence of 
this knowledge, ayurvedic massage gets interpreted as a tourism-generated distortion. As mentioned 
earlier, Ayurveda aims at enhancing health and longevity than purely address disease treatment. 
Seasonal diet regimens, routine cleansing, massage and wellness treatment were part of preventive, 
palliative, and rejuvenative practices. In fact rejuvenation is one of the eight branches of Ayurveda. 
Panchakarma (cleansing therapy) is a process that is not only part of disease treatment, but also part 
of rejuvenation and seasonal wellness treatments. The classics recommend annual wellness treatment 
but do not prescribe a season. In Kerala, Karkidakam month in the peak monsoon season (July 15 to 
August 15) is considered the most ideal for Sukha Chikitsa (i.e., wellness treatment). 
                                                 
466 Though the reasons are not known, it would have been surprising if it had worked out. Apollo is a giant business conglomerate, 
one of the first to get into high-cost hospital chains for the elite. AVS is a therapy focused non-profit trust.  
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Classical Ayurveda was historically considered a 
luxury commodity. In fact, the classic compendium 
Charaka  Samhita has been criticized for being elitist. It 
expects ‘affordability’ is one of the criteria expected 
from an ideal patient. Though there are guidelines on 
how to manage treatment for the poor, much of the 
focus on daily regiment and life style, and prescription 
for cleansing and rejuvenation seemed to have been 
tailored to meet the requirements of an elite leisure 
class. Charaka Samhita, with a touch of humor states that “the original patrons (for rejuvenation) were 
none other than holy  men who had left their Spartan life in the Himalayas for a life of ease and plenty 
in the plains only to become obese, inactive and infirm. Thereafter, they hastened back to the 
Himalayas and received the formulas for rejuvenation from (Lord) Indra” (Valiathan 2003: lxviii).  
But why did Panchakarma acquire special significance in Kerala? This is a difficult question to 
answer, as the variables involved are many and spread over centuries of multi-dimensional history. 
Ayurvedic practitioners and history scholars attribute the continuity and popularity of the therapies to 
two disparate cultural art forms, one of war and one of entertainment; Kalari, the martial arts and 
Kathakkali, the dance-art form. Both demanded flexibility of limbs and suppleness of the body.467 The 
dance movements of Kathakkali that took shape during 17th century is said to be heavily influenced by 
Kalari. The story of origins of Kalari go far back into medieval history of a prolonged state of war that 
led to compulsory military training, the proliferation of gymnasia and suicide squads468. The injuries 
they sustained during training and war made them experts in this science, and in the knowledge of 
anatomy, making them expert orthopedics. Many also achieved expertise in Marma, a branch of 
                                                 
467 In modern Kerala, Kathakkali is a marginalized art form. On the other hand, Malayalam movie celebrities, the modern 
counterparts of Kathakkali artists are one of the most important consumers of wellness treatment today. In early 2010 
newspapers were abuzz with the news of Mohanlal (one of the top two male superstars in Malayalam) undergoing Sukha Chikitsa. 
In an interview the star said, “Don’t we give our car for service once in a while? This is just like that. The body also needs 
servicing. In my case, I have been doing it annually for the past 23 years (14 day treatment)” (Mathrubhumi, 2010).   
468 During much of the period in ancient and medieval times, Kerala was ruled by the Chera kingdom. A constant threat to this 
empire was from the neighboring Chola kingdom of Tamil Nadu. In the 11th century, a prolonged war dragged on between these 
two kingdoms creating a somewhat Sparta-like military requirement in Kerala. Compulsory military training was introduced. 
Salais (schools) were converted to Kalaris (gymnasia). Namboothiri Brahmins transferred their attention from temples and 
priestly duties to these institutions. The institution of Chavers (suicide squads) also arose during the same time (Menon 1967). 
 
Elephants undergoing Karkidakam season 
wellness treatment: Guruvayoor Temple, 
August, 2009 
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Ayurveda/Siddha that dealt with pressure points. Panchakarma was still the realm of the vaidyan, but 
the widespread presence of Kalari trained people made the skills and human resource readily available 
for preparatory procedures. The preparatory procedures that were part of ayurvedic treatment were 
accessible to all classes, but full-fledged wellness therapies were by and large affordable only to the 
elite. Joseph Vaidyan, an elderly vaidyan from a third generation Vaidyan family in an interior town in 
Kottayam, enjoys responding to questions that bring back old memories.   
In my childhood, about five decades ago, Sukha Chikitsa was essentially a luxury commodity that 
only the elite could afford. The elites, mostly rich land owners and merchant class, owned the 
basic infrastructure for wellness treatment, i.e., mainly a Droni (massage table with grooves for 
collecting oil), related accessories and space for treatment. They could afford the services of a 
vaidyan and masseurs. Such people got their treatment done annually in Karkidakam for 7-28 days. 
People from the less privileged class would borrow this equipment during off seasons.  
However, not all wellness treatment was limited to elite consumption. Until recently, the 
procedures were either done at the patient’s house or in the vaidyan’s house depending on the 
patient’s class, affordability and complexity of the required procedure. Joseph vaidyan said that it was 
also common for laborers to undergo massage sessions following back-breaking work, to revive their 
sore muscles. There was no dearth for masseur service providers, either Kalari trained people or 
ayurvedic doctor’s assistants. Procedures and material could also be tailored according to affordability, 
a reason for their widespread use and continued survival. In a village in interior Kottayam, Mukundan, 
a 56 year old farmer, recollects his days of youth (that is, mid 60s), “Gurukkal (respectable term for a 
Kalari practitioner) was very popular. It was common to hear this statement among average middle-
income farmers planning to go for a massage to Gurukkal, “Oru mai vazahakam kittattenne” (let the 
body get some flexibility).  
Growth in hospitals with in-patient facilities spiraled in the 70s during which period a few 
located in large cities recognized the needs of an expanding upper middle class469. Annamma, a 
housewife aged 65 in interior Kottayam, was introduced to wellness treatment by her uncle, a 
prominent businessman, in the early 80s. Since then every year she has been undergoing wellness 
treatment in an ayurvedic hospital in Kottayam. The hospital, one of the pioneers in the wellness 
market, was named Sukhodaya (‘the rise of wellness'). Quick to recognize a new  niche in the late 70s, 
                                                 
469 Mainly rubber/spice estate owners, businessmen, families rich with remittances from gulf, and so on. 
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predating tourist commodification, it began to advertize wellness treatments targeting the upper 
middle class. Annamma was known to constantly urging her friends and relatives to try it out. 
According to her cousin, it was her strategy to remind others of her position of wealth. Not many were 
able to afford the treatment then; cost of a session used to be around ` 4000 ($80). Annamma’s 
nephew, Tony, a 45 year old small factory owner talks about his treatment experience for the last 20 
years. Since his business began looking up five years ago, he has been getting annual wellness 
treatment in a mid-range hospital. Until then, he used to go to the local branch of the reputed CVN 
Kalari for an occasional massage, which he says “can make your body twist and turn a few degrees 
more than normal!” Now wellness treatment is no more a luxury, “So many smaller centers have 
opened. Even workers at my factory are able to afford Sukha Chikitsa in the Karkidakam season.” It 
was this commodification that enabled Suresh, a Keralite scientist in Bombay to undergo a full-fledged 
ayurvedic massage regime locally. In the past forty years, he had been a regular buyer of medicines 
from Kerala ayurvedic agencies. It was only in the past decade that they had expanded to include 
wellness therapies, something he had never dreamt of being able to access without going to Kerala.  
The clientele that Charaka Samhita had in mind when the procedures were formulated had not 
changed, except that the target population he had in mind is no more a minority. The service class had 
expanded creating millions of people with problems similar to the Himalaya-returned yogis – sedentary 
life, irregular diet, over indulgence and stress. They have some additional problems now. They live in 
urban concrete jungles away from nature, buy food from supermarkets and have lost touch with the 
Indian way of life, food and philosophy. They are ready to pay sky-high prices for a few square feet of 
green space away from urban noise and pollution. They are ready to shell out hard earned money for 
the quintessential Indian grandmother’s cuisine repackaged as ayurvedic food, and to squat in front of 
the television to learn yoga. Caught between wayward schedules, they feel the need of an expert to 
dictate them Dinacharya (daily regime) and Ritucharya (seasonal regime). In a nutshell, they are ready 
to pay through their noses for being educated in the basics of right living written two millennia ago – 
how  to eat, how to think and how to behave right to maintain health, avoid illness and enhance 
longevity. 
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8.10 Discussion  
There are several reasons for the growth of the therapy market, the most important being 
growing internal demand by an increasingly aging population, increased demand for inpatient 
treatment, increased affordability of an expanded middle class and demands from an affluent diaspora. 
The tourist market must have significantly contributed by providing a model for commercialization to 
tap an already existing market both by popularizing wellness services and creating a hype that allowed 
new capital to flow into the service segment. Ayurveda otherwise always depended on traditional 
stakeholders who, in market parlance, were ‘limited’ by their therapy and non-profit orientation. An 
upcoming hospital franchisee service provider addressing a gathering of fresh Ayurveda graduates, “you 
need to move away from the preconception that Ayurveda is not profitable.”  The financial consultant 
hired by the group educated them on making an ayurvedic hospital a profitable venture, the success 
which would depend on “how many consultations you are able to convert into treatment”. Though 
profit-mindset is often interpreted as a distortion, some new generation doctors question why Ayurveda 
alone has to be bound by the service mindset. They point out that in a money-driven economy, it is the 
non-profitability of Ayurveda that draws talent away from the field vis-à-vis the profitability of 
allopathy. In their view, flow of capital carries more meaning than just monetary value; it raises the 
prestige of Ayurveda in the public’s eyes.  
I argue that of the greatest concern from the perspective of ayurveda’s affordability to the 
masses, are not visible diversions like the proliferation of dubious massage parlors but the unnoticed 
overselling of services to unsuspecting patients that occurs in conventional spaces frequented by 
middle and lower income groups. In the biomedical market, vagueness of diagnosis and treatment has 
been used to push therapeutic interventions like surgery. Ayurveda provides an array of concepts 
conducive for commodifying forces to exploit most important of which are:  
 Individualization, a primary feature and strength of the ayurvedic approach to diagnosis and 
treatment provides immense scope for convenient re-interpretation.  
 The broad compass of Ayurveda that includes diet, lifestyle modification and cleansing makes it 
easy to build in several elements into packages. For example, it is common to find 
commonplace Indian food being marketed as premium ayurvedic diet.  
 Preventive and wellness treatments have infinite potential for commodification because the 
hospital is no more limited by the relatively narrow context of disease and illness.  
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I came across first hand, one such instance of therapy-pushing, a doctor strongly recommending 
a Udvartana (reverse-massage) package to a lady who wanted a solution for obesity without making any 
mention of diet or life style modification470. I heard a similar story from a respondent, an educated 
young woman who went with a complaint of obesity to a medium range ayurvedic hospital in 
Thrissur.471 An ayurvedic college lecturer in Kerala who studied in a capitation institution in Karnataka 
said she quit her job from a hospital in Bangalore after a few months because of pressure from the 
establishment to prescribe expensive therapies to patients.  
Interestingly, while there is much talk about other distortions, there is silence on this subject, 
perhaps because every stakeholder in Ayurveda benefits from service commodification. The only person 
who has been vocal on this issue, is Late Dr. Raghavan Thirumulpad, one of the most admired 
contemporary ayurvedic scholar-practitioners in Kerala, who died recently, at the age of 90. An icon of 
tradition and austerity, Dr. Thirumulpad in his late 80s was objective and level headed; he was open to 
modernization and was sympathetic to the pressures of business. Given such credentials, I consider his 
views on the subject worth close attention. He acknowledges legitimate uses of Panchakarma for 
cleansing and rejuvenation, but warns that it can be counterproductive when unnecessarily done.   
There is plenty of media publicity which claims that Panchakarma as the apex of ayurvedic 
treatment, which have also served to attract people’s attention. Leading hospitals like Arya 
Vaidya Sala and Vaidyaratnam, have become models in this approach. We cannot ignore the 
economic advantage that accrues to Ayurveda system as a industry and business by way of such 
activities. This is the time when wealth is considered the standard of success in any front. There is 
no point in insisting that Ayurveda alone should remain aloof from this trend. As much as in profit, 
one should also put effort in service is all we can suggest...But Panchakarma is being done in 
situations where cleansing wouldn’t have been necessary, could have been treated by medicine 
alone (Thirumulpad 2002: 305-306).   
Supporting Dr. Thirumulpad’s argument that treatment in Kerala was Shamana Pradhanam 
(pacification-centric), Murali (2009) points out that Ayurveda identifies three stages of disease in terms 
of gravity (mild, moderate and severe), and Shodhana Chikitsa (cleansing) should be done only to 
address serious cases. Mild and moderate conditions should be handled with medicine, diet or life style 
modification. He points out two problems with the cleansing method: firstly, it is expensive, and 
                                                 
470 Reluctant to do the procedure, the lady sheepishly said she expected some decoction to take care of her problem. The doctor 
conceded and almost wrote the prescription, but he managed to sweet talk her into trying the package. 
471She was subjected to the same procedure package – the hospital did not take into consideration that her problem was 
hormonal and had to be dealt with systemically. Her experience was particularly bad, as she ended up having skin abrasions. 
Reverse-massaging is done with medicinal powder and is expected to be done by skilled therapists.  
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secondly, it is harsh on the patient and should be therefore avoided when unnecessary. Thirumulpad’s 
biggest worry was with regard to ayurveda’s affordability to the masses.  
All this is possible for only who have extraordinary wealth. Charaka mentions this. The chapter 
called Upakalpaneeya in Vimana Sthanam where he talks about Shodhana Chikitsa (cleansing) he 
says, “only kings or people like kings or people with extraordinary wealth can afford this kind of 
treatment. But even poor people also afflicted by grave diseases”……If you can consider treatment 
equivalent to food and cloth and are able to meet the basic requirement, it can be simplified such 
that it becomes affordable to anybody. The large institutions that are motivated by money, will 
not be able to pay much attention to this issue. Despite that, I feel, this issue needs to be 
deliberated on (Thirumulpad 2002: 305-306). 
Unlike a segment of traditional stakeholders who are conservative and opposed to change, at 
the age of 86 he wrote, acknowledging the need for change and also the constraints of today’s 
practitioners,  
Ayurveda will continue to change. And it must. The principles will remain the same, but intelligent 
people will make appropriate changes when the practice at different places for different people…I 
learnt Ayurveda from my guru spending no money. I was advised against treating my profession as 
a means to making money. It is not the case today; people have to now spend a lot to become a 
doctor. I cannot sit in judgment on these changes… (Thirumulpad 2008:16).”  
Post tourist popularization has created a rush for self-financed Ayurvedic education; Kerala 
which had a shortage of ayurvedic doctors up to mid 2000s, by the end of the decade has reached a 
situation where doctors have to register their names in the employment exchange (Anand 2010). 
Students in self-financing institutions spend a capitation fee of `100 – 200 thousand ($2000-4000), 
annual fee of `100, 000 ($2000) and half of that money ($1000) for boarding and lodging, for five years. 
Approximately the total cost would be around Rs one million ($20,000).   
A natural response of the State to curb alleged malpractice is to introduce new forms of 
regulation and standardization. But for mandating the presence of ayurvedic doctors in tourist centers 
and voluntary tourist center certification, there had been no regulation to police the service sector. To 
address this problem, the Kerala government put forward The Kerala Ayurveda Health Centers 
Ordinance in 2007, requiring Ayurvedic Health Centers to be licensed under Categories A, B and C. 
Category B centers were forbidden from in-patient treatment. Category C centers could not undertake 
complicated treatments including the cleansing treatments. The Bill met with opposition from the  
Ayurvedic Hospital Management Association (AHMA) and the Ayurvedic Medical Association of India 
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(AMAI) who submitted memorandums to the government expressing their reservations472. It is now 
under revision; the government had acceded to several of the demands made.473 A doctor who runs a 
ten bed hospital in Central Kerala pointed out that Bill “made it difficult for legitimate Ayurveda 
practitioners to run health centers, but makes it easy for quacks”. Similar issues have been raised in 
the AMAI memorandum, which points out many of the conditions as unviable for average practitioners 
with small clinics to comply with (AMAI 2009).  
In October 2009 the ISMH Department put forth an accreditation policy for Ayush health 
Centers in India474. A minimum bed strength of 10 beds is essential for an AYUSH Hospital to be 
considered for the Accreditation Program. This policy has been received with much enthusiasm by the 
tourism industry and other large groups. Though there was no serious objection to the policy from any 
quarters, questions were raised about the appropriateness of applying the biomedical format to 
ayurvedic hospital (for example, Editorial 2010a). Though it may not be harmful, there is a fear that 
quality gets decided by material parameters easily conjured up by capital than reputation built over a 
life time of committed service. Thus far, five hospitals from Kerala have obtained accreditation of 
which all but one are non-traditional stakeholders.475 The next step taken by the Indian government 
was to add Panchakarma to its list of standardization projects. A workshop that involved Panchakarma 
experts across the country was conducted in 
February 2010.  The debates showed 
differences in every single aspect of 
procedure, far more variable than medicine 
preparations. The consensus was to be built 
towards development of “standard 
operating procedures” for Panchakarma to 
eventually evolve a policy of Good Panchakarma Practices. The pressure on homogenization of services 
was coming after a decade of the implementation of Good Manufacturing Practices policy. Once again 
                                                 
472 As learnt from meeting with Dr. Jojy Thachil, General Secretary of AMAI in 2009. 
473 As learnt from meeting with Dr. P. Udaykumar, the General Secretary of AMAI in Feb. 2012.   
474 National Accreditation Board For Hospitals and Healthcare Providers (NABH), Government of India. 
475A tourist group, a modern Ayurvedic hospital chain, a missionary run biomedical hospital with an Ayurveda wing and a 
superspecialty Ayurvedic eye hospital.  
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commodification had demanded its inevitable price, the need for standardization and regulation476.  
8.11 Conclusion 
Researchers have been concerned that when culture is commodified in the context of tourism 
to cater to the outsiders’ gaze, it leads to loss of meaning and identity, but some scholars have argued 
that it can also help to preserve or reinforce ethnic identity (Stronza 2001). The discussion in this 
chapter has noted several instances of diversion that show both these facets of commodification. 
Tourist commodification has stretched the “commodity context” (Appadurai 1986), making it saleable 
in new spaces where conventional checks and balances do not operate. This allows for unbridled 
commercialization that often compromises the conventional ethos of Ayurveda. Of the various 
commonly alleged ‘distortions’, the most visible is the mushrooming of massage parlors that traditional 
stakeholders fear will tarnish the image of Ayurveda. The next significant development is the 
proliferation of menu-driven and market-driven therapy packages that are inconsistent with the 
fundamental ayurvedic principle of individual tailoring of diagnosis and treatment.  
On the flip side, though there is much hue and cry about the casual selling of Ayurveda to 
pleasure-seeking tourists, it has served to spread awareness and create a brand value for Ayurveda in 
general and for Kerala Ayurveda in particular. There is a steady stream of both Indians and foreign 
nationals trickling into Kerala to access ayurvedic medical or/and health services. Profiles of such 
patients have begun to appear in various media. A recent issue of Ayurveda Tourism monthly carried a 
write-up from a 30 year old muscular dystrophy patient from Finland who significantly improved with 
ayurvedic treatment in Kerala for which she returns every year. The article quotes her statement that 
her experience had inspired many family members and friends to follow suit (Thorstrom 2012). 
Service commodification has brought back attention to Ayurveda’s health maintenance and 
wellness facets that were neglected in the disease-centric paradigm. Owing to shift in focus from 
illness to wellness, the line between hospital and resort has blurred; the “commodity context” 
(Appadurai 1986) has not only diversified but has also become ambiguous. This is complicated by the 
entry of new service providers who re-invent conventional concepts to suit market logic. At the same 
                                                 
476 Account based on participant observation in Panchakarma Global Summit, 5-6 Feb, 2010. Cheruthuruthy, Kerala.  
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time, it should be recognized that Panchakarma and rejuvenation were not novel inventions made to 
cater to the tourist market, but procedures that were part and parcel of classical ayurvedic practice in 
Kerala, though limited to elite classes because of affordability. Though there were sporadic attempts 
in the 80s to cater to an emerging elite, it was tourist interest that acted as a catalyst in its shift from 
luxury to a mass commodity. This created new modes and contexts of selling, some of which departed 
from existing traditions. The ayurvedic landscape in Kerala today shows the existence of both 
traditions, the old and the new, and a seamless continuum between the two. Whether a particular 
format is considered a distortion or a creative re-invention is a question that may not lend to an easy 
resolution.  
Tourism has certainly expanded the space for Ayurveda into previously unexplored territories. 
The revenue potential of the field has forced the State’s attention to a neglected segment bringing in 
much needed patronage for research, training and global canvassing. Tourism-induced entrepreneurial 
atmosphere has enabled fresh money to flow into the field of Ayurveda that was otherwise dependent 
on the limited capabilities of conventional stakeholders. This has gone on to create new infrastructure, 
providing a platform for Ayurveda to compete with biomedicine in becoming a potentially profitable 
segment. But at the same time, traditional stakeholders find that the State which aggressively 
promotes ayurvedic tourism contributes little towards meeting the increased demands for regulation 
that such commodification has brought forth. Service commodification is now overtaking 
pharmaceuticalization; this phenomena demands the coining of a new term. Kerala Ayurveda that 
remained affordable to the masses in the era of pharmaceuticalization, is perhaps in the danger of 
losing its non-elite orientation in this new era of commodification.  
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9. CH 9: MEDICINE COMMODITIES: REINVENTIONS AND DIVERSIONS  
Though service commodities have stolen the show, medicine commodities have also expanded 
their market to new niches. Being part and parcel of ayurvedic services, they have undergone some 
transformation in terms of content, form and channels of circulation. Due to overcrowding and 
saturation in the classical market, manufacturers across the board, new and old, big and small are 
finding their profit margins dwindling. Though established manufacturing groups in Kerala have 
diversified by investing in therapy, tourism and wellness segments, they have remained faithful to the 
classical market as far as medicines are concerned. Over the last decade they have found a way to 
reinvent their products using new technology without straying out of the traditional framework 
(Section 2.2). While old stakeholders manage to hold their ground by banking on traditional brand 
loyalty, some newcomers in the market try to make their mark by bringing in fancy products and 
product categories. Some capitalize on the expanded tourist and wellness services market (Section 
2.3), some others on heavily marketed OTC products in controversial categories like aphrodisiacs and 
anti-obesity drugs (Section 2.4). The pre-cursor to this trend was the memory product market built 
around the reputation of the herb brahmi (Section 2.5).  
Some of these changes have breached traditional ethos of ayurvedic medicine selling and have 
become hotly contested in Kerala today. Meanwhile, a range of new products have mushroomed in the 
vague boundaries between food and medicine, some of which threaten to break the boundaries of 
convention (Section 2.6). The biggest challenge comes from less visible transformations that might 
influence the content of the medicine, like the use of hydro-alcoholic extracts or modified extracts to 
enhance certain active ingredients. Though these are not significant trends as yet, manufacturers’ 
desire to tap the global neutraceutical market could eventually subject them to external pressures on 
standardization (Section 2.6). With new stakeholders entering the ayurvedic market, ayurvedic 
medicinal herbs and ingredients are being dragged out of context to create newfangled products whose 
‘ayurvedicness’ has become suspect (Section 2.7).  Some of the traditional ayurvedic stakeholders feel 
compelled to meet new standards of evidence as they move to please the global consumer. Others are 
resentful of new hegemonies wherein ayurvedic physicians are often relegated to mute spectators.  
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9.1 Classical products in new avatars 
In trying to break the barriers that classical products pose in terms of convenience of 
consumption and palatability, manufacturers in Kerala, bound as they were in the classical framework, 
found an innovative solution. The idea was to keep the products and their identities intact, and instead 
tinker with the forms. This began as a low-profile R&D activity in the early 2000s amidst much 
uncertainty. AVS found it important to inform its users of their efforts in this direction,  assuring 
customers it will be done without corrupting the traditional product, 
Recently, Arya Vaidya Sala has embarked on a venture of modernizing some of the conventional 
dosage forms by converting them into more user compliant forms. Example : 
 Bitter tasting liquid kashayam into the more convenient form of tablet. 
 Incinerated bhasmam (mineral ash) into more reliable and accurate dosage form of 
capsule. 
 Messy and greasy tailam into more convenient and less 
greasy form of gel. 
All these modifications are attempted only after confirming about 
retaining the original quality of the traditional medicines by 
conducting a series of formulation and clinical studies477  
The products that started trickling into the market included: 
 Bhasmam capsules – repackaging incinerated mineral ash in capsules  
 Churnam capsules – repackaging of herbal powders in capsules 
 Gulikas as tablets – conversion of hand-rolled pills into tablets 
 Syrup forms of  decoctions  
 Lehyam Granules – conversion of lickable jams into granules 
 Sugar-free and fat-free products 
 Kashayam Tablets – formulation of decoctions into tablets 
 Soft-gel capsules –repackaging of oils into soft-gel capsules 
 
Manufacturers are ‘required’ to register the transformed product as a proprietary drug. So the 
classical product, not only gets converted in form, but also undergoes a change in terms of intellectual 
property ownership. The first three are limited to the simple and straightforward process of 
repackaging for convenient dose delivery and ease of use. The syrup form of juices and decoctions is 
less common and is used only for branded products. The Lehyam granule form is novel, but has entered 
the market without much fan fare. Granulators are used to turn the messy jam-like Lehyams into dry 
granules chewable or dissolvable in water/milk/honey. A popular product in this category is Eladi 
                                                 
477 Arya Vaidya Sala, e-brochure, www. avs. com. 
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Lehyam, the flag-ship proprietary product of Kandamkulathy Vaidyasala, one of  
the earliest to be converted to he chewable 
granule form. But despite the obvious 
convenience, very few products are found in the 
granule form. Two products in this category were 
born out of an unlikely partnership between a 
public sector company Hindustan Latex Ltd. (HLL) 
and AVS, with the latter as the technology 
partner. Lactohill, a prescription galactagogue, is 
a flavored granular version of the classical 
Stanyajananarasayanam. Chyavanule, is a granule 
form of Chyawanaprash,  recommended as an OTC 
tonic targeted to ‘the 30 plus in the corporate 
world.’ For AVS, which had no branded product until 
then,  this is indeed a big unconventional step; an unsettling one for the classically oriented. So far 
Kerala manufacturers had by and large restrained from selling classical products as OTC, but lately 
they have begun to realize that “Ayurveda makes business sense”( see above image).  
The use of capsule material and binders in pills are unacceptable to traditionalists who 
consider these ‘un-ayurvedic’ substances. More problematic however has been the use of sugar-
substitutes and flavors. A central policy permitting the use of excipients478 issued in Oct. 2008479 paved 
a path for clearing legal hurdles for such usage, raising several other questions. The then Health 
Secretary of Ayush shot a letter to the Ayurvedic Pharmacopeia Committee raising concerns.480 There is 
much public concern about the new excipients (Jagdale 2009), especially problematic because the 
                                                 
478 excipient n. An inert substance used as a diluent or vehicle for a drug 
479 In a notification dated 23/10/2008,  the Union government amended the Drugs and Cosmetics Act 1940, to allow Ayurvedic 
and other traditional drug makers to use materials such as antioxidants, flavoring  agents and sweeteners.  
480 He said the notification had caused much confusion among the industry and the consumers.  He raised special concern on the 
lack of clarity on permissible limits of artificial sweeteners, pointing out that in the US products containing saccharin were 
required to carry statutory warning. He pointed out that unlike Allopathic medicines, Ayush products are used long-term as 
health supplements, and recommended to make statutory warning mandatory for products meant to treat diabetes. Ayush 
Document. F.No. K.11020/1/2008-DC (AYUSH) 
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public is misled to believe that the products are classical (Rashid 2006, Varshney 2008). 
With diabetes and hyperlipidemia becoming widespread in the population, there is a hesitation 
to consume medicines containing sugar and fat, especially Lehyams, i.e., medicinal jams with jaggery 
base, Ghritams made with ghee base, and fermented preparations that use jaggery as a catalyst for 
fermentation481. The most common modifications are sugar-free syrups and Lehyams re-invented as 
sugar-free and fat-free granules, the less common being ghee-based preparations as fat-free granules.  
Ayurvedic jam Chyawanprash is one of the products most subject to modification in the form of 
sugar-free and fat-free products, and in their rebirth as proprietary products, sometimes with changed 
names. For example, Dabur calls its sugar-free product as Chyawanprakash. More often than not, the 
name is maintained, with just the tag sugar-free added to it.  The Chyavanule of HLL is promoted as 
fat-free, the tag ‘No Ghee’ figuring prominently on the product package (See above image). Himani’s 
Sona-chandi Chyawanprash with gold, silver and saffron, aims at the uber rich. Oushadhi has gone a 
step ahead making chocolate flavored Chyawanprash. Some North Indian companies have evolved 
Chyawanprash into a category. Misappropriation of classical Chyawanprash recipes was one of the 
topics taken up for discussion at a meeting of Ayush's Technical Advisory Board in late 2007. The Drug 
Controller General of India declared that the use of prefixes like ‘Chyawan’ suggesting links with 
classical ayurveda constituted misbranding (Varshney 2008).  
Of all the form changes, the most glamorous are kashayam-tablets and soft-gelatin capsules. 
The latter enclose medicinal oils meant for internal consumption. The form per se is not new to 
Ayurveda;482what is new is its use in repackaging classical medicines. But given the cost of technology, 
prices are high; convenience remains a luxury commodity. Consequently demand is low and even large 
manufacturers like AVS have only five products in the category. As of now, it is more of a status 
symbol; for the first time it has given the large classical manufacturers with an exclusive status 
marker. The AVS brochure launching soft-gel capsules carries the slogan, “Modern technology in 
propagation of the science of heritage.” Four virtues are listed: “Easy absorption, exact dose delivery, 
                                                 
481 This category is unlikely to be easily transformable unless jaggery is replaced by other substances as aid in fermentation. 
482 Dabur’s Pudinhara, a soft gel capsule containing concentrated mint essence, has been in the market for long. 
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ensured efficacy and added convenience483”. The form has not called forth any objection from 
practitioners, perhaps because the process is not considered transformative. The same cannot be said 
of the decoction tablet, whose path has been riddled with controversy right from its inception.  
9.2 Is the decoction tablet the same as the decoction?  
Conversion of decoction into tablet has come almost exactly a century after it was first 
commodified and put on the shelf, a step that can be considered as the next important move in the 
commodification of the Kerala ayurvedic pharmacopeia. Though 
not as transformative and central, it is symbolic of new era 
transformations. Arya Vaidya Nilayam (AVN), one of the 
contenders who lays claim for introducing the decoction tablet 
in the market, proudly displays its achievements in the 
industrial exposition at Coimbatore in August 2008 (see image 
on the right). The owner MD of AVN, Dr. Ramesh R. Varier is 
upset that they do not get the prime mover advantage, because 
others quickly moved into the segment that he had created with 
much effort. “We do not get to reap the benefit of the 
investment we put in the technology and its promotion. Our 
investment in publicizing the new product has become advantageous to others. There has to be some 
way to protect intellectual property exclusivity, at least for a while”. The problem, however, is that 
processes like these are too obvious for anyone to claim exclusivity.  
The initial growth of the product segment was slow, as manufacturers struggled to rationalize 
the process. As for the technology, it is a simple process of spray-drying the traditional liquid 
decoction, removing the moisture content and converting the solid residue into a pill. But there were 
many pain points to handle, and each manufacturer had to perfect the technology on their own.484 For 
those who cracked it early, it was a matter of pride to declare technological superiority over others. By 
                                                 
483 Arya Vaidya Sala, promotional leaflet, n.d. 
484 The modern tablet form demands more binders, making it difficult to handle dosage apportioning. Dehydrated herbal material 
is not readily amenable to pill form. Biomedical and homeopathic pills do not have to accommodate biomass.   
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Coimbatore lists decoction tablet 
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the end of the first decade of the new millennium, the  trend had got firmly established; most large 
and medium manufacturers had arrived at their own methods of making the product . 
 However, reception from the Kerala market has been lukewarm. The forms per se were not 
new, but identities of classical products are inseparable from their forms. Though most proprietary 
products are produced in non-conventional forms, there is no room for conflict as they lack standards 
for comparison. But in the case of classical medicines, the consumer is caught between a conventional 
product with established credibility and a modified form of dubious quality.    
The decoction tablet met with considerable resistance from ayurvedic practitioners in Kerala. 
One argument was that ‘taste’ has a pharmacological action and therefore the purpose is defeated 
when the pill is swallowed or when it is rendered taste-neutral (for example, Vasudevan 2003). Another 
concern was that manufacturers were following diverse ways of fixing dosage causing confusion among 
the users (for example, Manoj 2010a).  Further, there was no guarantee that all were following the 
right production process. Head, R&D of a large ayurvedic manufacturing company was apprehensive 
that less scrupulous manufacturers who did not have access to the right technology would end up using 
finely powdered ingredients without putting them through the water extraction process. According to 
ayurvedic pharmacological logic, the differentiation 
between powders, pills and decoctions is there for a 
reason. The basic logic of the decoction is to extract 
plant chemicals by boiling raw drug ingredients in 
water; volatile material is allowed to evaporate during 
the open boiling. After passing the liquid decoction 
through a sieve, the residual bio-matter is disposed of. 
The right process of making the decoction tablet would 
be to derive the decoction from this traditional 
process, and then subject the liquid decoction to spray 
drying. The difference between the decoction and tablet, is therefore nothing but the presence and 
absence of moisture content. But if a manufacturer were to skip the process of water extraction, and 
 
Kashayam Tablets and Softgel Capsules 
displayed at the AVS stall, Arogya Expo 
Thrissur, 2009 
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instead micro-pulverize the material and convert it into tablets, the end product would not be the 
same. 
Most manufacturers are defensive. They do not claim it to be the best form; for reasons known 
and unknown classical forms are considered indisputably the best. They point out that the decoction 
tablet is essentially a spray 
dried form of liquid decoction 
and there should be no logical 
reason for  
substantial difference. 
Assistant Manager, R&D of a 
large manufacturer says  “It is 
an inevitable compromise”. 
The production manager of 
another manufacturer says, 
“Of the pancha kashaya 
kalpanas (five forms of decoction), kashayam  itself is the worst form, but we depend on it because the 
rest are not saleable. This is just one more compromise….though it may be less efficacious it is still 
better to replace a less palatable form rather than lose customers.” This sentiment is repeated by 
manufacturer after manufacturer. A respondent from the R&D department at AVS says they are 
helpless because the younger generation which is used to palatable biomedicine refuses to consume 
bitter decoctions. Gesturing the hand in resignation, he said, “If we are not quick enough to respond to 
this attitude change, customers would move to better tasting medicines”. This is no exaggeration. I 
had occasionally come across practitioners asking their patients485 whether they are willing to consume 
decoctions, quite often meeting with resistance. In one such interaction, the patient, a girl in her early 
20s had come in with her mother. After the consultation was over, the doctor told asked her, “The 
problem will be resolved with this medicine, but are you ready to drink kashayam?” The girl refused 
point blank, forcing the doctor to find an alternative. After she left, the doctor told me ruefully,  
                                                 
485 This would happen only with new patients, especially the younger generation.  
 
AVP Booklet: Justification for Kashaya tablets 
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The Vaidyans of earlier times were fortunate – patients would cherish every drop of advice they 
gave, followed whatever they were told to, whether it is taking a bitter decoction or following a 
strict diet regimen. But these days you have to ask the patients and make sure that you give what 
they like. Otherwise, they won’t come back or they will not take the medicines properly. Then 
they will return with the same complaint or a more complicated complaint.  
Such patients, manufacturers complain, have increased in number. Ayurvedic doctors have to 
be sensitive to patient compliance. Only a few patients like Mamatha refuse without hesitation, most 
feel awkward to express their preference. Doctors take care not to prescribe medicines that patients 
are unlikely to take. Diet regimen 
(Pathya) is an important aspect of 
Ayurveda that doctors have had to 
make significant compromise. By 
being rigid, they are afraid they 
might lose them to other systems of 
medicine486. In one amusing episode 
I witnessed during an interview, the 
doctor was busy on the phone  
and his secretarial assistant was 
casually chatting with the patient. 
The patient was an obese Muslim 
lady who wanted to lose weight. 
The assistant identified her 
consumption of non-vegetarian biriyanis487 as a problem and strictly advised her against eating such 
food. The doctor who overheard this gently chided her with a smile, “Are you planning to chase away 
my patients?”and went on to reassure the patient not to worry about diet restrictions.  
To counter the resistance, manufacturers are going out of their way to educate consumers 
(mainly ayurvedic practitioners) of the efficacy of the new decoction tablet. For example, the AVP 
                                                 
486In biomedicine, one just has to swallow the pills whereas homeopathic pills that constitute negligible amount of medicine 
mixed in sugar pellets are so palatable that they need to be kept at a safe distance from children. 
487 Because of its Persian origins, Biriyani (a fried rice preparation with mutton/chicken) is a regular food among the Muslim 
communities in Kerala. 
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booklet on kashayam tablets explains the rationale of the new form, and also provides an FAQ to 
answer potential questions from practitioners emphasizing on its equivalence to the classical decoction 
(See images  above). One common argument in favor of the decoction tablet is that it does away with 
the need for using preservatives, and is therefore superior to the industrially produced decoction. 
There are no prescribed standards and uniformity in preservative use. Large manufacturers by and 
large use 10 ml. of Sodium Benzoate in 200 ml. decoction. But extreme kinds of practices are reported. 
On the one hand, manufacturers of dubious reputation allegedly used liberal quantities of preservatives 
to prolong shelf-life. On the other, practitioner-manufacturers worried about the safety and efficacy 
use less preservatives. Manoj (2010b) points out that while as per US regulations, the permissible rate 
was 0.1%, many were found to be using 0.5%. 
Controversy over new forms in Kerala was loud enough to catch the attention of the media (for 
example, Nambudiri 2002, Hindu 2002).  
New dosage forms are further crippling ayurveda. We are losing the very basic concept of health 
and healing. Since one is not ready to prepare kashayam with the angadi marunnu or the pari 
Marunnu (raw drugs) prescribed, you can buy readymade kashayams. When you buy 200 ml of 
kashayam, you are buying 190 ml of kashayam and almost 10 ml of sodium benzoate…We accepted 
that compromise, almost from the time ayurveda got bottled by the industry. Now the 
pharmaceutical companies have come up with newer dosage forms and you get tablets, capsules 
and even ayurveda injections. Kashayams are available in tablet forms. Choornams are available in 
the tablet form. They will definitely work. The capsule will disintegrate inside the stomach. But 
you will never get the effect of the same old kalpana or the traditional processing techniques like 
kashayam, churnam, ghritam etc.(Hindu 2002) 
Surprisingly, the above critique quoted in a newspaper report does not come from a conservative 
traditional vaidyan, but from an ayurvedic doctor employed by one of the largest manufacturers of 
Kerala Ayurvedic products. However, Dr. P. K. Warrier, the chief-physician and MD of AVS states, 
“Classical formulations have internal strengths which allow them to be converted into more convenient 
modern forms like tablets, capsules, gels, syrups, etc.” (Warrier 2006:30). This statement has to be 
taken special note of, as it comes from one of the most respected ayurvedic scholars in Kerala, and 
from a manufacturer rooted in the classical tradition. AVS has always been the trend-setter in the 
market; no manufacturer changes prices unless AVS does. The fact that AVS and other large traditional 
groups like Vaidyaratnam and AVP have embraced the technology with open arms implies that it is a 
trend that has come to stay. It is likely to eventually get rooted and the controversy forgotten, just as 
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it happened with the commodification of decoction a century ago. However, this does not mean that it 
does not meet with resistance from practitioners.  Though it is a century since the bottled decoction is 
in the market, there are consumers who are still ready to make decoctions at home.  
Despite all the publicity and hype, in the Kerala market, the new forms still remain on the 
fringe. The expensiveness of the products coupled with the conservativeness of both practitioners and 
consumers make their market penetration slow. So conservative is the ayurvedic market in Kerala that 
even minor modifications becomes a matter worthy of discussion. Take for instance, the use of PET 
bottles instead of glass bottles for packaging – a transformation that began in the late 90s had become 
an established trend by the end of the decade488. Today is it is difficult to find a manufacturer who 
does not sell medicines in PET bottles. As a consumer, I remember choosing one brand over the other 
just because a particular medicine was available in a plastic bottle. Such consumer preference that 
went up with increasing mobility of work force489 would have forced manufacturers to make the switch, 
besides the fact that it also worked convenient for them to transport and ship their products. I had 
little suspected that it could still have strong detractors until I overheard an conversation at the clinic-
pharmacy of Vaidyamadham at Palakkad, a clinic-pharmacy run by an Ashtavaidyan family. A Malayali 
customer, a Bombay resident, was visibly taken aback when he learnt that medicines would be shipped 
only in plastic bottles. The cashier at the counter explained that  sending medicine in glass bottles 
through postal service was a tricky affair, but the customer grumbled on and on about the safety and 
efficacy of medicine in a ‘plastic’ bottle. It was indeed ironical to find a ‘purist’ establishment that 
had taken measured steps in adapting to the demands of the market, in an apologetic modernist 
position vis-à-vis a conservative consumer.  
Though during the period of my field work, I had heard such occasional murmurs of disapproval 
from various quarters including patients, doctors and sellers, I had no expectation that it would be 
anything more than a  inconsequential minority position that would soon fade away. But recently, one 
of the largest companies announced its decision to revert to glass bottles, citing their own 
experimental finding that fermented medicines packed in pet bottles undergo qualitative changes. 
                                                 
488 This paralleled the trend in the food product market, for example, semi-solid products like pickles and ghee. Initially, it was 
not considered a cost-effective proposition – pet bottles were more expensive and were not recyclable.     
489This was particularly true for Kerala, which is known for its highly mobile workforce.   
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They pointed out that “though it works better from a business perspective, they were doing this 
keeping in mind “Ayurveda’s unnathi (progress)”, requesting consumers for forbearance (Nagarjuna 
2012). Given this milieu, it would have been indeed surprising if a change in form or content of 
classical medicine is welcomed without dissent. The market outside Kerala is more receptive. Two 
manufacturers who were in the process of expanding their reach outside Kerala reported that they 
were getting more orders from outside the State, especially from Karnataka and Maharashtra. Non-
Malayalees are unaccustomed to consuming bitter decoctions (See Michael’s story, end of Section 3.1). 
With increasing number of them seeking Kerala Ayurveda, moves like this might be in the interest of 
not only the industry, but in the long run, the survival of the bitter decoction itself. The R&D Managing 
Assistant of one ayurvedic manufacturing company said, “What is the use of principles if we can’t 
attract customers? Instead of losing them to biomedicine, it is better we at least compromise a bit to 
keep them”.  
9.3 Products capitalizing on the service market 
Ayurvedic services are almost never free of medicine commodities, and consequently, when 
services are commodified, medicines automatically get a free vehicle to ride on. When the context and 
format of services change, medicines also undergo some amount of transformation to suit the new 
context and requirements of new consumers. In Panchakarma centers in tourist regions, therapy 
requirements for medicines are being met in three common ways:  
1. Complex medicines are bought from established manufacturers.  
2. Medicinal material required for certain procedures are almost always prepared in-house, quite 
often freshly made for the procedure and  
3. Oils required in large quantities are made in-house or bought at a bulk price from small 
manufacturers or household level producers.  
Each category has a different connection to the ayurvedic commodity chain in Kerala. The first 
draws from the old commodity chain; the second is most often made in-house. The third category, the 
most visible in the market, consists of an array of new commodities geared towards tourist and 
wellness consumption. For example, the independent center that Brian visited (see Section 8.3) took 
recourse to all three methods. They bought complex medicinal oils like Dhanwantaram oil from 
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Vaidyaratnam, a large manufacturer. For procedures like Njavara Kizhi and Ela Kizhi they prepared the 
medicines in-house. They sourced the third category of products from a one-man establishment, who 
hailed from a family with a traditional martial art tradition. He made the oils at home and supplied to 
most of the hotels and resorts in the backwater tourist region of Kumarakom.  
The third category of commodities is also connected to exclusive export channels that are 
linked to the international ayurvedic spa market. These have a distinct advantage over medicine 
commodities; unlike internal medicines they do not face a regulatory barrier. Over and above this, they 
can easily pretend to be cosmetics, an issue that bothers ayurvedic practitioners abroad as damaging to 
Ayurveda’s identity as a serious medical system (see Section 8.7.2).   
9.3.1 Ayurveda: Degreased and Deodorized 
 A new commodity segment that has evolved to meet the demand for tourist and wellness Ayurveda is 
‘Ayurvedic Massage Oil’ or simply ‘Massage oil’; a category that was almost absent till 90s, but now as 
ubiquitous as the ayurvedic hair oil. The manufacturers of this commodity are a medley, ranging from 
small women’s self-help groups to multinational FMCG manufacturers, from 
street side vendors to  reputed Ayurveda manufacturers. The doctor at a 
certified ayurvedic center said they use specific oils tailored to the procedure 
and patient’s condition, but not generic massage oils.  The initial response to 
the market was either from unheard of small local companies that had little to 
care about their reputation or from companies without ayurvedic identity. Such 
products are commonly found in tourist regions in gift shops, perfume and 
cosmetic shops. The image on the right shows “ayurvedic massage oil” listed in 
a list of aromatic oils, on a board displayed in front of a  perfume showroom in a 
tourist region of Kumarakom. The product capitalized on the global popularity 
of herbs like turmeric and neem.  
 One of the few Kerala origin tourist focused range of products visible in the Ayurvedic 
industrial exposition in mid-2008 was Svaztha (stylized form of Svastha, i.e. wellness). The 
manufacturer,  Chempenkulam Ayurveda Pharma, does not confirm to common sense expectations. It is 
 
Ayurvedic Massage 
Oil in the list of 
aromatic oils 
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run by Dr. C. A. Gopi, a doctor-manufacturer whose low-key establishment is tucked between the spice 
shops in the Thekkadi hill station. Though his grandfather’s vaidyashala was upgraded to a modernized 
production unit in the 60s, the current production is meant to serve clinical use, restricted to around 
250 commonly required medicines. His clinic and small health center are not upgraded to cater to the 
tourist industry, nor are there any signs of significant departure from routine clinical practice. When 
asked, he said, “My focus mainly revolves around therapy. I have a small inpatient facility that I hope 
to expand.” By all measures, it was difficult to imagine such an unconventional and market-savvy idea 
floating out of such a low profile, therapy-centric establishment. Being located at the heart of Kerala’s 
hill resorts bombarded with tourist flurry, the doctor must have found the opportunity irresistible. The 
product range is tastefully designed and creatively branded. The brochure of Svaztha states, 
Medicines are prepared in the traditional and special metal vessel made of 'panchaloha' patra 
(made of five metals - gold, silver, copper, iron, and brass). Only prescribed types of fire woods 
are used. Organic sesame is bought directly from the farmers, and the oil is extracted in wooden 
grinders – as it was in olden days. The herbs are collected from own garden and from the heart of 
Periyar Tiger Reserve Forest by the tribal people490.  
Unlike the modern ayurvedic product, here the emphasis is not on technology and modernity, 
but on tradition and uniqueness. This attempt to enclave a mass commodity from its de-identified mass 
status (Appadurai 1986), is an apt illustration of the emphasis of the tourist induced service market on 
tradition. However, in the same breath, Svaztha massage oils claim to be “stain less and non-greasy”, 
giving a small concession to the Westerners’ aversion to the greasiness and smelliness of ayurvedic oils. 
Svaztha remained low key, not surprising, given the background of the manufacturer. But the trend of 
de-greasing and de-odorizing the massage oils was fast spreading in the tourist market. In 2010 
industrial exposition in Kochi, Sahyadri showcased a new range of degreased and scented massage oils 
packed in swanky aluminium bottles. They innovated new commodity categories: Relax Soft (Children 
Massage Oil), Relax Smooth (Ladies Massage Oil), and Relax Strong  (Gents Massage Oil). Ayurvedic 
commodities are now beginning to be subjected to gender differentiation, a common technique used to 
differentiate commodities in the consumer market.  
Interestingly, just as traditional manufacturers have begun to enter the tourist market, there is  
a reverse trend of tourist stakeholders entering the manufacturing market. Some tourist groups who 
                                                 
490 Chempenkulam Ayurveda Pharma, Kottayam, promotional leaflet, n.d. 
 363 
 
were typically rebranding bulk purchased products for in-house use, started rolling out their own 
brands of medicines aiming at the tourist and export market. Their product ideas are inspired by their 
face to face experience with western tourists. In the Feb. 2012 industrial exposition in Trivandrum, I 
was taken aback to find a new range of products by Kairali Resorts, branded ‘traditional’ depicted by a 
picture showing a surgical procedure in ancient India (see image below). The same old classical  
products were being re-invented, not as modern but as 
traditional products491. It would be indeed ironical if 
tourist induced demand creates a parallel channel for the 
re-emergence of classical products, albeit couched in 
stylish post-modern avatars.  
An old manufacturer attempting to follow the 
celebrity endorsement technique of selling an OTC 
product, takes the opportunity to educate the audience on 
“what is real Ayurveda”. Sitaram Ayurveda Pharmacy is 
desperate to differentiate his tradition-based product, a branded hair oil, from the new and 
“unauthentic” OTCs. The advertisement for the product appeared in a popular Malayalam daily entitled 
“Does it mean that it when it comes to hair products anything can be experimented with?” It points 
out that modern problems like pollution and life style contribute to hair loss and other problems, 
forcing people to look for solutions. The consumer is asked, “But can you close your eyes and believe in 
any product that claims itself to be ayurvedic?” and told, “This is where the relevance of Real 
Ayurveda comes in,” and further challenged,  “How do you recognize real492 Ayurveda”. Three ways of 
identification are provided.  
Textual base: Which text is the formula based on? For example, Narasimham Oil is based on Vagbhata’s 
Ashtanga Hridayam.  
Tradition: the background of the manufacturer. Like for example, Sitaram Pharmacy is 89 years old.  
Color and Smell: Avoid using oils that have an agreeable fragrance or which is totally transparent. Such 
oils are either purified or made by adding artificial fragrances (Malayala Manorama 2010).  
                                                 
491 The term ‘traditional’ used by some researchers (for example, Bode 2008) is not a term in use in the domestic market. 
492 Though the advertisement in Malayalam, English word ‘real’ is used. Compared to other South Indian languages, Malayalam 
liberally uses English words with or without some transformation, without struggling to look for substitutes.  
 Classical medicines recast as ‘traditional’ 
Products displayed at Kairali Stall, Arogya 
Industrial Expo, Thrissur 2009 
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In other words, the disagreeable smell of ayurvedic oils becomes a marker for authenticity, 
debunking “degreased and deodorized Ayurveda” as unauthentic.   
9.3.2  Wellness Commodities: Dosha-shopping 
Ayurvedic massage oils are not the only products that have emerged in this market. At the next 
level are up-market products by FMCG manufactures and cosmetic manufacturers aimed at the Western 
or the Indian elite audience. Numerous wellness products and cosmetic products have sprung up, riding 
on the wellness bandwagon. Among the fore-runners in this segment were a range of cosmetics and 
health care products along with the wellness chain of “Lever Ayush Therapy Centers” Targeted at the 
modern health-conscious elite customer, the kind of clientele expected to access wellness treatment, 
this range includes rejuvenatives, cosmetics like hair oil and cream, and a few OTC products. The 
names are strange and comic sounding combinations of Sanskrit/Hindi and English, perhaps meant to 
keep it authentic and  understandable for the cosmopolitan Indian. Example, Ayush Hair Poshak Oil, 
poshak means supportive, Ayush Headache Nashak Roll-on, nashak means destructive. They claim that 
their products, ‘bring authentic wisdom from AVP’, meet ‘international Unilever Standards for safety 
and quality.’ ‘the goodness of Ayurveda in “pleasant or tasty  and convenient-to-use formats493’. 
Targeting Western tourists has also geared Kerala manufactures to address the export market, 
however miniscule. So far exports are limited to 10% of the total turnover of finished ayurvedic 
medicine in India; for Kerala companies it is an insignificant 1-2%. Very few manufactures from Kerala 
have exports worth mention. Traditional manufacturers like AVS are uninterested; interested groups 
like the AVP with its high-cost WHO complaint GMP factory are still struggling with regulatory barriers. 
Even selling to countries in the Indian subcontinent like Sri Lanka, Pakistan and Bangladesh continues 
to be a struggle494. This being the case, most of the product movement happens through private 
unorganized channels, that is, to individual customers or through therapy centers and joint ventures in 
a few locations495. To mention some of the illustrious ones, AVP has three centers in Malaysia; SNA 
which trains biomedical doctors in Italy through its tie-up with Ayurveda Point has a steady market 
                                                 
493 Hindustan Unilever Limited. Press Release, 03-06-2002.  
494 Ayurvedic Manufacturers’ Business meet to dicuss draft proposal for trade with SAARC countries, Feb. 14, 2012.  
495 Manufacturers like to brag of their presence in several countries, are unsurprisingly unenthusiastic about sharing details about 
these non-glamorous low-end channels.  
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base in its alumni; Vaidyaratnam and a few other companies have agencies run by Keralite doctors 
practicing in the Middle East; Nagarjuna has a substantial clientele in Russia; KAL following its 
acquisition by the US based Katra Health Care has access to customers in US through their thee Kerala 
Ayurveda clinics.  
 Over the last two decades, ayurvedic manufacturers in Kerala have learnt that addressing the 
western market is a different ball game. In this market, one has to fit products in categories that 
Western customers are most familiar with, the most salient being the dosha typologies. In the 
conventional ayurvedic framework, discerning doshas is a vaidyan’s job, a complex activity that is 
sometime subconscious, sometimes deemphasized, sometimes ignored. 
But for a few typologies that are common knowledge496, it is rare to hear 
doctors or patients discuss constitutional dosha typologies. But western 
consumers are known to be preoccupied with dosha typologies. Some 
online sellers have even designed the hilarious-sounding purchase option, “Shop by Dosha”.  
Companies like Maharishi Ayurveda which produced its own version 
of Ayurveda in the 80s have been making commodities tuned to the 
western market that sound remotely ayurvedic to an Indian ear.  
But now this trend has become widespread. Many traditional 
manufacturers now sell non-traditional products named after Dosha 
types, Vata/Pitta/Kapha Massage Oils (see image on the left). 
Kerala Ayurveda Pharmacy also makes dosha typology oils but with 
the suffix tailam, the Sanskrit term for oil. Some of the more 
market-savvy manufacturers carry a descriptive subtitle proclaiming Ayurvedic Massage Oil along with 
the classical name, making it consumer-friendly without compromising on their classical identities.  
                                                 
496 E.g., certain complaints are commonly referred by typology, arthritis as Vata complaint or acidity as Pitta complaint.  
 
Classical oils classified by Dosha: 
displayed at Desheeya 
Pharmacy’s stall, Bengaluru 2010 
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9.3.3 Medicines integrated with therapy: Njavara Kizhi 
Among the images most commonly used to advertize ayurvedic therapies in the tourist and 
wellness market, the most popular are that of Shirodhara, of oil pouring on a carved earthen vessel on 
the forehead of a male/female lying down on an 
aesthetically carved wooden massage table. The 
next in popularity is the image of two masseurs in 
action, rubbing the boluses over a half-clothed 
supine body, commonly female, which most often 
than not is visibly blonde. The generic name of the 
bolus massage is Kizhi, a Malayalam term equivalent 
to the Sanskrit term Pinda Sweda.  One popular 
variant of this procedure, considered a contribution 
of Kerala, is Njavara Kizhi, i.e., rice-bolus massage. 
Once a merely therapeutic ayurvedic procedure in 
Kerala, Njavara Kizhi  has now acquired a new fame in the tourist and wellness commodity chain. 
Perhaps its exoticness is what makes it a popular item on tourist menus and therapy packages.  
Njavara, a variety of medicinal rice, is perhaps the only medicinal plant whose trajectory has 
been influenced by the new commodification centered around tourism. An important chapter in the life 
of njavara opened in November, 2007, when Kerala was awarded geographical indication for the rice 
variety497. Njavara is  part of the species of Oriza sativa, but distinct from the other rice varieties in 
many ways. Ayurvedic classics describe the medicinal properties of a rice strain called Sashtika, i.e., 
‘60 days’ referring to its short maturity period. Though it represents a composite of varietal types, its 
gene pool is distinct from that of other rice varieties, conjectured to represent an ancient 
unadulterated gene pool (Sreejayan et al 2005). There are two varieties of njavara, the black glume 
and golden glume, the former drought-resistant and the latter susceptible to drought. While physicians 
in North Kerala prefer the former, those in South Kerala prefer the latter. Within each variety, there 
                                                 
497 This had become possible because of the historical exclusivity of Kerala in the production of this rice variety.  
 
Shirodhara table with a poster behind in the 
background, Industrial Exposition, Trivandrum 
2012 
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are two sub-types, one with awn and one without. (See Appendix F for its ayurvedic pharmacological 
properties). External application of njavara is commonly prescribed in the treatment of neurological 
disorders, arthritis and emaciation of limbs. The porridge of njavara grains in milk is prescribed as 
special food for invalids and infants. It is also part of the seasonal medicinal rice (Karkidaka Kanji) 
consumption routine. There are  two procedures of application, one is Njavara Theppu, which involves 
application of a paste of njavara cooked in milk all over the body. Second, and the most popular is 
Njavara Kizhi, which is rubbing of boluses filled with njavara paste infused with kurunthoti decoction 
and dipped in milk.  The procedure relies on only two medicinal ingredients, both of which happen to 
be index plants. The procedure is expected to soften the body, make the joints supple, increase 
hunger, alleviate lethargy, improve circulation and sleep. 498 
Given the nature of medicament used in such procedures, it is common for doctors/therapy 
centers to have them prepared in-house. For example, for ElaKizhi (leaf bolus massage), seven 
different leaves are required, all in fresh form.499  The manager at Brian’s center said that all of these 
except karinochi were herbs/shrubs available from the commons and were plucked by their assistants, 
whenever required. As there was no other way of getting karinochi, they had cultivated the tree in 
their small yard. The fast growing tree had already grown to a height of 10 ft; its delicate bluish leaves 
reflecting the sunlight, made a pretty sight.  
9.3.4 The Panchakarma range  
Among the slew of new commodities in the market, one category stands apart – novel and 
strictly traditional at the same time. In mid 2000s, a small company called Ayu:care hit upon a new 
niche, an innovative idea of marketing therapy-based products for the outside Kerala market. They 
called it  the Panchakarma Range, exclusively targeting the therapy market with 15-20 products, 
mostly classical ayurvedic oils and powders and a few proprietary massage oils. The founder, an 
ayurvedic practitioner who started his career with a small 15-bedded hospital, began manufacturing 
medicines to meet inhouse needs. As the popularity of Panchakarma spread across India, he identified 
                                                 
498 A full body procedure requires 600 gms of rice, 500 gms of Kurunthoti root, 2 liters of milk and 8 liters of water. 
499 Karinochi (vitex negundo), avanakk,  (Castor, Ricnis communis), datura (Datura ummam), erikku (Calotropis gigantea) 
tamarind (Tamarindus officinalis), muringa (drumstick, Moringa olifera) and karanja (Pongamia pinnata). 
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a potential for therapy commodities to circulate in the same channel. But it remains a low-profile 
segment, their own market restricted to a few hundred doctors outside Kerala as reported by their 
marketing manager.  
9.3.5 Do-it-yourself Ayurveda 
Not satisfied with the Panchakarma therapy products, in 2010, Ayu:care introduced a new 
product, again therapy based, but a step ahead of all other commodities. Ayu:care Kizhi converts a 
clinical procedure performed by a skilled therapist, including the medicament prepared in-house into a 
“do-it-yourself-kit”. The product leaflet says, “Ayu:care KIZHI is most advanced and scientifically 
designed for conducting ayurvedic swedana treatment (medicated fomentation therapy)500”.  
 
There is much disquiet in the ayurvedic community about this development. A serious therapy 
procedure has been taken out of its context, simplified and converted into an off the shelf commodity. 
The product, coming soon after the company’s foray into the controversial anti-obesity oil (see Section 
9.4), had rubbed salt on an already festering wound. In June 2011, ayurvedic practitioners represented 
by AMAI complained to the Ayurvedic Drugs Controller requesting immediate action against the sale of 
such “fake products”. The General Secretary of AMAI complained that “the manufacturers of Ayur Kizhi 
is giving wide publicity for this product violating laws and its formulation processes are against the 
principles of Ayurveda.” In April 2012, after the company refused to reply to repeated memos, the 
                                                 
500 Ayu:care, promotional leaflet, n.d. Also e-brochure at http://www.ayucareayurveda.com/home/kizhi 
 
 
Traditional Kizhi Do-it-yourself Kizhi Kit 
Source: Ayu:Care e-brochure 
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Kerala Drugs Control Department raided the manufacturing unit and confiscated the products for 
violation of DCA and DMR501 (DR 2011).  
9.3.6 Non-medicine commodities riding on service  
 The  service market also created an equipment niche that brought its own specialized 
stakeholders. These are mainly wooden massage tables, boxes for steam bath and other Panchakarma 
equipments.  The material ranged from specific wood 
recommended in the classics like venga to material suited 
for modern convenience like FRP. Such equipment from 
Kerala are also finding a lucrative export market in 
Europe. There are many companies that now specialize in 
manufacturing Panchakarma equipment, some of which 
have grown very big. For example, Esteem Services, a 
Thrissur-based company established in 1999 has grown to 
a million dollar’s turnover specializing in Panchakarma 
equipment. A few ayurvedic manufactures like AVP also entered the market to supply equipment. 
There are also emerging modern versions of these equipments, like the automatic Shirodhara unit, that 
was demonstrated at the Ayurveda industrial exposition, October 2008.  
  
Traditional Shirodhara Unit 
Arogya Expo, Thrissur, 2009 
Automatic Shirodhara Unit: Demonstration 
Arogya Expo, Thrissur, 2009 
                                                 
 501 DCA: Drug and Cosmetics Act 1940, DMR: Drug and Magic Remedies Act 1958. The Department had given licenses for 'Ayur 
Kizhi Oil' and ‘Ayur Kizhi Powder’, but no license has been given exclusively for the single product 'Ayur Kizhi kit'. 
 
An equipment manufacturer’s Stall, Arogya 
Industrial Expo, Thrissur, 2009 
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A commodity unrelated to Panchakarma that has got a new lease of life is “Ayurvastra” is, 
“Ayurvedic Textiles,” fabric dyed in medicinal herbs meant to have therapeutic effect. A specialist 
weaver family group in Trivandrum that supplied these clothes to the erstwhile royalty has now found a 
lucrative export market, especially in Jap an, Italy and France. The group is also now marketing 
“Ayurvedic Houses” aiming at a niche domestic luxury market. The use of the brand by unconnected 
business groups irks Ravindran, a weaver from the  original family of weavers, but he is least concerned 
about intellectual property protection. He is confident that nobody else would be able to decode the 
family secret of ayurvedic dyeing technique (which is free of chemical mordants).  
The other increasingly popular new commodity is ayurvedic diagnostic software. The first in 
this category was Ayur-soft launched in 2006 by Pune-based Centre for Development of Advanced 
Computing (CDAC), a R&D Institute under the Ministry of IT. It was announced as “a vision of converting 
classical ayurvedic texts into comprehensive, authentic, intelligent and interactive knowledge 
repositories with complex analytical tools502”. The organization was approached by the NIH of US and 
L’Oreal for customization (Bhuyan 2006). In 2008, AVP launched RUDRA (Random Uninterrupted 
Documentation for Retrospective Analysis)  to examine patients and document the proof of medical 
examination and consultation. The system was expected to act as a 'third eye' that monitors doctors 
while they check patients (Nampoothiry  2008).    
9.4  New and controversial OTC segments 
The last half of the decade saw a rising trend in big-budget OTC products in the Kerala 
Ayurveda market. The sound bites created by this segment can be misleading. In reality, there are only 
a small number of companies503, whose name and fame are constructed around one or two heavily 
advertised OTC products. There is much disquiet about this development among the ayurvedic 
community and also among the general public. Dr. T. Sivadasan, the Kerala Ayurvedic Drugs Controller 
pointed out that the Department is helpless because the law is toothless. Some practitioners point out 
that the problem is not with laws, but lack of political will. They point out that the money flowing into 
                                                 
502 The full desktop package was priced at ` 12,350 ($247), the multi-user intranet version was priced at RS 50,000 ($1000). 
503 Agnivesh (2011) finds half of the full page ayurvedic advertisements in a woman’s bi-monthly belonged to just two companies. 
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the media, especially television in Kerala, is too big and they attribute this to be the reason for State 
inaction.504  
Aggressive advertisement based selling was until recently limited to a few OTC products – 
mainly cosmetics like ayurvedic hair oils  and soaps,  and a few neutraceuticals (for example, memory 
products). None of these products made therapeutic claims. Low profile products claiming miraculous 
cure circulated in local spaces, either through street vendors 
or advertized on small shoddy bills stuck on public walls, like 
bus stands and rest rooms. More often that not, these 
addressed stigma-bearing illnesses like STDs and hemorrhoids. 
The scenario has changed in the past half a decade. While 
some of the new products like hair oils and soaps are 
innocuous and legitimately OTC, those that have raised 
concern are prescription-products that are dragged into the 
OTC realm, boosted with exaggerated  and unsubstantiated 
health claims. The products tend to be astronomically priced, 
often promoted through celebrity endorsement and aggressive 
pricing strategy that allows for high commission to sellers at 
all levels. Agnivesh (2011:88), on analyzing advertisements in a 
woman’s magazine comments “it would appear that the second priority of a Malayali after wearing 
clothes is using Ayurvedic concoctions”. Besides the fact that they clearly violate the stipulations of 
the Drugs and Magic Remedies Act 1958, a common concern is regarding the style and language of the 
advertisements that often resemble the street medicine vendors’ sales pitch505, threatening the 
respectability of ‘serious Ayurveda’. Unlike rest of the country where the industry seemed to have had 
an upper hand in meaning making, in Kerala, practitioners are strident in questioning the industry’s 
ways. The critics are loud enough to catch the attention of various media (for example, Hindu 2002, 
                                                 
504 Incidentally, all large political parties of the State have a direct or indirect stake in Malayalam television channels. Kairali: 
Marxist party, Amrita: BJP, India Vision: Muslim  League, and Jai Hind: Congress party.  
505 In Malayalam movies, it is very common to see the portrayal of quack street vendors who go street selling a medicine or two 
extolling its virtues to cure any and every health problem. 
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Nampoothiry 2008). 
Of the segments, three  are most visible: aphrodisiacs, anti-obesity products and cosmetics, of 
which the first two have been the most controversial. Cosmetics too have been controversial, but for a 
different reason. Some of the classical ayurvedic medicine manufacturers feel selling soap should not 
be a priority for a serious ayurvedic company. They feel that the cosmetic overkill is lightening the 
gravity of Ayurveda in public eyes. Ayurvedic soaps emerged as a hot category only in the past decade. 
Previously, there were two companies that specialized in ayurvedic soap making and had minted 
millions with a single product each. Of these Chandrika, a bath soap with 7 essential oils was the 
brainchild of a traditional vaidyan from Kerala, was launched in 1940. The other ayurvedic bath soap 
with 18 herbs, Medimix, a Kerala based company from Chennai, was launched in 1969 by an ayurvedic 
doctor, also from a vaidyan family. These were made and marketed at a time when it was not 
fashionable to sell ayurvedic soap. The market of these two soaps was limited to South India, mainly 
Kerala. Since 2000s, there has been a boom in the ayurvedic soap market, with several larger cosmetic 
groups entering the market. Chandrika had achieved a brand value of ` 280 mn ($5.6 mn) when it was 
acquired by the FMCG wing of IT major WIPRO in 2004. It was during this period that  many otherwise 
herbal cosmetic manufacturers started coming out with products labeled ayurvedic. All of a sudden the 
word ayurvedic was everywhere, on toothpastes, shampoos, hair oils, skin care products. Overnight, 
cosmetic giants like Shahnaz herbals began to sport the Ayurveda brand. Very few established 
ayurvedic manufacturers have been able to resist participating in this booming market, estimated to be 
2.3 billion rupees (Kamat 2007).  
The expansion of the OTC segment in Kerala and the increase in magnitude of ad spending 
seems to have had its beginnings in a single product, Musli Power Extra, an aphrodisiac.  It is no 
exaggeration if we call it Kerala’s most controversial ayurvedic product of the decade. The company 
Kunnath Pharmaceuticals is founded by K. C. Abraham, a farmer turned entrepreneur. He claims to 
have been a farmer who wanted to cash in on the Viagra hype with a herbal substitute. This idea he 
claims was developed to cash in on the huge surplus of a herb called Safed musali which had no 
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market506. An unofficial version is that he fell prey to the Safed musali hype (also see footnote 392)507, 
and had reached the brink of bankruptcy. Either way, this was certainly an example of turning a 
problem into a opportunity.  The company founded in 2005, saw a meteoric rise with the single 
product, with a 100 fold increase in annual turnover, 4.5 mn in 2005 to 450 mn in 2012 (Note the irony: 
AVS with a century of history makes a little over than double this money with over 500 products). 
The category of aphrodisiacs per se is not new to Ayurveda508. Of the large number of 
formulations in the classics, many included animal products (Valiathan 2003), but the aphrodisiacs in 
the market today are all purely herbal, perhaps keeping in harmony with the modern Ayurveda’s 
“vegetarian” image.  But in modern Indian society where public reference to sexuality is taboo, 
aphrodisiacs were restricted to a few invisible spaces. 1. Shady street corners, where groups of men 
are seen huddled around a vendor displaying herbs, pills and exotic stuff like the tail of the monitor 
lizard. 2. As a serious health complaint addressed within the doctor’s clinic. 3 Over the counter raw 
drugs, for example Shilajit. 4. Aphrodisiacs masquerading as ‘rejuvenating tonics’ or ‘fertility drugs’, 
and  5. Products by small unknown manufacturers sold furtively through raw drug shops.  
Kunnath Pharma broke this taboo by 
boldly launching the product as a herbal 
aphrodisiac, cashing in on the combined fame 
of the herb’s traditional reputation as an 
aphrodisiac, the increased value of brand 
Ayurveda, and the market buzz around Viagra. 
The advertisement blared through all media, 
newspapers television and giant hoardings 
popped up  in the skylines of all major cities, 
                                                 
 
 
507 Safed musali cultivation started in parts of Kerala in early 2000s, when a few Hyderabad and Bangalore-based firms got in 
touch with Kerala farmers, urging them to grow the herb. For the first two years the companies brought back the herbs, after 
that the companies disappeared. Farmers had paid through their nose for the saplings, and were at a heavy loss when they had 
the crop ready and there was no one to buy.  
508 Charaka Samhita recommended the use of aphrodisiacs to all men who sought offspring and pleasure; the author was “totally 
lacking in prudishness in his references to sexual activity” (Valiathan 2003). 
 
Musli Power’s giant hoarding towering over Thrissur 
city skyline 
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with the roots of Safed Musali stylized to form a suggestive image  (see image above), making the 
average conservative Malayalee squirm in embarrassment. But ever since it entered the market, the 
product has been making headlines for all the wrong reasons. In the very first year, advertizing the 
product as Herbal Viagra, landed him in a law suit with Pfizer. One set of allegations was on the 
appropriateness of the herb used (black Vs white musali). Some argued that the white variety was not 
part of ayurvedic texts. In the next few years, there have been several allegations of adulteration, 
none of which have been proved. Exasperated with the rumors, in 2010, K. C. Abraham announced a 10 
million rupee ($200,000) challenge, saying he would pay that amount to anyone who could prove 
adulteration.509  
In early 2010, the Kerala government took the company to court on two counts. Firstly, the 
company was accused of using the white variety while the approval was for the black. The second case 
was for flouting the provisions of the Drug and Magic Remedies Act which prohibits advertisement of 
aphrodisiacs. Meanwhile, in late 2010, the company got into trouble for unauthorized use of posters of 
an adult rated Malayalam movie. Finally in April 2011, after several unsuccessful raids and allegations, 
the Kerala Ayurvedic Drugs Controller’s office was able to 
get the high court to ban its production and distribution. 
The ban was subsequently lifted by the High Court which 
issued strict stipulations regarding advertisement, after 
which it has toned down the advertisement. Now the 
product is accompanied by a simple slogan, “for a healthy 
and happy family,” comparable to Kingfisher (alcohol brand) 
advertising mineral water!  
But the ayurvedic community in Kerala was disgruntled with the product for a different set of 
reasons. Firstly, the product was making exaggerated claims aimed at fertility, claiming a success rate 
of 80-85% based on reportedly dubious clinical trials. Secondly, priced at a whopping ` 25-35 ($0.5-0.7) 
a capsule, the company was believed to be minting money luring innocent buyers with tall claims. 
                                                 
509 Of the two varieties of Musali,  the North-Indian pharmacopeia used the white (Safed) variety  and the Kerala pharmacopea 
used Nilappana (Curculigo orchioides), or the black Musali. The two are botanically different, but considered variants of the 
Ayurvedic drug Musali.  
 
Musli power hoarding post court verdict 
 375 
 
There was a fear that such large scale scams would make Ayurveda suspect in public eyes. Finally, 
unlike small companies that sold low profile aphrodisiacs aimed at a selective audience and away from 
the public eye, here an aphrodisiac was being sold in broad limelight, that too riding on the brand 
value of Ayurveda. The magnitude of the publicity campaign was so high that it almost gave a sleazy 
look to Ayurveda itself, which was already getting sullied by the spread of ‘massage parlors’.  The 
Ayurvedic Drugs Inspector who carried out raids on the company is reported to have said, “This 
purported herbal remedy has been bringing a lot of bad name for Ayurveda. Foreigners who tried this 
formulation and find it fake blame our system Ayurveda, not the product” (Padanna 2010).  
Ironically, the success story of this product led to the mushrooming of ayurvedic aphrodisiacs 
across the country, with occasional reports of raids appearing in newspapers. In Gujarat, a few 
companies were raided for selling ayurvedic aphrodisiacs adulterated with Sidenafil citrate.510 The 
Punjab Ayurvedic Drugs Controller ordered a moratorium on the registration of aphrodisiacs and the 
use of certain prefixes and suffixes in medicine names, claiming it was bringing infamy to Ayurveda511. 
On the other hand, ironically, many respectable companies in Kerala rushed in to exploit the segment. 
Surprisingly, among the forerunners was Oushadhi, Kerala’s State owned company.  
Whatever be the controversy, the founder of Kunnath Pharmaceuticals, K. C. Abraham received 
Vyavasaya Pratibha award for excellence in business from the President of India, in February 2010. His 
success story would have tempted many others to follow the OTC route to make a fast buck. Most like 
Sitaram Ayurveda Pharmacy, keep themselves restricted to celebrity advertizing of simple hair care 
products.  Pankajakasthuri and Kandamkulathy Vaidyasala, the proprietary-focused companies 
advertize their flagship therapeutic OTC products, Breathe Eazy and Eladi, respectively. Both of these, 
being cough and phlegm remedies, fall into the traditional OTC segment and have not courted any 
controversy. However, Nupal Remedies Pvt. Ltd., a traditional vaidyan founded company known 
historically for its aggressive advertisement  of branded products has taken a step further. The recent 
advertisement strategy used to promote Kamilari, a lever supplement, is raising several eyebrows. 
                                                 
510 Gujarat Beware of Viagra-mixed 'Ayurvedic' aphrodisiacs. www. DrugsControl.org. July 10, 2005 
511 www. DrugsControl.org 
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Connecting one of Kerala’s most infamous afflictions, excessive alcohol consumption,512 to liver 
problems, Nupal not only tells drunkards that this will help their liver but also makes it sound like they 
could carry on with their drinking as far as they continued taking this medicine. Nupal’s television 
advertisement in a Malayalam television channel goes like this: 
A little girl warning her young father “This beer will eat up your liver.” Dad asks, “So what to do?” 
The daughter giggles, looks at her mother and says “Mummy says nothing to fear, it is enough if 
you take Kamilari.”  
A grey haired doctor in white coat with stethoscope hanging from his neck,  proclaims with 
authority “Alcohol destroys 70-80% of your liver, without manifesting any external symptoms. 
Kamilari will regenerate the part that alcohol destroys, 100%, the power of Ayurveda clinically 
proven, no side-effects” 
The family appears together all smiles, and the father declares, “Healthy and happy family!” 
The product leaflet further elaborates: While consuming alcohol, 90% of alcohol reaches the liver 
and turns into carbon dioxide and water. This chemical process produces a byproduct called 
acetaldehyde which remains in the liver. This substance destroys the liver cells and leads to 
alcoholic cirrhosis. Simultaneously, a chemical substance called tetra hydro isoquinolines (THIQ) 
gets accumulated in the brain. This substance prompts the brain to require more and more 
alcohol, which in turn forces alcohol consumption……Kamilari improves the day to day functions of 
an alcohol ravaged liver. Continuous use of Kamilari, curtails the daily intake levels of alcohol, 
and ultimately neutralizes the action of THIQ and may induce the user to stop alcohol altogether. 
The damaged liver cells are progressively healed with Kamilari…..Kamilari virtually throws a ring 
of security around the liver….. 
The bottom of the leaflet is adorned with a slogan, “Kamilari promises a world free of liver 
diseases”.  
This is an instance of how branded medicine can lead to medicalization, expanding the catchment of a 
medicine that was traditionally meant to address liver problems. This power of redefining a patient, is 
noticed by a Keralite ayurvedic practitioner-scholar,  
“It would appear that medicines are made not for those who need it, but with a confidence that 
the needy can be ‘made’. How can this be done? Creating patients is not possible (though 
allopathic doctors actually do even that, it is said!), but you can always frighten a person who 
takes an occasional peg about the havoc it is going to do to his liver…(Agnivesh 2011: 85). 
The next shocker came from Ayu:care. Perhaps dissatisfied with the limited reach of their innovative 
Panchakarma range, in 2009, they came out with Lavana Tailam,  an anti-obesity OTC medicine (see 
image below for advertisement of the product). The product, an oil for external application, was 
aggressively advertized over all media, accompanied by exaggerated claims of its ability to cure 
                                                 
512 Kerala has the highest per capita consumption (1.76 gallons) per person a year, overtaking traditionally hard-drinking states 
like Punjab and Haryana. 40% of revenues of the State’s annual budget come from alcohol (Biswas 2010) 
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obesity overnight. The advertisement campaign focused steadfastly on the “classical basis” of the 
product, the main ingredient being a simple oil-extract of rock salt. The product was an instant hit. 
When I visited the company office, the marketing desk was constantly buzzing with customers’ calls, 
most of them from outside Kerala, including Karnataka, Andhra and Tamil Nadu. The marketing desk 
was manned by the marketing manager himself who was fielding all calls using his multi-lingual skills.  
 The commercial success of the product inspired them to bring two other products. Njavara Tailam, oil 
of capitalizing on the new found fame of medicinal rice njavara (the index plant), and Vaji Thailam, an 
aphrodisiac oil. The other two did not attract much attention, but Lavana Tailam was the next 
controversial product after Musli Power Extra. In fact, this product was hotly debated in various forums 
including popular dailies. The reason 
why it got more discussion space was 
the product’s claim that it is founded 
on classical ayurvedic principles. The 
proprietor MD of the company, Dr. 
Mahesh Menon has posted a short 
video on You Tube answering all 
allegations, emphasizing the 
product’s “classical textual 
foundation”, saying he had chanced 
upon a reference to this medicine in 
the classical texts during his MD 
education in Pune (Ayu:care 2012).   
All together there is a cacophony of Ayurveda advertisements on television and print media. In 
2011, ayurvedic medicines led OTC segment in print at the national level, with a share of 
32%.(Hindustan Times 2011). Anti-obesity, estimated to be a ` 18 billion ($360 mn) market (Dewan 
2009) has been among the main targets. In Kerala, some of the most advertized products include 
Santhosh Pharmacy’s Fat Win capsule,  Bhagawathy Madom’s Fat Free capsules, Sreedhariyam’s 
 
Print advertisement for Lavana Thailam  
an anti-obesity ayurvedic medicinal oil  
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Smartlean, and Dhatri’s Real Slim Oil. Concerns have been raised by several quarters about the 
reliability of these medicines and the ethics of advertising (Francis 2009, Jayan 2008).  
Ayurvedic practitioners and manufacturers point a finger at the Drug Controlling authority’s 
inability to regulate. Dr. T. Sivadasan, the Ayurvedic Drugs Controller of Kerala throws up his hand in 
helplessness. “The DMR has no teeth” he says, “If you file a case against a company, it takes ages for 
justice to be delivered. If they lose the case, they have to pay a small fine, and reword the 
advertisement. By this time, they will not only recover their investment they will make substantial 
profit.” The General Secretary of AMAI, demanded an inquiry into the veracity of claims made for 
Ayu:care’s anti-obesity and aphrodisiac products, pointing out that such “fake products” would 
“diminish the dignity of the ayurvedic professionals in the country (Ayurbhishak 2012).” A reputed 
Ashtavaidyan, Dr. K P B Moosad, wrote a letter to the editor of a popular English daily complaining of 
the proliferation of un-ayurvedic products.  
 
T 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Letter to Editor by Dr. K P B Moosad: New Indain Express, April 5, 2008 
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The issue seemed to have reached the boiling point when in early November 2012, rumors of 
large scale raids on Ayurveda firms in Kerala started pouring in hitherto unheard of online Malayalam 
news media. Drugs Intelligence Division raided offices and wholesale depots of some of the aggressive 
OTC sellers including a couple of high flying companies (Madhyamam 2012), leading to confiscation of 
50 mn rupee worth of  ayurvedic medicines. They raided wholesale depots in 13 of the 14 districts in 
Kerala as well as the production units of Dhatri, Indulekha, Sreedhariyam and confiscated 8 products, 
mostly oils and other cosmetics for external application. This was followed  by a warning by the Health 
Secretary. The primary allegation was of misleading advertisements and unsubstantiated claims. Query 
was also raised about the pricing rationale. A 100 ml  bottle of Indulekha hair oil, whose production 
cost was less than ` 10 ($0.2) was sold at ` 400 ($8). Interestingly, all the news reports were published 
by online media, one of which was headlined, “Again media hijacked, news on raids was scuttled (One 
India 2012). The report alleged that the news of the raids appeared in none of the television channels 
or newspapers, pointing out that the advertisement revenue was so huge that none of the media 
wanted to displease the companies, substantiating views I had earlier heard from some ayurvedic 
practitioners and manufacturers. But the Ayurveda Hospital Management Association alleged that the 
raids were motivated by interests of MNCs. However, post raids, the advertisements continue 
unabated.  
While such high-profile ‘quackery’ is visible, there are many invisible small companies peddling 
spurious drugs. For example, a company sent an as SMS advertisement  saying, “Get diabetes reduce 
with only 1 month course, FDA approved, Kerala Ayurvedic. No side effect. 1,800/- only, money back 
offer”. The journalist who followed this story, met the company representative who claimed the 
company was established in 1834, and that the capsule was approved by the Indian Medical Association 
and the Food and Drug Administration, neither of seem remotely plausible nor have any connection to 
Ayurveda. The Ayurvedic Drug Controller of Kerala was unaware of the existence of this company 
(Datta 2011). For those who are aware of the status of the State’s Ayurvedic Drug Control Department, 
this will not come as a surprise. The Department has been historically under the administrative control 
of the Biomedical Drug Control Department, without a separate building and adequate resources. After 
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years of demand, protests and sit-ins, finally in 2010 the State government yielded and created a 
separate Ayurvedic division in the Drug Control Department, but the  Department continued to be 
hopelessly understaffed. Three ayurvedic drug control inspectors working under the Drug Controller are 
expected to cover 1000 odd manufacturers across 14 districts. They are expected to check the 
production facility, to award licenses, and to keep an eye on the distribution network. Dr. P. Y. John, 
the Ayurvedic Drugs Inspector for Ernakulam zone, for instance, is in charge of 479 manufacturers, 
each of whom he is expected to visit twice a year. He says this is humanly impossible and that at least 
one inspector per 100 manufacturers would be essential if the government is serious about regulation. 
 Ayurveda community in Kerala is disgruntled that the government that runs global campaigns 
to sell Ayurveda to tourists pays scanty attention to meet the basic requirements of the domestic 
ayurvedic sector.  Practitioners constantly complain about the State government’s neglect of Ayurveda, 
the step motherly attitude that favors modern medicine, and so on, that often gets voiced in media 
reports. For instance, a media article based on interviews of practitioners states, “Most practitioners 
oppose the use of Ayurveda as a bait to attract tourists. They demand that the government promote 
Ayurveda which will attract patients, not tourists, to Kerala  (Abraham and Jayadevan 2012).” Another 
media report aired the compliant of AMAI, of gross disregard for Ayurveda in the comprehensive health 
policy panel of the State; only one of the 15 panel members was an Ayurvedic doctor (TNN 2013).  
It usually happens that the State steps in with regulatory measures, after a critical mass of  
controversy is built up. And this happened in December 2008 when AYUSH prepared a Draft Bill on 
Clinical Trials requiring mandatory clinical trials for future proprietary medicines which was received 
with a mixed reaction. Kerala manufacturers convened a meet to discuss its implications. There was a 
general feeling that such a regulation was useful to check unscrupulous elements from coming up with 
spurious products. But they also expressed two major reservations, cost being one. Even large 
manufactures were worried about the cost. Some including the representative from AVS were 
concerned about interests of small manufacturers. The second objection was to the biomedical 
framework of clinical trials, an issue that has been highly debated ever since.513 Ayurvedic practitioners 
have ethical and epistemological problems in conducting randomized clinical trials. They say it is  
                                                 
513 Manufacturers’ meet to discuss the Clinical Trial Draft Bill, Thrissur, Feb. 14, 2009. 
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against ayurvedic ethics to 
use deception (placebo) or to 
deny treatment (to the 
control group). They find the 
framework of randomized 
trials epistemologically 
inconsistent in many ways. 
For example, classification of 
patients into groups based on 
diseases, instead of individual 
constitutions. An ayurvedic doctor-researcher narrates her experience in participating in the execution 
of a clinical trial of an antimalarial drug by AYUSH. She found no place for ayurvedic diagnostic of the 
pathology; the presence of the disease and its cure was confirmed by presence/absence of malaria in 
the blood smear. Further, the NMEP (National Malaria Eradication Program) dictated that the ayurvedic 
medicine should be given only for three days to be equivalent to the chloroquine dosage. So even when 
results showed that the parasite count had come down considerably following the administration of the 
ayurvedic medicine, it was considered a failure (Rao 2003). 
 The demand for “evidence” continues to mount. While a minority hold their ground saying it is 
none of their business to provide evidence, majority of ayurvedic researchers struggle to provide some 
evidence using biomedical parameters. Some others follow a mid-way, finding innovative ways to adapt 
the biomedical framework to suit ayurvedic parameters, e.g., classifying patients by body constitution 
(prakriti) or by taking recourse to newly emerging sciences like systems biology (see section 4.3.1).  
9.5 The memory market: an unnoticed pre-cursor to the OTC boom  
The pre-cursor to the current ayurvedic OTC boom has gone by far unnoticed and unquestioned 
- a two decade old memory product segment, built over the reputation of a single herb brahmi. Though 
the memory enhancing property of brahmi was traditionally known, its neutraceutical usage was 
 
Ayurvedic Manufacturers meet to discuss implications of clinical trial 
draft notification, Thrissur, 2009 
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limited to neonatal care and hair care514. It was not even used as part of the popular ayurvedic 
rejuvenatives like Chyawanaprash (48 ingredients) or Dashamoolarishtam (72 ingredients). In 1996, 
Velvette International Pharma Products Limited launched a commodity called Memory Plus with much 
fan fare, inaugurated by the then Prime Minister Narasimha Rao. This drug was developed by the 
Central Drug Research Institute (CDRI), Lucknow, a premier central government organization. 
Subsequently, a number of celebrities including the chess grandmaster Vishwanathan Anand endorsed 
the product. It was this product that opened up the new wave of commodification of brahmi. Memory 
Plus succeeded in reviving the fame of brahmi across urban consumers in India.  
Interestingly, potent plants that go into far more classical preparations (for example index 
plants like koovalam or kurunthoti), do not enjoy the popularity of brahmi. This is probably because 
the medicinal property that brahmi is known for has a high ‘commodity candidacy’ (Appadurai 1986) as 
a neutraceutical.  The high social value for academic performance makes memory and intelligence 
premium attributes, conducive to mass marketing.  For the expanding middle class that does not want 
to leave any stone unturned to improve their wards’ grade sheets, brahmi makes one more irresistible 
promise.  Naturally, the popular images that appears on product packages and advertisements of 
brahmi are visuals of students in school uniform with books in hand (see image below) 
Memory Plus was riddled with controversy right from its inception. 
Right after the launch, the Indian Council of Medical Research, dominated 
by biomedical researchers, questioned its credibility, citing insufficient 
drug trials. Later on in 1998, a random survey conducted by the CDRI  
revealed that the drug had appallingly lower active ingredients than 
stipulated, following which the manufacturer’s license was transferred to 
another company. However, the product went on to open a floodgate for 
the commodification of brahmi’s memory enhancing attribute. Today 
almost every large and medium pharmacy in India has a brahmi product. 
Typical products are named either after the herb, or use the word ‘memory’ or its Hindi/Sanskrit 
                                                 
514 A review of products in the Ayurvedic Pharmacopeia of India, show that its use was highly selective and restricted to 
therapeutic purposes. Sarasvatarishta, an Ayurvedic wine whose primary ingredient was Brahmi was known to stimulate 
development of intellect, but its Ayurvedic use was mostly limited to the therapeutic context. 
 
Santhosh Brahmi with 
images of school children 
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synonyms or combine both.  
The response from ayurvedic manufacturers in Kerala has been mixed. A section of the 
traditional large pharmacies like Kottakkal, Vaidyaratnam, SNA and Oushadhi have remained aloof; in 
their hands brahmi remains just another ayurvedic ingredient, with restricted therapeutic application, 
problem-specific and patient-specific. On the other hand, many large manufacturers including some 
traditional stakeholders, have jumped on to the memory bandwagon515. Two aggressively advertized 
brahmi products in Kerala are Santosh Brahmi and Jothish Brahmi, both from small companies516. 
Jothish Brahmi517 is among three ayurvedic products that figured in the top 20 brands in Kerala (Hindu 
2009). The television commercial for Santosh Brahmi, a product prominently displayed in most 
biomedical stores, shows a toddler reminding her grandfather that the eye glasses he was searching for 
was sitting right on his forehead. An ominous warning follows: “small instances of forgetfulness are 
indicative of memory loss. Ayurveda is the only solution. Before it gets worse, make it a habit of taking 
Santosh Brahmi every day. It is suitable for people of all ages”.   
Unlike classical preparations, these are designed as OTC products many of which are also sold 
outside the ayurvedic distribution system. They are similar to the neutraceuticals or dietary 
supplements in the international market, though in India they are sold as ayurvedic or herbal 
medicines. Another technique employed to capitalize on the neutraceutical value of popular herbs, is 
to combine them with a well known classical medical formulation, thereby creating a new product 
niche in the otherwise crowded brahmi product market. (e.g., Chyawan Brahmi and Triphala Brahmi).  
Once more, I am tempted to extend the analogy from the Malayalam movie industry that I 
brought up in Section 2.3. In the quintessential Malayalam movie of the past (up to mid 90s), though 
the hero had a central role, every supporting actor had a character role to play. Though heroes had the 
highest star power and popularity, the supporting actors had their own niches; given their versatility, 
they got far higher role opportunities. In the past decade, with large capital entering the movie 
industry, the heroes have evolved into superheroes. The story has begun to revolve around them 
                                                 
515 Some popular products in Kerala are, Brahmi Pearls (KAL), Smaranshakti (AVP), Brahmi plus smrithi granules (Nagarjuna), 
Brahmi Shakti (SD pharmacy), Brahmi Rich (Kandamkulathy), Manomitram (=friend of the mind, from AVN). 
516 In fact, the companies are known by the brand values of these products than by their own identities. 
517 from AshtaVaidya Herbal Pharma 
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reducing the importance of other characters. A similar trend is what we observe in the commodity 
careers of ingredients of ayurvedic medicines. The commercial approach to preparing proprietary 
formulations has made a radical departure from the classical multi-component thinking. The idea is to 
group many herbs with similar properties together to create a blockbuster. For example, the two 
Brahmis are not found together in the two above mentioned formulations or in Brahmi Ghritam, but 
many proprietary products combine the two. Some add another memory herb Shankapushpi also along. 
An extreme example of such a combination is the multi-crore grossing aphrodisiac Musli Power Extra, 
which combines several potent aphrodisiac herbs in a single pill. By contrast, the components of a 
classical ayurvedic poly-herbal formulation have diverse properties, and fulfill different functions, like 
increasing bioavailability, improving digestion, reducing anxiety, improving vitality, and so on (See 
Section 5.5). Let us take for example the classical brain rejuvenative Saraswatarishtam. It has 7 
primary and 13 secondary ingredients, of which brahmi is the principle ingredient – it is four times 
greater in quantity than the other ingredients. None of the other herbs are there for their memory 
enhancing property, not even the other brahmi. This is also true of Brahmi Drakshadi Kashayam and 
most of the classical preparations.  
9.6 Riding on the vague boundaries between food and medicine  
A noticeable trend in the current era of commodification, not just in Kerala but all of India, is 
the emergence of products that are somewhere between food and medicine, but cannot be classified 
as either. Though this appears to be a new form of commodification, it is not inherently contradictory 
to ayurvedic philosophy. In Ayurveda, the boundary between food and medicine has always been 
amorphous. Many of the material used in food is medicinal, especially spices (for example, turmeric as 
anti-bacterial, asafetida as carminative, ginger as digestive). Medicinal herbs are also used in daily 
food (e.g., dry curry of tazhuthama) or in beverages ( e.g., juice of koovalam fruit) or as seasonal diets 
(for example, seasonal medicinal porridge). Some of these household practices have been going out of 
use due to unavailability of ingredients, lack of knowledge and lack of time.  Commodification appears 
to have reviving such practices by providing an off the shelf solution, for example, the seasonal 
medicinal porridge (See section 6.5.1).  
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But the new wave of commodification does not stop at reproducing traditional forms. 
Manufacturers invent new forms, new products and new niches. In doing so, they exploit traditional 
cultural values and memories, but quite often go beyond them. Following the index plant brahmi takes 
us through some of these transformations. In the case of brahmi, Centella asiatica, the North Indian 
brahmi, has been traditionally part of food but not Bacopa. However, with the modern popularity of 
brahmi as a brain tonic, Bacopa has also been forced to enter a new commodity life on the shelves of 
food stores. One such popular commodity in the Kerala market is Brahmi Jam, a brain child of 
Phytomed foundation, a new market-savvy player without ayurvedic background. They identified a 
niche, designed a successful product, outsourced production to a small ayurvedic manufacturer in 
interior central Kerala and launched a colorful promotional campaign with advertisements in print and 
television media. Large cut-outs in the shape of Brahmi Jam bottle were embedded with seven small 
bottles  containing samples of the seven constituent herbs and displayed prominently in pharmacies to 
attract customer attention. The product was distributed through a variety of networks, grocery stores,  
general medical shops, ayurvedic retail stores and raw drug shops. The 
product is accompanied with a title slogan, “Spread on the taste. Bring on 
the health.” The product is based on brahmi, that has “a proven quality 
of improving memory,” The product “improves learning ability” and 
“children concentrate more and recall better” when it is “used on a 
regular basis in their diet”. The product talks of ‘ayurvedic principles’, 
‘antioxidant agents’, ‘organic, containing no chemicals and artificial 
colors’, in the same breath, all aimed to charm the modern discerning 
health conscious consumer. The television advertisement of Brahmi Jam features a school girl who 
shocks teachers with her superior intelligence and outsmarts her parents with her quick wit.  
Teas and biscuits have been ideal targets of ayurvedic or herbal augmentation. Tata Tea 
introduced in March 2007, a new brand called Tata Tea Life launched in the health and wellness 
market, which included brahmi along with four other herbs and spices. AVP, one of the largest 
ayurvedic manufacturers in Kerala, the first to open a food division, launched brahmi biscuits along  
 
Brahmi Jam 
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with two others, Ashwagandha and 
Chyawanprash biscuits. SD Pharmacy 
launched Chyawana Rusk.  Nirapara, 
one of the biggest rice brands in Kerala, 
added brahmi along with five other 
herbs to preprocessed rice powder that 
goes into the making of puttu, a 
steamed rice preparation unique to 
Kerala. Interestingly, even public corporations have gotten into the new commodification mood. 
MILMA, the Milk Federation of Kerala, launched a product called Brahmi Tone Sweet in July 2007, and 
announced its intention of introducing a non-sweet version for the diabetic market.  
Though there was no distinction between food and medicine in ayurvedic philosophy, the 
purpose, mode and frequency of consumption was dictated by custom. In the market context, claims 
made are evidently linked to commercial logic. Unbridled by regulation, they cross the boundary of 
wellness and step into the territory of medicine. For example, a cornflake product fortified with 
brahmi, produced by Amrapali,  promises that it “reduces stress”, it is used as a “memory enhancer” 
“cures epilepsy, bronchitis and rheumatism” and that its “Its antioxidant property is used as potent 
nerve and cardio tonic”. It is not only large companies that cash on such trends. Small companies 
across the country produce numerous such products selling in local markets. A small company from 
southern Karnataka was found selling a simple product, brahmi milk mix as a memory enhancer; 
classics recommend brahmi to be consumed with milk. A few small ayurvedic companies were seen 
marketing a range of herb decoctions and syrups in Bangalore targeting the urban health-conscious. 
Some are meant to be all-purpose health drinks, some recommended for serious diseases like diabetics. 
Most of them provide no information on the kind and quantity of ingredients and preservatives used. 
These are sold as health food products, though often accompanied by serious medical advice. This may 
be justified on the grounds that Ayurveda does not make a strict distinction between nutrition and 
medicine. However, in the modern market such products escape the regulation of Ayurveda 
  
Chyavana Rusk Chyavana, Ashwagandha biscuits 
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establishment, and are not covered under any other regulation as India lacks a general policy on herbal 
drugs and products.  
A less visible segment are micro-sellers like women’s self help groups and cooperatives. While 
most of them tend to make known products, some venture into innovations that go beyond traditional 
boundaries. An example is Gram Niketan, an NGO with 40 branches that has launched several herbal 
products manufactured and promoted through women’s self help groups. Among their product range of 
nutritious dietary supplements, is a semi-solid extract of brahmi combined with a few other herbs. One 
of their branches that I visited, that has over 300 women as members, are all urged to grow herbs like 
brahmi to save on the input cost. Most of their products are built over the cultural familiarity and 
ayurvedic knowledge of medicinal herbs, but create a unique niche that is neither food nor medicine, 
neither traditional nor modern. Such products that try to fit in the food niche, escape the regulations 
of the medicine market. A local raw drug shop keeper said that women from this NGO had approached 
him with their products, but he had declined because the products were neither traditional nor  
registered as proprietary medicines.  
A Gujarat based company makes “Intella Biscuits” to enhance memory, which they claim is 
manufactured by a clinical psychologist. The product carries instructions for consumption that look 
suspiciously like those found on medicinal products.  
INTELLA BISCUITS is best used throughout the academic year to maximize your learning experience. However, 
using INTELLA BISCUITS for the first time closer to the exam period will still make a difference. It is never too 
late to start! 
CHILD: Take 4-6 BISCUITS daily or as Directed by Physician. 
ADULTS: Take 6-8 BISCUITS daily or as Directed by Physician. 
Information on the nature of physician who was qualified to be able to prescribe dosage for biscuits, 
was unfortunately not provided in the brochure. A report published ten years ago in a reputed Indian 
environmental magazine lamented the international exploitation of the herbal market, and blamed the 
ayurvedic companies squarely for their inability to commodify the popularity of brahmi or Gotukola 
(Down to Earth 1997). The high standards set by the author to match the Gotukola drink sold by the 
California-based Mrs. Wiggles Rocket Juice Company are evidently now being met. 
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9.7  Ayurvedic Ingredients, Un-ayurvedic Commodities 
Despite the media hype and publicity, high-profile outsiders who seek Ayurveda as a system of 
medicine for its own sake are a minority when compared to those interested in ayurvedic herbs or herb 
components. Large multinational firms, mainly biomedical and neutraceutical, aim at harvesting the 
chemicals out of the plants and utilizing the associated knowledge to fit it within their categories of 
meaning. Neutraceuticals, the next trillion dollar global market (Pilzer 2001) is increasingly being 
considered as a market that traditional systems of medicine like Ayurveda feel obligated to tap. That 
Ayurveda has not been able to exploit this market effectively is an often heard lament from various 
quarters, including policy makers, scientists and business analysts. For example,  
Herbal medicines also find market as neutraceuticals whose current market is estimated at about 
$ 80–250 billion in USA and also in Europe. India is sitting on a gold mine of well-recorded and well 
practiced knowledge of traditional herbal medicine. But, unlike China, India has not been able to 
capitalize on this herbal wealth by promoting its use in the developed world despite their renewed 
interest in herbal medicines (Kamboj 2000). 
This thrust towards exploiting the global market and the neutraceutical 
market have begun to have some influence, leading to the marketing of 
ayurvedic herbs in new market-friendly avatars. The most important transition 
in the social life of brahmi after the Memory Plus popularity was its transition 
to a single herb commodity. This took it out of the polyherbal context and 
provided it an independent identity. Here brahmi represents the commodity 
life of a number of popular herbs that have acquired a new social life in the 
form of single herb capsules. Unlike ayurvedic polyherbal products, single herbs have easy access to 
global markets as dietary supplements. The pioneer company that probably was the trend-setter was 
the historically export-focused Himalaya Herbal Health Care.518 This soon caught up as a fashion in the 
market. Now single herb capsules adorn a few of the Kerala manufacturers’ product portfolios, 
especially those with professed export orientation, like KAL and Nagarjuna. Such products do not figure 
in Nagarjuna’s routine product catalogue, but its export brochure lists 11 single herb products including 
brahmi, with a note: “herbs can be provided in the required combinations also”.  
                                                 
518It makes 25 pure herb capsules, which also includes another of the index herbs, koovalam. 
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The next avatar of brahmi is in the form of a dietary supplement in international markets, 
though no ayurvedic manufacturer from Kerala has ventured in this direction as yet. Ayurvedic 
manufacturers in Kerala feel it is unethical to modify a medicine into a health supplement and make it 
buyable over the counter. “Ayurveda is being hijacked by the neutraceuticals lobby” complained the 
General Secretary of the Kerala manufacturer body AMMOI in a media interview (Jayakumar 2008). Mr. 
Ranjit Puranik, owner-CEO of Dhootapapeshwar, General Secretary of Ayurvedic Drug Manufacturers 
Association (2002-2010), current executive member of Pharmexcil, is often heard advocating strategy 
plans to the industry for getting an entry into the developed countries market 519. Despite this, he 
admits to being squeamish at the whole idea of having to sell ayurvedic medicines as 
neutraceuticals520.  Let alone neutraceuticals, manufacturers like AVS are yet to evolve a strategy for 
meeting demands for their own foreign patients.  
“It is a diversion” proclaims Dr. Vasudevan, ayurvedic practitioner and Director of the AVP’s 
educational trust, in a popular media article. He lists key principles of ayurveda that are violated by 
the new products, viz., the logic of combination (Samyogam), processing (Samskaram), the form 
(Kalpana), processing (Pakam), and dosage (Matra), giving examples for each. One example is of a 
product in the market that combines two ingredients with contradictory characteristics. He says, “a 
patent product is normally prepared considering the active principle in each herb” which goes against 
ayurveda’s holistic perception of the herb’s properties (Vasudevan 2003:41). Ayurvedic manufacturers 
and practitioners in Kerala have little control over the meaning of the ayurvedic herb, of its use and 
efficacy that are being constantly changed by processes outside the ayurvedic commodity chain. 
Though common, the usage “ayurvedic herb” is inaccurate. It is important to note that a herb used in 
Ayurveda does not by default make it ayurvedic, it is the process and the logic behind the formulation 
which is ayurvedic. A herb has its own life outside the ayurvedic commodity chain, in other systems of 
Indian medicine, modern neutraceutical use, biomedical use and so on. Pharmacologists are constantly 
dissecting herbs in attempts to isolate constituents with pharmacological promise. The phytochemical 
industry aims at extracting the active ingredients to convert them to patentable and saleable phyto-
                                                 
519 Various forums on four national conferences that I attended during field work.   
520 Interview, Feb. 20, 2012 
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molecules. Bacopa monnieri (brahmi) is one of the most researched ayurvedic medicinal plants521, and 
naturally figures in numerous process and product patents. It is classified as belonging to the 
‘nootropic’ class of drugs (smart-drugs). The compounds responsible for the memory enhancing effects 
are identified as triterpenoid saponins called ‘bacosides’, especially bacoside A and bacoside B (Russo 
and Borrelli 2005).  
Extract technology has the potential to transform the ayurvedic commodity life of brahmi, by 
overcoming the problem of perishability and seasonality. Herbal extracts are in demand from various 
quarters, the cosmetic industry, food industry, and especially for exports. Despite abundant availability 
fresh herbs, extract industry in Kerala is pretty much invisible. Most of the large extract industries are 
located in North India, often owned by large raw drug suppliers for whom it serves as a highly 
profitable route to value addition. Arjuna and Elixir are among the few companies in Kerala that supply 
extracts, but very few ayurvedic manufacturers in Kerala accept brahmi or any other herbal extract in 
its new avatar. Some manufacturers have begun to use aquatic extracts, but restrict the use to making 
proprietary medicines. Industrial extraction has the potential to modify the end product in ways that 
may be difficult to establish equivalence. Since understanding the exact nature of a polyherbal product 
is beyond even the latest of chemical technologies, ayurvedic manufacturers prefer to keep the SOP 
constant and in line with traditional processes. It is common in ayurvedic medicine making to have 
different kinds of processes made of the same herb or combinations. For example, Dhanwantaram 
Kashayam is a water extract, whereas Dhanwantararishtam is an alcoholic (self-generated) extract. 
Modern extract technologies may use solvents that may be inconsistent with ayurvedic standards. In 
2008, AYUSH permitted the use of hydro-alcoholic extracts, an issue that remains contentious (Kamat 
2008). While some modern scientists feel that traditional processing leads to wastage, most ayurvedic 
manufacturers in Kerala are not sure whether the wastage is intended. The Chief of Technical Services 
of AVS, Dr. T S Muraleedharan  points out that use of extracts is incompatible with ayurvedic logic, 
There is no reason to believe that more of a certain set of ingredients is what causes the efficacy 
because of limitations of chemical tests in revealing the underlying nature of a polyherbal product 
whose efficacy is mainly based on synergy, we find it safe to stick to traditionally laid procedures.  
A different angle on extracts is presented by Dr. Ramesh Varier, the owner-MD of Arya Vaidya 
                                                 
521 A search for Bacopa in PubMed database gave 130 hits.  
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Nilayam, the pioneer in kashayam tablets. While prioritizing innovation in new production technology, 
he is at the same time firmly grounded in classical therapeutic tradition, trying to keep the interest of 
the practitioner in mind while adding value to the manufacturer’s role in new ways. Excited by what he 
saw in the Korean market which he recently visited, he says, “Each individual herb extract is available 
in the market, and just imagine having that here! It gives enormous power to the vaidyans, enabling 
them to formulate a medicine based on any permutation and combination”. He feels this is the right 
direction to go because it is a win-win situation for both manufacturers and practitioners. He says, 
“Industrial manufacturing has led to a situation where practitioners have lost control over ingredients 
and are in the danger of getting limited to the use of market-available standard formulations”.  
As for brahmi, its commodity life is highly likely to expand in this direction, if not within 
ayurvedic commodity chain, outside it, as part of various herbal concoctions ranging from  cosmetics to 
neutraceuticals. Today both in the Indian and international market, there are countless herbal 
products in the form of dietary supplements that sell standardized and modified extracts of brahmi. 
Sami Labs provides standardized extract called bacopin with minimum bacosides 20%, Avesthagen 
offers BacopaMax with 60% bacosides. For many modern phytomedicine and neutraceutical 
manufacturers, brahmi’s ‘ayurvedic origins’ are an important selling point. But what goes into the end 
product is a substantially modified extract which is standardized based on various active ingredients, 
resulting in a product whose ayurvedicness becomes questionable. To illustrate, let us look at the 
product BacoMind produced by Natural Remedies, a Bangalore based company herbal extract company.  
BacoMind(patent pending) is a clinically proven (both in elderly and children) enriched 
standardized phytochemical composition derived from the plant Bacopa monnieri, which is well 
known in Ayurveda as a “brain tonic”… launched after extensive research work by has scientific 
backup of multiple in vitro, animal and clinical studies to substantiate its beneficial effects as a 
cognition enhancer and in the management of age related neurodegenerative disorders. 
This product, standardized for nine different chemical constituents, provides extensive 
preclinical and clinical data to support the claims. The brochure  extols the ayurvedic origins of brahmi 
depicting an ancient sage writing on a palm leaf together with citations of verses from ancient 
ayurvedic texts are provided in one page. On another page, brahmi’s pharmacological prowess is 
demonstrated in modern pharmacological parlance, ‘agonist activation of 6 5-HT-1A receptors’ 
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‘activity modulation of acetylcholine release” and so on, buttressed with impressive graphics of 
chemical structures of each active ingredient. Through Baco Mind, brahmi enters products around the 
world, accompanied by strange herbs from far off lands. It is sold to people as an ‘ayurvedic 
ingredient’ in a product that has little to do with ayurvedic principles. An Australian company 
manufactures a product called ‘Mega memory: with BacoMind’ combining it with Gingko, Centella 
asiatica, piperine, alpha linoeic acid and vitamin E. The product page online declares, ‘BacoMind® is a 
patented extract of the popular ayurvedic brain herb brahmi’. A Canadian company sells a memory 
capsule called Solutions Mind that includes BacoMind, Ginseng and Gingko. Another Australian company 
simply sells BacoMind rebranded along with its name as ‘Ethical Nutrients Memory Booster.’ 
Ayurvedic companies are being persuaded to look at the active ingredient as a marker to 
ensure minimum standards of their products. The usual argument is that chemical parameters for 
quality become important when traditional principles of harvesting are not followed.  Classical texts 
have strict rules about harvesting, sometimes specific to the particular medicine preparation. For 
example, the brahmi for Saraswatarishtam is to be plucked on the Pooyam Nakshatram (a particular 
star), two hours before sunrise, in the Brahma Mahoorta (auspicious time in Hindu calendar522). Since 
such rules are not followed any more, it is argued that the herbs are highly variable in their medicinal 
content, and there is a need to use marker standardization to ensure reliability.  
 As of now, ayurvedic manufacturers are 
not bound to follow these, but those who target 
export markets or biomedical markets are 
already using such parameters. For example, 
Himalaya and Charak explicitly mention the 
active ingredient constituent in their product 
brochures. Charak’s Ostolief tablets addressing 
osteoarthritis is standardized for Boswellic Acid 
at 85% (See image). Even in relatively 
conservative Kerala, export-oriented manufacturers have taken the first steps in that direction. 
                                                 
522 Between 04:08 - 04:56 a.m, believed to be the time when the intellect is at its sharpest.  
Charak’s anti-arthritis therapy medicine 
standardized for 85% Boswellic Acid  
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Nagarjuna, in its export range sells its Nature Range “Gotukola” as a herbal supplement, standardized 
for Asiaticosides. Kerala Ayurveda Ltd. (KAL) has sent two products revised as per UFSDA  norms in 2008 
of which its brahmi product has been one (KAL 2009). These developments do portend forthcoming 
global standardization pressures. At the same time, Dr. K. Anil Kumar, Executive Director of KAL 
himself states the difficulty of exporting classical products, points out, “Many are  attempting to 
bypass the obstructions by exporting products based on single drugs. But remember! Any country can 
export herbal drugs. Only India could export authentic ayurvedic medicines. Ayurveda got its identity 
by using formulations that effectively reduced the side effects of single drugs (Kumar 2003:2).”  
The effect of such modifications are not necessarily limited to products. Demands for 
particular active ingredients could have repercussions on the plant itself. Though the average Kerala 
farmer is unfamiliar with the active ingredient market, the scientists at farmers’ workshops conducted 
by the Kerala agricultural university were seen talking about cultivars in terms of their constituent 
content. Regional Research Laboratory of Jammu has standardized a cultivar that has higher bacoside 
content. For companies like Himalaya that produces products with chromatographic fingerprinting, it 
makes practical sense to get into contract farming of cultivars with higher levels of the marker 
constituents.  In late 2008, brahmi along with three other ayurvedic herbs raked up controversy when 
agricultural scientists in Kerala announced success in creating a GM version of the herbs. A media 
report soon quoted a scientist at the department of AYUSH in Delhi.  
Scientists may pursue R&D on herbal plants but officially GM is not permitted in Ayurveda. 
Scientists believe in increasing a single positive attribute but Ayurveda insists on using the holistic 
character of a plant… (Dasgupta 2008).  
The GM approach to herb manipulation though seems appalling from an ayurvedic point of 
view, is a mere extension of the modern pharmacological interest in ayurvedic herbs as a source of new 
chemical entities. Just as agricultural scientists try to breed varieties with high bacoside content, 
genetic engineering of plants to increase necessary constituent parts or chemical constituents must 
have appeared as a logical next step to biotechnologists. After all, though the herbs are used in 
Ayurveda, herbs have their own identity outside these systems. One of the scientists involved in the 
genetic modification experiment, when asked about the research objective responded, 
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Bacosides A or B have been shown to be important  pharmaceutical molecules and we thought that 
if we could increase the Bacoside content of this plant it would be beneficial for the industry  to 
meet the demand for this molecule. Even today if someone could enhance either taxol or 
Campothecin content  even by 50% by any means it would be a great service to human society and 
also  to environment.  
The argument was logical within his line of inquiry, a pursuit he saw as not only beneficial to 
the industry but also a service to human society and environment. But the news of genetic  
modification of herbs rang alarm bells across the ayurvedic community. The heart of the alternative 
medicine or herbal business is the ‘pristineness’ the herb, pushing the industry towards more organic 
and natural. The expected role of science here is not to alter the herb but to ratify, explain and 
validate its utility. Later in The ayurvedic community’s objection to genetic modification became one 
of the important hurdles in the path of implementation of Bt-Brinjal given the use of wild relatives of 
brinjal in the production of ayurvedic medicines (for details see Kudlu and Stone 2003). The Kerala 
sentiment towards genetic modification is evident from the letter that Kerala Chief Minister 
Achuthanandan wrote to the Prime Minister. Apart from expressing worry that contamination from 
genetic modification could damage the trade prospects of the State in the international market, he 
pointed out that, “Kerala is also an important centre of diversity of medicinal plants and heritage of 
traditional medicines like ayurveda. Serious concern has already been expressed by the Ayurveda 
practitioners on GM research being undertaken on various crops.”  
It is the interest in chemical constituents of plants and the global neutraceutical market that 
has drawn a number of scientists, biotechnologists, pharmacologists and pharmacologists to the 
Ayurveda field. Though some attention has always been there, the upsurge in attention has been 
recent, 80% of the articles on Ayurveda in life sciences and chemistry have been post 2000523. This 
interest and attention, at the outset is welcomed by the ayurvedic community which feels finally 
esteemed for the value of its knowledge so far devalued. At the same time, there is also resentment 
following the gradual realization that the outsiders’ interest lies mainly in herbs or  chemicals based on 
herbs, not in the philosophy of Ayurveda, which is often discarded as obsolete and unscientific.  
In the Ayurveda Conference at Coimbatore, a Western speaker (see image below) who was 
trying to bring home the need for ayurvedic therapy to “satisfy the western approach to proof” was 
                                                 
523 Total number of hits in Google Scholar, out of 4450 articles returned, 3950 were post 2000.  
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challenged by an irate ayurvedic practitioner in the audience who objected to the imposing of western 
expectations and standards of what constitutes science.  
 
 
 
 
The speaker, visibly  taken aback, defended himself saying he was merely responding to 
ayurvedic interest in addressing the global market. He did not seem to realize that the ayurvedic 
community had various stakeholders and selling to the West was not necessarily a  universal objective 
among them. Likewise the dissenter also did not realize his challenge was pointless; the speaker was 
after all addressing a section of the Indian ayurvedic community that was trying to sell Ayurveda to the 
West. In fact, the key theme of the International ayurvedic Conference organized by Arya Vaidya 
Pharmacy, “Globalizing Ayurveda,” and the speaker was invited to aid in the project of ‘translation’ in 
the interest of a section of the ayurvedic industry which was eyeing the global market.  
After the initial euphoria, there is a slow realization that the glory of Ayurveda is being taken 
away by scientists from other streams, who begin to dictate terms to their Ayurveda fraternity, chiding 
them for being “conservative,” persuading them to be “open to science524.”An ayurvedic doctor who 
                                                 
524 Observed in several conference presentations by non-Ayurvedic scientists.  
 
An American scholar presenting at an ayurvedic Conference, Coimbatore, 2008: Background – 
collage of PowerPoint slide excerpts 
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recognizes this, vents his ire in his blog525,  
Scientists of other streams or fake practitioners of Ayurveda become the authoritative 
spokespersons of Ayurveda in high-end forums like seminars, symposiums, workshops or 
intellectual conclaves of other sort. This is a tragedy. We have academic experts as well as well-
versed practitioners of the system in plenty…..It should be realized that the number of decision-
makers or policy-makers of the governing systems of any era is a bare-minimum. Naturally the 
representatives of those systems which have irrefutable social presence get spontaneous entry 
into the cream of the policy-making camp. It should be admitted with disgrace that we have not 
achieved that stature yet. 
But historically ayurvedic practitioners have always been ready to take on the blame for the 
deterioration of Ayurveda on their own weak shoulders. The blogger points out,  
`The fault is not theirs but it is ours. Nobody else is to be blamed for this vacuum. We are 
responsible. This should change. We should start talking about our system without 
delay…Otherwise, the words aired as Ayurveda in front of the global audience will be fractional 
and biased. It is a disturbing reality that most of the Indian scientific community has limited or no 
exposure to our traditional knowledge systems. This is nothing connected with personal likes or 
dislikes. Our system of basic education is very much biased towards the western ‘scientific’ ideas 
and predictably, they consider ancient Indian knowledge systems as rituals, myths or pseudo-
sciences.  
9.8 Conclusion 
The discussion in this chapter has centered around new commodities, to use Appadurai’s terms, 
commodities ‘diverted’ from their regular ‘paths’. “The diversion of commodities from their customary 
paths always carries a risky and morally ambiguous aura…the spirit of entrepreneurship and that of 
moral taint enter the picture simultaneously (Appadurai 1986:27).”  This is true of all the diversions 
discussed in this chapter. Each diversion has a potential to distort existing practice while at the same 
time the potential to provide for innovations catering to emerging needs. Products capitalizing on the 
service market have been mainly inspired by the tourist market and its spin-off, the wellness segment. 
These diversions serve to provide new entrepreneurial opportunities, mainly leading to re-packaging 
and re-invention of traditional commodities. They are also characterized by a ‘morally ambiguous aura’ 
that has created much anxiety among traditional stakeholders, who respond in various ways by 
resisting, challenging and even creatively accommodating the diversions. Of the other diversions, the 
form change of classical medicines though controversial, is a minor issue and as of now, poses no threat 
to the original form. The expansion in OTC segment is new only to Kerala, but even here, they do not 
                                                 
525 http://sunethri.blogspot.com/2009/08/address-global-audience-needs-and.html 
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seem to pose a threat to the classical segment. The aura of moral ambiguity here is mainly surrounding 
the breach in advertisement ethics, a matter that is more a failure of the regulatory mechanism than a 
drastic diversion in the path of the classical commodity.  
Diversion towards the neutraceutical path however, can be more threatening, as it calls for  a 
modification of the commodity in terms of its content rather than just form. It is also a segment much 
likely to be affected by commercial logic, given its connection the flowing in of big capital. But here 
again, the actors that participate in the diversion are different, mostly natural extract firms, 
multinational neutraceutical and biomedical pharmaceutical companies (for example,  Pharma giants 
like Ranbaxy and Cadilla have recently entered the ayurvedic OTC segment). While it does carry a 
potential to distort the definition of ayurvedic medicine in a global context, its role in influencing the 
domestic ayurvedic market, as of now, is a distant threat. The most challenging to the traditional 
sector that the classical manufacturers need to watch for is the prescription medicine commodity. This 
was not the subject of discussion in this chapter because it is not a new trend; it is an old diversion 
whose role in Ayurveda in the larger national context is well established and has substantially 
challenged classical Ayurveda as elaborated by researchers Bode (2006, 2008) and Banerjee (2002, 
2009) (as discussed in Chapter 2). As of today, it is still a  minor segment in the domestic segment in 
Kerala, but there is a feeling that this could change. The AVS’s decision to launch prescription products 
breaking its century old single-minded commitment to the classical is indicative of this change. 
However, this does not give a clear indication of the extent of change in the domestic market because 
in the past decade, many Kerala manufacturers including AVS have been targeting markets in other 
parts of the country and are in turn being influenced by non-Keralite customers. Inside the Kerala 
market, the trajectory and significance of this change is closely tied to the prescription habits of 
ayurvedic practitioners, which is in turn closely linked to the skilling process, as was elaborated in 
Chapter 4. To estimate the extent of transition in Kerala, it is important to study both historic 
production profiles of manufacturers and prescription  practices of ayurvedic doctors.    
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CH 10 CONCLUSION 
The central focus of this dissertation has been the analysis of the distinctness of Kerala’s 
approach to commodifying Ayurveda. In investigating into the power of commodification in influencing 
the meaning of a cultural practice, we encountered a case of a cultural commodity  generating an 
alternative commodification model, subsumed within the ethos of its original cultural practice. This 
subculture of Ayurveda whose practice and consumption was limited to Keralites has catapulted to 
become an iconic representative of ‘authentic’ and ‘original’ Ayurveda in the past two decades of 
global tourist commodification of Ayurveda. This makes the analysis of the difference additionally 
significant. Was the difference responsible for the new wave of commodification? Will the hitherto 
preserved integrity continue to hold given that it is now the inspirational core of the new wave that has 
not only national but global dimensions? These are questions too broad to be answered here. Rather 
than providing answers, the dissertation attempts to bring attention to variables that have hitherto 
been unattended to.  
Recent anthropological research on commodities has been guarded in taking a normative view 
of commodification induced changes, consistent with the discipline’s fundamental position on the 
dynamism of culture. From this perspective, changes have been seen as creative re-inventions, a view 
that has informed the analysis of  commodification of various cultural commodities526 ranging from the 
mechanical reproduction of food (Bestor 2000) to the globalization of Congolese music (White 1998). In 
most human endeavors like music or art, commodification-driven diversions can be treated as creative 
reinventions. But unlike most elements of culture that are “mobile, mixable, unfettered” (Wilk 2000: 
18), medicine has parameters that makes reinvention problematic. Though meanings of health and 
disease are themselves open to renegotiation, concerns about ‘irrational distortion” (Leslie 1976) are 
also legitimate, and cannot be ruled out as being judgmental. This is because, unlike most commodities 
where traders play the role of “cultural brokers that engage in the management of meaning” (White 
1998), medicine has officially designated expert mediators – doctors  who are  bound by a professional 
                                                 
526While all commodities are cultural, cultural commodities are those “that can be distributed and sold as commodities, but 
which retain to some extent visible signs of the producer’s identity, be it national, cultural or individual” (White 2000). 
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code. In the context of ayurvedic commodification, concerns are often raised about commercial logic 
overtaking medical logic, of the commodifiable facets of the medical system overshadowing other 
facets; not much different from those raised with regard to biomedicine. But at the same time, it is 
important to remember that Ayurveda unlike biomedicine is not restricted to a narrow disease-centric 
approach to health and  is inclusive of dynamic areas of culture ranging from food to life style that 
provide the potential for creative reinventions.  
Keeping this complication aside, the analysis in the first part of the dissertation takes off from 
the concrete dimension of Ayurveda as represented by pharmaceuticals. I have demonstrated that the 
trajectory of commodification of ayurvedic pharmaceuticals in Kerala stands in stark contrast to that of 
rest of India with its focus on classical medicines as opposed to proprietary medicines. The significance 
of this difference lies in the fact that the former are ‘open-source knowledge based commodities” that 
do not allow intellectual property concentration and by virtue of being embedded in the Ayurvedic 
therapeutic context, limit the commodification potential of ayurvedic medicines. Ayurvedic industry 
elsewhere in India used the strategies of selling prescription and OTC products to circumvent the 
ayurvedic physician and the therapeutic context, that were “barriers to commodification” 
(Kloppenburg 2004). This led to the redefinition of the meaning and identity of ayurvedic commodities 
and to “diversions” that stretched its “commodity context” (Appadurai 1986). By maintaining the focus 
on classical medicines, the Kerala industry kept the ayurvedic physician within the loop and thereby 
helped in keeping the integrity of ayurvedic practice. Kerala’s deviation from the larger norm has been 
noticed but its significance ignored. It is either seen as an exception (Bode 2008) or as merely being 
slower on the path of commercialization (Harilal 2010). In fact, expecting the ayurvedic industry in 
Kerala to soon catch up with the national trend, Harilal expresses doubt on its continued survival as an 
integral therapeutic system. While acknowledging the winds of change blowing over Kerala, I argue 
that it is important to understand the uniqueness of Kerala’s trajectory of commodification, against 
the backdrop of which the change unfolding today can be better understood. I have further argued that 
it is this culture of integrated practice preserved in Kerala that provided the raw material and impetus 
for the new era of commodification that has unfolded in the past two decades. Triggered by western 
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tourist interest, Kerala’s Panchakarma” (a set of cleansing therapies) and related therapies, a classical 
tradition of Ayurveda that had fallen out of use in rest of the country, evolved to become the selling 
point of ayurvedic tourism. This eventually led to a radical change in the commodification of Ayurveda 
not only in Kerala, but in rest of India. In the process, Kerala evolved as a new inspirational core for 
Ayurveda in India, leading to the emergence of a brand Kerala in Ayurveda. The analysis of the 
commodity trajectory of Ayurveda in Kerala assumes special significance given its centrality to the very 
identity of Ayurveda today.  
In trying to analyze Kerala’s unique trajectory of industrial commodification, I have argued 
that manufacturers in Kerala had the “commitment factor” lacking among manufacturers elsewhere. 
Most of them derive part of their identity by their involvement in the treatment segment and are 
therefore governed by ‘practitioner logic’. AVS, the largest ayurvedic manufacturer in Kerala designed 
as a charitable trust, played a formative role and set the trend for “committed manufacturing”. 
Commercial logic was made subservient to ‘practitioner logic’. In view of keeping the integrity of 
clinical practice, the pharmacopeia was prioritized rather than individual viability of a particular 
medicine. This was made viable by the agency distribution model which provided an exclusive channel 
for the circulation of classical medicines bundled with doctor’s consultation.  
But at the same time it cannot be denied that this education-service-medicine model 
intentionally or unintentionally evolved to become a good ‘business plan’, which is not therefore free 
of the influence of commercial logic. However, the ‘irrational distortion’ Leslie predicted is less likely 
to occur in the context of therapy products, because of the fundamental difference between 
biomedicine and Ayurveda in the nature of knowledge that goes into the production of medicines. 
Ayurvedic medicine partly falls in the expert realm and partly in the popular realm. Even in the expert 
realm it is inherently not as commodifiable as biomedicine. In biomedicine, medicine making is not the 
doctor’s domain; drugs, and knowledge related to prescription of drugs, flow from centralized 
institutions to practitioners. Unlike biomedicine that relies heavily on privatized intellectual property, 
Ayurveda depends on a large body of open-source knowledge  based in classical texts and collective 
metis. The strength of classical medicines are that though they are in the expert realm, by virtue of 
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being open-source they are less centrally controllable. The knowledge of medicines and their making is 
part of the doctors’ skilling process over which industry has little control over. Unlike biomedical drug 
companies that produce both the product and associated knowledge, ayurvedic manufacturers take up 
only the lower order ‘processing’ function. By and large, rather than creating demand, they cater to 
existing demand that is shaped by historical collective culture of clinical practice.  
Hence, at the root of ‘commercial viability’ of the open-source model is the continuity of a 
cultural practice, the robustness of it I attribute to its historical evolution in Kerala as a ‘mass 
commodity’ in contrast to its elitist status elsewhere in the country.  Ethnographical evidence 
presented in Part Two shows that ayurvedic practice is pervasive in the popular culture of Kerala, that 
goes beyond medicines to preventive, restorative and rejuvenative regimens. The ethnography of the 
raw drug shop in Chapter 5 provides an index to this culture. The most salient of these are medicinal 
diet regimes that lie between the vague boundaries of food and medicine. The medicaments used for 
such purposes, that I collectively refer to as “traditional-popular formulations,” are based in widely 
distributed household knowledge. The centrality of the poly-herbal decoction, another distinct feature 
of the Kerala pharmacopeia, has made medicine making a household activity, in contrast to the 
mainstream Indian mineral-centric pharmacopeia that relegates medicine making to an expert realm. 
This also has an important implication for conservation. It connected people to ayurvedic ingredients 
and to their plant sources, thereby promoting the development of popular cultural stakes in medicinal 
resources in the commons. In Chapter 8, I have argued for the superiority of cultural stakes over 
economic stakes in long-term conservation of medicinal resources. However, for the forest-dwellers 
who are  the main suppliers of forest commodities, cultural stakes are derived from community-specific 
oral medical traditions unconnected to Ayurveda.    
Ethnographic evidence presented in Chapter 3 adds some historical explanation to Ayurveda’s 
mass commodity status in Kerala. It shows that unlike elsewhere in India where there remained a gulf 
between elite and popular Ayurveda, in Kerala, practitioners from various castes, religions and classes 
were found to be participating in a common practice tradition closely linked to classical texts. The 
regional State government, both pre-independent and post-independent, provided a policy 
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environment conducive to the continuity of this practice tradition. Continued State patronage for 
ayurvedic systems under the 19th Century State of Travancore not only provided financial support, but 
an environment favorable to indigenous knowledge systems. In addition, the post independent Kerala 
State played a proactive role in participating in manufacturing, therapy and education, providing a 
formidable counterbalance  to commodity forces by keeping Ayurveda affordable for the masses.  
If we attempt to identify stakeholders who have “the power to control the meaning of the 
commodity” (Radin and Sunder 2005:16) it is possible to discern some of the reasons for Kerala’s 
uniqueness. Though manufacturing industry is the biggest in terms of muscle power, in Kerala, the rest 
of the stakeholders (practitioners, academy, public and the State) continue to have a strong voice in 
the construction of the meaning and identity of Ayurveda. Elsewhere in India, the progressive 
weakening of practitioner power that began with colonial policies of delegitimization continued with 
post independence (Leslie 1969). The State’s privileging of the  “cultural authority of science” (Prakash 
1999: 3) created an environment in which both practitioners and the public moved away from 
indigenous medical systems, setting an environment conducive for deskilling.  In this milieu, the 
manufacturing sector emerged as the most powerful stakeholder, without a strong counterbalancing 
force to question its ways and means. 
I have argued that the turning point of commodification of Ayurveda in Kerala is the bottling of 
the decoctions following which the industry managed to persuade doctors and consumers to stop 
making medicines.  The resulting deskilling of consumers, as described in Part 2, is neither complete 
nor irreversible. It is important to differentiate between commodities like medicine that are in the 
expert realm which are more vulnerable to centralized control over meaning-making than commodities 
in the popular realm. Deskilling is less likely to be effective in circumstances where cultural habits are 
strong-rooted and knowledge and skills related to it are more distributed, like for instance in the case 
of food. “Even the largest behemoths of the food industry have to deal with the resistance and 
indifference of consumers, and the inherent contradictions of their tastes and demands...(Wilk 2000: 
20)” In the aftermath of the factory produced decoction, the home decoction making culture continues 
to co-exist. In fact, new solutions have emerged in the market that promise to aid in the process of 
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cooking decoctions at home. In the past decade, simple technological solutions have emerged that help 
in maintaining the identity of classical products while changing them to forms convenient and 
palatable. Commodification in this context, appears to aid the maintenance of a tradition that was 
otherwise facing extinction due deskilling.  
But at the same time, industrial production furthered the process of homogenization that was 
set in motion by modern institutionalization. The concept of metis i.e., local practical knowledge 
(Scott 1998) provided the analytical framework to comprehend ayurvedic knowledge in juxtaposition 
with pressures of homogenization. Concepts of ‘alienation’ (Marx 1876) and ‘deskilling’ (Stone 2007) 
further help in unpacking the nuances of the process of knowledge and skill loss that results from 
industrial commodification. I have argued in Part two that Ayurveda does have both static and changing 
components, and that the latter that is essentially metis is often shortchanged by the “hegemony of 
high-modernist science” (Scott 1998) which, in favor of universality and uniformity, exalts the former.  
In Chapter 4, I have argued that industrialized commodification distances practitioners from 
making medicines and thereby from associated cognitive processes that feed into innovation.  The 
result has parallels with agricultural deskilling which “is not the displacement of a static set of skills 
but rather the disruption of an ongoing process of skilling” (Stone 2007:73). Practitioners’ involvement 
in medicine making is important in keeping intact the cognitive processes (what I refer to as ‘thinking 
medicine’) that have hitherto contributed to the production of ayurvedic knowledge. Distancing them 
from medicine making also distanced them from plants and their sources. In Chapter 8, I have 
described how increased distance of producers from raw material contributes to a crisis in medicine 
quality and conservation. Ethnographies of index plants demonstrate the knowledge-intensive role 
played by fresh herb collector-aggregators who in the absence of a direct relationship between 
practitioners and raw material, wield enormous influence in shaping identities of medicinal 
ingredients.  
But in the context of practitioner deskilling, industry appears to be more a dependent than an 
independent variable. The most important factor in the deskilling of the practitioner I suggest is the 
weakening of the skilling process caused by the shift from a practice-centric gurukula system to a text-
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centric institutional format inimical to the transmission of collective metis. Deskilled practitioners 
provided the industry more room to expand; the industry merely furthered the process of deskilling by 
providing a convenient alternative. However, contrary to routine expectations of the industry 
benefiting from practitioner deskilling, the classical product based industry of Kerala appears to be 
suffering from its consequences. In a national conference in early 2012, the  General Secretary of the 
largest ayurvedic manufacturers’ association of Kerala raised an alarm with regard to poor quality of 
output of ayurvedic colleges, complaining that it was threatening the classical market. He warned that 
unless ayurvedic education was reformed, classical focused companies like his would be forced to shift 
their marketing strategies towards proprietary products. This substantiates the observation I made 
earlier — ayurvedic industry in Kerala makes products to cater existing demand, which has its 
foundation in practitioner knowledge of classical medicine. 
The situation that industry in Kerala is facing today is comparable to the national scene in the 
60s, when committed manufacturers were forced to switch from classical to other segments owing to 
the moving away of their client base. Is Kerala going in the same direction? Is Harilal’s (2010) portent 
of an impending threat to Ayurveda’s integrity in the lines of what happened in rest of India drawing 
close? What factors would tilt the scale in favor of proprietary medicines? It is beyond the scope of the 
thesis to answer these questions. However, I suggest that the difference between the ayurvedic milieu 
inside and outside Kerala has to be taken into account in addressing these questions. The difference is 
important because Ayurveda in Kerala provides a multi-stakeholder situation that offers more 
resistance to commodification than elsewhere in India. I have established that the Kerala 
manufacturers themselves are a different lot who give primacy to practitioner logic and have 
established a commercial model that continues to be viable. So much so that even new generation 
proprietary-focused companies adhere to the same model to earn respectability. Those who do not do 
this are considered unscrupulous “nouveau riche” (Agnivesh 2011). To some extent they are able to 
influence the market by creating new segments like cosmetics and aphrodisiacs that even traditional 
stakeholders have rushed in to participate. But they are fringe stakeholders in terms of identity; their 
potential for meaning making appears to be limited, as yet.  
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This being the case, I conjecture that the real threat is not from cosmetics or neutraceuticals 
as Harilal (2010) portends, which have more of an ‘expanding’ rather than ‘diverting’ influence, but 
from branded prescription medicines that can potentially displace classical medicines. The potential of 
such displacement is directly proportionate to consumer and practitioner deskilling. However, the 
Kerala classical manufacturing industry, instead of simply moving away to more lucrative pastures is 
innovating new ways to retain the classical market. On one hand, faced with the prospect of losing 
market due to practitioner deskilling, a section of the Kerala industry is taking proactive action to 
intervene in the skilling process. On the other hand, classical products are being repackaged and 
presented in new forms to stop consumers from straying away to other convenient and palatable 
alternatives.  
Adding a twist to the story, the post tourist ayurvedic market centered around service and 
therapy shows a potential to rekindle the classical market.  Unlike the industrial era of the past 
century, the commodification trajectory post tourist Ayurveda is no more linear and predictable. In  
Part 3, I have described a shift in ayurvedic market that can be called paradigmatic – the focus of 
commodification in the past two decades shifted not only from pharmaceuticals to services, but also 
from illness to wellness. This led to the revival of other aspects of Ayurveda that were neglected in the 
era of pharmaceuticalization. In Kerala, this led to the expansion of a seasonal wellness therapy 
(Karkidaka Sukha Chikitsa)  from an elite practice to a mass commodity. But in the rest of India, that 
had no history of such practice, Panchakarma centers spread like wild fire, creating new categories of 
wellness clinics and wellness consumers.  
In Kerala, it led to the further expansion of the therapy segment and made ayurvedic services 
an area for investment of new capital. The consequence is ironical; Ayurveda in Kerala which had 
escaped being governed by the commercial logic in the pharmaceutical era, now appears to have 
become inextricably caught in its web. The emergence of new consumers with unconventional 
expectations, together with non-ayurvedic stakeholders unfettered by practitioner ethos, has created 
the opportunity for numerous diversions, some of which appear to carve new “paths” for further 
commodification. This provides a climate conducive for “irrational distortions” like for instance, the 
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menu and package model of therapy vending. Ironically, Ayurveda’s subjective and individualized 
approach, makes it eminently commodifiable. In addition to this, unlike classical commodities that 
catered to knowledgeable insiders, Kerala Ayurveda is increasingly targeted to outsiders. The 
“commodity context” (Appadurai 1986) has been stretched to new geographies (outside Kerala) and 
new spaces (outside the doctor’s clinic). The “morally ambiguous aura” (Appadurai 1986) created in 
the wake of commodification of a cultural practice out of its traditional context makes way for 
diversions and reinterpretations that are often controversial. The inherent ambiguity of the 
fundamental attributes of ayurveda, (like for example, the concept of ‘enhancing health’, the 
subjectivity of individualized protocols, and so on) makes it difficult to draw a line between irrational 
distortions and creative re-inventions.  
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APPENDICES 
Appendix A:  Sample Details 
1. Manufacturing companies – representative and distinct features 
 Three represent the Arya Vaidya guru lineage (i.e., AVS alumni): AVS, AVP & AVN 
 Four represent the Ashtavaidyan family tradition: Vaidyaratnam, SNA, Vaidyamadham & Vaidyaraj 
 Two are owned by the Kerala State: Oushadhi and Ayurdhara Pharmaceuticals 
 Three represent historical proprietary focus: Kandamkulathy, Nupal & Kalan Pharmaceuticals. 
 Companies with professed traditionalist policies: Keraleeya Ayurveda Samajam & Vaidyamadham  
 Two new generation companies with non-conventional OTC focus: Ayu:care & Kunnath  
 Niche product companies: AVN for decoction tablets and Everest Pharma for decoction powders.  
 Ownership by religious organizations: Santigiri Ashram (Ezhava Hindu), Sahyadri (Christian 
missionary NGO) 
 Publicly listed companies: Nagarjuna Herbal Concentrates Ltd.  and Kerala Ayurveda Limited (KAL) 
 Treatment oriented production units: Vaidyamadham Vaidyasala and Nangelil Pharmacy 
 Other distinct features of companies selected:  
o Sitaram Ayurveda Pharmacy for being the first company to obtain Good Manufacturing Practice 
certificate. 
o Santigiri, distinct in their ownership of a raw drug franchisee.  
o Keraleeya Ayurveda Samajam and Vaidyamadham Vaidyasala for their historical professed ‘purist’ 
approach to modern commodification.  
o Traditional companies participating in tourist and post-tourist commodification: AVP, KAL and 
Kandamkulathy Vaidyasala  
o Companies with international joint ventures: SNA  (with Italy) and KAL (United States) 
o Chempenkulam Ayurveda Pharma, a small manufacturer in a tourist region, with tourist focused 
massage oil range. 
 
 
2. District wise classification of manufacturers, raw drug shops and retail ayurvedic agencies 
 Thrissur Ernakulam Idukki Kottayam Other districts Total 
Manufacturers 13 8 6   34 
Raw drug shops 3 4 8 1 
1 Wayanad 
1 TVM 
18 
Retail Ayurvedic agencies527 4 4 5   15 
 
  
                                                 
527 These included agencies of 4 large, 4 medium and 2 small manufacturers. 
 408 
 
3. Practitioners’ Sample 
 Of the 17 traditional practitioners, nine were from Idukki, two from Kottayam, four from Trichur 
and two from Ernakulam.  
 Specializations: four generalists, two single-root practitioners, two Marma specialists, one Kalari 
practitioner, three poison healers, two eye-specialists, one veterinarian, one pediatrician and one 
burn-cure vaidyan. Three of these were women. Two held ‘A’ class medical practitioners license 
issued by the government of Kerala. Of the rest, ten had registration numbers issued by 
practitioner guilds.  
 Nature of employment: Of the 16 degree-holding practitioners in the sample, three were 
government practitioners, one was employed by an agency, one employed by a hospital, two were 
independent consultants without agency, three were hospital owners and the rest six were owners 
of clinic cum manufacturer agency. Besides this, many other respondents in the manufacturing 
node were also practitioners.  
 The 9 Scheduled Tribe medical practitioners interviewed represented five communities. One each 
from the Kadar, Urali, and Kuruchiyar communities, two Muthuvans, and three Kanis. Seven of the 
Vaidyans were certified by KIRTADS. 
 The outside Kerala practitioner sample included 10 degree holding practitioners from various other 
parts of India and two Italian practitioners whom I met during Ayurvedic conferences.  
 
4. Students and Teachers: Break-up 
 Kerala Outside Kerala 
Government/aided 2 0 
Private 2 5 (3 Keralites) 
MD student 1 3 
Teachers 3 2 
5. Tourist node sample 
Classified by location  Classified by type  
Backwaters in 
Kumarakom, Kottayam 
6 Exclusive Ayurvedic resorts 3 (one owned by the State 
Fort Kochi, Ernakulam 
district 
5 
Small independent ayurveda 
centers 
5 
Thekkady hill resort, 
Idukki district 
3 Hotels with manufacturers’ tie-up 3 
Beaches – Kovalam, 
Varkala 
5 
wellness center with 
manufacturer’s tie-up 
1 
Interior regions 2 
hotels with small Ayurveda 
centers 
3 (one with tie-up with a local 
large hospital) 
  
Regular clinic cum spa in non-
tourist town 
1 
  Tourist therapy- centric places 
3 (1 by a large manufacturer, 
2 run by doctors) 
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6. List of office holders, government and non-government 
 Directors of the State Ayush Directorate, 2006-2011 
 Director of Department of Ayurvedic Medical Education (DAME) 
 State Ayurvedic Drug Controller and Drug Inspectors   
 CEO and other officers of State Medicinal Plant Board,  
 Director of Kerala Pharmacognosy Department 
 Tourist officer, Calicut 
 Two members of CCIM (Central Council for Indian Medicine) from Kerala 
 Forest conservator of Idukki and two other forest officials 
 Chairman and other staff of SCST Federation 
 Researcher scientists at  Medicinal and Aromatic Plant Research Institute, Odakkali  
 Director of KIRTADS, Kerala Institute for Research Training and Development Studies of 
Scheduled Castes & Scheduled Tribes 
 Director of  Indian Institute of Panchakarma.  
 CEO of Ayurvedic industrial cluster (CARE) in Trichur  
 The General Secretary of AMMOI- Ayurvedic Manufacturing Association of India 
 Two General Secretaries of AMAI - Ayurvedic Medical Association of India, the largest 
practitioner association of Kerala 
 The ex-General Secretary of ADMA - Ayurvedic Drug Manufacturers Association, the largest 
national manufacturers association (and also member of Executive Committee of Pharmexcil)  
 General Secretary of Ayurvedic manufacturers, Karnataka who is also the Director of National 
Consortium of Ayush Industrial Clusters.  
 
7. List of Conferences/workshops observed/participated during fieldwork 
 International conference on Ayurveda and Arogya Expo in Coimbatore, Aug. 21-25th 2008 
 3rd World Ayurveda Congress and Ayurveda exposition in Jaipur, 16-21 December 2008  
 Global Ayurveda Business Summit in Kochi, 25-26th March, 2010 
 Arogya Industrial Exposition, 11th-15th February, 2009, Thrissur 
 Kerala, 4th World Ayurveda Congress and exposition in Bangalore, 9-13th Dec. 2010 
 Global Ayurveda Festival, Kerala 9th-14th Feb. 2012 in Trivandrum, Kerala. 
 All Kerala Ayurvedic Manufacturers Annual Meeting, Thrissur, August 1-2, 2009 
 Ayurvedic Manufacturers’ meet to discuss the Clinical Trial Draft Bill, Thrissur, Feb. 14, 2009 
 A state wide protest march by Ayurvedic doctors and students, Feb. 26, 2008. 
 Ayurvedic pharmaceutical manufacturing workshop, Aug. 2008. 
 National Workshop for Standardizing Panchakarma in Thrissur, 5-6 Feb, 2010. Cheruthuruthy, 
Kerala. 
 Ayurvedic academic seminar, Kottakkal Arya Vaidya Sala, Ernakulam, Oct. 12, 2008  
 Ashtanga Satram, a  symposium focusing on the recital of classical Ayurvedic text Ashtanga 
Hridayam, Dec. 13-30, 2009, Kanyakumari.  
 Two Kerala Ayurveda Mandalam meetings in Kochi. 
 State level meet of Parmparya vaidyans, Feb.8, 2009, Kochi 
 State level meet of Ayurvedic paraprofessionals, July 22, 2009, Palakkad 
 An Ayurveda medical camp, Ernakulam 
 Kerala Travel Mart at Ernakulam, an international tourism marketing event organized by the 
Travel industry. 23-26 2010, Kochi. 
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Appendix B: Profiles of Ayurvedic pharmaceutical agencies 
1. AN town 
These are representative of the three common categories, an exclusive franchisee of a large 
manufacturer, franchisee of a medium sized pharmacy run combined with the raw drug business, and 
an outlet of a local doctor-manufacturer hailing from a traditional Vaidya family. 
The agency of Arya Vaidya Sala (AVS) is run by an Ayurvedic doctor couple. They stock around 250 
medicines in sufficient quantity and a bottle or two to represent the rest of the pharmacopeia (AVS 
makes around 530 classical medicines). Around 70% of the medicines sales is driven by prescription, Of 
the remaining 30%,  around half are repeat patients. The most common medicines bought over the 
counter are 3-4 wines, mainly digestives and tonics, 3-4 oils used for hair care, joint pains and post 
delivery care, and 3-4 decoctions.  They stock no non-AVS medicine, as is expected of AVS franchises; 
agencies of other manufacturers have the liberty to stock non-competitive products of other 
companies.  
The agency of Kandankulathi, a medium sized pharmacy based in central Kerala, is run by a raw drug 
shop keeper. Given the increasing consumption of finished medicine by people, he found it a wiser 
move to expand his net; finished medicine now constitutes 30 % of his sales. Since it was difficult for 
him to get an agency of a large pharmacy, he chose a medium sized pharmacy with local reputation. 
He does not have a doctor for consultation, mainly because of a space constraint. Prescription sales 
account for half the turnover of finished medicines. He stocks a number of ethical and proprietary 
products of North Indian companies that are pushed by distributors. These are kept on credit, on the 
condition that they be taken back if unsold. He also sells semi-processed medicines, mainly decoction 
mixes manufactured by two local micro level companies. Common products in this category are 
mixtures meant to treat urinary calculi and hemorrhoids.  
Aravind Pharmacy, a small traditional pharmacy, is the oldest in the town. The doctor-owner of the 
pharmacy inherited it from his father who was a diploma holding traditional practitioner. He makes 
around 150-200 classical medicines for use in treatment. Given the scale of his practice, he does not 
find it viable to make rare medicines, which patients buy from the agency of their choice. His shop is 
located on a main road near the bust stand, as a result of which 30% of his sales come from walk-in 
customers. He does not make any proprietary medicine nor stock any proprietary medicines of other 
manufacturers.  
2. PS village 
The franchisee of Vaidyaratnam, one of the top five Kerala manufacturers, is run by a middle-aged 
man who returned after a few years of working in the Middle East. He wanted to invest some of his 
savings in a safe and comfortable business. He stocks around 200 classical medicines in the shop. He 
also has a dozen proprietary medicines, which are mainly sold on prescription. In general, he said 50% 
were sold on prescriptions and rest appear to be repeat prescriptions. “They have to be, because but 
for a handful that are popular, rest are not known to people, and anyway consultation is free, so 
people don’t worry about  meeting the doctor.” A doctor comes twice a week for consultation. The 
doctor who works at five other clinics is a beginner, and is yet to establish himself.  
Owner of the traditional pharmacy in the old junction was reluctant to speak. This I learnt later was 
because it was an establishment run by a traditional practitioner family, but did not have a doctor in 
this generation. In such cases, the license would be usually in the name of an absentee doctor. This 
pharmacy made around 150 classical medicines, and a couple of traditional proprietary medicines. 
They also sold a few proprietary medicines of various other companies, mainly those that were pushed 
by local distributors.  Despite the presence of agencies of large manufactures, the pharmacy survived 
on the trust and good will built over generations. In fact, despite the small scale and absence of 
doctor, the owner had found it meaningful enough to go for a Good Manufacturing Practice (GMP) 
certification by the Ayurvedic Drug Controlling authority.  
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Appendix C: Treatment Protocol on Chikungunya management 
(Example for complexity of Ayurvedic diagnostic and treatment protocol) 
 
Developed by the State Epidemic Cell of the Ayurvedic Medical Association of India (AMAI), 
a Kerala based Ayurvedic practitioners’ association 
Important: Information(s) on this page are from Ayurveda Medical Association of India and are 
intended for qualified ayurvedic physicians only. 
(I)  Three point management approaches should be adopted 
(i) Acute management   (ii) Post fever arthralgia management  (iii) Prevention 
(II) In acute Phase (2-3 days) the following symptoms can be seen 
(i) Sudden onset of fever Up to 39 to 40°C   (ii) Intermittent shaking chills     (iii) Headache   (iv) 
Nausea, vomiting   (v) Joint pain with or without swelling      (vi) Low back pain   (vii) Rash    (viii) May 
remit for 1-2 days & then return"saddle back" fever curve  
(III) In this stage the following medications are found very effective 
(1)In fever and pain 
(i)  Amrutharishtam + Punarnavasavam 20-30 ml tds 
(ii) 2 Vettumaran gulika with Ginger juice and Honey tds 
(iii) 2 Sudarsanam gulika tds   (iv) Sudarsanachoornam ¼ tsp with  30 ml Amrutharishtam tds   (v) 2 
Mukkamukkadukadi gulika tds 
(vi) 2 Sooryaprabha gulika with Ginger juice tds 
(vii) Amruthotharam kashayam with 2 Vettumaran tds 
(viii) Godanthi bhasmam 200mg with honey bd   
(2) In nausea and vomiting    
(i)Thaleesapathradi vatakam sos    (ii) ½ Vilwadi gulika with honey tds 
(iii) Vilwadi lehyam sos   (iv) 2 Dhanwantaram gulika with shadamgam tds 
(v) Water boiled with [a. dhanyakam   b. sunti   c. ela]   (vi) Water boiled with Guloochi stem   (vii) 
Tender coconut water   (viii) Medicine contained  Bhoonimba are found very effective in all cases.  
Thrisun tab is also found effective in acute fever 
(IV) Formula to make fever reducing drug suggested by Dr Unnikrishnan (Note: Dr Unnikrishnan is 
Professor in Dept of  Pharmacology, AVC, Tvpm) 
(i) Godanthi bhasmam 100mg + Sudarsanachoornam 100 mg + Guloochi extract 5ml + Vettumaran 
100mg 
(V) Dhoopanam 
(i) Aparajitha dhoopachoornam should be fumed in the room of the patient.  It will stimulate the 
resistance of the patient against the infection. It is not meant for mosquito eradication. 
(ii) Mustard, Neem leaves, Induppu (Saindhavam) and little ghee 
(iii) Gulgulu, Akil, Chenchalyam, Vayambu, Kadukka, Neem leaves, Inthuppu and little ghee 
(VI) In the post fever Arthralgia, following are the general symptoms; 
(i) Polyarticular, migratory   (ii) Predominantly affect small joints of Hands, wrists, ankles and feet, 
with less involvement of larger joints     (iii) Pain on movement [a. worse in the morning   b. improved 
by mild       exercise   c. exacerbated by strenuous exercise]   (iv) Swelling may occur but       fluid 
accumulation is uncommon    (v) Generalized myalgias, back & shoulder     pain - common   (vi) 
Swelling of feet   (vii) Achilles tendonitis 
In this stage Ayurvedic management should be designed in accordance with Dosha predominance. We 
grouped the symptoms as follows; 
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1) Vata predominant symptoms 
(i) Polyarthralgia with minimal inflammation - In this condition the following medicine can be given; 
(i) Dashamoola kashayam   (ii) Balapunarnavadi kashayam   (iii) Indukantham         kashayam   (iv) 
Yogarajagulgulu   (v) Shaddharanam   (vi) Karpooradi thailam      (local application)   (vii) Formula for 
fresh decoction [ a. Guloochi 6 parts  b. Musta 4 parts   c. sunti 2 parts]   (viii) IP management [a. 
upanahasewdam      b. dhanyamladhara   c. naleeswedam with tulasi leaves, manual] 
(2) Pith predominant symptoms 
(i) Patechial maculo papular rashes    (ii) Desquamation in feet, testes,  vulva etc   (iii) Oral lesions   
(iv) Par aesthesia   (v) Restlessness   (vi) Apathy   (vii) Confusion 
In this condition the following medicine can be given: (i) Guloochyadi kashayam   (ii) Punarnavadi 
kashayam   (iii) Amruthagulgulu     (iv) Chandraprabha   (v) Formula for fresh decoction (a. Guloochi 6 
parts b. bhoonimbam 4 parts   c. sunti 2 parts)   (vi) Jadamayadilepachoornam local     (vii) IP 
Management (a. lepam) 
(3) Kapha predominance symptoms 
(i) Swellings of legs, feet, nape, wrist joints etc     (ii) Cervical and inguinal lymph adenitis 
 In this condition the following medicine can be given -(i) Gulguluthikthakam kashayam    (ii) Varanadi 
kashayam     (iii) Raasnasapthakam kashayam    (iv) Gokshuradigulgulu     (v) Simhanadagulgulu    
(vi) Formula for fresh decoction [a. Guloochi 6 parts -  b. amalaki 4 parts   c. musta 2 parts]    
(vii) IP Management [a. valooka       swedam  (manal kizhi)   b. dhanyamladhara   c. naleeswedam] 
      In all cases Sallaki preparations are found very effective 
(VII) Diet 
  (1) Dos -     (i) Light food like kanji   (ii) Yoosha of mudga, kulatha   (iii) Vegetable curry  with low oil 
and coconut [ a. carrot   b. koval   c. snake guard (padavalam)      d. kaipa (bitter guard)   e. muringa 
(drum stick)   f. amara (beans)]   (iv) small  fishes   (v) bread    (vi) Drinking water [a. sunti   b. pepper   
c. dhanyakam      d. kattu thulasi] 
  (2) Donts -     (i) Leafy vegetables   (ii) Uzhunnu (Black gram)   (iii) Curd   (iv) Banana  (v) Sour 
substance   (vi) Big fishes   (vii) Meat   (viii) Heavy foods  (ix) Oily foods 
(VIII) Prevention: According to the principles of prevention in Janapadodhwamsaneeya Vyadhi a single 
remedy can be given to all. The following drugs are selected for prevention 
  (1) Medication 
(i) Indukantham kashayam   (ii) Sudarssanam gulika (iii) Mukkamukkadukadi gulika   (iv) Vilwadi gulika    
(v) Rajanyadi choornam (children)  (vi) Indukantham ghrutham (children) 
  (2) Mosquito eradication  
(i) Decoction of tobacco leaves with neem oil and soap   (ii) Garlic juice spray  (iii) Dhoopam [a. 
mustard, neem leaves, inthuppu (saindhavam) and little ghee 
      b. gulgulu, akil, chenchalyam, vayambu, kaduku, neem leaves, inthuppu and  little ghee] 
(IX) Mandatory lab tests 
     (i) Blood routine   (ii) Bleeding time, Clotting time, Platelet count      (iii) Viral assays   (iv) ASO, RA, 
TSH, LFT 
(X) Most found complications 
     (i) Thyroiditis   (ii) Loss of libido   (iii) Profuse loss of scalp hair      (iv) Hyper pigmentation   (v) 
Menstrual cycle irregularity   (vi) Lethargy 
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Appendix D: Ayurvedic Pharmacology: Basic concepts 
1. The classificatory system of objects based in Vaisheshika 
Charaka Samhita accepts the Vaisheshika view that world is made up of six Padarthas (objects of 
experience), but each of these are described  differently in the context of application to medicine.  
i. Substance(Dravya): The only one category that is independent by itself is  the substance, which 
forms the substratum on which the five others are built.  Charaka defines substance as that which 
possesses quality and action in relation to inherence and is also the inseparable material cause of 
all effects. There are nine such substances, the Panchabhutas, that is five elements,  earth, water, 
fire, air, ether and four other substances, time, space, manas (mind), and atma (self)   
ii. Quality (Gunas): Charaka classifies qualities into sensible (sound, touch, color, taste and smell) 
and physical qualities are classified into Guruvadya Gunas and Paradya Gunas. Guruvadya Gunas 
are twenty, listed on ten dimensions.  
Paradya Gunas (Physico-pharmacological qualities) 
Aparadya Gunas (Para-
pharmacological qualities) 
Continuum Gunas (Qualities) Gunas (Qualities) 
Weight Guru Laghu Heavy Light Paratva Priority/proximity 
Temperatur
e 
Sheeta Ushna Cold Hot Aparatva 
Inferiority/unimporta
nce/remoteness 
Emolliency Snigdha Rooksha 
Moist/Unc
tuous 
Dry Samyoga Conjunction 
Intensity Manda Tikshna Slow/dull intense Vibhaga Disjunction 
Fluidity Sthira Chara Stable Mobile Yukti Reason 
Rigidity Mridu Kathina Soft Hard Prthaktva Individuality 
Adhesion Vishada Picchila Clear Sticky Parimana 
measurement by 
weight 
Texture Shlakshna Khara Smooth Rough Samskara Transformation 
Density Sookshma Sthoola Subtle Gross Abhyasa Habit or Practice 
Viscosity Sandra Drava Solid Liquid   
 
iii. Activity (Karma): Five kinds of movements are listed, upward, downward, contraction, expansion 
and movement in general. All kinds of karmas rest on substances, and cause the things to which 
they belong to move.  
iv. Generality(Samanya): stands for the property that tends to make certain things to be regarded as 
similar; hence the common   characteristic belonging to many individuals.  
v. Particularity (Vishesha): The presence of that what makes a thing diverse. Vishesha serves the 
purpose of differentiating one individual substance from another and also distinguishing itself from 
all other things.  It is the basis of exclusion. 
vi. Samavaya: The inseparable relation of inherence is a relation by virtue of which two different 
things (Padarthas), such as substance and attribute, substance and movement, substance and 
Samanya, Substance and Vishesha, cause and effect, all appear so unified that they represent one 
whole inseparable reality, and appear to the onlooker as one and the same thing.  
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2. List of Karmas according to Charaka Samhita 
 
1. Jeevaniya   (Invigorators) 
2. Brimhaneeya   (Nourishing drugs) 
3. Lekhaniya   (Reducing corpulence) 
4. Bhedhaneeya   (Cathartics) 
5. Sandhaneeya   (Healers of wound)   
6. Deepaniya   (Digestive stimulants)   
7. Balya   (Strength Promoters)   
8. Varnya (Complexion Promoters)   
9. Kantya   (Useful for throat)    
10. Hrudya   (Cardiac tonics)    
11. Tripthighna   (Removes the sense of Pseudo 
contentment)    
12. Arshoghna   (Anti-haemorroidals)    
13. Kushtaghna   (Curatives of all skin diseases):    
14. Kandooghna   (Anti pruritic)    
15. Krimighna   (Anti- infective)    
16. Vishaghna   (Anti-toxic)    
17. Sthanyajanana   (Galactogogue)    
18. Sthanya shodhana   (Galacto-purificator)    
19. Shukrajanana   (Spermatopoitics)    
20. Shukra Shodhana   (Spermato purificator)    
21. Snehopaga   (Adjuvants of unction)    
22. Swedhopaga   (Adjuants of fomentation)    
23. Vamanopaga   (Adjuvants of emesis)    
24. Virechanopaga   (Adjuvants of purgation) 
25. Asthapanopaga   (Adjuvants of decoction 
enema  
26. Anuvasanopaga   (Adjuvants of oil enema)    
27. Sirovirechaneeya   (Adjuvants of for 
elimination of Doshas from the head)   
28. Chardinigrahana   (Anti emetics)    
29. Thrusna Nigrahana (Thirst restraining drugs)    
30. Hikkanigrahana   (Anti- Hiccup)    
31. Pureeshasangrahaneeya   (Anti – Diarrhoeal) 
32. Pureeshavirajaneeya   (Bowel Anti- discoloring 
agents)    
33. Moothra Sangrahaneeya   (Anti diuretics)    
34. Moothravivarjaneeya   (Urinary anti- 
discoloring agents):    
35. Moothravirechaneeya   (Diuretics)    
36. Kasahara   (Antitussives)    
37. Swaasahara   (Broncho dilators)    
38. Swayathuhara   (Anti inflammatory / curatives 
of edema)    
39. Jwarahara   (Anti pyretics)    
40. Sramahara   (Fatigue relievers)    
41. Dahaprashamana   (Curatives of Burning 
syndrome)    
42. Sheethaprashamana   (Curatives of cold)    
43. Udardaprashamana   (Curatives of urticaria)      
44. Shoolaprashamana   (Antispasmodics)    
45. Angamardhaprasamana   (Bodyache relievers)    
46. Sonithastapana   (Blood purifiers)    
47. Vedanasthapa   (Analgesics)    
48. Sangnasthapana   (Restoratives of 
consciousness)    
49. Prajasthapana   (Anti-abortificiants 
or procreators)    
50. Vayahasthapana   (Rejuvenators) 
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Appendix E: Differences in Pharmacopeia: North Indian Vs Kerala Ayurvedic manufacturers 
 
 
Categories of formulations in terms of % of the total classical pharmacopeia 
 
Non-Kerala manufacturers Kerala manufacturers 
 
Dabur Baidyanath SDL Avg AVS AVP VR 
Nagarjun
a 
Oushadhi Sitaram SNA Avg 
 
large large large 
 
large large large large Large medium medium 
 
Decoctions 2 0 2 1.5 16 15 15 16 14 19 22 17 
Medicated oils 10 13 0 7.5 28 37 26 26 36 27 24 29 
Ayur. Vines 15 12 12 13.1 9 10 12 13 12 13 13 12 
Medicated 
ghees 
1 3 0 1.6 9 0 11 9 20 9 10 10 
Medicated jams 5 0 1 1.8 9 8 7 11 
 
9 8 9 
Powders 7 10 6 7.7 8 8 18 7 
 
10 13 11 
Tablets 9 8 8 8.3 12 17 9 12 14 8 9 12 
Distillates 0 1 0 0.5 
        
Guggulu-based 2 5 11 6.0 
        
Ointments 
       
1 
   
1 
Reiterations 
    
3 
   
3 
  
3 
 
100 100 100 100.0 100 100 100 100 100 100 100 100 
Mineral 
Preparations 
47 48 61 51.9 9 5 1 0 3 0 1 3 
Total Classical 214 269 133 205.3 483 393 439 322 293 351 269 364 
 
 
  
0.0 
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20.0 
30.0 
40.0 
50.0 
60.0 
NK-avg 
K-Avg 
 416 
 
9.9 Appendix F: Pharmacological Attributes of Index Herbs 
 
 
 
 
Rasa/ 
Taste 
Guna/ 
Quality 
Virya/ 
Potenc
y 
Vipaka/ 
Post-
digestive 
effect 
Karma/ 
Action 
Source 
Sida 
cordifolia 
(atibala) 
closest to 
Kerala’s 
bala (See 
section 7.2.4) 
Madhura 
(sweet) 
Pichila 
(sticky), 
Snigdha 
(unctuous) 
Sheeta 
(cold) 
Madhura 
(sweet) 
Ameliorate Pitta and Vata, 
anti-diarrheal, sperm 
promoting,  complexion 
promoting, vigor promoting, 
and strength promoting 
API 2008 
Part 1 
Volume 3. 
Pp: 110-111 
Kattupadava
lam/ 
Trichosanthe
s anguina 
Tikta 
(bitter) 
Laghu 
(light) 
Snigdha 
(unctuous) 
Ushna 
(hot) 
Katu 
(pungent) 
appetizer, digestive, 
germicidal, laxative, 
aphrodisiac 
Sivarajan and 
Balachandran   
1994, Pp.370-
371 
Koovalam/ 
Aegle 
marmelos 
fruit pulp 
Katu 
(pungent) 
Tikta 
(bitter) 
Kashaya 
(astringent) 
Laghu 
(light) 
Rooksha 
(dry) 
 
Ushna 
(hot) 
Katu 
(pungent) 
 
Appetizer, digestive… 
Alleviates Vata and Kapha, 
strengthening 
API 2008 
Part 1 Volume 1 
Pp. 35-36 
Koovalam/ 
Aegle 
marmelos 
Root 
Madhura 
Laghu 
(light) 
Sheeta 
(cold) 
Madhura 
(sweet) 
Mutrala (diuretic), 
Tridosaghna, (alleviates 
tridoshas) 
API 2008 
Part 1 Volume 3 
Pp. 29-31 
Koovalam/ 
Aegle 
marmelos 
Stem bark 
Tikta 
(bitter), 
Kashaya 
(astringent)
Madhura 
(sweet) 
Teekshna 
(sharp) 
Rooksha 
(dry) 
Laghu 
Ushna 
(hot) 
Katu 
(pungent) 
Deepaniya, Kaphahara, 
Vatahara, Sangrahi, Pittakara, 
Vishaghna 
Appetizer, Alleviates Vata and 
Kapha, accumulative, anti-
poison 
API 2008 
Part 1, Volume 4 
Pp.13-14 
Njavara/ 
Oriza sativa 
Kashaya 
(astringent)
Madhura 
(sweet) 
Anuras 
Laghu 
(light) 
Snigdha 
(unctuous)
, Mridu 
(soft) 
Sheeta 
(cold) 
Madhura 
(sweet) 
Hrdya, Pittahara, Ruchikara,  
Cardiac, alleviates Pitta, 
tasty, anti-poison, mildly 
increases Pitta and Kapha, 
fattening, good for voice 
API 2008 
Part 1 Vol.3 
Pp. 182-183 
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Appendix G : Traditional Healers certified by KIRTADS 
KIRTADS certified senior healers 
 Shankaran Vaidyan, a Urali Vaidyan in his 70s now had also a thriving consultation and he had even 
established two centers in two different places. Though highly reputed and extremely successful, 
he lost money due to mismanagement. A raw drug agent who used to supply medicinal material to 
him said, that in his hey days Shankar’s weekly purchase would amount to around Rs 60,000 ($1200) 
of raw material. His production cost was not that high, around Rs 15-16 a bottle of medicinal oil 
which he sold for Rs 30-40 “Not a bad margins, but you know about their (tribal people’s) 
capability in handling money (implied incapability), so all the profit he made went down the 
drain”. 
 Muthu Vaidyan, a Muthuvan Vaidyan’s residence is in interior Idukki, by the side of a state highway 
which does attract a regular clientele, but his practice is low key compared to the others. But he 
has widely traveled, worked in tribal camps made friends with mainstream Vaidyans and talks much 
about the exploitation of tribal medicinal knowledge by others  
 Eeswaran Kani Vaidyan is a 55 year old tribal healer who practices in Njaraneeli, a small village 
between Vithura and Palode, on the inner layer of the main road. He was one of the faculty 
members in the KIRTADS training program and was designated as a Chief Tribal Healer. He has a 
waiting room with 20 seats, along with a pharmacy counter to dispense medicines. He is highly 
reputed and he gets a lot of patients from Trivandrum city. An aluminum framed glass fabricated 
cubicle for the doctor with a hip modern ceiling. Local people are used to cars and jeeps bringing 
wealthy plains patients to their village. During the interview, a patient came in a hired taxi from 
Trivandrum, that would have cost them Rs. 600 ($12) for the transport.   
 Appukuttan Kani Vaidyan is perhaps the only tribal healer with a full-fledged inpatient hospital. 
This 83 year old who was designated as Chief Tribal Healer in the KIRTADS program was exposed to 
medicine from the age of 7 collecting herbs for his grandfather was a Plathi (officially designated 
tribal healer). His hospital is housed in a modern concrete building with tiled flooring. The nine bed 
hospital built with a grant of 4 lakh from government has 9 beds and two steam rooms and one 
Dharapathi. He has two three people to assist him, run the steam bath make medicines etc. he also 
get help in collecting medicines 
 
KIRTADS trained young healers 
 Among the young healers, the most successful is Rajesh Vaidyan from Kuruchiyar who joined the 
program after a 12th standard education. He gets reportedly around 300 visitors an average on a 
day. The clinic had 40 pluckers to make medicines and the herbs were collected from around the 
forest. When I asked the pharmacy assistant if I can take a photograph of the premises, “you can 
take photos for yourself, but please don’t publish it anywhere” and then he explained, “We are 
already struggling to deal with the crowd and we really don’t want more people to come”.  
 
 Mokshadayakan Vaidyan is a KIRTADS alumni, a 33 year old Kani practicing in Vithura town near 
Trivandrum. He moved from an interior location to the town owing to popular demand to near 
town. Besides prescribed medicines, he has also some oils, herbal juices and decoctions for sale. 
He also has a traditional steam bath outside his house for which he charge 200 per session. He puts 
around 66 herbs into the water; the steam is made to pass through for about 20 to 30 minutes 
during the treatment based on the health of the patient.  
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Appendix H: Kattupadavalam Farming: Three Vignettes 
1. Collective farming of kattupadavalam: Lakkam Kudi, a Muthuvan hamlet  
Lakkam Kudi is located on the top of a hill which is 2000 ft. vertical climb from the Lakkam junction on 
the interstate highway between Munnar and Marayur. The community consists of  46 families of 
Muthuvan tribe who are collectively farming kattupadavalam. They are unfortunate to live in a 
protected sanctuary where the only  forest products they are able to access is wild yam and honey. 
Being located right in the middle of a protected forest, they are not involved in MFP collection The 
only cash bringing source was an aromatic medicinal grass, a native of this habitat called Inchipullu 
i.e., Citronella (Cymbopogon flexobus). Though it is used in Ayurvedic medicine, its extract is more in 
demand from the cosmetic industry. During harvest they distil around 2 to 2.5 liters of the oil per day 
which they sell to the GSCS at a price of Rs 550 ($11) per liter.  
They are familiar with kattupadavalam as a forest creeper, but it was not part of their own 
pharmacopeia. The MPSC had given them the saplings and the know-how, motivating them to try it out. 
They have been told to avoid using any fertilizer or pesticide. Some of them own cows, so they use the 
dung to fertilize.  All they had to do was to provide some support for the creepers to climb. They 
harvest the whole plant 1.5-2 ft from above the root, during the month of January, after the plant 
fruits and ripen enough for replanting. An agent from the society comes with a pickup truck to collect 
harvested material. In the last harvesting season (in the winter of 2008) they got 50,000 rupees from 
500 plants. Given the distance from the forest and the ease of cultivation, it works out more profitable 
to grow kattupadavalam than collect. They would have to had to spend one whole day wandering 
around the forest just to collect 10 kilograms.   
Krishnan Vaidyan, now in his early 70s earned his livelihood as a watcher in the forest. He gives an 
overview of the health care resort pattern of the community. They do use medicinal herbs for home 
remedies. There are also two traditional vaidyans left in the hamlet who treat minor complaints like 
stomach upset, cold, mild fever, sprain and so on. For everything else they go to the hospital. Earlier 
vaidyans would treat factures, but not anymore. The Tata Tea Co. which employs a number of workers 
from this community provide free medical facility to the whole community. He said, “now our medicine 
does not have any effect because of the effects of English medicine”. 
2. Profile of an individual kattupadavalam farmer  
Ayyappan, a young Muthuvan who lives in outskirts of Marayur village. Being a mason by profession, he 
earns double the wages of an unskilled wage laborer. He is therefore more well to do than the average 
tribal, and owns four small parcels of land, each 0.1 to 0.15 acres.  He used to cultivate some tubers 
and vegetables on the land in the hill slopes, till the collection agent of the society introduced him to 
kattupadavalam. He was familiar with the plant, having been to the forest for a number of times to 
collect. Three years ago, (i.e. sometime in 2005-2006) he brought a few seeds that he not only planted 
in his own property but also in a few common spaces like the dry bed of a seasonal brook. He is 
delighted with the plant’s success. Without any additional work or input, he managed to earn Rs 20,000 
($400) from the total harvest in a season, equivalent to his two months income from  masonry work. 
Within three years he has found some of the plants to be more luxuriant, he proudly shows off the 
seeds that he has saved from those plants to make his next crops more successful.   
3. Profile of a non-tribal medicinal plant farmer cum forest produce collection agent  
I met Muthaya when he came to sell kattupadavalam to the Devikulam GSCS. His stock included some 
of his farm produce and also material collected from other farmers. Being a large farmer who owned a 
Jeep, which he also used for running rental  taxi services he automatically became a collection agent 
for farmers in the remote  village of Thalayar. His farm has a veritable collection of medicinal plants 
that naturally grow in the region. He has been involved in the collection of medicinal plants since the 
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year 1976. He grew medicinal plants earlier in small numbers like many other farmers with land, for 
household purpose. But he eventually realized that it made sense to grow plants that fetched a good 
price and had a long harvesting window. This was possible only because as a trader he was in touch 
with the market and knew the nature and source of demand. He would limit or expand the space for 
farming depending on market fluctuations. Two medicinal plants he found most profitable were 
Chittaratha (Alpinia calcarata/galangal) and Vayambu (Acorus calamus). Both plants were dispersed 
randomly in his multi-crop farm, not occupying much space but ready to spread further if the market 
demands. Last year he harvested around 300 kilograms of Chittaratha for which he got a price of Rs 42 
per kg.  He also harvested a ton of Vayambu for Rs 15-20. This year there was no market for either of 
them. Talking about kattupadavalam he said, “It is the easiest plant to grow, though it’s germination 
rate is poor. From 1000 seeds, you get 100 plants of which 25 will survive. But from those 25 plants, I 
got 120 kg. dry matter, sold at Rs. 90 a kilo. Though the income may not be as high as cash crops like 
cardamom, growing the plant hardly needs any labor.” 
 
Appendix I: Sample Ayurveda Wellness Package 
Rejuvenation Package: Ayurvedashram, Trichur 
Description  7 Days  14 Days  21 Days  28 Days  
Abhyangam  3  3  5  8  
Steam bath  1  1  1  1  
Ksheera Dhara  2  2  2  2  
PPS  3  3  6  6  
Thakradhara  1  1  3  3  
Shirodhara   3  3  7  
Kati/Snehavasti   3  3  2  
Avagaham  2  2  5  5  
Njavaratheppu  3  3  3  3  
Ksheeradhoomam  1  1  1  1  
Kativasthi   3  3  2  
Njavarakizhi   3  5  5  
Pizhichil   3  3  7  
Dhanyamla Dhara    2  2  
Herbal Facial  1  1  1  1  
Virechanam   1  1  1  
Note: These treatments are subject to change after direct consultations with our physicians.   
Our all inclusive cost including pickup / drop from/to Kochi airport plus accommodation and food on 
single occupancy as also on twin sharing basis for one person are as under: 
 
7 Days  14 Days  21 Days  28 Days  
Single Occupancy  US $ 800  US $ 1300  US $ 1800  US $ 2300  
Twin Sharing  US $ 650  US $ 950  US $ 1200  US $ 1400  
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Appendix J Medical infrastructure in Kerala and India 
1. Public Medical Institutions in Kerala 
  Institutions Beds 
Patients treated 
in 2006 (in lakhs) 
Patients treated 
in 2007(in lakhs) 
  2006 2007 2006 2007 IP OP IP OP 
1 Allopathy 1279 1279 45405 45553 23.0 461.77 20..27 468.11 
2 Ayurveda 871 871 3940 4020 0.57 209.9 0.50 222.47 
3 Homoeopathy 561 561 1170 1170 0.21 127.6 0.25 135.33 
 Total 2711 2711 50515 50743 23.78 799.27 21.02 825.91 
Source: Government Survey Data, from Directorate of Ayurveda, Trivandrum. 
 
2. Private Medical Institutions in Kerala 
  1986 1995 2004 
1 Modern Medicine 3565    4288 4825 
2 Ayurveda 3925 4922 4332 
3 Homeopathy 2078 3118 3226 
4 Others 95 290 535 
 Total 9663 12618 12918 
 
Source: Economic Review of Kerala,  2009 
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3.  Ayurvedic institutions in India: Statewise Statistics 
 
Source: Annual Report, 2008, Department of Ayush, New Delhi. 
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Appendix K Ayurvedic Conferences and associated Ayurvedic Industrial Expositions 
  
International conference on Ayurveda and Arogya Expo in Coimbatore, Aug. 21-25th 2008 
 
 
3rd World Ayurveda Congress and Ayurveda industrial exposition in Jaipur, 16-21 December 2008  
  
Global Ayurveda Business Meet and Industrial Expoosition in Kochi, 25-26th March, 2010 
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Arogya Conference and Industrial Exposition, Thrissur, 11th-15th February, 2009 
  
Kerala, 4th World Ayurveda Congress and Industrial Exposition in Bangalore, 9-13th Dec. 2010 
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Global Ayurveda Festival, Kerala 9th-14th Feb. 2012 in Trivandrum, Kerala. 
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GLOSSARY 
 
Allopathy/allopathic = term used to refer to biomedicine in India 
Angadi/Angadi marunnu = raw drugs (The literal meaning of Angadi is ‘market’) 
Arishtam = self-generated alcoholic medicine preparation (with boiled ingredients) 
Arogyapacha (Trichopus zeylanicus) = the plant that was internationally famous for benefit=sharing 
agreement 
Asavam = self-generated alcoholic medicine preparation (with raw ingredients). 
Ashtanga Hridayam = the last of the compendiums in the compendium triad, C.7th century CE written 
by Vagbhata. Significant because it is the foundation text of classical Ayurvedic practice in Kerala. 
Ashtavaidyan tradition = medical tradition shared by 18 Namboothiri brahmin families who claim to be 
the first to learn Ayurveda from the Buddhist physician=scholar Vagbhata (C. 600 CE). Only eight of 
these families are extant. 
Bala = Sanskrit drug name for the Malayalam kurunthoti.  
Bilva = Sanskrit drug name for the Malayalam koovalam. 
Brahmi = Bacopa monnieri, an index plant  
Charaka Samhita = the first known Indian classical medical compendium, part of the compendium triad, 
C. 1st BCE 
Chikitsa = treatment 
Choornam/Churnam = powder, adjective used to refer to medicinal powder. 
Classical medicines = medicines based on officially approved classical texts as per the Drugs and 
Cosmetics Act 1940. Classical products need not be registered, they have to carry the name of the 
reference text on their labels.  
Decoction tablet = decoction converted to tablet 
Dhara = pouring of liquid (oil, milk, buttermilk, etc.) over the body. Hence, Shirodhara, pouring over 
head.   
Dosha = humor, also used to refer to a imbalance of the humor. There are three humors, Vata, Pitta 
and Kapha, together termed Tridosha. 
Ethical medicines = Term used in Indian market to refer to prescription (Rx) medicines 
Ezhava = a historically marginalized caste in Kerala, professionally toddy-tappers, known to be closely 
associated with traditional medical practice 
Federation = used to refer to SCST Federation, nodal agency of medicinal plant collection in Kerala. 
Ghritam = ghee, adjective used to refer to ghee=based medicine preparations  
Gulika = pill  
Gurukula = residential master-disciple mode of education taking place in the Guru’s house or in a space 
attached to Guru’s house. 
Jeevani = The product made with Arogyapacha  
Kalari =  the gym where Kalari is taught 
Kalari-Marma Vaidyan= practitioner who combines the knowledge of Kalari and Marmam 
Kalaripayattu = martial art tradition of Kerala 
Karkidaka Kanji = medicinal rice=porridge consumed during the Karkidakam season. 
Karkidakam = last month in the Malayalam calendar during the peak monsoons (Mid July to mid 
August). The season  recommended for wellness treatment and for medicinal diet regimes. This is also 
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the time considered ideal to read scriptures, and hence also called Ramayana Masam (the month of 
Ramayana) 
Kashayam = decoction 
Kashayam tablet= decoction converted to tablet 
Kattupadavalam = Trichosanthes cucumerina, an index plant  
Keraleeya = of Kerala (like in Keraleeya Panchakarma) 
Keralite = term used to denote residents of Kerala. 
Kizhi = bolus massage 
Koovalam  = Aegle marmelos, an index plant  
Kurunthoti = Sida rhombifolia spp. retusa, an index plant 
Kuzhambu  = thick oil, meant for topical application 
Lehyam = medicinal jam-like preparations, literally ‘lickables’ 
Malayalee = term used to denote residents of Kerala, based on the local language  
Malayalam = language of Kerala 
Manipravalam = Ancient Malayalam, in vogue up to 16 the century.  
Marma = pressure point 
Marmam/Marma Vaidyam = specialized branch of medicines that is based on the theory of pressure 
points. 
Marunnu = medicine 
Namboothiri = Community of Brahmins native to Kerala. 
Njavara  = a variety of medicinal rice, Oriza sativa spp., an index plant 
Njavara Kizhi = bolus massage with medicinal rice, Njavara 
Open-source = knowledge based in documents that are open to all for use and experimentation. 
Orientalists = term denoting the British who favored indigenous knowledge, education and languages 
during the colonial period.  (as opposed to anglicists= British who favored anglicization of India)  
Ottamooli practitioner = ‘single-root’ practitioner, practitioner who specializes in giving medicine to a 
narrow range of ailments (mainly urinary problems, hemorrhoids, migraine). Unlike other generalist 
traditional practitioners they are not considered to be learned in theoretical knowledge and are 
secretive about their medicines. 
Pacha Marunnu = fresh raw drugs 
Panchakarma = a class of five cleansing therapies.  These include therapeutic vomiting (vamana), 
Purgation (virechana), nasal application of medicine (nasya), enema (vasti) and blood-letting using 
leeches or incisions (rakta-moksham). 
Paramparya = traditional 
Paramparya vaidyan = traditional vaidyan, a popular usage for those who have learnt their knowledge 
in a traditional system, either from Gurukula or from family members. 
Pashchatkarma = class of procedures meant to be followed after the administration of Panchakarma. 
Petti Marunnu = dry raw drugs (Petti means box, raw drug shops typically have box with 64 
compartments) 
Poorvakarma = preparatory procedures for Panchakarma, classified into two: Oleation (snehana) and 
Sudation (swedana).   
Proprietary ayurvedic medicines = new formulations registered with the regional drug controller. 
Rasa = has several meanings. Used in the text to mean taste or mineral preparation.  
Rasayana = rejuvenation, rejuvenative.  
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Sahasrayogam = literally ‘thousand formulations’, a popular Malayalam practitioner’s hand book of 
unknown antiquity. 
Samhita = compendium 
Sarngadhara Samhita = master classic on pharmacology, dated to 13th century CE. 
Scheduled caste/tribe = Scheduled Caste and Tribes are designated communities in the constitution 
(Article 366 (25), who are protected with policies of positive discrimination as they are considered 
historically marginalized. While there is some overlap, typically scheduled caste members are 
untouchable communities within the Hindu fold, whereas Scheduled Tribe members are those who 
were historically secluded from the mainstream, and mainly lived in endogamous groups in hilly regions 
and forests.  
Sushruta Samhita = the second medical compendium, part of the compendium triad 
Siddha =  One of the five recognized Indian systems of medicine, based in Tamil Nadu, South India. 
Sukha Chikitsa = wellness treatment 
Tailams  = oils  
Traditional knowledge = knowledge acquired through informal social networks.  
Traditional medicines/formulations = medicines based in popular tradition 
Traditional practitioner = the practitioner who has acquired medical knowledge outside modern 
institutions, either through family members or Gurus (as opposed to institutionally trained).  
Traditional stakeholders = those who have been historically involved in the Ayurvedic segment either as 
manufacturers or as therapy service providers.  
Traditional-popular formulations = a term I use to refer to a range of formulations based in popular 
seasonal and  post delivery diet regimes, they may or may not have a textual track record.  
Tribal = member of the Scheduled tribes 
Unani = Unani is a product of a marriage between Persian and Indian medicine, often considered to be 
Islamic medicine as opposed to Ayurveda which is considered Hindu. 
Vagbhata = Author of the last compendium, Ashtanga Hridayam, assumed to have been a Buddhist sage. 
Vaidyan/Vaidya: Though this is an umbrella term for a practitioner of any system of medicine including 
biomedicine, it is typically used to refer to practitioners of indigenous systems of medicine. It is used 
in the dissertation to refer to ayurvedic doctors who are informally trained (licensed or unlicensed) in 
contrast with those who are institutionally trained. 
Vaidyashala = pharmacy, where medicines are made and sold. 
Vati = Pill  
Velan = a Scheduled caste community in Kerala which traditionally specialized in pediatrics 
(Balavadiya) 
Vishavaidya = Poison healer 
Yogam  = Formulation 
Yukti = Reason/reasoning 
 
 
